Gene/Locus,Gene/Locus_name,Gene/Locus_MIM_number,Phenotype,Phenotype_MIM_number,Inheritance,Comments,Gene
"DEL1p36, C1DELp36",Chromosome 1p36 deletion syndrome,607872,Chromosome 1p36 deletion syndrome,607872,IC,contiguous gene deletion syndrome,DEL1p36
"ISG15, G1P2, IFI15, IMD38",ISG15 ubiquitin-like modifier,147571,Immunodeficiency 38,616126,AR,-,ISG15
"AGRN, CMS8",Agrin,103320,"Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects",615120,AR,-,AGRN
"TNFRSF4, TXGP1L, OX40, ACT35, IMD16","Tumor necrosis factor receptor superfamily, member 4",600315,?Immunodeficiency 16,615593,AR,mutation identified in 1 IMD16 family,TNFRSF4
"B3GALT6, SEMDJL1, EDSSPD2","UDP-Gal:beta-Gal beta-1,3-galactosyltransferase polypeptide 6",615291,"Ehlers-Danlos syndrome, spondylodysplastic type, 2",615349,AR,-,B3GALT6
"B3GALT6, SEMDJL1, EDSSPD2","UDP-Gal:beta-Gal beta-1,3-galactosyltransferase polypeptide 6",615291,"Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures",271640,AR,-,B3GALT6
"DVL1, DRS2",Dishevelled 1 (homologous to Drosophila dsh),601365,"Robinow syndrome, autosomal dominant 2",616331,AD,-,DVL1
"ATAD3A, HAYOS","ATPase family, AAA domain-containing, member 3A",612316,Harel-Yoon syndrome,617183,"AD,AR",one family with AR inheritance reported,ATAD3A
"TMEM240, C1orf70, SCA21",Transmembrane protein 240,616101,Spinocerebellar ataxia 21,607454,AD,-,TMEM240
"GNB1, MRD42","Guanine nucleotide-binding protein, beta polypeptide-1",139380,"Leukemia, acute lymphoblastic, somatic",613065,-,-,GNB1
"GNB1, MRD42","Guanine nucleotide-binding protein, beta polypeptide-1",139380,"Mental retardation, autosomal dominant 42",616973,AD,-,GNB1
"GABRD, GEFSP5, EIG10, EJM7","Gamma-aminobutyric acid (GABA) A receptor, delta",137163,"{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}",613060,AD,-,GABRD
"GABRD, GEFSP5, EIG10, EJM7","Gamma-aminobutyric acid (GABA) A receptor, delta",137163,"{Epilepsy, idiopathic generalized, 10}",613060,AD,-,GABRD
"GABRD, GEFSP5, EIG10, EJM7","Gamma-aminobutyric acid (GABA) A receptor, delta",137163,"{Epilepsy, juvenile myoclonic, susceptibility to}",613060,AD,-,GABRD
"SKI, SGS",Avian sarcoma viral (v-ski) oncogene homolog,164780,Shprintzen-Goldberg syndrome,182212,AD,formerly mapped to 1q22-q24,SKI
"PEX10, NALD, PBD6A, PBD6B",Peroxisome biogenesis factor 10,602859,Peroxisome biogenesis disorder 6A (Zellweger),614870,AR,-,PEX10
"PEX10, NALD, PBD6A, PBD6B",Peroxisome biogenesis factor 10,602859,Peroxisome biogenesis disorder 6B,614871,AR,-,PEX10
"PRDM16, MEL1, LVNC8, CMD1LL",PR domain-containing protein 16,605557,"Cardiomyopathy, dilated, 1LL",615373,AD,-,PRDM16
"PRDM16, MEL1, LVNC8, CMD1LL",PR domain-containing protein 16,605557,Left ventricular noncompaction 8,615373,AD,-,PRDM16
"SMIM1, VEL",Small integral membrane protein 1,615242,"[Blood group, Vel system]",615264,AR,-,SMIM1
"CEP104, GLYBP, KIAA0562, JBTS25","Centrosomal protein, 104kD",616690,Joubert syndrome 25,616781,AR,-,CEP104
"NPHP4, SLSN4",Nephrocystin 4,607215,Nephronophthisis 4,606966,AR,-,NPHP4
"NPHP4, SLSN4",Nephrocystin 4,607215,Senior-Loken syndrome 4,606996,AR,-,NPHP4
ESPN,"Espin, mouse, homolog of",606351,"Deafness, autosomal recessive 36",609006,AR,-,ESPN
ESPN,"Espin, mouse, homolog of",606351,"Deafness, neurosensory, without vestibular involvement, autosomal dominant",-,-,-,ESPN
"PLEKHG5, KIAA0720, DSMA4, CMTRIC","Pleckstrin homology domain-containing protein, family G, member 5",611101,"Charcot-Marie-Tooth disease, recessive intermediate C",615376,AR,-,PLEKHG5
"PLEKHG5, KIAA0720, DSMA4, CMTRIC","Pleckstrin homology domain-containing protein, family G, member 5",611101,"Spinal muscular atrophy, distal, autosomal recessive, 4",611067,AR,-,PLEKHG5
"CAMTA1, KIAA0833, CANPMR",Calmodulin-binding transcription activator 1,611501,"Cerebellar ataxia, nonprogressive, with mental retardation",614756,AD,-,CAMTA1
SCZD12,Schizophrenia 12,608543,{Schizophrenia 12},181500,AD,max lod at D1S1612,SCZD12
"PER3, FASPS3","Period, Drosophila, homolog of, 3",603427,"?Advanced sleep phase syndrome, familial, 3",616882,AD,mutation identified in 1 FASPS3 family,PER3
"DJ1, PARK7",Oncogene DJ-1,602533,"Parkinson disease 7, autosomal recessive early-onset",606324,AR,-,DJ1
"SLC45A1, DNB5, IDDNPF","Solute carrier family 45, member 1",605763,Intellectual developmental disorder with neuropsychiatric features,617532,AR,-,SLC45A1
"RERE, NEDBEH",RE repeats-encoding gene,605226,"Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart",616975,AD,-,RERE
"H6PD, GDH, G6PDH, CORTRD1",Hexose-6-phosphate dehydrogenase,138090,Cortisone reductase deficiency 1,604931,AR,digenic triallelic mutations with HSD11B1,H6PD
"PIK3CD, APDS, IMD14","Phosphatidylinositol 3-kinase, catalytic, 110kD, delta",602839,Immunodeficiency 14,615513,AD,-,PIK3CD
"NMNAT1, NMNAT, PNAT1, LCA9",Nicotinamide nucleotide adenylyltransferase 1,608700,Leber congenital amaurosis 9,608553,AR,-,NMNAT1
"KIF1B, CMT2A, CMT2A1, NBLST1",Kinesin family member 1B,605995,"?Charcot-Marie-Tooth disease, type 2A1",118210,AD,mutation identified in 1 CMT2A1 family,KIF1B
"KIF1B, CMT2A, CMT2A1, NBLST1",Kinesin family member 1B,605995,Pheochromocytoma,171300,AD,-,KIF1B
"KIF1B, CMT2A, CMT2A1, NBLST1",Kinesin family member 1B,605995,"{Neuroblastoma, susceptibility to, 1}",256700,"AD,IC",-,KIF1B
"PEX14, PBD13A",Peroxisome biogenesis factor 14,601791,Peroxisome biogenesis disorder 13A (Zellweger),614887,AR,-,PEX14
"TARDBP, TDP43, ALS10",TAR DNA-binding protein,605078,"Amyotrophic lateral sclerosis 10, with or without FTD",612069,AD,"pseudogenes on 2, 6, 8, 13, 20",TARDBP
"TARDBP, TDP43, ALS10",TAR DNA-binding protein,605078,"Frontotemporal lobar degeneration, TARDBP-related",612069,AD,-,TARDBP
MASP2,Mannan-binding lectin serine protease 2,605102,MASP2 deficiency,613791,AR,-,MASP2
"MTOR, FRAP1, SKS",Mechanistic target of rapamycin,601231,"Focal cortical dysplasia, type II, somatic",607341,-,-,MTOR
"MTOR, FRAP1, SKS",Mechanistic target of rapamycin,601231,Smith-Kingsmore syndrome,616638,AD,-,MTOR
"UBIAD1, TERE1, SCCD",UbiA prenyltransferase domain-containing protein 1,611632,"Corneal dystrophy, Schnyder type",121800,AD,-,UBIAD1
"MAD2L2, MAD2B, FANCV","Mitotic arrest-deficient 2, S. cerevisiae, homolog-like 2",604094,"?Fanconi anemia, complementation group V",617243,AR,mutation identified in 1 FANCV patient; pseudogene on 14q21-q23,MAD2L2
MTHFR,Methylenetetrahydrofolate reductase,607093,Homocystinuria due to MTHFR deficiency,236250,AR,-,MTHFR
MTHFR,Methylenetetrahydrofolate reductase,607093,"{Neural tube defects, susceptibility to}",601634,AR,-,MTHFR
MTHFR,Methylenetetrahydrofolate reductase,607093,"{Schizophrenia, susceptibility to}",181500,AD,-,MTHFR
MTHFR,Methylenetetrahydrofolate reductase,607093,"{Thromboembolism, susceptibility to}",188050,AD,-,MTHFR
MTHFR,Methylenetetrahydrofolate reductase,607093,"{Vascular disease, susceptibility to}",-,-,-,MTHFR
"NPPA, PND, ANP, ATFB6, ATRST2",Natriuretic peptide precursor A,108780,"Atrial fibrillation, familial, 6",612201,AD,-,NPPA
"NPPA, PND, ANP, ATFB6, ATRST2",Natriuretic peptide precursor A,108780,Atrial standstill 2,615745,AR,-,NPPA
"PLOD1, LH1, LLH, EDSKCL1","Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase)",153454,"Ehlers-Danlos syndrome, kyphoscoliotic type, 1",225400,AR,-,PLOD1
"MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B",Mitofusin 2,608507,"Charcot-Marie-Tooth disease, axonal, type 2A2A",609260,AD,-,MFN2
"MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B",Mitofusin 2,608507,"Charcot-Marie-Tooth disease, axonal, type 2A2B",617087,AR,-,MFN2
"MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B",Mitofusin 2,608507,Hereditary motor and sensory neuropathy VIA,601152,AD,-,MFN2
"CTRC, CLCR",Chymotrypsin,601405,"{Pancreatitis, chronic, susceptibility to}",167800,AD,-,CTRC
CLCNKA,"Chloride channel, kidney, A",602024,"Bartter syndrome, type 4b, digenic",613090,DR,11kb from CLCNKB; simultaneous mutation in CLCNKA and CLCNKB,CLCNKA
CLCNKB,"Chloride channel, kidney, B",602023,"Bartter syndrome, type 3",607364,AR,unequal crossingover with CLCNKA,CLCNKB
CLCNKB,"Chloride channel, kidney, B",602023,"Bartter syndrome, type 4b, digenic",613090,DR,-,CLCNKB
"EPHA2, ECK, CTPP1, CTPA, ARCC2, CTRCT6",Ephrin receptor EphA2,176946,"Cataract 6, multiple types",116600,AD,-,EPHA2
"ATP13A2, PARK9, KRPPD, SPG78","ATPase, type 13A2",610513,Kufor-Rakeb syndrome,606693,AR,mutation identified in 1 family with CLN12,ATP13A2
"ATP13A2, PARK9, KRPPD, SPG78","ATPase, type 13A2",610513,"Spastic paraplegia 78, autosomal recessive",617225,AR,-,ATP13A2
"SDHB, SDH2, SDHIP, PGL4, CWS2","Succinate dehydrogenase complex, subunit B, iron sulfur (Ip)",185470,Cowden syndrome 2,612359,AD,1 of 2 polypeptides,SDHB
"SDHB, SDH2, SDHIP, PGL4, CWS2","Succinate dehydrogenase complex, subunit B, iron sulfur (Ip)",185470,Gastrointestinal stromal tumor,606764,"AD,IC",-,SDHB
"SDHB, SDH2, SDHIP, PGL4, CWS2","Succinate dehydrogenase complex, subunit B, iron sulfur (Ip)",185470,Paraganglioma and gastric stromal sarcoma,606864,-,-,SDHB
"SDHB, SDH2, SDHIP, PGL4, CWS2","Succinate dehydrogenase complex, subunit B, iron sulfur (Ip)",185470,Paragangliomas 4,115310,AD,-,SDHB
"SDHB, SDH2, SDHIP, PGL4, CWS2","Succinate dehydrogenase complex, subunit B, iron sulfur (Ip)",185470,Pheochromocytoma,171300,AD,-,SDHB
"PADI3, UHS1","Peptidylarginine deiminase, type III",606755,Uncombable hair syndrome,191480,AR,-,PADI3
"PADI4, PADI5, PAD","Peptidylarginine deiminase, type IV",605347,"{Rheumatoid arthritis, susceptibility to}",180300,-,-,PADI4
"PADI6, PREMBL2","Peptidylarginine deiminase, type VI",610363,Preimplantation embryonic lethality 2,617234,AR,-,PADI6
"PAX7, RMS2",Paired box homeotic gene-7,167410,"Rhabdomyosarcoma 2, alveolar",268220,AR,fused with FKHR in rhabdomyosarcoma,PAX7
"ALDH4A1, ALDH4, P5CDH","Aldehyde dehydrogenase 4 family, member A1 (delta-1-pyrroline 5-carboxylate dehydrogenase)",606811,"Hyperprolinemia, type II",239510,AR,-,ALDH4A1
"EMC1, KIAA0090, CAVIPMR","Endoplasmic reticulum membrane protein complex, subunit 1",616846,"Cerebellar atrophy, visual impairment, and psychomotor retardation",616875,AR,-,EMC1
"PLA2G2A, PLA2B, PLA2L, MOM1","Phospholipase A2, group IIA, platelets, synovial fluid",172411,{Colorectal cancer},114500,AD,-,PLA2G2A
"PLA2G5, FRFB","Phospholipase A2, group V",601192,"[Fleck retina, familial benign]",228980,AR,-,PLA2G5
"PINK1, PARK6",PTEN-induced putative kinase 1,608309,"Parkinson disease 6, early onset",605909,AR,-,PINK1
"DDOST, OST, OST48, CDG1R",Dolichyl-diphosphooligosaccharide-protein glycosyltransferase,602202,"?Congenital disorder of glycosylation, type Ir",614507,AR,mutation (cmpd het) identified in 1 CDG1R patient,DDOST
ECE1,Endothelin converting enzyme 1,600423,"?Hirschsprung disease, cardiac defects, and autonomic dysfunction",613870,AD,mutation identified in 1 HCAD patient,ECE1
ECE1,Endothelin converting enzyme 1,600423,"{Hypertension, essential, susceptibility to}",145500,Mu,-,ECE1
"ALPL, HOPS, TNSALP","Alkaline phosphatase, liver/bone/kidney",171760,"Hypophosphatasia, adult",146300,"AD,AR",-,ALPL
"ALPL, HOPS, TNSALP","Alkaline phosphatase, liver/bone/kidney",171760,"Hypophosphatasia, childhood",241510,AR,-,ALPL
"ALPL, HOPS, TNSALP","Alkaline phosphatase, liver/bone/kidney",171760,"Hypophosphatasia, infantile",241500,AR,-,ALPL
"ALPL, HOPS, TNSALP","Alkaline phosphatase, liver/bone/kidney",171760,Odontohypophosphatasia,146300,"AD,AR",-,ALPL
"HSPG2, PLC, SJS, SJA, SJS1",Heparan sulfate proteoglycan of basement membrane (perlecan),142461,"Dyssegmental dysplasia, Silverman-Handmaker type",224410,AR,-,HSPG2
"HSPG2, PLC, SJS, SJA, SJS1",Heparan sulfate proteoglycan of basement membrane (perlecan),142461,"Schwartz-Jampel syndrome, type 1",255800,AR,-,HSPG2
"CDC42, TKS","Cell division cycle 42 (GTP-binding protein, 25kD)",116952,Takenouchi-Kosaki syndrome,616737,-,-,CDC42
"WNT4, SERKAL","Wingless-type MMTV integration site family, member 4",603490,?SERKAL syndrome,611812,AR,mutation identified in 1 SERKAL family,WNT4
"WNT4, SERKAL","Wingless-type MMTV integration site family, member 4",603490,Mullerian aplasia and hyperandrogenism,158330,AD,-,WNT4
C1QA,"Complement component 1, q subcomponent, A chain",120550,C1q deficiency,613652,AR,-,C1QA
"C1QC, C1QG","Complement component 1, q subcomponent, C chain",120575,C1q deficiency,613652,AR,-,C1QC
C1QB,"Complement component 1, q subcomponent, B chain",120570,C1q deficiency,613652,AR,-,C1QB
"EPHB2, EPHT3, DRT, ERK, PCBC, CAPB",eph tyrosine kinase 3 (ephrin receptor EphB2),600997,"{Prostate cancer/brain cancer susceptibility, somatic}",603688,-,-,EPHB2
"KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF",Lysine-specific demethylase 1A,609132,"Cleft palate, psychomotor retardation, and distinctive facial features",616728,AD,-,KDM1A
"RPL11, DBA7",Ribosomal protein L11,604175,Diamond-Blackfan anemia 7,612562,AD,-,RPL11
GALE,UDP galactose-4-epimerase,606953,Galactose epimerase deficiency,230350,AR,-,GALE
HMGCL,3-hydroxy-3-methylglutaryl-Coenzyme A lyase,613898,HMG-CoA lyase deficiency,246450,AR,-,HMGCL
FUCA1,"Fucosidase, alpha-L- 1, tissue",612280,Fucosidosis,230000,AR,8cM distal to RH; pseudogene on 2q31-q32,FUCA1
"GRHL3, SOM, TFCP2L4, VWS2",Grainyhead-like 3,608317,Van der Woude syndrome 2,606713,AD,-,GRHL3
RHCE,Rhesus system C and E polypeptides,111700,"Rh-null disease, amorph type",-,-,?order: C-E-D,RHCE
RHCE,Rhesus system C and E polypeptides,111700,"[Blood group, Rhesus]",111690,-,-,RHCE
"LDLRAP1, ARH, FHCB2, FHCB1",Low density lipoprotein receptor adaptor protein 1,605747,"Hypercholesterolemia, familial, autosomal recessive",603813,-,-,LDLRAP1
"SELENON, SEPN1, SELN, RSMD1, CFTD",Selenoprotein N,606210,"Muscular dystrophy, rigid spine, 1",602771,AR,-,SELENON
"SELENON, SEPN1, SELN, RSMD1, CFTD",Selenoprotein N,606210,"Myopathy, congenital, with fiber-type disproportion",255310,"AD,AR",-,SELENON
"SLC30A2, ZNT2, TNZD","Solute carrier family 30 (zinc transporter), member 2",609617,"Zinc deficiency, transient neonatal",608118,AD,-,SLC30A2
"DHDDS, HDS, RP59, DEDSM",Dehydrodolichyl diphosphate synthase,608172,"?Congenital disorder of glycosylation, type 1bb",613861,AR,mutation identified in 1 CDG1BB patient,DHDDS
"DHDDS, HDS, RP59, DEDSM",Dehydrodolichyl diphosphate synthase,608172,Developmental delay and seizures with or without movement abnormalities,617836,AD,-,DHDDS
"DHDDS, HDS, RP59, DEDSM",Dehydrodolichyl diphosphate synthase,608172,Retinitis pigmentosa 59,613861,AR,-,DHDDS
"ARID1A, C1orf4, B120, SMARCF1, MRD14, CSS2","AT rich interactive domain 1A, SWI-like",603024,Coffin-Siris syndrome 2,614607,AD,-,ARID1A
"PIGV, HPMRS1","Phosphatidylinositol glycan, class V",610274,Hyperphosphatasia with mental retardation syndrome 1,239300,AR,-,PIGV
"NR0B2, SHP","Nuclear receptor subfamily 0, group B, member 2",604630,"Obesity, mild, early-onset",601665,"AD,Mu,AR",-,NR0B2
"KDF1, C1orf172, ECTD12",Keratinocyte differentiation factor 1,616758,"?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type",617337,AD,mutation identified in 1 ECTD12 family,KDF1
"SLC9A1, NHE1, APNH, LIKNS","Solute carrier family 9 (sodium/hydrogen exchanger), member 1 (antiporter, Na+/H+, amiloride sensitive)",107310,?Lichtenstein-Knorr syndrome,616291,AR,mutation identified in 1 LIKNS family,SLC9A1
"FCN3, HAKA1",Ficolin 3,604973,Immunodeficiency due to ficolin 3 deficiency,613860,AR,-,FCN3
"AHDC1, MRD25",AT-hook DNA-binding motif-containing protein 1,615790,Xia-Gibbs syndrome,615829,AD,-,AHDC1
"EPB41, EL1",Erythrocyte surface protein band 4.1,130500,Elliptocytosis-1,611804,-,-,EPB41
"MECR, NRBF1, DYTOABG",Mitochondrial trans-2-enoyl-CoA reductase,608205,"Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities",617282,AR,-,MECR
"SDC3, SYND3, SDCN",Syndecan 3,186357,"{Obesity, association with}",601665,"AD,Mu,AR",-,SDC3
"CCDC28B, MGC1203",Coiled-coil domain-containing protein 28B,610162,"{Bardet-Biedl syndrome 1, modifier of}",209900,"AR,DR",-,CCDC28B
"LCK, IMD22",Lymphocyte-specific protein tyrosine kinase,153390,?Immunodeficiency 22,615758,AR,LCK/TCRB fusion in leukemia; mutation identified in 1 IMD22 patient,LCK
"YARS, CMTDIC, TYRRS, YTS, YRS",Tyrosyl-tRNA synthetase,603623,"Charcot-Marie-Tooth disease, dominant intermediate C",608323,AD,-,YARS
"HPCA, DYT2","Hippocalcin, 23kD, Ca2+-binding protein",142622,"Dystonia 2, torsion, autosomal recessive",224500,AR,-,HPCA
AK2,"Adenylate kinase-2, mitochondrial",103020,Reticular dysgenesis,267500,AR,-,AK2
"GJB4, CX30.3, EKVP2","Gap junction protein, beta-4",605425,Erythrokeratodermia variabilis et progressiva 2,617524,AD,-,GJB4
"GJB3, CX31, DFNA2B, EKVP1","Gap junction protein, beta-3",603324,"Deafness, autosomal dominant 2B",612644,AD,same YAC as GJA4,GJB3
"GJB3, CX31, DFNA2B, EKVP1","Gap junction protein, beta-3",603324,"Deafness, autosomal dominant, with peripheral neuropathy",-,-,-,GJB3
"GJB3, CX31, DFNA2B, EKVP1","Gap junction protein, beta-3",603324,"Deafness, autosomal recessive",-,-,-,GJB3
"GJB3, CX31, DFNA2B, EKVP1","Gap junction protein, beta-3",603324,"Deafness, digenic, GJB2/GJB3",220290,"DD,AR",-,GJB3
"GJB3, CX31, DFNA2B, EKVP1","Gap junction protein, beta-3",603324,Erythrokeratodermia variabilis et progressiva 1,133200,"AD,AR",-,GJB3
"COL8A2, FECD1, PPCD2","Collagen VIII, alpha-2 polypeptide",120252,"Corneal dystrophy, Fuchs endothelial, 1",136800,AD,-,COL8A2
"COL8A2, FECD1, PPCD2","Collagen VIII, alpha-2 polypeptide",120252,"Corneal dystrophy, posterior polymorphous 2",609140,AD,-,COL8A2
"CSF3R, GCSFR, SCN7",Colony-stimulating factor-3 receptor (granulocyte),138971,"Neutropenia, severe congenital, 7, autosomal recessive",617014,AR,-,CSF3R
"SNIP1, PMRED",SMAD nuclear interacting protein 1,608241,"Psychomotor retardation, epilepsy, and craniofacial dysmorphism",614501,AR,-,SNIP1
"RSPO1, FLJ40906","Roof plate-specific spondin, mouse, homolog of, 1",609595,Palmoplantar hyperkeratosis and true hermaphroditism,610644,AR,-,RSPO1
"RSPO1, FLJ40906","Roof plate-specific spondin, mouse, homolog of, 1",609595,Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal,610644,AR,-,RSPO1
"TRIT1, IPT, COXPD35",tRNA isopentenyltransferase 1,617840,Combined oxidative phosphorylation deficiency 35,617873,AR,-,TRIT1
"MFSD2A, MCPH15",Major facilitator superfamily domain-containing protein 2A,614397,"Microcephaly 15, primary, autosomal recessive",616486,AR,-,MFSD2A
"PPT1, CLN1",Palmitoyl-protein thioesterase 1,600722,"Ceroid lipofuscinosis, neuronal, 1",256730,AR,-,PPT1
"ZMPSTE24, FACE1, STE24, MADB",Zinc metalloproteinase STE24,606480,Mandibuloacral dysplasia with type B lipodystrophy,608612,AR,-,ZMPSTE24
"ZMPSTE24, FACE1, STE24, MADB",Zinc metalloproteinase STE24,606480,"Restrictive dermopathy, lethal",275210,AR,-,ZMPSTE24
"COL9A2, EDM2, STL5","Collagen IX, alpha-2 polypeptide",120260,"?Stickler syndrome, type V",614284,AR,mutation identified in1 STL5 family,COL9A2
"COL9A2, EDM2, STL5","Collagen IX, alpha-2 polypeptide",120260,"Epiphyseal dysplasia, multiple, 2",600204,AD,-,COL9A2
"KCNQ4, DFNA2A","Potassium voltage-gated channel, KQT-like subfamily, member 4",603537,"Deafness, autosomal dominant 2A",600101,AD,-,KCNQ4
"CTPS1, CTPS, IMD24",Cytidine 5'-triphosphate synthetase 1,123860,Immunodeficiency 24,615897,AR,-,CTPS1
"CLDN19, HOMG5",Claudin 19,610036,"Hypomagnesemia 5, renal, with ocular involvement",248190,AR,-,CLDN19
"P3H1, LEPRE1, GROS1, OI8",Prolyl 3-hydroxylase 1,610339,"Osteogenesis imperfecta, type VIII",610915,AR,-,P3H1
"ERMAP, SC, RD",Erythroblast membrane-associated protein,609017,"[Blood group, Radin]",111620,-,-,ERMAP
"ERMAP, SC, RD",Erythroblast membrane-associated protein,609017,"[Blood group, Scianna system]",111750,-,-,ERMAP
"SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN","Solute carrier family 2 (facilitated glucose transporter), member 1",138140,Dystonia 9,601042,AD,probably in 1p33,SLC2A1
"SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN","Solute carrier family 2 (facilitated glucose transporter), member 1",138140,"GLUT1 deficiency syndrome 1, infantile onset, severe",606777,"AD,AR",-,SLC2A1
"SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN","Solute carrier family 2 (facilitated glucose transporter), member 1",138140,"GLUT1 deficiency syndrome 2, childhood onset",612126,AD,-,SLC2A1
"SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN","Solute carrier family 2 (facilitated glucose transporter), member 1",138140,Stomatin-deficient cryohydrocytosis with neurologic defects,608885,AD,-,SLC2A1
"SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN","Solute carrier family 2 (facilitated glucose transporter), member 1",138140,"{Epilepsy, idiopathic generalized, susceptibility to, 12}",614847,AD,-,SLC2A1
"MPL, TPOR, MPLV, THCYT2","Myeloproliferative leukemia virus, homolog of",159530,"Myelofibrosis with myeloid metaplasia, somatic",254450,-,-,MPL
"MPL, TPOR, MPLV, THCYT2","Myeloproliferative leukemia virus, homolog of",159530,Thrombocythemia 2,601977,"AD,SMu",-,MPL
"MPL, TPOR, MPLV, THCYT2","Myeloproliferative leukemia virus, homolog of",159530,"Thrombocytopenia, congenital amegakaryocytic",604498,AR,-,MPL
"SZT2, KIAA0467, EIEE18","Seizure threshold 2, mouse, homolog of",615463,"Epileptic encephalopathy, early infantile, 18",615476,AR,-,SZT2
"PTPRF, LAR, BNAH2","Protein tyrosine phosphatase, receptor type, f polypeptide",179590,"?Breasts and/or nipples, aplasia or hypoplasia of, 2",616001,AR,mutation identified in 1 BNAH2 family,PTPRF
"ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15","ST3 beta-galactoside alpha-2,3-sialyltransferase 3",606494,"?Epileptic encephalopathy, early infantile, 15",615006,AR,mutation identified in 1 EIEE15 family,ST3GAL3
"ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15","ST3 beta-galactoside alpha-2,3-sialyltransferase 3",606494,"Mental retardation, autosomal recessive 12",611090,AR,-,ST3GAL3
"SLC6A9, GLYT1, GCENSG","Solute carrier family 6 (neurotransmitter transporter, glycine), member 9",601019,Glycine encephalopathy with normal serum glycine,617301,AR,-,SLC6A9
PTCH2,"Patched, Drosophila, homolog of, 2",603673,"Basal cell carcinoma, somatic",605462,-,-,PTCH2
PTCH2,"Patched, Drosophila, homolog of, 2",603673,Basal cell nevus syndrome,109400,AD,-,PTCH2
PTCH2,"Patched, Drosophila, homolog of, 2",603673,"Medulloblastoma, somatic",155255,-,-,PTCH2
EIF2B3,"Eukaryotic translation initiation factor 2B, subunit 3",606273,Leukoencephalopathy with vanishing white matter,603896,AR,-,EIF2B3
UROD,Uroporphyrinogen decarboxylase,613521,Porphyria cutanea tarda,176100,"AD,AR",-,UROD
UROD,Uroporphyrinogen decarboxylase,613521,"Porphyria, hepatoerythropoietic",176100,"AD,AR",-,UROD
"MUTYH, MYH","MutY, E. coli, homolog of",604933,"Adenomas, multiple colorectal",608456,AR,-,MUTYH
"MUTYH, MYH","MutY, E. coli, homolog of",604933,"Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas",132600,SMu,-,MUTYH
"MUTYH, MYH","MutY, E. coli, homolog of",604933,"Gastric cancer, somatic",613659,-,-,MUTYH
"TOE1, PCH7",Target of EGR1,613931,"Pontocerebellar hypoplasia, type 7",614969,AR,-,TOE1
MMACHC,MMACHC gene,609831,"Methylmalonic aciduria and homocystinuria, cblC type",277400,AR,-,MMACHC
"PRDX1, PRXI, PAGA, NKEFA",Peroxiredoxin 1,176763,"Methylmalonic aciduria and homocystinuria, cblC type, digenic",277400,AR,pseudogene PAGB on 9p22,PRDX1
"POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76","Protein 0-mannose beta-1,2-N-acetylglucosaminyltransferase",606822,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3",253280,AR,-,POMGNT1
"POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76","Protein 0-mannose beta-1,2-N-acetylglucosaminyltransferase",606822,"Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3",613151,AR,-,POMGNT1
"POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76","Protein 0-mannose beta-1,2-N-acetylglucosaminyltransferase",606822,"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3",613157,AR,-,POMGNT1
"POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76","Protein 0-mannose beta-1,2-N-acetylglucosaminyltransferase",606822,Retinitis pigmentosa 76,617123,AR,-,POMGNT1
"RAD54L, HR54, HRAD54","RAD54, S. cerevisiae, homolog-like",603615,"Adenocarcinoma, colonic, somatic",-,-,-,RAD54L
"RAD54L, HR54, HRAD54","RAD54, S. cerevisiae, homolog-like",603615,"Lymphoma, non-Hodgkin, somatic",605027,-,-,RAD54L
"RAD54L, HR54, HRAD54","RAD54, S. cerevisiae, homolog-like",603615,"{Breast cancer, invasive ductal}",114480,AD,-,RAD54L
FAAH,Fatty acid amide hydrolase,602935,"{Drug addiction, susceptibility to}",606581,-,-,FAAH
"STIL, SIL, MCPH7",SCL/TAL1-interrupting locus,181590,"Microcephaly 7, primary, autosomal recessive",612703,AR,within about 250kb of SCL,STIL
"FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11",Forkhead box E3,601094,"Anterior segment dysgenesis 2, multiple subtypes",610256,AR,-,FOXE3
"FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11",Forkhead box E3,601094,"Cataract 34, multiple types",612968,-,-,FOXE3
"FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11",Forkhead box E3,601094,"{Aortic aneurysm, familial thoracic 11, susceptibility to}",617349,AD,-,FOXE3
"ORC1, ORC1L","Origin recognition complex, subunit 1, S. cerevisiae, homolog",601902,Meier-Gorlin syndrome 1,224690,AR,-,ORC1
"COA7, RESA1, SELRC1, C1orf163",Cytochrome C oxidase assembly factor,615623,?Mitochondrial complex IV deficiency,220110,"Mi,AR",mutation identified in 1 COX4D patient,COA7
SCP2,Sterol carrier protein-2,184755,?Leukoencephalopathy with dystonia and motor neuropathy,613724,AR,mutation identified in 1 LKDMN patient,SCP2
"CPT2, IIAE4",Carnitine palmitoyltransferase II,600650,"CPT II deficiency, infantile",600649,AR,formerly at 1p13,CPT2
"CPT2, IIAE4",Carnitine palmitoyltransferase II,600650,"CPT II deficiency, lethal neonatal",608836,AR,-,CPT2
"CPT2, IIAE4",Carnitine palmitoyltransferase II,600650,"CPT II deficiency, myopathic, stress-induced",255110,"AD,AR",-,CPT2
"CPT2, IIAE4",Carnitine palmitoyltransferase II,600650,"{Encephalopathy, acute, infection-induced, 4, susceptibility to}",614212,"AD,AR",-,CPT2
"LRP8, APOER2, MCI1",Low density lipoprotein receptor-related protein 8 (Apolipoprotein E receptor 2),602600,"{Myocardial infarction, susceptibility to}",608446,-,-,LRP8
"DHCR24, KIAA0018",24-dehydrocholesterol reductase,606418,Desmosterolosis,602398,AR,-,DHCR24
BSND,Barttin,606412,"Bartter syndrome, type 4a",602522,AR,-,BSND
BSND,Barttin,606412,Sensorineural deafness with mild renal dysfunction,602522,AR,-,BSND
"PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1","Proprotein convertase, subtilisin/kexin-type, 9",607786,"Hypercholesterolemia, familial, 3",603776,-,-,PCSK9
"PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1","Proprotein convertase, subtilisin/kexin-type, 9",607786,{Low density lipoprotein cholesterol level QTL 1},603776,-,-,PCSK9
C8A,"Complement component-8, alpha polypeptide",120950,"C8 deficiency, type I",613790,AR,-,C8A
C8B,"Complement component-8, beta polypeptide",120960,"C8 deficiency, type II",613789,AR,-,C8B
"DAB1, SCA37","Disabled, Drosophila, homolog 1",603448,Spinocerebellar ataxia 37,615945,AD,-,DAB1
"TACSTD2, TROP2, M1S1",Tumor-associated calcium signal transducer 2,137290,"Corneal dystrophy, gelatinous drop-like",204870,AR,-,TACSTD2
"OPHLC, C1DUPp31.3, DUP1p31.3",Omphalocele due to duplication of 1p31.3,164750,Omphalocele due to duplication of 1p31.3,164750,AD,duplication of 710kb at 1p31.3,OPHLC
"NFIA, BRMUTD",Nuclear factor I/A,600727,Brain malformations with or without urinary tract defects,613735,IC,-,NFIA
"DOCK7, KIAA1771, EIEE23",Dedicator of cytokinesis 7,615730,"Epileptic encephalopathy, early infantile, 23",615859,AR,-,DOCK7
"ANGPTL3, ANGPT5, FHBL2",Angiopoietin-like 3,604774,"Hypobetalipoproteinemia, familial, 2",605019,AR,-,ANGPTL3
"FOXD3, AIS1, VAMAS2",Forkhead box D3,611539,"{Autoimmune disease, susceptibility to, 1}",607836,AD,-,FOXD3
"ALG6, CDG1C","Alg6, S. cerevisiae, homolog of",604566,"Congenital disorder of glycosylation, type Ic",603147,AR,-,ALG6
"PGM1, GSD14, CDG1T",Phosphoglucomutase-1,171900,"Congenital disorder of glycosylation, type It",614921,AR,distal to ACADM; formerly 1p22.1,PGM1
"ROR1, NTRKR1",Receptor tyrosine kinase-like orphan receptor 1,602336,"?Deafness, autosomal recessive 108",617654,AR,mutation identified in 1 DFNB108 family,ROR1
"DNAJC6, DJC6, KIAA0473, PARK19","DNAJ, E. coli, homolog of, subfamily C, member 6",608375,"Parkinson disease 19a, juvenile-onset",615528,AR,-,DNAJC6
"DNAJC6, DJC6, KIAA0473, PARK19","DNAJ, E. coli, homolog of, subfamily C, member 6",608375,"Parkinson disease 19b, early-onset",615528,AR,-,DNAJC6
"LEPR, OBR, LEPRD",Leptin receptor,601007,"Obesity, morbid, due to leptin receptor deficiency",614963,-,-,LEPR
"SLC35D1, UGTREL7, KIAA0260, SHNKND","Solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1",610804,Schneckenbecken dysplasia,269250,AR,-,SLC35D1
"IL23R, IBD17",Interleukin 23 receptor,607562,"{Inflammatory bowel disease 17, protection against}",612261,-,-,IL23R
"IL23R, IBD17",Interleukin 23 receptor,607562,"{Psoriasis, protection against}",605606,-,-,IL23R
"RPE65, RP20, LCA2","Retinal pigment epithelium-specific protein, 65kD",180069,Leber congenital amaurosis 2,204100,AR,-,RPE65
"RPE65, RP20, LCA2","Retinal pigment epithelium-specific protein, 65kD",180069,Retinitis pigmentosa 20,613794,AR,-,RPE65
CTH,Cystathionine gamma-lyase,607657,Cystathioninuria,219500,AR,previously assigned to chr.16,CTH
CTH,Cystathionine gamma-lyase,607657,"Homocysteine, total plasma, elevated",-,-,-,CTH
"TNNI3K, CCDD",TNNI3-interacting kinase,613932,?Cardiac conduction disease with or without dilated cardiomyopathy,616117,AD,mutation identified in 1 CCDD family,TNNI3K
"ACADM, MCAD","Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain",607008,"Acyl-CoA dehydrogenase, medium chain, deficiency of",201450,AR,-,ACADM
"NEXN, NELIN, CMD1CC, CMH20","Nexilin, rat, homolog of",613121,"Cardiomyopathy, dilated, 1CC",613122,AD,-,NEXN
"NEXN, NELIN, CMD1CC, CMH20","Nexilin, rat, homolog of",613121,"Cardiomyopathy, hypertrophic, 20",613876,AD,-,NEXN
"BCL10, IMD37",B-cell leukemia/lymphoma 10,603517,?Immunodeficiency 37,616098,AR,mutation identified in 1 IMD37 patient,BCL10
"BCL10, IMD37",B-cell leukemia/lymphoma 10,603517,"Lymphoma, MALT, somatic",137245,-,-,BCL10
"BCL10, IMD37",B-cell leukemia/lymphoma 10,603517,"{Lymphoma, follicular, somatic}",605027,-,-,BCL10
"BCL10, IMD37",B-cell leukemia/lymphoma 10,603517,"{Male germ cell tumor, somatic},",273300,-,-,BCL10
"BCL10, IMD37",B-cell leukemia/lymphoma 10,603517,"{Mesothelioma, somatic}",156240,-,-,BCL10
"BCL10, IMD37",B-cell leukemia/lymphoma 10,603517,"{Sezary syndrome, somatic}",-,-,-,BCL10
"ZNF644, MYP21",Zinc finger protein 644,614159,"Myopia 21, autosomal dominant",614167,AD,-,ZNF644
"HFM1, MER3, POF9","Hfm1, ATP-dependent DNA helicase, S. cerevisiae, homolog of",615684,Premature ovarian failure 9,615724,AR,-,HFM1
"BRDT, SPGF21","Bromodomain, testis-specific",602144,?Spermatogenic failure 21,617644,AR,mutation identified in 1 SPGF21 patient,BRDT
"GLML, GVM, VMGLOM",Glomulin,601749,Glomuvenous malformations,138000,AD,-,GLML
"GFI1, ZNF163, SCN2",Growth factor independent 1,600871,"?Neutropenia, nonimmune chronic idiopathic, of adults",607847,AD,mutation identified in 1 SCN2 patient and 1 NICINA patient,GFI1
"GFI1, ZNF163, SCN2",Growth factor independent 1,600871,"?Neutropenia, severe congenital 2, autosomal dominant",613107,AD,-,GFI1
"RPL5, DBA6",Ribosomal protein L5,603634,Diamond-Blackfan anemia 6,612561,AD,-,RPL5
"GCLM, GLCLR","Glutamate-cysteine ligase, modifier subunit",601176,"{Myocardial infarction, susceptibility to}",608446,-,-,GCLM
"ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2","ATP-binding transporter, retina-specific",601691,Cone-rod dystrophy 3,604116,-,-,ABCA4
"ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2","ATP-binding transporter, retina-specific",601691,Fundus flavimaculatus,248200,AR,-,ABCA4
"ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2","ATP-binding transporter, retina-specific",601691,"Retinal dystrophy, early-onset severe",248200,AR,-,ABCA4
"ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2","ATP-binding transporter, retina-specific",601691,Retinitis pigmentosa 19,601718,AR,-,ABCA4
"ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2","ATP-binding transporter, retina-specific",601691,Stargardt disease 1,248200,AR,-,ABCA4
"ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2","ATP-binding transporter, retina-specific",601691,"{Macular degeneration, age-related, 2}",153800,AD,-,ABCA4
"ABCD3, PXMP1, PMP70, CBAS5","ATP-binding cassette, subfamily D, member 3 (peroxisomal membrane protein 1, 70kD)",170995,"?Bile acid synthesis defect, congenital, 5",616278,AR,mutation identified in 1 CBAS5 family,ABCD3
"ALG14, CMS15","Alg14, S. cerevisiae, homolog of",612866,"?Myasthenic syndrome, congenital, 15, without tubular aggregates",616227,-,mutation identified in 1 CMSWTA family,ALG14
"DPYD, DPD",Dihydropyrimidine dehydrogenase,612779,5-fluorouracil toxicity,274270,AR,-,DPYD
"DPYD, DPD",Dihydropyrimidine dehydrogenase,612779,Dihydropyrimidine dehydrogenase deficiency,274270,AR,-,DPYD
"AGL, GDE","Amylo-1,6-glucosidase, 4-alpha-glucanotransferase (glycogen debranching enzyme)",610860,Glycogen storage disease IIIa,232400,AR,-,AGL
"AGL, GDE","Amylo-1,6-glucosidase, 4-alpha-glucanotransferase (glycogen debranching enzyme)",610860,Glycogen storage disease IIIb,232400,AR,-,AGL
"SLC35A3, AMRS","Solute carrier family 35 (UDP-GlcNAc transporter), member 3",605632,"?Arthrogryposis, mental retardation, and seizures",615553,AR,mutation identified in 1 family,SLC35A3
"SASS6, SAS6, MCPH14",SAS-6 centriolar assembly protein,609321,"?Microcephaly 14, primary, autosomal recessive",616402,AR,mutation identified in 1 MCPH14 family,SASS6
"DBT, BCATE2",Dihydrolipoamide branched chain transacylase (E2 component of branched chain keto acid dehydrogenase complex),248610,"Maple syrup urine disease, type II",248600,AR,pseudogene on 3q24,DBT
"CDC14A, DFNB105","Cell division cycle 14, S. cerevisiae, homolog A",603504,"Deafness, autosomal recessive 105",616958,AR,-,CDC14A
"GPR88, STRG, COCPMR",G protein-coupled receptor 88,607468,"?Chorea, childhood-onset, with psychomotor retardation",616939,AR,mutation identified in 1 COCPMR family,GPR88
"COL11A1, STL2","Collagen XI, alpha-1 polypeptide",120280,Fibrochondrogenesis 1,228520,AR,-,COL11A1
"COL11A1, STL2","Collagen XI, alpha-1 polypeptide",120280,Marshall syndrome,154780,AD,-,COL11A1
"COL11A1, STL2","Collagen XI, alpha-1 polypeptide",120280,"Stickler syndrome, type II",604841,AD,-,COL11A1
"COL11A1, STL2","Collagen XI, alpha-1 polypeptide",120280,"{Lumbar disc herniation, susceptibility to}",603932,-,-,COL11A1
"SLC25A24, SCAMC1","Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24",608744,Fontaine progeroid syndrome,612289,AD,-,SLC25A24
"GPSM2, LGN, PINS, DFNB82, CMCS",G protein signaling modulator 2,609245,Chudley-McCullough syndrome,604213,AR,-,GPSM2
"TAF13, TAF2K, MRT60","TAF13 RNA polymerase II, TATA box-binding protein-associated factor, 18kD",600774,"Mental retardation, autosomal recessive 60",617432,AR,-,TAF13
"SARS, SERS, NEDMAS",Seryl-tRNA synthetase,607529,"?Neurodevelopmental disorder with microcephaly, ataxia, and seizures",617709,AR,mutation identified in 1 NEDMAS family,SARS
"SORT1, NT3, LDLCQ6",Sortilin,602458,[Low density lipoprotein cholesterol level QTL6],613589,AD,-,SORT1
"GNAI3, ARCND1","Guanine nucleotide-binding protein (G-protein), alpha-inhibiting activity polypeptide-3",139370,Auriculocondylar syndrome 1,602483,AD,-,GNAI3
"GNAT2, ACHM4","Guanine nucleotide-binding protein (G-protein), alpha-transducing (transducin) activity polypeptide-2",139340,Achromatopsia 4,613856,-,-,GNAT2
"AMPD2, SPG63, PCH9","Adenosine monophosphate deaminase-2, isoform L",102771,?Spastic paraplegia 63,615686,AR,mutation identified in 1 SPG63 family,AMPD2
"AMPD2, SPG63, PCH9","Adenosine monophosphate deaminase-2, isoform L",102771,"Pontocerebellar hypoplasia, type 9",615809,AR,-,AMPD2
"ALX3, FND1",Aristaless-like homeobox 3,606014,Frontonasal dysplasia 1,136760,AR,-,ALX3
"SLC6A17, NTT4, MRT48","Solute carrier family 6 (neurotransmitter transporter), member 17",610299,"Mental retardation, autosomal recessive 48",616269,AR,-,SLC6A17
"KCNA2, EIEE32","Potassium channel, voltage-gated, Shaker-related subfamily, member 2",176262,"Epileptic encephalopathy, early infantile, 32",616366,AD,-,KCNA2
"DRAM2, TMEM77, CORD21",Damage-regulated autophagy modulator 2,613360,Cone-rod dystrophy 21,616502,AR,-,DRAM2
"KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9","Potassium voltage-gated channel, Shal-related subfamily, member 3",605411,Brugada syndrome 9,616399,AD,-,KCND3
"KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9","Potassium voltage-gated channel, Shal-related subfamily, member 3",605411,Spinocerebellar ataxia 19,607346,AD,-,KCND3
"SLC16A1, MCT1, HHF7, MCT1D","Solute carrier family 16 (monocarboxylic acid transporters), member 1",600682,Erythrocyte lactate transporter defect,245340,AD,-,SLC16A1
"SLC16A1, MCT1, HHF7, MCT1D","Solute carrier family 16 (monocarboxylic acid transporters), member 1",600682,"Hyperinsulinemic hypoglycemia, familial, 7",610021,AD,-,SLC16A1
"SLC16A1, MCT1, HHF7, MCT1D","Solute carrier family 16 (monocarboxylic acid transporters), member 1",600682,Monocarboxylate transporter 1 deficiency,616095,"AD,AR",-,SLC16A1
"LRIG2, LIG2, KIAA0806, UFS2",Leucine-rich repeats- and immunoglobulin-like domains-containing protein 2,608869,Urofacial syndrome 2,615112,AR,-,LRIG2
"PTPN22, PEP, PTPN8, LYP","Protein tyrosine phosphatase, nonreceptor-type 22",600716,"{Diabetes, type 1, susceptibility to}",222100,AR,-,PTPN22
"PTPN22, PEP, PTPN8, LYP","Protein tyrosine phosphatase, nonreceptor-type 22",600716,"{Rheumatoid arthritis, susceptibility to}",180300,-,-,PTPN22
"PTPN22, PEP, PTPN8, LYP","Protein tyrosine phosphatase, nonreceptor-type 22",600716,{Systemic lupus erythematosus susceptibility to},152700,AD,-,PTPN22
"AP4B1, SPG47, CPSQ5","Adaptor-related protein complex 4, beta-1 subunit",607245,"Spastic paraplegia 47, autosomal recessive",614066,AR,-,AP4B1
"AMPD1, MMDD","Adenosine monophosphate deaminase-1, muscle",102770,Myopathy due to myoadenylate deaminase deficiency,615511,AR,-,AMPD1
"NRAS, ALPS4, NS6, CMNS, NCMS",Neuroblastoma RAS viral (v-ras) oncogene homolog,164790,"?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic",614470,-,cen-CD2-NGFB-NRAS,NRAS
"NRAS, ALPS4, NS6, CMNS, NCMS",Neuroblastoma RAS viral (v-ras) oncogene homolog,164790,"Colorectal cancer, somatic",114500,-,-,NRAS
"NRAS, ALPS4, NS6, CMNS, NCMS",Neuroblastoma RAS viral (v-ras) oncogene homolog,164790,"Epidermal nevus, somatic",162900,-,-,NRAS
"NRAS, ALPS4, NS6, CMNS, NCMS",Neuroblastoma RAS viral (v-ras) oncogene homolog,164790,"Melanocytic nevus syndrome, congenital, somatic",137550,-,-,NRAS
"NRAS, ALPS4, NS6, CMNS, NCMS",Neuroblastoma RAS viral (v-ras) oncogene homolog,164790,"Neurocutaneous melanosis, somatic",249400,-,-,NRAS
"NRAS, ALPS4, NS6, CMNS, NCMS",Neuroblastoma RAS viral (v-ras) oncogene homolog,164790,Noonan syndrome 6,613224,AD,-,NRAS
"NRAS, ALPS4, NS6, CMNS, NCMS",Neuroblastoma RAS viral (v-ras) oncogene homolog,164790,"Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic",163200,-,-,NRAS
"NRAS, ALPS4, NS6, CMNS, NCMS",Neuroblastoma RAS viral (v-ras) oncogene homolog,164790,"Thyroid carcinoma, follicular, somatic",188470,-,-,NRAS
"TSHB, CHNG4","Thyroid-stimulating hormone, beta polypeptide",188540,"Hypothyroidism, congenital, nongoitrous 4",275100,AR,centromeric to NGFB,TSHB
"NGF, NGFB, HSAN5","Nerve growth factor, beta",162030,"Neuropathy, hereditary sensory and autonomic, type V",608654,AR,same 310kb fragment as TSHB; order: cen-CD2-CD58-ATP1A1-NGF-TSHB-NRAS-tel,NGF
"VANGL1, STBM2",Vang-like 1,610132,Caudal regression syndrome,600145,AD,-,VANGL1
"VANGL1, STBM2",Vang-like 1,610132,"{Neural tube defects, susceptibility to}",182940,AD,-,VANGL1
CASQ2,"Calsequestrin, fast-twitch, skeletal muscle-2",114251,"Ventricular tachycardia, catecholaminergic polymorphic, 2",611938,AR,-,CASQ2
"IGSF3, LCDD","Immunoglobulin superfamily, member 3",603491,?Lacrimal duct defect,149700,AR,mutation identified in 1 LCDD family,IGSF3
TBX15,T-box 15,604127,Cousin syndrome,260660,AR,-,TBX15
"WARS2, NEMMLAS",Tryptophanyl-tRNA synthetase 2,604733,"Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures",617710,AR,-,WARS2
HSD3B2,"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase, type 2 (adrenal, gonadal)",613890,"Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency",201810,AR,-,HSD3B2
"PHGDH, NLS1, PHGDHD",Phosphoglycerate dehydrogenase,606879,Neu-Laxova syndrome 1,256520,AR,-,PHGDH
"PHGDH, NLS1, PHGDHD",Phosphoglycerate dehydrogenase,606879,Phosphoglycerate dehydrogenase deficiency,601815,AR,-,PHGDH
HMGCS2,"3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2, mitochondrial",600234,HMG-CoA synthase-2 deficiency,605911,AR,-,HMGCS2
"NOTCH2, AGS2, HJCYS","Notch, Drosophila, homolog of, 2",600275,Alagille syndrome 2,610205,AD,-,NOTCH2
"NOTCH2, AGS2, HJCYS","Notch, Drosophila, homolog of, 2",600275,Hajdu-Cheney syndrome,102500,AD,-,NOTCH2
"DEL1q21, C1DELq21",Chromosome 1q21.1 deletion syndrome,612474,Chromosome 1q21.1 deletion syndrome,612474,"AD,IC",contiguous gene deletion syndrome,DEL1q21
"DUP1q21, C1DUPq21",Chromosome 1q21.1 duplication syndrome,612475,Chromosome 1q21.1 duplication syndrome,612475,"AD,IC",contiguous gene duplication syndrome,DUP1q21
"PEX11B, PEX14B",Peroxisome biogenesis 11B,603867,?Peroxisome biogenesis disorder 14B,614920,AR,mutation identified in 1 PEX14B patient,PEX11B
"RBM8A, RBM8B, TAR, C1DELq21.1, DEL1q21.1",RNA-binding motif protein 8A,605313,Thrombocytopenia-absent radius syndrome,274000,AR,pseudogene on chr.14,RBM8A
"HJV, HFE2A",Hemojuvelin,608374,"Hemochromatosis, type 2A",602390,AR,between D1S442 and D1S2347,HJV
"GJA5, CX40, ATFB11","Gap junction protein, alpha-5, 40kD (connexin 40)",121013,"Atrial fibrillation, familial, 11",614049,AD,-,GJA5
"GJA5, CX40, ATFB11","Gap junction protein, alpha-5, 40kD (connexin 40)",121013,"Atrial standstill, digenic (GJA5/SCN5A)",108770,AD,-,GJA5
"GJA8, CX50, CTRCT1, CZP1, CAE1",Gap junction membrane channel protein alpha-8 (connexin 50),600897,"Cataract 1, multiple types",116200,AD,-,GJA8
"SF3B4, SF3B49, SAP49, AFD1","Splicing factor 3B, subunit 4",605593,"Acrofacial dysostosis 1, Nager type",154400,AD,-,SF3B4
"VPS45A, VPS45, SCN5","Vacuolar protein sorting 45, yeast, homolog of, A",610035,"Neutropenia, severe congenital, 5, autosomal recessive",615285,AR,-,VPS45A
"PRPF3, HPRP3, RP18","Precursor mRNA-processing factor 3, S. cerevisiae, homolog of",607301,Retinitis pigmentosa 18,601414,AD,-,PRPF3
"TARS2, COXPD21",Threonyl-tRNA synthetase 2,612805,?Combined oxidative phosphorylation deficiency 21,615918,AR,mutation identified in one COXPD21 family,TARS2
"ECM1, URBWD",Extracellular matrix protein-1,602201,Urbach-Wiethe disease,247100,AR,-,ECM1
"ADAMTSL4, TSRC1, ECTOL2",ADAMTS-like 4,610113,Ectopia lentis et pupillae,225200,AR,-,ADAMTSL4
"ADAMTSL4, TSRC1, ECTOL2",ADAMTS-like 4,610113,"Ectopia lentis, isolated, autosomal recessive",225100,AR,-,ADAMTSL4
CTSK,Cathepsin K,601105,Pycnodysostosis,265800,AR,-,CTSK
"PRUNE1, DRES17, NMIHBA",Prune exopolyphosphatase 1,617413,"Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies",617481,AR,-,PRUNE1
"ZNF687, KIAA1441, PDB6",Zinc finger protein 687,610568,Paget disease of bone 6,616833,AD,fused with AML1 in t(1;21),ZNF687
RFX5,"Regulatory factor X, 5 (influences HLA class II expression)",601863,"Bare lymphocyte syndrome, type II, complementation group C",209920,AR,-,RFX5
RFX5,"Regulatory factor X, 5 (influences HLA class II expression)",601863,"Bare lymphocyte syndrome, type II, complementation group E",209920,AR,-,RFX5
"POGZ, KIAA0461, MRD37, WHSUS",POGO transposable element with ZNF domain,614787,White-Sutton syndrome,616364,AD,-,POGZ
"RORC, RORG, RZRG, IMD42",RAR-related orphan receptor C,602943,Immunodeficiency 42,616622,AR,-,RORC
"TCHH, THH, THL, TRHY, UHS3",Trichohyalin,190370,?Uncombable hair syndrome 3,617252,AR,mutation identified in 1 UHS3 patient,TCHH
"FLG, ATOD2",Filaggrin,135940,Ichthyosis vulgaris,146700,AD,-,FLG
"FLG, ATOD2",Filaggrin,135940,"{Dermatitis, atopic, susceptibility to, 2}",605803,-,-,FLG
LOR,Loricrin,152445,Vohwinkel syndrome with ichthyosis,604117,AD,-,LOR
"GATAD2B, KIAA1150, p68, MRD18",GATA zinc finger domain-containing protein 2B,614998,"Mental retardation, autosomal dominant 18",615074,AD,-,GATAD2B
"RPS27, MPS1, DBA17",Ribosomal protein S27,603702,?Diamond-Blackfan anemia 17,617409,AD,mutation identified in 1 DBA17 patient,RPS27
"TPM3, NEM1, CFTD, CAPM1",Tropomyosin 3,191030,CAP myopathy 1,609284,"AD,AR",TRK = chimera of TPM3 and NTRK1; NEM1 to 1q21-q23 by Fd,TPM3
"TPM3, NEM1, CFTD, CAPM1",Tropomyosin 3,191030,"Myopathy, congenital, with fiber-type disproportion",255310,"AD,AR",-,TPM3
"TPM3, NEM1, CFTD, CAPM1",Tropomyosin 3,191030,"Nemaline myopathy 1, autosomal dominant or recessive",609284,"AD,AR",-,TPM3
"HAX1, SCN3",HCLS1-associated protein X1,605998,"Neutropenia, severe congenital 3, autosomal recessive",610738,AR,-,HAX1
"IL6R, IL6RQ, IL6Q",Interleukin-6 receptor,147880,"[Interleukin 6, serum level of, QTL]",614752,-,IL6R-like gene on chr.9,IL6R
"IL6R, IL6RQ, IL6Q",Interleukin-6 receptor,147880,"[Interleukin-6 receptor, soluble, serum level of, QTL]",614689,-,-,IL6R
"CHRNB2, EFNL3","Cholinergic receptor, nicotinic, beta polypeptide-2",118507,"Epilepsy, nocturnal frontal lobe, 3",605375,-,linked to AMY in mouse,CHRNB2
"ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6","Adenosine deaminase, RNA-specific",146920,Aicardi-Goutieres syndrome 6,615010,AR,-,ADAR
"ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6","Adenosine deaminase, RNA-specific",146920,Dyschromatosis symmetrica hereditaria,127400,AD,-,ADAR
"PMVK, PMK, POROK1",Phosphomevalonate kinase,607622,"Porokeratosis 1, multiple types",175800,AD,-,PMVK
"FLAD1, FADS, LSMFLAD","Flavin adenine dinucleotide synthetase, S. cerevisiae, homolog of",610595,Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency,255100,AR,-,FLAD1
"DPM3, CDG1O",Dolichyl-phosphate mannosyltransferase 3,605951,"Congenital disorder of glycosylation, type Io",612937,-,-,DPM3
"MUC1, PUM, MCKD1","Mucin 1, transmembrane",158340,Medullary cystic kidney disease 1,174000,AD,5cM proximal to SPTA1,MUC1
GBA,"Glucosidase, acid beta",606463,"Gaucher disease, perinatal lethal",608013,AR,pseudogene GBAP ~16kb 3' to GBA,GBA
GBA,"Glucosidase, acid beta",606463,"Gaucher disease, type I",230800,AR,-,GBA
GBA,"Glucosidase, acid beta",606463,"Gaucher disease, type II",230900,AR,-,GBA
GBA,"Glucosidase, acid beta",606463,"Gaucher disease, type III",231000,AR,-,GBA
GBA,"Glucosidase, acid beta",606463,"Gaucher disease, type IIIC",231005,AR,-,GBA
GBA,"Glucosidase, acid beta",606463,"{Lewy body dementia, susceptibility to}",127750,AD,-,GBA
GBA,"Glucosidase, acid beta",606463,"{Parkinson disease, late-onset, susceptibility to}",168600,"IC,Mu",-,GBA
"PKLR, PK1","Pyruvate kinase, liver and RBC type",609712,"Adenosine triphosphate, elevated, of erythrocytes",102900,AD,-,PKLR
"PKLR, PK1","Pyruvate kinase, liver and RBC type",609712,Pyruvate kinase deficiency,266200,AR,-,PKLR
"FDPS, FPS, POROK9",Farnesyl diphosphate synthase,134629,"Porokeratosis 9, multiple types",616631,AD,-,FDPS
"ASH1L, KIAA1420, ASH1, MRD52","ash1 (absent, small, or homeotic), Drosophila, homolog of",607999,"Mental retardation, autosomal dominant 52",617796,AD,-,ASH1L
"MSTO1, MMYAT","Misato 1, mitochondrial distribution and morphology regulator",617619,"Myopathy, mitochondrial, and ataxia",617675,"AD,AR",-,MSTO1
"YY1AP1, YAP, HCCA2, GRNG",YY1 associated protein 1,607860,Grange syndrome,602531,AR,-,YY1AP1
"RIT1, RIT, ROC1, NS8",Ric-like protein without CAAX motif 1,609591,Noonan syndrome 8,615355,AD,-,RIT1
"ARHGEF2, GEFH1, KIAA0651, NEDMHM",RHO guanine nucleotide exchange factor 2,607560,?Neurodevelopmental disorder with midbrain and hindbrain malformations,617523,AR,mutation identified in 1 NEDMHM family,ARHGEF2
"LAMTOR2, MAPBPIP, p14","Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2",610389,Immunodeficiency due to defect in MAPBP-interacting protein,610798,AR,-,LAMTOR2
"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",Lamin A/C,150330,"Cardiomyopathy, dilated, 1A",115200,AD,-,LMNA
"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",Lamin A/C,150330,"Charcot-Marie-Tooth disease, type 2B1",605588,AR,-,LMNA
"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",Lamin A/C,150330,"Emery-Dreifuss muscular dystrophy 2, AD",181350,AD,-,LMNA
"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",Lamin A/C,150330,"Emery-Dreifuss muscular dystrophy 3, AR",616516,AR,-,LMNA
"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",Lamin A/C,150330,"Heart-hand syndrome, Slovenian type",610140,AD,-,LMNA
"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",Lamin A/C,150330,Hutchinson-Gilford progeria,176670,"AD,AR",-,LMNA
"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",Lamin A/C,150330,"Lipodystrophy, familial partial, type 2",151660,AD,-,LMNA
"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",Lamin A/C,150330,Malouf syndrome,212112,AD,-,LMNA
"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",Lamin A/C,150330,Mandibuloacral dysplasia,248370,AR,-,LMNA
"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",Lamin A/C,150330,"Muscular dystrophy, congenital",613205,AD,-,LMNA
"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",Lamin A/C,150330,"Muscular dystrophy, limb-girdle, type 1B",159001,AD,-,LMNA
"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",Lamin A/C,150330,"Restrictive dermopathy, lethal",275210,AR,-,LMNA
"SEMA4A, SEMB, RP35, CORD10",Semaphorin 4A,607292,Cone-rod dystrophy 10,610283,AR,-,SEMA4A
"SEMA4A, SEMB, RP35, CORD10",Semaphorin 4A,607292,Retinitis pigmentosa 35,610282,"AD,AR",-,SEMA4A
"NAXE, APOA1BP, AIBP, PEBEL",NAD(P)HX epimerase,608862,"Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy",617186,AR,-,NAXE
"PRCC, RCCP1","Papillary renal cell carcinoma, translocation-associated",179755,"Renal cell carcinoma, papillary",605074,-,t(X;1)(p11;q21); fuses with TFE3 in RCCP,PRCC
"NTRK1, TRKA, MTC","Neurotrophic tyrosine kinase, receptor, type 1",191315,"Insensitivity to pain, congenital, with anhidrosis",256800,AR,TRK = chimera of TPM3 and NTRK1,NTRK1
"NTRK1, TRKA, MTC","Neurotrophic tyrosine kinase, receptor, type 1",191315,"Medullary thyroid carcinoma, familial",155240,AD,-,NTRK1
"SPTA1, EL2, SPH3, HS3, HPP","Spectrin, alpha, erythrocytic-1",182860,Elliptocytosis-2,130600,AD,17cM proximal to FY,SPTA1
"SPTA1, EL2, SPH3, HS3, HPP","Spectrin, alpha, erythrocytic-1",182860,Pyropoikilocytosis,266140,AR,-,SPTA1
"SPTA1, EL2, SPH3, HS3, HPP","Spectrin, alpha, erythrocytic-1",182860,"Spherocytosis, type 3",270970,AR,-,SPTA1
"ACKR1, DARC, FY, GPD, WBCQ1",Atypical chemokine receptor 1 (Duffy antigen receptor for chemokines),613665,"[Blood group, Duffy system]",110700,"AD,AR","by A, 1q22-q23",ACKR1
"ACKR1, DARC, FY, GPD, WBCQ1",Atypical chemokine receptor 1 (Duffy antigen receptor for chemokines),613665,[White blood cell count QTL],611862,AR,-,ACKR1
"ACKR1, DARC, FY, GPD, WBCQ1",Atypical chemokine receptor 1 (Duffy antigen receptor for chemokines),613665,"{Malaria, vivax, protection against}",611162,-,-,ACKR1
PIGM,"Phosphatidylinositol glycan, class M",610273,Glycosylphosphatidylinositol deficiency,610293,AR,-,PIGM
"KCNJ10, SESAME","Potassium inwardly-rectifying channel, subfamily J, member 10",602208,"Enlarged vestibular aqueduct, digenic",600791,AR,-,KCNJ10
"KCNJ10, SESAME","Potassium inwardly-rectifying channel, subfamily J, member 10",602208,SESAME syndrome,612780,AR,-,KCNJ10
"ATP1A2, FHM2, MHP2","ATPase, Na+K+ transporting, alpha-2 polypeptide",182340,Alternating hemiplegia of childhood 1,104290,AD,-,ATP1A2
"ATP1A2, FHM2, MHP2","ATPase, Na+K+ transporting, alpha-2 polypeptide",182340,"Migraine, familial basilar",602481,AD,-,ATP1A2
"ATP1A2, FHM2, MHP2","ATPase, Na+K+ transporting, alpha-2 polypeptide",182340,"Migraine, familial hemiplegic, 2",602481,AD,-,ATP1A2
"CASQ1, VMCQA","Calsequestrin, fast-twitch, skeletal muscle-1",114250,"Myopathy, vacuolar, with CASQ1 aggregates",616231,AD,-,CASQ1
"DCAF8, WDR42A, GAN2",DDB1- and CUL4-associated factor 8,615820,"?Giant axonal neuropathy 2, autosomal dominant",610100,AD,mutation identified in 1 GAN2 family,DCAF8
"PEX19, PXF, HK33, D1S2223E, PBD12A",Peroxisome biogenesis factor 19 (peroxisomal farnesylated protein),600279,Peroxisome biogenesis disorder 12A (Zellweger),614886,AR,-,PEX19
"COPA, AILJK","Coatomer protein complex, subunit alpha",601924,"{Autoimmune interstitial lung, joint, and kidney disease}",616414,AD,-,COPA
NCSTN,Nicastrin,605254,"Acne inversa, familial, 1",142690,AD,-,NCSTN
"VANGL2, LTAP","Vang-like 2 (loop-tail, mouse, homolog of)",600533,Neural tube defects,182940,AD,-,VANGL2
"CD244, NAIL, NKR2B4, SLAMF4",CD244 antigen,605554,"{Rheumatoid arthritis, susceptibility to}",180300,-,-,CD244
"USF1, HYPLIP1",Upstream transcription factor 1,191523,"{Hyperlipidemia, familial combined, susceptibility to}",602491,-,-,USF1
"NECTIN 4, PVRL4, PRR4, EDSS1",Nectin 4,609607,Ectodermal dysplasia-syndactyly syndrome 1,613573,AR,-,NECTIN 4
PPOX,Protoporphyrinogen oxidase,600923,Porphyria variegata,176200,AD,-,PPOX
NDUFS2,"NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kD",602985,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",-,NDUFS2
APOA2,Apolipoprotein A-II,107670,Apolipoprotein A-II deficiency,-,-,-,APOA2
APOA2,Apolipoprotein A-II,107670,"{Hypercholesterolemia, familial, modifier of}",143890,AD,-,APOA2
"MPZ, CMT1B, CMTDID, CHM, DSS",Myelin protein zero,159440,"Charcot-Marie-Tooth disease, dominant intermediate D",607791,AD,-,MPZ
"MPZ, CMT1B, CMTDID, CHM, DSS",Myelin protein zero,159440,"Charcot-Marie-Tooth disease, type 1B",118200,AD,-,MPZ
"MPZ, CMT1B, CMTDID, CHM, DSS",Myelin protein zero,159440,"Charcot-Marie-Tooth disease, type 2I",607677,AD,-,MPZ
"MPZ, CMT1B, CMTDID, CHM, DSS",Myelin protein zero,159440,"Charcot-Marie-Tooth disease, type 2J",607736,AD,-,MPZ
"MPZ, CMT1B, CMTDID, CHM, DSS",Myelin protein zero,159440,Dejerine-Sottas disease,145900,"AD,AR",-,MPZ
"MPZ, CMT1B, CMTDID, CHM, DSS",Myelin protein zero,159440,"Neuropathy, congenital hypomyelinating",605253,"AD,AR",-,MPZ
"MPZ, CMT1B, CMTDID, CHM, DSS",Myelin protein zero,159440,Roussy-Levy syndrome,180800,AD,-,MPZ
"SDHC, PGL3","Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kD",602413,Gastrointestinal stromal tumor,606764,"AD,IC",-,SDHC
"SDHC, PGL3","Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kD",602413,Paraganglioma and gastric stromal sarcoma,606864,-,-,SDHC
"SDHC, PGL3","Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kD",602413,Paragangliomas 3,605373,AD,-,SDHC
"FCGR2A, IGFR2, CD32","Fc fragment of IgG, low affinity IIa, receptor for (CD32)",146790,"{Lupus nephritis, susceptibility to}",152700,AD,FCG2 and FCG3 within 250kb,FCGR2A
"FCGR2A, IGFR2, CD32","Fc fragment of IgG, low affinity IIa, receptor for (CD32)",146790,"{Malaria, severe, susceptibility to}",611162,-,-,FCGR2A
"FCGR2A, IGFR2, CD32","Fc fragment of IgG, low affinity IIa, receptor for (CD32)",146790,"{Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}",219700,AR,-,FCGR2A
"FCGR3A, CD16, IGFR3, IMD20","Fc fragment of IgG, low affinity III, receptor for (CD16)",146740,Immunodeficiency 20,615707,AR,FCGR2A and FCGR3A within 250kb antigen,FCGR3A
"FCGR2B, CD32","Fc fragment of IgG, low affinity IIb, receptor for",604590,"{Malaria, resistance to}",611162,-,-,FCGR2B
"FCGR2B, CD32","Fc fragment of IgG, low affinity IIb, receptor for",604590,"{Systemic lupus erythematosus, susceptibility to}",152700,AD,-,FCGR2B
"ATF6, ACHM7",Activating transcription factor-6,605537,Achromatopsia 7,616517,AR,-,ATF6
"DDR2, NTRKR3, TKT","Discoidin domain receptor family, member 2",191311,"Spondylometaepiphyseal dysplasia, short limb-hand type",271665,AR,-,DDR2
RGS5,Regulator of G protein signaling-5,603276,[Blood pressure regulation QTL],145500,Mu,-,RGS5
"PBX1, CAKUHED",Pre-B cell leukemia transcription factor-1,176310,"Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay",617641,AD,pseudogene PBXP1 on chr.3,PBX1
"TMCO1, CFSMR",Transmembrane and coiled-coil domains protein 1,614123,"Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome",213980,AR,-,TMCO1
"CD247, CD3Z, TCRZ, IMD25",CD247 antigen,186780,?Immunodeficiency 25,610163,AR,mutation identified in one IMD25 patient,CD247
"ADCY10, SAC, HCA2","Adenylyl cyclase 10, soluble",605205,"{Hypercalciuria, absorptive, susceptibility to}",143870,AD,-,ADCY10
TBX19,T-box 19,604614,Adrenocorticotropic hormone deficiency,201400,AR,-,TBX19
ATP1B1,"ATPase, Na+K+ transporting, beta-1 polypeptide",182330,[Blood pressure regulation QTL],145500,Mu,-,ATP1B1
"SLC19A2, THTR1, TRMA, THMD1","Solute carrier family 19 (thiamine transporter), member 2",603941,Thiamine-responsive megaloblastic anemia syndrome,249270,AR,-,SLC19A2
"F5, THPH2, RPRGL1","Coagulation factor V (proaccelerin, labile factor)",612309,Factor V deficiency,227400,AR,Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment,F5
"F5, THPH2, RPRGL1","Coagulation factor V (proaccelerin, labile factor)",612309,Thrombophilia due to activated protein C resistance,188055,AD,-,F5
"F5, THPH2, RPRGL1","Coagulation factor V (proaccelerin, labile factor)",612309,{Budd-Chiari syndrome},600880,AR,-,F5
"F5, THPH2, RPRGL1","Coagulation factor V (proaccelerin, labile factor)",612309,"{Pregnancy loss, recurrent, susceptibility to, 1}",614389,AD,-,F5
"F5, THPH2, RPRGL1","Coagulation factor V (proaccelerin, labile factor)",612309,"{Stroke, ischemic, susceptibility to}",601367,Mu,-,F5
"F5, THPH2, RPRGL1","Coagulation factor V (proaccelerin, labile factor)",612309,"{Thrombophilia, susceptibility to, due to factor V Leiden}",188055,AD,-,F5
"GORAB, SCYL1BP1, NTKLBP1, GO","Golgin, RAB6-interacting",607983,Geroderma osteodysplasticum,231070,AR,-,GORAB
"PRRX1, PMX1, PHOX1, AGOTC",Paired-related homeobox gene 1,167420,Agnathia-otocephaly complex,202650,"AD,AR",-,PRRX1
"FMO3, TMAU",Flavin-containing monooxygenase 3,136132,Trimethylaminuria,602079,AR,-,FMO3
"MYOC, TIGR, GLC1A, JOAG, GPOA",Myocilin (trabecular meshwork-induced glucocorticoid response protein),601652,"Glaucoma 1A, primary open angle",137750,AD,-,MYOC
"PIGC, GPI2, GPIBD16, MRT62","Phosphatidylinositol glycan, class C",601730,Glycosylphosphatidylinositol biosynthesis defect 16,617816,-,-,PIGC
"FASLG, TNFSF6, APT1LG1, FASL, ALPS1B","Fas ligand (TNF superfamily, member 6)",134638,"Autoimmune lymphoproliferative syndrome, type IB",601859,AD,-,FASLG
"FASLG, TNFSF6, APT1LG1, FASL, ALPS1B","Fas ligand (TNF superfamily, member 6)",134638,"{Lung cancer, susceptibility to}",211980,AR,-,FASLG
"TNFSF4, GP34, OX4OL","Tumor necrosis factor ligand superfamily, member 4",603594,"{Myocardial infarction, susceptibility to}",608446,-,-,TNFSF4
"DARS2, ASPRS. LBSL",Aspartyl-tRNA synthetase 2,610956,Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation,611105,AR,-,DARS2
"SERPINC1, AT3, AT3D, THPH7",Antithrombin III,107300,Thrombophilia due to antithrombin III deficiency,613118,"AD,AR",~17cM distal to FY,SERPINC1
"PDCN, NPHS2, SRN1",Podocin,604766,"Nephrotic syndrome, type 2",600995,AR,modifies phenotype of NPHS1 mutations to FSGS,PDCN
"TOR1AIP1, LAP1, LAP1B, LGMD2Y",Torsin A-interacting protein 1,614512,"?Muscular dystrophy, limb-girdle, type 2Y",617072,AR,mutation identified in 1 LGMD2Y family,TOR1AIP1
"LHX4, CPHD4",LIM homeo box gene 4,602146,"Pituitary hormone deficiency, combined, 4",262700,AD,fused to IGH in ALL,LHX4
"XPR1, SYG1, IBGC6",Xenotropic and polytropic retrovirus receptor,605237,"Basal ganglia calcification, idiopathic, 6",616413,AD,-,XPR1
"GLUL, GLNS",Glutamate-ammonia ligase (glutamine synthase),138290,"Glutamine deficiency, congenital",610015,AR,pseudogene on chr.9,GLUL
"RNASEL, RNS4, PRCA1, HPC1","Ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)",180435,Prostate cancer 1,601518,AD,-,RNASEL
"LAMC2, LAMNB2, LAMB2T","Laminin, gamma-2 (nicein, 100kD; kalinin, 105kD; BM600, 100kD)",150292,"Epidermolysis bullosa, junctional, Herlitz type",226700,AR,-,LAMC2
"LAMC2, LAMNB2, LAMB2T","Laminin, gamma-2 (nicein, 100kD; kalinin, 105kD; BM600, 100kD)",150292,"Epidermolysis bullosa, junctional, non-Herlitz type",226650,AR,-,LAMC2
NCF2,"Neutrophil cytosolic factor-2, 65kD",608515,Chronic granulomatous disease due to deficiency of NCF-2,233710,AR,-,NCF2
"TSEN15, SEN15, C1orf19, PCH2F","tRNA splicing endonuclease 15, S. cerevisiae, homolog of",608756,"Pontocerebellar hypoplasia, type 2F",617026,AR,-,TSEN15
"HMCN1, FBLN6, FIBL6, ARMD1",Hemicentin (fibulin 6),608548,"{Macular degeneration, age-related, 1}",603075,AD,-,HMCN1
"PRG4, CACP, MSF, SZP, HAPO",Proteoglycan 4 (megakaryocyte stimulating factor; hemangiopoietin),604283,Camptodactyly-arthropathy-coxa vara-pericarditis syndrome,208250,AR,-,PRG4
"CDC73, HRPT2, C1orf28","Cell division cycle protein 73, S. cerevisiae, homolog of",607393,"Hyperparathyroidism, familial primary",145000,AD,-,CDC73
"CDC73, HRPT2, C1orf28","Cell division cycle protein 73, S. cerevisiae, homolog of",607393,Hyperparathyroidism-jaw tumor syndrome,145001,AD,-,CDC73
"CDC73, HRPT2, C1orf28","Cell division cycle protein 73, S. cerevisiae, homolog of",607393,Parathyroid adenoma with cystic changes,145001,AD,-,CDC73
"CDC73, HRPT2, C1orf28","Cell division cycle protein 73, S. cerevisiae, homolog of",607393,Parathyroid carcinoma,608266,-,-,CDC73
"KCNT2, SLICK, EIEE57","Potassium channel, subfamily T, member 2",610044,"?Epileptic encephalopathy, early infantile, 57",617771,AD,mutation identified in 1 EIEE57 patient,KCNT2
"CFH, HF1, HUS, ARMD4, AHUS1",Complement factor H,134370,Basal laminar drusen,126700,AD,-,CFH
"CFH, HF1, HUS, ARMD4, AHUS1",Complement factor H,134370,Complement factor H deficiency,609814,"AD,AR",-,CFH
"CFH, HF1, HUS, ARMD4, AHUS1",Complement factor H,134370,"{Hemolytic uremic syndrome, atypical, susceptibility to, 1}",235400,"AD,AR",-,CFH
"CFH, HF1, HUS, ARMD4, AHUS1",Complement factor H,134370,"{Macular degeneration, age-related, 4}",610698,-,-,CFH
"CFHR3, FHR3, HLF4, CFHL3",Complement factor H-related 3,605336,"{Hemolytic uremic syndrome, atypical, susceptibility to}",235400,"AD,AR",-,CFHR3
"CFHR3, FHR3, HLF4, CFHL3",Complement factor H-related 3,605336,"{Macular degeneration, age-related, reduced risk of}",603075,AD,-,CFHR3
"CFHR1, FHR1, HFL1, CFHL1",Complement factor H-related 1,134371,"{Hemolytic uremic syndrome, atypical, susceptibility to}",235400,"AD,AR",-,CFHR1
"CFHR1, FHR1, HFL1, CFHL1",Complement factor H-related 1,134371,"{Macular degeneration, age-related, reduced risk of}",603075,AD,-,CFHR1
"CFHR5, CFHL5, FHR5, CFHR5D",Complement factor H-related 5,608593,Nephropathy due to CFHR5 deficiency,614809,AD,-,CFHR5
F13B,"Coagulation factor XIII, B polypeptide",134580,Factor XIIIB deficiency,613235,AR,-,F13B
"ASPM, MCPH5","Abnormal spindle-like, microcephaly-associated",605481,"Microcephaly 5, primary, autosomal recessive",608716,AR,-,ASPM
"CRB1, RP12, LCA8","Crumbs, Drosophila, homolog of, 1",604210,Leber congenital amaurosis 8,613835,-,-,CRB1
"CRB1, RP12, LCA8","Crumbs, Drosophila, homolog of, 1",604210,Pigmented paravenous chorioretinal atrophy,172870,AD,-,CRB1
"CRB1, RP12, LCA8","Crumbs, Drosophila, homolog of, 1",604210,"Retinitis pigmentosa-12, autosomal recessive",600105,AR,-,CRB1
"PTPRC, CD45, LCA","Protein tyrosine phosphatase, receptor type, c polypeptide",151460,"Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive",608971,AR,-,PTPRC
"PTPRC, CD45, LCA","Protein tyrosine phosphatase, receptor type, c polypeptide",151460,"{Hepatitis C virus, susceptibility to}",609532,-,-,PTPRC
"KIF14, KIAA0042, MKS12",Kinesin family member 14,611279,?Meckel syndrome 12,616258,AR,mutation identified in 1 MKS12 family,KIF14
"DDX59, OFD5",DEAD box polypeptide 59,615464,Orofaciodigital syndrome V,174300,AR,-,DDX59
"CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1","Calcium channel, voltage-dependent, L type, alpha 1S subunit",114208,"Hypokalemic periodic paralysis, type 1",170400,AD,"in mouse, mutation causes muscular dysgenesis",CACNA1S
"CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1","Calcium channel, voltage-dependent, L type, alpha 1S subunit",114208,{Malignant hyperthermia susceptibility 5},601887,AD,-,CACNA1S
"CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1","Calcium channel, voltage-dependent, L type, alpha 1S subunit",114208,"{Thyrotoxic periodic paralysis, susceptibility to, 1}",188580,IC,-,CACNA1S
PKP1,Plakophilin-1,601975,Ectodermal dysplasia/skin fragility syndrome,604536,-,-,PKP1
"TNNT2, CMH2, CMD1D, RCM3, LVNC6","Troponin-T2, cardiac",191045,"Cardiomyopathy, dilated, 1D",601494,AD,-,TNNT2
"TNNT2, CMH2, CMD1D, RCM3, LVNC6","Troponin-T2, cardiac",191045,"Cardiomyopathy, familial restrictive, 3",612422,AD,-,TNNT2
"TNNT2, CMH2, CMD1D, RCM3, LVNC6","Troponin-T2, cardiac",191045,"Cardiomyopathy, hypertrophic, 2",115195,AD,-,TNNT2
"TNNT2, CMH2, CMD1D, RCM3, LVNC6","Troponin-T2, cardiac",191045,Left ventricular noncompaction 6,601494,AD,-,TNNT2
"UBE2T, HSPC150, FANCT",Ubiquitin-conjugating enzyme E2T,610538,"Fanconi anemia, complementation group T",616435,AR,-,UBE2T
"SYT2, CMS7, MYSPC",Synaptotagmin-2,600104,"Myasthenic syndrome, congenital, 7, presynaptic",616040,AD,-,SYT2
"CHI3L1, GP39, YKL40, ASRT7",Chitinase 3-like 1 (cartilage glycoprotein-39),601525,"{Asthma-related traits, susceptibility to, 7}",611960,-,-,CHI3L1
"CHI3L1, GP39, YKL40, ASRT7",Chitinase 3-like 1 (cartilage glycoprotein-39),601525,"{Schizophrenia, susceptibility to}",181500,AD,-,CHI3L1
"CHIT, CHITD",Chitotriosidase,600031,[Chitotriosidase deficiency],614122,AR,-,CHIT
"SNRPE, HYPT11",Small nuclear ribonucleoprotein polypeptide E,128260,Hypotrichosis 11,615059,AD,-,SNRPE
"REN, HNFJ2",Renin,179820,"Hyperuricemic nephropathy, familial juvenile 2",613092,AD,~24cM distal to AT3,REN
"REN, HNFJ2",Renin,179820,Renal tubular dysgenesis,267430,AR,-,REN
"REN, HNFJ2",Renin,179820,[Hyperproreninemia],-,-,-,REN
"KISS1, HH13",KISS1 metastasis suppressor,603286,?Hypogonadotropic hypogonadism 13 with or without anosmia,614842,AR,mutation identified in 1 HH13 family,KISS1
"PPP1R15B, CREP, MSSGM2","Protein phosphatase 1, regulatory subunit 15B",613257,"Microcephaly, short stature, and impaired glucose metabolism 2",616817,AR,-,PPP1R15B
"CNTN2, TAX, TAX1, FAME5",Contactin 2 (transiently-expressed axonal glycoprotein),190197,"?Epilepsy, myoclonic, familial adult, 5",615400,AR,1 family identified with mutation,CNTN2
"DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1, SPG23",Dual serine/threonine and tyrosine protein kinase,612666,Congenital anomalies of kidney and urinary tract 1,610805,AD,-,DSTYK
"DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1, SPG23",Dual serine/threonine and tyrosine protein kinase,612666,Spastic paraplegia 23,270750,AR,-,DSTYK
"IL10, CSIF, GVHDS",Interleukin-10,124092,"{Graft-versus-host disease, protection against}",614395,-,-,IL10
"IL10, CSIF, GVHDS",Interleukin-10,124092,"{HIV-1, susceptibility to}",609423,-,-,IL10
"IL10, CSIF, GVHDS",Interleukin-10,124092,"{Rheumatoid arthritis, progression of}",180300,-,-,IL10
"CD55, DAF, CROM, CHAPLE",CD55 antigen (blood group Cromer),125240,"Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy",226300,AR,-,CD55
"CD55, DAF, CROM, CHAPLE",CD55 antigen (blood group Cromer),125240,[Blood group Cromer],613793,AR,-,CD55
"CR2, C3DR, SLEB9, CVID7",Complement component (3d/Epstein-Barr virus) receptor-2,120650,"Immunodeficiency, common variable, 7",614699,AR,-,CR2
"CR2, C3DR, SLEB9, CVID7",Complement component (3d/Epstein-Barr virus) receptor-2,120650,"{Systemic lupus erythematosus, susceptibility to, 9}",610927,-,-,CR2
"CR1, C3BR",Complement component (3b/4b) receptor-1,120620,CR1 deficiency,-,-,-,CR1
"CR1, C3BR",Complement component (3b/4b) receptor-1,120620,"[Blood group, Knops system]",607486,-,-,CR1
"CR1, C3BR",Complement component (3b/4b) receptor-1,120620,{?SLE susceptibility},-,-,-,CR1
"CR1, C3BR",Complement component (3b/4b) receptor-1,120620,"{Malaria, severe, resistance to}",611162,-,-,CR1
"MCP, CD46, AHUS2","Membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen)",120920,"{Hemolytic uremic syndrome, atypical, susceptibility to, 2}",612922,"AD,AR",-,MCP
"LAMB3, AI1A","Laminin, beta-3 (nicein, 125kD; kalinin, 140kD; BM600, 125kD)",150310,"Amelogenesis imperfecta, type IA",104530,AD,-,LAMB3
"LAMB3, AI1A","Laminin, beta-3 (nicein, 125kD; kalinin, 140kD; BM600, 125kD)",150310,"Epidermolysis bullosa, junctional, Herlitz type",226700,AR,-,LAMB3
"LAMB3, AI1A","Laminin, beta-3 (nicein, 125kD; kalinin, 140kD; BM600, 125kD)",150310,"Epidermolysis bullosa, junctional, non-Herlitz type",226650,AR,-,LAMB3
"HSD11B1, HSD11, HSD11L, CORTRD2","Hydroxysteroid, 11-beta, dehydrogenase 1",600713,Cortisone reductase deficiency 2,614662,AD,digenic triallelic mutations with H6PD,HSD11B1
"IRF6, VWS, LPS, PIT, PPS1, OFC6",Interferon regulatory factor 6,607199,Popliteal pterygium syndrome 1,119500,AD,OFC6 in enhancer 5' of IRF6,IRF6
"IRF6, VWS, LPS, PIT, PPS1, OFC6",Interferon regulatory factor 6,607199,van der Woude syndrome,119300,AD,-,IRF6
"IRF6, VWS, LPS, PIT, PPS1, OFC6",Interferon regulatory factor 6,607199,{Orofacial cleft 6},608864,IC,-,IRF6
"SYT14, SCAR11",Synaptotagmin 14,610949,"Spinocerebellar ataxia, autosomal recessive 11",614229,AR,-,SYT14
"KCNH1, EAG, TMBTS, ZLS1","Potassium voltage-gated channel, subfamily H, member 1 (ether-a-go-go, drosophila, homolog of)",603305,Temple-Baraitser syndrome,611816,AD,-,KCNH1
"KCNH1, EAG, TMBTS, ZLS1","Potassium voltage-gated channel, subfamily H, member 1 (ether-a-go-go, drosophila, homolog of)",603305,Zimmermann-Laband syndrome 1,135500,AD,-,KCNH1
"RD3, LCA12, C1orf36","Retinal degeneration 3, mouse, homolog of",180040,Leber congenital amaurosis 12,610612,AR,-,RD3
"NEK2, RP67",Never in mitosis gene a-related kinase 2,604043,?Retinitis pigmentosa 67,615565,AR,"pseudogenes on chr. 2, 14, and 22; mutation identified in 1 family",NEK2
"FLVCR1, AXPC1, PCARP",Feline leukemia virus subgroup C receptor 1,609144,"Ataxia, posterior column, with retinitis pigmentosa",609033,AR,-,FLVCR1
"PTPN14, PEZ, CATLPH","Protein tyrosine phosphatase, nonreceptor-type, 14",603155,?Choanal atresia and lymphedema,613611,AR,mutation identified in 1 CATLPH family,PTPN14
"DEL1q41q42, C1DELq41q42",Chromosome 1q41-q42 deletion syndrome,612530,Chromosome 1q41-q42 deletion syndrome,612530,IC,contiguous gene deletion of 1.7Mb,DEL1q41q42
"CENPF, CILD31, STROMS","Centromere autoantigen F, 400kD",600236,Stromme syndrome,243605,AR,-,CENPF
"USH2A, RP39",Usherin,608400,Retinitis pigmentosa 39,613809,-,-,USH2A
"USH2A, RP39",Usherin,608400,"Usher syndrome, type 2A",276901,AR,-,USH2A
"TGFB2, LDS4","Transforming growth factor, beta-2",190220,Loeys-Dietz syndrome 4,614816,AD,-,TGFB2
"SLC30A10, ZNT10, HMNDYT1","Solute carrier family 30 (zinc transporter), member 10",611146,Hypermanganesemia with dystonia 1,613280,AR,-,SLC30A10
"IARS2, CAGSSS",Isoleucyl-tRNA synthetase 2,612801,"?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia",616007,AR,mutation identified in 1 CAGSSS family,IARS2
"RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2",RAB3 GTPase-activating protein (noncatalytic) subunit 2,609275,Martsolf syndrome,212720,AR,-,RAB3GAP2
"RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2",RAB3 GTPase-activating protein (noncatalytic) subunit 2,609275,Warburg micro syndrome 2,614225,AR,-,RAB3GAP2
"TLR5, TIL3, SLEB1, MELIOS",Toll-like receptor-5,603031,"{Legionnaire disease, susceptibility to}",608556,-,-,TLR5
"TLR5, TIL3, SLEB1, MELIOS",Toll-like receptor-5,603031,"{Melioidosis, susceptibility to}",615557,-,-,TLR5
"TLR5, TIL3, SLEB1, MELIOS",Toll-like receptor-5,603031,"{Systemic lupus erythematosus, resistance to}",601744,-,-,TLR5
"TLR5, TIL3, SLEB1, MELIOS",Toll-like receptor-5,603031,"{Systemic lupus erythematosus, susceptibility to, 1}",601744,-,-,TLR5
"WDR26, SKDEAS",WD repeat-containing protein 26,617424,Skraban-Deardorff syndrome,617616,AD,-,WDR26
"LBR, PHA",Lamin B receptor,600024,?Reynolds syndrome,613471,AD,-,LBR
"LBR, PHA",Lamin B receptor,600024,Greenberg skeletal dysplasia,215140,AR,-,LBR
"LBR, PHA",Lamin B receptor,600024,Pelger-Huet anomaly,169400,AD,-,LBR
EPHX1,"Epoxide hydroxylase 1, microsomal xenobiotic",132810,"Hypercholanemia, familial",607748,-,-,EPHX1
"PYCR2, HLD10",Pyrroline-5-carboxylate reductase 2,616406,"Leukodystrophy, hypomyelinating, 10",616420,AR,-,PYCR2
"PSEN2, AD4, STM2, CMD1V",Presenilin 2,600759,Alzheimer disease-4,606889,AD,-,PSEN2
"PSEN2, AD4, STM2, CMD1V",Presenilin 2,600759,"Cardiomyopathy, dilated, 1V",613697,AD,-,PSEN2
"ADCK3, COQ8, CABC1, SCAR9, ARCA2, COQ10D4",AARF domain-containing kinase 3,606980,"Coenzyme Q10 deficiency, primary, 4",612016,AR,-,ADCK3
"GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C","Gap junction protein, gamma-2 (47kD)",608803,"Leukodystrophy, hypomyelinating, 2",608804,AR,-,GJC2
"GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C","Gap junction protein, gamma-2 (47kD)",608803,"Lymphedema, hereditary, IC",613480,AD,-,GJC2
"GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C","Gap junction protein, gamma-2 (47kD)",608803,"Spastic paraplegia 44, autosomal recessive",613206,AR,-,GJC2
"IBA57, C1orf69, MMDS3, SPG74","IBA57, S. cerevisiae, homolog of",615316,?Multiple mitochondrial dysfunctions syndrome 3,615330,AR,mutation identified in 1 MMDS3 family and 1 SPG74 family,IBA57
"IBA57, C1orf69, MMDS3, SPG74","IBA57, S. cerevisiae, homolog of",615316,"?Spastic paraplegia 74, autosomal recessive",616451,AR,-,IBA57
"ACTA1, ASMA, NEM3, CFTD1, SHPM","Actin, alpha-1, skeletal muscle",102610,"?Myopathy, scapulohumeroperoneal",616852,AD,mutation identified in 1 SHPM family,ACTA1
"ACTA1, ASMA, NEM3, CFTD1, SHPM","Actin, alpha-1, skeletal muscle",102610,"Myopathy, actin, congenital, with cores",161800,"AD,AR",-,ACTA1
"ACTA1, ASMA, NEM3, CFTD1, SHPM","Actin, alpha-1, skeletal muscle",102610,"Myopathy, actin, congenital, with excess of thin myofilaments",161800,"AD,AR",-,ACTA1
"ACTA1, ASMA, NEM3, CFTD1, SHPM","Actin, alpha-1, skeletal muscle",102610,"Myopathy, congenital, with fiber-type disproportion 1",255310,"AD,AR",-,ACTA1
"ACTA1, ASMA, NEM3, CFTD1, SHPM","Actin, alpha-1, skeletal muscle",102610,"Nemaline myopathy 3, autosomal dominant or recessive",161800,"AD,AR",-,ACTA1
PCAP,Predisposing for prostate cancer,602759,"{Prostate cancer, susceptibility to}",176807,AD,-,PCAP
"COG2, LDLC, CDG2Q",Component of oligomeric golgi complex 2,606974,"?Congenital disorder of glycosylation, type IIq",617395,AR,mutation identified in 1 CDG2Q patient,COG2
"AGT, SERPINA8",Angiotensinogen,106150,Renal tubular dysgenesis,267430,AR,-,AGT
"AGT, SERPINA8",Angiotensinogen,106150,"{Hypertension, essential, susceptibility to}",145500,Mu,-,AGT
"AGT, SERPINA8",Angiotensinogen,106150,"{Preeclampsia, susceptibility to}",-,-,-,AGT
"ARV1, EIEE38","ARV1, S. cerevisiae, homolog of",611647,"Epileptic encephalopathy, early infantile, 38",617020,AR,-,ARV1
"GNPAT, DHAPAT, RCDP2",Glyceronephosphate O-acyltransferase,602744,"Rhizomelic chondrodysplasia punctata, type 2",222765,AR,-,GNPAT
"SPRTN, DVC1, C1orf124, RJALS",SprT-like N-terminal domain protein,616086,Ruijs-Aalfs syndrome,616200,AR,-,SPRTN
"EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH","Egl9, C. elegans, homolog of, 1",606425,"Erythrocytosis, familial, 3",609820,AD,-,EGLN1
"EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH","Egl9, C. elegans, homolog of, 1",606425,"[Hemoglobin, high altitude adaptation]",609070,AD,-,EGLN1
"DISC1, SCZD9",Disrupted in schizophrenia 1,605210,"{Schizophrenia 9, susceptibility to}",604906,-,-,DISC1
DISC2,Disrupted in schizophrenia 2,606271,Schizophrenia,181500,AD,noncoding antisense RAN,DISC2
"COA6, C1orf31, CEMCOX4",Cytochrome c oxidase assembly factor 6,614772,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4",616501,AR,-,COA6
"IRF2BP2, CVID14",Interferon regulatory factor 2-binding protein 2,615332,"?Immunodeficiency, common variable, 14",617765,AD,mutation identified in 1 CVID14 family,IRF2BP2
"TBCE, KCS, KCS1, HRD, PEAMO",Tubulin-specific chaperone E,604934,"Encephalopathy, progressive, with amyotrophy and optic atrophy",617207,AR,-,TBCE
"TBCE, KCS, KCS1, HRD, PEAMO",Tubulin-specific chaperone E,604934,Hypoparathyroidism-retardation-dysmorphism syndrome,241410,AR,-,TBCE
"TBCE, KCS, KCS1, HRD, PEAMO",Tubulin-specific chaperone E,604934,"Kenny-Caffey syndrome, type 1",244460,AR,-,TBCE
"B3GALNT2, MGC39558, MDDGA11","Beta-1,3-N-acetylgalactosaminyltransferase 2",610194,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11",615181,AR,-,B3GALNT2
"LYST, CHS1",Lysosomal trafficking regulator,606897,Chediak-Higashi syndrome,214500,AR,-,LYST
"EDARADD, ED3, EDA3, ECTD11B, ECTD11A",EDAR-associated death domain,606603,"Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant",614940,AD,-,EDARADD
"EDARADD, ED3, EDA3, ECTD11B, ECTD11A",EDAR-associated death domain,606603,"Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive",614941,AR,-,EDARADD
"ACTN2, CMD1AA, CMH23","Actinin, alpha-2",102573,"Cardiomyopathy, dilated, 1AA, with or without LVNC",612158,AD,-,ACTN2
"ACTN2, CMD1AA, CMH23","Actinin, alpha-2",102573,"Cardiomyopathy, hypertrophic, 23, with or without LVNC",612158,AD,-,ACTN2
"MTR, HMAG",5-methyltetrahydrofolate-homocysteine methyltransferase 1,156570,"Homocystinuria-megaloblastic anemia, cblG complementation type",250940,AR,-,MTR
"MTR, HMAG",5-methyltetrahydrofolate-homocysteine methyltransferase 1,156570,"{Neural tube defects, folate-sensitive, susceptibility to}",601634,AR,-,MTR
"RYR2, VTSIP, ARVD2, ARVC2",Ryanodine receptor-2 (cardiac),180902,Arrhythmogenic right ventricular dysplasia 2,600996,AD,-,RYR2
"RYR2, VTSIP, ARVD2, ARVC2",Ryanodine receptor-2 (cardiac),180902,"Ventricular tachycardia, catecholaminergic polymorphic, 1",604772,AD,-,RYR2
"CHRM3, PBS, EGBRS","Cholinergic receptor, muscarinic, 3",118494,?Prune belly syndrome,100100,AR,mutation identified in 1 PBS family,CHRM3
"FMN2, MRT47",Formin 2,606373,"Mental retardation, autosomal recessive 47",616193,AR,-,FMN2
"GREM2, PRDC, STHAG9","Gremlin 2 homolog, cystine knot superfamily",608832,"Tooth agenesis, selective, 9",617275,AD,-,GREM2
"FH, HLRCC, MCUL1, FMRD",Fumarate hydratase,136850,Fumarase deficiency,606812,AR,-,FH
"FH, HLRCC, MCUL1, FMRD",Fumarate hydratase,136850,Leiomyomatosis and renal cell cancer,150800,AD,-,FH
"SDCCAG8, CCCAP, SLSN7, BBS16",Serologically defined colon cancer antigen 8,613524,Bardet-Biedl syndrome 16,615993,AR,-,SDCCAG8
"SDCCAG8, CCCAP, SLSN7, BBS16",Serologically defined colon cancer antigen 8,613524,Senior-Loken syndrome 7,613615,-,-,SDCCAG8
"AKT3, PKBG, MPPH2",v-Akt murine thymoma viral oncogene homolog 3,611223,Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2,615937,AD,-,AKT3
"ZBTB18, ZNF238, RP58, MRD22",Zinc finger and BTB domain containing 18,608433,"Mental retardation, autosomal dominant 22",612337,AD,-,ZBTB18
"COX20, FAM36A","Cytochrome c oxidase 20, S. cerevisiae, homolog of",614698,Mitochondrial complex IV deficiency,220110,"Mi,AR",-,COX20
"HNRNPU, HNRPU, SAFA, EIEE54",Heterogeneous nuclear ribonucleoprotein U,602869,"Epileptic encephalopathy, early infantile, 54",617391,AD,-,HNRNPU
"NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34","NLR family, pyrin domain containing 3",606416,CINCA syndrome,607115,AD,-,NLRP3
"NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34","NLR family, pyrin domain containing 3",606416,"Deafness, autosomal dominant 34, with or without inflammation",617772,AD,-,NLRP3
"NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34","NLR family, pyrin domain containing 3",606416,Familial cold-induced inflammatory syndrome 1,120100,AD,-,NLRP3
"NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34","NLR family, pyrin domain containing 3",606416,Muckle-Wells syndrome,191900,AD,-,NLRP3
HYT3,"Hypertension, essential, susceptibility to, 3",607329,"{Hypertension, essential, susceptibility to, 3}",145500,Mu,-,HYT3
"TPO, TPX, TDH2A",Thyroid peroxidase,606765,Thyroid dyshormonogenesis 2A,274500,AR,-,TPO
"PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA, ASGD7","Peroxidasin, Drosophila, homolog of",605158,"Anterior segment dysgenesis 7, with sclerocornea",269400,AR,-,PXDN
"MYT1L, KIAA1106, MRD39",Myelin transcription factor 1-like,613084,"Mental retardation, autosomal dominant 39",616521,AD,-,MYT1L
"TRAPPC12, TTC15, PEBAS","Trafficking protein particle complex, subunit 12",614139,"Encephalopathy, progressive, early-onset, with brain atrophy and spasticity",617669,AR,-,TRAPPC12
"RNASEH1, PEOB2",Ribonuclease H1,604123,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2",616479,AR,pseudogenes on chr. 17 and chr.1,RNASEH1
"RPS7, DBA8",Ribosomal protein S7,603658,Diamond-Blackfan anemia 8,612563,AD,-,RPS7
"COLEC11, CLK1, 3MC2",Collectin 11,612502,3MC syndrome 2,265050,AR,-,COLEC11
"SOX11, MRD27",SRY (sex-determining region Y)-box 11,600898,"Mental retardation, autosomal dominant 27",615866,AD,-,SOX11
"KIDINS220, ARMS, SINO","Kinase D-interacting substrate, 220kD",615759,"Spastic paraplegia, intellectual disability, nystagmus, and obesity",617296,AD,-,KIDINS220
"ADAM17, TACE, NISBD1",A disintegrin and metalloproteinase domain 17,603639,"?Inflammatory skin and bowel disease, neonatal, 1",614328,AR,mutation identified in 1 NISBD1 family,ADAM17
"KLF11, TIEG2, FKLF1, FKLF, MODY7",Kruppel-like factor 11,603301,"Maturity-onset diabetes of the young, type VII",610508,-,-,KLF11
ODC1,Ornithine decarboxylase-1,165640,"{Colonic adenoma recurrence, reduced risk of}",114500,AD,pseudogene ODCP on 7q31-qter,ODC1
LPIN1,Lipin 1,605518,"Myoglobinuria, acute recurrent, autosomal recessive",268200,AR,related to LSL,LPIN1
"NBAS, NAG, SOPH, ILFS2",Neuroblastoma-amplified sequence,608025,Infantile liver failure syndrome 2,616483,AR,-,NBAS
"NBAS, NAG, SOPH, ILFS2",Neuroblastoma-amplified sequence,608025,"Short stature, optic nerve atrophy, and Pelger-Huet anomaly",614800,AR,-,NBAS
"MYCN, NMYC, ODED, MODED",Oncogene NMYC,164840,Feingold syndrome 1,164280,AD,proximal to APOB,MYCN
"WDR35, NAOFEN, KIAA1336, CED2, SRTD7",WD repeat-containing protein 35,613602,Cranioectodermal dysplasia 2,613610,AR,-,WDR35
"WDR35, NAOFEN, KIAA1336, CED2, SRTD7",WD repeat-containing protein 35,613602,Short-rib thoracic dysplasia 7 with or without polydactyly,614091,AR,-,WDR35
"MATN3, EDM5, HOA, OS2",Matrilin 3,602109,?Spondyloepimetaphyseal dysplasia,608728,AR,mutation identified in 1 SEMDM family,MATN3
"MATN3, EDM5, HOA, OS2",Matrilin 3,602109,"Epiphyseal dysplasia, multiple, 5",607078,AD,-,MATN3
"MATN3, EDM5, HOA, OS2",Matrilin 3,602109,{Osteoarthritis susceptibility 2},140600,AD,-,MATN3
"APOB, FLDB, LDLCQ4",Apolipoprotein B (including Ag(x) antigen),107730,"Hypercholesterolemia, due to ligand-defective apo B",144010,AD,1 gene for liver apo-B100 and gut apo-B48; Ag linked,APOB
"APOB, FLDB, LDLCQ4",Apolipoprotein B (including Ag(x) antigen),107730,Hypobetalipoproteinemia,615558,AR,-,APOB
"ADCY3, BMIQ19",Adenylate cyclase-3,600291,"{Obesity, susceptibility to, BMIQ19}",617885,-,-,ADCY3
POMC,Proopiomelanocortin (adrenocorticotropin/beta-lipotropin),176830,"Obesity, adrenal insufficiency, and red hair due to POMC deficiency",609734,AR,-,POMC
POMC,Proopiomelanocortin (adrenocorticotropin/beta-lipotropin),176830,"{Obesity, early-onset, susceptibility to}",601665,"AD,Mu,AR",-,POMC
"DNMT3A, TBRS",DNA methyltransferase 3A,602769,"Acute myeloid leukemia, somatic",601626,-,-,DNMT3A
"DNMT3A, TBRS",DNA methyltransferase 3A,602769,Tatton-Brown-Rahman syndrome,615879,AD,-,DNMT3A
"ASXL2, KIAA1685, SHAPNS",Additional sex combs-like 2,612991,Shashi-Pena syndrome,617190,AD,-,ASXL2
"HADHA, MTPA","Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/ enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit",600890,"Fatty liver, acute, of pregnancy",609016,AR,-,HADHA
"HADHA, MTPA","Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/ enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit",600890,"HELLP syndrome, maternal, of pregnancy",609016,AR,-,HADHA
"HADHA, MTPA","Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/ enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit",600890,LCHAD deficiency,609016,AR,-,HADHA
"HADHA, MTPA","Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/ enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit",600890,Trifunctional protein deficiency,609015,AR,-,HADHA
HADHB,"Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase /enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit",143450,Trifunctional protein deficiency,609015,AR,-,HADHB
"DRC1, CCDC164, C2orf39, CILD21","Dynein regulatory complex, subunit 1, Chlamydomonas, homolog of",615288,"Ciliary dyskinesia, primary, 21",615294,AR,-,DRC1
"OTOF, DFNB9, NSRD9, AUNB1",Otoferlin,603681,"Auditory neuropathy, autosomal recessive, 1",601071,AR,symbolized DFNB6 by authors,OTOF
"OTOF, DFNB9, NSRD9, AUNB1",Otoferlin,603681,"Deafness, autosomal recessive 9",601071,AR,-,OTOF
"KCNK3, TASK, PPH4","Potassium channel, subfamily K, member 3",603220,"Pulmonary hypertension, primary, 4",615344,AD,-,KCNK3
"AGBL5, CCP5, RP75",AATP/GTP-binding protein-like 5,615900,Retinitis pigmentosa 75,617023,AR,-,AGBL5
KHK,Ketohexokinase (fructokinase),614058,[Fructosuria],229800,AR,-,KHK
"CAD, CDG1Z, EIEE50",CAD trifunctional protein of pyrimidine biosynthesis,114010,"Epileptic encephalopathy, early infantile, 50",616457,AR,-,CAD
"MPV17, MTDPS6","Mpv17 transgene, mouse, glomerulosclerosis, homolog of",137960,Mitochondrial DNA depletion syndrome 6 (hepatocerebral type),256810,AR,-,MPV17
EIF2B4,"Eukaryotic translation initiation factor 2B, subunit 4",606687,Leukoencephalopathy with vanishing white matter,603896,AR,-,EIF2B4
EIF2B4,"Eukaryotic translation initiation factor 2B, subunit 4",606687,Ovarioleukodystrophy,603896,AR,-,EIF2B4
"ZNF513, RP58",Zinc finger protein 513,613598,?Retinitis pigmentosa 58,613617,AR,mutation identified in 1 RP58 family,ZNF513
"IFT172, SLB, KIAA1179, SRTD10, RP71","Intraflagellar transport 172, Chlamydomonas, homolog of",607386,Retinitis pigmentosa 71,616394,AR,-,IFT172
"IFT172, SLB, KIAA1179, SRTD10, RP71","Intraflagellar transport 172, Chlamydomonas, homolog of",607386,Short-rib thoracic dysplasia 10 with or without polydactyly,615630,AR,-,IFT172
"GCKR, GKRP, FGQTL5",Glucokinase (hexokinase 4) regulatory protein,600842,[Fasting plasma glucose level QTL 5],613463,-,-,GCKR
"PPP1CB, NSLH2","Protein phosphatase-1, catalytic subunit, beta isoform",600590,Noonan syndrome-like disorder with loose anagen hair 2,617506,AD,-,PPP1CB
C2orf71,Chromosome 2 open reading frame 71,613425,Retinitis pigmentosa 54,613428,-,-,C2orf71
"ALK, NBLST3",Anaplastic lymphoma kinase (Ki-1),105590,"{Neuroblastoma, susceptibility to, 3}",613014,-,-,ALK
"XDH, XAN1",Xanthine dehydrogenase (xanthine oxidase),607633,"Xanthinuria, type I",278300,AR,-,XDH
SRD5A2,"Steroid-5-alpha-reductase, alpha polypeptide-2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha-2)",607306,Pseudovaginal perineoscrotal hypospadias,264600,AR,-,SRD5A2
"SPAST, SPG4",Spastin,604277,"Spastic paraplegia 4, autosomal dominant",182601,AD,-,SPAST
"NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4","NLR family, caspase recruitment domain-containing 4",606831,?Familial cold autoinflammatory syndrome 4,616115,AD,mutation identified in 1 FCAS4 family,NLRC4
"NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4","NLR family, caspase recruitment domain-containing 4",606831,Autoinflammation with infantile enterocolitis,616050,AD,-,NLRC4
MACOM,"Macrophthalmia, colobomatous, with microcornea",602499,"Macrophthalmia, colobomatous, with microcornea",602499,AD,-,MACOM
"CYP1B1, GLC3A, ASGD6","Cytochrome P450, subfamily I, dioxin-inducible, polypeptide 1",601771,"Anterior segment dysgenesis 6, multiple subtypes",617315,-,-,CYP1B1
"CYP1B1, GLC3A, ASGD6","Cytochrome P450, subfamily I, dioxin-inducible, polypeptide 1",601771,"Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset",231300,AR,-,CYP1B1
"SOS1, GINGF, GF1, HGF, NS4","Son of sevenless, Drosophila, homolog of, 1",182530,"?Fibromatosis, gingival, 1",135300,AD,mutation identified in 1 GINGF1 family,SOS1
"SOS1, GINGF, GF1, HGF, NS4","Son of sevenless, Drosophila, homolog of, 1",182530,Noonan syndrome 4,610733,AD,-,SOS1
"DEL2p21, C2DELp21",Homozygous 2p21 deletion syndrome,606407,Hypotonia-cystinuria syndrome,606407,AR,contiguous gene syndrome disrupting SLC3A1 and PREPL genes,DEL2p21
"HAAO, VCRL1","3-hydroxyanthranilate 3,4-dioxygenase",604521,"Vertebral, cardiac, renal, and limb defects syndrome 1",617660,AR,-,HAAO
"DYNC2LI1, D2LIC, LIC3, SRTD15","Dynein, cytoplasmic 2, light intermediate chain 1",617083,Short-rib thoracic dysplasia 15 with polydactyly,617088,AR,-,DYNC2LI1
ABCG5,"ATP-binding cassette, subfamily G, member 5",605459,Sitosterolemia,210250,AR,-,ABCG5
"ABCG8, GBD4","ATP-binding cassette, subfamily G, member 8",605460,Sitosterolemia,210250,AR,-,ABCG8
"ABCG8, GBD4","ATP-binding cassette, subfamily G, member 8",605460,{Gallbladder disease 4},611465,-,-,ABCG8
"LRPPRC, LRP130, LSFC",Leucine-rich PPR motif-containing protein,607544,"Leigh syndrome, French-Canadian type",220111,AR,-,LRPPRC
"SLC3A1, ATR1, D2H, NBAT","Solute carrier family 3 (cystine, dibasic and neutral amino acid transporters), member 1",104614,Cystinuria,220100,"AD,AR",-,SLC3A1
"PREPL, KIAA0436, CMS22",Prolyl endopeptidase-like,609557,"?Myasthenic syndrome, congenital, 22",616224,AR,mutation identified in 1 CMS22 patient,PREPL
"SIX3, HPE2","Sine oculis homeo box, Drosophila, homolog of, 3",603714,Holoprosencephaly 2,157170,AD,-,SIX3
"SIX3, HPE2","Sine oculis homeo box, Drosophila, homolog of, 3",603714,Schizencephaly,269160,-,-,SIX3
"EPAS1, MOP2, HIF2A, ECYT4",Endothelial PAS domain protein 1,603349,"Erythrocytosis, familial, 4",611783,-,-,EPAS1
"CRIPT, SSMDF",Cystine-rich PDZ binding protein,604594,Short stature with microcephaly and distinctive facies,615789,AR,-,CRIPT
"MCFD2, F5F8D2",Multiple coagulation factor deficiency protein 2,607788,"Factor V and factor VIII, combined deficiency of",613625,-,-,MCFD2
"TTC7A, TTC7, KIAA1140, MINAT, GIDID",Tetratricopeptide repeat domain 7A,609332,Gastrointestinal defects and immunodeficiency syndrome,243150,AR,-,TTC7A
"CALM2, LQT15",Calmodulin-2,114182,Long QT syndrome 15,616249,AD,-,CALM2
"EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8",Epithelial cellular adhesion molecule,185535,"Colorectal cancer, hereditary nonpolyposis, type 8",613244,-,previously assigned to 4q,EPCAM
"EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8",Epithelial cellular adhesion molecule,185535,"Diarrhea 5, with tufting enteropathy, congenital",613217,AR,-,EPCAM
"MSH2, COCA1, FCC1, HNPCC1","mutS, E. coli, homolog of, 2",609309,"Colorectal cancer, hereditary nonpolyposis, type 1",120435,AD,-,MSH2
"MSH2, COCA1, FCC1, HNPCC1","mutS, E. coli, homolog of, 2",609309,Mismatch repair cancer syndrome,276300,AR,-,MSH2
"MSH2, COCA1, FCC1, HNPCC1","mutS, E. coli, homolog of, 2",609309,Muir-Torre syndrome,158320,AD,-,MSH2
"MSH6, GTBP, HNPCC5","MutS, E. coli, homolog of, 6",600678,"Colorectal cancer, hereditary nonpolyposis, type 5",614350,AD,0.5 Mb from MSH2,MSH6
"MSH6, GTBP, HNPCC5","MutS, E. coli, homolog of, 6",600678,"Endometrial cancer, familial",608089,-,-,MSH6
"MSH6, GTBP, HNPCC5","MutS, E. coli, homolog of, 6",600678,Mismatch repair cancer syndrome,276300,AR,-,MSH6
"LHCGR, LHR, LCGR",Luteinizing hormone/choriogonadotropin receptor,152790,"Leydig cell adenoma, somatic, with precocious puberty",176410,-,-,LHCGR
"LHCGR, LHR, LCGR",Luteinizing hormone/choriogonadotropin receptor,152790,Leydig cell hypoplasia with hypergonadotropic hypogonadism,238320,AR,-,LHCGR
"LHCGR, LHR, LCGR",Luteinizing hormone/choriogonadotropin receptor,152790,Leydig cell hypoplasia with pseudohermaphroditism,238320,AR,-,LHCGR
"LHCGR, LHR, LCGR",Luteinizing hormone/choriogonadotropin receptor,152790,"Luteinizing hormone resistance, female",238320,AR,-,LHCGR
"LHCGR, LHR, LCGR",Luteinizing hormone/choriogonadotropin receptor,152790,"Precocious puberty, male",176410,AD,-,LHCGR
"FSHR, ODG1",Follicle stimulating hormone receptor,136435,Ovarian dysgenesis 1,233300,AR,-,FSHR
"FSHR, ODG1",Follicle stimulating hormone receptor,136435,Ovarian hyperstimulation syndrome,608115,AD,-,FSHR
"FSHR, ODG1",Follicle stimulating hormone receptor,136435,Ovarian response to FSH stimulation,276400,AR,-,FSHR
"NRXN1, PTHSL2, SCZD17",Neurexin 1,600565,Pitt-Hopkins-like syndrome 2,614325,AR,-,NRXN1
"NRXN1, PTHSL2, SCZD17",Neurexin 1,600565,"{Schizophrenia, susceptibility to, 17}",614332,-,-,NRXN1
"DEL2p16.1-p15, C2DELp161-p15",Chromosome 2p16.1-p15 deletion syndrome,612513,Chromosome 2p16.1-p15 deletion syndrome,612513,IC,contiguous gene deletion syndrome,DEL2p16.1-p15
"CCDC88A, KIAA1212, HKRP1, GIRDIN, APE, GIV, PEHOL",Coiled-coil domain-containing protein 88A,609736,?PEHO syndrome-like,617507,AR,mutation identified in 1 PEHOL family,CCDC88A
"PNPT1, OLD35, COXPD13, DFNB70",Polyribonucleotide nucleotidyltransferase 1,610316,Combined oxidative phosphorylation deficiency 13,614932,AR,-,PNPT1
"PNPT1, OLD35, COXPD13, DFNB70",Polyribonucleotide nucleotidyltransferase 1,610316,"Deafness, autosomal recessive 70",614934,AR,-,PNPT1
"EFEMP1, FBNL, DHRD",EGF-containing fibulin-like extracellular matrix protein 1 (fibrillin-like),601548,Doyne honeycomb degeneration of retina,126600,AD,-,EFEMP1
"PHF9, FANCL",PHD finger protein 9,608111,"Fanconi anemia, complementation group L",614083,AR,-,PHF9
"BCL11A, CTIP1, EVI9, KIAA1809, DILOS",B-cell CLL/lymphoma 11A,606557,Dias-Logan syndrome,617101,AD,-,BCL11A
"PEX13, ZWS, NALD, PBD11A, PBD11B",Peroxisome biogenesis factor 13 (peroxin 13),601789,Peroxisome biogenesis disorder 11A (Zellweger),614883,AR,-,PEX13
"PEX13, ZWS, NALD, PBD11A, PBD11B",Peroxisome biogenesis factor 13 (peroxin 13),601789,Peroxisome biogenesis disorder 11B,614885,AR,-,PEX13
"FAM161A, RP28","Family with sequence similarity 161, member A",613596,Retinitis pigmentosa 28,606068,-,-,FAM161A
"EHBP1, KIAA0903, HPC12",EH domain-binding protein 1,609922,"{Prostate cancer, hereditary, 12}",611868,-,-,EHBP1
"WDPCP, C2orf86, BBS15, CHDTHP",WD repeat-containing planar cell polarity effector,613580,?Bardet-Biedl syndrome 15,615992,AR,mutation identified in 1 BBS15 family and 1 CHDTHP patient,WDPCP
"WDPCP, C2orf86, BBS15, CHDTHP",WD repeat-containing planar cell polarity effector,613580,"?Congenital heart defects, hamartomas of tongue, and polysyndactyly",217085,AR,-,WDPCP
"SLC1A4, SATT, ASCT1, SPATCCM","Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4",600229,"Spastic tetraplegia, thin corpus callosum, and progressive microcephaly",616657,AR,-,SLC1A4
"ANTXR1, TEM8, ATR, GAPO",Anthrax toxin receptor 1,606410,GAPO syndrome,230740,AR,mutation identified in 1 HCI patient,ANTXR1
"ANTXR1, TEM8, ATR, GAPO",Anthrax toxin receptor 1,606410,"{?Hemangioma, capillary infantile, susceptibility to}",602089,AD,-,ANTXR1
"GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1",Glutamine-fructose-6-phosphate transaminase,138292,"Myasthenia, congenital, 12, with tubular aggregates",610542,AR,-,GFPT1
"NFU1, HIRIP, MMDS1","NFU1 iron-sulfur cluster scaffold, S. cerevisiae, homolog of",608100,Multiple mitochondrial dysfunctions syndrome 1,605711,AR,-,NFU1
"TIA1, WDM",TIA1 cytotoxic granule-associated RNA-binding protein,603518,Welander distal myopathy,604454,"AD,AR",-,TIA1
"FIGLA, POF6","Factor in germline alpha, mouse, homolog of",608697,Premature ovarian failure 6,612310,AD,-,FIGLA
"CD207, LANGERIN, CLEC4K",CD207 antigen,604862,[?Birbeck granule deficiency],613393,-,mutation identified in 1 patient,CD207
"ATP6B1, VPP3","ATPase, H+ transporting, lysosomal, beta polypeptide, 58kD (vacuolar proton pump, subunit 3)",192132,Renal tubular acidosis with deafness,267300,AR,-,ATP6B1
MCEE,Methylmalonyl-CoA epimerase,608419,Methylmalonyl-CoA epimerase deficiency,251120,AR,-,MCEE
"DYSF, LGMD2B, MMD1",Dysferlin,603009,Miyoshi muscular dystrophy 1,254130,AR,-,DYSF
"DYSF, LGMD2B, MMD1",Dysferlin,603009,"Muscular dystrophy, limb-girdle, type 2B",253601,AR,-,DYSF
"DYSF, LGMD2B, MMD1",Dysferlin,603009,"Myopathy, distal, with anterior tibial onset",606768,AR,-,DYSF
"CYP26B1, CYP26A2, P450RAI2, RHFCA","Cytochrome P450, subfamily XXVIB, polypeptide 1",605207,Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies,614416,-,-,CYP26B1
SPR,Sepiapterin reductase,182125,"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency",612716,"?AD,AR",-,SPR
"ALMS1, ALSS, KIAA0328",Alstrom syndrome gene,606844,Alstrom syndrome,203800,AR,-,ALMS1
"TPRKB, GAMOS5",TP53RK-binding protein,608680,Galloway-Mowat syndrome 5,617731,AR,-,TPRKB
"STAMBP, AMSH, MICCAP",STAM binding protein,606247,Microcephaly-capillary malformation syndrome,614261,AR,-,STAMBP
"ACTG2, ACTA3, VSCM","Actin, gamma-2, smooth muscle, enteric",102545,Visceral myopathy,155310,AD,-,ACTG2
"DGUOK, DGK, MTDPS3, PEOB4, NCPH","Deoxyguanosine kinase, mitochondrial",601465,Mitochondrial DNA depletion syndrome 3 (hepatocerebral type),251880,AR,-,DGUOK
"DGUOK, DGK, MTDPS3, PEOB4, NCPH","Deoxyguanosine kinase, mitochondrial",601465,"Portal hypertension, noncirrhotic",617068,AR,-,DGUOK
"DGUOK, DGK, MTDPS3, PEOB4, NCPH","Deoxyguanosine kinase, mitochondrial",601465,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4",617070,AR,-,DGUOK
"BOLA3, MMDS2","BolA, E. coli, homolog of, 3",613183,Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia,614299,AR,-,BOLA3
"DCTN1, HMN7B","Dynactin 1 (p150, glued, Drosophila, homolog of)",601143,"Neuropathy, distal hereditary motor, type VIIB",607641,AD,-,DCTN1
"DCTN1, HMN7B","Dynactin 1 (p150, glued, Drosophila, homolog of)",601143,Perry syndrome,168605,AD,-,DCTN1
"DCTN1, HMN7B","Dynactin 1 (p150, glued, Drosophila, homolog of)",601143,"{Amyotrophic lateral sclerosis, susceptibility to}",105400,"AD,AR",-,DCTN1
"MOGS, GCS1, CDG2B",Mannosyl-oligosaccharide glucosidase,601336,"Congenital disorder of glycosylation, type IIb",606056,AR,-,MOGS
"HTRA2, OMI, PARK13, PRSS25, MGCA8",HTRA serine peptidase 2,606441,"3-methylglutaconic aciduria, type VIII",617248,AR,-,HTRA2
"HTRA2, OMI, PARK13, PRSS25, MGCA8",HTRA serine peptidase 2,606441,{Parkinson disease 13},610297,-,-,HTRA2
"DEL2p12p11.2, C2DELp12p11.2",Chromosome 2p12-p11.2 deletion syndrome,613564,Chromosome 2p12-p11.2 deletion syndrome,613564,-,contiguous gene deletion syndrome,DEL2p12p11.2
"SUCLG1, SUCLA1, MTDPS9","Succinate-CoA ligase, alpha subunit",611224,Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria),245400,AR,-,SUCLG1
"ELMOD3, RBED1, DFNB88",ELMO/CED12 domain-containing protein 3,615427,"?Deafness, autosomal recessive 88",615429,AR,one family identified with mutation,ELMOD3
"GGCX, VKCFD1",Gamma-glutamyl carboxylase,137167,Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency,610842,-,-,GGCX
"GGCX, VKCFD1",Gamma-glutamyl carboxylase,137167,"Vitamin K-dependent clotting factors, combined deficiency of, 1",277450,AR,-,GGCX
"SFTPB, SFTB3, SMDP1","Pulmonary surfactant-associated protein B, 18kD",178640,"Surfactant metabolism dysfunction, pulmonary, 1",265120,AR,-,SFTPB
"SIAT9, ST3GALV, SPDRS",Sialyltransferase 9,604402,Salt and pepper developmental regression syndrome,609056,AR,-,SIAT9
"POLR1A, RPA194, AFDCIN","Polymerase I, RNA, subunit A",616404,"Acrofacial dysostosis, Cincinnati type",616462,AD,-,POLR1A
"REEP1, C2orf23, SPG31, HMN5B",Receptor expression-enhancing protein 1,609139,"?Neuronopathy, distal hereditary motor, type VB",614751,AD,mutation identified in 1 HMN5B family,REEP1
"REEP1, C2orf23, SPG31, HMN5B",Receptor expression-enhancing protein 1,609139,"Spastic paraplegia 31, autosomal dominant",610250,AD,-,REEP1
CD8A,"CD8 antigen, alpha polypeptide (p32)",186910,"CD8 deficiency, familial",608957,AR,distal to IGK,CD8A
"EIF2AK3, PEK, PERK, WRS",Eukaryotic translation initiation factor 2-alpha kinase 3,604032,Wolcott-Rallison syndrome,226980,AR,-,EIF2AK3
"RPIA, RPI, RPIAD",Ribose 5-phosphate isomerase A,180430,?Ribose 5-phosphate isomerase deficiency,608611,AR,mutation identified in 1 RPAID patient,RPIA
"IGKC, IGKCD",Immunoglobulin kappa constant region,147200,Kappa light chain deficiency,614102,AR,-,IGKC
"ADRA2B, ADRA2L1, FAME2","Adrenergic, alpha-2B-, receptor",104260,"Epilepsy, myoclonic, familial adult, 2",607876,AD,-,ADRA2B
TMEM127,Transmembrane protein 127,613403,"{Pheochromocytoma, susceptibility to}",171300,AD,-,TMEM127
"SNRNP200, ASCC3L1, KIAA0788, RP33",Small nuclear ribonucleoprotein 200kD (U5),601664,Retinitis pigmentosa 33,610359,AD,-,SNRNP200
"LMAN2L, VIPL, MRT52",LMAN2-like protein,609552,"?Mental retardation, autosomal recessive, 52",616887,AR,mutation identified in 1 MRT52 family,LMAN2L
"CNNM4, ACDP4",Cyclin M4,607805,Jalili syndrome,217080,AR,-,CNNM4
"ZAP70, SRK, ADMIO2, IMD48","Zeta-chain associated protein kinase, 70kD (syk-related tyrosine kinase)",176947,"Autoimmune disease, multisystem, infantile-onset, 2",617006,AR,-,ZAP70
"ZAP70, SRK, ADMIO2, IMD48","Zeta-chain associated protein kinase, 70kD (syk-related tyrosine kinase)",176947,Immunodeficiency 48,269840,AR,-,ZAP70
"VWA3B, SCAR22",von Willebrand factor A domain-containing protein 3B,614884,"?Spinocerebellar ataxia, autosomal recessive 22",616948,AR,mutation identified in 1 SCAR22 family,VWA3B
"CNGA3, CNG3, ACHM2","Cyclic nucleotide-gated channel, alpha-3",600053,Achromatopsia 2,216900,AR,-,CNGA3
"COA5, C2orf64, PET191, CEMCOX3",Cytochrome c oxidase assembly factor 5,613920,"?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3",616500,AR,mutation identified in 1 CEMCOX3 family,COA5
"LIPT1, LIPT1D",Lipoyltransferase 1,610284,Lipoyltransferase 1 deficiency,616299,AR,-,LIPT1
"SLC5A7, CHT1, HMN7A, CMS20","Solute carrier family 5 (choline transporter), member 7",608761,"Myasthenic syndrome, congenital, 20, presynaptic",617143,AR,-,SLC5A7
"SLC5A7, CHT1, HMN7A, CMS20","Solute carrier family 5 (choline transporter), member 7",608761,"Neuronopathy, distal hereditary motor, type VIIA",158580,AD,-,SLC5A7
"RANBP2, NUP358, ANE1, IIAE3",RAN-binding protein 2,601181,"{Encephalopathy, acute, infection-induced, 3, susceptibility to}",608033,AD,-,RANBP2
"EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B","Ectodysplasin 1, anhidrotic receptor (downless, mouse, homolog of)",604095,"Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",129490,AD,-,EDAR
"EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B","Ectodysplasin 1, anhidrotic receptor (downless, mouse, homolog of)",604095,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive",224900,AR,-,EDAR
"EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B","Ectodysplasin 1, anhidrotic receptor (downless, mouse, homolog of)",604095,"[Hair morphology 1, hair thickness]",612630,-,-,EDAR
"NPHP1, NPH1, SLSN1, JBTS4",Nephrocystin,607100,Joubert syndrome 4,609583,AR,-,NPHP1
"NPHP1, NPH1, SLSN1, JBTS4",Nephrocystin,607100,"Nephronophthisis 1, juvenile",256100,AR,-,NPHP1
"NPHP1, NPH1, SLSN1, JBTS4",Nephrocystin,607100,Senior-Loken syndrome-1,266900,AR,-,NPHP1
"MERTK, RP38",Mer tyrosine kinase protooncogene,604705,Retinitis pigmentosa 38,613862,AR,-,MERTK
"CKAP2L, RADMIS",Cytoskeleton-associated protein 2-like,616174,Filippi syndrome,272440,AR,-,CKAP2L
IL1B,"Interleukin-1, beta",147720,{Gastric cancer risk after H. pylori infection},137215,AD,"within 430kb of IL1RN, IL1A",IL1B
"IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14",Interleukin 36 receptor antagonist,605507,"Psoriasis 14, pustular",614204,AR,-,IL36RN
"IL1RN, MVCD4, DIRA",Interleukin-1 receptor antagonist,147679,Interleukin 1 receptor antagonist deficiency,612852,AR,-,IL1RN
"IL1RN, MVCD4, DIRA",Interleukin-1 receptor antagonist,147679,{Gastric cancer risk after H. pylori infection},137215,AD,-,IL1RN
"IL1RN, MVCD4, DIRA",Interleukin-1 receptor antagonist,147679,{Microvascular complications of diabetes 4},612628,-,-,IL1RN
PAX8,Paired box homeotic gene-8,167415,"Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia",218700,AD,-,PAX8
"STEAP3, TSAP6, AHMIO2",Six-transmembrane epithelial antigen of prostate 3,609671,"?Anemia, hypochromic microcytic, with iron overload 2",615234,AD,mutation identified in 1 AHMIO2 family,STEAP3
"GLI2, HPE9, CJS",GLI-Kruppel family member GLI2 (oncogene GLI2),165230,Culler-Jones syndrome,615849,AD,-,GLI2
"GLI2, HPE9, CJS",GLI-Kruppel family member GLI2 (oncogene GLI2),165230,Holoprosencephaly 9,610829,AD,-,GLI2
"RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN","RNA, U4, small nuclear, AT-AC form",601428,"Microcephalic osteodysplastic primordial dwarfism, type I",210710,AR,-,RNU4ATAC
"RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN","RNA, U4, small nuclear, AT-AC form",601428,Roifman syndrome,616651,AR,-,RNU4ATAC
"GYPC, GE, GPC",Glycophorin C,110750,"[Blood group, Gerbich]",616089,-,-,GYPC
"GYPC, GE, GPC",Glycophorin C,110750,"{Malaria, resistance to}",611162,-,-,GYPC
"BIN1, AMPHL, CNM2",Box-dependent MYC-interacting protein-1 (amphiphysin-like),601248,Centronuclear myopathy 2,255200,AR,-,BIN1
"ERCC3, XPB, TTD2","Excision-repair cross-complementing rodent repair deficiency, complementation group 3",133510,"Trichothiodystrophy 2, photosensitive",616390,AR,-,ERCC3
"ERCC3, XPB, TTD2","Excision-repair cross-complementing rodent repair deficiency, complementation group 3",133510,"Xeroderma pigmentosum, group B",610651,AR,-,ERCC3
"PROC, PC, THPH3, THPH4",Protein C (inactivator of coagulation factors Va and VIIIa),612283,"Thrombophilia due to protein C deficiency, autosomal dominant",176860,AD,-,PROC
"PROC, PC, THPH3, THPH4",Protein C (inactivator of coagulation factors Va and VIIIa),612283,"Thrombophilia due to protein C deficiency, autosomal recessive",612304,AR,-,PROC
"LIMS2, PINCH2, LGMD2W",LIM and senescent cell antigen-like domains 2,607908,"Muscular dystrophy, limb-girdle, type 2W",616827,AR,mutation identified in 1 LGMD2W family,LIMS2
"HS6ST1, HS6ST, HH15",Heparan sulfate 6-O-sulfotransferase 1,604846,{Hypogonadotropic hypogonadism 15 with or without anosmia},614880,AD,-,HS6ST1
"CCDC115, CCP1, CDG2O",Coiled-coil domain-containing protein 115,613734,"Congenital disorder of glycosylation, type IIo",616828,AR,-,CCDC115
"CFC1, CRYPTIC, HTX2",Cryptic protein,605194,"Heterotaxy, visceral, 2, autosomal",605376,AD,-,CFC1
"RAB3GAP1, WARBM1, P130","RAB3 GTPase-activating protein, catalytic subunit",602536,Warburg micro syndrome 1,600118,AR,-,RAB3GAP1
"LCT, LAC, LPH",Lactase (lactase-phlorizin hydrolase),603202,"Lactase deficiency, congenital",223000,AR,-,LCT
MCM6,"Minichromosome maintenance deficient (mis5, S. pombe) 6",601806,Lactase persistence/nonpersistence,223100,AD,mutations in introns 9 and 13,MCM6
"DARS, HBSL, HBSL",Aspartyl tRNA synthetase,603084,Hypomyelination with brainstem and spinal cord involvement and leg spasticity,615281,AR,-,DARS
"CXCR4, D2S201E, NPY3R, WHIMS",Chemokine (C-X-C motif) receptor 4 (neuropeptide Y receptor Y3),162643,"Myelokathexis, isolated",-,-,-,CXCR4
"CXCR4, D2S201E, NPY3R, WHIMS",Chemokine (C-X-C motif) receptor 4 (neuropeptide Y receptor Y3),162643,WHIM syndrome,193670,AD,-,CXCR4
"HNMT, MRT51",Histamine N-methyltransferase,605238,"Mental retardation, autosomal recessive 51",616739,AR,-,HNMT
"HNMT, MRT51",Histamine N-methyltransferase,605238,"{Asthma, susceptibility to}",600807,AD,-,HNMT
"KYNU, KYNUU, VCRL2",Kynureninase,605197,?Hydroxykynureninuria,236800,AR,mutation identified in 1 KYNUU family,KYNU
"KYNU, KYNUU, VCRL2",Kynureninase,605197,"Vertebral, cardiac, renal, and limb defects syndrome 2",617661,AR,-,KYNU
"ZEB2, ZFHX1B, SMADIP1, SIP1",Zinc finger E box-binding homeobox 2,605802,Mowat-Wilson syndrome,235730,AD,-,ZEB2
"ORC4, ORC4L","Origin recognition complex, subunit 4, S. cerevisiae, homolog of",603056,Meier-Gorlin syndrome 2,613800,AR,-,ORC4
"MBD5, KIAA1461, MRD1",Methyl-CpG-binding domain protein 5,611472,"Mental retardation, autosomal dominant 1",156200,AD,-,MBD5
"KIF5C, NKHC2, CDCBM2",Kinesin family member 5C,604593,"Cortical dysplasia, complex, with other brain malformations 2",615282,AD,-,KIF5C
"C2orf25, MMADHC",Chromosome 2 open reading frame 25,611935,"Homocystinuria, cblD type, variant 1",277410,AR,-,C2orf25
"C2orf25, MMADHC",Chromosome 2 open reading frame 25,611935,"Methylmalonic aciduria and homocystinuria, cblD type",277410,AR,-,C2orf25
"C2orf25, MMADHC",Chromosome 2 open reading frame 25,611935,"Methylmalonic aciduria, cblD type, variant 2",277410,AR,-,C2orf25
"NEB, NEM2",Nebulin,161650,"Nemaline myopathy 2, autosomal recessive",256030,AR,-,NEB
"CACNB4, EJM6, EA5, EIG9","Calcium channel, voltage-dependent, beta 4 subunit",601949,"Episodic ataxia, type 5",613855,AD,-,CACNB4
"CACNB4, EJM6, EA5, EIG9","Calcium channel, voltage-dependent, beta 4 subunit",601949,"{Epilepsy, idiopathic generalized, susceptibility to, 9}",607682,AD,-,CACNB4
"CACNB4, EJM6, EA5, EIG9","Calcium channel, voltage-dependent, beta 4 subunit",601949,"{Epilepsy, juvenile myoclonic, susceptibility to, 6}",607682,AD,-,CACNB4
GPD2,Glycerol-3-phosphate dehydrogenase 2 (mitochondrial),138430,"{Diabetes, type 2, susceptibility to}",125853,AD,pseudogene on 19,GPD2
"ACVR1, ACVRLK2, ALK2, FOP","Activin A receptor, type I",102576,Fibrodysplasia ossificans progressiva,135100,AD,-,ACVR1
"ITGB6, AI1H","Integrin, beta-6",147558,"Amelogenesis imperfecta, type IH",616221,AR,-,ITGB6
"IFIH1, MDA5, AGS7, SGMRT1",Interferon induced with helicase C domain 1,606951,Aicardi-Goutieres syndrome 7,615846,AD,-,IFIH1
"IFIH1, MDA5, AGS7, SGMRT1",Interferon induced with helicase C domain 1,606951,Singleton-Merten syndrome 1,182250,AD,-,IFIH1
"SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS","Sodium channel, voltage-gated, type II, alpha subunit",182390,"Epileptic encephalopathy, early infantile, 11",613721,AD,4 related genes on chr.2,SCN2A
"SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS","Sodium channel, voltage-gated, type II, alpha subunit",182390,"Seizures, benign familial infantile, 3",607745,AD,-,SCN2A
"GALNT3, HHS, HFTC",UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3,601756,"Tumoral calcinosis, hyperphosphatemic, familial",211900,AR,-,GALNT3
"TTC21B, THM1, NPHP12, SRTD4, ATD4",Tetratricopeptide repeat domain 21B,612014,Nephronophthisis 12,613820,"AD,AR",-,TTC21B
"TTC21B, THM1, NPHP12, SRTD4, ATD4",Tetratricopeptide repeat domain 21B,612014,Short-rib thoracic dysplasia 4 with or without polydactyly,613819,AR,-,TTC21B
"SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3","Sodium channel, voltage-gated, type I, alpha polypeptide",182389,"Epilepsy, generalized, with febrile seizures plus, type 2",604403,AD,-,SCN1A
"SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3","Sodium channel, voltage-gated, type I, alpha polypeptide",182389,"Epileptic encephalopathy, early infantile, 6 (Dravet syndrome)",607208,AD,-,SCN1A
"SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3","Sodium channel, voltage-gated, type I, alpha polypeptide",182389,"Febrile seizures, familial, 3A",604403,AD,-,SCN1A
"SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3","Sodium channel, voltage-gated, type I, alpha polypeptide",182389,"Migraine, familial hemiplegic, 3",609634,AD,-,SCN1A
"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D","Sodium channel, voltage-gated, type IX, alpha subunit",603415,"Epilepsy, generalized, with febrile seizures plus, type 7",613863,AD,-,SCN9A
"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D","Sodium channel, voltage-gated, type IX, alpha subunit",603415,"Erythermalgia, primary",133020,AD,-,SCN9A
"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D","Sodium channel, voltage-gated, type IX, alpha subunit",603415,"Febrile seizures, familial, 3B",613863,AD,-,SCN9A
"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D","Sodium channel, voltage-gated, type IX, alpha subunit",603415,"HSAN2D, autosomal recessive",243000,AR,-,SCN9A
"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D","Sodium channel, voltage-gated, type IX, alpha subunit",603415,"Insensitivity to pain, congenital",243000,AR,-,SCN9A
"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D","Sodium channel, voltage-gated, type IX, alpha subunit",603415,"Paroxysmal extreme pain disorder,",167400,AD,-,SCN9A
"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D","Sodium channel, voltage-gated, type IX, alpha subunit",603415,Small fiber neuropathy,133020,AD,-,SCN9A
"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D","Sodium channel, voltage-gated, type IX, alpha subunit",603415,"{Dravet syndrome, modifier of}",607208,AD,-,SCN9A
"DUP2q31.1, C2DUPq31.1",Chromosome 2q31.1 duplication syndrome,613681,Chromosome 2q31.1 duplication syndrome,613681,AD,duplication of 9 HOXD genes and MTX2,DUP2q31.1
"ABCB11, BSEP, SPGP, PFIC2, BRIC2","ATP-binding cassette, subfamily B, member 11 (bile salt export pump)",603201,"Cholestasis, benign recurrent intrahepatic, 2",605479,AR,-,ABCB11
"ABCB11, BSEP, SPGP, PFIC2, BRIC2","ATP-binding cassette, subfamily B, member 11 (bile salt export pump)",603201,"Cholestasis, progressive familial intrahepatic 2",601847,AR,-,ABCB11
"LRP2, DBS",Low density lipoprotein-related protein 2,600073,Donnai-Barrow syndrome,222448,AR,-,LRP2
BBS5,BBS gene 5,603650,Bardet-Biedl syndrome 5,615983,AR,-,BBS5
"KLHL41, KBTBD10, SARCOSIN, NEM9",Kelch-like family member 41,607701,Nemaline myopathy 9,615731,AR,-,KLHL41
"GAD1, SCP, CPSQ1","Glutamate decarboxylase-1, brain, 67kD",605363,"?Cerebral palsy, spastic quadriplegic, 1",603513,AR,mutation identified in 1 CPSQ1 family,GAD1
"DCAF17, C20orf37",DDB1- and CUL4-associated factor 17,612515,Woodhouse-Sakati syndrome,241080,AR,-,DCAF17
"SLC25A12, ARALAR, EIEE39","Solute carrier family 25 (mitochondrial carrier, Aralar), member 12",603667,"Epileptic encephalopathy, early infantile, 39",612949,AR,-,SLC25A12
ITGA6,"Integrin, alpha-6",147556,"Epidermolysis bullosa, junctional, with pyloric stenosis",226730,AR,-,ITGA6
"ZAK, MLTK, MRK, SFMMP, CNM6",Leucine zipper- and sterile alpha motif-containing kinase,609479,Centronuclear myopathy 6 with fiber-type disproportion,617760,AR,-,ZAK
"ZAK, MLTK, MRK, SFMMP, CNM6",Leucine zipper- and sterile alpha motif-containing kinase,609479,Split-foot malformation with mesoaxial polydactyly,616890,AR,-,ZAK
"CDCA7, JPO1, ICF3",Cell division cycle-associated 7,609937,Immunodeficiency-centromeric instability-facial anomalies syndrome 3,616910,-,-,CDCA7
"WIPF1, WASPIP, WIP, WAS2","WAS/WASL-interacting protein family, member 1",602357,?Wiskott-Aldrich syndrome 2,614493,-,mutation identified in 1 WAS2 patient,WIPF1
"CHRNA1, ACHRD, CMS1B, CMS1A","Cholinergic receptor, nicotinic, alpha polypeptide-1, muscle",100690,"Multiple pterygium syndrome, lethal type",253290,AR,-,CHRNA1
"CHRNA1, ACHRD, CMS1B, CMS1A","Cholinergic receptor, nicotinic, alpha polypeptide-1, muscle",100690,"Myasthenic syndrome, congenital, 1A, slow-channel",601462,AD,-,CHRNA1
"CHRNA1, ACHRD, CMS1B, CMS1A","Cholinergic receptor, nicotinic, alpha polypeptide-1, muscle",100690,"Myasthenic syndrome, congenital, 1B, fast-channel",608930,"AD,AR",-,CHRNA1
"CHN1, CHN, ARHGAP2, RHOGAP2, DURS2","Chimerin 1 (GTPase-activating protein, rho, 2)",118423,Duane retraction syndrome 2,604356,-,-,CHN1
"HOXD13, HOX4I, SPD1, BDSD",Homeo box-D13,142989,?Brachydactyly-syndactyly syndrome,610713,-,mutation identified in 1 BDSD family,HOXD13
"HOXD13, HOX4I, SPD1, BDSD",Homeo box-D13,142989,"Brachydactyly, type D",113200,AD,-,HOXD13
"HOXD13, HOX4I, SPD1, BDSD",Homeo box-D13,142989,"Brachydactyly, type E",113300,AD,-,HOXD13
"HOXD13, HOX4I, SPD1, BDSD",Homeo box-D13,142989,"Syndactyly, type V",186300,AD,-,HOXD13
"HOXD13, HOX4I, SPD1, BDSD",Homeo box-D13,142989,Synpolydactyly 1,186000,AD,-,HOXD13
"HOXD10, HOX4D",Homeo box-D10,142984,"Charcot-Marie-Tooth disease, foot deformity of",192950,AD,-,HOXD10
"HOXD10, HOX4D",Homeo box-D10,142984,"Vertical talus, congenital",192950,AD,-,HOXD10
DEL2q31,Chromosome 2q31.2 deletion syndrome,612345,Chromosome 2q31.2 deletion syndrome,612345,-,contiguous gene deletion syndrome,DEL2q31
"NFE2L2, NRF2, IMDDHH","Nuclear factor, erythroid-derived 2-like 2",600492,"Immunodeficiency, developmental delay, and hypohomocysteinemia",617744,AD,-,NFE2L2
"AGPS, ADHAPS, RCDP3",Alkylglycerone-phosphate synthase,603051,"Rhizomelic chondrodysplasia punctata, type 3",600121,AR,-,AGPS
"PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2",Phosphodiesterase 11A,604961,"Pigmented nodular adrenocortical disease, primary, 2",610475,AD,-,PDE11A
"PRKRA, PACT, RAX, DYT16","Protein kinase, interferon-inducible double-stranded RNA-dependent activator",603424,Dystonia 16,612067,AR,-,PRKRA
"PJVK, DFNB59",Pejvakin,610219,"Deafness, autosomal recessive 59",610220,AR,-,PJVK
"TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, SALMY",Titin,188840,"Cardiomyopathy, dilated, 1G",604145,-,-,TTN
"TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, SALMY",Titin,188840,"Cardiomyopathy, familial hypertrophic, 9",613765,AD,-,TTN
"TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, SALMY",Titin,188840,"Muscular dystrophy, limb-girdle, type 2J",608807,AR,-,TTN
"TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, SALMY",Titin,188840,"Myopathy, proximal, with early respiratory muscle involvement",603689,-,-,TTN
"TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, SALMY",Titin,188840,Salih myopathy,611705,AR,-,TTN
"TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, SALMY",Titin,188840,"Tibial muscular dystrophy, tardive",600334,AD,-,TTN
"CERKL, RP26",Ceramide kinase-like,608381,Retinitis pigmentosa 26,608380,-,-,CERKL
"NEUROD1, NIDDM",Neurogenic differentiation 1,601724,Maturity-onset diabetes of the young 6,606394,-,-,NEUROD1
"NEUROD1, NIDDM",Neurogenic differentiation 1,601724,"{Diabetes mellitus, noninsulin-dependent}",125853,AD,-,NEUROD1
"FRZB, FRZB1, SRFP3, OS1",Frizzled-related protein,605083,{Osteoarthritis susceptibility 1},165720,Mu,-,FRZB
"COL3A1, EDSVASC","Collagen III, alpha-1 polypeptide",120180,"Ehlers-Danlos syndrome, vascular type",130050,AD,in same 35kb segment as COL5A2,COL3A1
"COL5A2, EDSCL2","Collagen V, alpha-2 polypeptide",120190,"Ehlers-Danlos syndrome, classic type, 2",130010,-,very close to COL3A1,COL5A2
"SLC40A1, SLC11A3, FPN1, IREG1, HFE4","Solute carrier family 40 (iron-regulated transporter), member 1",604653,"Hemochromatosis, type 4",606069,AD,-,SLC40A1
"GDF8, MSTN, MSLHP",Growth differentiation factor-8 (myostatin),601788,Muscle hypertrophy,614160,-,-,GDF8
HIBCH,3-hydroxyisobutyryl-CoA hydrolase,610690,3-hydroxyisobutryl-CoA hydrolase deficiency,250620,AR,-,HIBCH
"STAT1, CANDF7, IMD31A, IMD31B, IMD31C",Signal transducer and activator of transcription-1,600555,"Immunodeficiency 31A, mycobacteriosis, autosomal dominant",614892,AD,-,STAT1
"STAT1, CANDF7, IMD31A, IMD31B, IMD31C",Signal transducer and activator of transcription-1,600555,"Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive",613796,AR,-,STAT1
"STAT1, CANDF7, IMD31A, IMD31B, IMD31C",Signal transducer and activator of transcription-1,600555,"Immunodeficiency 31C, autosomal dominant",614162,AD,-,STAT1
"STAT4, SLEB11",Signal transducer and activator of transcription-4,600558,"{Systemic lupus erythematosus, susceptibility to, 11}",612253,-,-,STAT4
"HECW2, NEDL2, KIAA1301, NDHSAL","HECT, C2, and WW domains-containing E3 ubiquitin-protein ligase 2",617245,"Neurodevelopmental disorder with hypotonia, seizures, and absent language",617268,AD,-,HECW2
"PGAP1, MRT42",Post-GPI attachment to proteins 1,611655,"Mental retardation, autosomal recessive 42",615802,AR,-,PGAP1
"SF3B1, SF3B155, SAP155, MDS","Splicing factor 3B, subunit 1",605590,"Myelodysplastic syndrome, somatic",614286,-,-,SF3B1
"HSPD1, SPG13, HSP60, HLD4",Heat-shock 60kD protein 1,118190,"Leukodystrophy, hypomyelinating, 4",612233,AR,-,HSPD1
"HSPD1, SPG13, HSP60, HLD4",Heat-shock 60kD protein 1,118190,"Spastic paraplegia 13, autosomal dominant",605280,AD,-,HSPD1
"MARS2, SPAX3, COXPD25",Methionyl-tRNA synthetase 2,609728,?Combined oxidative phosphorylation deficiency 25,616430,AR,mutation identified in 1 COXPD25 family,MARS2
"MARS2, SPAX3, COXPD25",Methionyl-tRNA synthetase 2,609728,"Spastic ataxia 3, autosomal recessive",611390,AR,-,MARS2
"SATB2, KIAA1034, GLSS",Special AT-rich sequence-binding protein 2,608148,Glass syndrome,612313,AD,-,SATB2
NDUFB3,"NADH-ubiquinone oxidoreductase 1 beta subcomplex, 3",603839,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR","pseudogenes on chr. 1, 9, and 14",NDUFB3
"CASP10, MCH4, ALPS2","Caspase 10, apoptosis-related cysteine protease",601762,"Autoimmune lymphoproliferative syndrome, type II",603909,AD,-,CASP10
"CASP10, MCH4, ALPS2","Caspase 10, apoptosis-related cysteine protease",601762,"Gastric cancer, somatic",613659,-,-,CASP10
"CASP10, MCH4, ALPS2","Caspase 10, apoptosis-related cysteine protease",601762,"Lymphoma, non-Hodgkin, somatic",605027,-,-,CASP10
"CASP8, MCH5, ALPS2B","Caspase 8, apoptosis-related cysteine protease",601763,"?Autoimmune lymphoproliferative syndrome, type IIB",607271,AR,mutation identified in 1 ALPS2B family,CASP8
"CASP8, MCH5, ALPS2B","Caspase 8, apoptosis-related cysteine protease",601763,"Hepatocellular carcinoma, somatic",114550,-,-,CASP8
"CASP8, MCH5, ALPS2B","Caspase 8, apoptosis-related cysteine protease",601763,"{Breast cancer, protection against}",114480,AD,-,CASP8
"CASP8, MCH5, ALPS2B","Caspase 8, apoptosis-related cysteine protease",601763,"{Lung cancer, protection against}",211980,AR,-,CASP8
"TMEM237, ALS2CR4, JBTS14",Transmembrane protein 237,614423,Joubert syndrome 14,614424,AR,-,TMEM237
"ALS2, ALSJ, PLSJ, IAHSP",Alsin,606352,"Amyotrophic lateral sclerosis 2, juvenile",205100,AR,-,ALS2
"ALS2, ALSJ, PLSJ, IAHSP",Alsin,606352,"Primary lateral sclerosis, juvenile",606353,AR,-,ALS2
"ALS2, ALSJ, PLSJ, IAHSP",Alsin,606352,"Spastic paralysis, infantile onset ascending",607225,AR,-,ALS2
"SUMO1, UBL1, SMT3, OFC10",Small ubiquitin-like modifier 1,601912,Orofacial cleft 10,613705,-,-,SUMO1
"BMPR2, PPH1, POVD1","Bone morphogenetic receptor, type II",600799,"Pulmonary hypertension, familial primary, 1, with or without HHT",178600,AD,-,BMPR2
"BMPR2, PPH1, POVD1","Bone morphogenetic receptor, type II",600799,"Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated",178600,AD,-,BMPR2
"BMPR2, PPH1, POVD1","Bone morphogenetic receptor, type II",600799,Pulmonary venoocclusive disease 1,265450,AD,-,BMPR2
"CTLA4, IDDM12, CELIAC3, ALPS5",Cytotoxic T-lymphocyte-associated serine esterase-4,123890,"Autoimmune lymphoproliferative syndrome, type V",616100,AD,-,CTLA4
"CTLA4, IDDM12, CELIAC3, ALPS5",Cytotoxic T-lymphocyte-associated serine esterase-4,123890,"{Celiac disease, susceptibility to, 3}",609755,-,-,CTLA4
"CTLA4, IDDM12, CELIAC3, ALPS5",Cytotoxic T-lymphocyte-associated serine esterase-4,123890,"{Diabetes mellitus, insulin-dependent, 12}",601388,-,-,CTLA4
"CTLA4, IDDM12, CELIAC3, ALPS5",Cytotoxic T-lymphocyte-associated serine esterase-4,123890,{Hashimoto thyroiditis},140300,AD,-,CTLA4
"CTLA4, IDDM12, CELIAC3, ALPS5",Cytotoxic T-lymphocyte-associated serine esterase-4,123890,"{Systemic lupus erythematosus, susceptibility to}",152700,AD,-,CTLA4
"ICOS, AILIM, CVID1",Inducible costimulator,604558,"Immunodeficiency, common variable, 1",607594,AR,-,ICOS
NDUFS1,"NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kD",157655,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",-,NDUFS1
"FASTKD2, KIAA0971",FAST kinase domains 2,612322,?Mitochondrial complex IV deficiency,220110,"Mi,AR",mutation identified in 1 family,FASTKD2
CREB1,cAMP-response element-binding protein-1,123810,"Histiocytoma, angiomatoid fibrous, somatic",612160,-,fusion gene with EWSR1,CREB1
"CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC","Crystallin, gamma D",123690,"Cataract 4, multiple types",115700,AD,-,CRYGD
"CRYGC, CRYG3, CTRCT2, CCL","Crystallin, gamma C",123680,"Cataract 2, multiple types",604307,AD,-,CRYGC
"CRYGB, CRYG2, CTRCT39","Crystallin, gamma B",123670,"Cataract 39, multiple types, autosomal dominant",615188,AD,-,CRYGB
"DUP2q35, C2DUPq35, SDTY1, SD1","Chromosome 2q35 duplication syndrome (syndactyly, type I)",185900,"Syndactyly, type 1, with or without craniosynostosis",185900,AD,-,DUP2q35
IDH1,"Isocitrate dehydrogenase, soluble",147700,"{Glioma, susceptibility to, somatic}",137800,-,-,IDH1
"PIKFYVE, PIP5K3","Phosphatidylinositol kinase, FYVE-finger containing",609414,Corneal fleck dystrophy,121850,AD,-,PIKFYVE
"UNC80, C2orf21, KIAA1843","Unc-80 homolog, NALCN activator",612636,"Hypotonia, infantile, with psychomotor retardation and characteristic facies 2",616801,AR,-,UNC80
"CPS1, PHN","Carbamoyl-phosphate synthetase 1, mitochondrial",608307,Carbamoylphosphate synthetase I deficiency,237300,AR,urea cycle enzyme,CPS1
"CPS1, PHN","Carbamoyl-phosphate synthetase 1, mitochondrial",608307,"{Pulmonary hypertension, neonatal, susceptibility to}",615371,-,-,CPS1
"CPS1, PHN","Carbamoyl-phosphate synthetase 1, mitochondrial",608307,{Venoocclusive disease after bone marrow transplantation},-,-,-,CPS1
"ERBB4, HER4, ALS19",Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 4,600543,Amyotrophic lateral sclerosis 19,615515,AD,-,ERBB4
PSHK2,"Pseudohyperkalemia, familial, 2, due to red cell leak",609153,"Pseudohyperkalemia, familial, 2, due to red cell leak",609153,AD,max lod at D2S1338,PSHK2
BARD1,BRCA1-associated RING domain 1,601593,"{Breast cancer, susceptibility to}",114480,AD,-,BARD1
"ABCA12, ARCI4A, ARCI4B, ICR2B, LI2","ATP-binding cassette, subfamily A, member 12",607800,"Ichthyosis, congenital, autosomal recessive 4A",601277,AR,-,ABCA12
"ABCA12, ARCI4A, ARCI4B, ICR2B, LI2","ATP-binding cassette, subfamily A, member 12",607800,"Ichthyosis, congenital, autosomal recessive 4B (harlequin)",242500,AR,-,ABCA12
"ATIC, PURH, AICAR",5-aminoimidazole-4-carboxyamide ribonucleotide formyltransferase/IMP cyclohydrolase,601731,AICA-ribosiduria due to ATIC deficiency,608688,AR,-,ATIC
"FN1, FN, LETS, FNZ, GFND2, SMDCF",Fibronectin-1,135600,Glomerulopathy with fibronectin deposits 2,601894,AD,-,FN1
"FN1, FN, LETS, FNZ, GFND2, SMDCF",Fibronectin-1,135600,Plasma fibronectin deficiency,614101,AD,-,FN1
"FN1, FN, LETS, FNZ, GFND2, SMDCF",Fibronectin-1,135600,"Spondylometaphyseal dysplasia, corner fracture type",184255,AD,-,FN1
"SMARCAL1, HARP, SIOD","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A-like",606622,Schimke immunoosseous dysplasia,242900,AR,-,SMARCAL1
"CXCR1, IL8RA","Chemokine, CXC motif, receptor 1",146929,"{AIDS, slow progression to}",609423,-,-,CXCR1
"MR1, TAHCCP2, KIPP1184, BRP17, PNKD1, FPD1, PDC, DYT8",Myofibrillogenesis regulator 1,609023,Paroxysmal nonkinesigenic dyskinesia 1,118800,AD,-,MR1
"NRAMP1, NRAMP, SLC11A1","Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",600266,"{Buruli ulcer, susceptibility to}",610446,-,within 220 kb of VIL1,NRAMP1
"NRAMP1, NRAMP, SLC11A1","Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",600266,"{Mycobacterium tuberculosis, susceptibility to infection by}",607948,-,-,NRAMP1
"BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1","bcs1, S. cerevisiae, homolog-like",603647,Bjornstad syndrome,262000,AR,-,BCS1L
"BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1","bcs1, S. cerevisiae, homolog-like",603647,GRACILE syndrome,603358,-,-,BCS1L
"BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1","bcs1, S. cerevisiae, homolog-like",603647,Leigh syndrome,256000,"Mi,AR",-,BCS1L
"BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1","bcs1, S. cerevisiae, homolog-like",603647,"Mitochondrial complex III deficiency, nuclear type 1",124000,AR,-,BCS1L
"CYP27A1, CYP27, CTX","Cytochrome P450, subfamily XXVIIA, polypeptide 1 (sterol 27-hydroxylase)",606530,Cerebrotendinous xanthomatosis,213700,AR,-,CYP27A1
"WNT10A, SSPS, STHAG4, OODD","Wingless-type MMTV integration site family, member 10A",606268,Odontoonychodermal dysplasia,257980,AR,-,WNT10A
"WNT10A, SSPS, STHAG4, OODD","Wingless-type MMTV integration site family, member 10A",606268,Schopf-Schulz-Passarge syndrome,224750,AR,-,WNT10A
"WNT10A, SSPS, STHAG4, OODD","Wingless-type MMTV integration site family, member 10A",606268,"Tooth agenesis, selective, 4",150400,"AD,AR",-,WNT10A
"CRYBA2, CTRCT42","Crystallin, beta A2",600836,?Cataract 42,115900,AD,mutation identified in 1 CTRCT42 family,CRYBA2
"IHH, BDA1",Indian hedgehog,600726,Acrocapitofemoral dysplasia,607778,AR,-,IHH
"IHH, BDA1",Indian hedgehog,600726,"Brachydactyly, type A1",112500,AD,-,IHH
"NHEJ1, XLF",Nonhomologous end-joining factor 1,611290,"Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation",611291,-,-,NHEJ1
"ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2","ATP-binding cassette, subfamily B, member 6",605452,Dyschromatosis universalis hereditaria 3,615402,AD,-,ABCB6
"ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2","ATP-binding cassette, subfamily B, member 6",605452,"Microphthalmia, isolated, with coloboma 7",614497,AD,-,ABCB6
"ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2","ATP-binding cassette, subfamily B, member 6",605452,"Pseudohyperkalemia, familial, 2, due to red cell leak",609153,AD,-,ABCB6
"ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2","ATP-binding cassette, subfamily B, member 6",605452,"[Blood group, Langereis system]",111600,-,-,ABCB6
"TUBA4A, TUBA1, ALS22","Tubulin, alpha-4A",191110,Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia,616208,AD,-,TUBA4A
"DNAJB2, HSJ1, HSPF3, DSMA5","DnaJ, E. coli, homolog of, subfamily B, member 2 (heat-shock protein, DNAJ-like 1)",604139,"Spinal muscular atrophy, distal, autosomal recessive, 5",614881,AR,-,DNAJB2
"DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R",Desmin,125660,"?Muscular dystrophy, limb-girdle, type 2R",615325,AR,1 family with LGMD2R identified with mutation,DES
"DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R",Desmin,125660,"Cardiomyopathy, dilated, 1I",604765,-,-,DES
"DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R",Desmin,125660,"Myopathy, myofibrillar, 1",601419,"AD,AR",-,DES
"DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R",Desmin,125660,"Scapuloperoneal syndrome, neurogenic, Kaeser type",181400,AD,-,DES
"SPEG, APEG1, CNM5",SPEG complex locus,615950,Centronuclear myopathy 5,615959,AR,-,SPEG
"GMPPA, AAMR",GDP-mannose pyrophosphorylase A,615495,"Alacrima, achalasia, and mental retardation syndrome",615510,AR,-,GMPPA
"OBSL1, KIAA0657, 3M2",Obscurin-like 1,610991,3-M syndrome 2,612921,-,-,OBSL1
"PAX3, WS1, HUP2, CDHS, WS3",Paired box homeotic gene-3,606597,Craniofacial-deafness-hand syndrome,122880,AD,-,PAX3
"PAX3, WS1, HUP2, CDHS, WS3",Paired box homeotic gene-3,606597,"Rhabdomyosarcoma 2, alveolar",268220,AR,-,PAX3
"PAX3, WS1, HUP2, CDHS, WS3",Paired box homeotic gene-3,606597,"Waardenburg syndrome, type 1",193500,AD,-,PAX3
"PAX3, WS1, HUP2, CDHS, WS3",Paired box homeotic gene-3,606597,"Waardenburg syndrome, type 3",148820,"AD,AR",-,PAX3
"AP1S3, PSORS15","Adaptor-related protein complex 1, sigma-3 subunit",615781,"{Psoriasis 15, pustular, susceptibility to}",616106,AD,-,AP1S3
"MRPL44, COXPD16",Mitochondrial ribosomal protein L44,611849,?Combined oxidative phosphorylation deficiency 16,615395,AR,Mutation identified in 1 family,MRPL44
"CUL3, PHA2E",Cullin 3,603136,"Pseudohypoaldosteronism, type IIE",614496,AD,-,CUL3
IRS1,Insulin receptor substrate-1,147545,"{Coronary artery disease, susceptibility to}",-,-,-,IRS1
IRS1,Insulin receptor substrate-1,147545,"{Diabetes mellitus, noninsulin-dependent}",125853,AD,-,IRS1
COL4A4,"Collagen IV, alpha-4 polypeptide",120131,"Alport syndrome, autosomal recessive",203780,AR,head-to-head with COL4A4 in same YAC,COL4A4
COL4A4,"Collagen IV, alpha-4 polypeptide",120131,"Hematuria, familial benign",-,-,-,COL4A4
COL4A3,"Collagen IV, alpha-3 polypeptide (Goodpasture antigen)",120070,"Alport syndrome, autosomal dominant",104200,AD,noncollagenous domain = Goodpasture antigen,COL4A3
COL4A3,"Collagen IV, alpha-3 polypeptide (Goodpasture antigen)",120070,"Alport syndrome, autosomal recessive",203780,AR,-,COL4A3
COL4A3,"Collagen IV, alpha-3 polypeptide (Goodpasture antigen)",120070,"Hematuria, benign familial",141200,AD,-,COL4A3
"MFF, C2orf33, EMPF2",Mitochondrial fission factor,614785,Encephalopathy due to defective mitochondrial and peroxisomal fission 2,617086,AR,-,MFF
"TM4SF20, SLI5","Transmembrane 4 L6 family, member 20",615404,{Specific language impairment 5},615432,AD,-,TM4SF20
"SLC19A3, THMD2, BBGD","Solute carrier family 19 (folate transporter), member 3",606152,Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2),607483,AR,-,SLC19A3
"TRIP12, MRD49",Thyroid hormone receptor interactor 12,604506,"Mental retardation, autosomal dominant 49",617752,AD,-,TRIP12
"BDMR, C2DELq37, DEL2q37",Chromosome 2q37 deletion syndrome,600430,Chromosome 2q37 deletion syndrome,600430,AD,-,BDMR
"SP110, IFI41, IFI75, VODI","SP110 nuclear body protein (interferon-induced protein 41, 30kD; interferon-induced protein 75, 52kD)",604457,Hepatic venoocclusive disease with immunodeficiency,235550,AR,-,SP110
"SP110, IFI41, IFI75, VODI","SP110 nuclear body protein (interferon-induced protein 41, 30kD; interferon-induced protein 75, 52kD)",604457,"{Mycobacterium tuberculosis, susceptibility to}",607948,-,-,SP110
"ARMC9, KIAA1868, JBTS30",Armadillo repeat-containing protein 9,617612,Joubert syndrome 30,617622,AR,-,ARMC9
"PDE6D, JBTS22","Phosphodiesterase 6D, cGMP-specific, rod, delta",602676,?Joubert syndrome 22,615665,AR,mutation identified in 1 JBTS22 family,PDE6D
"DIS3L2, PRLMNS","Dis3 mitotic control, S. cerevisiae, homolog-like 2",614184,Perlman syndrome,267000,AR,-,DIS3L2
"ECEL1, XCE, DA5D",Endothelin-converting enzyme-like 1,605896,"Arthrogryposis, distal, type 5D",615065,AR,-,ECEL1
"PRSS56, MCOP6","Protease, serine, 56",613858,"Microphthalmia, isolated 6",613517,AR,-,PRSS56
"CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C","Cholinergic receptor, nicotinic, delta polypeptide",100720,"?Myasthenic syndrome, congenital, 3A, slow-channel",616321,AD,mutation identified in 1 CMS3A patient and 1 CMS3C family,CHRND
"CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C","Cholinergic receptor, nicotinic, delta polypeptide",100720,"?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency",616323,AR,-,CHRND
"CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C","Cholinergic receptor, nicotinic, delta polypeptide",100720,"Multiple pterygium syndrome, lethal type",253290,AR,-,CHRND
"CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C","Cholinergic receptor, nicotinic, delta polypeptide",100720,"Myasthenic syndrome, congenital, 3B, fast-channel",616322,AR,-,CHRND
"CHRNG, ACHRG","Cholinergic receptor, nicotinic, gamma polypeptide",100730,Escobar syndrome,265000,AR,tightly linked to CHRND by RE,CHRNG
"CHRNG, ACHRG","Cholinergic receptor, nicotinic, gamma polypeptide",100730,"Multiple pterygium syndrome, lethal type",253290,AR,-,CHRNG
"GIGYF2, KIAA0642, PARK11",GRB10-interacting GYF protein 2,612003,{Parkinson disease 11},607688,-,-,GIGYF2
"KCNJ13, SVD, LCA16","Potassium inwardly-rectifying channel, subfamily J, member 13",603208,Leber congenital amaurosis 16,614186,AR,-,KCNJ13
"KCNJ13, SVD, LCA16","Potassium inwardly-rectifying channel, subfamily J, member 13",603208,Snowflake vitreoretinal degeneration,193230,AD,-,KCNJ13
"ATG16L1, APG16L, IBD10",Autophagy 16-like 1,610767,{Inflammatory bowel disease (Crohn disease) 10},611081,-,-,ATG16L1
"SAG, RP47",S-antigen; retina and pineal gland (arrestin),181031,Oguchi disease-1,258100,AR,-,SAG
"SAG, RP47",S-antigen; retina and pineal gland (arrestin),181031,Retinitis pigmentosa 47,613758,-,-,SAG
"UGT1A1, UGT1, GNT1, BILIQTL1","UDP glycosyltransferase 1 family, polypeptide A1",191740,"Crigler-Najjar syndrome, type I",218800,AR,-,UGT1A1
"UGT1A1, UGT1, GNT1, BILIQTL1","UDP glycosyltransferase 1 family, polypeptide A1",191740,"Crigler-Najjar syndrome, type II",606785,AR,-,UGT1A1
"UGT1A1, UGT1, GNT1, BILIQTL1","UDP glycosyltransferase 1 family, polypeptide A1",191740,"Hyperbilirubinemia, familial transient neonatal",237900,AR,-,UGT1A1
"UGT1A1, UGT1, GNT1, BILIQTL1","UDP glycosyltransferase 1 family, polypeptide A1",191740,"[Bilirubin, serum level of, QTL1]",601816,-,-,UGT1A1
"UGT1A1, UGT1, GNT1, BILIQTL1","UDP glycosyltransferase 1 family, polypeptide A1",191740,[Gilbert syndrome],143500,AR,-,UGT1A1
"COL6A3, DYT27, BTHLM1, UCMD1","Collagen VI, alpha-3 polypeptide",120250,Bethlem myopathy 1,158810,"AD,AR",close to CRBP1,COL6A3
"COL6A3, DYT27, BTHLM1, UCMD1","Collagen VI, alpha-3 polypeptide",120250,Dystonia 27,616411,AR,-,COL6A3
"COL6A3, DYT27, BTHLM1, UCMD1","Collagen VI, alpha-3 polypeptide",120250,Ullrich congenital muscular dystrophy 1,254090,"AD,AR",-,COL6A3
MLPH,Melanophilin,606526,"Griscelli syndrome, type 3",609227,AR,-,MLPH
"PER2, FASPS1, KIAA0347","Period, Drosophila, homolog of, 2",603426,"Advanced sleep phase syndrome, familial, 1",604348,AD,-,PER2
"TRAF3IP1, MIPT3, SLSN9",TNF receptor-associated factor 3-interacting protein 1,607380,Senior-Loken syndrome 9,616629,AR,-,TRAF3IP1
"TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS","Twist, Drosophila, homolog of, 2 (dermis-expressed protein 1, mouse, homolog of)",607556,Ablepharon-macrostomia syndrome,200110,AD,-,TWIST2
"TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS","Twist, Drosophila, homolog of, 2 (dermis-expressed protein 1, mouse, homolog of)",607556,Barber-Say syndrome,209885,AD,-,TWIST2
"TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS","Twist, Drosophila, homolog of, 2 (dermis-expressed protein 1, mouse, homolog of)",607556,"Focal facial dermal dysplasia 3, Setleis type",227260,AR,-,TWIST2
NDUFA10,"NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 10",603835,Leigh syndrome,256000,"Mi,AR",-,NDUFA10
"CAPN10, NIDDM1",Calpain-10,605286,"{Diabetes mellitus, noninsulin-dependent 1}",601283,-,-,CAPN10
"KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9",Kinesin family member 1A,601255,"Mental retardation, autosomal dominant 9",614255,AD,incorrectly assigned to chr.9,KIF1A
"KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9",Kinesin family member 1A,601255,"Neuropathy, hereditary sensory, type IIC",614213,AR,-,KIF1A
"KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9",Kinesin family member 1A,601255,"Spastic paraplegia 30, autosomal recessive",610357,AR,-,KIF1A
"AGXT, SPAT","Alanine-glyoxylate aminotransferase, liver-specific peroxisomal",604285,"Hyperoxaluria, primary, type 1",259900,AR,-,AGXT
"D2HGDH, D2HGD",D-2-hydroxyglutarate dehydrogenase,609186,D-2-hydroxyglutaric aciduria,600721,AR,-,D2HGDH
"PDCD1, SLEB2",Programmed cell death 1,600244,"{Multiple sclerosis, disease progression, modifier of}",126200,Mu,-,PDCD1
"PDCD1, SLEB2",Programmed cell death 1,600244,"{Systemic lupus erythematosus, susceptibility to, 2}",605218,-,-,PDCD1
"DEL3pterp25, C3DELpterp25",3p- syndrome (chromosome 3pter-p25 deletion syndrome),613792,3p- syndrome,613792,AD,contiguous gene deletion syndrome,DEL3pterp25
HPC5,"Prostate cancer, hereditary, 5",609299,"{Prostate cancer, hereditary, 5}",176807,AD,between D3S1270 and D3S4559,HPC5
"TRNT1, SIFD, RPEM","tRNA nucleotidyltransferase, CCA-adding, 1",612907,Retinitis pigmentosa and erythrocytic microcytosis,616959,AR,pseudogenes on chromosomes 1 and 22,TRNT1
"TRNT1, SIFD, RPEM","tRNA nucleotidyltransferase, CCA-adding, 1",612907,"Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay",616084,AR,-,TRNT1
"CRBN, MRT2",Cereblon,609262,"Mental retardation, autosomal recessive 2",607417,AR,between D3S3525 and D3S1560,CRBN
"SUMF1, FGE",Sulfatase-modifying factor-1,607939,Multiple sulfatase deficiency,272200,AR,-,SUMF1
"ITPR1, SCA15, SCA16, SCA29","Inositol 1,4,5-triphosphate receptor, type 1",147265,Gillespie syndrome,206700,"AD,AR",-,ITPR1
"ITPR1, SCA15, SCA16, SCA29","Inositol 1,4,5-triphosphate receptor, type 1",147265,Spinocerebellar ataxia 15,606658,AD,-,ITPR1
"ITPR1, SCA15, SCA16, SCA29","Inositol 1,4,5-triphosphate receptor, type 1",147265,"Spinocerebellar ataxia 29, congenital nonprogressive",117360,AD,-,ITPR1
"CAV3, LGMD1C, LQT9",Caveolin-3,601253,"Cardiomyopathy, familial hypertrophic",192600,AD,within 7-10kb of OXTR,CAV3
"CAV3, LGMD1C, LQT9",Caveolin-3,601253,"Creatine phosphokinase, elevated serum",123320,AD,-,CAV3
"CAV3, LGMD1C, LQT9",Caveolin-3,601253,Long QT syndrome 9,611818,AD,-,CAV3
"CAV3, LGMD1C, LQT9",Caveolin-3,601253,"Muscular dystrophy, limb-girdle, type IC",607801,"AD,AR",-,CAV3
"CAV3, LGMD1C, LQT9",Caveolin-3,601253,"Myopathy, distal, Tateyama type",614321,AD,-,CAV3
"CAV3, LGMD1C, LQT9",Caveolin-3,601253,Rippling muscle disease,606072,AD,-,CAV3
"SETD5, KIAA1757",SET domain-containing protein 5,615743,"Mental retardation, autosomal dominant 23",615761,AD,-,SETD5
"MTMR14, C3orf29, HJUMPY",Myotubularin-related protein 14,611089,"{Centronuclear myopathy, autosomal, modifier of}",160150,AD,-,MTMR14
"BRPF1, BR140, IDDDFP","Bromodomain- and PHD finger-containing protein 1, 140kD",602410,Intellectual developmental disorder with dysmorphic facies and ptosis,617333,AD,-,BRPF1
OGG1,8-hydroxyguanine DNA glycosylase,601982,"Renal cell carcinoma, clear cell, somatic",144700,-,-,OGG1
"CIDEC, FSP27, CIDE3, FPLD5",Cell death-inducing DFFA-like effector C,612120,"?Lipodystrophy, familial partial, type 5",615238,AR,1 patient identified with mutation,CIDEC
"JAGN1, SCN6","Jagunal, Drosophila, homolog of, 1",616012,"Neutropenia, severe congenital, 6, autosomal recessive",616022,AR,-,JAGN1
"IL17RC, IL17RL, CANDF9",Interleukin 17 receptor C,610925,"Candidiasis, familial, 9",616445,AR,-,IL17RC
"CRELD1, AVSD2",Cysteine-rich protein with EGF-like domains 1,607170,"Atrioventricular septal defect, partial, with heterotaxy syndrome",606217,AD,-,CRELD1
"CRELD1, AVSD2",Cysteine-rich protein with EGF-like domains 1,607170,"{Atrioventricular septal defect, susceptibility to, 2}",606217,AD,-,CRELD1
"FANCD2, FANCD, FACD, FAD","Fanconi anemia, complementation group D2",613984,"Fanconi anemia, complementation group D2",227646,AR,-,FANCD2
VHL,VHL gene,608537,"Erythrocytosis, familial, 2",263400,AR,-,VHL
VHL,VHL gene,608537,"Hemangioblastoma, cerebellar, somatic",-,-,-,VHL
VHL,VHL gene,608537,Pheochromocytoma,171300,AD,-,VHL
VHL,VHL gene,608537,"Renal cell carcinoma, somatic",144700,-,-,VHL
VHL,VHL gene,608537,von Hippel-Lindau syndrome,193300,AD,-,VHL
GHRL,Ghrelin,605353,"{Obesity, susceptibility to}",601665,"AD,Mu,AR",-,GHRL
"ATP2B2, PMCA2","ATPase, Ca++ transporting, plasma membrane, 2",108733,"{Deafness, autosomal recessive 12, modifier of}",601386,AR,-,ATP2B2
"SLC6A1, GABATR, MAE","Solute carrier family 6 (neurotransmitter transporter, GABA), member 1",137165,Myoclonic-atonic epilepsy,616421,AD,-,SLC6A1
SYN2,Synapsin II,600755,"{Schizophrenia, susceptibility to}",181500,AD,-,SYN2
"PPARG, PPARG1, PPARG2, CIMT1, GLM1","Peroxisome proliferator activated receptor, gamma",601487,Carotid intimal medial thickness 1,609338,-,"PPARG1, PPARG2 from same gene",PPARG
"PPARG, PPARG1, PPARG2, CIMT1, GLM1","Peroxisome proliferator activated receptor, gamma",601487,"Insulin resistance, severe, digenic",604367,AD,-,PPARG
"PPARG, PPARG1, PPARG2, CIMT1, GLM1","Peroxisome proliferator activated receptor, gamma",601487,"Lipodystrophy, familial partial, type 3",604367,AD,-,PPARG
"PPARG, PPARG1, PPARG2, CIMT1, GLM1","Peroxisome proliferator activated receptor, gamma",601487,"Obesity, severe",601665,"AD,Mu,AR",-,PPARG
"PPARG, PPARG1, PPARG2, CIMT1, GLM1","Peroxisome proliferator activated receptor, gamma",601487,"[Obesity, resistance to]",-,-,-,PPARG
"PPARG, PPARG1, PPARG2, CIMT1, GLM1","Peroxisome proliferator activated receptor, gamma",601487,"{Diabetes, type 2}",125853,AD,-,PPARG
"TSEN2, SEN2, PCH2B","tRNA splicing endonuclease 2, S. cerevisiae, homolog of",608753,Pontocerebellar hypoplasia type 2B,612389,AR,-,TSEN2
"RAF1, CRAF, NS5, CMD1NN",Oncogene RAF1,164760,"Cardiomyopathy, dilated, 1NN",615916,AD,-,RAF1
"RAF1, CRAF, NS5, CMD1NN",Oncogene RAF1,164760,LEOPARD syndrome 2,611554,-,-,RAF1
"RAF1, CRAF, NS5, CMD1NN",Oncogene RAF1,164760,Noonan syndrome 5,611553,AD,-,RAF1
WNT7A,"Wingless-type MMTV integration site family, member 7A",601570,Fuhrmann syndrome,228930,AR,-,WNT7A
WNT7A,"Wingless-type MMTV integration site family, member 7A",601570,"Ulna and fibula, absence of, with severe limb deficiency",276820,AR,-,WNT7A
"TMEM43, ARVD5, ARVC5, EDMD7",Transmembrane protein 43,612048,Arrhythmogenic right ventricular dysplasia 5,604400,AD,-,TMEM43
"TMEM43, ARVD5, ARVC5, EDMD7",Transmembrane protein 43,612048,"Emery-Dreifuss muscular dystrophy 7, AD",614302,AD,-,TMEM43
"XPC, XPCC",XPC gene,613208,"Xeroderma pigmentosum, group C",278720,AR,-,XPC
"CCDC174, HSPC212, IHPM",Coiled-coil domain-containing protein 174,616735,"Hypotonia, infantile, with psychomotor retardation",616816,AR,-,CCDC174
"COLQ, EAD, CMS5",Collagenic tail of endplate acetylcholinesterase,603033,"Myasthenic syndrome, congenital, 5",603034,AR,-,COLQ
BTD,Biotinidase,609019,Biotinidase deficiency,253260,AR,-,BTD
"SGOL1, SGO, SGO1, CAID",Shugoshin-like 1,609168,Chronic atrial and intestinal dysrhythmia,616201,AR,-,SGOL1
"RPL15, DBA12",Ribosomal protein L15,604174,?Diamond-Blackfan anemia 12,615550,AD,mutation identified in 1 family,RPL15
"THRB, ERBA2, THR1, PRTH","Thyroid hormone receptor, beta (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog-2)",190160,Thyroid hormone resistance,188570,AD,-,THRB
"THRB, ERBA2, THR1, PRTH","Thyroid hormone receptor, beta (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog-2)",190160,"Thyroid hormone resistance, autosomal recessive",274300,AR,-,THRB
"THRB, ERBA2, THR1, PRTH","Thyroid hormone receptor, beta (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog-2)",190160,"Thyroid hormone resistance, selective pituitary",145650,AD,-,THRB
"RARB, HAP, MCOPS12","Retinoic acid receptor, beta polypeptide",180220,"Microphthalmia, syndromic 12",615524,"AD,AR",-,RARB
"NGLY1, PNG1, CDDG, CDG1V",N-glycanase 1,610661,Congenital disorder of deglycosylation,615273,AR,-,NGLY1
"TGFBR2, HNPCC6, AAT3, MFS2, LDS2","Transforming growth factor, beta receptor II, 70-80kD",190182,"Colorectal cancer, hereditary nonpolyposis, type 6",614331,-,-,TGFBR2
"TGFBR2, HNPCC6, AAT3, MFS2, LDS2","Transforming growth factor, beta receptor II, 70-80kD",190182,"Esophageal cancer, somatic",133239,-,-,TGFBR2
"TGFBR2, HNPCC6, AAT3, MFS2, LDS2","Transforming growth factor, beta receptor II, 70-80kD",190182,Loeys-Dietz syndrome 2,610168,AD,-,TGFBR2
"STT3B, SIMP, CDG1X","STT3B, subunit of the oligosaccharyltransferase complex (catalytic)",608605,"?Congenital disorder of glycosylation, type Ix",615597,AR,mutation identified in 1 family,STT3B
"GPD1L, KIAA0089",Glycerol-3-phosphate dehydrogenase 1-like,611778,Brugada syndrome 2,611777,-,-,GPD1L
"GLB1, MPS4B","Galactosidase, beta-1",611458,"GM1-gangliosidosis, type I",230500,AR,3p14.2-p11 excluded,GLB1
"GLB1, MPS4B","Galactosidase, beta-1",611458,"GM1-gangliosidosis, type II",230600,AR,-,GLB1
"GLB1, MPS4B","Galactosidase, beta-1",611458,"GM1-gangliosidosis, type III",230650,AR,-,GLB1
"GLB1, MPS4B","Galactosidase, beta-1",611458,Mucopolysaccharidosis type IVB (Morquio),253010,AR,-,GLB1
"CRTAP, CASP, OI7",Cartilage-associated protein,605497,"Osteogenesis imperfecta, type VII",610682,AR,-,CRTAP
"MLH1, COCA2, HNPCC2","mutL, E. coli, homolog of, 1",120436,"Colorectal cancer, hereditary nonpolyposis, type 2",609310,-,-,MLH1
"MLH1, COCA2, HNPCC2","mutL, E. coli, homolog of, 1",120436,Mismatch repair cancer syndrome,276300,AR,-,MLH1
"MLH1, COCA2, HNPCC2","mutL, E. coli, homolog of, 1",120436,Muir-Torre syndrome,158320,AD,-,MLH1
"PLCD1, NDNC3","Phospholipase C, delta-1",602142,"Nail disorder, nonsyndromic congenital, 3, (leukonychia)",151600,"AD,AR",-,PLCD1
"DLEC1, DLC1",Deleted in lung and esophageal cancer 1,604050,Esophageal cancer,133239,AD,-,DLEC1
"DLEC1, DLC1",Deleted in lung and esophageal cancer 1,604050,Lung cancer,211980,AR,-,DLEC1
"MYD88, MYD88D",Myeloid differentiation primary response gene 88,602170,"Macroglobulinemia, Waldenstrom, somatic",153600,-,-,MYD88
"MYD88, MYD88D",Myeloid differentiation primary response gene 88,602170,"Pyogenic bacterial infections, recurrent, due to MYD88 deficiency",612260,-,-,MYD88
"ACVR2B, ACTRIIB, HTX4","Activin A receptor, type IIB",602730,"Heterotaxy, visceral, 4, autosomal",613751,-,-,ACVR2B
"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2","Sodium channel, voltage-gated, type V, alpha polypeptide",600163,"Atrial fibrillation, familial, 10",614022,AD,-,SCN5A
"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2","Sodium channel, voltage-gated, type V, alpha polypeptide",600163,Brugada syndrome 1,601144,AD,-,SCN5A
"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2","Sodium channel, voltage-gated, type V, alpha polypeptide",600163,"Cardiomyopathy, dilated, 1E",601154,AD,-,SCN5A
"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2","Sodium channel, voltage-gated, type V, alpha polypeptide",600163,"Heart block, nonprogressive",113900,AD,-,SCN5A
"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2","Sodium channel, voltage-gated, type V, alpha polypeptide",600163,"Heart block, progressive, type IA",113900,AD,-,SCN5A
"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2","Sodium channel, voltage-gated, type V, alpha polypeptide",600163,Long QT syndrome-3,603830,AD,-,SCN5A
"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2","Sodium channel, voltage-gated, type V, alpha polypeptide",600163,Sick sinus syndrome 1,608567,AR,-,SCN5A
"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2","Sodium channel, voltage-gated, type V, alpha polypeptide",600163,"Ventricular fibrillation, familial, 1",603829,-,-,SCN5A
"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2","Sodium channel, voltage-gated, type V, alpha polypeptide",600163,"{Sudden infant death syndrome, susceptibility to}",272120,AR,-,SCN5A
"SCN10A, FEPS2","Sodium channel, voltage-gated, type X, alpha subunit",604427,"Episodic pain syndrome, familial, 2",615551,AD,-,SCN10A
"SCN11A, HSAN7, FEPS3","Sodium channel, voltage-gated, type XI, alpha subunit",604385,"Episodic pain syndrome, familial, 3",615552,AD,-,SCN11A
"SCN11A, HSAN7, FEPS3","Sodium channel, voltage-gated, type XI, alpha subunit",604385,"Neuropathy, hereditary sensory and autonomic, type VII",615548,AD,-,SCN11A
"CX3CR1, GPR13, V28",Chemokine (C-X3-C) receptor 1 (G protein-coupled receptor-13),601470,"{Coronary artery disease, resistance to}",607339,-,-,CX3CR1
"CX3CR1, GPR13, V28",Chemokine (C-X3-C) receptor 1 (G protein-coupled receptor-13),601470,"{Macular degeneration, age-related, 12}",613784,-,-,CX3CR1
"CX3CR1, GPR13, V28",Chemokine (C-X3-C) receptor 1 (G protein-coupled receptor-13),601470,{Rapid progression to AIDS from HIV1 infection},609423,-,-,CX3CR1
"SLC25A38, SIDBA2","Solute carrier family 25, member 38",610819,"Anemia, sideroblastic, 2, pyridoxine-refractory",205950,AR,-,SLC25A38
"RPSA, LAMR1, LAMBR, ICAS",Ribosomal protein SA,150370,"Asplenia, isolated congenital",271400,AD,-,RPSA
"CTNNB1, MRD19, EVR7","Catenin (cadherin-associated protein), beta 1, 88kD",116806,"Colorectal cancer, somatic",114500,-,-,CTNNB1
"CTNNB1, MRD19, EVR7","Catenin (cadherin-associated protein), beta 1, 88kD",116806,Exudative vitreoretinopathy 7,617572,AD,-,CTNNB1
"CTNNB1, MRD19, EVR7","Catenin (cadherin-associated protein), beta 1, 88kD",116806,"Hepatocellular carcinoma, somatic",114550,-,-,CTNNB1
"CTNNB1, MRD19, EVR7","Catenin (cadherin-associated protein), beta 1, 88kD",116806,"Medulloblastoma, somatic",155255,-,-,CTNNB1
"CTNNB1, MRD19, EVR7","Catenin (cadherin-associated protein), beta 1, 88kD",116806,"Mental retardation, autosomal dominant 19",615075,AD,-,CTNNB1
"CTNNB1, MRD19, EVR7","Catenin (cadherin-associated protein), beta 1, 88kD",116806,"Ovarian cancer, somatic",167000,-,-,CTNNB1
"CTNNB1, MRD19, EVR7","Catenin (cadherin-associated protein), beta 1, 88kD",116806,"Pilomatricoma, somatic",132600,-,-,CTNNB1
"KLHL40, SYRP, KBTBD5, NEM8",Kelch-like 40,615340,"Nemaline myopathy 8, autosomal recessive",615348,-,-,KLHL40
"POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8","Protein O-mannose beta-1,2-N-acetylglucosaminyltransferase 2",614828,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8",614830,AR,-,POMGNT2
"ANO10, TMEM16K, SCAR10",Anoctamin 10,613726,"Spinocerebellar ataxia, autosomal recessive 10",613728,AR,-,ANO10
"ABHD5, CGI58, IECN2, NCIE2",Abhydrolase domain containing 5,604780,Chanarin-Dorfman syndrome,275630,AR,-,ABHD5
"LARS2, PRLTS4, HLASA","Leucyl-tRNA synthetase, mitochondrial",604544,"?Hydrops, lactic acidosis, and sideroblastic anemia",617021,AR,mutation identified in 1 HLASA patient,LARS2
"LARS2, PRLTS4, HLASA","Leucyl-tRNA synthetase, mitochondrial",604544,Perrault syndrome 4,615300,AR,-,LARS2
"SLC6A20, XT3",X transporter protein 3,605616,Hyperglycinuria,138500,AD,-,SLC6A20
"SLC6A20, XT3",X transporter protein 3,605616,"Iminoglycinuria, digenic",242600,"AR,DR",-,SLC6A20
"LZTFL1, BBS17",Leucine zipper transcription factor-like 1,606568,Bardet-Biedl syndrome 17,615994,AR,-,LZTFL1
"FYCO1, CATC2, CTRCT18",FYVE and coiled-coil domain containing 1,607182,"Cataract 18, autosomal recessive",610019,AR,-,FYCO1
"CCR5, CMKBR5, CCCKR5, IDDM22",Chemokine (C-C) receptor 5,601373,"{Diabetes mellitus, insulin-dependent, 22}",612522,-,-,CCR5
"CCR5, CMKBR5, CCCKR5, IDDM22",Chemokine (C-C) receptor 5,601373,"{Hepatitis C virus, resistance to}",609532,-,-,CCR5
"CCR5, CMKBR5, CCCKR5, IDDM22",Chemokine (C-C) receptor 5,601373,"{HIV infection, susceptibility/resistance to}",-,-,-,CCR5
"CCR5, CMKBR5, CCCKR5, IDDM22",Chemokine (C-C) receptor 5,601373,"{West nile virus, susceptibility to}",610379,-,-,CCR5
"TMIE, DFNB6",Transmembrane inner ear-expressed gene,607237,"Deafness, autosomal recessive 6",600971,AR,-,TMIE
"MYL3, CMH8","Myosin, light polypeptide-3, alkali; ventricular, skeletal, slow",160790,"Cardiomyopathy, hypertrophic, 8",608751,AD,-,MYL3
"PTHR1, PTHR, PFE",Parathyroid hormone receptor-1,168468,"Chondrodysplasia, Blomstrand type",215045,AR,-,PTHR1
"PTHR1, PTHR, PFE",Parathyroid hormone receptor-1,168468,Eiken syndrome,600002,AR,-,PTHR1
"PTHR1, PTHR, PFE",Parathyroid hormone receptor-1,168468,"Failure of tooth eruption, primary",125350,AD,-,PTHR1
"PTHR1, PTHR, PFE",Parathyroid hormone receptor-1,168468,"Metaphyseal chondrodysplasia, Murk Jansen type",156400,AD,-,PTHR1
"NBEAL2, KIAA0540, GPS, BDPLT4",Neurobeachin-like 2,614169,Gray platelet syndrome,139090,AR,-,NBEAL2
"SETD2, SET2, HYPB, HBP231, KIAA1732, LLS",SET domain-containing protein 2,612778,Luscan-Lumish syndrome,616831,AD,-,SETD2
"DHX30, DDX30, RETCOR, KIAA0890, NEDMIAL",DEAH box polypeptide 30,616423,Neurodevelopmental disorder with severe motor impairment and absent language,617804,-,-,DHX30
"TREX1, AGS1, CRV, HERNS",3' repair exonuclease 1,606609,"Aicardi-Goutieres syndrome 1, dominant and recessive",225750,"AD,AR",-,TREX1
"TREX1, AGS1, CRV, HERNS",3' repair exonuclease 1,606609,Chilblain lupus,610448,AD,-,TREX1
"TREX1, AGS1, CRV, HERNS",3' repair exonuclease 1,606609,"Vasculopathy, retinal, with cerebral leukodystrophy",192315,AD,-,TREX1
"TREX1, AGS1, CRV, HERNS",3' repair exonuclease 1,606609,"{Systemic lupus erythematosus, susceptibility to}",152700,AD,-,TREX1
"COL7A1, NDNC8","Collagen VII, alpha-1 polypeptide",120120,EBD inversa,226600,AR,-,COL7A1
"COL7A1, NDNC8","Collagen VII, alpha-1 polypeptide",120120,"EBD, Bart type",132000,AD,-,COL7A1
"COL7A1, NDNC8","Collagen VII, alpha-1 polypeptide",120120,"EBD, localisata variant",-,-,-,COL7A1
"COL7A1, NDNC8","Collagen VII, alpha-1 polypeptide",120120,"Epidermolysis bullosa dystrophica, AD",131750,AD,-,COL7A1
"COL7A1, NDNC8","Collagen VII, alpha-1 polypeptide",120120,"Epidermolysis bullosa dystrophica, AR",226600,AR,-,COL7A1
"COL7A1, NDNC8","Collagen VII, alpha-1 polypeptide",120120,Epidermolysis bullosa pruriginosa,604129,"AD,AR",-,COL7A1
"COL7A1, NDNC8","Collagen VII, alpha-1 polypeptide",120120,"Epidermolysis bullosa, pretibial",131850,"AD,AR",-,COL7A1
"COL7A1, NDNC8","Collagen VII, alpha-1 polypeptide",120120,"Toenail dystrophy, isolated",607523,AD,-,COL7A1
"COL7A1, NDNC8","Collagen VII, alpha-1 polypeptide",120120,Transient bullous of the newborn,131705,"AD,AR",-,COL7A1
"SLC25A20, CACT, CAC","Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 (carnitine-acylcarnitine translocase)",613698,Carnitine-acylcarnitine translocase deficiency,212138,AR,pseudogene on 6p12,SLC25A20
NDUFAF3,"NADH dehydrogenase 1 alpha subcomplex, assembly factor 3",612911,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",-,NDUFAF3
"QARS, GLNRS, MSCCA",Glutaminyl-tRNA synthetase,603727,"Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy",615760,AR,-,QARS
"LAMB2, LAMS, NPHS5","Laminin, beta-2 (laminin S)",150325,"Nephrotic syndrome, type 5, with or without ocular abnormalities",614199,-,-,LAMB2
"LAMB2, LAMS, NPHS5","Laminin, beta-2 (laminin S)",150325,Pierson syndrome,609049,AR,-,LAMB2
"KLHDC8B, CHL",Kelch domain-containing protein 8B,613169,"{Hodgkin lymphoma, susceptibility to}",236000,AR,-,KLHDC8B
"AMT, NKH, GCE",Aminomethyltransferase (glycine cleavage system protein T),238310,Glycine encephalopathy,605899,AR,-,AMT
"DAG1, DAG, MDDGC9, MDDGA9",Dystrophin-associated glycoprotein-1,128239,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9",616538,AR,-,DAG1
"DAG1, DAG, MDDGC9, MDDGA9",Dystrophin-associated glycoprotein-1,128239,"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9",613818,AR,-,DAG1
"GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14",GDP-mannose pyrophosphorylase B,615320,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14",615350,AR,-,GMPPB
"GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14",GDP-mannose pyrophosphorylase B,615320,"Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14",615351,AR,-,GMPPB
"GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14",GDP-mannose pyrophosphorylase B,615320,"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14",615352,AR,-,GMPPB
"TRAIP, TRIP, RNF206, SCKL9",TRAF-interacting protein,605958,Seckel syndrome 9,616777,AR,-,TRAIP
"MST1R, RON, NPCA3",Macrophage stimulating 1 receptor (c-met-related tyrosine kinase),600168,"{Nasopharyngeal carcinoma, susceptibility to, 3}",617075,AD,-,MST1R
"GNAT1, CSNBAD3, CSNB1G","Guanine nucleotide-binding protein (G protein), alpha-transducing (transducin) activity polypeptide-1",139330,"Night blindness, congenital stationary, autosomal dominant 3",610444,AD,-,GNAT1
"GNAT1, CSNBAD3, CSNB1G","Guanine nucleotide-binding protein (G protein), alpha-transducing (transducin) activity polypeptide-1",139330,"Night blindness, congenital stationary, type 1G",616389,AR,-,GNAT1
"GNAI2, GNAI2B, GIP","Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide-2",139360,Pituitary ACTH-secreting adenoma,-,-,"on 12p13-p12, GNAI2L",GNAI2
"GNAI2, GNAI2B, GIP","Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide-2",139360,"Ventricular tachycardia, idiopathic",192605,AD,-,GNAI2
"HYAL1, MPS9",Hyaluronoglucosaminidase 1,607071,?Mucopolysaccharidosis type IX,601492,AR,mutation identified in 1 MPS9 patient,HYAL1
RASSF1,RAS association domain family protein 1,605082,Lung cancer,211980,AR,epigenetically inactivated,RASSF1
"ZMYND10, BLU",Zinc finger MYND domain-containing protein 10,607070,"Ciliary dyskinesia, primary, 22",615444,AR,-,ZMYND10
"NPR2L, NPRL2, FFEVF2","Npr2, S. cerevisiae, homolog of",607072,"Epilepsy, familial focal, with variable foci 2",617116,AD,-,NPR2L
"CISH, BACTS2",Cytokine inducible SH2-containing protein,602441,"{Bacteremia, susceptibility to}",614383,-,-,CISH
"CISH, BACTS2",Cytokine inducible SH2-containing protein,602441,"{Malaria, susceptibility to}",611162,-,-,CISH
"CISH, BACTS2",Cytokine inducible SH2-containing protein,602441,"{Tuberculosis, susceptibility to}",607948,-,-,CISH
"MAPKAP3, 3PK, MDPT3",Mitogen-activated protein kinase-activated protein kinase-3,602130,"?Macular dystrophy, patterned, 3",617111,AD,mutation identified in 1 MDPT3 family,MAPKAP3
"ACY1, ACY1D",Aminoacylase-1,104620,Aminoacylase 1 deficiency,609924,AR,-,ACY1
"POC1A, PIX2, SOFT","POC1 centriolar protein, Chlamydomonas, homolog of, A",614783,"Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis",614813,AR,-,POC1A
"GLYCTK, GLYCTK1",Glycerate kinase,610516,D-glyceric aciduria,220120,AR,-,GLYCTK
"DNAH1, HL11, DNAHC1, HDHC7, SPGF18, CILD37","Dynein, axonemal, heavy chain-1",603332,"?Ciliary dyskinesia, primary, 37",617577,AR,mutation identified in 1 CILD37 family,DNAH1
"DNAH1, HL11, DNAHC1, HDHC7, SPGF18, CILD37","Dynein, axonemal, heavy chain-1",603332,Spermatogenic failure 18,617576,AR,-,DNAH1
"BAP1, TPDS",BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase),603089,Tumor predisposition syndrome,614327,AD,-,BAP1
"TNNC1, CMD1Z, CMH13","Troponin-C1, slow",191040,"Cardiomyopathy, dilated, 1Z",611879,-,-,TNNC1
"TNNC1, CMD1Z, CMH13","Troponin-C1, slow",191040,"Cardiomyopathy, hypertrophic, 13",613243,AD,-,TNNC1
"ITIH4, PK120, ITIHL1","Inter-alpha (globulin) inhibitor, H4 polypeptide",600564,"{Hypercholesterolemia, susceptibility to}",143890,AD,-,ITIH4
"RFT1, CDG1N","RFT1, S. cerevisiae, homolog of",611908,"Congenital disorder of glycosylation, type In",612015,AR,-,RFT1
"PRKCD, CVID9, ALPS3","Protein kinase C, delta",176977,"Autoimmune lymphoproliferative syndrome, type III",615559,AR,mutation identified in 1 family,PRKCD
"TKT, SDDHD",Transketolase,606781,"Short stature, developmental delay, and congenital heart defects",617044,AR,-,TKT
"CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA","Calcium channel, voltage-dependent, L type, alpha 1D subunit",114206,"Primary aldosteronism, seizures, and neurologic abnormalities",615474,AD,-,CACNA1D
"CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA","Calcium channel, voltage-dependent, L type, alpha 1D subunit",114206,Sinoatrial node dysfunction and deafness,614896,AR,-,CACNA1D
WNT5A,"Wingless-type MMTV integration site family, member 5A",164975,"Robinow syndrome, autosomal dominant 1",180700,AD,-,WNT5A
"IL17RD, SEF, HH18","Interleukin 17, receptor D (Sef, zebrafish, homolog of)",606807,Hypogonadotropic hypogonadism 18 with or without anosmia,615267,"AD,DD,AR",-,IL17RD
"HESX1, RPX, CPHD5",Homeo box gene expressed in ES cells,601802,Growth hormone deficiency with pituitary anomalies,182230,"AD,AR",-,HESX1
"HESX1, RPX, CPHD5",Homeo box gene expressed in ES cells,601802,"Pituitary hormone deficiency, combined, 5",182230,"AD,AR",-,HESX1
"HESX1, RPX, CPHD5",Homeo box gene expressed in ES cells,601802,Septooptic dysplasia,182230,"AD,AR",-,HESX1
"APPL1, APPL, MODY14","Adaptor protein containing PH domain, PTB domain, and leucine zipper motif 1",604299,"{Maturity-onset diabetes of the young, type 14}",616511,AD,-,APPL1
"FLNB, SCT, AOI, LRS1",Filamin B,603381,"Atelosteogenesis, type I",108720,AD,-,FLNB
"FLNB, SCT, AOI, LRS1",Filamin B,603381,"Atelosteogenesis, type III",108721,AD,-,FLNB
"FLNB, SCT, AOI, LRS1",Filamin B,603381,Boomerang dysplasia,112310,AD,-,FLNB
"FLNB, SCT, AOI, LRS1",Filamin B,603381,Larsen syndrome,150250,AD,-,FLNB
"FLNB, SCT, AOI, LRS1",Filamin B,603381,Spondylocarpotarsal synostosis syndrome,272460,AR,-,FLNB
"DNASE1L3, SLEB16",Deoxyribonuclease I-like 3,602244,Systemic lupus erythematosus 16,614420,AR,-,DNASE1L3
"PDHB, PDHBD","Pyruvate dehydrogenase, E1 beta polypeptide",179060,Pyruvate dehydrogenase E1-beta deficiency,614111,-,-,PDHB
"ACOX2, BRCACOX, CBAS6","Acyl-Coenzyme A oxidase 2, branched chain",601641,"Bile acid synthesis defect, congenital, 6",617308,AR,-,ACOX2
"ATXN7, SCA7, OPCA3",Ataxin 7,607640,Spinocerebellar ataxia 7,164500,AD,-,ATXN7
"SLC25A26, SAMC, COXPD28","Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 26",611037,Combined oxidative phosphorylation deficiency 28,616794,AR,-,SLC25A26
"EOGT, EOGT1, C3orf64, AOS4",EGF domain-specific O-linked N-acetylglucosamine transferase,614789,Adams-Oliver syndrome 4,615297,AR,-,EOGT
"LMOD3, NEM10",Leiomodin 3,616112,Nemaline myopathy 10,616165,AR,-,LMOD3
"MITF, WS2A, CMM8, COMMAD",Microphthalmia-associated transcription factor,156845,COMMAD syndrome,617306,AR,-,MITF
"MITF, WS2A, CMM8, COMMAD",Microphthalmia-associated transcription factor,156845,Tietz albinism-deafness syndrome,103500,AD,-,MITF
"MITF, WS2A, CMM8, COMMAD",Microphthalmia-associated transcription factor,156845,"Waardenburg syndrome, type 2A",193510,AD,-,MITF
"MITF, WS2A, CMM8, COMMAD",Microphthalmia-associated transcription factor,156845,"Waardenburg syndrome/ocular albinism, digenic",103470,AD,-,MITF
"MITF, WS2A, CMM8, COMMAD",Microphthalmia-associated transcription factor,156845,"{Melanoma, cutaneous malignant, susceptibility to, 8}",614456,-,-,MITF
"FOXP1, QRF1",Forkhead box P1,605515,Mental retardation with language impairment and with or without autistic features,613670,AD,-,FOXP1
"PROK2, PK2, BV8, HH4",Prokineticin 2,607002,Hypogonadotropic hypogonadism 4 with or without anosmia,610628,AD,-,PROK2
"ROBO2, SAX3, KIAA1568","Roundabout, Drosophila, homolog of, 2",602431,Vesicoureteral reflux 2,610878,-,-,ROBO2
"GBE1, GSD4, APBD",Glycogen branching enzyme,607839,Glycogen storage disease IV,232500,AR,-,GBE1
"GBE1, GSD4, APBD",Glycogen branching enzyme,607839,"Polyglucosan body disease, adult form",263570,AR,-,GBE1
"CHMP2B, DMT1, VPS2B, ALS17","CHMP family, member 2B",609512,Amyotrophic lateral sclerosis 17,614696,AD,-,CHMP2B
"CHMP2B, DMT1, VPS2B, ALS17","CHMP family, member 2B",609512,"Dementia, familial, nonspecific",600795,AD,-,CHMP2B
"POU1F1, PIT1, CPHD1","POU domain, class 1, transcription factor 1 (Pit1, growth hormone factor 1)",173110,"Pituitary hormone deficiency, combined, 1",613038,"AD,AR",-,POU1F1
"PROS1, THPH5, THPH6","Protein S, alpha",176880,"Thrombophilia due to protein S deficiency, autosomal dominant",612336,AD,pseudogene PROSP contiguous on chr.3,PROS1
"PROS1, THPH5, THPH6","Protein S, alpha",176880,"Thrombophilia due to protein S deficiency, autosomal recessive",614514,AR,-,PROS1
"ARL13B, ARL2L1, JBTS8",ADP-ribosylation factor-like 13B,608922,Joubert syndrome 8,612291,AR,-,ARL13B
"ARL6, BBS3, RP55",ADP-ribosylation factor-like 6,608845,?Retinitis pigmentosa 55,613575,-,mutation identified in 1 RPS55 family,ARL6
"ARL6, BBS3, RP55",ADP-ribosylation factor-like 6,608845,Bardet-Biedl syndrome 3,600151,AR,-,ARL6
"ARL6, BBS3, RP55",ADP-ribosylation factor-like 6,608845,"{Bardet-Biedl syndrome 1, modifier of}",209900,"AR,DR",-,ARL6
CPOX,Coproporphyrinogen oxidase,612732,Coproporphyria,121300,AD,-,CPOX
CPOX,Coproporphyrinogen oxidase,612732,Harderoporphyria,121300,AD,-,CPOX
"TBC1D23, PCH11","TBC1 domain family, member 23",617687,"Pontocerebellar hypoplasia, type 11",617695,AR,-,TBC1D23
"TFG, HMSNP, SPG57",TRK-fused gene,602498,"?Spastic paraplegia 57, autosomal recessive",615658,AR,fused with NR4A3 or NTRK1; mutation identified in 1 SPG57 family,TFG
"TFG, HMSNP, SPG57",TRK-fused gene,602498,"Hereditary motor and sensory neuropathy, Okinawa type",604484,AD,-,TFG
"IMPG2, IPM200, RP56, VMD5",Interphotoreceptor matrix proteoglycan 2,607056,"Macular dystrophy, vitelliform, 5",616152,AD,-,IMPG2
"IMPG2, IPM200, RP56, VMD5",Interphotoreceptor matrix proteoglycan 2,607056,Retinitis pigmentosa 56,613581,AR,-,IMPG2
"TRMT10C, RG9MTD1, MRPP1, COXPD30","tRNA methyltransferase 10, S. cerevisiae, homolog of, C",615423,Combined oxidative phosphorylation deficiency 30,616974,AR,-,TRMT10C
"CD96, TACTILE",CD96 antigen,606037,C syndrome,211750,AD,-,CD96
"CFAP44, WDR52, SPGF20",Cilia- and flagella-associated protein 44,617559,?Spermatogenic failure 20,617593,AR,mutation identified in 1 SPGF20 patient,CFAP44
"DEL3q13.31, C13DELq13.31",Chromosome 3q13.31 deletion syndrome,615433,Chromosome 3q13.31 deletion syndrome,615433,AD,-,DEL3q13.31
"ATP6V1A1, HO68, ARCL2D","ATPase, H+ transporting, lysosomal alpha polypeptide, 70-kD, isoform 1",607027,"Cutis laxa, autosomal recessive, type IID",617403,AR,-,ATP6V1A1
"DRD3, ETM1, FET1",Dopamine receptor D3,126451,"{Essential tremor, hereditary, 1}",190300,AD,-,DRD3
"DRD3, ETM1, FET1",Dopamine receptor D3,126451,"{Schizophrenia, susceptibility to}",181500,AD,-,DRD3
"ZBTB20, ZNF288, DPZF, PRIMS",Zinc finger and BTB-domain containing 20,606025,Primrose syndrome,259050,AD,-,ZBTB20
"ARHGAP31, CDGAP, KIAA1204, AOS1",Rho GTPase-activating protein 31,610911,Adams-Oliver syndrome 1,100300,AD,-,ARHGAP31
"POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4, LGMD2Z",Protein O-glucosyltransferase 1,615618,"?Muscular dystrophy, limb-girdle, type 2Z",617232,AR,mutation identified in 1 LGMD2Z family,POGLUT1
"POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4, LGMD2Z",Protein O-glucosyltransferase 1,615618,Dowling-Degos disease 4,615696,AD,-,POGLUT1
"TIMMDC1, C3orf1",Translocase of inner mitochondrial membrane domain-containing protein 1,615534,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",-,TIMMDC1
"HGD, AKU","Homogentisate 1,2-dioxygenase (homogentisate oxidase)",607474,Alkaptonuria,203500,AR,-,HGD
"IQCB1, NPHP5, KIAA0036",IQ motif-containing protein B1,609237,Senior-Loken syndrome 5,609254,AR,-,IQCB1
"ILDR1, DFNB42",Immunoglobulin-like domain-containing receptor 1,609739,"Deafness, autosomal recessive 42",609646,AR,-,ILDR1
"CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1",Calcium-sensing receptor,601199,Hypercalciuric hypercalcemia,-,-,15cM from RHO,CASR
"CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1",Calcium-sensing receptor,601199,"Hyperparathyroidism, neonatal",239200,"AD,AR",-,CASR
"CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1",Calcium-sensing receptor,601199,"Hypocalcemia, autosomal dominant",601198,AD,-,CASR
"CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1",Calcium-sensing receptor,601199,"Hypocalcemia, autosomal dominant, with Bartter syndrome",601198,AD,-,CASR
"CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1",Calcium-sensing receptor,601199,"Hypocalciuric hypercalcemia, type I",145980,AD,-,CASR
"CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1",Calcium-sensing receptor,601199,"{Calcium, serum level of}",-,-,-,CASR
"CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1",Calcium-sensing receptor,601199,"{Epilepsy idiopathic generalized, susceptibility to, 8}",612899,-,-,CASR
"CSTA, STFA, STF1, AREI, PSS4",Cystatin A (stefin A),184600,Peeling skin syndrome 4,607936,AR,-,CSTA
"DIRC2, RCC4",Disrupted in renal carcinoma 2,602773,Renal cell carcinoma,144700,-,t(2;3)(q35;q21) in renal cell carcinoma,DIRC2
"ADCY5, FDFM",Adenylate cyclase-5,600293,"Dyskinesia, familial, with facial myokymia",606703,AD,-,ADCY5
"MYLK, MLCK, AAT7",Myosin-light-polypeptide kinase,600922,"Aortic aneurysm, familial thoracic 7",613780,AD,pseudogene on 3p13,MYLK
"KALRN, HAPIP, DUO, CHDS5",Kalirin,604605,"{Coronary heart disease, susceptibility to, 5}",608901,-,-,KALRN
"UMPS, OPRT",Uridine monophosphate synthetase (orotate phosphoribosyl transferase and orotidine-5'-decarboxylase),613891,Orotic aciduria,258900,AR,-,UMPS
"ZNF148, ZFP148, GDACCF",Zinc finger protein-148,601897,"Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies",617260,AD,-,ZNF148
"UROC1, UROCD",Urocanase domain-containing protein 1,613012,?Urocanase deficiency,276880,AR,mutation identified in 1 UROCD patient,UROC1
"MCM2, CDCL1, DFNA70","Minichromosome maintenance deficient, S. cerevisiae, 2, homolog of (mitotin)",116945,"?Deafness, autosomal dominant 70",616968,AD,mutation identified in 1 DFNA70 family,MCM2
"SEC61A1, SEC61, HNFJ4","Sec61 complex, alpha-1 subunit",609213,"Hyperuricemic nephropathy, familial juvenile, 4",617056,AD,-,SEC61A1
"GATA2, DCML, MONOMAC, IMD21",GATA-binding protein-2,137295,Emberger syndrome,614038,AD,-,GATA2
"GATA2, DCML, MONOMAC, IMD21",GATA-binding protein-2,137295,Immunodeficiency 21,614172,AD,-,GATA2
"GATA2, DCML, MONOMAC, IMD21",GATA-binding protein-2,137295,"{Leukemia, acute myeloid, susceptibility to}",601626,AD,-,GATA2
"GATA2, DCML, MONOMAC, IMD21",GATA-binding protein-2,137295,"{Myelodysplastic syndrome, susceptibility to}",614286,-,-,GATA2
"RAB7, CMT2B, PSN",Ras-associated protein RAB7,602298,"Charcot-Marie-Tooth disease, type 2B",600882,AD,-,RAB7
ACAD9,"Acyl-CoA dehydrogenase family, member 9",611103,Mitochondrial complex I deficiency due to ACAD9 deficiency,611126,AR,-,ACAD9
GP9,"Glycoprotein IX, platelet",173515,"Bernard-Soulier syndrome, type C",231200,AR,-,GP9
"ZNF9, CNBP1, DM2, PROMM",Zinc finger protein-9 (a cellular retroviral nucleic acid-binding protein),116955,Myotonic dystrophy 2,602668,AD,-,ZNF9
"IFT122, WDR10, CED1","Intraflagellar transport 122, homolog of",606045,Cranioectodermal dysplasia 1,218330,AR,-,IFT122
"RHO, RP4, OPN2, CSNBAD1",Rhodopsin (opsin 2),180380,"Night blindness, congenital stationary, autosomal dominant 1",610445,-,-,RHO
"RHO, RP4, OPN2, CSNBAD1",Rhodopsin (opsin 2),180380,"Retinitis pigmentosa 4, autosomal dominant or recessive",613731,"AD,AR",-,RHO
"RHO, RP4, OPN2, CSNBAD1",Rhodopsin (opsin 2),180380,Retinitis punctata albescens,136880,"AD,AR",-,RHO
"ATP2C1, BCPM, HHD","ATPase, Ca(2+)-sequestering",604384,Hailey-Hailey disease,169600,AD,-,ATP2C1
"MRPL3, MRL3, COXPD9",Mitochondrial ribosomal protein L3,607118,Combined oxidative phosphorylation deficiency 9,614582,AR,-,MRPL3
"UBA5, UBE1DC1, EIEE44, SCAR24",Ubiquitin-like modifier activating enzyme 5,610552,"?Spinocerebellar ataxia, autosomal recessive 24",617133,AR,mutation identified in 1 SCAR24 family,UBA5
"UBA5, UBE1DC1, EIEE44, SCAR24",Ubiquitin-like modifier activating enzyme 5,610552,"Epileptic encephalopathy, early infantile, 44",617132,AR,-,UBA5
"NPHP3, NPH3, RHPD1, MKS7",Nephrocystin 3,608002,Meckel syndrome 7,267010,AR,-,NPHP3
"NPHP3, NPH3, RHPD1, MKS7",Nephrocystin 3,608002,Nephronophthisis 3,604387,AR,-,NPHP3
"NPHP3, NPH3, RHPD1, MKS7",Nephrocystin 3,608002,Renal-hepatic-pancreatic dysplasia 1,208540,AR,-,NPHP3
"BFSP2, CP49, CP47, CTRCT12","Beaded filament structural protein 2 (cytoskeletal protein, 49 kD)",603212,"Cataract 12, multiple types",611597,AD,-,BFSP2
"TF, TFQTL1",Transferrin,190000,Atransferrinemia,209300,AR,-,TF
"SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2","Solute carrier organic anion transporter family, member 2A1",601460,"Hypertrophic osteoarthropathy, primary, autosomal recessive 2",614441,AR,-,SLCO2A1
"CEP63, SCKL6","Centrosomal protein, 63kD",614724,?Seckel syndrome 6,614728,AR,mutation identified in 1 family,CEP63
"KY, MFM7",Kyphoscoliosis peptidase,605739,"Myopathy, myofibrillar, 7",617114,AR,-,KY
PCCB,"Propionyl Coenzyme A carboxylase, beta polypeptide",232050,Propionicacidemia,606054,AR,pccB complementation group,PCCB
"STAG1, MRD47",Stromal antigen 1,604358,"Mental retardation, autosomal dominant 47",617635,AD,-,STAG1
"DZIP1L, DZIP2, PKD5",DAZ-interacting zinc finger protein 1-like,617570,Polycystic kidney disease 5,617610,AR,-,DZIP1L
"FOXL2, BPES, BPES1, PFRK, POF3",Forkhead transcription factor FOXL2,605597,"Blepharophimosis, epicanthus inversus, and ptosis, type 1",110100,AD,-,FOXL2
"FOXL2, BPES, BPES1, PFRK, POF3",Forkhead transcription factor FOXL2,605597,"Blepharophimosis, epicanthus inversus, and ptosis, type 2",110100,AD,-,FOXL2
"FOXL2, BPES, BPES1, PFRK, POF3",Forkhead transcription factor FOXL2,605597,Premature ovarian failure 3,608996,AD,-,FOXL2
"MRPS22, C3orf5, COXPD5",Mitochondrial ribosomal protein S22,605810,Combined oxidative phosphorylation deficiency 5,611719,AR,-,MRPS22
"COPB2, MCPH19","Coatomer protein complex, subunit beta-2",606990,"?Microcephaly 19, primary, autosomal recessive",617800,AR,mutation identified in 1 MCPH19 family,COPB2
"ATR, FRP1, SCKL1, FCTCS",Ataxia-telangiectasia and Rad3-related (FRAP-related protein-1),601215,"?Cutaneous telangiectasia and cancer syndrome, familial",614564,AD,mutation identified in 1 FCTCS family,ATR
"ATR, FRP1, SCKL1, FCTCS",Ataxia-telangiectasia and Rad3-related (FRAP-related protein-1),601215,Seckel syndrome 1,210600,AR,-,ATR
"SLC9A9, AUTS16","Solute carrier family 9 (sodium/hydrogen exchanger), member A9",608396,{?Autism susceptibility 16},613410,-,mutation identified in 1 family,SLC9A9
"PLOD2, LH2, TLH, BRKS2","Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase) 2",601865,Bruck syndrome 2,609220,AR,-,PLOD2
"ZIC1, CRS6","Zic family, member 1",600470,Craniosynostosis 6,616602,AD,-,ZIC1
"AGTR1, AGTR1A, AT2R1",Angiotensin receptor 1,106165,Renal tubular dysgenesis,267430,AR,-,AGTR1
"AGTR1, AGTR1A, AT2R1",Angiotensin receptor 1,106165,"{Hypertension, essential}",145500,Mu,-,AGTR1
"GYG1, GSD15",Glycogenin 1,603942,?Glycogen storage disease XV,613507,AR,mutation identified in 1 GSD15 patient,GYG1
"GYG1, GSD15",Glycogenin 1,603942,Polyglucosan body myopathy 2,616199,AR,-,GYG1
HPS3,HPS gene 3,606118,Hermansky-Pudlak syndrome 3,614072,AR,-,HPS3
CP,Ceruloplasmin,117700,Cerebellar ataxia,604290,AR,~15cM from TF,CP
CP,Ceruloplasmin,117700,"Hemosiderosis, systemic, due to aceruloplasminemia",604290,AR,-,CP
CP,Ceruloplasmin,117700,"[Hypoceruloplasminemia, hereditary]",604290,AR,-,CP
"CLRN1, USH3A, USH3, RP61",Clarin 1,606397,Retinitis pigmentosa 61,614180,-,frequent in Finland; ?digenic interaction with MYO7A,CLRN1
"CLRN1, USH3A, USH3, RP61",Clarin 1,606397,"Usher syndrome, type 3A",276902,AR,-,CLRN1
"P2RY12, P2Y12, BDPLT8","Purinergic receptor P2Y, G protein-coupled, 12",600515,"Bleeding disorder, platelet-type, 8",609821,AR,-,P2RY12
"MME, CD10, CALLA, NEP, CMT2T, SCA43",Membrane metallo-endopeptidase (common acute lymphocytic leukemia antigen),120520,?Spinocerebellar ataxia 43,617018,AD,mutation identified in 1 SCA43 family,MME
"MME, CD10, CALLA, NEP, CMT2T, SCA43",Membrane metallo-endopeptidase (common acute lymphocytic leukemia antigen),120520,"Charcot-Marie-Tooth disease, axonal, type 2T",617017,"AD,AR",-,MME
"SLC33A1, ACATN, AT1, SPG42, CCHLND","Solute carrier family 33 (acetyl-CoA transporter), member 1",603690,"Congenital cataracts, hearing loss, and neurodegeneration",614482,AR,-,SLC33A1
"SLC33A1, ACATN, AT1, SPG42, CCHLND","Solute carrier family 33 (acetyl-CoA transporter), member 1",603690,"Spastic paraplegia 42, autosomal dominant",612539,AD,-,SLC33A1
MLF1,Myeloid leukemia factor-1,601402,"Leukemia, acute myeloid",601626,AD,-,MLF1
"GFM1, EFG1, GFM, COXPD1",Mitochondrial elongation factor G1,606639,Combined oxidative phosphorylation deficiency 1,609060,AR,-,GFM1
"IFT80, KIAA1374, WDR56, SRTD2, ATD2","Intraflagellar transport 80, Chlamydomonas, homolog of",611177,Short-rib thoracic dysplasia 2 with or without polydactyly,611263,AR,-,IFT80
"B3GALT3, GLCT3, GLOB","UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 3",603094,"[Blood group, globoside system]",615021,-,-,B3GALT3
"B3GALT3, GLCT3, GLOB","UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 3",603094,"[Blood group, P1PK system, P(k) phenotype]",111400,-,-,B3GALT3
SI,Sucrase-isomaltase,609845,"Sucrase-isomaltase deficiency, congenital",222900,AR,-,SI
"PDCD10, TFAR15, CCM3",Programmed cell death 10,609118,Cerebral cavernous malformations 3,603285,-,-,PDCD10
"SERPINI1, PI12",Protease inhibitor 12,602445,"Encephalopathy, familial, with neuroserpin inclusion bodies",604218,AD,-,SERPINI1
"MECOM, EVI1, RUSAT2",MDS1 and EVS1 complex locus,165215,Radioulnar synostosis with amegakaryocytic thrombocytopenia 2,616738,AD,-,MECOM
"TERC, TRC3, TR, DKCA1, PFBMFT2",Telomerase RNA component,602322,"Dyskeratosis congenita, autosomal dominant 1",127550,AD,-,TERC
"TERC, TRC3, TR, DKCA1, PFBMFT2",Telomerase RNA component,602322,{Aplastic anemia},614743,AD,-,TERC
"TERC, TRC3, TR, DKCA1, PFBMFT2",Telomerase RNA component,602322,"{Pulmonary fibrosis, idiopathic, susceptibility to}",614743,AD,-,TERC
"SLC7A14, KIAA1613, RP68","Solute carrier family 7, member 14",615720,Retinitis pigmentosa 68,615725,AR,-,SLC7A14
"SLC2A2, GLUT2","Solute carrier family 2 (facilitated glucose transporter), member 2",138160,Fanconi-Bickel syndrome,227810,AR,-,SLC2A2
"SLC2A2, GLUT2","Solute carrier family 2 (facilitated glucose transporter), member 2",138160,"{Diabetes mellitus, noninsulin-dependent}",125853,AD,-,SLC2A2
"TNIK, KIAA0551, MRT54",TRAF2-and NCK-interacting kinase,610005,"Mental retardation, autosomal recessive 54",617028,AR,-,TNIK
APMR1,Alopecia-mental retardation syndrome 1,203650,Alopecia-mental retardation syndrome 1,203650,AR,max lod at D3S3583,APMR1
"PLD1, CVDD","Phospholipase D1, phosphatidylcholine-specific",602382,"Cardiac valvular defect, developmental",212093,AR,-,PLD1
"GHSR, GHDP",Growth hormone secretagogue receptor,601898,"Growth hormone deficiency, isolated partial",615925,"AD,AR",-,GHSR
"SPATA16, SPGF6",Spermatogenesis-associated protein 16,609856,?Spermatogenic failure 6,102530,AR,mutation identified in 1 SPGF6 family,SPATA16
"TBL1XR1, TBLR1, IRA1, C21, MRD41",Transducin-beta-like 1 receptor 1,608628,"Mental retardation, autosomal dominant 41",616944,AD,-,TBL1XR1
"TBL1XR1, TBLR1, IRA1, C21, MRD41",Transducin-beta-like 1 receptor 1,608628,Pierpont syndrome,602342,AD,-,TBL1XR1
"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5","Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide",171834,"Breast cancer, somatic",114480,-,-,PIK3CA
"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5","Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide",171834,"CLOVE syndrome, somatic",612918,-,-,PIK3CA
"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5","Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide",171834,"Colorectal cancer, somatic",114500,-,-,PIK3CA
"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5","Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide",171834,Cowden syndrome 5,615108,-,-,PIK3CA
"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5","Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide",171834,"Gastric cancer, somatic",613659,-,-,PIK3CA
"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5","Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide",171834,"Hepatocellular carcinoma, somatic",114550,-,-,PIK3CA
"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5","Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide",171834,"Keratosis, seborrheic, somatic",182000,-,-,PIK3CA
"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5","Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide",171834,"Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic",602501,-,-,PIK3CA
"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5","Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide",171834,"Nevus, epidermal, somatic",162900,-,-,PIK3CA
"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5","Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide",171834,"Nonsmall cell lung cancer, somatic",211980,-,-,PIK3CA
"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5","Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide",171834,"Ovarian cancer, somatic",167000,-,-,PIK3CA
"GNB4, CMTD1F","Guanine nucleotide-binding protein, beta-4",610863,"Charcot-Marie-Tooth disease, dominant intermediate F",615185,AD,-,GNB4
CCDC39,Coiled-coil domain-containing protein 39,613798,"Ciliary dyskinesia, primary, 14",613807,-,-,CCDC39
"DNAJC19, TIM14","DnaJ (Hsp40) homolog, subfamily C, member 19 (translocase of inner mitochondrial membrane 14, yeast, homolog of)",608977,"3-methylglutaconic aciduria, type V",610198,AR,-,DNAJC19
"SOX2, MCOPS3",SRY (sex determining region Y)-box 2,184429,"Microphthalmia, syndromic 3",206900,AD,-,SOX2
"SOX2, MCOPS3",SRY (sex determining region Y)-box 2,184429,Optic nerve hypoplasia and abnormalities of the central nervous system,206900,AD,-,SOX2
"MCCC1, MCCA",3-Methylcrotonyl-CoA carboxylase 1,609010,3-Methylcrotonyl-CoA carboxylase 1 deficiency,210200,AR,-,MCCC1
"KLHL24, KRIP6, EBSSH",Kelch-like 24,611295,"Epidermolysis bullosa simplex, generalized, with scarring and hair loss",617294,AD,-,KLHL24
"EIF2B5, LVWM, CACH, CLE","Eukaryotic translation initiation factor 2B, subunit 5",603945,Leukoencephalopathy with vanishing white matter,603896,AR,-,EIF2B5
"EIF2B5, LVWM, CACH, CLE","Eukaryotic translation initiation factor 2B, subunit 5",603945,Ovarioleukodystrophy,603896,AR,-,EIF2B5
"DVL3, DRS3",Dishevelled 3 (homologous to Drosophila dsh),601368,"Robinow syndrome, autosomal dominant 3",616894,AD,-,DVL3
"ALG3, NOT56L, CDGS4, CDG1D","Alg3, S. cerevisiae, homolog of",608750,"Congenital disorder of glycosylation, type Id",601110,AR,-,ALG3
"EIF4G1, EIF4G, PARK18","Eukaryotic translation initiation factor 4 gamma, 1",600495,{Parkinson disease 18},614251,AD,amplified in squamous cell lung cancer,EIF4G1
"CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT",Chloride channel-2,600570,Leukoencephalopathy with ataxia,615651,AR,-,CLCN2
"CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT",Chloride channel-2,600570,"{Epilepsy, idiopathic generalized, susceptibility to, 11}",607628,AD,-,CLCN2
"CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT",Chloride channel-2,600570,"{Epilepsy, juvenile absence, susceptibility to, 2}",607628,AD,-,CLCN2
"CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT",Chloride channel-2,600570,"{Epilepsy, juvenile myoclonic, susceptibility to, 8}",607628,AD,-,CLCN2
"THPO, MGDF, MPLLG, TPO, THCYT1",Thrombopoietin (megakaryocyte growth and development factor),600044,Thrombocythemia 1,187950,AD,-,THPO
"EHHADH, PBFE, LBFP, FRTS3","Enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase",607037,?Fanconi renotubular syndrome 3,615605,AD,mutation identified in 1 family,EHHADH
"LIPH, LAH2, ARWH2, HYPT7",Lipase H,607365,Hypotrichosis 7,604379,AR,-,LIPH
"LIPH, LAH2, ARWH2, HYPT7",Lipase H,607365,"Woolly hair, autosomal recessive 2 with or without hypotrichosis",604379,AR,-,LIPH
"IGF2BP2, IMP2",Insulin-like growth factor 2 mRNA-binding protein 2,608289,"{Diabetes mellitus, noninsulin-dependent, susceptibility to}",125853,AD,-,IGF2BP2
"CRYGS, CRYG8, CTRCT20","Crystallin, gamma S",123730,"Cataract 20, multiple types",116100,AD,-,CRYGS
"AHSG, APMR1",Alpha-2HS-glycoprotein,138680,?Alopecia-mental retardation syndrome 1,203650,AR,mutation identified in 1 APMR1 family,AHSG
"HRG, THPH11",Histidine-rich glycoprotein,142640,Thrombophilia due to elevated HRG,613116,AD,-,HRG
"HRG, THPH11",Histidine-rich glycoprotein,142640,Thrombophilia due to HRG deficiency,613116,AD,-,HRG
"KNG1, KNG",Kininogen 1,612358,[High molecular weight kininogen deficiency],228960,AR,-,KNG1
"KNG1, KNG",Kininogen 1,612358,[Kininogen deficiency],228960,AR,-,KNG1
"ADIPOQ, APM1, GBP28, ADIPQTL1","Adipocyte-, C1q-, and collagen domain-containing",605441,Adiponectin deficiency,612556,-,-,ADIPOQ
"MASP1, CRARF, 3MC1",Mannan-binding lectin serine protease-1 (C4/C2 activating component of Ra-reactive factor),600521,3MC syndrome 1,257920,AR,-,MASP1
LPP,Lipoma-preferred-partner gene,600700,"Leukemia, acute myeloid",601626,AD,fused with HMGIC in lipoma; fused with MLL in leukemia,LPP
LPP,Lipoma-preferred-partner gene,600700,Lipoma,-,-,-,LPP
"TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8",Tumor protein p63 (tumor protein p73-like),603273,ADULT syndrome,103285,AD,-,TP63
"TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8",Tumor protein p63 (tumor protein p73-like),603273,"Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3",604292,AD,-,TP63
"TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8",Tumor protein p63 (tumor protein p73-like),603273,Hay-Wells syndrome,106260,AD,-,TP63
"TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8",Tumor protein p63 (tumor protein p73-like),603273,Limb-mammary syndrome,603543,AD,-,TP63
"TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8",Tumor protein p63 (tumor protein p73-like),603273,Orofacial cleft 8,129400,AD,-,TP63
"TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8",Tumor protein p63 (tumor protein p73-like),603273,Rapp-Hodgkin syndrome,129400,AD,-,TP63
"TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8",Tumor protein p63 (tumor protein p73-like),603273,Split-hand/foot malformation 4,605289,AD,-,TP63
"P3H2, LEPREL1, MCVD",Prolyl 3-hydroxylase 2,610341,"Myopia, high, with cataract and vitreoretinal degeneration",614292,AR,-,P3H2
"CLDN1, SEMP1, ILVASC",Claudin 1,603718,"Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis",607626,AR,-,CLDN1
"CLDN16, PCLN1, HOMG3",Claudin 16 (paracellin 1),603959,"Hypomagnesemia 3, renal",248250,AR,-,CLDN16
"CCDC50, C3orf6, DFNA44",Coiled-coil domain-containing protein 50,611051,"?Deafness, autosomal dominant 44",607453,AD,mutation identified in 1 DFNA44 family,CCDC50
"FGF12, FHF1, EIEE47",Fibroblast growth factor-12,601513,"Epileptic encephalopathy, early infantile, 47",617166,AD,-,FGF12
"DEL3q29, MICRODEL3q29",Chromosome 3q29 microdeletion syndrome,609425,Chromosome 3q29 microdeletion syndrome,609425,IC,contiguous gene deletion syndrome,DEL3q29
"DUP3q29, MICRODUP3q29",Chromosome 3q29 microduplication syndrome,611936,Chromosome 3q29 microduplication syndrome,611936,AD,contiguous gene duplication syndrome,DUP3q29
"OPA1, NTG, NPG, BERHS, MTDPS14",Optic atrophy 1 gene,605290,?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896,-,mutation identified in 1 MTDPS14 family,OPA1
"OPA1, NTG, NPG, BERHS, MTDPS14",Optic atrophy 1 gene,605290,Behr syndrome,210000,AR,-,OPA1
"OPA1, NTG, NPG, BERHS, MTDPS14",Optic atrophy 1 gene,605290,Optic atrophy 1,165500,AD,-,OPA1
"OPA1, NTG, NPG, BERHS, MTDPS14",Optic atrophy 1 gene,605290,Optic atrophy plus syndrome,125250,AD,-,OPA1
"OPA1, NTG, NPG, BERHS, MTDPS14",Optic atrophy 1 gene,605290,"{Glaucoma, normal tension, susceptibility to}",606657,-,-,OPA1
"TFRC, TFR, CD71, IMD46",Transferrin receptor,190010,Immunodeficiency 46,616740,AR,-,TFRC
"PCYT1A, CTPCT, PCYT1, SMDCRD","Phosphate cytidylyltransferase 1, choline, alpha isoform",123695,Spondylometaphyseal dysplasia with cone-rod dystrophy,608940,AR,-,PCYT1A
"TCTEX1D2, SRTD17",TCTEX1 domain-containing protein 2,617353,Short-rib thoracic dysplasia 17 with or without polydactyly,617405,AR,-,TCTEX1D2
RNF168,RING finger protein 168,612688,RIDDLE syndrome,611943,AR,-,RNF168
"CEP19, C3orf34, MOSPGF","Centrosomal protein, 19kD",615586,Morbid obesity and spermatogenic failure,615703,AR,mutation identified in 1 family,CEP19
"RUBCN, RUBICON, KIAA0226, SCAR15","RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein",613516,"?Spinocerebellar ataxia, autosomal recessive 15",615705,AR,mutation identified in 1 family,RUBCN
"RPL35A, DBA5",Ribosomal protein L35A,180468,Diamond-Blackfan anemia 5,612528,AD,previous assignment to chr.18 in error,RPL35A
WHS,Wolf-Hirschhorn syndrome,194190,Wolf-Hirschhorn syndrome,194190,IC,contiguous gene syndrome; critical region 200kb region 1.9Mb from telomere,WHS
"ZNF141, D4S90, PAPA6",Zinc finger protein-141 (clone pHZ-44),194648,"?Polydactyly, postaxial, type A6",615226,AR,1 family identified with mutation,ZNF141
"PIGG, GPI7, MRT53",Phosphatidylinositol glycan anchor biosynthesis class G protein,616918,"Mental retardation, autosomal recessive 53",616917,AR,-,PIGG
"PDE6B, PDEB, RP40, CSNBAD2","Phosphodiesterase-6B, cGMP-specific, rod, beta",180072,"Night blindness, congenital stationary, autosomal dominant 2",163500,AD,-,PDE6B
"PDE6B, PDEB, RP40, CSNBAD2","Phosphodiesterase-6B, cGMP-specific, rod, beta",180072,Retinitis pigmentosa-40,613801,AR,-,PDE6B
"SLC26A1, SAT1, CAON","Solute carrier family 26 (sulfate transporter), member 1",610130,"?Nephrolithiasis, calcium oxalate",167030,AR,mutation identified in 1 CAON patient,SLC26A1
"IDUA, IDA","Iduronidase, alpha-L-",252800,Mucopolysaccharidosis Ih,607014,AR,-,IDUA
"IDUA, IDA","Iduronidase, alpha-L-",252800,Mucopolysaccharidosis Ih/s,607015,AR,-,IDUA
"IDUA, IDA","Iduronidase, alpha-L-",252800,Mucopolysaccharidosis Is,607016,AR,-,IDUA
"RNF212, ZHP3",Ring finger protein 212,612041,Recombination rate QTL 1,612042,-,-,RNF212
"UVSSA, KIAA1530, UVSS3",UV-stimulated scaffold protein A,614632,UV-sensitive syndrome 3,614640,AR,-,UVSSA
"FGFR3, ACH",Fibroblast growth factor receptor-3,134934,Achondroplasia,100800,AD,-,FGFR3
"FGFR3, ACH",Fibroblast growth factor receptor-3,134934,"Bladder cancer, somatic",109800,-,-,FGFR3
"FGFR3, ACH",Fibroblast growth factor receptor-3,134934,CATSHL syndrome,610474,"AD,AR",-,FGFR3
"FGFR3, ACH",Fibroblast growth factor receptor-3,134934,"Cervical cancer, somatic",603956,-,-,FGFR3
"FGFR3, ACH",Fibroblast growth factor receptor-3,134934,"Colorectal cancer, somatic",114500,-,-,FGFR3
"FGFR3, ACH",Fibroblast growth factor receptor-3,134934,Crouzon syndrome with acanthosis nigricans,612247,AD,-,FGFR3
"FGFR3, ACH",Fibroblast growth factor receptor-3,134934,Hypochondroplasia,146000,AD,-,FGFR3
"FGFR3, ACH",Fibroblast growth factor receptor-3,134934,LADD syndrome,149730,AD,-,FGFR3
"FGFR3, ACH",Fibroblast growth factor receptor-3,134934,Muenke syndrome,602849,AD,-,FGFR3
"FGFR3, ACH",Fibroblast growth factor receptor-3,134934,"Nevus, epidermal, somatic",162900,-,-,FGFR3
"FGFR3, ACH",Fibroblast growth factor receptor-3,134934,SADDAN,616482,AD,-,FGFR3
"FGFR3, ACH",Fibroblast growth factor receptor-3,134934,"Spermatocytic seminoma, somatic",273300,-,-,FGFR3
"FGFR3, ACH",Fibroblast growth factor receptor-3,134934,"Thanatophoric dysplasia, type I",187600,AD,-,FGFR3
"FGFR3, ACH",Fibroblast growth factor receptor-3,134934,"Thanatophoric dysplasia, type II",187601,AD,-,FGFR3
"NAT8L, CML3, NACED",N-acetyltransferase 8-like,610647,?N-acetylaspartate deficiency,614063,AR,mutation identified in 1 patient,NAT8L
"SH3BP2, CRPM",SH3-domain binding protein 2,602104,Cherubism,118400,AD,-,SH3BP2
ADD1,"Adducin-1, alpha",102680,"{Hypertension, essential, salt-sensitive}",145500,Mu,-,ADD1
"HTT, HD, IT15, LOMARS",Huntingtin,613004,Huntington disease,143100,AD,distal to D4S10,HTT
"HTT, HD, IT15, LOMARS",Huntingtin,613004,Lopes-Maciel-Rodan syndrome,617435,AR,-,HTT
"DOK7, C4orf25, CMS10",Downstream of tyrosine kinase 7,610285,?Fetal akinesia deformation sequence,208150,AR,mutation identified in 1 FADS family,DOK7
"DOK7, C4orf25, CMS10",Downstream of tyrosine kinase 7,610285,"Myasthenic syndrome, congenital, 10",254300,AR,-,DOK7
"LRPAP1, A2MRAP, MYP23",Low density lipoprotein-related protein-associated protein 1 (alpha-2-macroglobulin receptor-associated protein 1),104225,"Myopia 23, autosomal recessive",615431,AR,-,LRPAP1
"MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3","Muscle segment homeo box, Drosophila, homolog of, 1 (homeo box 7)",142983,"Ectodermal dysplasia 3, Witkop type",189500,AD,-,MSX1
"MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3","Muscle segment homeo box, Drosophila, homolog of, 1 (homeo box 7)",142983,Orofacial cleft 5,608874,-,-,MSX1
"MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3","Muscle segment homeo box, Drosophila, homolog of, 1 (homeo box 7)",142983,"Tooth agenesis, selective, 1, with or without orofacial cleft",106600,AD,-,MSX1
"EVC2, LBN, WAD",EVC2 (limbin) gene,607261,Ellis-van Creveld syndrome,225500,AR,-,EVC2
"EVC2, LBN, WAD",EVC2 (limbin) gene,607261,Weyers acrofacial dysostosis,193530,AD,-,EVC2
EVC,EVC gene,604831,?Weyers acrofacial dysostosis,193530,AD,mutation identified in 1 WAD patient,EVC
EVC,EVC gene,604831,Ellis-van Creveld syndrome,225500,AR,-,EVC
"WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41",Wolframin,606201,?Cataract 41,116400,AD,mutation identified in 1 CTRCT41 family,WFS1
"WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41",Wolframin,606201,"Deafness, autosomal dominant 6/14/38",600965,AD,-,WFS1
"WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41",Wolframin,606201,Wolfram syndrome 1,222300,AR,-,WFS1
"WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41",Wolframin,606201,"Wolfram-like syndrome, autosomal dominant",614296,AD,-,WFS1
"WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41",Wolframin,606201,"{Diabetes mellitus, noninsulin-dependent, association with}",125853,AD,-,WFS1
"HMX1, H6",Homeo box (H6 family) 1,142992,Oculoauricular syndrome,612109,AR,-,HMX1
"SLC2A9, GLUT9, UAQTL2","Solute carrier family 2 (facilitated glucose transporter), member 9",606142,"Hypouricemia, renal, 2",612076,"AD,AR",-,SLC2A9
"SLC2A9, GLUT9, UAQTL2","Solute carrier family 2 (facilitated glucose transporter), member 9",606142,"{Uric acid concentration, serum, QTL 2}",612076,"AD,AR",-,SLC2A9
"DRD5, DRD1B, DRD1L2",Dopamine receptor D5,126453,"Dystonia, primary cervical",-,-,pseudogenes on 2p11 and 1q21,DRD5
"DRD5, DRD1B, DRD1L2",Dopamine receptor D5,126453,"{Attention deficit-hyperactivity disorder, susceptibility to}",143465,AD,-,DRD5
"DRD5, DRD1B, DRD1L2",Dopamine receptor D5,126453,"{Blepharospasm, primary benign}",606798,IC,-,DRD5
"RAB28, CORD18",Ras-associated protein 28,612994,Cone-rod dystrophy 18,615374,AR,-,RAB28
"NKX3-2, BAPX1, SMMD","Bagpipe homeo box, Drosophila, homolog of",602183,Spondylo-megaepiphyseal-metaphyseal dysplasia,613330,AR,-,NKX3-2
"CC2D2A, KIAA1345, MKS6",Coiled-coil and C2 domains-containing protein 2A,612013,COACH syndrome,216360,AR,-,CC2D2A
"CC2D2A, KIAA1345, MKS6",Coiled-coil and C2 domains-containing protein 2A,612013,Joubert syndrome 9,612285,AR,-,CC2D2A
"CC2D2A, KIAA1345, MKS6",Coiled-coil and C2 domains-containing protein 2A,612013,Meckel syndrome 6,612284,AR,-,CC2D2A
"PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4",Prominin 1,604365,Cone-rod dystrophy 12,612657,-,-,PROM1
"PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4",Prominin 1,604365,"Macular dystrophy, retinal, 2",608051,AD,-,PROM1
"PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4",Prominin 1,604365,Retinitis pigmentosa 41,612095,AR,-,PROM1
"PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4",Prominin 1,604365,Stargardt disease 4,603786,-,-,PROM1
"TAPT1, CMVFR, OCLSBG",Transmembrane anterior posterior transformation 1,612758,"Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type",616897,AR,-,TAPT1
"QDPR, DHPR",Quinoid dihydropteridine reductase,612676,"Hyperphenylalaninemia, BH4-deficient, C",261630,AR,-,QDPR
"SEPSECS, SLA, LP, PCH2D",O-phosphoserine tRNA-selenocysteine tRNA synthase,613009,Pontocerebellar hypoplasia type 2D,613811,AR,-,SEPSECS
SLC34A2,"Solute carrier family 34 (sodium/phosphate cotransporter), member 2",604217,Pulmonary alveolar microlithiasis,265100,AR,-,SLC34A2
"RBPJ, RBPSUH, IGKJRB1, AOS3",Recombination signal-binding protein 1 for kappa J region,147183,Adams-Oliver syndrome 3,614814,AD,"pseudogenes at 9q13, 9p13, and 3q25",RBPJ
"TLR1, TIL. LPRS5",Toll-like receptor-1,601194,"{Leprosy, protection against}",613223,-,-,TLR1
"TLR1, TIL. LPRS5",Toll-like receptor-1,601194,"{Leprosy, susceptibility to, 5}",613223,-,-,TLR1
"WDR19, SRTD5, ATD5, NPHP13, CED4",WD repeat-containing protein 19,608151,?Cranioectodermal dysplasia 4,614378,AR,mutation identified in 1 CED4 family and 1 SRTD5 family,WDR19
"WDR19, SRTD5, ATD5, NPHP13, CED4",WD repeat-containing protein 19,608151,?Short-rib thoracic dysplasia 5 with or without polydactyly,614376,AR,-,WDR19
"WDR19, SRTD5, ATD5, NPHP13, CED4",WD repeat-containing protein 19,608151,Nephronophthisis 13,614377,AR,-,WDR19
"WDR19, SRTD5, ATD5, NPHP13, CED4",WD repeat-containing protein 19,608151,Senior-Loken syndrome 8,616307,AR,-,WDR19
"LIAS, PDHLD, HGCLAS",Lipoic acid synthase,607031,"Hyperglycinemia, lactic acidosis, and seizures",614462,AR,-,LIAS
"UCHL1, PARK5, SPG79, NDGOA",Ubiquitin C-terminal esterase L1,191342,"Spastic paraplegia 79, autosomal recessive",615491,AR,mutation identified in 1 PARK5 family,UCHL1
"UCHL1, PARK5, SPG79, NDGOA",Ubiquitin C-terminal esterase L1,191342,"{?Parkinson disease 5, susceptibility to}",613643,-,-,UCHL1
"PHOX2B, NBPHOX, PMX2B, NBLST2, CCHS",Paired mesoderm homeo box 2B,603851,"Central hypoventilation syndrome, congenital, with or without Hirschsprung disease",209880,AD,-,PHOX2B
"PHOX2B, NBPHOX, PMX2B, NBLST2, CCHS",Paired mesoderm homeo box 2B,603851,Neuroblastoma with Hirschsprung disease,613013,-,-,PHOX2B
"PHOX2B, NBPHOX, PMX2B, NBLST2, CCHS",Paired mesoderm homeo box 2B,603851,"{Neuroblastoma, susceptibility to, 2}",613013,-,-,PHOX2B
"SLC30A9, C4orf1, HUEL, BILAPES","Solute carrier family 30 (zinc transporter), member 9",604604,?Birk-Landau-Perez syndrome,617595,AR,mutation identified in 1 BILAPES family,SLC30A9
GRXCR1,"Glutaredoxin, cysteine-rich, 1",613283,"Deafness, autosomal recessive 25",613285,AR,-,GRXCR1
"GUF1, EF4, EIEE40","GTPase, S. cerevisiae, homolog of",617064,"?Epileptic encephalopathy, early infantile, 40",617065,AR,mutation identified in 1 EIEE40 family,GUF1
GABRA2,"Gamma-aminobutyric acid (GABA) A receptor, alpha-2",137140,"{Alcohol dependence, susceptibility to}",103780,Mu,-,GABRA2
"GABRB1, EIEE45","Gamma-aminobutyric acid (GABA) A receptor, beta-1",137190,"Epileptic encephalopathy, early infantile, 45",617153,AD,-,GABRB1
"CORIN, CRN, TMPRSS10, ATC2, PEE5","Corin, serine peptidase",605236,Preeclampsia/eclampsia 5,614595,-,-,CORIN
"CNGA1, CNCG1, RP49","Cyclic nucleotide gated channel, alpha 1",123825,Retinitis pigmentosa 49,613756,-,-,CNGA1
"SGCB, LGMD2E","Sarcoglycan, beta (43kD dystrophin-associated glycoprotein)",600900,"Muscular dystrophy, limb-girdle, type 2E",604286,AR,-,SGCB
"CHIC2, BTL",Cysteine-rich hydrophobic domain 2 (Brx-like gene translocated in leukemia),604332,"{Leukemia, acute myeloid}",601626,AD,-,CHIC2
PDGFRA,"Platelet-derived growth factor receptor, alpha polypeptide",173490,"Gastrointestinal stromal tumor, somatic",606764,-,same 700bp segment as KIT; fused to BCR or FIP1L1,PDGFRA
PDGFRA,"Platelet-derived growth factor receptor, alpha polypeptide",173490,"Hypereosinophilic syndrome, idiopathic, resistant to imatinib",607685,"IC,SMu",-,PDGFRA
"KIT, PBT",Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene,164920,"Gastrointestinal stromal tumor, familial",606764,"AD,IC",same 700bp segment as PDGFRA,KIT
"KIT, PBT",Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene,164920,"Germ cell tumors, somatic",273300,-,-,KIT
"KIT, PBT",Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene,164920,"Leukemia, acute myeloid",601626,AD,-,KIT
"KIT, PBT",Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene,164920,Mast cell disease,154800,AD,-,KIT
"KIT, PBT",Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene,164920,Piebaldism,172800,AD,-,KIT
KDR,Kinase insert domain receptor,191306,"Hemangioma, capillary infantile, somatic",602089,-,?mutant in TAPVR1,KDR
KDR,Kinase insert domain receptor,191306,"{Hemangioma, capillary infantile, susceptibility to}",602089,AD,-,KDR
"SRD5A3, SRD5A2L, CDG1Q, KRIZI",Steroid 5-alpha-reductase 3,611715,"Congenital disorder of glycosylation, type Iq",612379,AR,-,SRD5A3
"SRD5A3, SRD5A2L, CDG1Q, KRIZI",Steroid 5-alpha-reductase 3,611715,Kahrizi syndrome,612713,AR,-,SRD5A3
"TMEM165, FT27, CDG2K",Transmembrane protein 165,614726,"Congenital disorder of glycosylation, type IIk",614727,AR,-,TMEM165
"CEP135, KIAA0635, MCPH8","Centrosomal protein, 135kD",611423,"Microcephaly 8, primary, autosomal recessive",614673,AR,-,CEP135
"SRP72, BMFS1","Signal recognition particle, 72kD",602122,Bone marrow failure syndrome 1,614675,AD,-,SRP72
"REST, NRSF, WT6, GINGF5, HGF5",RE1-silencing transcription factor,600571,"Fibromatosis, gingival, 5",617626,AD,-,REST
"REST, NRSF, WT6, GINGF5, HGF5",RE1-silencing transcription factor,600571,"{Wilms tumor 6, susceptibility to}",616806,-,-,REST
"IGFBP7, MAC25, RAMSVPS",Insulin-like growth factor-binding protein-7,602867,Retinal arterial macroaneurysm with supravalvular pulmonic stenosis,614224,AR,-,IGFBP7
"TECRL, TERL, SRD5A2L2, GPSN2L, CPVT3","Trans-2,3-enoyl-CoA reductase-like protein",617242,"Ventricular tachycardia, catecholaminergic polymorphic, 3",614021,AR,-,TECRL
"GNRHR, LHRHR, HH7",Gonadotropin-releasing hormone receptor,138850,Hypogonadotropic hypogonadism 7 without anosmia,146110,AR,placed at 4q12 or 4q13 by some,GNRHR
"UGT2B17, BMND12","UDP-glucuronyltransferase, family 2, beta-17",601903,"{Bone mineral density QTL 12, osteoporosis}",612560,-,-,UGT2B17
MUC7,"Mucin 7, salivary",158375,"{Asthma, protection against}",600807,AD,-,MUC7
"AMTN, AI3B",Amelotin,610912,"?Amelogenesis imperfecta, type IIIB",617607,AD,mutation identified in 1 AI3B family,AMTN
"AMBN, AI1F",Ameloblastin,601259,"Amelogenesis imperfecta, type IF",616270,AR,mutation identified in 1 AI1F family,AMBN
"ENAM, AIH2, AI1C",Enamelin,606585,"Amelogenesis imperfecta, type IB",104500,AD,-,ENAM
"ENAM, AIH2, AI1C",Enamelin,606585,"Amelogenesis imperfecta, type IC",204650,AR,-,ENAM
"SLC4A4, NBC1, KNBC","Solute carrier family 4, sodium bicarbonate cotransporter, member 4",603345,"Renal tubular acidosis, proximal, with ocular abnormalities",604278,AR,-,SLC4A4
"ALB, ANALBA, FDAH",Albumin,103600,Analbuminemia,616000,-,linked to GC,ALB
"ALB, ANALBA, FDAH",Albumin,103600,[Dysalbuminemic hyperthyroxinemia],615999,-,-,ALB
"AFP, HPAFP, AFPD",Alpha-fetoprotein,104150,Alpha-fetoprotein deficiency,615969,AR,order: 5'-ALB-3'--5'-AFP-3',AFP
"AFP, HPAFP, AFPD",Alpha-fetoprotein,104150,[Hereditary persistence of alpha-fetoprotein],615970,AD,-,AFP
"DEL4q21, C4DELq21",Chromosome 4q21 deletion syndrome,613509,Chromosome 4q21 deletion syndrome,613509,IC,contiguous gene deletion if at least 30 genes,DEL4q21
"ODAPH, C4orf26",Odontogenesis-associated phosphoprotein,614829,"Amelogenesis imperfecta, type IIA4",614832,AR,-,ODAPH
"SCARB2, CD36L2, LIMPII, AMRF, EPM4","Scavenger receptor class B, member 2",602257,"Epilepsy, progressive myoclonic 4, with or without renal failure",254900,AR,-,SCARB2
"FRAS1, FRASRS1",FRAS1 gene,607830,Fraser syndrome 1,219000,AR,-,FRAS1
"ANTXR2, CMG2, HFS",Anthrax toxin receptor 2,608041,Hyaline fibromatosis syndrome,228600,AR,-,ANTXR2
"PRDM8, EPM10",PR domain-containing protein 8,616639,"?Epilepsy, progressive myoclonic, 10",616640,AR,mutation identified in 1 EPM10 family,PRDM8
"FGF5, TCMGLY",Fibroblast growth factor-5,165190,Trichomegaly,190330,AR,-,FGF5
"HNRNPDL, HNRPDL, JKTBP, LGMD1G",Heterogeneous nuclear ribonucleoprotein D-like protein,607137,"Muscular dystrophy, limb-girdle, type 1G",609115,AD,-,HNRNPDL
"COQ2, COQ10D1, MSA1","CoQ2, S. cerevisiae, homolog of (parahydroxybenzoate-polyprenyltransferase, mitochondrial)",609825,"Coenzyme Q10 deficiency, primary, 1",607426,AR,-,COQ2
"COQ2, COQ10D1, MSA1","CoQ2, S. cerevisiae, homolog of (parahydroxybenzoate-polyprenyltransferase, mitochondrial)",609825,"{Multiple system atrophy, susceptibility to}",146500,"AD,AR",-,COQ2
"WDFY3, ALFY, BCHS, MCPH18",WD repeat- and FYVE domain-containing protein 3,617485,"?Microcephaly 18, primary, autosomal dominant",617520,AD,mutation identified in 1 MCPH18 family,WDFY3
"DSPP, DPP, DGI1, DFNA39, DTDP2",Dentin sialophosphoprotein,125485,"Deafness, autosomal dominant 39, with dentinogenesis",605594,AD,-,DSPP
"DSPP, DPP, DGI1, DFNA39, DTDP2",Dentin sialophosphoprotein,125485,"Dentin dysplasia, type II",125420,AD,-,DSPP
"DSPP, DPP, DGI1, DFNA39, DTDP2",Dentin sialophosphoprotein,125485,"Dentinogenesis imperfecta, Shields type II",125490,AD,-,DSPP
"DSPP, DPP, DGI1, DFNA39, DTDP2",Dentin sialophosphoprotein,125485,"Dentinogenesis imperfecta, Shields type III",125500,AD,-,DSPP
"DMP1, ARHR, ARHP",Dentin matrix acidic phosphoprotein,600980,"Hypophosphatemic rickets, AR",241520,AR,-,DMP1
PKD2,Polycystin-2,173910,Polycystic kidney disease 2,613095,AD,-,PKD2
"ABCG2, BCRP, ABCP, UAQTL1, GOUT1","ATP-binding cassette, subfamily G, member 2",603756,[Junior blood group system],614490,-,-,ABCG2
"ABCG2, BCRP, ABCP, UAQTL1, GOUT1","ATP-binding cassette, subfamily G, member 2",603756,"[Uric acid concentration, serum, QTL1]",138900,?AD,-,ABCG2
"PPM1K, PP2CM, PTMP, MSUDMV","Protein phosphatase, PP2C domain-containing, 1K",611065,"?Maple syrup urine disease, mild variant",615135,-,mutation identified in 1 MSUDMV family,PPM1K
"PIGY, HPMRS6","Phosphatidylinositol glycan, class Y",610662,Hyperphosphatasia with mental retardation syndrome 6,616809,AR,-,PIGY
"SNCA, NACP, PARK1, PARK4","Synuclein, alpha (non A4 component of amyloid precursor)",163890,"Dementia, Lewy body",127750,AD,-,SNCA
"SNCA, NACP, PARK1, PARK4","Synuclein, alpha (non A4 component of amyloid precursor)",163890,Parkinson disease 1,168601,AD,-,SNCA
"SNCA, NACP, PARK1, PARK4","Synuclein, alpha (non A4 component of amyloid precursor)",163890,Parkinson disease 4,605543,AD,-,SNCA
"GRID2, SCAR18","Glutamate receptor, ionotropic, delta-2",602368,"Spinocerebellar ataxia, autosomal recessive 18",616204,AR,-,GRID2
"SMARCAD1, KIAA1122, ETL1, HEL1, ADERM, BASNS","SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily A, DEAD/H box-containing, 1",612761,Adermatoglyphia,136000,AD,-,SMARCAD1
"SMARCAD1, KIAA1122, ETL1, HEL1, ADERM, BASNS","SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily A, DEAD/H box-containing, 1",612761,Basan syndrome,129200,AD,-,SMARCAD1
"BMPR1B, ALK6, AMDD, BDA2, BDA1D","Bone morphogenetic protein receptor, type IB",603248,"Acromesomelic dysplasia, Demirhan type",609441,AR,-,BMPR1B
"BMPR1B, ALK6, AMDD, BDA2, BDA1D","Bone morphogenetic protein receptor, type IB",603248,"Brachydactyly, type A1, D",616849,AD,-,BMPR1B
"BMPR1B, ALK6, AMDD, BDA2, BDA1D","Bone morphogenetic protein receptor, type IB",603248,"Brachydactyly, type A2",112600,AD,-,BMPR1B
DNAJB14,"DNAJ/HSP40 homolog, subfamily B, member 14",617478,-,-,-,-,DNAJB14
"EIF4E, EIF4EL1, AUTS19",Eukaryotic translation initiation factor 4E,133440,"{Autism, susceptibility to, 19}",615091,-,pseudogene on 20,EIF4E
"ADH1B, ADH2","Alcohol dehydrogenase IB (class I), beta polypeptide",103720,"{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}",-,-,-,ADH1B
"ADH1B, ADH2","Alcohol dehydrogenase IB (class I), beta polypeptide",103720,"{Alcohol dependence, protection against}",103780,Mu,-,ADH1B
"ADH1C, ADH3","Alcohol dehydrogenase IC (class I), gamma polypeptide",103730,"{Alcohol dependence, protection against}",103780,Mu,-,ADH1C
"ADH1C, ADH3","Alcohol dehydrogenase IC (class I), gamma polypeptide",103730,"{Parkinson disease, susceptibility to}",168600,"IC,Mu",-,ADH1C
"TRMT10A, RG9MTD2, MSSGM1","tRNA methyltransferase 10, S. cerevisiae, homolog of, A",616013,"Microcephaly, short stature, and impaired glucose metabolism 1",616033,AR,-,TRMT10A
MTP,"Microsomal triglyceride transfer protein, 88kD",157147,Abetalipoproteinemia,200100,AR,-,MTP
MTP,"Microsomal triglyceride transfer protein, 88kD",157147,"{Metabolic syndrome, protection against}",605552,AD,-,MTP
"PPP3CA, PPP2B, CALNA, CNA1, IECEE1","Protein phosphatase-3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha)",114105,"Epileptic encephalopathy, infantile or early childhood, 1",617711,AD,-,PPP3CA
"SLC39A8, BIGM103, CDG2N","Solute carrier family 39 (zinc transporter), member 8",608732,"Congenital disorder of glycosylation, type IIn",616721,AR,-,SLC39A8
"NFKB1, CVID12",Nuclear factor of kappa light chain gene enhancer in B-cells 1 (p105),164011,"Immunodeficiency, common variable, 12",616576,AD,-,NFKB1
"MANBA, MANB1","Mannosidase, beta A, lysosomal",609489,"Mannosidosis, beta",248510,AR,linked in mouse to Adl-3,MANBA
"CISD2, WFS2, ZCD2, ERIS",CDGSH iron sulfur domain protein 2,611507,Wolfram syndrome 2,604928,AR,-,CISD2
"CENPE, MCPH13","Centromere autoantigen E, 312kD",117143,"?Microcephaly 13, primary, autosomal recessive",616051,AR,mutation identified in 1 MCPH13 family,CENPE
"TACR3, NK3R, HH11",Tachykinin receptor 3,162332,Hypogonadotropic hypogonadism 11 with or without anosmia,614840,AR,-,TACR3
"TET2, KIAA1546, MDS","TET oncogene family, member 2",612839,"Myelodysplastic syndrome, somatic",614286,-,-,TET2
"PPA2, SCFI, SCFAI","Pyrophosphatase, inorganic, 2",609988,"?Sudden cardiac failure, alcohol-induced",617223,AR,mutation identified in 1 SCFAI family,PPA2
"PPA2, SCFI, SCFAI","Pyrophosphatase, inorganic, 2",609988,"Sudden cardiac failure, infantile",617222,AR,-,PPA2
"TBCK, IHPRF3",TBC1 domain-containing kinase,616899,"Hypotonia, infantile, with psychomotor retardation and characteristic facies 3",616900,AR,-,TBCK
"AIMP1, SCYE1, EMAP2, EMAPII, HLD3",ARS-interacting multifunctional protein 1,603605,"Leukodystrophy, hypomyelinating, 3",260600,AR,-,AIMP1
"CYP2U1, SPG56","Cytochrome P450, family 2, subfamily U, polypeptide 1",610670,"Spastic paraplegia 56, autosomal recessive",615030,AR,-,CYP2U1
"HADHSC, SCHAD, HHF4","L-3-hydroxyacyl-CoA dehydrogenase, short chain",601609,3-hydroxyacyl-CoA dehydrogenase deficiency,231530,AR,-,HADHSC
"HADHSC, SCHAD, HHF4","L-3-hydroxyacyl-CoA dehydrogenase, short chain",601609,"Hyperinsulinemic hypoglycemia, familial, 4",609975,AR,-,HADHSC
"COL25A1, CLAC, CFEOM5","Collagen, type XXV, alpha-1 polypeptide",610004,"Fibrosis of extraocular muscles, congenital, 5",616219,AR,-,COL25A1
"CFI, FI, AHUS3, ARMD13",Complement factor I,217030,Complement factor I deficiency,610984,AR,40kb distal to EGF,CFI
"CFI, FI, AHUS3, ARMD13",Complement factor I,217030,"{Hemolytic uremic syndrome, atypical, susceptibility to, 3}",612923,AD,-,CFI
"CFI, FI, AHUS3, ARMD13",Complement factor I,217030,"{Macular degeneration, age-related, 13, susceptibility to}",615439,AD,-,CFI
"LRIT3, FIGLER4, CSNB1F","Leucine-rich repeat, immunoglobulin-like, and transmembrane domains-containing protein 3",615004,"Night blindness, congenital stationary (complete), 1F, autosomal recessive",615058,AR,-,LRIT3
"EGF, URG, HOMG4",Epidermal growth factor (urogastrone),131530,"Hypomagnesemia 4, renal",611718,-,linked to ADH3; cen-ADH3-EGF-IL2-qter,EGF
"PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4",Paired-like homeodomain transcription factor-2,601542,Anterior segment dysgenesis 4,137600,AD,-,PITX2
"PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4",Paired-like homeodomain transcription factor-2,601542,"Axenfeld-Rieger syndrome, type 1",180500,AD,-,PITX2
"PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4",Paired-like homeodomain transcription factor-2,601542,Ring dermoid of cornea,180550,AD,-,PITX2
"LARP7, PIP7S, ALAZS","La ribonucleoprotein domain family, member 7",612026,Alazami syndrome,615071,AR,-,LARP7
"ANK2, LQT4","Ankyrin-2, nonerythrocytic",106410,"Cardiac arrhythmia, ankyrin-B-related",600919,AD,-,ANK2
"ANK2, LQT4","Ankyrin-2, nonerythrocytic",106410,Long QT syndrome 4,600919,AD,-,ANK2
"PRSS12, BSSP3, MRT1","Protease, serine, 12",606709,"Mental retardation, autosomal recessive 1",249500,AR,-,PRSS12
"SEC24D, KIAA0755, CLCRP2","Sec24-related gene family, member D",607186,Cole-Carpenter syndrome 2,616294,AR,-,SEC24D
"MYOZ2, CMH16",Myozenin 2,605602,"Cardiomyopathy, hypertrophic, 16",613838,AD,-,MYOZ2
"PRDM5, BCS2",PR domain-containing protein 5,614161,Brittle cornea syndrome 2,614170,AR,-,PRDM5
"ANXA5, ENX2, RPRGL3",Annexin A5 (endonexin II),131230,"{Pregnancy loss, recurrent, susceptibility to, 3}",614391,AD,-,ANXA5
BBS7,BBS7 gene,607590,Bardet-Biedl syndrome 7,615984,AR,-,BBS7
"TRPC3, TRP3, SCA41","Transient receptor potential cation channel, subfamily C, member 3",602345,?Spinocerebellar ataxia 41,616410,AD,mutation identified in one SCA41 patient,TRPC3
"KIAA1109, ALKKUCS",KIAA1109 gene,611565,Alkuraya-Kucinskas syndrome,617822,AR,-,KIAA1109
"IL21, CVID11",Interleukin 21,605384,"?Immunodeficiency, common variable, 11",615767,AR,mutation identified in 1 CVID11 patient,IL21
"BBS12, FLJ35630, C4orf24",BBS12 gene,610683,Bardet-Biedl syndrome 12,615989,AR,1Mb centromeric to BBS,BBS12
"SPATA5, SPAF, EHLMRS",Spermatogenesis-associated protein 5,613940,"Epilepsy, hearing loss, and mental retardation syndrome",616577,AR,-,SPATA5
"FAT4, VMLDS2, HKLLS2","FAT tumor suppressor, Drosophila, homolog of, 4",612411,Hennekam lymphangiectasia-lymphedema syndrome 2,616006,AR,-,FAT4
"FAT4, VMLDS2, HKLLS2","FAT tumor suppressor, Drosophila, homolog of, 4",612411,Van Maldergem syndrome 2,615546,AR,-,FAT4
"PLK4, STK18, SAK, MCCRP2",Polo-like kinase 4 (serine/threonine protein kinase-18),605031,"Microcephaly and chorioretinopathy, autosomal recessive, 2",616171,AR,-,PLK4
"MFSD8, MGC33302, CLN7, CCMD",Major facilitator superfamily domain-containing protein 8,611124,"Ceroid lipofuscinosis, neuronal, 7",610951,AR,-,MFSD8
"MFSD8, MGC33302, CLN7, CCMD",Major facilitator superfamily domain-containing protein 8,611124,Macular dystrophy with central cone involvement,616170,AR,-,MFSD8
"NAA15, NARG1, NATH, MRD50","N-alpha-acetyltransferase 15, NatA auxiliary subunit",608000,"Mental retardation, autosomal dominant 50",617787,AD,-,NAA15
"RAB33B, SMC2",Ras-associated protein RAB33B,605950,Smith-McCort dysplasia 2,615222,AR,-,RAB33B
UCP1,"Uncoupling protein 1 (mitochondrial, proton carrier)",113730,"{Obesity, susceptibility to}",601665,"AD,Mu,AR",-,UCP1
"GYPB, SS, MNS",Glycophorin B (includes Ss blood group),111740,"[Blood group, Ss]",-,-,-,GYPB
"GYPB, SS, MNS",Glycophorin B (includes Ss blood group),111740,"{Malaria, resistance to}",611162,-,-,GYPB
"GYPA, MN, GPA",Glycophorin A (includes MN blood group),111300,"[Blood group, MN]",-,-,male lod = 3.79 at theta 0.32 vs. GC,GYPA
"GYPA, MN, GPA",Glycophorin A (includes MN blood group),111300,"{Malaria, resistance to}",611162,-,-,GYPA
MMAA,MMAA gene,607481,"Methylmalonic aciduria, vitamin B12-responsive",251100,AR,-,MMAA
"EDNRA, MFDA",Endothelin receptor type A,131243,Mandibulofacial dysostosis with alopecia,616367,AD,-,EDNRA
"EDNRA, MFDA",Endothelin receptor type A,131243,"{Migraine, resistance to}",157300,AD,-,EDNRA
"NR3C2, MLR, MCR","Nuclear receptor subfamily 3, group C, member 2 (mineralocorticoid receptor; aldosterone receptor)",600983,"Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy",605115,-,-,NR3C2
"NR3C2, MLR, MCR","Nuclear receptor subfamily 3, group C, member 2 (mineralocorticoid receptor; aldosterone receptor)",600983,"Pseudohypoaldosteronism type I, autosomal dominant",177735,AD,-,NR3C2
"LRBA, LBA, CDC4L, CVID8","Lipopolysaccharide-responsive, beige-like anchor protein",606453,"Immunodeficiency, common variable, 8, with autoimmunity",614700,AR,-,LRBA
"MAB21L2, MCSKS14","MAB21, C. elegans, homolog-like 2",604357,Microphthalmia/coloboma and skeletal dysplasia syndrome,615877,"AD,AR",-,MAB21L2
"TRIM2, KIAA0517, CMT2R",Tripartite motif-containing protein 2,614141,"Charcot-Marie-Tooth disease, type 2R",615490,AR,-,TRIM2
"TLR2, TIL4",Toll-like receptor-2,603028,"{Colorectal cancer, susceptibility to}",114500,AD,-,TLR2
"TLR2, TIL4",Toll-like receptor-2,603028,"{Leprosy, susceptibility to}",246300,AD,-,TLR2
"TLR2, TIL4",Toll-like receptor-2,603028,"{Mycobacterium tuberculosis, susceptibility to}",607948,-,-,TLR2
FGB,"Fibrinogen, beta polypeptide",134830,"Afibrinogenemia, congenital",202400,AR,4q31 by A; proximal to GYPB/GYPA,FGB
FGB,"Fibrinogen, beta polypeptide",134830,"Dysfibrinogenemia, congenital",616004,-,-,FGB
FGB,"Fibrinogen, beta polypeptide",134830,"Hypofibrinogenemia, congenital",202400,AR,-,FGB
FGA,"Fibrinogen, alpha polypeptide",134820,"Afibrinogenemia, congenital",202400,AR,-,FGA
FGA,"Fibrinogen, alpha polypeptide",134820,"Amyloidosis, familial visceral",105200,AD,-,FGA
FGA,"Fibrinogen, alpha polypeptide",134820,"Dysfibrinogenemia, congenital",616004,-,-,FGA
FGA,"Fibrinogen, alpha polypeptide",134820,"Hypodysfibrinogenemia, congenital",616004,-,-,FGA
"TRIP4q32.1q32.2, C4TRIPq32.1q32.2",Chromosome 4q32.1-q32.2 triplication syndrome,613603,Chromosome 4q32.1-q32.2 triplication syndrome,613603,AD,-,TRIP4q32.1q32.2
FGG,"Fibrinogen, gamma polypeptide",134850,"Afibrinogenemia, congenital",202400,AR,linked to MN,FGG
FGG,"Fibrinogen, gamma polypeptide",134850,"Dysfibrinogenemia, congenital",616004,-,-,FGG
FGG,"Fibrinogen, gamma polypeptide",134850,Hypodysfibrinogenemia,616004,-,-,FGG
FGG,"Fibrinogen, gamma polypeptide",134850,"Hypofibrinogenemia, congenital",202400,AR,-,FGG
"LRAT, LCA14",Lecithin retinol acyltransferase,604863,Leber congenital amaurosis 14,613341,AR,-,LRAT
"LRAT, LCA14",Lecithin retinol acyltransferase,604863,"Retinal dystrophy, early-onset severe",613341,AR,-,LRAT
"LRAT, LCA14",Lecithin retinol acyltransferase,604863,"Retinitis pigmentosa, juvenile",613341,AR,-,LRAT
"GUCY1A3, GUC1A3, GUCSA3, MYMY6","Guanylate cyclase 1, soluble, alpha 3",139396,Moyamoya 6 with achalasia,615750,AR,-,GUCY1A3
"TDO2, TPH2, TRPO, HYPTRP",Tryptophan oxygenase,191070,[?Hypertryptophanemia],600627,AR,mutation identified in 1 HYPTRP patient,TDO2
"GLRB, HKPX2","Glycine receptor, beta subunit",138492,"Hyperekplexia 2, autosomal recessive",614619,-,-,GLRB
"ETFDH, MADD",Electron transfer flavoprotein:ubiquinone oxidoreductase,231675,Glutaric acidemia IIC,231680,AR,-,ETFDH
"MSMO1, SC4MOL, ERG25, MCCPD",Methylsterol monooxygenase 1,607545,"Microcephaly, congenital cataract, and psoriasiform dermatitis",616834,AR,-,MSMO1
"TLL1, TLL, ASD6",Tolloid-like 1,606742,Atrial septal defect 6,613087,AD,-,TLL1
"PALLD, KIAA0992, PNCA1","Palladin, mouse, homolog of",608092,"{Pancreatic cancer, susceptibility to, 1}",606856,-,-,PALLD
"NEK1, SRTD6, SRPS2A, ALS24",Never in mitosis gene A-related kinase 1,604588,Short-rib thoracic dysplasia 6 with or without polydactyly,263520,"AR,DR",1 patient showed heterozygous NEK2 and DYNC2H1 mutations,NEK1
"NEK1, SRTD6, SRPS2A, ALS24",Never in mitosis gene A-related kinase 1,604588,"{Amyotrophic lateral sclerosis, susceptibility to, 24}",617892,-,-,NEK1
"HPGD, PGDH1, PHOAR1",Hydroxyprostaglandin dehydrogenase 15-(NAD),601688,Cranioosteoarthropathy,259100,AR,-,HPGD
"HPGD, PGDH1, PHOAR1",Hydroxyprostaglandin dehydrogenase 15-(NAD),601688,"Digital clubbing, isolated congenital",119900,AR,-,HPGD
"HPGD, PGDH1, PHOAR1",Hydroxyprostaglandin dehydrogenase 15-(NAD),601688,"Hypertrophic osteoarthropathy, primary, autosomal recessive 1",259100,AR,-,HPGD
"VEGFC, VRP, LMPH1D",Vascular endothelial growth factor C,601528,"Lymphedema, hereditary, ID",615907,AD,-,VEGFC
AGA,Aspartylglucosaminidase,613228,Aspartylglucosaminuria,208400,AR,-,AGA
"TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9",Teneurin transmembrane protein 3,610083,"Microphthalmia, isolated, with coloboma 9",615145,AR,-,TENM3
"FSHD1, FSHD1A",Facioscapulohumeral muscular dystrophy 1,158900,Facioscapulohumeral muscular dystrophy 1,158900,AD,due to D4Z4 macrosatellite repeat on 4q35,FSHD1
"TRAPPC11, C4orf41, LGMD2S","Trafficking protein particle complex, subunit 11",614138,"Muscular dystrophy, limb-girdle, type 2S",615356,AR,-,TRAPPC11
"CCDC111, MYP22",Coiled-coil domain containing 111,615421,"Myopia 22, autosomal dominant",615420,AD,-,CCDC111
"SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2","Solute carrier family 25 (mitochondrial carrier) member 4 (adenine nucleotide translocator-1, skeletal muscle)",103220,Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD,617184,AD,-,SLC25A4
"SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2","Solute carrier family 25 (mitochondrial carrier) member 4 (adenine nucleotide translocator-1, skeletal muscle)",103220,Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR,615418,AR,-,SLC25A4
"SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2","Solute carrier family 25 (mitochondrial carrier) member 4 (adenine nucleotide translocator-1, skeletal muscle)",103220,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2",609283,AD,-,SLC25A4
"UFSP2, C4orf20, BHD",UFM1-specific protease 2,611482,"?Hip dysplasia, Beukes type",142669,AD,mutation identified in 1 BHD family,UFSP2
"TLR3, IIAE2",Toll-like receptor-3,603029,"{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2}",613002,"AD,AR",-,TLR3
"TLR3, IIAE2",Toll-like receptor-3,603029,"{HIV1 infection, resistance to}",609423,-,-,TLR3
"CYP4V2, BCD","Cytochrome P450, family 4, subfamily V, polypeptide 2",608614,Bietti crystalline corneoretinal dystrophy,210370,AR,-,CYP4V2
"KLKB1, KLK3, PKKD",Kallikrein B plasma 1 (Fletcher factor),229000,Fletcher factor (prekallikrein) deficiency,612423,AR,similar to F11,KLKB1
F11,Coagulation factor XI (plasma thromboplastin antecedent),264900,"Factor XI deficiency, autosomal dominant",612416,-,not closely linked to MNS,F11
F11,Coagulation factor XI (plasma thromboplastin antecedent),264900,"Factor XI deficiency, autosomal recessive",612416,-,-,F11
"SDHA, SDH1, SDHF, CMD1GG, PGL5","Succinate dehydrogenase complex, subunit A, flavoprotein",600857,"Cardiomyopathy, dilated, 1GG",613642,-,copy on 3q29,SDHA
"SDHA, SDH1, SDHF, CMD1GG, PGL5","Succinate dehydrogenase complex, subunit A, flavoprotein",600857,Leigh syndrome,256000,"Mi,AR",-,SDHA
"SDHA, SDH1, SDHF, CMD1GG, PGL5","Succinate dehydrogenase complex, subunit A, flavoprotein",600857,Mitochondrial respiratory chain complex II deficiency,252011,AR,-,SDHA
"SDHA, SDH1, SDHF, CMD1GG, PGL5","Succinate dehydrogenase complex, subunit A, flavoprotein",600857,Paragangliomas 5,614165,AD,-,SDHA
"SLC9A3, NHE3, DIAR8","Solute carrier family 9 (sodium/hydrogen exchanger), member 3",182307,"Diarrhea 8, secretory sodium, congenital",616868,AR,pseudogene on chr.10,SLC9A3
"TRIP13, 16E1BP, MVA3",Thyroid hormone receptor interactor 13,604507,Mosaic variegated aneuploidy syndrome 3,617598,AR,-,TRIP13
"SLC6A19, HND","Solute carrier family 6 (neurotransmitter transporter), member 19",608893,Hartnup disorder,234500,AR,-,SLC6A19
"SLC6A19, HND","Solute carrier family 6 (neurotransmitter transporter), member 19",608893,Hyperglycinuria,138500,AD,-,SLC6A19
"SLC6A19, HND","Solute carrier family 6 (neurotransmitter transporter), member 19",608893,"Iminoglycinuria, digenic",242600,"AR,DR",-,SLC6A19
"TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9",Telomerase reverse transcriptase,187270,"{Dyskeratosis congenita, autosomal dominant 2}",613989,"AD,AR",deleted in cri du chat,TERT
"TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9",Telomerase reverse transcriptase,187270,"{Dyskeratosis congenita, autosomal recessive 4}",613989,"AD,AR",-,TERT
"TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9",Telomerase reverse transcriptase,187270,"{Leukemia, acute myeloid}",601626,AD,-,TERT
"TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9",Telomerase reverse transcriptase,187270,"{Melanoma, cutaneous malignant, 9}",615134,-,-,TERT
"TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9",Telomerase reverse transcriptase,187270,"{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}",614742,AD,-,TERT
"SLC6A3, DAT1, PKDYS","Solute carrier family 6 (neurotransmitter transporter, dopamine), member 3",126455,"Parkinsonism-dystonia, infantile",613135,AR,-,SLC6A3
"SLC6A3, DAT1, PKDYS","Solute carrier family 6 (neurotransmitter transporter, dopamine), member 3",126455,"{Nicotine dependence, protection against}",188890,-,-,SLC6A3
NDUFS6,"NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kD",603848,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",-,NDUFS6
"NSUN2, TRM4, SAKI, MISU, MRT5","NOP2/SUN RNA methyltransferase family, member 2",610916,"Mental retardation, autosomal recessive 5",611091,AR,-,NSUN2
MTRR,Methionine synthase reductase,602568,"Homocystinuria-megaloblastic anemia, cbl E type",236270,AR,-,MTRR
MTRR,Methionine synthase reductase,602568,"{Neural tube defects, folate-sensitive, susceptibility to}",601634,AR,-,MTRR
"CCT5, KIAA0098, CCTE","chaperonin containing TCP1, subunit 5 (epsilon)",610150,"Neuropathy, hereditary sensory, with spastic paraplegia",256840,AR,-,CCT5
"DNAH5, HL1, PCD, CILD3","Dynein, axonemal, heavy chain 5",603335,"Ciliary dyskinesia, primary, 3, with or without situs inversus",608644,-,-,DNAH5
"TRIO, MRD44",Triple functional domain,601893,"Mental retardation, autosomal dominant 44",617061,AD,-,TRIO
"OTULIN, FAM105B, GUM, AIPDS",OTU deubiquitinase with linear linkage specificity,615712,"Autoinflammation, panniculitis, and dermatosis syndrome",617099,AR,-,OTULIN
"ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD","Ank, mouse, homolog of",605145,Chondrocalcinosis 2,118600,AD,-,ANKH
"ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD","Ank, mouse, homolog of",605145,Craniometaphyseal dysplasia,123000,AD,-,ANKH
"FAM134B, HSAN2B","Family with sequence similarity 134, member B",613114,"Neuropathy, hereditary sensory and autonomic, type IIB",613115,AR,-,FAM134B
ADHD4,"Attention deficit-hyperactivity disorder, susceptibility to, 4",608906,{Attention deficit-hyperactivity disorder},143465,AD,-,ADHD4
"DUP5p13, C5DUPp13",Chromosome 5p13 duplication syndrome,613174,Chromosome 5p13 duplication syndrome,613174,IC,-,DUP5p13
HYT6,"Hypertension, essential, susceptibility to, 6",610262,"{Hypertension, essential, susceptibility to, 6}",145500,Mu,-,HYT6
"SLC45A2, MATP, AIM1, SHEP5, OCA4","Solute carrier family 45, member 2",606202,"Albinism, oculocutaneous, type IV",606574,-,-,SLC45A2
"SLC45A2, MATP, AIM1, SHEP5, OCA4","Solute carrier family 45, member 2",606202,"[Skin/hair/eye pigmentation 5, black/nonblack hair]",227240,AR,-,SLC45A2
"SLC45A2, MATP, AIM1, SHEP5, OCA4","Solute carrier family 45, member 2",606202,"[Skin/hair/eye pigmentation 5, dark/fair skin]",227240,AR,-,SLC45A2
"SLC45A2, MATP, AIM1, SHEP5, OCA4","Solute carrier family 45, member 2",606202,"[Skin/hair/eye pigmentation 5, dark/light eyes]",227240,AR,-,SLC45A2
"AMACR, CBAS4, AMACRD",Alpha-methylacyl-CoA racemase,604489,Alpha-methylacyl-CoA racemase deficiency,614307,AR,-,AMACR
"AMACR, CBAS4, AMACRD",Alpha-methylacyl-CoA racemase,604489,"Bile acid synthesis defect, congenital, 4",214950,AR,-,AMACR
"DNAJC21, DNAJA5, BMFS3","DNAJ/HSP40 homolog, subfamily C, member 21",617048,Bone marrow failure syndrome 3,617052,AR,-,DNAJC21
"AGXT2, AGT2, BAIBA",Alanine-glyoxylate aminotransferase 2,612471,"[Beta-aminoisobutyric acid, urinary excretion of]",210100,AR,-,AGXT2
"PRLR, MFAB, HPRL",Prolactin receptor,176761,?Hyperprolactinemia,615555,AD,mutation identified in 1 family with HPRL,PRLR
"PRLR, MFAB, HPRL",Prolactin receptor,176761,Multiple fibroadenomas of the breast,615554,AD,-,PRLR
"IL7R, IL7RA, CD127",Interleukin-7 receptor,146661,"Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type",608971,AR,-,IL7R
"NADK2, C5orf33, DECRD","NAD kinase 2, mitochondrial",615787,"?2,4-dienoyl-CoA reductase deficiency",616034,AR,mutation identified in 1 DECRD family,NADK2
"SLC1A3, EAAT1, EA6","Solute carrier family 1 (glial high affinity glutamate transporter), member 3",600111,"Episodic ataxia, type 6",612656,AD,-,SLC1A3
"NIPBL, CDLS1",Nipped-B-like (delangin),608667,Cornelia de Lange syndrome 1,122470,AD,-,NIPBL
"C5orf42, JBTS17, OFD6",Chromosome 5 open reading frame 42,614571,Joubert syndrome 17,614615,AR,-,C5orf42
"C5orf42, JBTS17, OFD6",Chromosome 5 open reading frame 42,614571,Orofaciodigital syndrome VI,277170,AR,-,C5orf42
"NUP155, KIAA0791, ATFB15","Nucleoporin, 155kD",606694,?Atrial fibrillation 15,615770,AR,mutation identified in 1 ATFB15 family,NUP155
"GDNF, HSCR3",Glial cell line derived neurotrophic factor,600837,Central hypoventilation syndrome,209880,AD,-,GDNF
"GDNF, HSCR3",Glial cell line derived neurotrophic factor,600837,"{Hirschsprung disease, susceptibility to, 3}",613711,AD,-,GDNF
"GDNF, HSCR3",Glial cell line derived neurotrophic factor,600837,"{Pheochromocytoma, modifier of}",171300,AD,-,GDNF
"LIFR, STWS, SWS, SJS2",Leukemia inhibitory factor receptor,151443,Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome,601559,AR,-,LIFR
"OSMR, OSMRB, PLCA1",Oncostatin M receptor,601743,"Amyloidosis, primary localized cutaneous, 1",105250,AD,-,OSMR
"FYB, SLAP130, ADAP, THC3",FYN-binding protein,602731,Thrombocytopenia 3,273900,AR,-,FYB
"C9, C9D, ARMD15",Complement component-9,120940,C9 deficiency,613825,-,-,C9
"C9, C9D, ARMD15",Complement component-9,120940,"{Macular degeneration, age-related, 15, susceptibility to}",615591,-,-,C9
C7,Complement component-7,217070,C7 deficiency,610102,-,-,C7
C6,Complement component-6,217050,C6 deficiency,612446,-,-,C6
C6,Complement component-6,217050,Combined C6/C7 deficiency,-,-,-,C6
"OXCT1, OXCT, SCOT",3-oxoacid CoA transferase 1,601424,Succinyl CoA:3-oxoacid CoA transferase deficiency,245050,-,-,OXCT1
"GHR, GHIP",Growth hormone receptor,600946,"Growth hormone insensitivity, partial",604271,-,-,GHR
"GHR, GHIP",Growth hormone receptor,600946,Increased responsiveness to growth hormone,-,-,-,GHR
"GHR, GHIP",Growth hormone receptor,600946,Laron dwarfism,262500,AR,-,GHR
"GHR, GHIP",Growth hormone receptor,600946,"{Hypercholesterolemia, familial, modifier of}",143890,AD,-,GHR
"NNT, GCCD4",Nicotinamide nucleotide transhydrogenase,607878,"Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency",614736,AR,-,NNT
FGF10,Fibroblast growth factor-10,602115,Aplasia of lacrimal and salivary glands,180920,AD,-,FGF10
FGF10,Fibroblast growth factor-10,602115,LADD syndrome,149730,AD,-,FGF10
"HCN1, BCNG1, EIEE24",Hyperpolarization-activated cyclic nucleotide-gated potassium channel 1,602780,"Epileptic encephalopathy, early infantile, 24",615871,AD,-,HCN1
"MOCS2, MPTS, MOCODB",Molybdenum cofactor synthesis-2,603708,Molybdenum cofactor deficiency B,252160,AR,-,MOCS2
"NDUFS4, AQDQ","NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kD (NADH-coenzyme Q reductase)",602694,Leigh syndrome,256000,"Mi,AR",-,NDUFS4
"NDUFS4, AQDQ","NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kD (NADH-coenzyme Q reductase)",602694,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",-,NDUFS4
"HSPB3, HSPL27, HMN2C, DHMN2C",Heat-shock 27kD protein 3,604624,"?Neuronopathy, distal hereditary motor, type IIC",613376,AD,mutation identified in 1 HMN2C family,HSPB3
"CCNO, UNG2, CILD29",Cyclin O,607752,"Ciliary dyskinesia, primary, 29",615872,AR,-,CCNO
"IL31RA, GLMR, GPL, PLCA2",Interleukin 31 receptor A,609510,"Amyloidosis, primary localized cutaneous, 2",613955,AD,-,IL31RA
"MAP3K1, MEKK1, MEKK, SRXY6",Mitogen-activated protein kinase kinase kinase 1,600982,46XY sex reversal 6,613762,AD,-,MAP3K1
"PDE4D, DPDE3, STRK1, ACRDYS2","Phosphodiesterase-4D, cAMP-specific (dunce, Drosophila, homolog of, phosphodiesterase-E3)",600129,"Acrodysostosis 2, with or without hormone resistance",614613,AD,-,PDE4D
"PDE4D, DPDE3, STRK1, ACRDYS2","Phosphodiesterase-4D, cAMP-specific (dunce, Drosophila, homolog of, phosphodiesterase-E3)",600129,"{Stroke, susceptibility to, 1}",606799,-,-,PDE4D
"DEL5q12, C5DELq12",Chromosome 5q12 deletion syndrome,615668,Chromosome 5q12 deletion syndrome,615668,AD,-,DEL5q12
"ERCC8, CKN1, CSA, UVSS2","Excision repair cross-complementing rodent repair deficiency, complementation group 8",609412,"Cockayne syndrome, type A",216400,AR,-,ERCC8
"ERCC8, CKN1, CSA, UVSS2","Excision repair cross-complementing rodent repair deficiency, complementation group 8",609412,UV-sensitive syndrome 2,614621,AR,-,ERCC8
"NDUFAF2, NDUFA12L, MMTN, B17.2L","NADH dehydrogenase 1 alpha subcomplex, assembly factor 2",609653,Leigh syndrome,256000,"Mi,AR",pseudogene on chr.2,NDUFAF2
"NDUFAF2, NDUFA12L, MMTN, B17.2L","NADH dehydrogenase 1 alpha subcomplex, assembly factor 2",609653,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",-,NDUFAF2
"ZSWIM6, KIAA1577, AFND, NEDMAGA",Zinc finger SWIM domain-containing protein 6,615951,Acromelic frontonasal dysostosis,603671,AD,-,ZSWIM6
"ZSWIM6, KIAA1577, AFND, NEDMAGA",Zinc finger SWIM domain-containing protein 6,615951,"Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features",617865,AD,-,ZSWIM6
"KIF2A, CDCBM3","Kinesin, heavy chain, 2",602591,"Cortical dysplasia, complex, with other brain malformations 3",615411,AD,-,KIF2A
"HTR1A, ADRB2RL1, PFMCD",5-hydroxytryptamine (serotonin) receptor-1A,109760,"Periodic fever, menstrual cycle dependent",614674,AD,-,HTR1A
"CWC27, SDCCAG10, RPSKA","CWC27 spliceosome-associated protein, X. cerevisiae, homolog of",617170,Retinitis pigmentosa with or without skeletal anomalies,250410,AR,-,CWC27
"PIK3R1, GRB1, AGM7, SHORT, IMD36","Phosphatidylinositol 3-kinase, regulatory, 1",171833,"?Agammaglobulinemia 7, autosomal recessive",615214,AR,mutation identified in 1 AGM7 family,PIK3R1
"PIK3R1, GRB1, AGM7, SHORT, IMD36","Phosphatidylinositol 3-kinase, regulatory, 1",171833,Immunodeficiency 36,616005,AD,-,PIK3R1
"PIK3R1, GRB1, AGM7, SHORT, IMD36","Phosphatidylinositol 3-kinase, regulatory, 1",171833,SHORT syndrome,269880,AD,-,PIK3R1
"MARVELD2, MARVD2, TRIC, DFNB49",Marvel domain-containing protein 2 (tricellulin),610572,"Deafness, autosomal recessive 49",610153,AR,-,MARVELD2
"OCLN, BLCPMG, PTORCH1",Occludin,602876,Pseudo-TORCH syndrome 1,251290,AR,-,OCLN
SMN2,"Survival of motor neuron 2, centromeric",601627,"{Spinal muscular atrophy, type III, modifier of}",253400,AR,-,SMN2
"SMN1, SMA1, SMA2, SMA3, SMA4","Survival of motor neuron 1, telomeric",600354,Spinal muscular atrophy-1,253300,AR,-,SMN1
"SMN1, SMA1, SMA2, SMA3, SMA4","Survival of motor neuron 1, telomeric",600354,Spinal muscular atrophy-2,253550,AR,-,SMN1
"SMN1, SMA1, SMA2, SMA3, SMA4","Survival of motor neuron 1, telomeric",600354,Spinal muscular atrophy-3,253400,AR,-,SMN1
"SMN1, SMA1, SMA2, SMA3, SMA4","Survival of motor neuron 1, telomeric",600354,Spinal muscular atrophy-4,271150,AR,-,SMN1
"MCCC2, MCCB",3-Methylcrotonyl-CoA carboxylase 2,609014,3-Methylcrotonyl-CoA carboxylase 2 deficiency,210210,AR,-,MCCC2
"CARTPT, CART",Cocaine- and amphetamine-regulated transcript prepropeptide,602606,"{?Obesity, susceptibility to}",601665,"AD,Mu,AR",mutation identified in 1 family,CARTPT
HEXB,"Hexosaminidase B, beta polypeptide",606873,"Sandhoff disease, infantile, juvenile, and adult forms",268800,AR,-,HEXB
"COL4A3BP, GPBP, CERT, MRD34",COL4A3-binding protein (ceramide transporter),604677,"Mental retardation, autosomal dominant 34",616351,AD,-,COL4A3BP
"PDE8B, PPNAD3, ADSD",Phosphodiesterase 8B,603390,"Pigmented nodular adrenocortical disease, primary, 3",614190,-,-,PDE8B
"PDE8B, PPNAD3, ADSD",Phosphodiesterase 8B,603390,"Striatal degeneration, autosomal dominant",609161,AD,-,PDE8B
"AP3B1, ADTB3A, HPS2","Adaptor-related protein complex 3, beta 1 subunit (adaptin, beta-3a)",603401,Hermansky-Pudlak syndrome 2,608233,AR,-,AP3B1
"ARSB, MPS6",Arylsulfatase B,611542,Mucopolysaccharidosis type VI (Maroteaux-Lamy),253200,AR,-,ARSB
"DMGDH, DMGDHD",Dimethylglycine dehydrogenase,605849,Dimethylglycine dehydrogenase deficiency,605850,AR,-,DMGDH
DHFR,Dihydrofolate reductase,126060,Megaloblastic anemia due to dihydrofolate reductase deficiency,613839,AR,-,DHFR
"MSH3, FAP4","mutS, E. coli, homolog of, 3",600887,"Endometrial carcinoma, somatic",608089,-,5' to DHFR,MSH3
"MSH3, FAP4","mutS, E. coli, homolog of, 3",600887,Familial adenomatous polyposis 4,617100,AR,-,MSH3
"RPS23, BTDD, MCINS",Ribosomal protein S23,603683,"Brachycephaly, trichomegaly, and developmental delay",617412,AD,-,RPS23
"XRCC4, SSMED","X-ray repair, complementing defective, repair in Chinese hamster cells-4",194363,"Short stature, microcephaly, and endocrine dysfunction",616541,AR,between D5S427 and D5S401,XRCC4
"VCAN, CSPG2, WGN, WGN1, ERVR",Versican (chondroitin sulfate proteoglycan-2),118661,Wagner syndrome 1,143200,AD,-,VCAN
PVNH5,Periventricular nodular heterotopia 5,612881,Periventricular nodular heterotopia 5,612881,-,"deletion range 6.3-17Mb, common range 5.8Mb",PVNH5
"RASA1, GAP, CMAVM, PKWS",RAS p21 protein activator 1 (GTPase activating protein),139150,"Basal cell carcinoma, somatic",605462,-,-,RASA1
"RASA1, GAP, CMAVM, PKWS",RAS p21 protein activator 1 (GTPase activating protein),139150,Capillary malformation-arteriovenous malformation,608354,AD,-,RASA1
"RASA1, GAP, CMAVM, PKWS",RAS p21 protein activator 1 (GTPase activating protein),139150,Parkes Weber syndrome,608355,AD,-,RASA1
"MEF2C, C5DELq14.3, DEL5q14.3","MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C)",600662,Chromosome 5q14.3 deletion syndrome,613443,AD,-,MEF2C
"MEF2C, C5DELq14.3, DEL5q14.3","MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C)",600662,"Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations",613443,AD,-,MEF2C
"ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C",Adhesion G protein-coupled receptor V1,602851,"?Febrile seizures, familial, 4",604352,AD,mutation identified in 1 FEB4 family,ADGRV1
"ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C",Adhesion G protein-coupled receptor V1,602851,"Usher syndrome, type 2C",605472,"DD,AR",-,ADGRV1
"ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C",Adhesion G protein-coupled receptor V1,602851,"Usher syndrome, type 2C, GPR98/PDZD7 digenic",605472,"DD,AR",-,ADGRV1
"NR2F1, TFCOUP1, ERBAL3, EAR3, BBSOAS","Nuclear receptor subfamily 2, group F, member 1 (transcription factor COUP 1)",132890,Bosch-Boonstra-Schaaf optic atrophy syndrome,615722,AD,-,NR2F1
"TTC37, KIAA0372",Tetratricopeptide repeat domain 37,614589,Trichohepatoenteric syndrome 1,222470,AR,-,TTC37
"PCSK1, NEC1, PC1, PC3, BMIQ12",Proprotein convertase subtilisin/kexin type 1,162150,Obesity with impaired prohormone processing,600955,AR,-,PCSK1
"PCSK1, NEC1, PC1, PC3, BMIQ12",Proprotein convertase subtilisin/kexin type 1,162150,"{Obesity, susceptibility to, BMIQ12}",612362,-,-,PCSK1
"CAST, PLACK",Calpastatin,114090,"Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads",616295,AR,-,CAST
"CHD1, PILBOS",Chromodomain helicase DNA binding protein-1,602118,Pilarowski-Bjornsson syndrome,617682,AD,-,CHD1
MDBS2,"Macular dystrophy, butterfly-shaped pigmentary, 2",608970,"Macular dystrophy, butterfly-shaped pigmentary, 2",608970,AD,between D5S433 and D5S410,MDBS2
"SLC25A46, HMSN6B","Solute carrier family 25, member 46",610826,"Neuropathy, hereditary motor and sensory, type VIB",616505,AR,-,SLC25A46
"WDR36, TAWDRP, GLC1G",WD repeat-containing protein 36,609669,"Glaucoma 1, open angle, G",609887,-,-,WDR36
"APC, GS, FPC, BTPS2",Adenomatous polyposis coli,611731,"Adenoma, periampullary, somatic",-,-,150kb distal to MCC,APC
"APC, GS, FPC, BTPS2",Adenomatous polyposis coli,611731,Adenomatous polyposis coli,175100,AD,-,APC
"APC, GS, FPC, BTPS2",Adenomatous polyposis coli,611731,Brain tumor-polyposis syndrome 2,175100,AD,-,APC
"APC, GS, FPC, BTPS2",Adenomatous polyposis coli,611731,"Colorectal cancer, somatic",114500,-,-,APC
"APC, GS, FPC, BTPS2",Adenomatous polyposis coli,611731,"Desmoid disease, hereditary",135290,AD,-,APC
"APC, GS, FPC, BTPS2",Adenomatous polyposis coli,611731,Gardner syndrome,175100,AD,-,APC
"APC, GS, FPC, BTPS2",Adenomatous polyposis coli,611731,"Gastric cancer, somatic",613659,-,-,APC
"APC, GS, FPC, BTPS2",Adenomatous polyposis coli,611731,"Hepatoblastoma, somatic",114550,-,-,APC
MCC,Mutated in colorectal cancers,159350,"Colorectal cancer, somatic",114500,-,-,MCC
"TRIM36, RBCC728, ANPH",Tripartite motif-containing protein 36,609317,?Anencephaly,206500,AR,mutation identified in 1 ANPH patient,TRIM36
SCZD1,"Schizophrenia susceptibility locus, chromosome 5-related",181510,{Schizophrenia},181500,AD,max lod at D5S820,SCZD1
"HSD17B4, PRLTS1",Hydroxysteroid (17-beta) dehydrogenase 4,601860,D-bifunctional protein deficiency,261515,AR,-,HSD17B4
"HSD17B4, PRLTS1",Hydroxysteroid (17-beta) dehydrogenase 4,601860,Perrault syndrome 1,233400,AR,-,HSD17B4
"LOX, AAT10",Lysyl oxidase,153455,"Aortic aneurysm, familial thoracic 10",617168,AD,-,LOX
"PRDM6, PRISM, PDA3",PR domain-containing protein 6,616982,Patent ductus arteriosus 3,617039,AD,-,PRDM6
"CEP120, CCDC100, SRTD13, JBTS31","Centrosomal protein, 120kD",613446,Joubert syndrome 31,617761,AR,-,CEP120
"CEP120, CCDC100, SRTD13, JBTS31","Centrosomal protein, 120kD",613446,Short-rib thoracic dysplasia 13 with or without polydactyly,616300,AR,-,CEP120
"ALDH7A1, ATQ1, EPD, PDE","Aldehyde dehydrogenase 7 family, member A1 (antiquitin 1)",107323,"Epilepsy, pyridoxine-dependent",266100,AR,-,ALDH7A1
"LMNB1, ADLD",Lamin B1,150340,"Leukodystrophy, adult-onset, autosomal dominant",169500,AD,-,LMNB1
"MEGF10, KIAA1780, EMARDD",Multiple epidermal growth factor-like domains 10,612453,"Myopathy, areflexia, respiratory distress, and dysphagia, early-onset",614399,AR,-,MEGF10
"MEGF10, KIAA1780, EMARDD",Multiple epidermal growth factor-like domains 10,612453,"Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant",614399,AR,-,MEGF10
"FBN2, CCA, EOMD",Fibrillin-2,612570,"Contractural arachnodactyly, congenital",121050,AD,-,FBN2
"FBN2, CCA, EOMD",Fibrillin-2,612570,"Macular degeneration, early-onset",616118,AD,-,FBN2
"HINT1, PRKCNH1, NMAN",Histidine triad nucleotide-binding protein 1 (protein kinase C inhibitor 1),601314,"Neuromyotonia and axonal neuropathy, autosomal recessive",137200,AR,-,HINT1
"LYRM7, MZM1L, MC3DN8",LYR motif-containing protein 7,615831,"Mitochondrial complex III deficiency, nuclear type 8",615838,AR,-,LYRM7
PCDHA@,Protocadherin-alpha gene cluster,604966,-,-,-,-,PCDHA@
PCDHB@,Protocadherin-beta gene cluster,604967,-,-,-,-,PCDHB@
PCDHG,Protocadherin-gamma gene cluster,604968,-,-,-,-,PCDHG
"P4HA2, MYP25","Procollagen-proline, 2-oxoglutarate-4-dioxygenase, alpha subunit, isoform 2",600608,"Myopia 25, autosomal dominant",617238,AD,-,P4HA2
RIL,LIM domain protein ril,603422,"{Osteoporosis, susceptibility to}",166710,AD,-,RIL
"SLC22A4, OCTN1","Solute carrier family 22 (organic cation transporter), member 4",604190,"{Rheumatoid arthritis, susceptibility to}",180300,-,-,SLC22A4
"SLC22A5, OCTN2, CDSP, SCD","Solute carrier, family 22 (organic cation transporter), member 5",603377,"Carnitine deficiency, systemic primary",212140,AR,-,SLC22A5
"IRF1, MAR",Interferon regulatory factor-1,147575,"Gastric cancer, somatic",613659,-,-,IRF1
"IRF1, MAR",Interferon regulatory factor-1,147575,"Myelodysplastic syndrome, preleukemic",-,-,-,IRF1
"IRF1, MAR",Interferon regulatory factor-1,147575,"Myelogenous leukemia, acute",-,-,-,IRF1
"IRF1, MAR",Interferon regulatory factor-1,147575,"Nonsmall cell lung cancer, somatic",211980,-,-,IRF1
"RAD50, NBSLD","RAD50, S. cerevisiae, homolog of",604040,Nijmegen breakage syndrome-like disorder,613078,-,-,RAD50
"IL13, ALRH, BHR1",Interleukin-13,147683,"{Allergic rhinitis, susceptibility to}",607154,-,-,IL13
"IL13, ALRH, BHR1",Interleukin-13,147683,"{Asthma, susceptibility to}",600807,AD,-,IL13
"UQCRQ, QPC, MC3DN4","Ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kD",612080,"Mitochondrial complex III deficiency, nuclear type 4",615159,AR,-,UQCRQ
"AFF4, AF5Q31, CHOPS","AF4/FMR2 family, member 4",604417,CHOPS syndrome,616368,AD,-,AFF4
"SAR1B, CMRD, SARA2, ANDD","Sar1a, S. cerevisiae, homolog 2",607690,Chylomicron retention disease,246700,AR,-,SAR1B
"PITX1, PTX1, BFT, POTX, CCF, LBNBG",Paired-like homeodomain transcription factor-1,602149,"Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly",119800,AD,-,PITX1
"PITX1, PTX1, BFT, POTX, CCF, LBNBG",Paired-like homeodomain transcription factor-1,602149,Liebenberg syndrome,186550,AD,-,PITX1
"TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD","Transforming growth factor, beta-induced, 68kD",601692,"Corneal dystrophy, Avellino type",607541,AD,-,TGFBI
"TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD","Transforming growth factor, beta-induced, 68kD",601692,"Corneal dystrophy, epithelial basement membrane",121820,AD,-,TGFBI
"TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD","Transforming growth factor, beta-induced, 68kD",601692,"Corneal dystrophy, Groenouw type I",121900,AD,-,TGFBI
"TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD","Transforming growth factor, beta-induced, 68kD",601692,"Corneal dystrophy, lattice type I",122200,AD,-,TGFBI
"TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD","Transforming growth factor, beta-induced, 68kD",601692,"Corneal dystrophy, lattice type IIIA",608471,AD,-,TGFBI
"TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD","Transforming growth factor, beta-induced, 68kD",601692,"Corneal dystrophy, Reis-Bucklers type",608470,-,-,TGFBI
"TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD","Transforming growth factor, beta-induced, 68kD",601692,"Corneal dystrophy, Thiel-Behnke type",602082,AD,-,TGFBI
"KLHL3, PHA2D",Kelch-like 3,605775,"Pseudohypoaldosteronism, type IID",614495,"AD,AR",-,KLHL3
"MYOT, TTOD, MFM3",Myotilin (titin immunoglobulin domain protein),604103,"Muscular dystrophy, limb-girdle, type 1A",159000,AD,-,MYOT
"MYOT, TTOD, MFM3",Myotilin (titin immunoglobulin domain protein),604103,"Myopathy, myofibrillar, 3",609200,AD,-,MYOT
"MYOT, TTOD, MFM3",Myotilin (titin immunoglobulin domain protein),604103,"Myopathy, spheroid body",182920,AD,-,MYOT
"REEP2, C5orf19, SPG72",Receptor expression-enhancing protein 2,609347,"?Spastic paraplegia 72, autosomal dominant",615625,"AD,AR",mutation identified in 1 family each SPG72 AR and AD,REEP2
"REEP2, C5orf19, SPG72",Receptor expression-enhancing protein 2,609347,"?Spastic paraplegia 72, autosomal recessive",615625,"AD,AR",-,REEP2
"HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4",Heat-shock 70kD protein-9 (mortalin),600548,"Anemia, sideroblastic, 4",182170,AD,-,HSPA9
"HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4",Heat-shock 70kD protein-9 (mortalin),600548,Even-plus syndrome,616854,AR,-,HSPA9
"CTNNA1, MDPT2","Catenin (cadherin-associated protein), alpha 1, 102kD",116805,"Macular dystrophy, patterned, 2",608970,AD,-,CTNNA1
"SIL1, BAP, MSS","Sil1, S. cerevisiae, homolog of",608005,Marinesco-Sjogren syndrome,248800,AR,-,SIL1
"MATR3, MPD2, ALS21",Matrin 3,164015,Amyotrophic lateral sclerosis 21,606070,AD,-,MATR3
"TMEM173, STING, MPYS, SAVI",Transmembrane protein 173,612374,"STING-associated vasculopathy, infantile-onset",615934,AD,-,TMEM173
"PURA, PUR1, MRD31",Purine-rich element binding protein A,600473,"Mental retardation, autosomal dominant 31",616158,AD,-,PURA
NDUFA2,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2 (8kD, B8)",602137,Leigh syndrome due to mitochondrial complex I deficiency,256000,"Mi,AR",-,NDUFA2
"HARS, USH3B, CMT2W",Histidyl-tRNA synthetase,142810,"Charcot-Marie-Tooth disease, axonal, type 2W",616625,AD,-,HARS
"HARS, USH3B, CMT2W",Histidyl-tRNA synthetase,142810,Usher syndrome type 3B,614504,AR,-,HARS
"HARS2, HARSL, HARSR, HO3, PRLTS2",Histidyl-tRNA synthetase 2,600783,?Perrault syndrome 2,614926,AR,mutation identified in 1 PRLTS2 family,HARS2
"DIAPH1, DFNA1, LFHL1, SCBMS","Diaphanous, Drosophila, homolog of, 1",602121,"Deafness, autosomal dominant 1",124900,AD,-,DIAPH1
"DIAPH1, DFNA1, LFHL1, SCBMS","Diaphanous, Drosophila, homolog of, 1",602121,"Seizures, cortical blindness, microcephaly syndrome",616632,AR,-,DIAPH1
"SPRY4, HH17","Sprouty, Drosophila, homolog of",607984,Hypogonadotropic hypogonadism 17 with or without anosmia,615266,AD,-,SPRY4
"ARHGAP26, GRAF",RHO GTPase-activating protein 26,605370,"Leukemia, juvenile myelomonocytic, somatic",607785,-,-,ARHGAP26
"NR3C1, GCR, GRL, GCRST","Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",138040,Glucocorticoid resistance,615962,AD,-,NR3C1
"GRXCR2, DFNB101","Glutaredoxin, cysteine-rich, 2",615762,"?Deafness, autosomal recessive 101",615837,AR,mutation identified in 1 DFNB101 family,GRXCR2
"LARS, LFIS, ILFS1",Leucyl-tRNA synthetase,151350,?Infantile liver failure syndrome 1,615438,AR,mutation identified in 1 family,LARS
"POU4F3, BRN3C","POU domain, class 4, transcription factor-3",602460,"Deafness, autosomal dominant 15",602459,AD,-,POU4F3
PPP2R2B,"Protein phosphatase 2, regulatory subunit B, beta",604325,Spinocerebellar ataxia 12,604326,AD,-,PPP2R2B
"SPINK1, PSTI, PCTT, TATI, TCP","Serine protease inhibitor, Kazal type I (pancreatic secretory trypsin inhibitor)",167790,"Pancreatitis, hereditary",167800,AD,-,SPINK1
"SPINK1, PSTI, PCTT, TATI, TCP","Serine protease inhibitor, Kazal type I (pancreatic secretory trypsin inhibitor)",167790,Tropical calcific pancreatitis,608189,"AD,AR",-,SPINK1
"SPINK1, PSTI, PCTT, TATI, TCP","Serine protease inhibitor, Kazal type I (pancreatic secretory trypsin inhibitor)",167790,"{Fibrocalculous pancreatic diabetes, susceptibility to}",608189,"AD,AR",-,SPINK1
"SCGB3A2, UGRP1","Secretoglobin, family 3A, member 2 (uteroglobin-related protein 1)",606531,"{Asthma, susceptibility to}",600807,AD,-,SCGB3A2
"SPINK5, LEKTI","Serine protease inhibitor, Kazal type, 5",605010,Netherton syndrome,256500,AR,-,SPINK5
"FBXO38, FBX38, MOKA, HMN2D",F-box only protein 38,608533,"Neuronopathy, distal hereditary motor, type IID",615575,AD,-,FBXO38
ADRB2,"Adrenergic, beta-2-, receptor, surface",109690,"Beta-2-adrenoreceptor agonist, reduced response to",-,-,-,ADRB2
ADRB2,"Adrenergic, beta-2-, receptor, surface",109690,"{Asthma, nocturnal, susceptibility to}",600807,AD,-,ADRB2
ADRB2,"Adrenergic, beta-2-, receptor, surface",109690,"{Obesity, susceptibility to}",601665,"AD,Mu,AR",-,ADRB2
"SH3TC2, KIAA1985, MNMN",SH3 domain and tetratricopeptide repeat domain 2,608206,"Charcot-Marie-Tooth disease, type 4C",601596,AR,-,SH3TC2
"SH3TC2, KIAA1985, MNMN",SH3 domain and tetratricopeptide repeat domain 2,608206,"Mononeuropathy of the median nerve, mild",613353,AD,-,SH3TC2
"PPARGC1B, PGC1B, PERC","Peroxisome proliferator-activated receptor-gamma, coactivator 1, beta",608886,"{Obesity, variation in}",601665,"AD,Mu,AR",-,PPARGC1B
"PDE6A, PDEA, RP43","Phosphodiesterase-6A, cGMP-specific, rod, alpha",180071,Retinitis pigmentosa 43,613810,-,-,PDE6A
"SLC26A2, DTD, DTDST, D5S1708, EDM4","Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter)",606718,Achondrogenesis Ib,600972,AR,distal to APC,SLC26A2
"SLC26A2, DTD, DTDST, D5S1708, EDM4","Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter)",606718,"Atelosteogenesis, type II",256050,AR,-,SLC26A2
"SLC26A2, DTD, DTDST, D5S1708, EDM4","Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter)",606718,De la Chapelle dysplasia,256050,AR,-,SLC26A2
"SLC26A2, DTD, DTDST, D5S1708, EDM4","Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter)",606718,Diastrophic dysplasia,222600,AR,-,SLC26A2
"SLC26A2, DTD, DTDST, D5S1708, EDM4","Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter)",606718,"Diastrophic dysplasia, broad bone-platyspondylic variant",222600,AR,-,SLC26A2
"SLC26A2, DTD, DTDST, D5S1708, EDM4","Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter)",606718,"Epiphyseal dysplasia, multiple, 4",226900,AR,-,SLC26A2
"CSF1R, FMS, HDLS",Colony-stimulating factor-1 receptor; oncogene FMS (McDonough feline sarcoma),164770,"Leukoencephalopathy, diffuse hereditary, with spheroids",221820,AD,FMS2 is 5' end,CSF1R
"PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS","Platelet-derived growth factor receptor, beta polypeptide",173410,"Basal ganglia calcification, idiopathic, 4",615007,AD,"fusion gene with ETV6, HIP1, RABPT5, or H4 in chronic myeloproliferative disorders",PDGFRB
"PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS","Platelet-derived growth factor receptor, beta polypeptide",173410,Kosaki overgrowth syndrome,616592,AD,-,PDGFRB
"PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS","Platelet-derived growth factor receptor, beta polypeptide",173410,Myeloproliferative disorder with eosinophilia,131440,AD,-,PDGFRB
"PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS","Platelet-derived growth factor receptor, beta polypeptide",173410,"Myofibromatosis, infantile, 1",228550,AD,-,PDGFRB
"PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS","Platelet-derived growth factor receptor, beta polypeptide",173410,"Premature aging syndrome, Penttinen type",601812,AD,-,PDGFRB
"CAMK2A, KIAA0968, CAMKA, MRD53",Calcium/calmodulin-dependent protein kinase II-alpha,114078,"Mental retardation, autosomal dominant 53",617798,AD,-,CAMK2A
"TCOF1, MFD1, TCS1",Treacle,606847,Treacher Collins syndrome 1,154500,AD,prox. to SPARC,TCOF1
"RPS14, EMTB",Ribosomal protein S14,130620,"Macrocytic anemia, refractory, due to 5q deletion, somatic",153550,-,-,RPS14
"NDST1, HSST, MRT46",N-deacetylase/N-sulfotransferase (heparan sulfate-N-deacetylase/N-sulfotransferase),600853,"Mental retardation, autosomal recessive 46",616116,AR,-,NDST1
"IRGM, LRG47, IFI1, IBD19","Immunity-related GTPase family, M",608212,{Inflammatory bowel disease (Crohn disease) 19},612278,-,-,IRGM
"IRGM, LRG47, IFI1, IBD19","Immunity-related GTPase family, M",608212,"{Mycobacterium tuberculosis, protection against}",607948,-,-,IRGM
GM2A,GM2 ganglioside activator protein,613109,"GM2-gangliosidosis, AB variant",272750,AR,pseudogene on chr.3,GM2A
"SLC36A2, PAT2","Solute carrier family 36 (proton/amino acid symporter), member 2",608331,Hyperglycinuria,138500,AD,-,SLC36A2
"SLC36A2, PAT2","Solute carrier family 36 (proton/amino acid symporter), member 2",608331,"Iminoglycinuria, digenic",242600,"AR,DR",-,SLC36A2
"FAT2, MEGF1, SCA45","Fat tumor suppressor, Drosophila, homolog of, 2",604269,Spinocerebellar ataxia 45,617769,AD,-,FAT2
"SPARC, ON, OI17","Osteonectin (secreted protein, acidic, cysteine-rich)",182120,"Osteogenesis imperfecta, type XVII",616507,AR,-,SPARC
"GLRA1, STHE, HKPX1","Glycine receptor, alpha-1 polypeptide",138491,"Hyperekplexia, hereditary 1, autosomal dominant or recessive",149400,"AD,AR",-,GLRA1
"SGCD, SGD, LGMD2F, CMD1L","Sarcoglycan, delta (35kD dystrophin-associated glycoprotein)",601411,"Cardiomyopathy, dilated, 1L",606685,-,mutant in Syrian hamster cardiomyopathy,SGCD
"SGCD, SGD, LGMD2F, CMD1L","Sarcoglycan, delta (35kD dystrophin-associated glycoprotein)",601411,"Muscular dystrophy, limb-girdle, type 2F",601287,AR,-,SGCD
"ITK, EMT, LPFS1",T-cell-specific tyrosine kinase; homolog of mouse T-cell itk/tsk tyrosine kinase,186973,Lymphoproliferative syndrome 1,613011,AR,-,ITK
"NIPAL4, ICHYN, ARCI6",NIPA-like domain-containing 4,609383,"Ichthyosis, congenital, autosomal recessive 6",612281,AR,-,NIPAL4
"IL12B, NKSF2, IMD29","Interleukin-12B (natural killer cell stimulatory factor-2, cytotoxic lymphocyte maturation factor-2, p40)",161561,"Immunodeficiency 29, mycobacteriosis",614890,AR,between GLR1 and GABRA1,IL12B
NIDDM4,"Diabetes mellitus, noninsulin-dependent, 4",608036,"{Diabetes mellitus, noninsulin-dependent}",125853,AD,-,NIDDM4
"GABRB2, ICEE2","Gamma-aminobutyric acid (GABA) A receptor, beta-2",600232,"Epileptic encephalopathy, infantile or early childhood, 2",617829,AD,-,GABRB2
"GABRA1, EJM5, ECA4, EIEE19","Gamma-aminobutyric acid (GABA) A receptor, alpha-1",137160,"Epileptic encephalopathy, early infantile, 19",615744,AD,in same 200kb as GABRG2,GABRA1
"GABRA1, EJM5, ECA4, EIEE19","Gamma-aminobutyric acid (GABA) A receptor, alpha-1",137160,"{Epilepsy, childhood absence, susceptibility to, 4}",611136,-,-,GABRA1
"GABRA1, EJM5, ECA4, EIEE19","Gamma-aminobutyric acid (GABA) A receptor, alpha-1",137160,"{Epilepsy, juvenile myoclonic, susceptibility to, 5}",611136,-,-,GABRA1
"GABRG2, GEFSP3, CAE2, ECA2","Gamma-aminobutyric acid (GABA) A receptor, gamma-2",137164,"Epilepsy, generalized, with febrile seizures plus, type 3",611277,AD,in alpha/beta/gamma cluster,GABRG2
"GABRG2, GEFSP3, CAE2, ECA2","Gamma-aminobutyric acid (GABA) A receptor, gamma-2",137164,"Febrile seizures, familial, 8",611277,AD,-,GABRG2
"GABRG2, GEFSP3, CAE2, ECA2","Gamma-aminobutyric acid (GABA) A receptor, gamma-2",137164,"{Epilepsy, childhood absence, susceptibility to, 2}",607681,AD,-,GABRG2
HMMR,Hyaluronan-mediated motility receptor (RHAMM),600936,"{Breast cancer, susceptibility to}",114480,AD,-,HMMR
"WWC1, KIBRA, KIAA0869, MEMRYQTL","WW, C2, and coiled-coil domain-containing 1",610533,"[Memory, enhanced, QTL]",615602,-,-,WWC1
"RARS, HLD9",Arginyl-tRNA synthetase,107820,"Leukodystrophy, hypomyelinating, 9",616140,AR,-,RARS
"DOCK2, IMD40",Dedicator of cytokinesis 2,603122,Immunodeficiency 40,616433,AR,-,DOCK2
"FOXI1, FKHL10, FREAC6",Forkhead box I1,601093,Enlarged vestibular aqueduct,600791,AR,some patients have digenic mutations with SLC26A4,FOXI1
KCNMB1,"Potassium large conductance calcium-activated channel, subfamily M, beta member 1",603951,"{Hypertension, diastolic, resistance to}",608622,AD,-,KCNMB1
NPM1,"Nucleophosmin 1 (nucleolar phosphoprotein B23, numatrin)",164040,"Leukemia, acute myeloid, somatic",601626,-,fused with RARA in APL,NPM1
"SH3PXD2B, TKS4, KIAA1295, FTHS",SH3 and PX domains-containing protein 2B,613293,Frank-ter Haar syndrome,249420,AR,-,SH3PXD2B
"NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2",NK2 homeobox-5 gene,600584,"Atrial septal defect 7, with or without AV conduction defects",108900,AD,near border with 5q35,NKX2-5
"NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2",NK2 homeobox-5 gene,600584,"Conotruncal heart malformations, variable",217095,-,-,NKX2-5
"NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2",NK2 homeobox-5 gene,600584,Hypoplastic left heart syndrome 2,614435,AD,-,NKX2-5
"NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2",NK2 homeobox-5 gene,600584,"Hypothyroidism, congenital nongoitrous, 5",225250,AD,-,NKX2-5
"NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2",NK2 homeobox-5 gene,600584,Tetralogy of Fallot,187500,AD,-,NKX2-5
"NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2",NK2 homeobox-5 gene,600584,Ventricular septal defect 3,614432,AD,-,NKX2-5
"MSX2, CRS2, HOX8","msh, Drosophila, homeo box homolog of, 2",123101,Craniosynostosis 2,604757,AD,-,MSX2
"MSX2, CRS2, HOX8","msh, Drosophila, homeo box homolog of, 2",123101,Parietal foramina 1,168500,AD,-,MSX2
"MSX2, CRS2, HOX8","msh, Drosophila, homeo box homolog of, 2",123101,Parietal foramina with cleidocranial dysplasia,168550,AD,-,MSX2
SNCB,"Synuclein, beta",602569,"Dementia, Lewy body",127750,AD,-,SNCB
"NSD1, ARA267, STO, SOTOS1",Nuclear receptor binding SET domain protein 1,606681,"Leukemia, acute myeloid",601626,AD,fusion gene with NUP98 in AML,NSD1
"NSD1, ARA267, STO, SOTOS1",Nuclear receptor binding SET domain protein 1,606681,Sotos syndrome 1,117550,AD,-,NSD1
"SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2","Solute carrier family 34 (sodium phosphate cotransporter), member 1",182309,?Fanconi renotubular syndrome 2,613388,AR,mutation identified in 1 FRTS2 family,SLC34A1
"SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2","Solute carrier family 34 (sodium phosphate cotransporter), member 1",182309,"Hypercalcemia, infantile, 2",616963,AR,-,SLC34A1
"SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2","Solute carrier family 34 (sodium phosphate cotransporter), member 1",182309,"Nephrolithiasis/osteoporosis, hypophosphatemic, 1",612286,AD,-,SLC34A1
"F12, HAF, HAE3",Coagulation factor XII (Hageman factor),610619,"Angioedema, hereditary, type III",610618,AD,-,F12
"F12, HAF, HAE3",Coagulation factor XII (Hageman factor),610619,Factor XII deficiency,234000,AR,-,F12
"DDX41, ABS, MPLPF",DEAD/H box 41,608170,"{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}",616871,AD,-,DDX41
"B4GALT7, XGALT1, XGPT1, EDSSPD1","Beta-1,4-galactosyltransferase 7",604327,"Ehlers-Danlos syndrome, spondylodysplastic type, 1",130070,AR,-,B4GALT7
"PROP1, CPHD2","Prophet of Pit1, paired-like homeodomain transcription factor",601538,"Pituitary hormone deficiency, combined, 2",262600,AR,-,PROP1
"NOLA2, NHP2, DKCB2","Nucleolar protein family A, member 2",606470,"Dyskeratosis congenita, autosomal recessive 2",613987,AR,-,NOLA2
"PHYKPL, AGXT2L2, PHLU",5-phosphohydroxy-L-lysine phospho-lyase,614683,[?Phosphohydroxylysinuria],615011,-,mutation identified in 1 PHLU patient,PHYKPL
"GRM6, MGLUR6, CSNB1B","Glutamate receptor, metabotropic, 6",604096,"Night blindness, congenital stationary (complete), 1B, autosomal recessive",257270,AR,-,GRM6
"ADAMTS2, NPI, EDSDERMS","A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 2 (procollagen I N-proteinase)",604539,"Ehlers-Danlos syndrome, dermatosparaxix type",225410,AR,-,ADAMTS2
"SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV",Sequestosome 1,601530,Frontotemporal dementia and/or amyotrophic lateral sclerosis 3,616437,AD,-,SQSTM1
"SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV",Sequestosome 1,601530,"Myopathy, distal, with rimmed vacuoles",617158,AD,-,SQSTM1
"SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV",Sequestosome 1,601530,"Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset",617145,AR,-,SQSTM1
"SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV",Sequestosome 1,601530,Paget disease of bone 3,167250,AD,-,SQSTM1
"FLT4, VEGFR3, PCL, LMPH1A",fms-related tyrosine kinase-4 (vascular endothelial growth factor receptor 3),136352,"Hemangioma, capillary infantile, somatic",602089,-,-,FLT4
"FLT4, VEGFR3, PCL, LMPH1A",fms-related tyrosine kinase-4 (vascular endothelial growth factor receptor 3),136352,"Lymphedema, hereditary, IA",153100,AD,-,FLT4
"DEL6pter, C6DELpter",Chromosome 6pter-p24 deletion syndrome,612582,Chromosome 6pter-p24 deletion syndrome,612582,IC,-,DEL6pter
"IRF4, LSIRF, SHEP8",Interferon regulatory factor-4,601900,"[Skin/hair/eye pigmentation, variation in, 8]",611724,-,dysregulated in t(6;14),IRF4
"FOXC1, FKHL7, FREAC3, IRID1, RIEG3, ASGD3","Forkhead, Drosophila, homolog-like 7",601090,"Anterior segment dysgenesis 3, multiple subtypes",601631,AD,-,FOXC1
"FOXC1, FKHL7, FREAC3, IRID1, RIEG3, ASGD3","Forkhead, Drosophila, homolog-like 7",601090,"Axenfeld-Rieger syndrome, type 3",602482,AD,-,FOXC1
"SERPINB6, PI6, PTI, SPI3, DFNB91",Protease inhibitor 6 (placental thrombin inhibitor),173321,"?Deafness, autosomal recessive 91",613453,AR,mutation identified in 1 DFNB91 family,SERPINB6
"NQO2, NMOR2","NAD(P)H dehydrogenase, quinone 2 (NAD(P)H menadione oxidoreductase-1, dioxin-inducible-2)",160998,{?Breast cancer susceptibility},114480,AD,-,NQO2
"TUBB2A, CDCBM5","Tubulin, beta-2A",615101,"Cortical dysplasia, complex, with other brain malformations 5",615763,AD,-,TUBB2A
"TUBB2B, CDCBM7","Tubulin, beta-2B",612850,"Cortical dysplasia, complex, with other brain malformations 7",610031,AD,TUBB2A is 70kb telomeric to TUBB2B,TUBB2B
"LYRM4, ISD11, C6orf149, COXPD19",LYR motif-containing protein 4,613311,?Combined oxidative phosphorylation deficiency 19,615595,AR,mutation identified in 1 family,LYRM4
"FARS2, FARS1, COXPD14, SPG77","Phenylalanyl-tRNA synthetase 2, mitochondrial",611592,Combined oxidative phosphorylation deficiency 14,614946,AR,-,FARS2
"FARS2, FARS1, COXPD14, SPG77","Phenylalanyl-tRNA synthetase 2, mitochondrial",611592,"Spastic paraplegia 77, autosomal recessive",617046,AR,-,FARS2
"F13A1, F13A","Coagulation factor XIII, A polypeptide",134570,Factor XIIIA deficiency,613225,AR,-,F13A1
"F13A1, F13A","Coagulation factor XIII, A polypeptide",134570,"{Myocardial infarction, protection against}",608446,-,-,F13A1
"F13A1, F13A","Coagulation factor XIII, A polypeptide",134570,"{Venous thrombosis, protection against}",188050,AD,-,F13A1
"DSP, KPPS2, PPKS2, DCWHKTA",Desmoplakin,125647,Arrhythmogenic right ventricular dysplasia 8,607450,AD,splice variants result in DP I and DP II,DSP
"DSP, KPPS2, PPKS2, DCWHKTA",Desmoplakin,125647,"Cardiomyopathy, dilated, with woolly hair and keratoderma",605676,AR,-,DSP
"DSP, KPPS2, PPKS2, DCWHKTA",Desmoplakin,125647,"Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis",615821,AD,-,DSP
"DSP, KPPS2, PPKS2, DCWHKTA",Desmoplakin,125647,"Epidermolysis bullosa, lethal acantholytic",609638,AR,-,DSP
"DSP, KPPS2, PPKS2, DCWHKTA",Desmoplakin,125647,Keratosis palmoplantaris striata II,612908,-,-,DSP
"DSP, KPPS2, PPKS2, DCWHKTA",Desmoplakin,125647,Skin fragility-woolly hair syndrome,607655,AR,-,DSP
"TFAP2A, AP2TF, BOFS",Transcription factor AP-2 alpha (activating enhancer-binding protein 2 alpha),107580,Branchiooculofacial syndrome,113620,AD,-,TFAP2A
"GCNT2, Ii, CTRCT13","Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme",600429,Adult i phenotype without cataract,110800,AD,previously assigned to 9q21,GCNT2
"GCNT2, Ii, CTRCT13","Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme",600429,Cataract 13 with adult i phenotype,116700,AR,-,GCNT2
"GCNT2, Ii, CTRCT13","Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme",600429,"[Blood group, Ii]",110800,AD,-,GCNT2
"MAK, RP62",Male germ cell-associated kinase,154235,Retinitis pigmentosa 62,614181,AR,-,MAK
"GCM2, GCMB, HRPT4","Glial cells missing, Drosophila, homolog of, 2",603716,Hyperparathyroidism 4,617343,AD,-,GCM2
"GCM2, GCMB, HRPT4","Glial cells missing, Drosophila, homolog of, 2",603716,"Hypoparathyroidism, familial isolated",146200,AD,-,GCM2
"EDN1, ARCND3, QME, HDLCQ7",Endothelin-1,131240,Auriculocondylar syndrome 3,615706,AR,-,EDN1
"EDN1, ARCND3, QME, HDLCQ7",Endothelin-1,131240,"Question mark ears, isolated",612798,AD,-,EDN1
"EDN1, ARCND3, QME, HDLCQ7",Endothelin-1,131240,{High density lipoprotein cholesterol level QTL 7},-,-,-,EDN1
"TBC1D7, PIG51, TBC7, MGCPH","TBC1 domain family, member 7",612655,"Macrocephaly/megalencephaly syndrome, autosomal recessive",248000,AR,-,TBC1D7
SCZD3,"Schizophrenia susceptibility locus, chromosome 6-related",600511,{Schizophrenia},181500,AD,?same as DTNBP1; cognitive deficit type,SCZD3
"DTNBP1, HPS7",Dystrobrevin-binding protein 1 (dysbindin),607145,Hermansky-Pudlak syndrome 7,614076,AR,-,DTNBP1
"ATXN1, ATX1, SCA1",Ataxin-1,601556,Spinocerebellar ataxia 1,164400,AD,-,ATXN1
"NHLRC1, EPM2A, EPM2B",NHL repeat-containing 1 gene (malin),608072,"Epilepsy, progressive myoclonic 2B (Lafora)",254780,AR,-,NHLRC1
"TPMT, TPMTD",Thiopurine S-methyltransferase,187680,"{Thiopurines, poor metabolism of, 1}",610460,AR,-,TPMT
"DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC",Doublecortin domain-containing protein 2,605755,"?Deafness, autosomal recessive 66",610212,AR,mutation identified in 1 DFNB66 family,DCDC2
"DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC",Doublecortin domain-containing protein 2,605755,Nephronophthisis 19,616217,AR,-,DCDC2
"DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC",Doublecortin domain-containing protein 2,605755,"Sclerosing cholangitis, neonatal",617394,AR,-,DCDC2
"ALDH5A1, SSADH",Succinic semialdehyde dehydrogenase,610045,Succinic semialdehyde dehydrogenase deficiency,271980,AR,-,ALDH5A1
"TDP2, TTRAP",Tyrosyl-DNA phosphodiesterase 2,605764,"Spinocerebellar ataxia, autosomal recessive 23",616949,AR,-,TDP2
"GMNN, MGORS6",Geminin,602842,Meier-Gorlin syndrome 6,616835,AD,-,GMNN
"FAM65B, C6orf32, KIAA0386, PL48, DFNB104","Family with sequence similarity 65, member B",611410,"?Deafness, autosomal recessive 104",616515,AR,mutation identified in 1 DFNB104 family,FAM65B
"SLC17A3, NPT4, UAQTL4, GOUT4","Solute carrier family 17 (sodium phosphate cotransporter), member 3",611034,"[Uric acid concentration, serum, QTL4]",612671,AD,-,SLC17A3
"SLC17A3, NPT4, UAQTL4, GOUT4","Solute carrier family 17 (sodium phosphate cotransporter), member 3",611034,{Gout susceptibility 4},612671,AD,-,SLC17A3
"HFE, HLA-H, HFE1, MVCD7, TFQTL2",Hemochromatosis gene,613609,Hemochromatosis,235200,AR,-,HFE
"HFE, HLA-H, HFE1, MVCD7, TFQTL2",Hemochromatosis gene,613609,[Transferrin serum level QTL2],614193,-,-,HFE
"HFE, HLA-H, HFE1, MVCD7, TFQTL2",Hemochromatosis gene,613609,"{Alzheimer disease, susceptibility to}",104300,AD,-,HFE
"HFE, HLA-H, HFE1, MVCD7, TFQTL2",Hemochromatosis gene,613609,{Microvascular complications of diabetes 7},612635,-,-,HFE
"HFE, HLA-H, HFE1, MVCD7, TFQTL2",Hemochromatosis gene,613609,"{Porphyria cutanea tarda, susceptibility to}",176100,"AD,AR",-,HFE
"HFE, HLA-H, HFE1, MVCD7, TFQTL2",Hemochromatosis gene,613609,"{Porphyria variegata, susceptibility to}",176200,AD,-,HFE
"HIST1H1E, H1F4, RMNS","Histone 1, H1e",142220,Rahman syndrome,617537,AD,-,HIST1H1E
"OR2J3, C3HEXS","Olfactory receptor, family 2, subfamily J, member 3",615016,"[C3HEX, ability to smell]",615082,AD,-,OR2J3
"MOG, NRCLP7",Myelin-oligodendrocyte glycoprotein,159465,?Narcolepsy 7,614250,AD,60kb telomeric to HLA-F; mutation identified in 1 NRCLP7 family,MOG
"ZFP57, TNDM1","Zinc finger protein 57, mouse, homolog of",612192,"Diabetes mellitus, transient neonatal, 1",601410,-,-,ZFP57
HLA-G,"HLA-G histocompatibility antigen, class I",142871,"{Asthma, susceptibility to}",600807,AD,-,HLA-G
HLA-A,"Major histocompatibility complex, class I, A",142800,"{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}",608579,-,-,HLA-A
"TUBB, TUBB5, M40, CDCBM6, CSCSC1","Tubulin, beta polypeptide",191130,"Cortical dysplasia, complex, with other brain malformations 6",615771,AD,-,TUBB
"TUBB, TUBB5, M40, CDCBM6, CSCSC1","Tubulin, beta polypeptide",191130,"Symmetric circumferential skin creases, congenital, 1",156610,AD,-,TUBB
"VARS2, KIAA1885, COXPD20",Valyl-tRNA synthetase 2,612802,Combined oxidative phosphorylation deficiency 20,615917,AR,-,VARS2
"CDSN, HTSS1, HYPT2, PSS1",Corneodesmosin,602593,Hypotrichosis 2,146520,AD,-,CDSN
"CDSN, HTSS1, HYPT2, PSS1",Corneodesmosin,602593,Peeling skin syndrome 1,270300,AR,-,CDSN
"HLA-C, PSORS1","Major histocompatibility complex, class I, C",142840,"{HIV-1 viremia, susceptibility to}",609423,-,-,HLA-C
"HLA-C, PSORS1","Major histocompatibility complex, class I, C",142840,{Psoriasis susceptibility 1},177900,Mu,-,HLA-C
"HLA-B, SPDA1","Major histocompatibility complex, class I, B",142830,"{Abacavir hypersensitivity, susceptibility to}",-,-,-,HLA-B
"HLA-B, SPDA1","Major histocompatibility complex, class I, B",142830,{Drug-induced liver injury due to flucloxacillin},-,-,-,HLA-B
"HLA-B, SPDA1","Major histocompatibility complex, class I, B",142830,"{Spondyloarthropathy, susceptibility to, 1}",106300,Mu,-,HLA-B
"HLA-B, SPDA1","Major histocompatibility complex, class I, B",142830,"{Stevens-Johnson syndrome, susceptibility to}",608579,-,-,HLA-B
"HLA-B, SPDA1","Major histocompatibility complex, class I, B",142830,"{Synovitis, chronic, susceptibility to}",-,-,-,HLA-B
"HLA-B, SPDA1","Major histocompatibility complex, class I, B",142830,"{Toxic epidermal necrolysis, susceptibility to}",608579,-,-,HLA-B
NFKBIL1,Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1,601022,"{Rheumatoid arthritis, susceptibility to}",180300,-,-,NFKBIL1
"LTA, TNFB",Lymphotoxin alpha (formerly tumor necrosis factor beta),153440,"{Leprosy, susceptibility to, 4}",610988,-,cen-DR-21OH-C4-BF-C2-TNF-LTA-HLA-B,LTA
"LTA, TNFB",Lymphotoxin alpha (formerly tumor necrosis factor beta),153440,"{Myocardial infarction, susceptibility to}",608446,-,-,LTA
"LTA, TNFB",Lymphotoxin alpha (formerly tumor necrosis factor beta),153440,"{Psoriatic arthritis, susceptibility to}",607507,-,-,LTA
"TNF, TNFA",Tumor necrosis factor (cachectin),191160,"{Asthma, susceptibility to}",600807,AD,5'-LTA--TNF-3' in 7kb segment (pter-cen); 210kb from HLA-B,TNF
"TNF, TNFA",Tumor necrosis factor (cachectin),191160,"{Dementia, vascular, susceptibility to}",-,-,-,TNF
"TNF, TNFA",Tumor necrosis factor (cachectin),191160,"{Malaria, cerebral, susceptibility to}",611162,-,-,TNF
"TNF, TNFA",Tumor necrosis factor (cachectin),191160,"{Migraine without aura, susceptibility to}",157300,AD,-,TNF
"TNF, TNFA",Tumor necrosis factor (cachectin),191160,"{Septic shock, susceptibility to}",-,-,-,TNF
"NCR3, 1C7, NKP30, CD337, MALS",Natural cytotoxicity triggering receptor 3,611550,"{Malaria, mild, susceptibility to}",609148,-,-,NCR3
"G6B, C6orf25, THAMY",G6B protein,606520,"?Thrombocytopenia, anemia, and myelofibrosis",617441,AR,mutation identified in 1 THAMY family,G6B
"MSH5, POF13","MutS, E. coli, homolog of, 5",603382,?Premature ovarian failure 13,617442,AR,mutation identified in POF13 family,MSH5
"VARS, VARS1, G7A, VARS2, NDMSCA",Valyl-tRNA synthetase,192150,"Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy",617802,AR,-,VARS
"NEU1, NEU, SIAL1",Neuraminidase 1 (lysosomal sialidase; sialidase 1),608272,"Sialidosis, type I",256550,AR,-,NEU1
"NEU1, NEU, SIAL1",Neuraminidase 1 (lysosomal sialidase; sialidase 1),608272,"Sialidosis, type II",256550,AR,-,NEU1
"SLC44A4, CTL4, C6orf29, DFNA72","Solute carrier family 44, member 4",606107,"?Deafness, autosomal dominant 72",617606,AD,mutation identified in 1 DFNA72 family,SLC44A4
"C2, ARMD14",Complement component-2,613927,C2 deficiency,217000,AR,no crossover with BF,C2
"C2, ARMD14",Complement component-2,613927,"{Macular degeneration, age-related, 14, reduced risk of}",615489,-,-,C2
"CFB, BF, GBG, AHUS4, ARMD14, CFBD",Complement factor B,138470,?Complement factor B deficiency,615561,-,mutation identified in 1 CFBD family,CFB
"CFB, BF, GBG, AHUS4, ARMD14, CFBD",Complement factor B,138470,"{Hemolytic uremic syndrome, atypical, susceptibility to, 4}",612924,AD,-,CFB
"CFB, BF, GBG, AHUS4, ARMD14, CFBD",Complement factor B,138470,"{Macular degeneration, age-related, 14, reduced risk of}",615489,-,-,CFB
"SKIV2L, SKI2, SKI2W, THES2","Superkiller viralicidic activity 2, S. cerevisiae, homolog, like",600478,Trichohepatoenteric syndrome 2,614602,AR,-,SKIV2L
"C4A, C4S, C4AD",Complement component-4A,120810,C4a deficiency,614380,AR,"order: HLA-B, C2, BF, C4A, C4B, CYP21, DR",C4A
"C4A, C4S, C4AD",Complement component-4A,120810,"[Blood group, Rodgers]",614374,-,-,C4A
"C4B, C4F, C4BD",Complement component-4B,120820,C4B deficiency,614379,-,10kb from C4S,C4B
"CYP21A2, CYP21, CA21H","Cytochrome P450, subfamily XXIA, polypeptide 2 (steroid 21-hydroxylase)",613815,"Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency",201910,AR,"linked to C2, C4, BF; 2 loci, A and B; only B active; pseudogene CYP21P contiguous on 6p",CYP21A2
"CYP21A2, CYP21, CA21H","Cytochrome P450, subfamily XXIA, polypeptide 2 (steroid 21-hydroxylase)",613815,"Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency",201910,AR,-,CYP21A2
"TNXB, TNX, TNXB1, TNXBS, TNXB2, EDSCLL, VUR8",Tenascin XB,600985,"Ehlers-Danlos syndrome, classic-like",606408,AR,-,TNXB
"TNXB, TNX, TNXB1, TNXBS, TNXB2, EDSCLL, VUR8",Tenascin XB,600985,Vesicoureteral reflux 8,615963,AD,-,TNXB
"BTNL2, SS2",Butyrophilin-like protein 2,606000,"{Sarcoidosis, susceptibility to, 2}",612387,AD,-,BTNL2
"HLA-DRB1, SS1","Major histocompatibility complex, class II, DR beta-1",142857,"{Multiple sclerosis, susceptibility to, 1}",126200,Mu,-,HLA-DRB1
"HLA-DRB1, SS1","Major histocompatibility complex, class II, DR beta-1",142857,"{Sarcoidosis, susceptibility to, 1}",181000,AD,-,HLA-DRB1
"HLA-DQA1, CELIAC1","Major histocompatibility complex, class II, DQ alpha-1",146880,"{Celiac disease, susceptibility to}",212750,"Mu,AR",-,HLA-DQA1
"HLA-DQB1, CELIAC1","Major histocompatibility complex, class II, DQ beta-1",604305,"{Celiac disease, susceptibility to}",212750,"Mu,AR",-,HLA-DQB1
"HLA-DQB1, CELIAC1","Major histocompatibility complex, class II, DQ beta-1",604305,"{Creutzfeldt-Jakob disease, variant, resistance to}",123400,AD,-,HLA-DQB1
"HLA-DQB1, CELIAC1","Major histocompatibility complex, class II, DQ beta-1",604305,"{Multiple sclerosis, susceptibility to, 1}",126200,Mu,-,HLA-DQB1
"TAP2, ABCB3, PSF2, RING11","Transporter 2, ATP-binding cassette, subfamily B",170261,"Bare lymphocyte syndrome, type I, due to TAP2 deficiency",604571,AR,tel-TAP1-LMP2-LMP1-TAP2-cen,TAP2
"TAP2, ABCB3, PSF2, RING11","Transporter 2, ATP-binding cassette, subfamily B",170261,Wegener-like granulomatosis,-,-,-,TAP2
"PSMB8, LMP7, RING10, JMP, NKJO, ALDD","Proteasome subunit, beta type, 8 (large multifunctional protease-7)",177046,"Autoinflammation, lipodystrophy, and dermatosis syndrome",256040,AR,between TAP1 and TAP2,PSMB8
"TAP1, ABCB2, RING4, PSF1","Transporter 1, ATP-binding cassette, subfamily B",170260,"Bare lymphocyte syndrome, type I",604571,AR,~7kb telomeric to TAP2,TAP1
"COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB","Collagen XI, alpha-2 polypeptide",120290,"Deafness, autosomal dominant 13",601868,AD,45kb centromeric of HLA-DPB2; 3'--5'-cen,COL11A2
"COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB","Collagen XI, alpha-2 polypeptide",120290,"Deafness, autosomal recessive 53",609706,AR,-,COL11A2
"COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB","Collagen XI, alpha-2 polypeptide",120290,Fibrochondrogenesis 2,614524,"AD,AR",-,COL11A2
"COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB","Collagen XI, alpha-2 polypeptide",120290,"Otospondylomegaepiphyseal dysplasia, autosomal dominant",184840,AD,-,COL11A2
"COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB","Collagen XI, alpha-2 polypeptide",120290,"Otospondylomegaepiphyseal dysplasia, autosomal recessive",215150,AR,-,COL11A2
"TAPBP, TPSN",TAP-binding protein (tapasin),601962,"Bare lymphocyte syndrome, type I",604571,AR,-,TAPBP
"SYNGAP1, MRD5",Synaptic Ras GTPase activating protein 1,603384,"Mental retardation, autosomal dominant 5",612621,AD,-,SYNGAP1
"UQCC2, C6orf126, M19",Ubiquinol-cytochrome c reductase complex assembly factor 2,614461,"?Mitochondrial complex III deficiency, nuclear type 7",615824,AR,mutation identified in 1 MC3DN7 patient,UQCC2
"LEMD2, NET25, CTRCT42",LEM domain-containing protein 2,616312,"Cataract 46, juvenile-onset",212500,AR,-,LEMD2
"HMGA1, HMGIY",High-mobility group AT-hook 1,600701,"{Diabetes mellitus, noninsulin-dependent, susceptibility to}",125853,AD,-,HMGA1
"RPS10, DBA9",Ribosomal protein S10,603632,Diamond-Blackfan anemia 9,613308,AD,-,RPS10
"FANCE, FACE","Fanconi anemia, complementation group E gene",613976,"Fanconi anemia, complementation group E",600901,AR,-,FANCE
"TULP1, RP14, LCA15",Tubby-like protein-1,602280,Leber congenital amaurosis 15,613843,AR,-,TULP1
"TULP1, RP14, LCA15",Tubby-like protein-1,602280,Retinitis pigmentosa 14,600132,AR,-,TULP1
"FKBP5, FKBP51",FK506-binding protein 5,602623,{Major depressive disorder and accelerated response to antidepressant drug treatment},608516,-,-,FKBP5
"LHFPL5, TMHS, DFNB67",LHFP-like protein 5,609427,"Deafness, autosomal recessive 67",610265,AR,-,LHFPL5
"SLC26A8, TAT1, SPGF3","Solute carrier family 26 (sulfate transporter), member 8",608480,Spermatogenic failure 3,606766,AD,-,SLC26A8
"PNPLA1, ARCI10",Patatin-like phospholipase domain-containing protein 1,612121,"Ichthyosis, congenital, autosomal recessive 10",615024,AR,-,PNPLA1
"MOCS1, MOCODA",Molybdenum cofactor synthesis-1,603707,Molybdenum cofactor deficiency A,252150,AR,-,MOCS1
TREM2,Triggering receptor expressed on myeloid cells 2,605086,Nasu-Hakola disease,221770,AR,-,TREM2
"GUCA1A, GCAP, COD3, CORD14","Guanylate cyclase activator 1A, retina",600364,Cone dystrophy-3,602093,AD,-,GUCA1A
"GUCA1A, GCAP, COD3, CORD14","Guanylate cyclase activator 1A, retina",600364,Cone-rod dystrophy 14,602093,AD,-,GUCA1A
"GUCA1B, GCAP2, GUCA2, RP48","Guanylate cyclase activator 1B, retina",602275,Retinitis pigmentosa 48,613827,-,-,GUCA1B
"PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1","Peripherin 2, mouse, homolog of",179605,"Choroidal dystrophy, central areolar 2",613105,AD,digenic RP with ROM1,PRPH2
"PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1","Peripherin 2, mouse, homolog of",179605,Leber congenital amaurosis 18,608133,"AD,AR",-,PRPH2
"PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1","Peripherin 2, mouse, homolog of",179605,"Macular dystrophy, patterned, 1",169150,AD,-,PRPH2
"PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1","Peripherin 2, mouse, homolog of",179605,"Macular dystrophy, vitelliform, 3",608161,AD,-,PRPH2
"PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1","Peripherin 2, mouse, homolog of",179605,Retinitis pigmentosa 7 and digenic,608133,"AD,AR",-,PRPH2
"PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1","Peripherin 2, mouse, homolog of",179605,Retinitis punctata albescens,136880,"AD,AR",-,PRPH2
GNMT,Glycine N-methyltransferase,606628,Glycine N-methyltransferase deficiency,606664,AR,-,GNMT
"PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2",Peroxisomal biogenesis factor 6 (peroxisomal AAA-type ATPase 1),601498,Heimler syndrome 2,616617,AR,-,PEX6
"PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2",Peroxisomal biogenesis factor 6 (peroxisomal AAA-type ATPase 1),601498,Peroxisome biogenesis disorder 4A (Zellweger),614862,AR,-,PEX6
"PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2",Peroxisomal biogenesis factor 6 (peroxisomal AAA-type ATPase 1),601498,Peroxisome biogenesis disorder 4B,614863,"AD,AR",-,PEX6
"PPP2R5D, MRD35","Protein phosphatase-2, regulatory subunit B (B56), delta isoform",601646,"Mental retardation, autosomal dominant 35",616355,AD,-,PPP2R5D
"CUL7, 3M1",Cullin 7,609577,3-M syndrome 1,273750,AR,-,CUL7
"POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11","Polymerase I, RNA, subunit C",610060,"Leukodystrophy, hypomyelinating, 11",616494,AR,-,POLR1C
"POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11","Polymerase I, RNA, subunit C",610060,Treacher Collins syndrome 3,248390,AR,-,POLR1C
"POLH, XPV","Polymerase, DNA, eta",603968,"Xeroderma pigmentosum, variant type",278750,AR,-,POLH
"RSPH9, CILD12","Radial spoke head 9, Chlamydomonas, homolog of",612648,"Ciliary dyskinesia, primary, 12",612650,-,-,RSPH9
"VEGF, MVCD1",Vascular endothelial growth factor,192240,{Microvascular complications of diabetes 1},603933,-,-,VEGF
"AARS2, KIAA1270, MTALARS, COXPD8, LKENP",Alanyl-tRNA synthetase 2,612035,Combined oxidative phosphorylation deficiency 8,614096,AR,-,AARS2
"AARS2, KIAA1270, MTALARS, COXPD8, LKENP",Alanyl-tRNA synthetase 2,612035,"Leukoencephalopathy, progressive, with ovarian failure",615889,AR,-,AARS2
"RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD",Runt-related transcription factor 2,600211,Cleidocranial dysplasia,119600,AD,-,RUNX2
"RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD",Runt-related transcription factor 2,600211,"Cleidocranial dysplasia, forme fruste, dental anomalies only",119600,AD,-,RUNX2
"RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD",Runt-related transcription factor 2,600211,"Cleidocranial dysplasia, forme fruste, with brachydactyly",119600,AD,-,RUNX2
"RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD",Runt-related transcription factor 2,600211,Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly,156510,AD,-,RUNX2
"CLIC5, DFNB103",Chloride intracellular channel 5,607293,"?Deafness, autosomal recessive 103",616042,AR,mutation identified in 1 DFNB103 family,CLIC5
"PLA2G7, PAFAH, PAFAD","Phospholipase A2, group VII (platelet-activating factor acetylhydrolase)",601690,Platelet-activating factor acetylhydrolase deficiency,614278,AR,-,PLA2G7
"PLA2G7, PAFAH, PAFAD","Phospholipase A2, group VII (platelet-activating factor acetylhydrolase)",601690,"{Asthma, susceptibility to}",600807,AD,-,PLA2G7
"PLA2G7, PAFAH, PAFAD","Phospholipase A2, group VII (platelet-activating factor acetylhydrolase)",601690,"{Atopy, susceptibility to}",147050,AD,-,PLA2G7
"CD2AP, CMS",CD2-associated protein,604241,"Glomerulosclerosis, focal segmental, 3",607832,-,-,CD2AP
"MUT, MCM",Methylmalonyl Coenzyme A mutase,609058,"Methylmalonic aciduria, mut(0) type",251000,AR,-,MUT
"RHAG, RH50A, OHST",Rhesus blood group-associated glycoprotein,180297,"Anemia, hemolytic, Rh-null, regulator type",268150,AD,-,RHAG
"RHAG, RH50A, OHST",Rhesus blood group-associated glycoprotein,180297,Overhydrated hereditary stomatocytosis,185000,AD,-,RHAG
"RHAG, RH50A, OHST",Rhesus blood group-associated glycoprotein,180297,Rh-mod syndrome,-,-,-,RHAG
"TFAP2B, CHAR, PDA2",Transcription factor AP-2 beta (activating enhancer-binding protein 2 beta),601601,Char syndrome,169100,AD,-,TFAP2B
"TFAP2B, CHAR, PDA2",Transcription factor AP-2 beta (activating enhancer-binding protein 2 beta),601601,Patent ductus arteriosus 2,617035,AD,-,TFAP2B
"FCYT, PKHD1, ARPKD, PKD4",Fibrocystin,606702,"Polycystic kidney disease 4, with or without hepatic disease",263200,AR,-,FCYT
"IL17F, ML1, CANDF6",Interleukin 17F,606496,"?Candidiasis, familial, 6, autosomal dominant",613956,-,mutation identified in 1 CANDF6 family,IL17F
"EFHC1, FLJ10466, EJM1, JAE, EJA1",EF hand domain (C-terminal)-containing 1,608815,"{Epilepsy, juvenile absence, susceptibility to, 1}",607631,AD,-,EFHC1
"EFHC1, FLJ10466, EJM1, JAE, EJA1",EF hand domain (C-terminal)-containing 1,608815,"{Myoclonic epilepsy, juvenile, susceptibility to, 1}",254770,AD,-,EFHC1
"ICK, MRK, KIAA0936, ECO",Intestinal cell kinase,612325,Endocrine-cerebroosteodysplasia,612651,AR,-,ICK
"ELOVL5, HELO1, SCA38",Elongation of very long chain fatty acids-like 5,611805,Spinocerebellar ataxia 38,615957,AD,-,ELOVL5
"GCLC, GLCLC","Glutamate-cysteine ligase, catalytic subunit",606857,Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency,230450,AR,-,GCLC
"GCLC, GLCLC","Glutamate-cysteine ligase, catalytic subunit",606857,"{Myocardial infarction, susceptibility to}",608446,-,-,GCLC
"DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2",Dystonin (bullous pemphigoid antigen 1),113810,"?Neuropathy, hereditary sensory and autonomic, type VI",614653,AR,?mutation identified in 1 HSAN6 family,DST
"DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2",Dystonin (bullous pemphigoid antigen 1),113810,"Epidermolysis bullosa simplex, autosomal recessive 2",615425,AR,-,DST
RAB23,Ras-associated protein RAB23,606144,Carpenter syndrome,201000,AR,-,RAB23
"DEL6q11q14, C6DELq11q14",Chromosome 6q11-q14 deletion syndrome,613544,Chromosome 6q11-q14 deletion syndrome,613544,IC,contiguous gene deletion syndrome,DEL6q11q14
ADHD3,"Attention deficit-hyperactivity disorder, susceptibility to, 2",608905,{Attention deficit-hyperactivity disorder},143465,AD,-,ADHD3
"EYS, RP25","Eyes shut, Drosophila, homolog of",612424,Retinitis pigmentosa 25,602772,AR,-,EYS
SCZD5,"Schizophrenia susceptibility locus, chromosome 6q-related",603175,{Schizophrenia},181500,AD,max lod at D6S1626 and D6S292,SCZD5
"LMBRD1, LMBD1, NESI, MAHCF",LMBR1 domain-containing protein 1,612625,"Methylmalonic aciduria and homocystinuria, cblF type",277380,AR,-,LMBRD1
"COL9A1, EDM6, STL4","Collagen IX, alpha-1 polypeptide",120210,"?Epiphyseal dysplasia, multiple, 6",614135,AD,mutation identified in 1 EDM6 family,COL9A1
"COL9A1, EDM6, STL4","Collagen IX, alpha-1 polypeptide",120210,"Stickler syndrome, type IV",614134,-,-,COL9A1
"RIMS1, RIM1, RIM, KIAA0340, CORD7",Regulating synaptic membrane exocytosis 1,606629,Cone-rod dystrophy 7,603649,-,-,RIMS1
"KCNQ5, MRD46","Potassium channel, voltage-gated, KQT-like subfamily, member 5",607357,"Mental retardation, autosomal dominant 46",617601,AD,-,KCNQ5
"KHDC3L, C6orf221, ECAT1, HYDM2","KH domain containing 3-like, subcortical maternal complex member",611687,"Hydatidiform mole, recurrent, 2",614293,AR,-,KHDC3L
"MTO1, COXPD10","Mitochondrial translation optimization 1, S. cerevisiae, homolog of",614667,Combined oxidative phosphorylation deficiency 10,614702,AR,-,MTO1
"SLC17A5, SIASD, SLD","Solute carrier family 17 (sodium phosphate), member 5",604322,Salla disease,604369,AR,-,SLC17A5
"SLC17A5, SIASD, SLD","Solute carrier family 17 (sodium phosphate), member 5",604322,"Sialic acid storage disorder, infantile",269920,AR,-,SLC17A5
"COL12A1, UCMD2, BTHLM2","Collagen, type XII, alpha-1",120320,?Ullrich congenital muscular dystrophy 2,616470,-,mutation identified in 1 UCMD2 family,COL12A1
"COL12A1, UCMD2, BTHLM2","Collagen, type XII, alpha-1",120320,Bethlem myopathy 2,616471,-,-,COL12A1
"MYO6, DFNA22, DFNB37",Myosin VI,600970,"Deafness, autosomal dominant 22",606346,AD,-,MYO6
"MYO6, DFNA22, DFNB37",Myosin VI,600970,"Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy",606346,AD,-,MYO6
"MYO6, DFNA22, DFNB37",Myosin VI,600970,"Deafness, autosomal recessive 37",607821,AR,-,MYO6
"IMPG1, IPM150, VMD4",Interphotoreceptor matrix proteoglycan-1,602870,"Macular dystrophy, vitelliform, 4",616151,AD,-,IMPG1
"LCA5, C6orf152",Lebercilin,611408,Leber congenital amaurosis 5,604537,-,-,LCA5
"ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34",Elongation of very long chain fatty acids 4,605512,"Ichthyosis, spastic quadriplegia, and mental retardation",614457,AR,-,ELOVL4
"ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34",Elongation of very long chain fatty acids 4,605512,Spinocerebellar ataxia 34,133190,AD,-,ELOVL4
"ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34",Elongation of very long chain fatty acids 4,605512,Stargardt disease 3,600110,AD,-,ELOVL4
"BCKDHB, E1B","Branched chain keto acid dehydrogenase E1, beta polypeptide",248611,"Maple syrup urine disease, type Ib",248600,AR,-,BCKDHB
"PGM3, AGM1, IMD23",Phosphoglucomutase-3 (N-acetylglucosamine-phosphate mutase 1),172100,Immunodeficiency 23,615816,AR,-,PGM3
"RIPPLY2, C6orf59, SCDO6","Ripply2, zebrafish, homolog of",609891,?Spondylocostal dysostosis 6,616566,AR,mutation identified in 1 SCDO6 family,RIPPLY2
"MRAP2, C6orf117, BMIQ18",Melanocortin 2 receptor accessory protein 2,615410,"{?Obesity, susceptibility to, BMIQ18}",615457,AD,mutation identified in 1 BMIQ18 individual,MRAP2
"TBX18, CAKUT2",T-box 18,604613,Congenital anomalies of kidney and urinary tract 2,143400,AD,-,TBX18
"NT5E, NT5","5' nucleotidase, ecto (CD73)",129190,Calcification of joints and arteries,211800,AR,-,NT5E
"SNX14, SCAR20",Sorting nexin 14,616105,"Spinocerebellar ataxia, autosomal recessive 20",616354,AR,-,SNX14
"SLC35A1, CST, CDG2F","Solute carrier family 35 (CMP-sialic acid transporter), member 1",605634,"Congenital disorder of glycosylation, type IIf",603585,AR,-,SLC35A1
"RARS2, RARSL, PCH6",Arginyl-tRNA synthetase 2,611524,"Pontocerebellar hypoplasia, type 6",611523,AR,-,RARS2
"MAP3K7, TAK1, CSCF, FMD2",Mitogen-activated protein kinase kinase kinase 7,602614,Cardiospondylocarpofacial syndrome,157800,AD,-,MAP3K7
"MAP3K7, TAK1, CSCF, FMD2",Mitogen-activated protein kinase kinase kinase 7,602614,Frontometaphyseal dysplasia 2,617137,AD,-,MAP3K7
"NDUFAF4, HRPAP20, C6orf66","NADH dehydrogenase 1 alpha subcomplex, assembly factor 4",611776,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",-,NDUFAF4
"FBXL4, FBL4, MTDPS13",F-box and leucine-rich repeat protein 4,605654,Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type),615471,AR,-,FBXL4
"DHS6S1, MCDR1","DNase1 hypersensitivity, chromosome 6, site 1",616842,"Macular dystrophy, North Carolina type",136550,AD,upstream of PRDM13 and CCNC,DHS6S1
SIM1,"Single-minded, Drosophila, homolog of, 1",603128,"Obesity, severe",601665,"AD,Mu,AR",-,SIM1
"GRIK2, GLUR6, MRT6","Glutamate receptor, ionotropic, kainate 2",138244,"Mental retardation, autosomal recessive, 6",611092,AR,-,GRIK2
"HACE1, KIAA1320, SPPRS",HECT domain- and ankyrin repeat-containing E3 ubiquitin protein ligase 1,610876,Spastic paraplegia and psychomotor retardation with or without seizures,616756,AR,-,HACE1
"BVES, HBVES, POPDC1, LGMD2X",Blood vessel epicardial substance,604577,"?Muscular dystrophy, limb-girdle, type 2X",616812,AR,mutation identified in 1 LGMD2X family,BVES
"ATG5, APG5, APG5L, ASP, SCAR25","Autophagy 5, S. cerevisiae, homolog of",604261,"?Spinocerebellar ataxia, autosomal recessive 25",617584,AR,mutation identified in one SCAR25 family,ATG5
"RTN4IP1, NIMP, OPA10",Reticulon 4-interacting protein 1,610502,"Optic atrophy 10 with or without ataxia, mental retardation, and seizures",616732,AR,-,RTN4IP1
"PDSS2, DLP1, C6orf210, COQ10D3","Prenyl diphosphate synthase, subunit 2",610564,"Coenzyme Q10 deficiency, primary, 3",614652,AR,-,PDSS2
"SOBP, JXC1, MRAMS","Sine oculis-binding protein, Drosophila, homolog of",613667,"Mental retardation, anterior maxillary protrusion, and strabismus",613671,AR,-,SOBP
"SEC63, PCLD2","Sec63, S. cerevisiae, homolog of",608648,Polycystic liver disease 2,617004,AD,-,SEC63
"OSTM1, GL, OPTB5","Osteopetrosis associated transmembrane protein 1 (grey-lethal, mouse, homolog of)",607649,"Osteopetrosis, autosomal recessive 5",259720,AR,-,OSTM1
"CD164, DFNA66",CD164 antigen,603356,"?Deafness, autosomal dominant 66",616969,AD,mutation identified in 1 DFNA66 family,CD164
"ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2",Zinc finger- and BTB domain-containing protein 24,614064,Immunodeficiency-centromeric instability-facial anomalies syndrome-2,614069,AR,-,ZBTB24
"FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP","Fig4, S. cerevisiae, homolog of",609390,"?Polymicrogyria, bilateral temporooccipital",612691,AR,mutation identified in 1 BTOP family,FIG4
"FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP","Fig4, S. cerevisiae, homolog of",609390,Amyotrophic lateral sclerosis 11,612577,AD,-,FIG4
"FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP","Fig4, S. cerevisiae, homolog of",609390,"Charcot-Marie-Tooth disease, type 4J",611228,AR,-,FIG4
"FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP","Fig4, S. cerevisiae, homolog of",609390,Yunis-Varon syndrome,216340,AR,-,FIG4
"TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8",TRAF3-interacting protein 2,607043,"?Candidiasis, familial, 8",615527,AR,mutation identified in 1 family with CANDF8,TRAF3IP2
"TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8",TRAF3-interacting protein 2,607043,{Psoriasis susceptibility 13},614070,-,-,TRAF3IP2
"WISP3, PPAC, PPD",Wnt-1 inducible signaling pathway protein 3,603400,"Arthropathy, progressive pseudorheumatoid, of childhood",208230,AR,-,WISP3
"WISP3, PPAC, PPD",Wnt-1 inducible signaling pathway protein 3,603400,Spondyloepiphyseal dysplasia tarda with progressive arthropathy,208230,AR,-,WISP3
"LAMA4, LAMA3, CMD1JJ","Laminin, alpha-4",600133,"Cardiomyopathy, dilated, 1JJ",615235,AD,-,LAMA4
COL10A1,"Collagen X, alpha-1 polypeptide",120110,"Metaphyseal chondrodysplasia, Schmid type",156500,AD,-,COL10A1
"DSE, SART2, EDSMC2",Dermatan sulfate epimerase,605942,"Ehlers-Danlos syndrome, musculocontractural type 2",615539,AR,-,DSE
"TSPYL1, TSPYL, SIDDT",Y-encoded testis-specific protein-like,604714,Sudden infant death with dysgenesis of the testes syndrome,608800,AR,-,TSPYL1
"RSPH4A, CILD11","Radial spoke head 4, Chlamydomonas, homolog of, A",612647,"Ciliary dyskinesia, primary, 11",612649,-,-,RSPH4A
"RFX6, RFXDC1, MTCHRS","Regulatory factor X, 6",612659,Mitchell-Riley syndrome,615710,AR,-,RFX6
"NUS1, NGBR, C6orf68, CDG1AA, MRD55","Nuclear undecaprenyl pyrophosphate synthase 1, S. cerevisiae, homolog of",610463,"?Congenital disorder of glycosylation, type 1aa",617082,AR,mutation identified in 1 CDG1AA family,NUS1
"NUS1, NGBR, C6orf68, CDG1AA, MRD55","Nuclear undecaprenyl pyrophosphate synthase 1, S. cerevisiae, homolog of",610463,"Mental retardation, autosomal dominant 55, with seizures",617831,AD,-,NUS1
"PLN, PLB, CMD1P, CMH18",Phospholamban,172405,"Cardiomyopathy, dilated, 1P",609909,-,-,PLN
"PLN, PLB, CMD1P, CMH18",Phospholamban,172405,"Cardiomyopathy, hypertrophic, 18",613874,AD,-,PLN
"MCM9, MCMDC1, ODG4",Minichromosome maintenance complex component 9,610098,Ovarian dysgenesis 4,616185,AR,-,MCM9
"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3","Gap junction protein, alpha-1, 43kD (connexin 43)",121014,Atrioventricular septal defect 3,600309,AD,pseudogene on chr.5,GJA1
"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3","Gap junction protein, alpha-1, 43kD (connexin 43)",121014,"Craniometaphyseal dysplasia, autosomal recessive",218400,AR,-,GJA1
"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3","Gap junction protein, alpha-1, 43kD (connexin 43)",121014,Erythrokeratodermia variabilis et progressiva 3,617525,AD,-,GJA1
"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3","Gap junction protein, alpha-1, 43kD (connexin 43)",121014,Hypoplastic left heart syndrome 1,241550,AR,-,GJA1
"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3","Gap junction protein, alpha-1, 43kD (connexin 43)",121014,Oculodentodigital dysplasia,164200,AD,-,GJA1
"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3","Gap junction protein, alpha-1, 43kD (connexin 43)",121014,"Oculodentodigital dysplasia, autosomal recessive",257850,AR,-,GJA1
"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3","Gap junction protein, alpha-1, 43kD (connexin 43)",121014,Palmoplantar keratoderma with congenital alopecia,104100,AD,-,GJA1
"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3","Gap junction protein, alpha-1, 43kD (connexin 43)",121014,"Syndactyly, type III",186100,AD,-,GJA1
"TRDN, TDN, CPVT5",Triadin,603283,"Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness",615441,AR,-,TRDN
"LAMA2, LAMM","Laminin, alpha-2 (merosin)",156225,"Muscular dystrophy, congenital merosin-deficient",607855,AR,-,LAMA2
"LAMA2, LAMM","Laminin, alpha-2 (merosin)",156225,"Muscular dystrophy, congenital, due to partial LAMA2 deficiency",607855,AR,-,LAMA2
RA,"Rheumatoid arthritis, susceptibility to",180300,"{Rheumatoid arthritis, susceptibility to}",180300,-,associated with SNP rs10499194 and rs6920220,RA
ARG1,"Arginase, liver",608313,Argininemia,207800,AR,-,ARG1
"MED23, MRT18",Mediator complex subunit 23,605042,"Mental retardation, autosomal recessive 18",614249,AR,-,MED23
"ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED","Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Ly-41 antigen, mouse, homolog of)",173335,"Arterial calcification, generalized, of infancy, 1",208000,AR,-,ENPP1
"ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED","Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Ly-41 antigen, mouse, homolog of)",173335,Cole disease,615522,AD,-,ENPP1
"ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED","Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Ly-41 antigen, mouse, homolog of)",173335,"Hypophosphatemic rickets, autosomal recessive, 2",613312,-,-,ENPP1
"ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED","Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Ly-41 antigen, mouse, homolog of)",173335,"{Diabetes mellitus, non-insulin-dependent, susceptibility to}",125853,AD,-,ENPP1
"ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED","Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Ly-41 antigen, mouse, homolog of)",173335,"{Obesity, susceptibility to}",601665,"AD,Mu,AR",-,ENPP1
"EYA4, DFNA10, CMD1J","Eyes absent, Drosophila, homolog of, 4",603550,"Cardiomyopathy, dilated, 1J",605362,-,-,EYA4
"EYA4, DFNA10, CMD1J","Eyes absent, Drosophila, homolog of, 4",603550,"Deafness, autosomal dominant 10",601316,AD,-,EYA4
AHI1,Abelson helper integration site 1,608894,Joubert syndrome 3,608629,AR,-,AHI1
"PEX7, RCDP1, PBD9B",Peroxisomal biogenesis factor-7,601757,Peroxisome biogenesis disorder 9B,614879,-,-,PEX7
"PEX7, RCDP1, PBD9B",Peroxisomal biogenesis factor-7,601757,"Rhizomelic chondrodysplasia punctata, type 1",215100,AR,-,PEX7
"IFNGR1, IMD27A, IMD27B","Immune interferon, receptor for",107470,"Immunodeficiency 27A, mycobacteriosis, AR",209950,AR,-,IFNGR1
"IFNGR1, IMD27A, IMD27B","Immune interferon, receptor for",107470,"Immunodeficiency 27B, mycobacteriosis, AD",615978,AD,-,IFNGR1
"IFNGR1, IMD27A, IMD27B","Immune interferon, receptor for",107470,"{H. pylori infection, susceptibility to}",600263,-,-,IFNGR1
"IFNGR1, IMD27A, IMD27B","Immune interferon, receptor for",107470,"{Hepatitis B virus infection, susceptibility to}",610424,-,-,IFNGR1
"IFNGR1, IMD27A, IMD27B","Immune interferon, receptor for",107470,"{Tuberculosis infection, protection against}",607948,-,-,IFNGR1
"IFNGR1, IMD27A, IMD27B","Immune interferon, receptor for",107470,"{Tuberculosis, susceptibility to}",607948,-,-,IFNGR1
"TNFAIP3, A20, OTUD7C, AISBL",Tumor necrosis factor-alpha-induced protein 3,191163,"Autoinflammatory syndrome, familial, Behcet-like",616744,AD,-,TNFAIP3
"DEL6q24q25, C6DELq25q25",Chromosome 6q24-q25 deletion syndrome,612863,Chromosome 6q25-q25 deletion syndrome,612863,-,-,DEL6q24q25
"CITED2, MRG1, P35SRJ, VSD2, ASD8","CBP/p300-interacting transactivator, with glu/asp-rich C-terminal domain, 2",602937,Atrial septal defect 8,614433,AD,?pseudogene on 1q22,CITED2
"CITED2, MRG1, P35SRJ, VSD2, ASD8","CBP/p300-interacting transactivator, with glu/asp-rich C-terminal domain, 2",602937,Ventricular septal defect 2,614431,AD,-,CITED2
"ADGRG6, PR126, VIGR, LCCS9",Adhesion G protein-coupled receptor G6,612243,Lethal congenital contracture syndrome 9,616503,AR,-,ADGRG6
"HIVEP2, MRD43",Human immunodeficiency virus type I enhancer-binding protein-2,143054,"Mental retardation, autosomal dominant 43",616977,AD,-,HIVEP2
"PEX3, PBD10A, PBD10B",Peroxisomal biogenesis factor-3,603164,?Peroxisome biogenesis disorder 10B,617370,AR,mutation identified in 1 PBD10B patient,PEX3
"PEX3, PBD10A, PBD10B",Peroxisomal biogenesis factor-3,603164,Peroxisome biogenesis disorder 10A (Zellweger),614882,AR,-,PEX3
"PLAGL1, ZAC, LOT1",Pleomorphic adenoma gene-like 1 (ZAC tumor suppressor),603044,"{Diabetes mellitus, transient neonatal}",601410,-,relaxed imprinting in TNDM,PLAGL1
"STX11, FHL4, HPLH4, HLH4",Syntaxin-11,605014,"Hemophagocytic lymphohistiocytosis, familial, 4",603552,AR,-,STX11
"EPM2A, MELF, EPM2",Laforin,607566,"Epilepsy, progressive myoclonic 2A (Lafora)",254780,AR,-,EPM2A
"GRM1, MGLUR1, GRM1A, SCAR13, SCA44","Glutamate receptor, metabotropic, 1",604473,Spinocerebellar ataxia 44,617691,AD,-,GRM1
"GRM1, MGLUR1, GRM1A, SCAR13, SCA44","Glutamate receptor, metabotropic, 1",604473,"Spinocerebellar ataxia, autosomal recessive 13",614831,AR,-,GRM1
"TAB2, MAP3K7IP2, KIAA0733, CHTD2",Tak1 (MAP3K7) binding protein 2,605101,"Congenital heart defects, nonsyndromic, 2",614980,AD,-,TAB2
"SUMO4, IDDM5",Small ubiquitin-like modifier 4,608829,"{Diabetes mellitus, insulin-dependent, 5}",600320,-,-,SUMO4
"IYD, DEHAL1, TDH4",Iodotyrosine deiodinase,612025,Thyroid dyshormonogenesis 4,274800,AR,-,IYD
"RMND1, COXPD11","Required for meiotic nuclear division 1, S. cerevisiae, homolog of",614917,Combined oxidative phosphorylation deficiency 11,614922,AR,-,RMND1
"ESR1, ESR, ESTRR",Estrogen receptor 1,133430,Estrogen resistance,615363,AR,-,ESR1
"ESR1, ESR, ESTRR",Estrogen receptor 1,133430,"{Atherosclerosis, susceptibility to}",-,-,-,ESR1
"ESR1, ESR, ESTRR",Estrogen receptor 1,133430,{Breast cancer},114480,AD,-,ESR1
"ESR1, ESR, ESTRR",Estrogen receptor 1,133430,"{HDL response to hormone replacement, augmented}",-,-,-,ESR1
"ESR1, ESR, ESTRR",Estrogen receptor 1,133430,"{Migraine, susceptibility to}",157300,AD,-,ESR1
"ESR1, ESR, ESTRR",Estrogen receptor 1,133430,"{Myocardial infarction, susceptibility to}",608446,-,-,ESR1
"SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4",Spectrin repeat-containing nuclear envelope protein 1 (nesprin 1),608441,"Emery-Dreifuss muscular dystrophy 4, autosomal dominant",612998,AD,-,SYNE1
"SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4",Spectrin repeat-containing nuclear envelope protein 1 (nesprin 1),608441,"Spinocerebellar ataxia, autosomal recessive 8",610743,AR,-,SYNE1
"ARID1B, BAF250B, KIAA1235, MRD12, CSS1",AT-rich interaction domain-containing protein 1B,614556,Coffin-Siris syndrome 1,135900,AD,-,ARID1B
"SERAC1, MEGDEL",Serine active site-containing protein 1,614725,"3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome",614739,AR,-,SERAC1
"GTF2H5, TTD3, TFB5, C6orf175, TTDA","General transcription factor IIH, polypeptide 5",608780,"Trichothiodystrophy 3, photosensitive",616395,-,-,GTF2H5
"RSPH3, RSHL2, RSP3, CILD32","Radial spoke head 3, Chlamydomonas, homolog of",615876,"Ciliary dyskinesia, primary, 32",616481,AR,-,RSPH3
"SOD2, MNSOD, MVCD6","Superoxide dismutase-2, mitochondrial",147460,{Microvascular complications of diabetes 6},612634,-,-,SOD2
"IGF2R, MPRI","Insulin-like growth factor-2 receptor (mannose-6-phosphate receptor, cation-independent)",147280,"Hepatocellular carcinoma, somatic",114550,-,behaves as a tumor suppressor,IGF2R
PLG,Plasminogen,173350,Dysplasminogenemia,217090,AR,20cM from TCP10A,PLG
PLG,Plasminogen,173350,"Plasminogen deficiency, type I",217090,AR,-,PLG
"PRKN, PARK2, PDJ, LPRS2",Parkin,602544,"Adenocarcinoma of lung, somatic",211980,-,shares 5' regulatory region and both 3' UTRs with PACRG,PRKN
"PRKN, PARK2, PDJ, LPRS2",Parkin,602544,"Adenocarcinoma, ovarian, somatic",167000,-,-,PRKN
"PRKN, PARK2, PDJ, LPRS2",Parkin,602544,"Parkinson disease, juvenile, type 2",600116,AR,-,PRKN
"PRKN, PARK2, PDJ, LPRS2",Parkin,602544,"{Leprosy, susceptibility to}",607572,-,-,PRKN
CHDM,Chordoma,215400,"{Chordoma, susceptibility to}",215400,AD,associated with duplication of the T gene,CHDM
"PDE10A, IOLOD, ADSD2",Phosphodiesterase 10A,610652,"Dyskinesia, limb and orofacial, infantile-onset",616921,AR,-,PDE10A
"PDE10A, IOLOD, ADSD2",Phosphodiesterase 10A,610652,"Striatal degeneration, autosomal dominant",616922,AD,-,PDE10A
"T, TFT, SAVA","Brachyury, mouse, homolog of",601397,Sacral agenesis with vertebral anomalies,615709,AR,-,T
"T, TFT, SAVA","Brachyury, mouse, homolog of",601397,"{Neural tube defects, susceptibility to}",182940,AD,-,T
"BRP44L, MPC1, MPYCD",Brain protein 44-like,614738,Mitochondrial pyruvate carrier deficiency,614741,AR,-,BRP44L
"RNASET2, RNASE6PL",Ribonuclease T2,612944,"Leukoencephalopathy, cystic, without megalencephaly",612951,AR,-,RNASET2
"SMOC2, SMAP2, DTDP1",Secreted modular calcium-binding protein 2,607223,"Dentin dysplasia, type I, with microdontia and misshapen teeth",125400,AR,-,SMOC2
THBS2,Thrombospondin 2,188061,"{Lumbar disc herniation, susceptibility to}",603932,-,-,THBS2
"ERMARD, C6orf70, PVNH6",Endoplasmic reticulum membrane-associated RNA degradation protein,615532,?Periventricular nodular heterotopia 6,615544,AD,-,ERMARD
"TBP, SCA17, HDL4",TATA box binding protein,600075,Spinocerebellar ataxia 17,607136,AD,-,TBP
"TBP, SCA17, HDL4",TATA box binding protein,600075,"{Parkinson disease, susceptibility to}",168600,"IC,Mu",-,TBP
CPVT3,"Ventricular tachycardia, catecholaminergic polymorphic, 3",614021,"Ventricular tachycardia, catecholaminergic polymorphic, 3",614021,AR,between D7S526 and D7S481,CPVT3
"FAM20C, DMP4","Family with sequence similarity 20, member C",611061,Raine syndrome,259775,AR,-,FAM20C
"DNAAF5, HEATR2, CILD18",Dynein axonemal assembly factor 5,614864,"Ciliary dyskinesia, primary, 18",614874,AR,-,DNAAF5
"MAD1L1, TXBP181","Mitotic arrest-deficient 1, yeast, homolog-like 1",602686,"Lymphoma, somatic",-,-,-,MAD1L1
"MAD1L1, TXBP181","Mitotic arrest-deficient 1, yeast, homolog-like 1",602686,"Prostate cancer, somatic",176807,-,-,MAD1L1
"LFNG, SCDO3",Lunatic fringe,602576,"?Spondylocostal dysostosis 3, autosomal recessive",609813,-,mutation identified in 1 SDO3 family,LFNG
"BRAT1, BAAT1, C7orf27, RMFSL",BRCA1-associated ATM activator 1,614506,"Rigidity and multifocal seizure syndrome, lethal neonatal",614498,AR,-,BRAT1
"IQCE, KIAA1023, PAPA7",IQ domain-containing protein E,617631,"?Polydactyly, postaxial, type A7",617642,AR,mutation identified in 1 PAPA7 family,IQCE
"CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A",Caspase recruitment domain-containing protein 11,607210,B-cell expansion with NFKB and T-cell anergy,616452,AD,-,CARD11
"CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A",Caspase recruitment domain-containing protein 11,607210,Immunodeficiency 11A,615206,AR,-,CARD11
"CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A",Caspase recruitment domain-containing protein 11,607210,Immunodeficiency 11B with atopic dermatitis,617638,AD,-,CARD11
"AP5Z1, KIAA0415, SPG48","Adaptor-related protein complex 5, zeta-1 subunit",613653,"Spastic paraplegia 48, autosomal recessive",613647,AR,-,AP5Z1
"ACTB, BRWS1","Actin, beta",102630,"?Dystonia, juvenile-onset",607371,AD,~20 pseudogenes also; mutation identified in twin DJO patients,ACTB
"ACTB, BRWS1","Actin, beta",102630,Baraitser-Winter syndrome 1,243310,AD,-,ACTB
"RNF216, TRIAD3, ZIN, CAHH",RING finger protein 216,609948,Cerebellar ataxia and hypogonadotropic hypogonadism,212840,AR,-,RNF216
"PMS2, PMSL2, HNPCC4","Postmeiotic segregation increased, S. cerevisiae, 2, homolog of",600259,"Colorectal cancer, hereditary nonpolyposis, type 4",614337,-,-,PMS2
"PMS2, PMSL2, HNPCC4","Postmeiotic segregation increased, S. cerevisiae, 2, homolog of",600259,Mismatch repair cancer syndrome,276300,AR,-,PMS2
"RAC1, MRD48",Ras-related C3 botulinum toxin substrate 1,602048,"Mental retardation, autosomal dominant 48",617751,AD,-,RAC1
"GLCCI1, TSSN1, GCTR",Glucocorticoid-induced transcript 1,614283,"{Glucocorticoid therapy, response to}",614400,-,-,GLCCI1
"ISPD, MDDGA7, MDDGC7",Isoprenoid synthase domain-containing protein,614631,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7",614643,AR,-,ISPD
"ISPD, MDDGA7, MDDGC7",Isoprenoid synthase domain-containing protein,614631,"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7",616052,AR,-,ISPD
"TWIST1, ACS3, SCS, CRS1, SWCOS","TWIST, Drosophila, homolog of, 1",601622,Craniosynostosis 1,123100,AD,-,TWIST1
"TWIST1, ACS3, SCS, CRS1, SWCOS","TWIST, Drosophila, homolog of, 1",601622,Robinow-Sorauf syndrome,180750,AD,-,TWIST1
"TWIST1, ACS3, SCS, CRS1, SWCOS","TWIST, Drosophila, homolog of, 1",601622,Saethre-Chotzen syndrome with or without eyelid anomalies,101400,AD,-,TWIST1
"TWIST1, ACS3, SCS, CRS1, SWCOS","TWIST, Drosophila, homolog of, 1",601622,Sweeney-Cox syndrome,617746,AD,-,TWIST1
"DNAH11, DNAHC11, CILD7, DNAHBL","Dynein, axonemal, heavy chain-11",603339,"Ciliary dyskinesia, primary, 7, with or without situs inversus",611884,AR,-,DNAH11
"IL6, IFNB2, BSF2, HSF, HGF","Interleukin-6 (interferon, beta-2)",147620,{Crohn disease-associated growth failure},266600,Mu,-,IL6
"IL6, IFNB2, BSF2, HSF, HGF","Interleukin-6 (interferon, beta-2)",147620,"{Diabetes, susceptibility to},",222100,AR,-,IL6
"IL6, IFNB2, BSF2, HSF, HGF","Interleukin-6 (interferon, beta-2)",147620,"{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}",108010,AD,-,IL6
"IL6, IFNB2, BSF2, HSF, HGF","Interleukin-6 (interferon, beta-2)",147620,"{Kaposi sarcoma, susceptibility to}",148000,AD,-,IL6
"IL6, IFNB2, BSF2, HSF, HGF","Interleukin-6 (interferon, beta-2)",147620,"{Rheumatoid arthritis, systemic juvenile}",604302,-,-,IL6
"FAM126A, DRCTNNB1A, HLD5",Hyccin,610531,"Leukodystrophy, hypomyelinating, 5",610532,AR,-,FAM126A
"KLHL7, RP42, CISS3",Kelch-like 7,611119,Cold-induced sweating syndrome 3,617055,AR,-,KLHL7
"KLHL7, RP42, CISS3",Kelch-like 7,611119,Retinitis pigmentosa 42,612943,AD,-,KLHL7
"GSDME, DFNA5",Gasdermin E,608798,"Deafness, autosomal dominant 5",600994,AD,-,GSDME
"CYCS, CYC, THC4","Cytochrome C, somatic",123970,Thrombocytopenia 4,612004,AD,-,CYCS
"HNRPA2B1, IBMPFD2",Heterogeneous nuclear ribonucleoprotein A2/B1,600124,?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2,615422,-,mutation identified in 1 family,HNRPA2B1
"SNX10, OPTB8",Sorting nexin 10,614780,"Osteopetrosis, autosomal recessive 8",615085,AR,-,SNX10
"HOXA1, HOX1F, BSAS",Homeo box-A1,142955,Athabaskan brainstem dysgenesis syndrome,601536,-,-,HOXA1
"HOXA1, HOX1F, BSAS",Homeo box-A1,142955,Bosley-Salih-Alorainy syndrome,601536,-,-,HOXA1
"HOXA2, MCOHI",Homeobox A2,604685,?Microtia with or without hearing impairment (AD),612290,"AD,AR",-,HOXA2
"HOXA2, MCOHI",Homeobox A2,604685,"?Microtia, hearing impairment, and cleft palate (AR)",612290,"AD,AR",-,HOXA2
"HOXA11, HOX1I, RUSAT1",Homeo box-A11,142958,Radioulnar synostosis with amegakaryocytic thrombocytopenia 1,605432,AD,-,HOXA11
"HOXA13, HOX1J",Homeo box-A13,142959,Guttmacher syndrome,176305,AD,-,HOXA13
"HOXA13, HOX1J",Homeo box-A13,142959,Hand-foot-uterus syndrome,140000,AD,-,HOXA13
"FKBP14, EDSKSCL2",FK506-binding protein 14,614505,"Ehlers-Danlos syndrome, kyphoscoliotic type, 2",614557,AR,-,FKBP14
"GARS, SMAD1, CMT2D, HMN5",Glycyl-tRNA synthetase,600287,"Charcot-Marie-Tooth disease, type 2D",601472,AD,-,GARS
"GARS, SMAD1, CMT2D, HMN5",Glycyl-tRNA synthetase,600287,"Neuropathy, distal hereditary motor, type VA",600794,AD,-,GARS
"AQP1, CHIP28, CO","Aquaporin-1 (channel-forming integral protein, 28kD)",107776,[Aquaporin-1 deficiency],110450,-,-,AQP1
"AQP1, CHIP28, CO","Aquaporin-1 (channel-forming integral protein, 28kD)",107776,"[Blood group, Colton]",110450,-,-,AQP1
"GHRHR, GHRFR, IGHD1B",Growth hormone releasing hormone receptor,139191,"Growth hormone deficiency, isolated, type IB",612781,-,-,GHRHR
GSBS,G-substrate,604088,"{Hypercholesterolemia, susceptibility to}",143890,AD,-,GSBS
"NT5C3A, NT5C3, UMPH1, PSN1","5' nucleotidase, cytosolic IIIA (uridine 5' monophosphate hydrolase 1)",606224,"Anemia, hemolytic, due to UMPH1 deficiency",266120,AR,pseudogenes on chr.4 and chr.7,NT5C3A
"RP9, PAP1","RP9 gene (pim1-associated protein, mouse, homolog of)",607331,?Retinitis pigmentosa 9,180104,AD,mutation identified in 1 patient,RP9
"PTHB1, BBS9",Parathyroid hormone-responsive B1 gene,607968,Bardet-Biedl syndrome 9,615986,AR,-,PTHB1
"BMPER, CV2",BMP binding endothelial regulator,608699,Diaphanospondylodysostosis,608022,AR,-,BMPER
"NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2",Neuropeptide S receptor 1,608595,"{Asthma, susceptibility to, 2}",608584,-,-,NPSR1
"TBX20, ASD4",T-box 20,606061,Atrial septal defect 4,611363,-,-,TBX20
"ANLN, FSFS8",Actin-binding protein anillin,616027,Focal segmental glomerulosclerosis 8,616032,AD,-,ANLN
"NME8, TXNDC3, SPTRX2, CILD6",NME/NM23 family member 8,607421,"Ciliary dyskinesia, primary, 6",610852,AR,-,NME8
"SFRP4, FRPHE, PYL",Secreted frizzled-related protein 4,606570,Pyle disease,265900,AR,-,SFRP4
"POU6F2, WTSL, WT5","POU domain, class 6, transcription factor 2",609062,{Wilms tumor susceptibility-5},601583,"AD,SMu",-,POU6F2
"CDK13, CDC2L5, CHED, CHDFIDD",Cyclin-dependent kinase 13,603309,"Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder",617360,AD,-,CDK13
"MPLKIP, C7orf11, ABHS, TTDN1, TTD4",M-phase specific PLK1 interacting protein,609188,"Trichothiodystrophy 4, nonphotosensitive",234050,AR,-,MPLKIP
"C7orf10, GA3",Chromosome 7 open reading frame 10,609187,Glutaric aciduria III,231690,AR,-,C7orf10
"GLI3, PAPA, PAPB",GLI-Kruppel family member GLI3 (oncogene GLI3),165240,Greig cephalopolysyndactyly syndrome,175700,AD,amplified in glioblastoma,GLI3
"GLI3, PAPA, PAPB",GLI-Kruppel family member GLI3 (oncogene GLI3),165240,Pallister-Hall syndrome,146510,AD,-,GLI3
"GLI3, PAPA, PAPB",GLI-Kruppel family member GLI3 (oncogene GLI3),165240,"Polydactyly, postaxial, types A1 and B",174200,AD,-,GLI3
"GLI3, PAPA, PAPB",GLI-Kruppel family member GLI3 (oncogene GLI3),165240,"Polydactyly, preaxial, type IV",174700,AD,-,GLI3
"GLI3, PAPA, PAPB",GLI-Kruppel family member GLI3 (oncogene GLI3),165240,"{Hypothalamic hamartomas, somatic}",241800,-,-,GLI3
BLVRA,Biliverdin reductase A,109750,Hyperbiliverdinemia,614156,"AD,AR",-,BLVRA
"PGAM2, PGAMM, GSD10","Phosphoglycerate mutase, muscle form",612931,Glycogen storage disease X,261670,AR,-,PGAM2
"GCK, HHF3",Glucokinase (hexokinase-4),138079,"Diabetes mellitus, noninsulin-dependent, late onset",125853,AD,proximal to TCRB,GCK
"GCK, HHF3",Glucokinase (hexokinase-4),138079,"Diabetes mellitus, permanent neonatal",606176,"AD,AR",-,GCK
"GCK, HHF3",Glucokinase (hexokinase-4),138079,"Hyperinsulinemic hypoglycemia, familial, 3",602485,AD,-,GCK
"GCK, HHF3",Glucokinase (hexokinase-4),138079,"MODY, type II",125851,AD,-,GCK
"CAMK2B, MRD54",Calcium/calmodulin-dependent protein kinase II-beta,607707,"Mental retardation, autosomal dominant 54",617799,AD,-,CAMK2B
"C7orf22, CCM2, MGC4067",Malcavernin,607929,Cerebral cavernous malformations-2,603284,AD,-,C7orf22
"ADCY1, DFNB44","Adenylate cyclase-1, brain",103072,"?Deafness, autosomal recessive 44",610154,AR,mutation identified in 1 DFNB44 family,ADCY1
"PKD1L1, HTX8",Polycystin 1L1,609721,"Heterotaxy, visceral, 8, autosomal",617205,AR,-,PKD1L1
"IKZF1, ZNFN1A1, IK1, LYF1, CVID13",Ikaros family zinc finger 1,603023,"Immunodeficiency, common variable, 13",616873,AD,fused with BCL6 in DLBL,IKZF1
DDC,DOPA decarboxylase (aromatic L-amino acid decarboxylase),107930,Aromatic L-amino acid decarboxylase deficiency,608643,AR,-,DDC
HPC4,"Prostate cancer, hereditary, 4",608658,"{Prostate cancer, susceptibility to, 4}",176807,AD,-,HPC4
"SRS, RSS",Silver-Russell syndrome,180860,Silver-Russell syndrome,180860,IC,maternal uniparental disomy of chromosome 7,SRS
"EGFR, NISBD2",Epidermal growth factor receptor,131550,"?Inflammatory skin and bowel disease, neonatal, 2",616069,AR,same as oncogene ERBB; mutation identified in 1 NISBD2 family,EGFR
"EGFR, NISBD2",Epidermal growth factor receptor,131550,"Adenocarcinoma of lung, response to tyrosine kinase inhibitor in",211980,AR,-,EGFR
"EGFR, NISBD2",Epidermal growth factor receptor,131550,"Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in",211980,AR,-,EGFR
"EGFR, NISBD2",Epidermal growth factor receptor,131550,"{Nonsmall cell lung cancer, susceptibility to}",211980,AR,-,EGFR
"PSPH, PSP, PSPHD",Phosphoserine phosphatase,172480,Phosphoserine phosphatase deficiency,614023,AR,-,PSPH
"CHCHD2, PARK22",Coiled-coil-helix-coiled-coil-helix domain-containing protein 2,616244,"Parkinson disease 22, autosomal dominant",616710,-,-,CHCHD2
"MLSM7, DEL7q, C7DELq",Monosomy 7 of bone marrow,252270,Myelodysplasia and leukemia syndrome with monosomy 7,252270,AR,-,MLSM7
"GUSB, MPS7","Glucuronidase, beta-",611499,Mucopolysaccharidosis VII,253220,AR,-,GUSB
ASL,Argininosuccinate lyase,608310,Argininosuccinic aciduria,207900,AR,-,ASL
"KCTD7, EPM3, CLN14",Potassium channel tetramerization domain containing 7,611725,"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions",611726,AR,-,KCTD7
"SBDS, SDS",SBDS gene,607444,Shwachman-Diamond syndrome,260400,AR,-,SBDS
"SBDS, SDS",SBDS gene,607444,"{Aplastic anemia, susceptibility to}",609135,-,-,SBDS
"KIAA0442, MRD26",KIAA0442 gene,607270,"Mental retardation, autosomal dominant 26",615834,AD,translocation break at 7q11.2,KIAA0442
"DEL7q11.23, C7DELq11.23","Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb",613729,"Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb",613729,-,contiguous gene deletion syndrome,DEL7q11.23
"DUP7q11.23, C7DUPq11.23",Chromosome 7q11.23 duplication syndrome,609757,Chromosome 7q11.23 duplication syndrome,609757,AD,-,DUP7q11.23
"WBS, WMS, WS, DEL7q11, C7DELq11",Williams-Beuren syndrome (chromosome 7q11.23 deletion syndrome),194050,Williams-Beuren syndrome,194050,AD,contiguous gene syndrome,WBS
"ELN, SVAS, ADCL1",Elastin,130160,"Cutis laxa, autosomal dominant",123700,AD,-,ELN
"ELN, SVAS, ADCL1",Elastin,130160,Supravalvar aortic stenosis,185500,AD,-,ELN
NCF1,"Neutrophil cytosolic factor-1, 47kD",608512,Chronic granulomatous disease due to deficiency of NCF-1,233700,AR,-,NCF1
HIP1,Huntingtin interacting protein-1,601767,"{Prostate cancer, progression of}",176807,AD,-,HIP1
POR,Cytochrome P450 oxidoreductase,124015,Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis,201750,AR,-,POR
POR,Cytochrome P450 oxidoreductase,124015,Disordered steroidogenesis due to cytochrome P450 oxidoreductase,613571,-,-,POR
"MDH2, EIEE51","Malate dehydrogenase, mitochondrial",154100,"Epileptic encephalopathy, early infantile, 51",617339,AR,-,MDH2
"HSPB1, HSP27, CMT2F, HMN2B",Heat-shock 27kD protein-1,602195,"Charcot-Marie-Tooth disease, axonal, type 2F",606595,AD,-,HSPB1
"HSPB1, HSP27, CMT2F, HMN2B",Heat-shock 27kD protein-1,602195,"Neuropathy, distal hereditary motor, type IIB",608634,AD,-,HSPB1
"YWHAG, EIEE56","Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma isoform",605356,"Epileptic encephalopathy, early infantile, 56",617665,AD,-,YWHAG
"ZP3, ZP3A, ZP3B, OOMD3",Zona pellucida glycoprotein-3 (sperm receptor),182889,Oocyte maturation defect 3,617712,AD,-,ZP3
"PTPN12, PTPG1","Protein tyrosine phosphatase, nonreceptor-type, 12",600079,"Colon cancer, somatic",114500,-,-,PTPN12
"MAGI2, AIP1, KIAA0705","Membrane-associated guanylate kinase, WW and PDZ domains-containing, 2",606382,Nephrotic syndrome 15,617609,AR,-,MAGI2
"CD36, CHDS7, BDPLT10",CD36 antigen (collagen type I),173510,Platelet glycoprotein IV deficiency,608404,AR,-,CD36
"CD36, CHDS7, BDPLT10",CD36 antigen (collagen type I),173510,[Macrothrombocytopenia],-,-,-,CD36
"CD36, CHDS7, BDPLT10",CD36 antigen (collagen type I),173510,"{Coronary heart disease, susceptibility to, 7}",610938,-,-,CD36
"CD36, CHDS7, BDPLT10",CD36 antigen (collagen type I),173510,"{Malaria, cerebral, reduced risk of}",611162,-,-,CD36
"CD36, CHDS7, BDPLT10",CD36 antigen (collagen type I),173510,"{Malaria, cerebral, susceptibility to}",611162,-,-,CD36
"HGF, DFNB39",Hepatic growth factor,142409,"Deafness, autosomal recessive 39",608265,AR,-,HGF
"PCLO, PCH3","Piccolo, mouse, homolog of",604918,"?Pontocerebellar hypoplasia, type 3",608027,AR,mutation identified in 1 PCHD3 family,PCLO
"SEMA3E, SEMAH, KIAA0331",Semaphorin 3E,608166,?CHARGE syndrome,214800,AD,mutation identified in 1 CHARGE patient,SEMA3E
"SEMA3A, SEMAD, COLL1, HH16",Semaphorin 3A,603961,{Hypogonadotropic hypogonadism 16 with or without anosmia},614897,AD,-,SEMA3A
"ABCB4, PGY3, MDR3, ICP3","ATP-binding cassette, subfamily B, member 4 (P-glycoprotein-3/multiple drug resistance-3)",171060,"Cholestasis, intrahepatic, of pregnancy, 3",614972,"AD,AR",within 500kb of MDR1,ABCB4
"ABCB4, PGY3, MDR3, ICP3","ATP-binding cassette, subfamily B, member 4 (P-glycoprotein-3/multiple drug resistance-3)",171060,"Cholestasis, progressive familial intrahepatic 3",602347,AR,-,ABCB4
"ABCB4, PGY3, MDR3, ICP3","ATP-binding cassette, subfamily B, member 4 (P-glycoprotein-3/multiple drug resistance-3)",171060,Gallbladder disease 1,600803,"AD,AR",-,ABCB4
"ABCB1, PGY1, MDR1, IBD13, CLCs","ATP-binding cassette, subfamily B, member 1 (P-glycoprotein-1/multiple drug resistance-1)",171050,{Colchicine resistance},120080,-,-,ABCB1
"ABCB1, PGY1, MDR1, IBD13, CLCs","ATP-binding cassette, subfamily B, member 1 (P-glycoprotein-1/multiple drug resistance-1)",171050,{Inflammatory bowel disease 13},612244,-,-,ABCB1
"SHFM1, SHFD1, SHSF1",Split hand/foot malformation (ectrodactyly) type 1,183600,Split hand/foot malformation 1,183600,AD,contiguous gene deletion syndrome,SHFM1
"AKAP9, YOTIAO, AKAP450",A-kinase anchor protein 9,604001,?Long QT syndrome-11,611820,AD,mutation identified in 1 LQT11 family,AKAP9
"CCM1, CAM, KRIT1",KREV interaction trapped 1,604214,Cavernous malformations of CNS and retina,116860,AD,-,CCM1
"CCM1, CAM, KRIT1",KREV interaction trapped 1,604214,Cerebral cavernous malformations-1,116860,AD,-,CCM1
"CCM1, CAM, KRIT1",KREV interaction trapped 1,604214,Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations,116860,AD,-,CCM1
"GATAD1, ODAG, CMD2B",GATA zinc finger domain-containing protein 1,614518,"?Cardiomyopathy, dilated, 2B",614672,AR,mutation identified in 1 GATAD1 family,GATAD1
"PEX1, ZWS1, PBD1A, PBD1B, HMLR1",Peroxisome biogenesis factor-1,602136,Heimler syndrome 1,234580,AR,-,PEX1
"PEX1, ZWS1, PBD1A, PBD1B, HMLR1",Peroxisome biogenesis factor-1,602136,Peroxisome biogenesis disorder 1A (Zellweger),214100,AR,-,PEX1
"PEX1, ZWS1, PBD1A, PBD1B, HMLR1",Peroxisome biogenesis factor-1,602136,Peroxisome biogenesis disorder 1B (NALD/IRD),601539,AR,-,PEX1
"CDK6, PLSTIRE, MCPH12",Cyclin-dependent kinase 6,603368,"?Microcephaly 12, primary, autosomal recessive",616080,AR,mutation identified in 1 MCPH12 family,CDK6
"SAMD9, NFTC, MIRAGE",Sterile alpha motif domain-containing protein 9,610456,MIRAGE syndrome,617053,AD,-,SAMD9
"SAMD9, NFTC, MIRAGE",Sterile alpha motif domain-containing protein 9,610456,"Tumoral calcinosis, familial, normophosphatemic",610455,AR,-,SAMD9
"SAMD9L, ATXPC",Sterile alpha motif domain-containing 9-like,611170,Ataxia-pancytopenia syndrome,159550,AD,-,SAMD9L
"CALCR, CRT",Calcitonin receptor,114131,"{Osteoporosis, postmenopausal, susceptibility}",166710,AD,not deleted in Williams syndrome,CALCR
"COL1A2, EDSCV, EDSARTH2","Collagen I, alpha-2 polypeptide",120160,"Ehlers-Danlos syndrome, arthrochalasia type, 2",617821,-,~17cM from CF,COL1A2
"COL1A2, EDSCV, EDSARTH2","Collagen I, alpha-2 polypeptide",120160,"Ehlers-Danlos syndrome, cardiac valvular type",225320,AR,-,COL1A2
"COL1A2, EDSCV, EDSARTH2","Collagen I, alpha-2 polypeptide",120160,"imperfecta, type III",259420,AD,-,COL1A2
"COL1A2, EDSCV, EDSARTH2","Collagen I, alpha-2 polypeptide",120160,"Osteogenesis imperfecta, type II",166210,AD,-,COL1A2
"COL1A2, EDSCV, EDSARTH2","Collagen I, alpha-2 polypeptide",120160,"Osteogenesis imperfecta, type IV",166220,AD,-,COL1A2
"COL1A2, EDSCV, EDSARTH2","Collagen I, alpha-2 polypeptide",120160,"{Osteoporosis, postmenopausal}",166710,AD,-,COL1A2
"SGCE, DYT11","Sarcoglycan, epsilon",604149,"Dystonia-11, myoclonic",159900,AD,pseudogene on 2q21; maternally imprinted,SGCE
"PON1, PON, ESA, MVCD5",Paraoxonase-1,168820,"{Coronary artery disease, susceptibility to}",-,-,-,PON1
"PON1, PON, ESA, MVCD5",Paraoxonase-1,168820,"{Coronary artery spasm 2, susceptibility to",-,-,-,PON1
"PON1, PON, ESA, MVCD5",Paraoxonase-1,168820,{Microvascular complications of diabetes 5},612633,-,-,PON1
"PON1, PON, ESA, MVCD5",Paraoxonase-1,168820,"{Organophosphate poisoning, sensitivity to}",-,-,-,PON1
"SLC25A13, CTLN2","Solute carrier family 25 (mitochondrial carrier, citrin), member 13",603859,"Citrullinemia, adult-onset type II",603471,AR,-,SLC25A13
"SLC25A13, CTLN2","Solute carrier family 25 (mitochondrial carrier, citrin), member 13",603859,"Citrullinemia, type II, neonatal-onset",605814,AR,-,SLC25A13
"DLX5, SHFM1D",Distal-less homeo box-5,600028,?Split-hand/foot malformation 1 with sensorineural hearing loss,220600,AR,mutation identified in 1 family,DLX5
"ASNS, ASNSD",Asparagine synthetase,108370,Asparagine synthetase deficiency,615574,AR,temperature sensitive G1 mutant,ASNS
"ARPC1B, ARC41, PLTEID","Actin-related protein 2/3 complex, subunit 1B",604223,Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease,617718,AR,-,ARPC1B
"CYP3A5, P450PCN3","Cytochrome P450, subfamily IIIA, polypeptide 5",605325,"{Hypertension, salt-sensitive essential, susceptibility to}",145500,Mu,-,CYP3A5
"AP4M1, SPG50, CPSQ3","Adaptor-related protein complex 4, mu-1 subunit",602296,"Spastic paraplegia 50, autosomal recessive",612936,AR,-,AP4M1
"TAF6, TAF2E, TAFII80, ALYUS","TAF6 RNA polymerase II, TATA box-binding protein-associated factor, 80kD",602955,Alazami-Yuan syndrome,617126,AR,-,TAF6
"STAG3, POF8",Stromalin 3,608489,Premature ovarian failure 8,615723,AR,-,STAG3
"TFR2, HFE3",Transferrin receptor 2,604720,"Hemochromatosis, type 3",604250,AR,-,TFR2
"EPO, MVCD2, ECYT5",Erythropoietin,133170,"Erythrocytosis, familial, 5",617907,-,-,EPO
"EPO, MVCD2, ECYT5",Erythropoietin,133170,{Microvascular complications of diabetes 2},612623,-,-,EPO
"EPHB4, HTK, MYK1, HFASD",Ephrin receptor EphB4 (hepatoma transmembrane kinase),600011,"{Hydrops fetalis, nonimmune, and/or atrial septal defect}",617300,AD,-,EPHB4
"ACHE, YT",Acetylcholinesterase (YT blood group),100740,"[Blood group, Yt system]",112100,-,blood group YT (112100) = epitope of ACHE,ACHE
"PAI1, PLANH1, SERPINE1","Plasminogen activator inhibitor, type I",173360,Plasminogen activator inhibitor-1 deficiency,613329,"AD,AR",-,PAI1
"PAI1, PLANH1, SERPINE1","Plasminogen activator inhibitor, type I",173360,"{Transcription of plasminogen activator inhibitor, modulator of}",-,-,-,PAI1
"AP1S1, CLAPS1, AP19, MEDNIK","Adaptor-related protein complex 1, sigma 1 subunit",603531,MEDNIK syndrome,609313,AR,-,AP1S1
"PLOD3, LH3","Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (lysyl hydroxylase 3)",603066,Lysyl hydroxylase 3 deficiency,612394,AR,previously assigned to 7q36,PLOD3
"SLC26A5, PRES, DFNB61","Solute carrier family 26, member 5",604943,"?Deafness, autosomal recessive 61",613865,AR,mutation identified in 1 DFNB61 family,SLC26A5
"RELN, RL, LIS2, ETL7",Reelin,600514,Lissencephaly 2 (Norman-Roberts type),257320,AR,-,RELN
"RELN, RL, LIS2, ETL7",Reelin,600514,"{Epilepsy, familial temporal lobe, 7}",616436,AD,-,RELN
"COG5, GOLTC1, GTC90, CDG2I",Component of oligomeric golgi complex 5,606821,"Congenital disorder of glycosylation, type IIi",613612,-,-,COG5
"SLC26A4, PDS, DFNB4, EVA, TDH2B","Solute carrier family 26 (sulfate transporter), member 4",605646,"Deafness, autosomal recessive 4, with enlarged vestibular aqueduct",600791,AR,some patients have digenic mutations with FOXI1,SLC26A4
"SLC26A4, PDS, DFNB4, EVA, TDH2B","Solute carrier family 26 (sulfate transporter), member 4",605646,Pendred syndrome,274600,AR,-,SLC26A4
"SLC26A3, DRA, CLD","Solute carrier family 26 (sulfate transporter), member 3",126650,"Diarrhea 1, secretory chloride, congenital",214700,AR,5' and close to PDS,SLC26A3
"DLD, LAD, PHE3, DLDD","Dihydrolipoamide dehydrogenase (E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex)",238331,Dihydrolipoamide dehydrogenase deficiency,246900,AR,-,DLD
"LAMB1, LIS5","Laminin, beta-1",150240,Lissencephaly 5,615191,AR,-,LAMB1
"PNPLA8, MMLA",Patatin-like phospholipase domain-containing protein 8,612123,?Mitochondrial myopathy with lactic acidosis,251950,AR,mutation identified in 1 MMLA family,PNPLA8
"PPP1R3A, PPP1R3","Protein phosphatase 1, regulatory subunit 3A",600917,"Insulin resistance, severe, digenic",125853,AD,-,PPP1R3A
"FOXP2, SPCH1, TNRC10, CAGH44",Forkhead box P2,605317,Speech-language disorder-1,602081,AD,-,FOXP2
"CAV1, BSCL3, CGL3, PPH3, LCCNS",Caveolin-1,601047,"?Lipodystrophy, congenital generalized, type 3",612526,-,mutation identified in 1 CGL3 family; mutation identified in 1 LCCNS family,CAV1
"CAV1, BSCL3, CGL3, PPH3, LCCNS",Caveolin-1,601047,"?Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome",606721,AD,-,CAV1
"CAV1, BSCL3, CGL3, PPH3, LCCNS",Caveolin-1,601047,"Pulmonary hypertension, primary, 3",615343,AD,-,CAV1
"MET, DFNB97, OSFD",Oncogene MET,164860,"?Deafness, autosomal recessive 97",616705,AR,mutation identified in 1 DFNB97 family,MET
"MET, DFNB97, OSFD",Oncogene MET,164860,"Hepatocellular carcinoma, childhood type, somatic",114550,-,-,MET
"MET, DFNB97, OSFD",Oncogene MET,164860,"Renal cell carcinoma, papillary, 1, familial and somatic",605074,-,-,MET
"MET, DFNB97, OSFD",Oncogene MET,164860,"{Osteofibrous dysplasia, susceptibility to}",607278,AD,-,MET
"CFTR, ABCC7, CF, MRP7","Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7)",602421,Congenital bilateral absence of vas deferens,277180,AR,distal and 5' to MET,CFTR
"CFTR, ABCC7, CF, MRP7","Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7)",602421,Cystic fibrosis,219700,AR,-,CFTR
"CFTR, ABCC7, CF, MRP7","Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7)",602421,Sweat chloride elevation without CF,-,-,-,CFTR
"CFTR, ABCC7, CF, MRP7","Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7)",602421,"{Bronchiectasis with or without elevated sweat chloride 1, modifier of}",211400,AD,-,CFTR
"CFTR, ABCC7, CF, MRP7","Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7)",602421,"{Hypertrypsinemia, neonatal}",-,-,-,CFTR
"CFTR, ABCC7, CF, MRP7","Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7)",602421,"{Pancreatitis, idiopathic}",167800,AD,-,CFTR
"TSPAN12, NET2, EVR5",Tetraspanin 12,613138,Exudative vitreoretinopathy 5,613310,AD,-,TSPAN12
"PTPRZ1, PTP18","Protein-tyrosine phosphatase, receptor-type, zeta-1, polypeptide",176891,"{H. pylori infection, susceptibility to}",600263,-,-,PTPRZ1
AASS,Alpha-aminoadipic semialdehyde synthase,605113,Hyperlysinemia,238700,AR,-,AASS
AASS,Alpha-aminoadipic semialdehyde synthase,605113,Saccharopinuria,268700,AR,-,AASS
"FEZF1, FEZ, ZNF312B, HH22",FEZ family zinc finger protein 1,613301,"Hypogonadotropic hypogonadism 22, with or without anosmia",616030,AR,-,FEZF1
"TAS2R16, T2R16","Taste receptor type 2, member 16",604867,[Beta-glycopyranoside tasting],-,-,-,TAS2R16
"TAS2R16, T2R16","Taste receptor type 2, member 16",604867,"{Alcohol dependence, susceptibility to}",103780,Mu,-,TAS2R16
"POT1, CMM10, GLM9",Protection of telomeres 1,606478,{Glioma susceptibility 9},616568,AD,-,POT1
"POT1, CMM10, GLM9",Protection of telomeres 1,606478,"{Melanoma, cutaneous malignant, susceptibility to, 10}",615848,AD,-,POT1
"PAX4, MODY9, KPD",Paired box homeotic gene-4,167413,"Diabetes mellitus, type 2",125853,AD,-,PAX4
"PAX4, MODY9, KPD",Paired box homeotic gene-4,167413,"Maturity-onset diabetes of the young, type IX",612225,-,-,PAX4
"PAX4, MODY9, KPD",Paired box homeotic gene-4,167413,"{Diabetes mellitus, ketosis-prone, susceptibility to}",612227,"AD,AR",-,PAX4
"LEP, OB, LEPD",Leptin (murine obesity homolog),164160,"Obesity, morbid, due to leptin deficiency",614962,AR,in mouse cen-Cola-2-Met-ob-Cpa-Tcrb-tel,LEP
"RBM28, ANES",RNA-binding motif protein 28,612074,"?Alopecia, neurologic defects, and endocrinopathy syndrome",612079,AR,mutation identified in 1 ANES family,RBM28
"IMPDH1, RP10, LCA11","Inosine-5'-monophosphate dehydrogenase, type I",146690,Leber congenital amaurosis 11,613837,-,pseudogene on 16p13.13,IMPDH1
"IMPDH1, RP10, LCA11","Inosine-5'-monophosphate dehydrogenase, type I",146690,Retinitis pigmentosa 10,180105,AD,-,IMPDH1
"OPN1SW, BCP, CBT","Blue cone pigment (opsin 1, short-wave-sensitive)",613522,"Colorblindness, tritan",190900,AD,-,OPN1SW
"FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5",Filamin C (actin-binding protein-280),102565,"Cardiomyopathy, familial hypertrophic, 26",-,-,-,FLNC
"FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5",Filamin C (actin-binding protein-280),102565,"Cardiomyopathy, familial restrictive 5",617047,AD,-,FLNC
"FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5",Filamin C (actin-binding protein-280),102565,"Myopathy, distal, 4",614065,AD,-,FLNC
"FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5",Filamin C (actin-binding protein-280),102565,"Myopathy, myofibrillar, 5",609524,AD,-,FLNC
"IRF5, IBD14, SLEB10",Interferon regulatory factor 5,607218,{Inflammatory bowel disease 14},612245,-,-,IRF5
"IRF5, IBD14, SLEB10",Interferon regulatory factor 5,607218,"{Systemic lupus erythematosus, susceptibility to, 10}",612251,-,-,IRF5
"TNPO3, TRNSR, LGMD1F",Transportin 3,610032,"Muscular dystrophy, limb-girdle, type 1F",608423,AD,-,TNPO3
"SMOH, SMO, CRJS","Smoothened, Drosophila, homolog of",601500,"Basal cell carcinoma, somatic",605462,-,-,SMOH
"SMOH, SMO, CRJS","Smoothened, Drosophila, homolog of",601500,"Curry-Jones syndrome, somatic mosaic",601707,-,-,SMOH
"MIR96, MIRN96, DFNA50",Micro RNA 96,611606,"Deafness, autosomal dominant 50",613074,AD,-,MIR96
"CEP41, TSGA14, JBTS15","Centrosomal protein, 41kD",610523,Joubert syndrome 15,614464,AR,-,CEP41
BPGM,"2,3-bisphosphoglycerate mutase",613896,Erythrocytosis due to bisphosphoglycerate mutase deficiency,222800,AR,-,BPGM
"NUP205, C7orf14, KIAA0225, NPHS13","Nucleoporin, 205kD",614352,"?Nephrotic syndrome, type 13",616893,-,mutation identified in 1 NPHS13 family,NUP205
"AKR1D1, SRD5B1, CBAS2","Bile acid synthesis defect, congenital, 2",604741,"Bile acid synthesis defect, congenital, 2",235555,AR,-,AKR1D1
"ATP6V0A4, ATP6N1B, VPP2, RTA1C, RTADR","ATPase, H+ transporting, lysosomal V0 subunit a isoform 4",605239,"Renal tubular acidosis, distal, autosomal recessive",602722,-,-,ATP6V0A4
"TBXAS1, GHOSAL, CYP5, BDPLT14","Thromboxane A synthase 1, platelet",274180,?Thromboxane synthase deficiency,614158,AD,-,TBXAS1
"TBXAS1, GHOSAL, CYP5, BDPLT14","Thromboxane A synthase 1, platelet",274180,Ghosal hematodiaphyseal syndrome,231095,AR,-,TBXAS1
"BRAF, NS7",Murine sarcoma viral (v-raf) oncogene homolog B1,164757,"Adenocarcinoma of lung, somatic",211980,-,pseudogene BRAF2 on Xq13 or 7q,BRAF
"BRAF, NS7",Murine sarcoma viral (v-raf) oncogene homolog B1,164757,Cardiofaciocutaneous syndrome,115150,AD,-,BRAF
"BRAF, NS7",Murine sarcoma viral (v-raf) oncogene homolog B1,164757,"Colorectal cancer, somatic",-,-,-,BRAF
"BRAF, NS7",Murine sarcoma viral (v-raf) oncogene homolog B1,164757,LEOPARD syndrome 3,613707,AD,-,BRAF
"BRAF, NS7",Murine sarcoma viral (v-raf) oncogene homolog B1,164757,"Melanoma, malignant, somatic",-,-,-,BRAF
"BRAF, NS7",Murine sarcoma viral (v-raf) oncogene homolog B1,164757,"Nonsmall cell lung cancer, somatic",-,-,-,BRAF
"BRAF, NS7",Murine sarcoma viral (v-raf) oncogene homolog B1,164757,Noonan syndrome 7,613706,AD,-,BRAF
"AGK, MULK, MTDPS10, CATC5, CTRCT38",Acylglycerol kinase,610345,"Cataract 38, autosomal recessive",614691,AR,-,AGK
"AGK, MULK, MTDPS10, CATC5, CTRCT38",Acylglycerol kinase,610345,Sengers syndrome,212350,AR,-,AGK
"TAS2R38, T2R61, PTC","Taste receptor, type 2, member 38",607751,[Phenylthiocarbamide tasting],171200,AD,-,TAS2R38
"PRSS1, TRY1","Protease, serine, 1 (trypsin 1)",276000,"Pancreatitis, hereditary",167800,AD,8 trypsinogen genes embedded in TCRB locus,PRSS1
"PRSS1, TRY1","Protease, serine, 1 (trypsin 1)",276000,Trypsinogen deficiency,614044,AR,-,PRSS1
"PRSS2, TRY2","Protease, serine, 2 (trypsin 2)",601564,"{Pancreatitis, chronic, protection against}",167800,AD,-,PRSS2
KEL,Kell blood group,613883,"[Blood group, Kell]",110900,-,-,KEL
CLCN1,"Chloride channel-1, skeletal muscle",118425,"Myotonia congenita, dominant",160800,AD,-,CLCN1
CLCN1,"Chloride channel-1, skeletal muscle",118425,"Myotonia congenita, recessive",255700,AR,-,CLCN1
CLCN1,"Chloride channel-1, skeletal muscle",118425,"Myotonia levior, recessive",-,-,-,CLCN1
"NOBOX, POF5","Newborn ovary homeobox, mouse, homolog of",610934,Premature ovarian failure 5,611548,AD,-,NOBOX
"TPK1, THMD5",Thiamine pyrophosphokinase,606370,Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type),614458,AR,-,TPK1
"CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1",Contactin-associated protein-like 2,604569,Cortical dysplasia-focal epilepsy syndrome,610042,AR,-,CNTNAP2
"CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1",Contactin-associated protein-like 2,604569,Pitt-Hopkins like syndrome 1,610042,AR,-,CNTNAP2
"CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1",Contactin-associated protein-like 2,604569,{Autism susceptibility 15},612100,-,-,CNTNAP2
"EZH2, EZH1, WVS","Enhancer of zeste, Drosophila, homolog of, 2",601573,Weaver syndrome,277590,AD,pseudogene on 21q22,EZH2
"KCNH2, LQT2, HERG, SQT1","Potassium voltage-gated channel, subfamily H, member 2 (human ether-a-go-go-related gene)",152427,Long QT syndrome 2,613688,AD,-,KCNH2
"KCNH2, LQT2, HERG, SQT1","Potassium voltage-gated channel, subfamily H, member 2 (human ether-a-go-go-related gene)",152427,Short QT syndrome 1,609620,-,-,KCNH2
"KCNH2, LQT2, HERG, SQT1","Potassium voltage-gated channel, subfamily H, member 2 (human ether-a-go-go-related gene)",152427,"{Long QT syndrome 2, acquired, susceptibility to}",613688,AD,-,KCNH2
NOS3,"Nitric oxide synthase 3, endothelial cell",163729,"{Alzheimer disease, late-onset, susceptibility to}",104300,AD,-,NOS3
NOS3,"Nitric oxide synthase 3, endothelial cell",163729,"{Coronary artery spasm 1, susceptibility to}",-,-,-,NOS3
NOS3,"Nitric oxide synthase 3, endothelial cell",163729,"{Hypertension, pregnancy-induced}",189800,AD,-,NOS3
NOS3,"Nitric oxide synthase 3, endothelial cell",163729,"{Hypertension, susceptibility to}",145500,Mu,-,NOS3
NOS3,"Nitric oxide synthase 3, endothelial cell",163729,"{Ischemic stroke, susceptibility to}",601367,Mu,-,NOS3
NOS3,"Nitric oxide synthase 3, endothelial cell",163729,{Placental abruption},-,-,-,NOS3
"CDK5, LIS7",Cyclin-dependent kinase 5,123831,?Lissencephaly 7 with cerebellar hypoplasia,616342,AR,mutation identified in 1 LIS7 family,CDK5
"ASB10, GLC1F",Ankyrin repeat- and SOCS box-containing protein 10,615054,"Glaucoma 1, open angle, F",603383,-,-,ASB10
"PRKAG2, WPWS, CMH6","Protein kinase, AMP-activated, noncatalytic, gamma-2",602743,"Cardiomyopathy, hypertrophic 6",600858,AD,-,PRKAG2
"PRKAG2, WPWS, CMH6","Protein kinase, AMP-activated, noncatalytic, gamma-2",602743,"Glycogen storage disease of heart, lethal congenital",261740,AD,-,PRKAG2
"PRKAG2, WPWS, CMH6","Protein kinase, AMP-activated, noncatalytic, gamma-2",602743,Wolff-Parkinson-White syndrome,194200,?AD,-,PRKAG2
"KMT2C, MLL3, KIAA1506, KLEFS2",Lysine (K)-specific methyltransferase 2C,606833,Kleefstra syndrome 2,617768,AD,-,KMT2C
"XRCC2, FANCU","X-ray repair, complementing defective, repair in Chinese hamster cells-2",600375,"?Fanconi anemia, complementation group U",617247,AR,mutation identified in 1 FANCU patient,XRCC2
"DPP6, VF2, MRD33",Dipeptidylpeptidase VI,126141,"Mental retardation, autosomal dominant 33",616311,-,-,DPP6
"DPP6, VF2, MRD33",Dipeptidylpeptidase VI,126141,"{Ventricular fibrillation, paroxysmal familial, 2}",612956,AD,-,DPP6
"SCZD16, C16DUPq36.3, DUP7q36.3","Chromosome 7q36.3 duplication syndrome, 362kb",613959,Schizophrenia 16,613959,-,362kb duplication that includes VIPR2,SCZD16
"SHH, HPE3, HLP3, SMMCI, MCOPCB5",Sonic hedgehog,600725,Holoprosencephaly 3,142945,AD,separate from TPT1,SHH
"SHH, HPE3, HLP3, SMMCI, MCOPCB5",Sonic hedgehog,600725,Microphthalmia with coloboma 5,611638,AD,-,SHH
"SHH, HPE3, HLP3, SMMCI, MCOPCB5",Sonic hedgehog,600725,Schizencephaly,269160,-,-,SHH
"SHH, HPE3, HLP3, SMMCI, MCOPCB5",Sonic hedgehog,600725,Single median maxillary central incisor,147250,AD,-,SHH
"LMBR1, ACHP, C7orf2, PPD2, THYP, LSS","Limb region 1, mouse, homolog of",605522,Acheiropody,200500,AR,-,LMBR1
"LMBR1, ACHP, C7orf2, PPD2, THYP, LSS","Limb region 1, mouse, homolog of",605522,Hypoplastic or aplastic tibia with polydactyly,188740,AD,-,LMBR1
"LMBR1, ACHP, C7orf2, PPD2, THYP, LSS","Limb region 1, mouse, homolog of",605522,Laurin-Sandrow syndrome,135750,AD,-,LMBR1
"LMBR1, ACHP, C7orf2, PPD2, THYP, LSS","Limb region 1, mouse, homolog of",605522,"Polydactyly, preaxial type II",174500,AD,-,LMBR1
"LMBR1, ACHP, C7orf2, PPD2, THYP, LSS","Limb region 1, mouse, homolog of",605522,"Syndactyly, type IV",186200,AD,-,LMBR1
"LMBR1, ACHP, C7orf2, PPD2, THYP, LSS","Limb region 1, mouse, homolog of",605522,"Triphalangeal thumb, type I",174500,AD,-,LMBR1
"LMBR1, ACHP, C7orf2, PPD2, THYP, LSS","Limb region 1, mouse, homolog of",605522,Triphalangeal thumb-polysyndactyly syndrome,174500,AD,-,LMBR1
"MNX1, HLXB9, HOXHB9, SCRA1",Motor neuron and pancreas homeobox 1,142994,Currarino syndrome,176450,AD,-,MNX1
"DNAJB6, MRJ, DJ4, LGMD1E","DNAJ/HSP40 homolog, subfamily B, member 6",611332,"Muscular dystrophy, limb-girdle, type 1E",603511,AD,previously assigned to 11q25,DNAJB6
"WDR60, SRTD8, SRPS6",WD repeat containing protein 60,615462,Short-rib thoracic dysplasia 8 with or without polydactyly,615503,AR,-,WDR60
"CLN8, EPMR",CLN8 gene,607837,"Ceroid lipofuscinosis, neuronal, 8",600143,AR,-,CLN8
"CLN8, EPMR",CLN8 gene,607837,"Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant",610003,AR,-,CLN8
"ARHGEF10, KIAA0294, SNCV",Rho guanine nucleotide exchange factor 10,608136,"?Slowed nerve conduction velocity, AD",608236,AD,mutation identified in 1 SNCV family,ARHGEF10
MCPH1,Microcephalin,607117,"Microcephaly 1, primary, autosomal recessive",251200,AR,genetic heterogeneity,MCPH1
RP1L1,RP1-like protein 1,608581,Occult macular dystrophy,613587,AD,-,RP1L1
"BLK, MODY11",BLK nonreceptor tyrosine kinase,191305,"Maturity-onset diabetes of the young, type 11",613375,AD,-,BLK
"GATA4, ASD2, VSD1, TACHD, TOF",GATA-binding protein-4,600576,?Testicular anomalies with or without congenital heart disease,615542,AD,mutations identified in 1 TACHD family,GATA4
"GATA4, ASD2, VSD1, TACHD, TOF",GATA-binding protein-4,600576,Atrial septal defect 2,607941,AD,-,GATA4
"GATA4, ASD2, VSD1, TACHD, TOF",GATA-binding protein-4,600576,Atrioventricular septal defect 4,614430,AD,-,GATA4
"GATA4, ASD2, VSD1, TACHD, TOF",GATA-binding protein-4,600576,Tetralogy of Fallot,187500,AD,-,GATA4
"GATA4, ASD2, VSD1, TACHD, TOF",GATA-binding protein-4,600576,Ventricular septal defect 1,614429,AD,-,GATA4
DLC1,Deleted in liver cancer 1,604258,"Colorectal cancer, somatic",114500,-,-,DLC1
"TUSC3, M33, D8S1992, MRT7, MRT22",Tumor suppressor candidate 3,601385,"Mental retardation, autosomal recessive 7",611093,AR,-,TUSC3
"MSR1, SCARA1, SRA",Macrophage scavenger receptor,153622,Barrett esophagus/esophageal adenocarcinoma,614266,-,~11cM distal to LPL,MSR1
"FGF20, RHDA2",Fibroblast growth factor-20,605558,?Renal hypodysplasia/aplasia 2,615721,AR,mutation identified in 1 RHDA2 family,FGF20
"VPS37A, HCRP1, SPG53",Vacuolar protein sorting 37A,609927,"Spastic paraplegia 53, autosomal recessive",614898,AR,-,VPS37A
"PDGFRL, PDGRL, PRLTS",Platelet-derived growth factor receptor-like,604584,"Colorectal cancer, somatic",114500,-,-,PDGFRL
"PDGFRL, PDGRL, PRLTS",Platelet-derived growth factor receptor-like,604584,"Hepatocellular cancer, somatic",114550,-,-,PDGFRL
"ASAH1, AC, SMAPME",N-acylsphingosine amidohydrolase (acid ceramidase) 1,613468,Farber lipogranulomatosis,228000,AR,-,ASAH1
"ASAH1, AC, SMAPME",N-acylsphingosine amidohydrolase (acid ceramidase) 1,613468,Spinal muscular atrophy with progressive myoclonic epilepsy,159950,AR,-,ASAH1
"NAT2, AAC2",Arylamine N-acetyltransferase-2,612182,"[Acetylation, slow]",243400,AR,acetylation polymorphism,NAT2
SCZD6,"Schizophrenia susceptibility locus, chromosome 8p-related",603013,{Schizophrenia},181500,AD,?neuregulin 1,SCZD6
"LPL, LIPD, HDLCQ11",Lipoprotein lipase,609708,"Combined hyperlipidemia, familial",144250,AD,-,LPL
"LPL, LIPD, HDLCQ11",Lipoprotein lipase,609708,Lipoprotein lipase deficiency,238600,AR,-,LPL
"LPL, LIPD, HDLCQ11",Lipoprotein lipase,609708,[High density lipoprotein cholesterol level QTL 11],-,-,-,LPL
"ATP6V1B2, ATP6B2, VPP3, DOOD, ZLS2","ATPase, H+ transporting, lysosomal, V1 subunit B, isoform 2",606939,"Deafness, congenital, with onychodystrophy, autosomal dominant",124480,AD,-,ATP6V1B2
"ATP6V1B2, ATP6B2, VPP3, DOOD, ZLS2","ATPase, H+ transporting, lysosomal, V1 subunit B, isoform 2",606939,Zimmermann-Laband syndrome 2,616455,AD,-,ATP6V1B2
"LZTS1, F37, FEZ1","Leucine zipper, putative tumor suppressor 1",606551,Esophageal squamous cell carcinoma,133239,AD,-,LZTS1
"FGF17, HH20",Fibroblast growth factor 17,603725,Hypogonadotropic hypogonadism 20 with or without anosmia,615270,AD,-,FGF17
"HR, AU, MUHH1, HYPT4","Hairless, mouse, homolog of",602302,Alopecia universalis,203655,AR,-,HR
"HR, AU, MUHH1, HYPT4","Hairless, mouse, homolog of",602302,Atrichia with papular lesions,209500,AR,-,HR
"HR, AU, MUHH1, HYPT4","Hairless, mouse, homolog of",602302,Hypotrichosis 4,146550,AD,-,HR
"SFTPC, SFTP2, SMDP2","Surfactant, pulmonary-associated protein C (pulmonary surfactant apoprotein-2, SP-C)",178620,"Surfactant metabolism dysfunction, pulmonary, 2",610913,AD,-,SFTPC
"BMP1, OI13",Bone morphogenetic protein-1,112264,"Osteogenesis imperfecta, type XIII",614856,AR,1kb 3' to SFTP2,BMP1
"SLC39A14, ZIP14, KIAA0062, HMNDYT2","Solute carrier family 39 (zinc transporter), member 14",608736,Hypermanganesemia with dystonia 2,617013,AR,-,SLC39A14
"TNFRSF10B, DR5, TRAILR2","Tumor necrosis factor receptor superfamily, member 10B",603612,"Squamous cell carcinoma, head and neck",275355,AR,-,TNFRSF10B
"NKX2-6, CSX2, CTHM","NK2, Drosophila, homolog of, 6",611770,Conotruncal heart malformations,217095,-,-,NKX2-6
"NKX2-6, CSX2, CTHM","NK2, Drosophila, homolog of, 6",611770,Persistent truncus arteriosus,217095,-,-,NKX2-6
"NEFL, CMT2E, CMT1F, CMTDIG","Neurofilament, light polypeptide",162280,"Charcot-Marie-Tooth disease, dominant intermediate G",617882,AD,-,NEFL
"NEFL, CMT2E, CMT1F, CMTDIG","Neurofilament, light polypeptide",162280,"Charcot-Marie-Tooth disease, type 1F",607734,"AD,AR",-,NEFL
"NEFL, CMT2E, CMT1F, CMTDIG","Neurofilament, light polypeptide",162280,"Charcot-Marie-Tooth disease, type 2E",607684,AD,-,NEFL
"GNRH1, LNRH, HH12",Gonadotropin-releasing hormone-1 (luteinizing-releasing hormone),152760,?Hypogonadotropic hypogonadism 12 with or without anosmia,614841,AR,mutation identified in 1 HH12 family,GNRH1
CHRNA2,"Cholinergic receptor, nicotinic, alpha polypeptide-2",118502,"Epilepsy, nocturnal frontal lobe, type 4",610353,AD,-,CHRNA2
EPHX2,"Epoxide hydrolase 2, cytoplasmic",132811,"{Hypercholesterolemia, familial, due to LDLR defect, modifier of}",143890,AD,-,EPHX2
ESCO2,"Establishment of cohesion 1, S. cerevisiae, homolog of, 2",609353,Roberts syndrome,268300,AR,-,ESCO2
ESCO2,"Establishment of cohesion 1, S. cerevisiae, homolog of, 2",609353,SC phocomelia syndrome,269000,AR,-,ESCO2
"EXTL3, EXTR1, ISDNA",Exostosin-like 3,605744,Immunoskeletal dysplasia with neurodevelopmental abnormalities,617425,AR,-,EXTL3
"GTF2E2, TTD6","General transcription factor IIE, polypeptide 2, beta subunit, 34kD",189964,"Trichothiodystrophy 6, nonphotosensitive",616943,AR,-,GTF2E2
"RECQL2, RECQ3, WRN","DNA helicase, RecQ-like 2",604611,Werner syndrome,277700,AR,-,RECQL2
"TTI2, C8orf41, MRT39",TELO2-interacting protein 2,614426,"Mental retardation, autosomal recessive 39",615541,AR,-,TTI2
SCLL,Chromosome 8p11 myeloproliferative syndrome (stem cell leukemia/lymphoma),613523,Chromosome 8p11 myeloproliferative syndrome,613523,-,translocation of FGFR1 (8p11) and various partners,SCLL
"ERLIN2, SPFH2, C8orf2, SPG18",Endoplasmic reticulum lipid raft-associated protein 2,611605,"Spastic paraplegia 18, autosomal recessive",611225,AR,-,ERLIN2
"PROSC, EPVB6D","Proline synthetase cotranscribed, bacteria, homolog of",604436,"Epilepsy, early-onset, vitamin B6-dependent",617290,AR,-,PROSC
ADRB3,"Adrenergic, beta-3-, receptor",109691,"{Obesity, susceptibility to}",601665,"AD,Mu,AR",-,ADRB3
STAR,Steroidogenic acute regulatory protein,600617,Lipoid adrenal hyperplasia,201710,AR,-,STAR
"DDHD2, KIAA0725, SPG54",DDHD domain-containing protein 2,615003,"Spastic paraplegia 54, autosomal recessive",615033,AR,-,DDHD2
"NSD3, WHSC1L1",Nuclear receptor-binding SET domain protein 3,607083,"Leukemia, acute myeloid",601626,AD,pseudogene on 17q21; fusion partner with NUP98 in AML,NSD3
"FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL",Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2),136350,Encephalocraniocutaneous lipomatosis,613001,SMo,"fused with BCR, CEP1, FOP, FIM in hematologic malignancies",FGFR1
"FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL",Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2),136350,Hartsfield syndrome,615465,AD,-,FGFR1
"FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL",Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2),136350,Hypogonadotropic hypogonadism 2 with or without anosmia,147950,AD,-,FGFR1
"FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL",Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2),136350,Jackson-Weiss syndrome,123150,AD,-,FGFR1
"FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL",Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2),136350,Osteoglophonic dysplasia,166250,AD,-,FGFR1
"FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL",Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2),136350,Pfeiffer syndrome,101600,AD,-,FGFR1
"FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL",Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2),136350,Trigonocephaly 1,190440,AD,-,FGFR1
"ADAM9, MDC9, MCMP, CORD9",A disintegrin and metalloproteinase domain 9,602713,Cone-rod dystrophy 9,612775,-,-,ADAM9
"ANK1, SPH1","Ankyrin-1, erythrocytic",612641,"Spherocytosis, type 1",182900,AD,-,ANK1
"KAT6A, MYST3, MOZ, ZNF220, MRD32",K(lysine) acetyltransferase 6A,601408,"Mental retardation, autosomal dominant 32",616268,AD,-,KAT6A
"IKBKB, NFKBIKB, IMD15","Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase of, beta",603258,Immunodeficiency 15,615592,AR,-,IKBKB
"SLC20A2, MLVAR, GLVR2, IBGC1","Solute carrier family 20, phosphate transporter, member 2 (murine leukemia virus, amphotropic, receptor for)",158378,"Basal ganglia calcification, idiopathic, 1",213600,AD,-,SLC20A2
"THAP1, DYT6",THAP domain-containing protein 1,609520,"Dystonia 6, torsion",602629,AD,-,THAP1
"RNF170, SNAX1",RING finger protein 170,614649,"Ataxia, sensory, 1, autosomal dominant",608984,AD,-,RNF170
"POMK, SGK196, MDDGA12, MDDGC12",Protein-O-mannose kinase,615247,"?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12",616094,AR,mutation in 1 MDDGC12 family has been reported,POMK
"POMK, SGK196, MDDGA12, MDDGC12",Protein-O-mannose kinase,615247,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12",615249,AR,-,POMK
"HGSNAT, TMEM76, MPS3C, RP73",Heparan-alpha-glucosaminide N-acetyltransferase,610453,Mucopolysaccharidosis type IIIC (Sanfilippo C),252930,AR,-,HGSNAT
"HGSNAT, TMEM76, MPS3C, RP73",Heparan-alpha-glucosaminide N-acetyltransferase,610453,Retinitis pigmentosa 73,616544,AR,-,HGSNAT
"PRKDC, HYRC1, DNPK1, IMD26","Protein kinase, DNA-activated, catalytic polypeptide (hyperradiosensitivity of murine SCID mutation, complementing-1)",600899,"Immunodeficiency 26, with or without neurologic abnormalities",615966,AR,-,PRKDC
"MCM4, NKGCD, NKCD, IMD54","Minichromosome maintenance deficient, S. cerevisiae, homolog of, 4",602638,Immunodeficiency 54,609981,AR,-,MCM4
"SNAI2, SLUG, WS2D","snail, Drosophila, homolog of, 2 (Neural crest transcription factor SLUG)",602150,Piebaldism,172800,AD,-,SNAI2
"SNAI2, SLUG, WS2D","snail, Drosophila, homolog of, 2 (Neural crest transcription factor SLUG)",602150,"Waardenburg syndrome, type 2D",608890,AR,-,SNAI2
"RB1CC1, CC1, KIAA0203",RB1-inducible coiled-coil 1,606837,"Breast cancer, somatic",114480,-,-,RB1CC1
"SOX17, VUR3",SRY-box 17,610928,Vesicoureteral reflux 3,613674,AD,-,SOX17
"RP1, ORP1",Oxygen-regulated photoreceptor protein-1 (retinitis pigmentosa-1),603937,Retinitis pigmentosa 1,180100,"AD,AR",-,RP1
"PLAG1, SGPA, PSA",Pleomorphic adenoma gene 1,603026,"Adenomas, salivary gland pleomorphic, somatic",181030,-,fused with CTNNB1 in SGPA,PLAG1
"IMPAD1, GPAPP, IMPA3",Inositol monophosphatase domain-containing protein 1,614010,"Chondrodysplasia with joint dislocations, GPAPP type",614078,AR,-,IMPAD1
"CA8, CALS, CARP, CAMRQ3",Carbonic anhydrase VIII,114815,Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3,613227,AR,-,CA8
"DEL8q12q21, C8DELq12q21",Bor-Duane hydrocephalus contiguous gene syndrome (chromosome 8q12.1-q21.2 deletion syndrome),600257,Bor-Duane hydrocephalus contiguous gene syndrome,600257,AD,-,DEL8q12q21
"CHD7, HH5",Chromodomain helicase DNA binding protein 7,608892,CHARGE syndrome,214800,AD,-,CHD7
"CHD7, HH5",Chromodomain helicase DNA binding protein 7,608892,Hypogonadotropic hypogonadism 5 with or without anosmia,612370,AD,-,CHD7
"ASPH, HAAH, FDLAB",Aspartate beta-hydroxylase (junctin; junctate),600582,Traboulsi syndrome,601552,AR,-,ASPH
"TTPA, TTP1, AVED","Tocopherol, alpha, transfer protein",600415,Ataxia with isolated vitamin E deficiency,277460,AR,-,TTPA
"CYP7B1, CBAS3, SPG5A","Cytochrome P450, subfamily VIIB (oxysterol 7-alpha-hydroxylase), polypeptide 1",603711,"Bile acid synthesis defect, congenital, 3",613812,AR,-,CYP7B1
"CYP7B1, CBAS3, SPG5A","Cytochrome P450, subfamily VIIB (oxysterol 7-alpha-hydroxylase), polypeptide 1",603711,"Spastic paraplegia 5A, autosomal recessive",270800,AR,-,CYP7B1
"DEL8q13, C8DELq13",Mesomelia-synostoses syndrome (Chromosome 8q13 deletion syndrome),600383,Mesomelia-synostoses syndrome,600383,AD,contiguous gene deletion of SULF1 and SLCO5A1,DEL8q13
"CSPP1, CSPP, JBTS21",Centrosome spindle pole-associated protein 1,611654,Joubert syndrome 21,615636,AR,-,CSPP1
"CPA6, CPAH, ETL5, FEB11",Carboxypeptidase A6,609562,"Epilepsy, familial temporal lobe, 5",614417,"AD,AR",-,CPA6
"CPA6, CPAH, ETL5, FEB11",Carboxypeptidase A6,609562,"Febrile seizures, familial, 11",614418,AR,-,CPA6
"EYA1, BOR, BOS1, OFC1","Eyes absent, Drosophila, homolog of, 1",601653,?Otofaciocervical syndrome,166780,AD,mutation identified in 1 OFC1 family,EYA1
"EYA1, BOR, BOS1, OFC1","Eyes absent, Drosophila, homolog of, 1",601653,Anterior segment anomalies with or without cataract,602588,AD,-,EYA1
"EYA1, BOR, BOS1, OFC1","Eyes absent, Drosophila, homolog of, 1",601653,Branchiootic syndrome 1,602588,AD,-,EYA1
"EYA1, BOR, BOS1, OFC1","Eyes absent, Drosophila, homolog of, 1",601653,"Branchiootorenal syndrome 1, with or without cataracts",113650,AD,-,EYA1
"DEL8q21.11, C8DELq21.11",Chromosome 8q21.11 deletion syndrome,614230,Chromosome 8q21.11 deletion syndrome,614230,"AD,IC","contiguous gene deletion; minimal region (GRCh37, 8:77226464-77766239",DEL8q21.11
"TRPA1, ANKTM1, FEPS1","Transient receptor potential cation channel, subfamily A, member 1 (ankyrin-like protein with transmembrane domains 1)",604775,"?Episodic pain syndrome, familial, 1",615040,AD,mutation identified in 1 FEPS1 family,TRPA1
"TMEM70, MC5DN2",Transmembrane protein 70,612418,"Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2",614052,AR,-,TMEM70
"JPH1, JP1, CMT2K",Junctophilin 1,605266,"?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K",607831,"AD,AR",mutation identified in 1 CMT2K family,JPH1
"GDAP1, CMT4A, CMT2K, CMTRIA",Ganglioside-induced differentiation-associated protein 1,606598,"Charcot-Marie-Tooth disease, axonal, type 2K",607831,"AD,AR",-,GDAP1
"GDAP1, CMT4A, CMT2K, CMTRIA",Ganglioside-induced differentiation-associated protein 1,606598,"Charcot-Marie-Tooth disease, axonal, with vocal cord paresis",607706,AR,-,GDAP1
"GDAP1, CMT4A, CMT2K, CMTRIA",Ganglioside-induced differentiation-associated protein 1,606598,"Charcot-Marie-Tooth disease, recessive intermediate, A",608340,AR,-,GDAP1
"GDAP1, CMT4A, CMT2K, CMTRIA",Ganglioside-induced differentiation-associated protein 1,606598,"Charcot-Marie-Tooth disease, type 4A",214400,AR,-,GDAP1
"PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3",Peroxisome biogenesis factor 2,170993,Peroxisome biogenesis disorder 5A (Zellweger),614866,AR,-,PEX2
"PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3",Peroxisome biogenesis factor 2,170993,Peroxisome biogenesis disorder 5B,614867,AR,-,PEX2
"IMPA1, MRT59",Inositol(myo)-1(or 4)-monophosphatase-1,602064,"Mental retardation, autosomal recessive 59",617323,AR,-,IMPA1
CA2,Carbonic anhydrase II,611492,"Osteopetrosis, autosomal recessive 3, with renal tubular acidosis",259730,AR,"CA1, CA2 linked in monkey and mouse",CA2
"CNGB3, ACHM3, ACHM1","Cyclic nucleotide-gated channel, beta-3",605080,Achromatopsia 3,262300,AR,-,CNGB3
"CNGB3, ACHM3, ACHM1","Cyclic nucleotide-gated channel, beta-3",605080,"Macular degeneration, juvenile",248200,AR,-,CNGB3
"NBN, NBS1",Nibrin,602667,Aplastic anemia,609135,-,-,NBN
"NBN, NBS1",Nibrin,602667,"Leukemia, acute lymphoblastic",613065,-,-,NBN
"NBN, NBS1",Nibrin,602667,Nijmegen breakage syndrome,251260,AR,-,NBN
"OTUD6B, DUBA5, IDDFSDA",OTU domain-containing protein 6B,612021,"Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies",617452,AR,-,OTUD6B
"DUP8q22.1, C8DUPq22.1",Chromosome 8q22.1 duplication syndrome (Leri pleonosteosis),151200,Leri pleonosteosis chromosome duplication syndrome,151200,AD,duplication of 0.9-1.2 Mb on 8q22.1,DUP8q22.1
"NMLFS, DEL8q22.1, C8DELq22.1",Nablus mask-like facial syndrome (chromosome 8q22.1 deletion syndrome),608156,Nablus mask-like facial syndrome,608156,"AD,IC",-,NMLFS
"TMEM67, MKS3, JBTS6, NPHP11",Transmembrane protein 67 (meckelin),609884,COACH syndrome,216360,AR,-,TMEM67
"TMEM67, MKS3, JBTS6, NPHP11",Transmembrane protein 67 (meckelin),609884,Joubert syndrome 6,610688,AR,-,TMEM67
"TMEM67, MKS3, JBTS6, NPHP11",Transmembrane protein 67 (meckelin),609884,Meckel syndrome 3,607361,AR,-,TMEM67
"TMEM67, MKS3, JBTS6, NPHP11",Transmembrane protein 67 (meckelin),609884,Nephronophthisis 11,613550,AR,-,TMEM67
"TMEM67, MKS3, JBTS6, NPHP11",Transmembrane protein 67 (meckelin),609884,"{Bardet-Biedl syndrome 14, modifier of}",615991,AR,-,TMEM67
"PDP1, PPM2C, PDPC",Pyruvate dehydrogenase phosphatase catalytic subunit 1,605993,Pyruvate dehydrogenase phosphatase deficiency,608782,AR,-,PDP1
RAD54B,"RAD54, S. cerevisiae, homolog of, B",604289,"Colon cancer, somatic",114500,-,-,RAD54B
RAD54B,"RAD54, S. cerevisiae, homolog of, B",604289,"Lymphoma, non-Hodgkin, somatic",605027,-,-,RAD54B
"NDUFAF6, C8orf38","NADH dehydrogenase (ubiquinone) complex I, assembly factor 6",612392,Leigh syndrome due to mitochondrial complex I deficiency,256000,"Mi,AR",-,NDUFAF6
"C8orf37, CORD16, RP64, BBS21",Chromosome 8 open reading frame 37,614477,Bardet-Biedl syndrome 21,617406,AR,-,C8orf37
"C8orf37, CORD16, RP64, BBS21",Chromosome 8 open reading frame 37,614477,Cone-rod dystrophy 16,614500,AR,-,C8orf37
"C8orf37, CORD16, RP64, BBS21",Chromosome 8 open reading frame 37,614477,Retinitis pigmentosa 64,614500,AR,-,C8orf37
"GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4",Growth/differentiation factor 6,601147,"Klippel-Feil syndrome 1, autosomal dominant",118100,AD,-,GDF6
"GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4",Growth/differentiation factor 6,601147,Leber congenital amaurosis 17,615360,AR,-,GDF6
"GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4",Growth/differentiation factor 6,601147,"Microphthalmia with coloboma 6, digenic",613703,AD,-,GDF6
"GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4",Growth/differentiation factor 6,601147,"Microphthalmia, isolated 4",613094,-,-,GDF6
"GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4",Growth/differentiation factor 6,601147,Multiple synostoses syndrome 4,617898,AD,-,GDF6
"UQCRB, UQBP, QPC, MC3DN3",Ubiquinol-cytochrome c reductase binding protein,191330,"Mitochondrial complex III deficiency, nuclear type 3",615158,AR,-,UQCRB
"PTDSS1, PSS1, KIAA0024, LMHD",Phosphatidylserine synthase 1,612792,Lenz-Majewski hyperostotic dwarfism,151050,AD,-,PTDSS1
"POP1, ANXD2","Processing of precursor 1, S. cerevisiae, homolog of",602486,Anauxetic dysplasia 2,617396,AR,-,POP1
"VPS13B, KIAA0532, COH1","Vacuolar protein sorting 13, yeast, homolog of, B",607817,Cohen syndrome,216550,AR,-,VPS13B
"SPAG1, CILD28",Sperm-associated antigen-1,603395,"Ciliary dyskinesia, primary, 28",615505,AR,-,SPAG1
"GRHL2, TFCP2L3, DFNA28, ECTDS",Grainyhead-like 2,608576,"Deafness, autosomal dominant 28",608641,AD,-,GRHL2
"GRHL2, TFCP2L3, DFNA28, ECTDS",Grainyhead-like 2,608576,Ectodermal dysplasia/short stature syndrome,616029,AR,-,GRHL2
"RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B","Ribonucleotide reductase M2 B, TP53 inducible",604712,Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy),612075,AR,-,RRM2B
"RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B","Ribonucleotide reductase M2 B, TP53 inducible",604712,Mitochondrial DNA depletion syndrome 8B (MNGIE type),612075,AR,-,RRM2B
"RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B","Ribonucleotide reductase M2 B, TP53 inducible",604712,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5",613077,AD,-,RRM2B
"FZD6, NDNC10","Frizzled, Drosophila, homolog of, 6",603409,"Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails)",614157,AR,-,FZD6
CTHRC1,Collagen triple-helix repeat-containing protein 1,610635,Barrett esophagus/esophageal adenocarcinoma,614266,-,-,CTHRC1
"SLC25A32, MFT, RREI","Solute carrier family 25 (mitochondrial carrier, folate), member 32",610815,"?Exercise intolerance, riboflavin-responsive",616839,AR,mutation identified in 1 RREI patient,SLC25A32
"DPYS, DHP",Dihydropyrimidinase,613326,Dihydropyrimidinuria,222748,AR,-,DPYS
"ZFPM2, FOG2, DIH3, SRXY9","Zinc finger protein, multitype 2 (friend of GATA2)",603693,46XY sex reversal 9,616067,AD,-,ZFPM2
"ZFPM2, FOG2, DIH3, SRXY9","Zinc finger protein, multitype 2 (friend of GATA2)",603693,Diaphragmatic hernia 3,610187,-,-,ZFPM2
"ZFPM2, FOG2, DIH3, SRXY9","Zinc finger protein, multitype 2 (friend of GATA2)",603693,Tetralogy of Fallot,187500,AD,-,ZFPM2
TRPS1,Zinc finger transcription factor TRPS1,604386,"Trichorhinophalangeal syndrome, type I",190350,AD,-,TRPS1
TRPS1,Zinc finger transcription factor TRPS1,604386,"Trichorhinophalangeal syndrome, type III",190351,AD,-,TRPS1
"TRPS2, LGCR, LGS","Trichorhinophalangeal syndrome, type II (Langer-Giedion syndrome)",150230,"Trichorhinophalangeal syndrome, type II",150230,AD,contiguous gene syndrome involving TRPS1 and EXT1,TRPS2
"RAD21, SCC1, NXP1, KIAA0078, CDLS4","Rad21, S. pombe, homolog of",606462,Cornelia de Lange syndrome 4,614701,AD,-,RAD21
"SLC30A8, ZNT8","Solute carrier family 30 (zinc transporter), member 8",611145,"{Diabetes mellitus, noninsulin-dependent, susceptibility to}",125853,AD,-,SLC30A8
EXT1,Exostosin 1,608177,Chondrosarcoma,215300,AR,distal to TRPS1,EXT1
EXT1,Exostosin 1,608177,"Exostoses, multiple, type 1",133700,AD,-,EXT1
"TNFRSF11B, OPG, OCIF, PDB5","Tumor necrosis factor receptor superfamily, member 11B (osteoprotegerin)",602643,"Paget disease of bone 5, juvenile-onset",239000,AR,-,TNFRSF11B
"COLEC10, CLL1, 3MC3",Collectin 10,607620,3MC syndrome 3,248340,AR,-,COLEC10
"TAF2, TAF2B, TAFII150, CIF150, MRT40","TAF2 RAN polymerase II, TATA box-binding protein-associated factor, 150kD",604912,"Mental retardation, autosomal recessive 40",615599,AR,-,TAF2
"RNF139, TRC8, RCA1",RING finger protein 139,603046,Renal cell carcinoma,144700,-,-,RNF139
"NDUFB9, UQOR22","NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 (22kD, B22)",601445,?Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",mutation identified in 1 family,NDUFB9
"WSHC5, KIAA0196, SPG8, RTSC1","WASH complex, subunit 5",610657,Ritscher-Schinzel syndrome 1,220210,AR,-,WSHC5
"WSHC5, KIAA0196, SPG8, RTSC1","WASH complex, subunit 5",610657,"Spastic paraplegia 8, autosomal dominant",603563,AD,-,WSHC5
"NSMCE2, NSE2, MMS21","Non-SMC element 2, S. cerevisiae, homolog of",617246,Seckel syndrome 10,617253,AR,-,NSMCE2
MYC,Avian myelocytomatosis viral (v-myc) oncogene homolog,190080,Burkitt lymphoma,113970,IC,cen-5'-3'-ter,MYC
"KCNQ3, EBN2, BFNC2","Potassium voltage-gated channel, KQT-like subfamily, member 3",602232,"Seizures, benign neonatal, 2",121201,AD,-,KCNQ3
"LRRC6, LRTP, CILD19",Leucine-rich repeat-containing protein 6,614930,"Ciliary dyskinesia, primary, 19",614935,AR,-,LRRC6
"TG, AITD3, TDH3",Thyroglobulin,188450,Thyroid dyshormonogenesis 3,274700,AR,distal to MYC,TG
"TG, AITD3, TDH3",Thyroglobulin,188450,"{Autoimmune thyroid disease, susceptibility to, 3}",608175,-,-,TG
"NDRG1, HMSNL, CMT4D",N-myc downstream-regulated gene 1,605262,"Charcot-Marie-Tooth disease, type 4D",601455,AR,-,NDRG1
"ZFAT1, ZNF406, AITD3",Zinc finger gene in autoimmune thyroid disease 1,610931,"{Autoimmune thyroid disease, susceptibility to, 3}",608175,-,-,ZFAT1
"KCNK9, TASK3","Potassium channel, subfamily K, member 9",605874,Birk-Barel mental retardation dysmorphism syndrome,612292,-,-,KCNK9
"TRAPPC9, NIBP, KIAA1882, MRT13",Trafficking protein particle complex 9,611966,"Mental retardation, autosomal recessive 13",613192,AR,-,TRAPPC9
"SLURP1, MDM",Secreted LY6/uPAR-related protein 1,606119,Meleda disease,248300,AR,-,SLURP1
"CYP11B1, P450C11, FHI","Cytochrome P450, subfamily XIB, polypeptide 1 (11-beta-hydroxylase; corticosteroid methyl-oxidase II (CMO II))",610613,"Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency",202010,AR,chimeric CYP11B1/CYP11B2 gene = anti-Lepore-like,CYP11B1
"CYP11B1, P450C11, FHI","Cytochrome P450, subfamily XIB, polypeptide 1 (11-beta-hydroxylase; corticosteroid methyl-oxidase II (CMO II))",610613,"Aldosteronism, glucocorticoid-remediable",103900,AD,-,CYP11B1
CYP11B2,"Cytochrome P450, subfamily XIB, polypeptide 2",124080,Aldosterone to renin ratio raised,-,-,-,CYP11B2
CYP11B2,"Cytochrome P450, subfamily XIB, polypeptide 2",124080,"Hypoaldosteronism, congenital, due to CMO I deficiency",203400,AR,-,CYP11B2
CYP11B2,"Cytochrome P450, subfamily XIB, polypeptide 2",124080,"Hypoaldosteronism, congenital, due to CMO II deficiency",610600,AR,-,CYP11B2
CYP11B2,"Cytochrome P450, subfamily XIB, polypeptide 2",124080,"{Low renin hypertension, susceptibility to}",-,-,-,CYP11B2
"GPIHBP1, HYPL1D",Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,612757,"Hyperlipoproteinemia, type 1D",615947,AR,-,GPIHBP1
"FAM83H, AI3A","Family with sequence similarity 83, member H",611927,"Amelogenesis imperfecta, type IIIA",130900,AD,-,FAM83H
"PUF60, FIR, SIAHBP1, VRJS","Poly-U-binding splicing factor, 60kD",604819,Verheij syndrome,615583,AD,-,PUF60
"PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND",Plectin 1,601282,?Epidermolysis bullosa simplex with nail dystrophy,616487,AR,mutation identified in 1 EBSND family,PLEC1
"PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND",Plectin 1,601282,Epidermolysis bullosa simplex with muscular dystrophy,226670,AR,-,PLEC1
"PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND",Plectin 1,601282,Epidermolysis bullosa simplex with pyloric atresia,612138,AR,-,PLEC1
"PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND",Plectin 1,601282,"Epidermolysis bullosa simplex, Ogna type",131950,AD,-,PLEC1
"PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND",Plectin 1,601282,"Muscular dystrophy, limb-girdle, type 2Q",613723,AR,-,PLEC1
"OPLAH, OPLAHD",5-oxoprolinase (ATP-hydrolyzing),614243,5-oxoprolinase deficiency,260005,"AD,AR",-,OPLAH
"GPAA1, GAA1, GPIBD15",Glycophosphatidylinositol anchor attachment protein 1,603048,Glycosylphosphatidylinositol biosynthesis defect 15,617810,-,-,GPAA1
"CYC1, MC3DN6",Cytochrome c1,123980,"Mitochondrial complex III deficiency, nuclear type 6",615453,AR,-,CYC1
"DGAT1, ARGP1, DIAR7",Diacylglycerol O-acyltransferase 1,604900,?Diarrhea 7,615863,AR,mutation identified in 1 DIAR7 family,DGAT1
"SLC52A2, GPR172A, GPCR41, PAR1, FLJ11856, BVVLS2","Solute carrier family 52, riboflavin transporter, member 2",607882,Brown-Vialetto-Van Laere syndrome 2,614707,AR,-,SLC52A2
"SLC39A4, ZIP4","Solute carrier family 36 (zinc transporter), member 4",607059,Acrodermatitis enteropathica,201100,AR,-,SLC39A4
"RECQL4, RTS, RECQ4","DNA helicase, RecQ-like 4",603780,Baller-Gerold syndrome,218600,AR,-,RECQL4
"RECQL4, RTS, RECQ4","DNA helicase, RecQ-like 4",603780,RAPADILINO syndrome,266280,AR,-,RECQL4
"RECQL4, RTS, RECQ4","DNA helicase, RecQ-like 4",603780,Rothmund-Thomson syndrome,268400,AR,-,RECQL4
"DEL9p, C9DELp",Chromosome 9p deletion syndrome,158170,Chromosome 9p deletion syndrome,158170,AD,-,DEL9p
"DEL9p24.3, C9DELp24.3, SRXY4",Chromosome 9p24.3 deletion syndrome,154230,46XY sex reversal 4,154230,-,-,DEL9p24.3
MRD2,"Mental retardation, autosomal dominant 2",614113,"Mental retardation, autosomal dominant 2",614113,AD,2 patients reported with genomic deletion or rearrangement including disruption of DOCK8,MRD2
DOCK8,Dedicator of cytokinesis 8,611432,"Hyper-IgE recurrent infection syndrome, autosomal recessive",243700,AR,-,DOCK8
"KANK1, KANK, ANKRD15, KIAA0172, CPSQ2",KN motif- and ankyrin repeat domain-containing protein 1,607704,"Cerebral palsy, spastic quadriplegic, 2",612900,-,-,KANK1
"SMARCA2, SNF2L2, NCBRS","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2",600014,Nicolaides-Baraitser syndrome,601358,AD,-,SMARCA2
"VLDLR, CAMRQ1",Very low density lipoprotein receptor,192977,Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1,224050,AR,-,VLDLR
"KCNV2, KV11.1, RCD3B","Potassium channel, voltage-gated, subfamily V, member 2",607604,Retinal cone dystrophy 3B,610356,AR,-,KCNV2
"GLIS3, ZNF515, NDH",GLIS family zinc finger protein 3,610192,"Diabetes mellitus, neonatal, with congenital hypothyroidism",610199,AR,-,GLIS3
"SLC1A1, EAAC1, SCZD18, DCBXA","Solute carrier family 1, member 1 (high-affinity glutamate transporter; excitatory amino acid carrier 1)",133550,Dicarboxylic aminoaciduria,222730,AR,mutation identified in 1 SCZD18 family,SLC1A1
"SLC1A1, EAAC1, SCZD18, DCBXA","Solute carrier family 1, member 1 (high-affinity glutamate transporter; excitatory amino acid carrier 1)",133550,{?Schizophrenia susceptibility 18},615232,-,-,SLC1A1
"JAK2, THCYT3",Janus kinase 2 (a protein-tyrosine kinase),147796,"Erythrocytosis, somatic",133100,-,-,JAK2
"JAK2, THCYT3",Janus kinase 2 (a protein-tyrosine kinase),147796,"Leukemia, acute myeloid, somatic",601626,-,-,JAK2
"JAK2, THCYT3",Janus kinase 2 (a protein-tyrosine kinase),147796,"Myelofibrosis, somatic",254450,-,-,JAK2
"JAK2, THCYT3",Janus kinase 2 (a protein-tyrosine kinase),147796,"Polycythemia vera, somatic",263300,-,-,JAK2
"JAK2, THCYT3",Janus kinase 2 (a protein-tyrosine kinase),147796,Thrombocythemia 3,614521,"AD,SMu",-,JAK2
"JAK2, THCYT3",Janus kinase 2 (a protein-tyrosine kinase),147796,"{Budd-Chiari syndrome, somatic}",600880,-,-,JAK2
"GLDC, HYGN1, GCSP, GCE, NKH","Glycine dehydrogenase (decarboxylating; glycine decarboxylase, glycine cleavage system protein P)",238300,Glycine encephalopathy,605899,AR,-,GLDC
"TYRP1, CAS2, GP75, SHEP11",Tyrosinase-related protein 1,115501,"Albinism, oculocutaneous, type III",203290,AR,-,TYRP1
"TYRP1, CAS2, GP75, SHEP11",Tyrosinase-related protein 1,115501,"[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)]",612271,-,-,TYRP1
"MPDZ, MUPP1, HYC2",Multiple PDZ domain protein,603785,"Hydrocephalus, nonsyndromic, autosomal recessive 2",615219,AR,-,MPDZ
"FREM1, C9orf154, BNAR, MOTA, TRIGNO2",FRAS1-related extracellular matrix protein 1,608944,Bifid nose with or without anorectal and renal anomalies,608980,-,-,FREM1
"FREM1, C9orf154, BNAR, MOTA, TRIGNO2",FRAS1-related extracellular matrix protein 1,608944,Manitoba oculotrichoanal syndrome,248450,AR,-,FREM1
"FREM1, C9orf154, BNAR, MOTA, TRIGNO2",FRAS1-related extracellular matrix protein 1,608944,Trigonocephaly 2,614485,AD,-,FREM1
"MTAP, DMSMFH",Methylthioadenosine phosphorylase,156540,Diaphyseal medullary stenosis with malignant fibrous histiocytoma,112250,AD,-,MTAP
"CDKN2A, MTS1, P16, MLM, CMM2","Cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4)",600160,Melanoma and neural system tumor syndrome,155755,AD,-,CDKN2A
"CDKN2A, MTS1, P16, MLM, CMM2","Cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4)",600160,"Orolaryngeal cancer, multiple",-,-,-,CDKN2A
"CDKN2A, MTS1, P16, MLM, CMM2","Cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4)",600160,Pancreatic cancer/melanoma syndrome,606719,AD,-,CDKN2A
"CDKN2A, MTS1, P16, MLM, CMM2","Cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4)",600160,"{Melanoma, cutaneous malignant, 2}",155601,AD,-,CDKN2A
"PLAA, PLAP, NDMSBA",Phospholipase A2-activating protein,603873,"Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies",617527,AR,-,PLAA
"IFT74, CCDC2, CMG1, BBS20","Intraflagellar transport 74, Chlamydomonas, homolog of",608040,?Bardet-Biedl syndrome 20,617119,AR,mutation identified in 1 BBS20 patient,IFT74
"TEK, TIE2, VMCM, GLC3E","TEK tyrosine kinase, endothelial",600221,"Glaucoma 3, primary congenital, E",617272,AD,-,TEK
"TEK, TIE2, VMCM, GLC3E","TEK tyrosine kinase, endothelial",600221,"Venous malformations, multiple cutaneous and mucosal",600195,AD,-,TEK
"C9orf72, FTDALS1, FTDALS, ALSFTD",Chromosome 9 open reading frame 72,614260,Frontotemporal dementia and/or amyotrophic lateral sclerosis 1,105550,AD,-,C9orf72
"DDX58, RIGI, SGMRT2",DEAD box polypeptide 58,609631,Singleton-Merten syndrome 2,616298,AD,-,DDX58
"TOPORS, P53BP3, LUN, RP31",Topoisomerase I-binding arginine/serine-rich protein,609507,Retinitis pigmentosa 31,609923,-,-,TOPORS
"APTX, AOA, AOA1",Aprataxin,606350,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",208920,AR,-,APTX
"B4GALT1, GGTB2, GT1, GTB, CDG2D",Glycoprotein-4-beta-galactosyltransferase-2 (EC 2.4.1.22),137060,"Congenital disorder of glycosylation, type IId",607091,AR,-,B4GALT1
"AQP7, GLYCQTL",Aquaporin-7,602974,[Glycerol quantitative trait locus],614411,AR,-,AQP7
AQP3,Aquaporin-3,600170,[Blood group GIL],607457,-,incorrectly mapped to chr.7,AQP3
"DNAI1, CILD1, ICS, PCD","Dynein, axonemal, intermediate chain 1",604366,"Ciliary dyskinesia, primary, 1, with or without situs inversus",244400,AR,-,DNAI1
"SIGMAR1, SRBP, ALS16, DSMA2",Sigma nonopioid intracellular receptor 1,601978,"?Amyotrophic lateral sclerosis 16, juvenile",614373,AR,mutation identified in 1 ALS16 family and 1 DSMA2 family,SIGMAR1
"SIGMAR1, SRBP, ALS16, DSMA2",Sigma nonopioid intracellular receptor 1,601978,"?Spinal muscular atrophy, distal, autosomal recessive, 2",605726,AR,-,SIGMAR1
GALT,Galactose-1-phosphate uridyltransferase,606999,Galactosemia,230400,AR,-,GALT
"IL11RA, CRSDA","Interleukin-11 receptor, alpha",600939,Craniosynostosis and dental anomalies,614188,AR,-,IL11RA
"VCP, IBMPFD1, ALS14, CMT2Y",Valosin-containing protein,601023,"Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia",613954,-,-,VCP
"VCP, IBMPFD1, ALS14, CMT2Y",Valosin-containing protein,601023,"Charcot-Marie-Tooth disease, type 2Y",616687,AD,-,VCP
"VCP, IBMPFD1, ALS14, CMT2Y",Valosin-containing protein,601023,Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1,167320,AD,-,VCP
"XRCC9, FANCG","X-ray repair, complementing defective, in Chinese hamster, 9",602956,"Fanconi anemia, complementation group G",614082,-,-,XRCC9
"PIGO, HPMRS2","Phosphatidylinositol glycan, class O",614730,Hyperphosphatasia with mental retardation syndrome 2,614749,AR,-,PIGO
"RUSC2, KIAA0375, IPORIN, MRT61",RUN and SH3 domain-containing 2,611053,"Mental retardation, autosomal recessive 61",617773,AR,-,RUSC2
"RMRP, RMRPR, CHH",Mitochondrial RNA-processing endoribonuclease,157660,Anauxetic dysplasia 1,607095,AR,-,RMRP
"RMRP, RMRPR, CHH",Mitochondrial RNA-processing endoribonuclease,157660,Cartilage-hair hypoplasia,250250,AR,-,RMRP
"RMRP, RMRPR, CHH",Mitochondrial RNA-processing endoribonuclease,157660,Metaphyseal dysplasia without hypotrichosis,250460,AR,-,RMRP
"TPM2, TMSB, AMCD1, DA1, DA2B, NEM4","Tropomyosin-2, beta",190990,"Arthrogryposis multiplex congenita, distal, type 1",108120,AD,-,TPM2
"TPM2, TMSB, AMCD1, DA1, DA2B, NEM4","Tropomyosin-2, beta",190990,"Arthrogryposis, distal, type 2B",601680,AD,-,TPM2
"TPM2, TMSB, AMCD1, DA1, DA2B, NEM4","Tropomyosin-2, beta",190990,CAP myopathy 2,609285,AD,-,TPM2
"TPM2, TMSB, AMCD1, DA1, DA2B, NEM4","Tropomyosin-2, beta",190990,"Nemaline myopathy 4, autosomal dominant",609285,AD,-,TPM2
"GBA2, KIAA1605, SPG46","Glucosidase, beta, acid 2",609471,"Spastic paraplegia 46, autosomal recessive",614409,AR,-,GBA2
"NPR2, ANPRB, AMDM, ECDM, SNSK",Natiuretic peptide receptor 2,108961,"Acromesomelic dysplasia, Maroteaux type",602875,AR,-,NPR2
"NPR2, ANPRB, AMDM, ECDM, SNSK",Natiuretic peptide receptor 2,108961,"Epiphyseal chondrodysplasia, Miura type",615923,AD,-,NPR2
"NPR2, ANPRB, AMDM, ECDM, SNSK",Natiuretic peptide receptor 2,108961,Short stature with nonspecific skeletal abnormalities,616255,AD,-,NPR2
"GNE, GLCNE, IBM2, DMRV, NM",UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,603824,Nonaka myopathy,605820,AR,-,GNE
"GNE, GLCNE, IBM2, DMRV, NM",UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,603824,Sialuria,269921,AD,-,GNE
"PAX5, BSAP, ALL3",Paired box homeotic gene-5 (B-cell lineage specific activator protein),167414,"{Leukemia, acute lymphoblastic, susceptibility to, 3}",615545,-,-,PAX5
"GRHPR, GLXR",Glyoxylate reductase/hydroxypyruvate reductase,604296,"Hyperoxaluria, primary, type II",260000,AR,-,GRHPR
"EXOSC3, RRP40, PCH1B",Exosome component 3,606489,"Pontocerebellar hypoplasia, type 1B",614678,AR,-,EXOSC3
"DFNA51, C9DUPq21.11, DUP9q21.11","Deafness, autosomal dominant 51 (chromosome 9q21.11 duplication syndrome)",613558,"Deafness, autosomal dominant 51",613558,AD,259kb duplication involving TJP2 and FAM189A2,DFNA51
"PRKACG, BDPLT19","Protein kinase, cAMP-dependent, catalytic, gamma",176893,"?Bleeding disorder, platelet-type, 19",616176,AR,mutation identified in 1 BDPLT19 family,PRKACG
"FXN, FRDA, FARR, X25",Frataxin,606829,Friedreich ataxia,229300,AR,-,FXN
"FXN, FRDA, FARR, X25",Frataxin,606829,Friedreich ataxia with retained reflexes,229300,AR,-,FXN
"TJP2, ZO2, PFIC4",Tight junction protein 2,607709,"Cholestasis, progressive familial intrahepatic 4",615878,AR,-,TJP2
"TJP2, ZO2, PFIC4",Tight junction protein 2,607709,"Hypercholanemia, familial",607748,-,-,TJP2
"MIR204, MIRN204, RDICC",Micro RNA 204,610942,?Retinal dystrophy and iris coloboma with or without cataract,616722,AD,mutation identified in 1 RDICC family,MIR204
"TMC1, DFNB7, DFNB11, DFNA36",Transmembrane channel-like protein 1,606706,"Deafness, autosomal dominant 36",606705,AD,-,TMC1
"TMC1, DFNB7, DFNB11, DFNA36",Transmembrane channel-like protein 1,606706,"Deafness, autosomal recessive 7",600974,AR,-,TMC1
"TRPM6, CHAK2, HOMG1","Transient receptor potential cation channel, subfamily M, member 6",607009,"Hypomagnesemia 1, intestinal",602014,AR,-,TRPM6
"VPS13A, CHAC",Vacuolar protein sorting 13A (chorein),605978,Choreoacanthocytosis,200150,AR,-,VPS13A
"GNAQ, SWS, CMC1","Guanine nucleotide-binding protein (G protein), q",600998,"Capillary malformations, congenital, 1, somatic, mosaic",163000,-,pseudogene on 2q,GNAQ
"GNAQ, SWS, CMC1","Guanine nucleotide-binding protein (G protein), q",600998,"Sturge-Weber syndrome, somatic, mosaic",185300,-,-,GNAQ
"CEP78, CRDHL","Centrosomal protein, 78kD",617110,Cone-rod dystrophy and hearing loss,617236,AR,-,CEP78
"PSAT1, PSAT, EPIP, PSATD, NLS2",Phosphoserine aminotransferase 1,610936,?Phosphoserine aminotransferase deficiency,610992,AR,mutation identified in 1 PSATD family,PSAT1
"PSAT1, PSAT, EPIP, PSATD, NLS2",Phosphoserine aminotransferase 1,610936,Neu-Laxova syndrome 2,616038,AR,-,PSAT1
"HNRNPK, HNRPK, AUKS",Heterogeneous nuclear ribonucleoprotein K,600712,Au-Kline syndrome,616580,AD,-,HNRNPK
"NTRK2, TRKB, OBHD, EIEE58","Neurotrophic tyrosine kinase, receptor, type 2",600456,"Epileptic encephalopathy, early infantile, 58",617830,AD,-,NTRK2
"NTRK2, TRKB, OBHD, EIEE58","Neurotrophic tyrosine kinase, receptor, type 2",600456,"Obesity, hyperphagia, and developmental delay",613886,AD,-,NTRK2
"ISCA1, HBLD2, HISCA, MMDS5","Iron-sulfur cluster assembly 1, S. cerevisiae, homolog of",611006,Multiple mitochondrial dysfunctions syndrome 5,617613,AR,-,ISCA1
"SECISBP2, SBP2",Selenocysteine insertion sequence-binding protein 2,607693,"Thyroid hormone metabolism, abnormal",609698,-,-,SECISBP2
AUH,AU-specific RNA-binding protein (3-methylglutaconyl-CoA hydratase),600529,"3-methylglutaconic aciduria, type I",250950,AR,-,AUH
"ROR2, BDB1, BDB, NTRKR2",Receptor tyrosine kinase-like orphan receptor 2,602337,"Brachydactyly, type B1",113000,AD,-,ROR2
"ROR2, BDB1, BDB, NTRKR2",Receptor tyrosine kinase-like orphan receptor 2,602337,"Robinow syndrome, autosomal recessive",268310,AR,-,ROR2
"SPTLC1, LBC1, SPT1, HSN1, HSAN","Serine palmitoyltransferase, long-chain base subunit 1",605712,"Neuropathy, hereditary sensory and autonomic, type IA",162400,AD,-,SPTLC1
"IARS, GRIDHH",Isoleucine-tRNA synthetase,600709,"Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy",617093,AR,-,IARS
"ASPN, PLAP1, OS3",Asporin,608135,{Lumbar disc degeneration},603932,-,-,ASPN
"ASPN, PLAP1, OS3",Asporin,608135,{Osteoarthritis susceptibility 3},607850,AD,-,ASPN
"BICD2, KIAA0699, SMALED2","Bicaudal D, Drosophila, homolog of, 2",609797,"Spinal muscular atrophy, lower extremity-predominant, 2, AD",615290,AD,-,BICD2
FBP1,Fructose-bisphosphatase 1,611570,"Fructose-1,6-bisphosphatase deficiency",229700,AR,-,FBP1
"FANCC, FACC","Fanconi anemia, complementation group C",613899,"Fanconi anemia, complementation group C",227645,AR,-,FANCC
"PTCH1, NBCCS, BCNS, HPE7","Patched, Drosophila, homolog of",601309,"Basal cell carcinoma, somatic",605462,-,-,PTCH1
"PTCH1, NBCCS, BCNS, HPE7","Patched, Drosophila, homolog of",601309,Basal cell nevus syndrome,109400,AD,-,PTCH1
"PTCH1, NBCCS, BCNS, HPE7","Patched, Drosophila, homolog of",601309,Holoprosencephaly 7,610828,AD,-,PTCH1
"ERCC6L2, RAD26L, BMFS2",ERCC6-like 2,615667,Bone marrow failure syndrome 2,615715,AR,-,ERCC6L2
"HSD17B3, EDH17B3",Hydroxysteroid (17-beta) dehydrogenase 3,605573,"Pseudohermaphroditism, male, with gynecomastia",264300,AR,-,HSD17B3
"TDRD7, KIAA1529, TRAP, CATC4, CTRCT36",Tudor domain-containing protein 7,611258,Cataract 36,613887,AR,-,TDRD7
"XPA, XPAC",XPA complementing gene,611153,"Xeroderma pigmentosum, group A",278700,AR,-,XPA
"FOXE1, FKHL15, TITF2, TTF2, NMTC4",Forkhead box E1 (thyroid transcription factor-2),602617,Bamforth-Lazarus syndrome,241850,AR,-,FOXE1
"FOXE1, FKHL15, TITF2, TTF2, NMTC4",Forkhead box E1 (thyroid transcription factor-2),602617,"{Thyroid cancer, nonmedullary, 4}",616534,AD,-,FOXE1
"NANS, SAS, SEMDCG",N-acetylneuraminic acid synthase (sialic acid synthase),605202,"Spondyloepimetaphyseal dysplasia, Camera-Genevieve type",610442,AR,-,NANS
"GABBR2, GPR51, EIEE59",Gamma-aminobutyric acid B receptor 2,607340,"Epileptic encephalopathy, early infantile, 59",617904,AD,-,GABBR2
"GABBR2, GPR51, EIEE59",Gamma-aminobutyric acid B receptor 2,607340,"{Nicotine dependence, protection against}",188890,-,-,GABBR2
"GABBR2, GPR51, EIEE59",Gamma-aminobutyric acid B receptor 2,607340,"{Nicotine dependence, susceptibility to}",188890,-,-,GABBR2
"ANKS6, PKDR1, NPHP16",Ankyrin repeat and sterile alpha motif domains-containing protein 6,615370,Nephronophthisis 16,615382,AR,-,ANKS6
"GALNT12, CRCS1",UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12,610290,"{Colorectal cancer, susceptibility to, 1}",608812,-,-,GALNT12
"TGFBR1, ALK5, AAT5, LDS1, MSSE","Transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kD)",190181,Loeys-Dietz syndrome 1,609192,AD,-,TGFBR1
"TGFBR1, ALK5, AAT5, LDS1, MSSE","Transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kD)",190181,"{Multiple self-healing squamous epithelioma, susceptibility to}",132800,AD,-,TGFBR1
"ALG2, CDGII, CMSTA3, CMS14","Alg2, S. cerevisiae, homolog of",607905,"?Congenital disorder of glycosylation, type Ii",607906,AR,mutation identified in 1 CDGII patient,ALG2
"ALG2, CDGII, CMSTA3, CMS14","Alg2, S. cerevisiae, homolog of",607905,"Myasthenic syndrome, congenital, 14, with tubular aggregates",616228,AR,-,ALG2
CSMF,"Chondrosarcoma, extraskeletal myxoid, fused to EWS in",600542,"Chondrosarcoma, extraskeletal myxoid",612237,-,t(9;17)(q22;q11); t(9;22)(q22;q11-q12),CSMF
"INVS, INV, NPHP2, NPH2",Inversin,243305,"Nephronophthisis 2, infantile",602088,AR,-,INVS
BAAT,Bile acid coenzyme A:amino acid N-acyltransferase (glycine N-choloyltransferase),602938,"Hypercholanemia, familial",607748,-,-,BAAT
ALDOB,"Aldolase B, fructose-bisphosphatase",612724,"Fructose intolerance, hereditary",229600,AR,-,ALDOB
"ABCA1, ABC1, HDLDT1, TGD",ATP-binding cassette 1,600046,"HDL deficiency, type 2",604091,-,-,ABCA1
"ABCA1, ABC1, HDLDT1, TGD",ATP-binding cassette 1,600046,Tangier disease,205400,AR,-,ABCA1
"ABCA1, ABC1, HDLDT1, TGD",ATP-binding cassette 1,600046,"{Coronary artery disease in familial hypercholesterolemia, protection against}",143890,AD,-,ABCA1
"FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4",Fukutin,607440,"Cardiomyopathy, dilated, 1X",611615,AR,-,FKTN
"FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4",Fukutin,607440,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4",253800,AR,-,FKTN
"FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4",Fukutin,607440,"Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4",613152,AR,-,FKTN
"FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4",Fukutin,607440,"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4",611588,AR,-,FKTN
"TMEM38B, TRICB, OI14",Transmembrane protein 38B,611236,"Osteogenesis imperfecta, type XIV",615066,-,-,TMEM38B
"IKBKAP, IKAP","Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase complex-associated protein",603722,"Dysautonomia, familial",223900,AR,-,IKBKAP
"FRRS1L, C9orf4, CG6, EIEE37",Ferric-chelate reductase 1-like,604574,"Epileptic encephalopathy, early infantile, 37",616981,AR,-,FRRS1L
"MUSK, CMS9, FADS",Receptor tyrosine kinase MuSK,601296,Fetal akinesia deformation sequence,208150,AR,-,MUSK
"MUSK, CMS9, FADS",Receptor tyrosine kinase MuSK,601296,"Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency",616325,AR,-,MUSK
"PRPF4, PRP4, HPRP4, RP70","Precursor mRNA-processing factor 4, S. cerevisiae, homolog of",607795,Retinitis pigmentosa 70,615922,AD,-,PRPF4
"ALAD, ALADH, PBGS","Aminolevulinate, delta-, dehydratase",125270,"Porphyria, acute hepatic",612740,AR,linked to ABO; ORM-ALAD-AK-ABO,ALAD
"ALAD, ALADH, PBGS","Aminolevulinate, delta-, dehydratase",125270,"{Lead poisoning, susceptibility to}",612740,AR,-,ALAD
"COL27A1, KIAA1870, STLS","Collagen, type XXVII, alpha-1",608461,?Steel syndrome,615155,AR,mutation identified in 1 STLS family,COL27A1
"WHRN, CIP98, KIAA1526, DFNB31, USH2D",Whirlin,607928,"Deafness, autosomal recessive 31",607084,AR,-,WHRN
"WHRN, CIP98, KIAA1526, DFNB31, USH2D",Whirlin,607928,"Usher syndrome, type 2D",611383,AR,-,WHRN
"TNC, HXB, DFNA56",Tenascin C (hexabrachion),187380,"Deafness, autosomal dominant 56",615629,AD,proximal to ABL,TNC
2018/12/1 0:00,Deleted in esophageal cancer 1,604767,Esophageal squamous cell carcinoma,133239,AD,-,2018/12/1 0:00
"TRIM32, HT2A, LGMD2H, BBS11",Tripartite-motif-containing protein 32,602290,?Bardet-Biedl syndrome 11,615988,AR,mutation identified in 1 BBS11 family,TRIM32
"TRIM32, HT2A, LGMD2H, BBS11",Tripartite-motif-containing protein 32,602290,"Muscular dystrophy, limb-girdle, type 2H",254110,AR,-,TRIM32
"CDK5RAP2, KIAA1633, MCPH3",CDK5 regulatory subunit-associated protein 2,608201,"Microcephaly 3, primary, autosomal recessive",604804,AR,-,CDK5RAP2
"C5, C5D, ECLZB",Complement component-5,120900,C5 deficiency,609536,-,-,C5
"C5, C5D, ECLZB",Complement component-5,120900,"[Eculizumab, poor response to]",615749,AD,-,C5
GSN,Gelsolin,137350,"Amyloidosis, Finnish type",105120,AD,40kb proximal to ABL,GSN
"CRB2, FSGS9, VMCKD","Crumbs, Drosophila, homolog of",609720,Focal segmental glomerulosclerosis 9,616220,AR,-,CRB2
"CRB2, FSGS9, VMCKD","Crumbs, Drosophila, homolog of",609720,Ventriculomegaly with cystic kidney disease,219730,AR,-,CRB2
"NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4","Nuclear receptor subfamily 5, group A, member 1",184757,"46, XX sex reversal 4",617480,AD,-,NR5A1
"NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4","Nuclear receptor subfamily 5, group A, member 1",184757,46XY sex reversal 3,612965,AD,-,NR5A1
"NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4","Nuclear receptor subfamily 5, group A, member 1",184757,Adrenocortical insufficiency,612964,AD,-,NR5A1
"NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4","Nuclear receptor subfamily 5, group A, member 1",184757,Premature ovarian failure 7,612964,AD,-,NR5A1
"NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4","Nuclear receptor subfamily 5, group A, member 1",184757,Spermatogenic failure 8,613957,AD,-,NR5A1
"LMX1B, NPS1","LIM homeo box transcription factor 1, beta",602575,Nail-patella syndrome,161200,AD,-,LMX1B
"LRSAM1, TAL, RIFLE, CMT2P",Leucine-rich repeat- and sterile alpha motif-containing 1,610933,"Charcot-Marie-Tooth disease, axonal, type 2P",614436,"AD,AR",-,LRSAM1
"STXBP1, UNC18, EIEE4",Syntaxin-binding protein 1,602926,"Epileptic encephalopathy, early infantile, 4",612164,AD,-,STXBP1
"MIR2861, MIRN2861, BMND15",Micro RNA 2861,613405,[Bone mineral density QTL 15],613418,"AD,AR",-,MIR2861
"ENG, END, HHT1, ORW",Endoglin,131195,"Telangiectasia, hereditary hemorrhagic, type 1",187300,AD,-,ENG
AK1,Adenylate kinase-1,103000,Hemolytic anemia due to adenylate kinase deficiency,612631,AR,"proximal to Ph1 break, 9q34.1; AK1 to ORM = 17cM",AK1
"DPM2, CDG1U","Dolichyl-phosphate mannosyltransferase 2, regulatory subunit",603564,"Congenital disorder of glycosylation, type Iu",615042,AR,-,DPM2
"DNM1, EIEE31",Dynamin-1,602377,"Epileptic encephalopathy, early infantile, 31",616346,AD,-,DNM1
"COQ4, COQ10D7","Coenzyme Q4, S. cerevisiae, homolog of",612898,"Coenzyme Q10 deficiency, primary, 7",616276,AR,-,COQ4
"SLC27A4, FATP4, IPS","Solute carrier family 27 (fatty acid transporter), member 4",604194,Ichthyosis prematurity syndrome,608649,-,-,SLC27A4
"GLE1, GLE1L, LCCS, LCCS1","Gle1, RNA export mediator, S. cerevisiae, homolog of",603371,"Arthrogryposis, lethal, with anterior horn cell disease",611890,-,-,GLE1
"GLE1, GLE1L, LCCS, LCCS1","Gle1, RNA export mediator, S. cerevisiae, homolog of",603371,Lethal congenital contracture syndrome 1,253310,AR,-,GLE1
"SPTAN1, NEAS, EIEE5","Spectrin, alpha, nonerythrocytic-1 (alpha-fodrin)",182810,"Epileptic encephalopathy, early infantile, 5",613477,AD,-,SPTAN1
"WDR34, SRTD11",WD repeat-containing protein 34,613363,Short-rib thoracic dysplasia 11 with or without polydactyly,615633,AR,-,WDR34
"LRRC8A, KIAA1437, AGM5",Leucine-rich repeat-containing 8A,608360,?Agammaglobulinemia 5,613506,AD,mutation identified in 1 AGM5 patient,LRRC8A
"DOLK, TMEM15, DK1, SEC59, KIAA1094, CDG1M",Dolichol kinase,610746,"Congenital disorder of glycosylation, type Im",610768,AR,-,DOLK
"DYT1, TOR1A",Torsin A,605204,"Dystonia-1, torsion",128100,AD,-,DYT1
"DYT1, TOR1A",Torsin A,605204,"{Dystonia-1, modifier of}",-,-,-,DYT1
"ASS1, ASS",Argininosuccinate synthetase 1,603470,Citrullinemia,215700,AR,"14 pseudogenes on 11 chromosomes, including X and Y and ASSP2 on 6p23-q12",ASS1
"PRDM12, HSAN8",PR domain-containing protein 12,616458,"Neuropathy, hereditary sensory and autonomic, type VIII",616488,AR,-,PRDM12
"EXOSC2, RRP4, SHRF",Exosome component 2,602238,"Short stature, hearing loss, retinitis pigmentosa, and distinctive facies",617763,AR,-,EXOSC2
"ABL1, CHDSKM",Abelson murine leukemia viral (v-abl) oncogene homolog 1,189980,Congenital heart defects and skeletal malformations syndrome,617602,AD,fusion hybrid gene with BCR1 in CML,ABL1
"ABL1, CHDSKM",Abelson murine leukemia viral (v-abl) oncogene homolog 1,189980,"Leukemia, Philadelphia chromosome-positive, resistant to imatinib",-,-,-,ABL1
"LAMC3, OCCM","Laminin, gamma-3",604349,"Cortical malformations, occipital",614115,AR,-,LAMC3
"NUP214, D9S46E, CAN, CAIN","Nucleoporin, 214kD",114350,"Leukemia, acute myeloid, somatic",601626,-,fused with DEK in AML; fused with ABL1 in T-ALL,NUP214
"NUP214, D9S46E, CAN, CAIN","Nucleoporin, 214kD",114350,"Leukemia, T-cell acute lymphoblastic, somatic",613065,-,-,NUP214
"POMT1, MDDGA1, MDDGB1, MDDGC1",Protein O-mannosyltransferase 1,607423,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1",236670,AR,-,POMT1
"POMT1, MDDGA1, MDDGB1, MDDGC1",Protein O-mannosyltransferase 1,607423,"Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1",613155,AR,-,POMT1
"POMT1, MDDGA1, MDDGB1, MDDGC1",Protein O-mannosyltransferase 1,607423,"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1",609308,AR,-,POMT1
"SETX, SCAR1, AOA2, ALS4",Senataxin,608465,"Amyotrophic lateral sclerosis 4, juvenile",602433,AD,-,SETX
"SETX, SCAR1, AOA2, ALS4",Senataxin,608465,"Spinocerebellar ataxia, autosomal recessive 1",606002,AR,-,SETX
"TSC1, LAM",Hamartin (tuberous sclerosis 1 gene),605284,"Focal cortical dysplasia, type II, somatic",607341,-,"linked to ABO, ABL",TSC1
"TSC1, LAM",Hamartin (tuberous sclerosis 1 gene),605284,Lymphangioleiomyomatosis,606690,-,-,TSC1
"TSC1, LAM",Hamartin (tuberous sclerosis 1 gene),605284,Tuberous sclerosis-1,191100,AD,-,TSC1
"GFI1B, BDPLT17",Growth factor-independent 1B,604383,"Bleeding disorder, platelet-type, 17",187900,"AD,AR",-,GFI1B
"CEL, BSSL, CELL, MODY8",Carboxyl-ester lipase (bile-salt stimulated lipase),114840,"Maturity-onset diabetes of the young, type VIII",609812,AD,-,CEL
ABO,ABO glycosyltransferase,110300,"[Blood group, ABO system]",616093,-,linked to AK1,ABO
"SURF1, CMT4K",Surfeit-1,185620,"Charcot-Marie-Tooth disease, type 4K",616684,AR,"distal to ABL, CAN",SURF1
"SURF1, CMT4K",Surfeit-1,185620,"Leigh syndrome, due to COX IV deficiency",256000,"Mi,AR",-,SURF1
"ADAMTS13, VWFCP, TTP","A disintegrin-like and metalloprotease with thrombospondin type 1 motif, 13",604134,"Thrombotic thrombocytopenic purpura, familial",274150,AR,-,ADAMTS13
"MYMK, TMEM8C",Myomaker,615345,Carey-Fineman-Ziter syndrome,254940,AR,-,MYMK
"ADAMTSL2, KIAA0605, GPHYSD1",ADAMTS-like protein 2,612277,Geleophysic dysplasia 1,231050,AR,-,ADAMTSL2
DBH,Dopamine-beta-hydroxylase,609312,Dopamine beta-hydroxylase deficiency,223360,AR,tightly linked to ABO,DBH
DBH,Dopamine-beta-hydroxylase,609312,"[Dopamine-beta-hydroxylase activity levels, plasma]",-,-,-,DBH
"SARDH, SARD, SAR",Sarcosine dehydrogenase,604455,[Sarcosinemia],268900,AR,-,SARDH
"COL5A1, EDSCL1","Collagen V, alpha-1 polypeptide",120215,"Ehlers-Danlos syndrome, classic type, 1",130000,AD,-,COL5A1
"SOHLH1, NOHLH, TEB2, ODG5",Spermatogenesis- and oogenesis-specific basic helix-look-helix protein 1,610224,Ovarian dysgenesis 5,617690,AR,-,SOHLH1
"KCNT1, KIAA1422, EIEE14, ENFL5","Potassium channel, subfamily T, member 1",608167,"Epilepsy, nocturnal frontal lobe, 5",615005,AD,-,KCNT1
"KCNT1, KIAA1422, EIEE14, ENFL5","Potassium channel, subfamily T, member 1",608167,"Epileptic encephalopathy, early infantile, 14",614959,AD,-,KCNT1
"LHX3, CPHD3",LIM/homeodomain protein LHX3,600577,"Pituitary hormone deficiency, combined, 3",221750,AR,"in mouse, close to Notch1; centromeric to ABL",LHX3
"CARD9, CANDF2",Caspase recruitment domain-containing protein 9,607212,"Candidiasis, familial, 2, autosomal recessive",212050,AR,-,CARD9
"PMPCA, KIAA0123, SCAR2","Peptidase, mitochondrial processing, alpha",613036,"Spinocerebellar ataxia, autosomal recessive 2",213200,AR,-,PMPCA
"INPP5E, MORMS, JBTS1, CORS1","Inositol polyphosphate-5-phosphatase, 72kD",613037,Joubert syndrome 1,213300,AR,-,INPP5E
"INPP5E, MORMS, JBTS1, CORS1","Inositol polyphosphate-5-phosphatase, 72kD",613037,"Mental retardation, truncal obesity, retinal dystrophy, and micropenis",610156,AR,-,INPP5E
"NOTCH1, TAN1, AOS5, AOVD1","Notch, Drosophila, homolog of, 1, translocation-associated",190198,Adams-Oliver syndrome 5,616028,AD,-,NOTCH1
"NOTCH1, TAN1, AOS5, AOVD1","Notch, Drosophila, homolog of, 1, translocation-associated",190198,Aortic valve disease 1,109730,AD,-,NOTCH1
"AGPAT2, LPAAB, BSCL, BSCL1",1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase-beta),603100,"Lipodystrophy, congenital generalized, type 1",608594,AR,-,AGPAT2
"MAN1B1, MRT15","Mannosidase, alpha, class 1B member 1",604346,"Mental retardation, autosomal recessive 15",614202,AR,-,MAN1B1
"GRIN1, NMDAR1, NDHMSR, NDHMSD","Glutamate receptor, ionotropic, N-methyl D-aspartate 1",138249,"Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant",614254,AD,-,GRIN1
"GRIN1, NMDAR1, NDHMSR, NDHMSD","Glutamate receptor, ionotropic, N-methyl D-aspartate 1",138249,"Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive",617820,AR,-,GRIN1
"TPRN, C9orf75, DFNB79",Taperin,613354,"Deafness, autosomal recessive 79",613307,AR,-,TPRN
"SLC34A3, NPTIIC, HHRH","Solute carrier family 34 (sodium/phosphate cotransporter), member 3",609826,Hypophosphatemic rickets with hypercalciuria,241530,AR,-,SLC34A3
"TUBB4B, TUBB2C, LCAEOD","Tubulin, beta-4B",602660,Leber congenital amaurosis with early-onset deafness,617879,AD,-,TUBB4B
"NSMF, NELF, HH9",NMDA receptor synaptonuclear signaling and neuronal migration factor,608137,Hypogonadotropic hypogonadism 9 with or without anosmia,614838,AD,-,NSMF
"EHMT1, EUHMTASE1, DEL9q34, KLEFS1",Euchromatic histone methyltransferase 1,607001,Kleefstra syndrome 1,610253,AD,-,EHMT1
"CACNA1B, CACNL1A5, DYT23","Calcium channel, voltage-dependent, L type, alpha 1B subunit",601012,?Dystonia 23,614860,AD,mutation identified in 1 DYT23 family,CACNA1B
"TUBB8, OOMD2","Tubulin, beta 8",616768,Oocyte maturation defect 2,616780,"AD,AR",-,TUBB8
"ZMYND11, BS69, BRAM1, MRD30",Zinc finger MYND domain-containing protein 11,608668,"Mental retardation, autosomal dominant 30",616083,AD,-,ZMYND11
"KLF6, COPEB, BCD1, ZF9",Kruppel-like factor-6,602053,"Gastric cancer, somatic",613659,-,-,KLF6
"KLF6, COPEB, BCD1, ZF9",Kruppel-like factor-6,602053,"Prostate cancer, somatic",176807,-,-,KLF6
"AKR1C2, DDH2, DD2, HAKRD, SRXY8","Aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase, type II)",600450,46XY sex reversal 8,614279,AR,-,AKR1C2
"AKR1C2, DDH2, DD2, HAKRD, SRXY8","Aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase, type II)",600450,"Obesity, hyperphagia, and developmental delay",-,-,-,AKR1C2
"AKR1C4, CHDR, CDR, HAKRA, DD4","Aldo-keto reductase family 1, member C4 (chlordecone reductase)",600451,"{46XY sex reversal 8, modifier of}",614279,AR,-,AKR1C4
"IL2RA, CD25, IL2R, IDDM10, IMD41","Interleukin-2 receptor, alpha",147730,Immunodeficiency 41 with lymphoproliferation and autoimmunity,606367,AR,-,IL2RA
"IL2RA, CD25, IL2R, IDDM10, IMD41","Interleukin-2 receptor, alpha",147730,"{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}",601942,-,-,IL2RA
"GATA3, HDR, HDRS",GATA-binding protein-3,131320,"Hypoparathyroidism, sensorineural deafness, and renal dysplasia",146255,AD,-,GATA3
"DHTKD1, KIAA1630, AMOXAD, CMT2Q",Dehydrogenase E1 and transketolase domains-containing protein 1,614984,2-aminoadipic 2-oxoadipic aciduria,204750,AR,mutation identified in 1 CMT2Q family,DHTKD1
"DHTKD1, KIAA1630, AMOXAD, CMT2Q",Dehydrogenase E1 and transketolase domains-containing protein 1,614984,"?Charcot-Marie-Tooth disease, axonal, type 2Q",615025,AD,-,DHTKD1
"OPTN, GLC1E, FIP2, HYPL, NRP, ALS12",Optineurin,602432,Amyotrophic lateral sclerosis 12,613435,-,-,OPTN
"OPTN, GLC1E, FIP2, HYPL, NRP, ALS12",Optineurin,602432,"Glaucoma 1, open angle, E",137760,AD,-,OPTN
"OPTN, GLC1E, FIP2, HYPL, NRP, ALS12",Optineurin,602432,"{Glaucoma, normal tension, susceptibility to}",606657,-,-,OPTN
"PHYH, PAHX",Phytanoyl-CoA hydroxylase,602026,Refsum disease,266500,AR,-,PHYH
"FRMD4A, KIAA1294, CCAFCA",FERM domain-containing protein 4A,616305,"?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia",616819,AR,mutation identified in 1 CCAFCA family,FRMD4A
"DCLRE1C, ARTEMIS, SCIDA",DNA cross-link repair protein 1C,605988,Omenn syndrome,603554,AR,-,DCLRE1C
"DCLRE1C, ARTEMIS, SCIDA",DNA cross-link repair protein 1C,605988,"Severe combined immunodeficiency, Athabascan type",602450,AR,-,DCLRE1C
"ITGA8, RHDA1","Integrin, alpha-8",604063,Renal hypodysplasia/aplasia 1,191830,AR,-,ITGA8
"CUBN, IFCR, MGA1",Cubilin (intrinsic factor-cobalamin receptor),602997,"Megaloblastic anemia-1, Finnish type",261100,AR,-,CUBN
"VIM, CTRCT30",Vimentin,193060,"Cataract 30, pulverulent",116300,AD,-,VIM
CACNB2,"Calcium channel, voltage-dependent, beta 2 subunit",600003,Brugada syndrome 4,611876,-,-,CACNB2
AF10,ALL1 fused gene from chromosome 10,602409,"Leukemia, acute myeloid",601626,AD,fuses with MLL and HEAB,AF10
"PTF1A, PACA, PAGEN2","Pancreas transcription factor 1, alpha subunit",607194,Pancreatic agenesis 2,615935,AR,-,PTF1A
"PTF1A, PACA, PAGEN2","Pancreas transcription factor 1, alpha subunit",607194,Pancreatic and cerebellar agenesis,609069,AR,-,PTF1A
"MYO3A, DFNB30",Myosin IIIA,606808,"Deafness, autosomal recessive 30",607101,AR,-,MYO3A
"PDSS1, TPT, COQ1, COQ10D2","Prenyl diphosphate synthase, subunit 1",607429,"Coenzyme Q10 deficiency, primary, 2",614651,AR,-,PDSS1
"ANKRD26, KIAA1074, THC2",Ankyrin repeat domain-containing protein 26,610855,Thrombocytopenia 2,188000,AD,-,ANKRD26
"YME1L1, YME1L, PAMP, OPA11",Mitochondrial escape 1-like 1,607472,?Optic atrophy 11,617302,AR,mutation identified in1 OPA11 family,YME1L1
"RAB18, WARBM3",Ras-associated protein RAB18,602207,Warburg micro syndrome 3,614222,AR,-,RAB18
"ARMC4, CILD23",Armadillo repeat-containing protein 4,615408,"Ciliary dyskinesia, primary, 23",615451,AR,-,ARMC4
"WAC, KIAA1844, DESSH",WW domain-containing adaptor with coiled-coil region,615049,Desanto-Shinawi syndrome,616708,AD,-,WAC
"MTPAP, PAPD1, SPAX4",Mitochondrial poly(A) polymerase,613669,"?Spastic ataxia 4, autosomal recessive",613672,AR,mutation identified in 1 SPAX4 family,MTPAP
"MAP3K8, COT, EST, TPL2",Mitogen-activated protein kinase kinase kinase 8 (cancer Osaka thyroid oncogene),191195,"Lung cancer, somatic",211980,-,-,MAP3K8
"ZEB1, TCF8, NIL2A, PPCD3, FECD6",Zinc finger E box-binding homeobox 1,189909,"Corneal dystrophy, Fuchs endothelial, 6",613270,-,-,ZEB1
"ZEB1, TCF8, NIL2A, PPCD3, FECD6",Zinc finger E box-binding homeobox 1,189909,"Corneal dystrophy, posterior polymorphous, 3",609141,-,-,ZEB1
"BMS1, BMS1L, KIAA0187, ACC","Bms1, ribosome assembly protein, S. cerevisiae, homolog of",611448,"?Aplasia cutis congenita, nonsyndromic",107600,AD,mutation identified in one ACC family,BMS1
"RET, MEN2A, HSCR1",RET transforming sequence; oncogene RET,164761,"Central hypoventilation syndrome, congenital",209880,AD,-,RET
"RET, MEN2A, HSCR1",RET transforming sequence; oncogene RET,164761,Medullary thyroid carcinoma,155240,AD,-,RET
"RET, MEN2A, HSCR1",RET transforming sequence; oncogene RET,164761,Multiple endocrine neoplasia IIA,171400,AD,-,RET
"RET, MEN2A, HSCR1",RET transforming sequence; oncogene RET,164761,Multiple endocrine neoplasia IIB,162300,AD,-,RET
"RET, MEN2A, HSCR1",RET transforming sequence; oncogene RET,164761,Pheochromocytoma,171300,AD,-,RET
"RET, MEN2A, HSCR1",RET transforming sequence; oncogene RET,164761,"{Hirschsprung disease, susceptibility to, 1}",142623,AD,-,RET
"CXCL12, SDF1","Chemokine, C-X-C motif, ligand 12 (stromal cell-derived factor 1)",600835,"{AIDS, resistance to}",609423,-,-,CXCL12
ALOX5,Arachidonate 5-lipoxygenase,152390,"{Asthma, diminished response to antileukotriene treatment in}",600807,AD,-,ALOX5
ALOX5,Arachidonate 5-lipoxygenase,152390,"{Atherosclerosis, susceptibility to}",-,-,-,ALOX5
"MSMB, HPC13","Microseminoprotein, beta",157145,"{Prostate cancer, hereditary, 13}",611928,-,-,MSMB
"GDF2, BMP9, HHT5",Growth differentiation factor 2 (bone morphogenetic protein 9),605120,"Telangiectasia, hereditary hemorrhagic, type 5",615506,AD,-,GDF2
"RBP3, RP66","Retinol-binding protein-3, interstitial",180290,?Retinitis pigmentosa 66,615233,AR,1 family identified with mutation,RBP3
"ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11","Excision repair cross complementing rodent repair deficiency, complementation group 6",609413,Cerebrooculofacioskeletal syndrome 1,214150,AR,-,ERCC6
"ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11","Excision repair cross complementing rodent repair deficiency, complementation group 6",609413,"Cockayne syndrome, type B",133540,AR,-,ERCC6
"ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11","Excision repair cross complementing rodent repair deficiency, complementation group 6",609413,De Sanctis-Cacchione syndrome,278800,AR,-,ERCC6
"ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11","Excision repair cross complementing rodent repair deficiency, complementation group 6",609413,Premature ovarian failure 11,616946,AD,-,ERCC6
"ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11","Excision repair cross complementing rodent repair deficiency, complementation group 6",609413,UV-sensitive syndrome 1,600630,AR,-,ERCC6
"ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11","Excision repair cross complementing rodent repair deficiency, complementation group 6",609413,"{Lung cancer, susceptibility to}",211980,AR,-,ERCC6
"ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11","Excision repair cross complementing rodent repair deficiency, complementation group 6",609413,"{Macular degeneration, age-related, susceptibility to, 5}",613761,-,-,ERCC6
"CHAT, CMS6",Choline acetyltransferase,118490,"Myasthenic syndrome, congenital, 6, presynaptic",254210,AR,-,CHAT
"SLC18A3, VACHT, CMS21","Solute carrier family 18 (vesicular acetylcholine), member 3",600336,"Myasthenic syndrome, congenital, 21, presynaptic",617239,AR,-,SLC18A3
"PRKG1, PRKG1B, PRKGR1B, AAT8","Protein kinase, cGMP-dependent, regulatory, type I",176894,"Aortic aneurysm, familial thoracic 8",615436,AD,-,PRKG1
"MBL2, MBL, MBP1, MBL2D, MBPD","Mannose-binding lectin 2, soluble (opsonic defect)",154545,"{Chronic infections, due to MBL deficiency}",614372,AD,near MEN2A,MBL2
"PCDH15, DFNB23, USH1F",Protocadherin 15,605514,"Deafness, autosomal recessive 23",609533,AR,-,PCDH15
"PCDH15, DFNB23, USH1F",Protocadherin 15,605514,"Usher syndrome, type 1D/F digenic",601067,"AR,DR",-,PCDH15
"PCDH15, DFNB23, USH1F",Protocadherin 15,605514,"Usher syndrome, type 1F",602083,AR,-,PCDH15
"TFAM, TCF6L2, TCF6L1, TCF6L3, MTTF1, TCF6, MTDPS15","Transcription factor A, mitochondrial",600438,?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type),617156,AR,mutation identified in 1 MTDPS15 family,TFAM
"BICC1, BICC, CYSRD","Bicaudal C, Drosophila, homolog of, 1",614295,"{Renal dysplasia, cystic, susceptibility to}",601331,AD,-,BICC1
"ANK3, MRT37","Ankyrin-3, node of Ranvier",600465,"?Mental retardation, autosomal recessive, 37",615493,AR,mutation identified in 1 family,ANK3
"ZNF365, UAN",Zinc finger protein 365,607818,"{Nephrolithiasis, uric acid, susceptibility to}",605990,-,-,ZNF365
"EGR2, KROX20","KROX-20, Drosophila, homolog of (early growth response-2)",129010,"Charcot-Marie-Tooth disease, type 1D",607678,AD,-,EGR2
"EGR2, KROX20","KROX-20, Drosophila, homolog of (early growth response-2)",129010,Dejerine-Sottas disease,145900,"AD,AR",-,EGR2
"EGR2, KROX20","KROX-20, Drosophila, homolog of (early growth response-2)",129010,"Neuropathy, congenital hypomyelinating, 1",605253,"AD,AR",-,EGR2
"CTNNA3, ARVD13","Catenin, alpha-3",607667,"Arrhythmogenic right ventricular dysplasia, familial, 13",615616,AD,-,CTNNA3
"DNAJC12, JDP1, HPANBH4","DNAJ/HSP40 homolog, subfamily C, member 12",606060,"Hyperphenylalaninemia, mild, non-BH4-deficient",617384,AR,-,DNAJC12
"MYPN, CMD1DD, CMH22, RCM4, NEM11",Myopalladin,608517,"Cardiomyopathy, dilated, 1KK",615248,AD,-,MYPN
"MYPN, CMD1DD, CMH22, RCM4, NEM11",Myopalladin,608517,"Cardiomyopathy, familial restrictive, 4",615248,AD,-,MYPN
"MYPN, CMD1DD, CMH22, RCM4, NEM11",Myopalladin,608517,"Cardiomyopathy, hypertrophic, 22",615248,AD,-,MYPN
"MYPN, CMD1DD, CMH22, RCM4, NEM11",Myopalladin,608517,"Nemaline myopathy 11, autosomal recessive",617336,AR,-,MYPN
"ATOH7, PHPVAR, NCRNA","Atonal, Drosophila, homolog of, 7",609875,"Persistent hyperplastic primary vitreous, autosomal recessive",221900,AR,-,ATOH7
"DNA2, DNA2L, KIAA0083, PEOA6, SCKL8","DNA replication helicase 2, yeast, homolog of",601810,?Seckel syndrome 8,615807,AR,mutation identified in 1 SCKL8 family,DNA2
"DNA2, DNA2L, KIAA0083, PEOA6, SCKL8","DNA replication helicase 2, yeast, homolog of",601810,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6",615156,AD,-,DNA2
"STOX1, PEE4",Storkhead box 1,609397,Preeclampsia/eclampsia 4,609404,-,-,STOX1
KIAA1279,KIAA1279 gene,609367,Goldberg-Shprintzen megacolon syndrome,609460,AR,-,KIAA1279
"HK1, HKD, HMSNR, RP79",Hexokinase-1,142600,Hemolytic anemia due to hexokinase deficiency,235700,AR,10p11.2 conflicting assignment; ?2 loci on chr.10,HK1
"HK1, HKD, HMSNR, RP79",Hexokinase-1,142600,"Neuropathy, hereditary motor and sensory, Russe type",605285,AR,-,HK1
"HK1, HKD, HMSNR, RP79",Hexokinase-1,142600,Retinitis pigmentosa 79,617460,AD,-,HK1
"NEUROG3, NGN3, ATOH5",Neurogenin 3,604882,"Diarrhea 4, malabsorptive, congenital",610370,AR,-,NEUROG3
"COL13A1, CMS19","Collagen XIII, alpha-1 polypeptide",120350,"Myasthenic syndrome, congenital, 19",616720,AR,~550kb proximal to P4HA,COL13A1
"NODAL, HTX5","Nodal, mouse, homolog of",601265,"Heterotaxy, visceral, 5",270100,AD,-,NODAL
"PRF1, HPLH2, FLH2",Perforin,170280,Aplastic anemia,609135,-,mistakenly assigned to chr.17,PRF1
"PRF1, HPLH2, FLH2",Perforin,170280,"Hemophagocytic lymphohistiocytosis, familial, 2",603553,AR,-,PRF1
"PRF1, HPLH2, FLH2",Perforin,170280,"Lymphoma, non-Hodgkin",605027,-,-,PRF1
"SGPL1, SPL, NPHS14",Sphingosine-1-phosphate lyase 1,603729,Nephrotic syndrome 14,617575,AR,-,SGPL1
"PCBD1, DCOH",Pterin-4a-carbinolamine dehydratase 1,126090,"Hyperphenylalaninemia, BH4-deficient, D",264070,AR,-,PCBD1
"SLC29A3, ENT3, PHID, HCLAP","Solute carrier family 29 (nucleoside transporter), member 3",612373,Histiocytosis-lymphadenopathy plus syndrome,602782,AR,-,SLC29A3
"CDH23, USH1D, DFNB12, PITA5",Cadherin-23 (otocadherin),605516,"Deafness, autosomal recessive 12",601386,AR,between D10S529 and D10S573,CDH23
"CDH23, USH1D, DFNB12, PITA5",Cadherin-23 (otocadherin),605516,"Usher syndrome, type 1D",601067,"AR,DR",-,CDH23
"CDH23, USH1D, DFNB12, PITA5",Cadherin-23 (otocadherin),605516,"Usher syndrome, type 1D/F digenic",601067,"AR,DR",-,CDH23
"CDH23, USH1D, DFNB12, PITA5",Cadherin-23 (otocadherin),605516,"{Pituitary adenoma 5, multiple types}",617540,AD,-,CDH23
"PSAP, SAP1",Prosaposin (sphingolipid activator protein-1),176801,Combined SAP deficiency,611721,AR,-,PSAP
"PSAP, SAP1",Prosaposin (sphingolipid activator protein-1),176801,"Gaucher disease, atypical",610539,-,-,PSAP
"PSAP, SAP1",Prosaposin (sphingolipid activator protein-1),176801,"Krabbe disease, atypical",611722,AR,-,PSAP
"PSAP, SAP1",Prosaposin (sphingolipid activator protein-1),176801,Metachromatic leukodystrophy due to SAP-b deficiency,249900,AR,-,PSAP
"CHST3, C6ST, C6ST1, HSD",Carbohydrate sulfotransferase 3,603799,Spondyloepiphyseal dysplasia with congenital joint dislocations,143095,AR,-,CHST3
"ASCC1, p50, SMABF2","Activating signal cointegrator 1 complex, subunit 1",614215,?Spinal muscular atrophy with congenital bone fractures 2,616867,AR,mutation identified in 1 SMABF2 family,ASCC1
"ASCC1, p50, SMABF2","Activating signal cointegrator 1 complex, subunit 1",614215,Barrett esophagus/esophageal adenocarcinoma,614266,-,-,ASCC1
"MICU1, CBARA1, MPXPS",Mitochondrial calcium uptake protein 1,605084,Myopathy with extrapyramidal signs,615673,AR,-,MICU1
"MRPS16, COXPD2",Mitochondrial ribosomal protein S16,609204,Combined oxidative phosphorylation deficiency 2,610498,AR,-,MRPS16
"PLAU, URK, QPD, BDPLT5","Plasminogen activator, urokinase",191840,Quebec platelet disorder,601709,AD,proximal to HOX11,PLAU
"PLAU, URK, QPD, BDPLT5","Plasminogen activator, urokinase",191840,"{Alzheimer disease, late-onset, susceptibility to}",104300,AD,-,PLAU
"VCL, CMD1W, CMH15",Vinculin,193065,"Cardiomyopathy, dilated, 1W",611407,-,-,VCL
"VCL, CMD1W, CMH15",Vinculin,193065,"Cardiomyopathy, hypertrophic, 15",613255,AD,-,VCL
ADK,Adenosine kinase,102750,Hypermethioninemia due to adenosine kinase deficiency,614300,AR,-,ADK
"KAT6B, MYST4, MORF, GTPTS",Lysine acetyltransferase 6B,605880,Genitopatellar syndrome,606170,AD,-,KAT6B
"KAT6B, MYST4, MORF, GTPTS",Lysine acetyltransferase 6B,605880,SBBYSS syndrome,603736,AD,-,KAT6B
"C10orf11, OCA7",Chromosome 10 open reading frame 11,614537,"Albinism, oculocutaneous, type VII",615179,AR,-,C10orf11
SCZD11,"Schizophrenia susceptibility locus, chromosome 10q-related",608078,{Schizophrenia},181500,AD,between D10S1677 and D10S1753,SCZD11
"KCNMA1, SLO, PNKD3, CADEDS","Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (slowpoke, Drosophila, homolog of)",600150,"?Cerebellar atrophy, developmental delay, and seizures",617643,AR,mutation identified in 1 CADEDS family,KCNMA1
"KCNMA1, SLO, PNKD3, CADEDS","Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (slowpoke, Drosophila, homolog of)",600150,"Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy",609446,AD,-,KCNMA1
"POLR3A, RPC1, RPC155, ADDH, HLD7","Polymerase III, RNA, subunit A",614258,"Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism",607694,AR,-,POLR3A
"RPS24, DBA3",Ribosomal protein S24,602412,Diamond-blackfan anemia 3,610629,AD,-,RPS24
"SFTPA2, SPA2, COLEC5","Surfactant, pulmonary-associated protein A2",178642,"Pulmonary fibrosis, idiopathic",178500,AD,contiguous with SFTPA1,SFTPA2
"ANXA11, ANX11, ALS23",Annexin A11 (annexin XI),602572,Amytrophic lateral sclerosis 23,617839,AD,-,ANXA11
"MAT1A, MATA1, SAMS1","Methionine adenosyltransferase I, alpha",610550,"Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency",250850,"AD,AR",-,MAT1A
"MAT1A, MATA1, SAMS1","Methionine adenosyltransferase I, alpha",610550,"Methionine adenosyltransferase deficiency, autosomal recessive",250850,"AD,AR",-,MAT1A
"DEL10q23, C10DELq23",Chromosome 10q22.3-q23.2 deletion syndrome,612242,Chromosome 10q22.3-q23.2 deletion syndrome,612242,-,-,DEL10q23
"CDHR1, PCDH21, PRCAD, CORD15, RP65","Cadherin-related family, member 1",609502,Cone-rod dystrophy 15,613660,AR,-,CDHR1
"CDHR1, PCDH21, PRCAD, CORD15, RP65","Cadherin-related family, member 1",609502,Retinitis pigmentosa 65,613660,AR,-,CDHR1
"RGR, RP44",Retinal G protein coupled receptor,600342,Retinitis pigmentosa 44,613769,-,-,RGR
"LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3",LIM domain binding 3,605906,"Cardiomyopathy, dilated, 1C, with or without LVNC",601493,AD,-,LDB3
"LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3",LIM domain binding 3,605906,"Cardiomyopathy, hypertrophic, 24",601493,AD,-,LDB3
"LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3",LIM domain binding 3,605906,Left ventricular noncompaction 3,601493,AD,-,LDB3
"LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3",LIM domain binding 3,605906,"Myopathy, myofibrillar, 4",609452,AD,-,LDB3
"BMPR1A, ACVRLK3, ALK3","Bone morphogenetic protein receptor, type IA",601299,"Juvenile polyposis syndrome, infantile form",174900,AD,-,BMPR1A
"BMPR1A, ACVRLK3, ALK3","Bone morphogenetic protein receptor, type IA",601299,"Polyposis syndrome, hereditary mixed, 2",610069,-,-,BMPR1A
"BMPR1A, ACVRLK3, ALK3","Bone morphogenetic protein receptor, type IA",601299,"Polyposis, juvenile intestinal",174900,AD,-,BMPR1A
GLUD1,Glutamate dehydrogenase-1,138130,Hyperinsulinism-hyperammonemia syndrome,606762,AD,pseudogene on Xq26-q28,GLUD1
"MINPP1, HIPER1",Multiple inositol polyphosphate phosphatase 1,605391,"Thyroid carcinoma, follicular",188470,AD,-,MINPP1
"PAPSS2, ATPSK2, BCYM4",3'-phosphoadenosine 5'-phosphosulfate synthase 2,603005,Brachyolmia 4 with mild epiphyseal and metaphyseal changes,612847,AR,-,PAPSS2
"KLLN, CWS4",Killin,612105,Cowden syndrome 4,615107,-,-,KLLN
"PTEN, MMAC1, GLM2, CWS1",Phosphatase and tensin homolog (mutated in multiple advanced cancers 1),601728,Bannayan-Riley-Ruvalcaba syndrome,153480,AD,-,PTEN
"PTEN, MMAC1, GLM2, CWS1",Phosphatase and tensin homolog (mutated in multiple advanced cancers 1),601728,Cowden syndrome 1,158350,AD,-,PTEN
"PTEN, MMAC1, GLM2, CWS1",Phosphatase and tensin homolog (mutated in multiple advanced cancers 1),601728,"Endometrial carcinoma, somatic",608089,-,-,PTEN
"PTEN, MMAC1, GLM2, CWS1",Phosphatase and tensin homolog (mutated in multiple advanced cancers 1),601728,Lhermitte-Duclos syndrome,158350,AD,-,PTEN
"PTEN, MMAC1, GLM2, CWS1",Phosphatase and tensin homolog (mutated in multiple advanced cancers 1),601728,Macrocephaly/autism syndrome,605309,AD,-,PTEN
"PTEN, MMAC1, GLM2, CWS1",Phosphatase and tensin homolog (mutated in multiple advanced cancers 1),601728,"Malignant melanoma, somatic",155600,-,-,PTEN
"PTEN, MMAC1, GLM2, CWS1",Phosphatase and tensin homolog (mutated in multiple advanced cancers 1),601728,PTEN hamartoma tumor syndrome,-,-,-,PTEN
"PTEN, MMAC1, GLM2, CWS1",Phosphatase and tensin homolog (mutated in multiple advanced cancers 1),601728,"Squamous cell carcinoma, head and neck, somatic",275355,-,-,PTEN
"PTEN, MMAC1, GLM2, CWS1",Phosphatase and tensin homolog (mutated in multiple advanced cancers 1),601728,VATER association with macrocephaly and ventriculomegaly,276950,AR,-,PTEN
"PTEN, MMAC1, GLM2, CWS1",Phosphatase and tensin homolog (mutated in multiple advanced cancers 1),601728,{Glioma susceptibility 2},613028,-,-,PTEN
"PTEN, MMAC1, GLM2, CWS1",Phosphatase and tensin homolog (mutated in multiple advanced cancers 1),601728,{Meningioma},607174,AD,-,PTEN
"PTEN, MMAC1, GLM2, CWS1",Phosphatase and tensin homolog (mutated in multiple advanced cancers 1),601728,"{Prostate cancer, somatic}",176807,-,-,PTEN
"LIPN, LIPL4, ARCI8, LI4","Lipase family, member N",613924,"Ichthyosis, congenital, autosomal recessive 8",613943,AR,-,LIPN
"ACTA2, ACTSA, AAT6, MYMY5","Actin, alpha-2, smooth muscle, aorta",102620,"Aortic aneurysm, familial thoracic 6",611788,AD,-,ACTA2
"ACTA2, ACTSA, AAT6, MYMY5","Actin, alpha-2, smooth muscle, aorta",102620,Moyamoya disease 5,614042,-,-,ACTA2
"ACTA2, ACTSA, AAT6, MYMY5","Actin, alpha-2, smooth muscle, aorta",102620,Multisystemic smooth muscle dysfunction syndrome,613834,AD,-,ACTA2
"FAS, TNFRSF6, APT1, CD95, ALPS1A",Fas cell surface death receptor,134637,"Autoimmune lymphoproliferative syndrome, type IA",601859,AD,-,FAS
"FAS, TNFRSF6, APT1, CD95, ALPS1A",Fas cell surface death receptor,134637,"Squamous cell carcinoma, burn scar-related, somatic",-,-,-,FAS
"FAS, TNFRSF6, APT1, CD95, ALPS1A",Fas cell surface death receptor,134637,{Autoimmune lymphoproliferative syndrome},601859,AD,-,FAS
"LIPA, CESD","Lipase A, lysosomal acid, cholesterol esterase",613497,Cholesteryl ester storage disease,278000,AR,?close to GOT,LIPA
"LIPA, CESD","Lipase A, lysosomal acid, cholesterol esterase",613497,Wolman disease,278000,AR,-,LIPA
"SLC16A12, MCT12, CTRCT47","Solute carrier family 16 (monocarboxylic acid transporter), member 12",611910,"Cataract 47, juvenile, with microcornea",612018,AD,mutation identified in 1 CTRCT47 family,SLC16A12
"KIF11, KNSL1, MCLMR",Kinesin family member 11,148760,"Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation",152950,AD,-,KIF11
"CYP26C1, FFDD4","Cytochrome P450, subfamily XXVIC, polypeptide 1",608428,Focal facial dermal dysplasia 4,614974,AR,-,CYP26C1
"CEP55, MARCH","Centrosomal protein, 55kD",610000,"Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly",236500,AR,-,CEP55
"FFAR4, O3FAR1, GPR120, PGR4, BMIQ10",Free fatty acid receptor 4,609044,"{Obesity, susceptibility to}",607514,-,-,FFAR4
"RBP4, RDCCAS, MCOPCB10","Retinol-binding protein-4, interstitial",180250,"Microphthalmia, isolated, with coloboma 10",616428,AD,just centromeric of CYP2C cluster,RBP4
"RBP4, RDCCAS, MCOPCB10","Retinol-binding protein-4, interstitial",180250,"Retinal dystrophy, iris coloboma, and comedogenic acne syndrome",615147,AR,-,RBP4
"PDE6C, PDEA2, COD4","Phosphodiesterase-6C, cGMP-specific, cone, alpha prime",600827,Cone dystrophy 4,613093,AR,-,PDE6C
"LGI1, EPT, ETL1, ADLTE, ADPEAF","Leucine-rich gene, glioma-inactivated, 1",604619,"Epilepsy, familial temporal lobe, 1",600512,AD,-,LGI1
"PLCE1, KIAA1516, NPHS3","Phospholipase C, epsilon-1",608414,"Nephrotic syndrome, type 3",610725,AR,-,PLCE1
"HELLS, LSH, ICF4","Helicase, lymphoid-specific",603946,Immunodeficiency-centromeric instability-facial anomalies syndrome 4,616911,AR,-,HELLS
"CYP2C, CYP2C19","Cytochrome P450, subfamily IIC (mephenytoin 4'-hydroxylase)",124020,"Clopidogrel, impaired responsiveness to",609535,AR,4 genes in order: cen-C18-C19-C9-C8-tel,CYP2C
"CYP2C, CYP2C19","Cytochrome P450, subfamily IIC (mephenytoin 4'-hydroxylase)",124020,Mephenytoin poor metabolizer,609535,AR,-,CYP2C
"CYP2C, CYP2C19","Cytochrome P450, subfamily IIC (mephenytoin 4'-hydroxylase)",124020,Omeprazole poor metabolizer,609535,AR,-,CYP2C
"CYP2C, CYP2C19","Cytochrome P450, subfamily IIC (mephenytoin 4'-hydroxylase)",124020,Proguanil poor metabolizer,609535,AR,-,CYP2C
CYP2C9,"Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 9",601130,Tolbutamide poor metabolizer,-,-,-,CYP2C9
CYP2C9,"Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 9",601130,Warfarin sensitivity,122700,AD,-,CYP2C9
"SHFM3, SHSF3, DUP10q24, C10DUPq24",Split-hand/foot malformation 3 (Chromosome 10q24 duplication syndrome),246560,"Split-hand/foot malformation 3, gene duplication syndrome",246560,AD,contiguous gene duplication syndrome,SHFM3
"ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3","Aldehyde dehydrogenase 18 family, member A1 (1-pyrroline-5-carboxylate synthetase)",138250,"Cutis laxa, autosomal dominant 3",616603,AD,GOT1 and GSAS in same pathway,ALDH18A1
"ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3","Aldehyde dehydrogenase 18 family, member A1 (1-pyrroline-5-carboxylate synthetase)",138250,"Cutis laxa, autosomal recessive, type IIIA",219150,"IC,AR",-,ALDH18A1
"ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3","Aldehyde dehydrogenase 18 family, member A1 (1-pyrroline-5-carboxylate synthetase)",138250,"Spastic paraplegia 9A, autosomal dominant",601162,AD,-,ALDH18A1
"ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3","Aldehyde dehydrogenase 18 family, member A1 (1-pyrroline-5-carboxylate synthetase)",138250,"Spastic paraplegia 9B, autosomal recessive",616586,AR,-,ALDH18A1
"TCTN3, TECT3, C10orf61, OFD4, JBTS18","Tectonic family, member 3",613847,Joubert syndrome 18,614815,AR,-,TCTN3
"TCTN3, TECT3, C10orf61, OFD4, JBTS18","Tectonic family, member 3",613847,Orofaciodigital syndrome IV,258860,AR,-,TCTN3
"ENTPD1, CD39, SPG64",Ectonucleoside triphosphate diphosphohydrolase 1 (CD39 antigen),601752,"Spastic paraplegia 64, autosomal recessive",615683,AR,-,ENTPD1
"BLNK, SLP65, AGM4","B-cell linker protein (SH2 domain-containing leukocyte protein, 65kD)",604515,?Agammaglobulinemia 4,613502,AR,mutation identified in 1 AGM4 family,BLNK
"HOGA1, DHDPSL, HP3",4-hydroxy-2-oxoglutarate aldolase 1,613597,"Hyperoxaluria, primary, type III",613616,-,-,HOGA1
"ZFYVE27, SPG33",Zinc finger FYVE domain-containing protein 27,610243,"Spastic paraplegia 33, autosomal dominant",610244,AD,-,ZFYVE27
HPS1,HPS gene 1,604982,Hermansky-Pudlak syndrome 1,203300,AR,-,HPS1
"HPSE2, HPA2, UFS1",Heparanase 2,613469,Urofacial syndrome 1,236730,AR,-,HPSE2
"GOT1, ASTQTL1","Glutamic-oxaloacetic transaminase-1, soluble (EC 2.6.1.1)",138180,"Aspartate aminotransferase, serum level of, QTL1",614419,-,10q26.1 = conflicting localization,GOT1
"COX15, CEMCOX2","Cytochrome c oxidase, subunit 15",603646,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2",615119,AR,-,COX15
"COX15, CEMCOX2","Cytochrome c oxidase, subunit 15",603646,Leigh syndrome due to cytochrome c oxidase deficiency,256000,"Mi,AR",-,COX15
"ABCC2, CMOAT","ATP-binding cassette, subfamily C, member 2 (canalicular multispecific organic anion transporter)",601107,Dubin-Johnson syndrome,237500,AR,-,ABCC2
"CPN1, SCPN, CPN","Carboxypeptidase N, polypeptide 1, 50-kD",603103,Carboxypeptidase N deficiency,212070,AR,-,CPN1
"ERLIN1, SPG62",Endoplasmic reticulum lipid raft-associated protein 1,611604,Spastic paraplegia 62,615681,AR,-,ERLIN1
"CHUK, IKBKA, NFKBIKA, IKKA, IKK1",Conserved helix-loop-helix ubiquitous kinase,600664,Cocoon syndrome,613630,-,-,CHUK
"CWF19L1, C19L1, SCAR17",CWF19-like protein 1,616120,"Spinocerebellar ataxia, autosomal recessive 17",616127,AR,-,CWF19L1
"PAX2, PAPRS, FSGS7",Paired box homeotic gene-2,167409,"Glomerulosclerosis, focal segmental, 7",616002,AD,-,PAX2
"PAX2, PAPRS, FSGS7",Paired box homeotic gene-2,167409,Papillorenal syndrome,120330,AD,-,PAX2
"TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5",Twinkle mtDNA helicase,606075,Mitochondrial DNA depletion syndrome 7 (hepatocerebral type),271245,AR,PEO digenic with POLG,TWNK
"TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5",Twinkle mtDNA helicase,606075,Perrault syndrome 5,616138,AR,-,TWNK
"TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5",Twinkle mtDNA helicase,606075,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",609286,AD,-,TWNK
PDZD7,PDZ domain-containing 7,612971,"Usher syndrome, type IIC, GPR98/PDZD7 digenic",605472,"DD,AR",-,PDZD7
PDZD7,PDZ domain-containing 7,612971,"{Retinal disease in Usher syndrome type IIA, modifier of}",276901,AR,-,PDZD7
"FGF8, HH6",Fibroblast growth factor-8,600483,Hypogonadotropic hypogonadism 6 with or without anosmia,612702,AD,-,FGF8
"HPS6, RU",HPS gene 6,607522,Hermansky-Pudlak syndrome 6,614075,AR,-,HPS6
"PITX3, CTPP4, CTRCT11, ASGD1",Paired-like homeodomain transcription factor-3,602669,"Anterior segment dysgenesis 1, multiple subtypes",107250,AD,-,PITX3
"PITX3, CTPP4, CTRCT11, ASGD1",Paired-like homeodomain transcription factor-3,602669,"Cataract 11, multiple types",610623,AD,-,PITX3
"PITX3, CTPP4, CTRCT11, ASGD1",Paired-like homeodomain transcription factor-3,602669,"Cataract 11, syndromic",610623,AD,-,PITX3
"NFKB2, LYT10, CVID10",Nuclear factor of kappa light chain gene enhancer in B-cells 2 (p49/p100); oncogene Lyt-10,164012,"Immunodeficiency, common variable, 10",615577,AD,-,NFKB2
"SUFU, SUFUXL, SUFUH, JBTS32",Suppressor of fused,607035,Basal cell nevus syndrome,109400,AD,-,SUFU
"SUFU, SUFUXL, SUFUH, JBTS32",Suppressor of fused,607035,Joubert syndrome 32,617757,AR,-,SUFU
"SUFU, SUFUXL, SUFUH, JBTS32",Suppressor of fused,607035,"Medulloblastoma, desmoplastic",155255,"AD,AR",-,SUFU
"SUFU, SUFUXL, SUFUH, JBTS32",Suppressor of fused,607035,"{Meningioma, familial, susceptibility to}",607174,AD,-,SUFU
"CYP17A1, CYP17, P450C17","Cytochrome P450, family 17, subfamily A, polypeptide 1 (steroid 17-alpha-hydroxylase)",609300,"17,20-lyase deficiency, isolated",202110,AR,at least 2 genes; distal to GOT1,CYP17A1
"CYP17A1, CYP17, P450C17","Cytochrome P450, family 17, subfamily A, polypeptide 1 (steroid 17-alpha-hydroxylase)",609300,"17-alpha-hydroxylase/17,20-lyase deficiency",202110,AR,-,CYP17A1
"CNNM2, ACDP2, HOMG6, HOMGSMR",Cyclin M2,607803,"Hypomagnesemia 6, renal",613882,AD,-,CNNM2
"CNNM2, ACDP2, HOMG6, HOMGSMR",Cyclin M2,607803,"Hypomagnesemia, seizures, and mental retardation",616418,"AD,AR",-,CNNM2
"NT5C2, NT5B, PNT5, SPG45","5' nucleotidase, cytosolic II",600417,"Spastic paraplegia 45, autosomal recessive",613162,AR,-,NT5C2
"STN1, OBFC1, AAF44","STN1, CST complex subunit",613128,Cerebroretinal microangiopathy with calcifications and cysts 2,617341,AR,-,STN1
"COL17A1, BPAG2, ERED","Collagen XVII, alpha-1 polypeptide",113811,"Epidermolysis bullosa, junctional, localisata variant",226650,AR,-,COL17A1
"COL17A1, BPAG2, ERED","Collagen XVII, alpha-1 polypeptide",113811,"Epidermolysis bullosa, junctional, non-Herlitz type",226650,AR,-,COL17A1
"COL17A1, BPAG2, ERED","Collagen XVII, alpha-1 polypeptide",113811,Epithelial recurrent erosion dystrophy,122400,AD,-,COL17A1
"CFAP43, WDR96, C10orf79, SPGF19",Cilia- and flagella-associated protein 43,617558,Spermatogenic failure 19,617592,AR,-,CFAP43
"ADD3, ADDL, CPSQ3","Adducin-3, gamma",601568,"Cerebral palsy, spastic quadriplegic, 3",617008,AR,fusion with NUP98 in T-ALL,ADD3
MXI1,MAX-interacting protein 1,600020,Neurofibrosarcoma,-,-,-,MXI1
MXI1,MAX-interacting protein 1,600020,"{Prostate cancer, susceptibility to}",176807,AD,-,MXI1
"SMC3, CSPG6, HCAP, BAM, CDLS3",Structural maintenance of chromosomes 3,606062,Cornelia de Lange syndrome 3,610759,AD,-,SMC3
RBM20,RNA-binding motif protein 20,613171,"Cardiomyopathy, dilated, 1DD",613172,AD,-,RBM20
"BBIP1, NCRNA00081, BBIP10, BBS18",BBSome interacting protein 1,613605,?Bardet-Biedl syndrome 18,615995,AR,mutation identified in 1 BBS18 family,BBIP1
"SHOC2, SIAA0862, SOC2, SUR8","Suppressor of clear, C. elegans, homolog of",602775,Noonan-like syndrome with loose anagen hair,607721,AD,-,SHOC2
"TCF7L2, TCF4",Transcription factor 7-like 2,602228,"{Diabetes mellitus, type 2, susceptibility to}",125853,AD,-,TCF7L2
"HABP2, PHBP, HGFAL, FSAP, NMTC5",Hyaluronan-binding protein 2,603924,"{?Thyroid cancer, nonmedullary, 5}",616535,AD,mutation identified in 1 NMTC5 family,HABP2
"HABP2, PHBP, HGFAL, FSAP, NMTC5",Hyaluronan-binding protein 2,603924,"{Venous thromboembolism, susceptibility to}",188050,AD,-,HABP2
"ADRB1, ADRB1R, RHR","Adrenergic, beta-1-, receptor",109630,[Resting heart rate],607276,-,close linkage to ADRA2R,ADRB1
"ADRB1, ADRB1R, RHR","Adrenergic, beta-1-, receptor",109630,"{Congestive heart failure and beta-blocker response, modifier of}",-,-,-,ADRB1
"PNLIP, PNLIPD",Pancreatic lipase,246600,?Pancreatic lipase deficiency,614338,AR,mutation identified in 1 family,PNLIP
"VAX1, MCOPS11",Ventral anterior homeo box 1,604294,"?Microphthalmia, syndromic 11",614402,AR,mutation identified in one MCOPS11 family,VAX1
"KCNK18, TRESK, TRIK, MGR13","Potassium channel, subfamily K, member 18",613655,"{Migraine, with or without aura, susceptibility to, 13}",613656,-,-,KCNK18
"DEL10q26, C10q26DEL",Chromosome 10q26 deletion syndrome,609625,Chromosome 10q26 deletion syndrome,609625,AD,-,DEL10q26
EMX2,"Empty spiracles, Drosophila, homolog of, 2",600035,Schizencephaly,269160,-,close to VAX1,EMX2
"NANOS1, NOS1, SPGF12","NANOS, Drosophila, homolog of, 1",608226,Spermatogenic failure 12,615413,AD,-,NANOS1
"SFXN4, COXPD18",Sideroflexin 4,615564,Combined oxidative phosphorylation deficiency 18,615578,AR,-,SFXN4
"BAG3, MFM6",BCL2-associated athanogene 3,603883,"Cardiomyopathy, dilated, 1HH",613881,AD,-,BAG3
"BAG3, MFM6",BCL2-associated athanogene 3,603883,"Myopathy, myofibrillar, 6",612954,AD,-,BAG3
"WDR11, DR11, KIAA1351, BRWD2, HH14",WD repeat-containing protein 11,606417,Hypogonadotropic hypogonadism 14 with or without anosmia,614858,AD,-,WDR11
"FGFR2, BEK, CFD1, JWS, TK14, BBDS",Fibroblast growth factor receptor-2 (bacteria-expressed kinase),176943,Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis,207410,AR,-,FGFR2
"FGFR2, BEK, CFD1, JWS, TK14, BBDS",Fibroblast growth factor receptor-2 (bacteria-expressed kinase),176943,Apert syndrome,101200,AD,-,FGFR2
"FGFR2, BEK, CFD1, JWS, TK14, BBDS",Fibroblast growth factor receptor-2 (bacteria-expressed kinase),176943,Beare-Stevenson cutis gyrata syndrome,123790,AD,-,FGFR2
"FGFR2, BEK, CFD1, JWS, TK14, BBDS",Fibroblast growth factor receptor-2 (bacteria-expressed kinase),176943,Bent bone dysplasia syndrome,614592,AD,-,FGFR2
"FGFR2, BEK, CFD1, JWS, TK14, BBDS",Fibroblast growth factor receptor-2 (bacteria-expressed kinase),176943,Craniofacial-skeletal-dermatologic dysplasia,101600,AD,-,FGFR2
"FGFR2, BEK, CFD1, JWS, TK14, BBDS",Fibroblast growth factor receptor-2 (bacteria-expressed kinase),176943,"Craniosynostosis, nonspecific",-,-,-,FGFR2
"FGFR2, BEK, CFD1, JWS, TK14, BBDS",Fibroblast growth factor receptor-2 (bacteria-expressed kinase),176943,Crouzon syndrome,123500,AD,-,FGFR2
"FGFR2, BEK, CFD1, JWS, TK14, BBDS",Fibroblast growth factor receptor-2 (bacteria-expressed kinase),176943,"Gastric cancer, somatic",613659,-,-,FGFR2
"FGFR2, BEK, CFD1, JWS, TK14, BBDS",Fibroblast growth factor receptor-2 (bacteria-expressed kinase),176943,Jackson-Weiss syndrome,123150,AD,-,FGFR2
"FGFR2, BEK, CFD1, JWS, TK14, BBDS",Fibroblast growth factor receptor-2 (bacteria-expressed kinase),176943,LADD syndrome,149730,AD,-,FGFR2
"FGFR2, BEK, CFD1, JWS, TK14, BBDS",Fibroblast growth factor receptor-2 (bacteria-expressed kinase),176943,Pfeiffer syndrome,101600,AD,-,FGFR2
"FGFR2, BEK, CFD1, JWS, TK14, BBDS",Fibroblast growth factor receptor-2 (bacteria-expressed kinase),176943,Saethre-Chotzen syndrome,101400,AD,-,FGFR2
"FGFR2, BEK, CFD1, JWS, TK14, BBDS",Fibroblast growth factor receptor-2 (bacteria-expressed kinase),176943,Scaphocephaly and Axenfeld-Rieger anomaly,-,-,-,FGFR2
"FGFR2, BEK, CFD1, JWS, TK14, BBDS",Fibroblast growth factor receptor-2 (bacteria-expressed kinase),176943,"Scaphocephaly, maxillary retrusion, and mental retardation",609579,-,-,FGFR2
"LOC387715, ARMD8",LOC387715 gene,611313,"{Macular degeneration, age-related, 8}",613778,-,-,LOC387715
"HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2",HTRA serine peptidase 1,602194,CARASIL syndrome,600142,AR,-,HTRA1
"HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2",HTRA serine peptidase 1,602194,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2",616779,AD,-,HTRA1
"HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2",HTRA serine peptidase 1,602194,"{Macular degeneration, age-related, 7}",610149,-,-,HTRA1
"HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2",HTRA serine peptidase 1,602194,"{Macular degeneration, age-related, neovascular type}",610149,-,-,HTRA1
"ACADSB, SBCAD","Acyl-Coenzyme A dehydrogenase, short/branched chain",600301,2-methylbutyrylglycinuria,610006,AR,-,ACADSB
"OAT, GACR",Ornithine aminotransferase,613349,Gyrate atrophy of choroid and retina with or without ornithinemia,258870,AR,pseudogene at Xp11.2,OAT
"MMP21, HTX7",Matrix metalloproteinase 21,608416,"Heterotaxy, visceral, 7, autosomal",616749,AR,-,MMP21
UROS,Uroporphyrinogen III synthase,606938,"Porphyria, congenital erythropoietic",263700,AR,-,UROS
"EBF3, COE3, HADDS",Early B-cell factor 3,607407,"Hypotonia, ataxia, and delayed development syndrome",617330,AD,-,EBF3
"NKX6-2, NKX6B, NKX6.2, SPAX8","NK6 transcription factor related, locus 2 (Drosophila)",605955,"Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy",617560,AR,-,NKX6-2
"ECHS1, SCEH, ECHS1D","Enoyl-CoA hydratase, short-chain, 1, mitochondrial",602292,Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency,616277,AR,-,ECHS1
"SYCE1, POF12, SPGF15",Synaptonemal complex central element protein 1,611486,?Premature ovarian failure 12,616947,AR,mutation identified in 1 POF12 and 1 SPGF15 family,SYCE1
"SYCE1, POF12, SPGF15",Synaptonemal complex central element protein 1,611486,?Spermatogenic failure 15,616950,AR,-,SYCE1
"DEL11p15p14, C11DELp15p14",Chromosome 11p15-p14 deletion syndrome (homozygous),606528,Chromosome 11p15-p14 deletion syndrome,606528,AR,contiguous gene deletion syndrome,DEL11p15p14
ICR1,H19-IGF2-imprinting control region,616186,Beckwith-Wiedemann syndrome,130650,AD,-,ICR1
"IFITM5, OI5",Interferon-induced transmembrane protein 5,614757,"Osteogenesis imperfecta, type V",610967,AD,-,IFITM5
IFITM3,Interferon-induced transmembrane protein 3,605579,"{Influenza, severe, susceptibility to}",614680,-,-,IFITM3
HRAS,Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog,190020,Congenital myopathy with excess of muscle spindles,218040,"AD,IC",pseudogene HRASP on X,HRAS
HRAS,Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog,190020,Costello syndrome,218040,"AD,IC",-,HRAS
HRAS,Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog,190020,"Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic",163200,-,-,HRAS
HRAS,Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog,190020,"{Bladder cancer, somatic}",109800,-,-,HRAS
HRAS,Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog,190020,"{Nevus sebaceous or woolly hair nevus, somatic}",162900,-,-,HRAS
HRAS,Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog,190020,"{Spitz nevus or nevus spilus, somatic}",137550,-,-,HRAS
HRAS,Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog,190020,"{Thyroid carcinoma, follicular, somatic}",188470,-,-,HRAS
"IRF7, IRF7A, IRF7B, IRF7C, IRF7H, IMD39",Interferon regulatory factor 7,605047,?Immunodeficiency 39,616345,AR,mutation identified in 1 family,IRF7
DRD4,Dopamine receptor D4,126452,Autonomic nervous system dysfunction,-,-,proximal to HRAS,DRD4
DRD4,Dopamine receptor D4,126452,[Novelty seeking personality],601696,?AD,-,DRD4
DRD4,Dopamine receptor D4,126452,{Attention deficit-hyperactivity disorder},143465,AD,-,DRD4
"DEAF1, SPN, ZMYND5, MRD24","Deaf1, Drosophila, homolog of",602635,"?Dyskinesia, seizures, and intellectual developmental disorder",617171,AR,mutation identified in 1 DYSEIDD family,DEAF1
"DEAF1, SPN, ZMYND5, MRD24","Deaf1, Drosophila, homolog of",602635,"Mental retardation, autosomal dominant 24",615828,AD,-,DEAF1
"EPS8L2, EPS8R2, DFNB106",EPS8-like protein 2,614988,Deafness autosomal recessive 106,617637,AR,-,EPS8L2
TALDO1,Transaldolase-1,602063,Transaldolase deficiency,606003,AR,pseudogene on chr.1,TALDO1
"SLC25A22, GC1, EIEE3","Solute carrier family 25 (mitochondrial carrier, glutamate), member 22",609302,"Epileptic encephalopathy, early infantile, 3",609304,AR,-,SLC25A22
"PNPLA2, TTS2, ATGL",Patatin-like phospholipase domain-containing protein 2,609059,Neutral lipid storage disease with myopathy,610717,AR,-,PNPLA2
"CD151, PETA3, SFA1, MER2",CD151 antigen,602243,Nephropathy with pretibial epidermolysis bullosa and deafness,609057,-,-,CD151
"CD151, PETA3, SFA1, MER2",CD151 antigen,602243,"[Blood group, Raph]",179620,-,-,CD151
MUC5B,"Mucin 5, subtype B, tracheobronchial",600770,"{Pulmonary fibrosis, idiopathic, susceptibility to}",178500,AD,-,MUC5B
"CTSD, CPSD, CLN10",Cathepsin D (lysosomal aspartyl protease),116840,"Ceroid lipofuscinosis, neuronal, 10",610127,AR,-,CTSD
"TNNI2, AMCD2B, DA2B, FSSV","Troponin I, fast-twitch skeletal muscle isoform",191043,"Arthrogryposis multiplex congenita, distal, type 2B",601680,AD,-,TNNI2
"TNNT3, AMCD2B, DA2B, FSSV","Troponin-T3, skeletal, fast",600692,"Arthrogryposis, distal, type 2B",601680,AD,-,TNNT3
"H19, D11S813E, ASM1, BWS, WT2",H19 gene,103280,Beckwith-Wiedemann syndrome,130650,AD,same 200kb fragment as IGF2,H19
"H19, D11S813E, ASM1, BWS, WT2",H19 gene,103280,Silver-Russell syndrome,180860,IC,-,H19
"H19, D11S813E, ASM1, BWS, WT2",H19 gene,103280,Wilms tumor 2,194071,"AD,SMu",-,H19
"IGF2, GRDF","Insulin-like growth factor-2, or somatomedin A",147470,"?Growth restriction, severe, with distinctive facies",616489,AD,mutation identified in 1 GRDF family,IGF2
"INS, MODY10, IDDM2",Insulin,176730,"Diabetes mellitus, insulin-dependent, 2",125852,AD,5'--INS-12.6kb-IGF2--3'; cen-HBBC-10cM-INS-2cM-HRAS1-3cM-TH,INS
"INS, MODY10, IDDM2",Insulin,176730,"Diabetes mellitus, permanent neonatal",606176,"AD,AR",-,INS
"INS, MODY10, IDDM2",Insulin,176730,Hyperproinsulinemia,616214,AD,-,INS
"INS, MODY10, IDDM2",Insulin,176730,"Maturity-onset diabetes of the young, type 10",613370,AD,-,INS
"TH, TYH",Tyrosine hydroxylase,191290,"Segawa syndrome, recessive",605407,AR,distal to HRAS1,TH
"CD81, TAPA1, CVID6",CD81 antigen (target of antiproliferative antibody-1),186845,"Immunodeficiency, common variable, 6",613496,AR,-,CD81
"KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2","Potassium voltage-gated channel, KQT-like subfamily, member 1",607542,"Atrial fibrillation, familial, 3",607554,AD,-,KCNQ1
"KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2","Potassium voltage-gated channel, KQT-like subfamily, member 1",607542,Jervell and Lange-Nielsen syndrome,220400,AR,-,KCNQ1
"KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2","Potassium voltage-gated channel, KQT-like subfamily, member 1",607542,Long QT syndrome 1,192500,AD,-,KCNQ1
"KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2","Potassium voltage-gated channel, KQT-like subfamily, member 1",607542,Short QT syndrome 2,609621,AD,-,KCNQ1
"KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2","Potassium voltage-gated channel, KQT-like subfamily, member 1",607542,"{Long QT syndrome 1, acquired, susceptibility to}",192500,AD,-,KCNQ1
"KCNQ1OT1, LIT1",KCNQ1-overlapping transcript 1,604115,Beckwith-Wiedemann syndrome,130650,AD,-,KCNQ1OT1
"CDKN1C, KIP2, BWS, IMAGE","Cyclin-dependent kinase inhibitor 1C (p57, Kip2)",600856,Beckwith-Wiedemann syndrome,130650,AD,rare cause of BWS,CDKN1C
"CDKN1C, KIP2, BWS, IMAGE","Cyclin-dependent kinase inhibitor 1C (p57, Kip2)",600856,IMAGE syndrome,614732,AD,-,CDKN1C
"SLC22A1L, BWSCR1A, IMPT1","Solute carrier family 22, member 1-like (Beckwith-Wiedemann region 1A; organic-cation transporter-like 2)",602631,"Breast cancer, somatic",114480,-,-,SLC22A1L
"SLC22A1L, BWSCR1A, IMPT1","Solute carrier family 22, member 1-like (Beckwith-Wiedemann region 1A; organic-cation transporter-like 2)",602631,"Lung cancer, somatic",211980,-,-,SLC22A1L
"SLC22A1L, BWSCR1A, IMPT1","Solute carrier family 22, member 1-like (Beckwith-Wiedemann region 1A; organic-cation transporter-like 2)",602631,"Rhabdomyosarcoma, somatic",268210,-,-,SLC22A1L
"PGAP2, FRAG1, HPMRS3, MRT17, MRT21",Post-GPI attachment to proteins 2,615187,Hyperphosphatasia with mental retardation syndrome 3,614207,AR,-,PGAP2
"STIM1, TAM1, IMD10, STRMK",Stromal interaction molecule 1,605921,Immunodeficiency 10,612783,AR,-,STIM1
"STIM1, TAM1, IMD10, STRMK",Stromal interaction molecule 1,605921,"Myopathy, tubular aggregate, 1",160565,AD,-,STIM1
"STIM1, TAM1, IMD10, STRMK",Stromal interaction molecule 1,605921,Stormorken syndrome,185070,AD,-,STIM1
HBB,Hemoglobin beta,141900,Delta-beta thalassemia,141749,AD,pseudogene HBBP1 between HBG and HBD loci,HBB
HBB,Hemoglobin beta,141900,"Erythremias, beta-",-,-,-,HBB
HBB,Hemoglobin beta,141900,"Heinz body anemias, beta-",140700,AD,-,HBB
HBB,Hemoglobin beta,141900,Hereditary persistence of fetal hemoglobin,141749,AD,-,HBB
HBB,Hemoglobin beta,141900,"Methemoglobinemias, beta-",-,-,-,HBB
HBB,Hemoglobin beta,141900,Sickle cell anemia,603903,AR,-,HBB
HBB,Hemoglobin beta,141900,"Thalassemia-beta, dominant inclusion-body",603902,-,-,HBB
HBB,Hemoglobin beta,141900,"Thalassemias, beta-",613985,-,-,HBB
HBB,Hemoglobin beta,141900,"{Malaria, resistance to}",611162,-,-,HBB
HBG1,"Hemoglobin, gamma A",142200,Fetal hemoglobin quantitative trait locus 1,141749,AD,-,HBG1
"HBG2, TNCY","Hemoglobin, gamma G",142250,"Cyanosis, transient neonatal",613977,AD,-,HBG2
"HBG2, TNCY","Hemoglobin, gamma G",142250,Fetal hemoglobin quantitative trait locus 1,141749,AD,-,HBG2
LCRB,Locus control region beta,152424,"Thalassemia, Hispanic gamma-delta-beta",613985,-,-,LCRB
"SMPD1, NPD","Sphingomyelin phosphodiesterase-1, acid lysosomal",607608,"Niemann-Pick disease, type A",257200,AR,-,SMPD1
"SMPD1, NPD","Sphingomyelin phosphodiesterase-1, acid lysosomal",607608,"Niemann-Pick disease, type B",607616,AR,-,SMPD1
"TPP1, CLN2, SCAR7",Tripeptidyl peptidase 1,607998,"Ceroid lipofuscinosis, neuronal, 2",204500,AR,-,TPP1
"TPP1, CLN2, SCAR7",Tripeptidyl peptidase 1,607998,"Spinocerebellar ataxia, autosomal recessive 7",609270,AR,-,TPP1
"DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2","Dachsous, Drosophila, homolog of, 1",603057,Mitral valve prolapse 2,607829,AD,-,DCHS1
"DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2","Dachsous, Drosophila, homolog of, 1",603057,Van Maldergem syndrome 1,601390,AR,-,DCHS1
"TUB, RDOB","Tubby, mouse, homolog of",601197,?Retinal dystrophy and obesity,616188,AR,mutation identified in 1 RDOB family,TUB
"DENND5A, RAB6IP1, KIAA1091, EIEE49",DENN domain-containing protein 5A,617278,"Epileptic encephalopathy, early infantile, 49",617281,AR,-,DENND5A
"SBF2, MTMR13, CMT4B2",SET binding factor 2 (myotubularin-related 13),607697,"Charcot-Marie-Tooth disease, type 4B2",604563,AR,-,SBF2
AMPD3,"Adenosine monophosphate deaminase-3, isoform E",102772,"[AMP deaminase deficiency, erythrocytic]",612874,AR,-,AMPD3
"TEAD1, TCF13, REF1",TEA domain family member 1,189967,Sveinsson chorioretinal atrophy,108985,AD,-,TEAD1
PTH,Parathyroid hormone,168450,"Hypoparathyroidism, autosomal dominant",146200,AD,~9cM distal to CALC1; distal to MYOD,PTH
PTH,Parathyroid hormone,168450,"Hypoparathyroidism, autosomal recessive",146200,AD,-,PTH
"FAR1, MLSTD2, PFCRD",Fatty acyl CoA reductase 1,616107,Peroxisomal fatty acyl-CoA reductase 1 disorder,616154,AR,-,FAR1
CYP2R1,"Cytochrome P450, subfamily IIR, polypeptide 1 (vitamin D 25-hydroxylase)",608713,Rickets due to defect in vitamin D 25-hydroxylation,600081,AR,-,CYP2R1
"KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13","Potassium inwardly-rectifying channel, subfamily J, member 11",600937,"Diabetes mellitus, transient neonatal, 3",610582,AD,4.5kb 3' of SUR,KCNJ11
"KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13","Potassium inwardly-rectifying channel, subfamily J, member 11",600937,"Diabetes, permanent neonatal, with or without neurologic features",606176,"AD,AR",-,KCNJ11
"KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13","Potassium inwardly-rectifying channel, subfamily J, member 11",600937,"Hyperinsulinemic hypoglycemia, familial, 2",601820,AR,-,KCNJ11
"KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13","Potassium inwardly-rectifying channel, subfamily J, member 11",600937,"Maturity-onset diabetes of the young, type 13",616329,AD,-,KCNJ11
"KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13","Potassium inwardly-rectifying channel, subfamily J, member 11",600937,"{Diabetes mellitus, type 2, susceptibility to}",125853,AD,-,KCNJ11
"ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2","ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)",600509,"Diabetes mellitus, noninsulin-dependent",125853,AD,-,ABCC8
"ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2","ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)",600509,"Diabetes mellitus, permanent neonatal",606176,"AD,AR",-,ABCC8
"ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2","ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)",600509,"Diabetes mellitus, transient neonatal 2",610374,-,-,ABCC8
"ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2","ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)",600509,"Hyperinsulinemic hypoglycemia, familial, 1",256450,"AD,AR",-,ABCC8
"ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2","ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)",600509,"Hypoglycemia of infancy, leucine-sensitive",240800,AD,-,ABCC8
"USH1C, DFNB18A",Harmonin (Usher syndrome 1C gene),605242,"Deafness, autosomal recessive 18A",602092,AR,Acadian and Samaritan variety,USH1C
"USH1C, DFNB18A",Harmonin (Usher syndrome 1C gene),605242,"Usher syndrome, type 1C",276904,AR,-,USH1C
"OTOG, OTGN, DFNB18B",Otogelin,604487,"Deafness, autosomal recessive 18B",614945,AR,-,OTOG
"KCNC1, EPM7","Potassium voltage-gated channel, Shaw-related subfamily, member 1",176258,"Epilepsy, progressive myoclonic 7",616187,AD,-,KCNC1
"HPS5, RU2, KIAA1017","HPS gene 5 (ruby-eye 2, mouse, homolog of)",607521,Hermansky-Pudlak syndrome 5,614074,AR,-,HPS5
"LDHA, LDH1, GSD11",Lactate dehydrogenase A,150000,Glycogen storage disease XI,612933,AR,-,LDHA
TSG101,Tumor susceptibility gene 101,601387,"Breast cancer, somatic",114480,-,-,TSG101
"CSRP3, CRP3, CLP, CMD1M, CMH12",Cysteine- and glycine-rich protein 3,600824,"?Cardiomyopathy, dilated, 1M",607482,-,mutation identified in 1 CMD1M family,CSRP3
"CSRP3, CRP3, CLP, CMD1M, CMH12",Cysteine- and glycine-rich protein 3,600824,"Cardiomyopathy, hypertrophic, 12",612124,AD,-,CSRP3
"SLC6A5, GLYT2, HKPX3","Solute carrier family 6 (neurotransmitter transporter, glycine), member 5",604159,Hyperekplexia 3,614618,"AD,AR",-,SLC6A5
"ANO5, TMEM16E, GDD1, LGMD2L",Anoctamin 5,608662,Gnathodiaphyseal dysplasia,166260,AD,-,ANO5
"ANO5, TMEM16E, GDD1, LGMD2L",Anoctamin 5,608662,Miyoshi muscular dystrophy 3,613319,AR,-,ANO5
"ANO5, TMEM16E, GDD1, LGMD2L",Anoctamin 5,608662,"Muscular dystrophy, limb-girdle, type 2L",611307,AR,-,ANO5
FANCF,"Fanconi anemia, complementation group F",613897,"Fanconi anemia, complementation group F",603467,-,-,FANCF
"ANO3, TMEM16C, C11orf25, DYT24",Anoctamin 3,610110,Dystonia 24,615034,AD,-,ANO3
"LGR4, GPR48, BNMD17",Leucine-rich repeat-containing G protein-coupled receptor 4,606666,"{Bone mineral density, low, susceptibility to}",615311,-,previously mapped to 5q34-q35.1,LGR4
"BDNF, BULN2, ANON2",Brain-derived neurotrophic factor,113505,"Central hypoventilation syndrome, congenital",209880,AD,homeology with NRF3 on 12p; at p14 boundary,BDNF
"BDNF, BULN2, ANON2",Brain-derived neurotrophic factor,113505,"{Anorexia nervosa, susceptibility to}",610269,-,-,BDNF
"BDNF, BULN2, ANON2",Brain-derived neurotrophic factor,113505,"{Bulimia nervosa, age of onset of weight loss in}",607499,Mu,-,BDNF
"BDNF, BULN2, ANON2",Brain-derived neurotrophic factor,113505,"{Memory impairment, susceptibility to}",-,-,-,BDNF
"BDNF, BULN2, ANON2",Brain-derived neurotrophic factor,113505,"{Obsessive-compulsive disorder, protection against}",164230,AD,-,BDNF
"FSHB, HH24","Follicle-stimulating hormone, beta polypeptide",136530,Hypogonadotropic hypogonadism 24 without anosmia,229070,AR,distal to AN2,FSHB
"DEL11p13, C11DELp13","Chromosome 11p13 deletion syndrome, distal",616902,"Chromosome 11p13 deletion syndrome, distal",616902,AD,-,DEL11p13
"DEL11p13, C11DELp13, WAGR","Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome (chromosome 11p13 deletion syndrome)",194072,"Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome",194072,"AD,SMu",deletion of WT1 and PAX6 genes,DEL11p13
"WAGRO, DEL11p14p12","Wilms tumor, aniridia, genitourinary anomalies, mental retardation, and obesity syndrome",612469,WAGRO syndrome,612469,-,contiguous gene deletion syndrome,WAGRO
"ELP4, PAX6NEB, AN2","Elongation protein 4, S. cerevisiae, homolog of",606985,?Aniridia 2,617141,AD,mutation identified in 1 AN2 patient,ELP4
"PAX6, AN2, MGDA, FVH1, ASGD5",Paired box homeotic gene-6,607108,?Coloboma of optic nerve,120430,AD,"mutation identified in 1 patient each with MDGA, COLBN, or COLB",PAX6
"PAX6, AN2, MGDA, FVH1, ASGD5",Paired box homeotic gene-6,607108,"?Coloboma, ocular",120200,AD,-,PAX6
"PAX6, AN2, MGDA, FVH1, ASGD5",Paired box homeotic gene-6,607108,?Morning glory disc anomaly,120430,AD,-,PAX6
"PAX6, AN2, MGDA, FVH1, ASGD5",Paired box homeotic gene-6,607108,Aniridia,106210,AD,-,PAX6
"PAX6, AN2, MGDA, FVH1, ASGD5",Paired box homeotic gene-6,607108,"Anterior segment dysgenesis 5, multiple subtypes",604229,-,-,PAX6
"PAX6, AN2, MGDA, FVH1, ASGD5",Paired box homeotic gene-6,607108,Cataract with late-onset corneal dystrophy,106210,AD,-,PAX6
"PAX6, AN2, MGDA, FVH1, ASGD5",Paired box homeotic gene-6,607108,Foveal hypoplasia 1,136520,AD,-,PAX6
"PAX6, AN2, MGDA, FVH1, ASGD5",Paired box homeotic gene-6,607108,Keratitis,148190,AD,-,PAX6
"PAX6, AN2, MGDA, FVH1, ASGD5",Paired box homeotic gene-6,607108,Optic nerve hypoplasia,165550,AD,-,PAX6
"WT1, NPHS4",Wilms tumor-1,607102,Denys-Drash syndrome,194080,"AD,SMu",clumped: pter-FSHB-AN2-WT1-CAT,WT1
"WT1, NPHS4",Wilms tumor-1,607102,Frasier syndrome,136680,"AD,SMu",-,WT1
"WT1, NPHS4",Wilms tumor-1,607102,Meacham syndrome,608978,-,-,WT1
"WT1, NPHS4",Wilms tumor-1,607102,"Mesothelioma, somatic",156240,-,-,WT1
"WT1, NPHS4",Wilms tumor-1,607102,"Nephrotic syndrome, type 4",256370,AD,-,WT1
"WT1, NPHS4",Wilms tumor-1,607102,"Wilms tumor, type 1",194070,"AD,SMu",-,WT1
"CD59, MIC11",CD59 antigen (p18-20),107271,"Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy",612300,AR,in mouse Ly-6 = multigene complex,CD59
CAT,Catalase,115500,Acatalasemia,614097,-,cen-CAT-WT1-AN2-pter,CAT
"PDHX, PDX1, E3BP, PDHXD","Pyruvate dehydrogenase complex, lipoyl-containing component X",608769,Lacticacidemia due to PDX1 deficiency,245349,AR,-,PDHX
"CD44, MDU2, MDU3, MIC4, IN",CD44 antigen (homing function),107269,"[Blood group, Indian system]",609027,-,-,CD44
"SLC1A2, EAAT2, EIEE41","Solute carrier family 1 (glial high affinity glutamate transporter), member 2",600300,"Epileptic encephalopathy, early infantile, 41",617105,AD,-,SLC1A2
"TRIM44, AN3",Tripartite motif-containing protein 44,612298,?Aniridia 3,617142,AD,mutation identified in 1 AN3 family,TRIM44
BMND8,Bone mineral density QTL 8,611739,{Osteoporosis},166710,AD,between D11S1392 and D11S4102,BMND8
RAG1,Recombination activating gene-1,179615,"Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity",609889,-,assignment to 14 in error,RAG1
RAG1,Recombination activating gene-1,179615,Combined cellular and humoral immune defects with granulomas,233650,AR,-,RAG1
RAG1,Recombination activating gene-1,179615,Omenn syndrome,603554,AR,-,RAG1
RAG1,Recombination activating gene-1,179615,"Severe combined immunodeficiency, B cell-negative",601457,AR,-,RAG1
RAG2,Recombination activating gene-2,179616,Combined cellular and humoral immune defects with granulomas,233650,AR,assignment to 14 in error,RAG2
RAG2,Recombination activating gene-2,179616,Omenn syndrome,603554,AR,-,RAG2
RAG2,Recombination activating gene-2,179616,"Severe combined immunodeficiency, B cell-negative",601457,AR,-,RAG2
"OI16, C16DELp11.2, DEL16p11.2","Osteogenesis imperfecta, type XVI (chromosome 11p11.2 deletion syndrome, 91.3kb)",616229,"Osteogenesis imperfecta, type XVI",616229,AR,-,OI16
PSS,Potocki-Shaffer syndrome,601224,Potocki-Shaffer syndrome,601224,-,contiguous gene syndrome caused by deletion of 11p11.2,PSS
"EXT2, SSMS",Exostosin 2,608210,"?Seizures, scoliosis, and macrocephaly syndrome",616682,AR,mutation identified in 1 SSMS family,EXT2
"EXT2, SSMS",Exostosin 2,608210,"Exostoses, multiple, type 2",133701,AD,-,EXT2
"ALX4, PFM2, FPP, FND2, CRS5","Aristaless-like 4, mouse, homolog of",605420,Frontonasal dysplasia 2,613451,AR,-,ALX4
"ALX4, PFM2, FPP, FND2, CRS5","Aristaless-like 4, mouse, homolog of",605420,Parietal foramina 2,609597,AD,-,ALX4
"ALX4, PFM2, FPP, FND2, CRS5","Aristaless-like 4, mouse, homolog of",605420,"{Craniosynostosis 5, susceptibility to}",615529,AD,-,ALX4
"CD82, SAR2, KAI1, ST6",CD82 antigen,600623,"{Prostate cancer, susceptibility to}",176807,AD,-,CD82
"SLC35C1, FUCT1, CDG2C","Solute carrier family 35, member C1 (GDP-Fucose transporter 1)",605881,"Congenital disorder of glycosylation, type IIc",266265,AR,-,SLC35C1
"MAPK8IP1, IB1",Mitogen-activated protein kinase 8-interacting protein 1,604641,"{Diabetes mellitus, noninsulin-dependent}",125853,AD,-,MAPK8IP1
"PEX16, PBD8A, PBD8B",Peroxisome biogenesis factor 16,603360,Peroxisome biogenesis disorder 8A (Zellweger),614876,AR,-,PEX16
"PEX16, PBD8A, PBD8B",Peroxisome biogenesis factor 16,603360,Peroxisome biogenesis disorder 8B,614877,AR,-,PEX16
"ZNF408, EVR6, RP72",Zinc finger protein 408,616454,?Exudative vitreoretinopathy 6,616468,AD,mutation identified in 1 EVR6 family,ZNF408
"ZNF408, EVR6, RP72",Zinc finger protein 408,616454,Retinitis pigmentosa 72,616469,AR,-,ZNF408
"F2, THPH1, RPRGL2",Coagulation factor II (thrombin),176930,Dysprothrombinemia,613679,AR,-,F2
"F2, THPH1, RPRGL2",Coagulation factor II (thrombin),176930,Hypoprothrombinemia,613679,AR,-,F2
"F2, THPH1, RPRGL2",Coagulation factor II (thrombin),176930,Thrombophilia due to thrombin defect,188050,AD,-,F2
"F2, THPH1, RPRGL2",Coagulation factor II (thrombin),176930,"{Pregnancy loss, recurrent, susceptibility to, 2}",614390,AD,-,F2
"F2, THPH1, RPRGL2",Coagulation factor II (thrombin),176930,"{Stroke, ischemic, susceptibility to}",601367,Mu,-,F2
"LRP4, MEGF7, CLSS, SOST2, CMS17",Low density lipoprotein receptor-related protein 4,604270,"?Myasthenic syndrome, congenital, 17",616304,AR,mutation identified in 1 CMS17 family,LRP4
"LRP4, MEGF7, CLSS, SOST2, CMS17",Low density lipoprotein receptor-related protein 4,604270,Cenani-Lenz syndactyly syndrome,212780,AR,-,LRP4
"LRP4, MEGF7, CLSS, SOST2, CMS17",Low density lipoprotein receptor-related protein 4,604270,Sclerosteosis 2,614305,"AD,AR",-,LRP4
DDB2,"Damage-specific DNA binding protein 2, 48kD",600811,"Xeroderma pigmentosum, group E, DDB-negative subtype",278740,AR,-,DDB2
"MYBPC3, CMH4, CMD1MM, LVNC10","Myosin-binding protein C, cardiac",600958,"Cardiomyopathy, dilated, 1MM",615396,AD,-,MYBPC3
"MYBPC3, CMH4, CMD1MM, LVNC10","Myosin-binding protein C, cardiac",600958,"Cardiomyopathy, hypertrophic, 4",115197,AD,-,MYBPC3
"MYBPC3, CMH4, CMD1MM, LVNC10","Myosin-binding protein C, cardiac",600958,Left ventricular noncompaction 10,615396,AD,-,MYBPC3
"SLC39A13, ZIP13, SCDEDS","Solute carrier family 39 (zinc transporter), member 13",608735,"Spondylocheirodysplasia, Ehlers-Danlos syndrome-like",612350,AR,-,SLC39A13
"RAPSN, CMS1D, CMS11, FADS","Receptor-associated protein of the synapse, 43kD",601592,Fetal akinesia deformation sequence,208150,AR,-,RAPSN
"RAPSN, CMS1D, CMS11, FADS","Receptor-associated protein of the synapse, 43kD",601592,"Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency",616326,AR,-,RAPSN
NDUFS3,"NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kD",603846,Leigh syndrome due to mitochondrial complex I deficiency,256000,"Mi,AR",-,NDUFS3
NDUFS3,"NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kD",603846,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",-,NDUFS3
"PTPRJ, DEP1","Protein tyrosine phosphatase, receptor type, J polypeptide",600925,"Colon cancer, somatic",114500,-,-,PTPRJ
"SCA20, DUP11q12, C11DUPq12","Spinocerebellar ataxia 20 (chromosome 11q12 duplication syndrome, 260kb)",608687,Spinocerebellar ataxia 20,608687,AD,contiguous gene duplication syndrome,SCA20
"C1NH, HAE1, HAE2, SERPING1",Complement component-1 inhibitor,606860,"Angioedema, hereditary, types I and II",106100,"AD,AR",-,C1NH
"C1NH, HAE1, HAE2, SERPING1",Complement component-1 inhibitor,606860,"Complement component 4, partial deficiency of",120790,AD,-,C1NH
"CLP1, HEAB, PCH10","Cleavage and polyadenylation factor I subunit 1, yeast, homolog of",608757,"Pontocerebellar hypoplasia, type 10",615803,AR,-,CLP1
"CTNND1, CTNND, BCDS2","Catenin (cadherin-associated protein), delta 1",601045,Blepharocheilodontic syndrome 2,617681,AD,-,CTNND1
"FAM111B, POIKTMP","Family with sequence similarity 111, member B",615584,"Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis",615704,AD,-,FAM111B
"FAM111A, KIAA1895, KCS2, GCLEB","Family with sequence similarity 111, member A",615292,Gracile bone dysplasia,602361,AD,-,FAM111A
"FAM111A, KIAA1895, KCS2, GCLEB","Family with sequence similarity 111, member A",615292,"Kenny-Caffey syndrome, type 2",127000,AD,-,FAM111A
"GIF, IF",Gastric intrinsic factor,609342,Intrinsic factor deficiency,261000,AR,-,GIF
"MS4A2, FCER1B","Membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for, beta polypeptide)",147138,"{Atopy, susceptibility to}",147050,AD,-,MS4A2
"MS4A1, CD20, CVID5","Membrane-spanning 4-domains, subfamily A, member 1",112210,"Immunodeficiency, common variable, 5",613495,AR,-,MS4A1
"ZP1, OOMD1",Zona pellucida glycoprotein 1,195000,Oocyte maturation defect 1,615774,AR,-,ZP1
"TMEM138, JBTS16",Transmembrane protein 138,614459,Joubert syndrome 16,614465,AR,-,TMEM138
"TMEM216, JBTS2, CORS2, MKS2",Transmembrane protein 216,613277,Joubert syndrome 2,608091,AR,-,TMEM216
"TMEM216, JBTS2, CORS2, MKS2",Transmembrane protein 216,613277,Meckel syndrome 2,603194,AR,-,TMEM216
"SDHAF2, SDH5, PGL2",Succinate dehydrogenase complex assembly factor 2,613019,Paragangliomas 2,601650,AD,-,SDHAF2
"BEST1, VMD2, ARB, RP50",Bestrophin 1,607854,"Bestrophinopathy, autosomal recessive",611809,-,-,BEST1
"BEST1, VMD2, ARB, RP50",Bestrophin 1,607854,"Macular dystrophy, vitelliform, 2",153700,AD,-,BEST1
"BEST1, VMD2, ARB, RP50",Bestrophin 1,607854,"Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma",193220,AD,-,BEST1
"BEST1, VMD2, ARB, RP50",Bestrophin 1,607854,"Retinitis pigmentosa, concentric",613194,-,-,BEST1
"BEST1, VMD2, ARB, RP50",Bestrophin 1,607854,Retinitis pigmentosa-50,613194,-,-,BEST1
"BEST1, VMD2, ARB, RP50",Bestrophin 1,607854,Vitreoretinochoroidopathy,193220,AD,-,BEST1
"FTH1, FTHL6, HFE5","Ferritin, heavy polypeptide 1",134770,"?Hemochromatosis, type 5",615517,AD,mutation identified in 1 family,FTH1
"ROM1, ROSP1, RP7",Rod outer segment membrane protein-1,180721,"Retinitis pigmentosa 7, digenic",608133,"AD,AR",digenic RP with RDS,ROM1
"B3GAT3, GLCATI, JDSCD","Beta-1,3-glucuronyltransferase 3",606374,"Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects",245600,AR,pseudogene on chr.3,B3GAT3
"GANAB, PKD3",Neutral alpha-glucosidase AB,104160,Polycystic kidney disease 3,600666,AD,-,GANAB
"UQCC3, C11orf83, MC3DN9",Ubiquinol-cytochrome C reductase complex assembly factor 3,616097,"?Mitochondrial complex III deficiency, nuclear type 9",616111,AR,mutation identified in 1 MC3DN9 patient,UQCC3
"BSCL2, SPG17, HMN5, PELD",Seipin,606158,"Encephalopathy, progressive, with or without lipodystrophy",615924,AR,-,BSCL2
"BSCL2, SPG17, HMN5, PELD",Seipin,606158,"Lipodystrophy, congenital generalized, type 2",269700,AR,-,BSCL2
"BSCL2, SPG17, HMN5, PELD",Seipin,606158,"Neuropathy, distal hereditary motor, type VA",600794,AD,-,BSCL2
"BSCL2, SPG17, HMN5, PELD",Seipin,606158,Silver spastic paraplegia syndrome,270685,AD,-,BSCL2
"OTDD, DEL11q13, C11DELq13",Otodental dysplasia (chromosome 11q13 deletion syndrome),166750,Otodental dysplasia chromosome deletion syndrome,166750,AD,between rs9666584 and rs41408348,OTDD
"ATL3, HSN1F",Atlastin 3,609369,"Neuropathy, hereditary sensory, type IF",615632,AD,-,ATL3
COX8A,"Cytochrome c oxidase, subunit VIIIA",123870,?Mitochondrial complex IV deficiency,220110,"Mi,AR",mutation identified in 1 COX4D patient,COX8A
"KIND3, URP2, MIG2B, FERMT3",Kindlin 3,607901,"Leukocyte adhesion deficiency, type III",612840,AR,-,KIND3
"SLC22A12, OAT4L, URAT1","Solute carrier family 22 (urate transporter), member 12",607096,"Hypouricemia, renal",220150,AR,-,SLC22A12
"RASGRP2, CDC25L",Ras guanyl nucleotide-releasing protein 2,605577,"?Bleeding disorder, platelet-type, 18",615888,AR,mutation identified in 1 BDPLT18 family,RASGRP2
PYGM,"Phosphorylase, glycogen, muscle",608455,McArdle disease,232600,AR,-,PYGM
MEN1,Menin,613733,"Adrenal adenoma, somatic",-,-,linked distal to PYGM,MEN1
MEN1,Menin,613733,"Angiofibroma, somatic",-,-,-,MEN1
MEN1,Menin,613733,Carcinoid tumor of lung,-,-,-,MEN1
MEN1,Menin,613733,"Lipoma, somatic",-,-,-,MEN1
MEN1,Menin,613733,Multiple endocrine neoplasia 1,131100,AD,-,MEN1
MEN1,Menin,613733,"Parathyroid adenoma, somatic",-,-,-,MEN1
"CAPN1, SPG76","Calpain, large polypeptide L1",114220,"Spastic paraplegia 76, autosomal recessive",616907,AR,-,CAPN1
"SCYL1, NTKL, SCAR21",SCY1-like 1,607982,"Spinocerebellar ataxia, autosomal recessive 21",616719,AR,-,SCYL1
"LTBP3, LTBP2, DASS, GPHYSD3",Latent transforming growth factor beta binding protein-3,602090,Dental anomalies and short stature,601216,AR,-,LTBP3
"LTBP3, LTBP2, DASS, GPHYSD3",Latent transforming growth factor beta binding protein-3,602090,Geleophysic dysplasia 3,617809,AD,-,LTBP3
"RNASEH2C, AYP1, FLJ20974, AGS3","Ribonuclease H2, subunit C",610330,Aicardi-Goutieres syndrome 3,610329,AR,-,RNASEH2C
"EFEMP2, FBLN4, UPH1, ARCL1B",EGF-containing fibulin-like extracellular matrix protein 2 (fibulin 4),604633,"Cutis laxa, autosomal recessive, type IB",614437,AR,-,EFEMP2
"FIBP, TROFAS","Fibroblast growth factor, acidic, intracellular binding protein",608296,Thauvin-Robinet-Faivre syndrome,617107,AR,-,FIBP
"BANF1, BAF, NGPS",Barrier to autointegration factor 1,603811,Nestor-Guillermo progeria syndrome,614008,AR,-,BANF1
"CATSPER1, CATSPER, SPGF7","Cation channel, sperm-associated, 1",606389,Spermatogenic failure 7,612997,AR,-,CATSPER1
"PACS1, SHMS, MRD17",Phosphofurin acidic cluster sorting protein 1,607492,Schuurs-Hoeijmakers syndrome,615009,AD,-,PACS1
"KLC2, SPOAN","Kinesin, light chain 2",611729,"Spastic paraplegia, optic atrophy, and neuropathy",609541,AR,-,KLC2
"B4GAT1, B3GNT1, IGNT, IGAT, MDDGA13","Beta-1,4glucuronyltransferase 1",605517,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13",615287,AR,-,B4GAT1
BBS1,BBS1 gene,209901,Bardet-Biedl syndrome 1,209900,"AR,DR",-,BBS1
"ACTN3, ACTN3D","Actinin, alpha-3",102574,[Alpha-actinin-3 deficiency],617749,-,-,ACTN3
"ACTN3, ACTN3D","Actinin, alpha-3",102574,[Sprinting performance],617749,-,-,ACTN3
"CTSF, CLN13",Cathepsin F,603539,"Ceroid lipofuscinosis, neuronal, 13, Kufs type",615362,AR,-,CTSF
"SPTBN2, SCA5, SCAR14","Spectrin, beta, nonerythrocytic, 2",604985,Spinocerebellar ataxia 5,600224,AD,-,SPTBN2
"SPTBN2, SCA5, SCAR14","Spectrin, beta, nonerythrocytic, 2",604985,"Spinocerebellar ataxia, autosomal recessive 14",615386,AR,-,SPTBN2
PC,Pyruvate carboxylase,608786,Pyruvate carboxylase deficiency,266150,AR,-,PC
"CLCF1, BSF3, CLC, CISS2",Cardiotrophin-like cytokine,607672,Cold-induced sweating syndrome 2,610313,AR,-,CLCF1
"CABP4, CRSD, CSNB2B",Calcium-binding protein 4,608965,"Cone-rod synaptic disorder, congenital nonprogressive",610427,AR,-,CABP4
"AIP, XAP2, ARA9, PITA1",Aryl hydrocarbon receptor-interacting protein,605555,"Pituitary adenoma 1, multiple types",102200,"AD,SMu",-,AIP
"AIP, XAP2, ARA9, PITA1",Aryl hydrocarbon receptor-interacting protein,605555,Pituitary adenoma predisposition,102000,AD,-,AIP
"CABP2, DFNB93",Calcium-binding protein 2,607314,"Deafness, autosomal recessive 93",614899,AR,-,CABP2
"NDUFV1, UQOR1","NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kD",161015,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",-,NDUFV1
"UNC93B1, IIAE1","UNC93, C. elegans, homolog of, B1",608204,"{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}",610551,-,-,UNC93B1
NDUFS8,"NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kD (NADH-coenzyme Q reductase)",602141,Leigh syndrome due to mitochondrial complex I deficiency,256000,"Mi,AR",previously assigned to 3q28,NDUFS8
"TCIRG1, TIRC7, OC116, OPTB1",T-cell immune regulator 1,604592,"Osteopetrosis, autosomal recessive 1",259700,AR,-,TCIRG1
"KMT5B, SUV420H1, CGI85, MRD51",Lysine methyltransferase 5B,610881,"Mental retardation, autosomal dominant 51",617788,AD,-,KMT5B
"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4",Low density lipoprotein receptor-related protein-5,603506,Exudative vitreoretinopathy 4,601813,"AD,AR",-,LRP5
"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4",Low density lipoprotein receptor-related protein-5,603506,"Hyperostosis, endosteal",144750,AD,-,LRP5
"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4",Low density lipoprotein receptor-related protein-5,603506,"Osteopetrosis, autosomal dominant 1",607634,AD,-,LRP5
"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4",Low density lipoprotein receptor-related protein-5,603506,Osteoporosis-pseudoglioma syndrome,259770,AR,-,LRP5
"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4",Low density lipoprotein receptor-related protein-5,603506,Osteosclerosis,144750,AD,-,LRP5
"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4",Low density lipoprotein receptor-related protein-5,603506,Polycystic liver disease with or without kidney cysts,617875,-,-,LRP5
"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4",Low density lipoprotein receptor-related protein-5,603506,"van Buchem disease, type 2",607636,AD,-,LRP5
"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4",Low density lipoprotein receptor-related protein-5,603506,[Bone mineral density variability 1],601884,AD,-,LRP5
"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4",Low density lipoprotein receptor-related protein-5,603506,{Osteoporosis},166710,AD,-,LRP5
"GAL, GALN, GLNN, ETL8",Galanin,137035,"?Epilepsy, familial temporal lobe, 8",616461,AD,mutation identified in 1 ETL8 family,GAL
CPT1A,"Carnitine palmitoyltransferase I, liver",600528,"CPT deficiency, hepatic, type IA",255120,AR,-,CPT1A
"IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S",Immunoglobulin mu binding protein 2,600502,"Charcot-Marie-Tooth disease, axonal, type 2S",616155,AR,-,IGHMBP2
"IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S",Immunoglobulin mu binding protein 2,600502,"Neuronopathy, distal hereditary motor, type VI",604320,AR,-,IGHMBP2
"TPCN2, TPC2, SHEP10",Two-pore segment channel 2,612163,"[Skin/hair/eye pigmentation 10, blond/brown hair]",612267,-,-,TPCN2
"CCND1, PRAD1, BCL1",Cyclin D1,168461,"{Colorectal cancer, susceptibility to}",114500,AD,pseudogene on 11q13,CCND1
"CCND1, PRAD1, BCL1",Cyclin D1,168461,"{Multiple myeloma, susceptibility to}",254500,SMu,-,CCND1
"CCND1, PRAD1, BCL1",Cyclin D1,168461,"{von Hippel-Lindau syndrome, modifier of}",193300,AD,-,CCND1
"FGF3, INT2",Fibroblast growth factor-3 (oncogene INT2),164950,"Deafness, congenital with inner ear agenesis, microtia, and microdontia",610706,AR,35kb 5' to HST1,FGF3
FADD,FAS-associating protein with death domain,602457,"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations",613759,AR,-,FADD
"SHANK2, CORTBP1, AUTS17",SH3 and multiple ankyrin repeat domains 2,603290,{Autism susceptibility 17},613436,-,-,SHANK2
"DHCR7, SLOS",Delta-7-dehydrocholesterol reductase,602858,Smith-Lemli-Opitz syndrome,270400,AR,-,DHCR7
NUMA1,Nuclear mitotic apparatus protein-1,164009,"Leukemia, acute promyelocytic, somatic",612376,-,fused with RARA in APL,NUMA1
"LRTOMT, LRTOMT1, LRTOMT2, DFNB63",Leucine-rich transmembrane O-methyltransferase,612414,"Deafness, autosomal recessive 63",611451,AR,-,LRTOMT
FOLR1,"Folate receptor-1, adult",136430,Neurodegeneration due to cerebral folate transport deficiency,613068,AR,telomeric of FGF3,FOLR1
"INPPL1, OPSMD",Inositol polyphosphate phosphatase-like 1,600829,Opsismodysplasia,258480,AR,-,INPPL1
"PHOX2A, ARIX, CFEOM2",Paired-like (astraless) homeobox 2a,602753,"Fibrosis of extraocular muscles, congenital, 2",602078,AR,-,PHOX2A
"CLPB, SKD3, MEGCANN, MGCA7",Caseinolytic peptidase B,616254,"3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia",616271,AR,-,CLPB
"DNAJB13, TSARG6, CILD34","DNAJ/HSP40 homolog, subfamily B, member 13",610263,"Ciliary dyskinesia, primary, 34",617091,AR,-,DNAJB13
"UCP2, BMIQ4",Uncoupling protein-2,601693,"{Obesity, susceptibility to, BMIQ4}",607447,-,-,UCP2
UCP3,Uncoupling protein-3,602044,"{Obesity, severe, and type II diabetes}",601665,"AD,Mu,AR",-,UCP3
"C2CD3, OFD14",C2 calcium-dependent domain-containing protein 3,615944,?Orofaciodigital syndrome XIV,615948,AR,mutation identified in 1 OFD14 patient and 1 OFD14 fetus,C2CD3
"KCNE3, HOKPP, HYPP","Potassium voltage-gated channel, ISK-related subfamily, member 3",604433,Brugada syndrome 6,613119,-,-,KCNE3
LIPT2,Lipoyl(octanoyl) transferase 2,617659,"Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities",617668,AR,-,LIPT2
"SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10","Serpin peptidase inhibitor, clade H, member 1",600943,"Osteogenesis imperfecta, type X",613848,AR,-,SERPINH1
"SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10","Serpin peptidase inhibitor, clade H, member 1",600943,"{Preterm premature rupture of the membranes, susceptibility to}",610504,-,-,SERPINH1
"ACER3, APHC, PHCA, PLDECO",Alkaline ceramidase 3,617036,"?Leukodystrophy, progressive, early childhood-onset",617762,AR,mutation identified in 1 PLDECO family,ACER3
"CAPN5, HTRA3, VRNI",Calpain 5,602537,"Vitreoretinopathy, neovascular inflammatory",193235,AD,-,CAPN5
"MYO7A, USH1B, DFNB2, DFNA11",Myosin VIIA,276903,"Deafness, autosomal dominant 11",601317,AD,-,MYO7A
"MYO7A, USH1B, DFNB2, DFNA11",Myosin VIIA,276903,"Deafness, autosomal recessive 2",600060,AR,-,MYO7A
"MYO7A, USH1B, DFNB2, DFNA11",Myosin VIIA,276903,"Usher syndrome, type 1B",276900,AR,-,MYO7A
SCZD2,"Schizophrenia susceptibility locus, chromosome 11-related",603342,{?Schizophrenia},181500,AD,-,SCZD2
"ALG8, CDG1H, PCLD3","Alg8, S. cerevisiae, homolog of",608103,"Congenital disorder of glycosylation, type Ih",608104,AR,-,ALG8
"ALG8, CDG1H, PCLD3","Alg8, S. cerevisiae, homolog of",608103,Polycystic liver disease 3 with or without kidney cysts,617874,-,-,ALG8
"NARS2, COXPD24",Asparaginyl-tRNA synthetase 2,612803,Combined oxidative phosphorylation deficiency 24,616239,AR,-,NARS2
"TENM4, ODZ4, TNM4, DOC4, KIAA1302, ETM5",Teneurin transmembrane protein 4,610084,"Essential tremor, hereditary, 5",616736,AD,-,TENM4
TMEM126B,Transmembrane protein 126B,615533,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",-,TMEM126B
"TMEM126A, OPA7",Transmembrane protein 126A,612988,Optic atrophy 7,612989,AR,-,TMEM126A
"PICALM, CALM, CLTH, LAP",Phosphatidylinositol-binding clathrin assembly protein,603025,"Leukemia, acute myeloid, somatic",601626,-,fuses with AF10 in t(10;11),PICALM
"EED, WAIT1, COGIS","Embryonic ectoderm development protein, mouse, homolog of",605984,Cohen-Gibson syndrome,617561,AD,-,EED
"HIKESHI, C11orf73, HLD13",Hikeshi,614908,"Leukodystrophy, hypomyelinating, 13",616881,AR,-,HIKESHI
"FZD4, EVR1","Frizzled, Drosophila, homolog of, 4",604579,Exudative vitreoretinopathy 1,133780,AD,-,FZD4
"FZD4, EVR1","Frizzled, Drosophila, homolog of, 4",604579,Retinopathy of prematurity,133780,AD,-,FZD4
"CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD",Cathepsin C,602365,Haim-Munk syndrome,245010,AR,-,CTSC
"CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD",Cathepsin C,602365,Papillon-Lefevre syndrome,245000,AR,-,CTSC
"CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD",Cathepsin C,602365,"Periodontitis 1, juvenile",170650,AR,-,CTSC
"TYR, SHEP3, CMM8, OCA1A, ATN",Tyrosinase,606933,"Albinism, oculocutaneous, type IA",203100,AR,-,TYR
"TYR, SHEP3, CMM8, OCA1A, ATN",Tyrosinase,606933,"Albinism, oculocutaneous, type IB",606952,-,-,TYR
"TYR, SHEP3, CMM8, OCA1A, ATN",Tyrosinase,606933,"Waardenburg syndrome/albinism, digenic",103470,AD,-,TYR
"TYR, SHEP3, CMM8, OCA1A, ATN",Tyrosinase,606933,"[Skin/hair/eye pigmentation 3, blue/green eyes]",601800,-,-,TYR
"TYR, SHEP3, CMM8, OCA1A, ATN",Tyrosinase,606933,"[Skin/hair/eye pigmentation 3, light/dark/freckling skin]",601800,-,-,TYR
"TYR, SHEP3, CMM8, OCA1A, ATN",Tyrosinase,606933,"{Melanoma, cutaneous malignant, susceptibility to, 8}",601800,-,-,TYR
MTNR1B,Melatonin receptor 1B,600804,"{Diabetes mellitus, type 2, susceptibility to}",125853,AD,-,MTNR1B
"MED17, CRSP6, CRSP77, TRAP80, DRIP80",Mediator complex subunit 17,603810,"Microcephaly, postnatal progressive, with seizures and brain atrophy",613668,AR,-,MED17
"MRE11A, MRE11, ATLD","Meiotic recombination 11, S. cerevisiae, homolog A of",600814,Ataxia-telangiectasia-like disorder 1,604391,AR,-,MRE11A
"CEP57, PIG8, TSP57, KIAA0092, MVA2",Centrosomal protein 57kD,607951,Mosaic variegated aneuploidy syndrome 2,614114,AR,-,CEP57
"MTMR2, CMT4B1",Myotubularin-related protein 2,603557,"Charcot-Marie-Tooth disease, type 4B1",601382,AR,-,MTMR2
"TRPC6, TRP6, FSGS2",Transient receptor potential channel-6,603652,"Glomerulosclerosis, focal segmental, 2",603965,-,-,TRPC6
"YAP1, COB1","Yes-associated protein 1, 65kD",606608,"Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation",120433,AD,-,YAP1
"MMP20, AI2A2",Matrix metalloproteinase-20 (enamelysin),604629,"Amelogenesis imperfecta, type IIA2",612529,AR,-,MMP20
"MMP1, CLG",Matrix metalloproteinase 1 (interstitial collagenase),120353,"COPD, rate of decline of lung function in",606963,-,-,MMP1
"MMP1, CLG",Matrix metalloproteinase 1 (interstitial collagenase),120353,"{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}",226600,AR,-,MMP1
"MMP3, STMY1, CHDS6","Matrix metalloproteinase 3 (stromelysin 1, progelatinase)",185250,"{Coronary heart disease, susceptibility to, 6}",614466,-,-,MMP3
"MMP13, CLG3, MANDP1, MDST",Matrix metalloproteinase 13 (collagenase 3),600108,Metaphyseal anadysplasia 1,602111,AD,-,MMP13
"MMP13, CLG3, MANDP1, MDST",Matrix metalloproteinase 13 (collagenase 3),600108,"Metaphyseal dysplasia, Spahr type",250400,AR,-,MMP13
"MMP13, CLG3, MANDP1, MDST",Matrix metalloproteinase 13 (collagenase 3),600108,"Spondyloepimetaphyseal dysplasia, Missouri type",602111,AD,-,MMP13
"DYNC2H1, DNCH2, DHC2, ATD3, SRPS2B, SRTD3","Dynein, cytoplasmic-2, heavy chain-1",603297,Short-rib thoracic dysplasia 3 with or without polydactyly,613091,"AR,DR",1 patient showed heterozygous NEK2 and DYNC2H1 mutations,DYNC2H1
"GRIA4, GLUR4, NEDSGA","Glutamate receptor, ionotropic, AMPA 4",138246,Neurodevelopmental disorder with or without seizures and gait abnormalities,617864,AD,-,GRIA4
ACAT1,Acetyl-Coenzyme A acetyltransferase-1 (acetoacetyl Coenzyme A thiolase),607809,Alpha-methylacetoacetic aciduria,203750,AR,cluster: cen-STMY2-CLG-STMY1-ter,ACAT1
"ATM, ATA, AT1","Ataxia-telangiectasia mutated (includes complementation groups A, C, D, and E)",607585,Ataxia-telangiectasia,208900,AR,-,ATM
"ATM, ATA, AT1","Ataxia-telangiectasia mutated (includes complementation groups A, C, D, and E)",607585,"Lymphoma, B-cell non-Hodgkin, somatic",-,-,-,ATM
"ATM, ATA, AT1","Ataxia-telangiectasia mutated (includes complementation groups A, C, D, and E)",607585,"Lymphoma, mantle cell, somatic",-,-,-,ATM
"ATM, ATA, AT1","Ataxia-telangiectasia mutated (includes complementation groups A, C, D, and E)",607585,"T-cell prolymphocytic leukemia, somatic",-,-,-,ATM
"ATM, ATA, AT1","Ataxia-telangiectasia mutated (includes complementation groups A, C, D, and E)",607585,"{Breast cancer, susceptibility to}",114480,AD,-,ATM
"EXPH5, SLAC2B, KIAA0624",Exophilin 5,612878,"Epidermolysis bullosa, nonspecific, autosomal recessive",615028,AR,-,EXPH5
"RDX, DFNB24",Radixin,179410,"Deafness, autosomal recessive 24",611022,AR,-,RDX
GTS,Gilles de la Tourette syndrome,137580,Tourette syndrome,137580,AD,"several loci suspected (e.g., 17q25)",GTS
JBS,Jacobsen syndrome,147791,Jacobsen syndrome,147791,IC,contiguous gene deletion syndrome,JBS
TCPT,"Thrombocytopenia, Paris-Trousseau type (deletion 11q23 syndrome)",188025,"?Thrombocytopenia, Paris-Trousseau type",188025,IC,contiguous gene deletion of 11q23,TCPT
PPP2R1B,"Protein phosphatase 2, structural/regulatory subunit A, beta",603113,Lung cancer,211980,AR,-,PPP2R1B
"ALG9, DIBD1, CDG1L, GIKANIS","Alg9, yeast, homolog of",606941,"Congenital disorder of glycosylation, type Il",608776,AR,-,ALG9
"ALG9, DIBD1, CDG1L, GIKANIS","Alg9, yeast, homolog of",606941,Gillessen-Kaesbach-Nishimura syndrome,263210,AR,-,ALG9
"CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2","Crystallin, alpha B",123590,"Cardiomyopathy, dilated, 1II",615184,AD,-,CRYAB
"CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2","Crystallin, alpha B",123590,"Cataract 16, multiple types",613763,"AD,AR",-,CRYAB
"CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2","Crystallin, alpha B",123590,"Myopathy, myofibrillar, 2",608810,AD,-,CRYAB
"CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2","Crystallin, alpha B",123590,"Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related",613869,AR,-,CRYAB
"DLAT, PDCE2",Dihydrolipoamide S-acetyltransferase,608770,Pyruvate dehydrogenase E2 deficiency,245348,AR,-,DLAT
"SDHD, PGL1, CWS3","Succinate dehydrogenase complex, subunit D, integral membrane protein",602690,"Carcinoid tumors, intestinal",114900,AD,-,SDHD
"SDHD, PGL1, CWS3","Succinate dehydrogenase complex, subunit D, integral membrane protein",602690,Cowden syndrome 3,615106,-,-,SDHD
"SDHD, PGL1, CWS3","Succinate dehydrogenase complex, subunit D, integral membrane protein",602690,"Merkel cell carcinoma, somatic",-,-,-,SDHD
"SDHD, PGL1, CWS3","Succinate dehydrogenase complex, subunit D, integral membrane protein",602690,Mitochondrial complex II deficiency,252011,AR,-,SDHD
"SDHD, PGL1, CWS3","Succinate dehydrogenase complex, subunit D, integral membrane protein",602690,Paraganglioma and gastric stromal sarcoma,606864,-,-,SDHD
"SDHD, PGL1, CWS3","Succinate dehydrogenase complex, subunit D, integral membrane protein",602690,"Paragangliomas 1, with or without deafness",168000,AD,-,SDHD
"SDHD, PGL1, CWS3","Succinate dehydrogenase complex, subunit D, integral membrane protein",602690,Pheochromocytoma,171300,AD,-,SDHD
PTS,6-pyruvoyltetrahydropterin synthase,612719,"Hyperphenylalaninemia, BH4-deficient, A",261640,AR,-,PTS
"ZBTB16, ZNF145, PLZF",Zinc finger- and BTB domain-containing protein 16 (promyelocytic leukemia zinc finger),176797,"Leukemia, acute promyelocytic, PL2F/RARA type",-,-,fused with RARA in APL of t(11;17) type,ZBTB16
"ZBTB16, ZNF145, PLZF",Zinc finger- and BTB domain-containing protein 16 (promyelocytic leukemia zinc finger),176797,"Skeletal defects, genital hypoplasia, and mental retardation",612447,AR,-,ZBTB16
APOA5,Apolipoprotein A-V,606368,"Hyperchylomicronemia, late-onset",144650,AD,"proximal to APOA1, APOC3, APOA4",APOA5
APOA5,Apolipoprotein A-V,606368,"{Hypertriglyceridemia, susceptibility to}",145750,AD,-,APOA5
"APOC3, HALP2",Apolipoprotein C-III,107720,Apolipoprotein C-III deficiency,614028,-,2.6kb 3' to APOA1,APOC3
APOA1,Apolipoprotein A-I,107680,"Amyloidosis, 3 or more types",105200,AD,-,APOA1
APOA1,Apolipoprotein A-I,107680,"ApoA-I and apoC-III deficiency, combined",-,-,-,APOA1
APOA1,Apolipoprotein A-I,107680,"Corneal clouding, autosomal recessive",-,-,-,APOA1
APOA1,Apolipoprotein A-I,107680,Hypoalphalipoproteinemia,604091,-,-,APOA1
"CEP164, KIAA1052","Centrosomal protein, 164kD",614848,Nephronophthisis 15,614845,AR,-,CEP164
"FXYD2, ATP1G1, HOMG2","FXYD domain-containing ion transport regulator 2 (sodium-potassium-ATPase, gamma polypeptide)",601814,"Hypomagnesemia 2, renal",154020,AD,-,FXYD2
"IL10RA, IL10R, IBD28","Interleukin-10 receptor, alpha",146933,"Inflammatory bowel disease 28, early onset, autosomal recessive",613148,AR,-,IL10RA
"SCN4B, LQT10, ATFB17","Sodium channel, voltage-gated, type IV, beta subunit",608256,"Atrial fibrillation, familial, 17",611819,AD,-,SCN4B
"SCN4B, LQT10, ATFB17","Sodium channel, voltage-gated, type IV, beta subunit",608256,Long QT syndrome-10,611819,AD,-,SCN4B
"SCN2B, ATFB14","Sodium channel, voltage-gated, type II, beta polypeptide",601327,"Atrial fibrillation, familial, 14",615378,AD,-,SCN2B
"CD3E, IMD18","CD3E antigen, epsilon polypeptide (TiT3 complex)",186830,Immunodeficiency 18,615615,AR,-,CD3E
"CD3E, IMD18","CD3E antigen, epsilon polypeptide (TiT3 complex)",186830,"Immunodeficiency 18, SCID variant",615615,AR,-,CD3E
"CD3D, T3D, IMD19","CD3D antigen, delta polypeptide (TiT3 complex)",186790,Immunodeficiency 19,615617,AR,3 CD3 genes in 50kb,CD3D
"CD3G, IMD17","CD3G antigen, gamma polypeptide (TiT3 complex)",186740,"Immunodeficiency 17, CD3 gamma deficient",615607,AR,-,CD3G
"KMT2A, MLL, HRX, HTRX1, WDSTS",Lysine (K)-specific methyltransferase 2E,159555,"Leukemia, myeloid/lymphoid or mixed-lineage",159555,AD,"fuses with ENL, AF4, AF9, GMPS",KMT2A
"KMT2A, MLL, HRX, HTRX1, WDSTS",Lysine (K)-specific methyltransferase 2E,159555,Wiedemann-Steiner syndrome,605130,AD,-,KMT2A
"ARCN1, SRMMD",Archain 1,600820,"Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay",617164,AD,60kb telomeric to MLL,ARCN1
"TREH, TREHD",Trehalase,275360,Trehalase deficiency,612119,AR,-,TREH
"SLC37A4, G6PT1","Solute carrier family 37 (glucose-6-phosphate transporter), member 4",602671,Glycogen storage disease Ib,232220,AR,-,SLC37A4
"SLC37A4, G6PT1","Solute carrier family 37 (glucose-6-phosphate transporter), member 4",602671,Glycogen storage disease Ic,232240,AR,-,SLC37A4
"VPS11, HLD12","Vacuolar protein sorting 11, yeast, homolog of",608549,"Leukodystrophy, hypomyelinating, 12",616683,AR,-,VPS11
"HMBS, PBGD, UPS",Hydroxymethylbilane synthase,609806,"Porphyria, acute intermittent",176000,AD,-,HMBS
"HMBS, PBGD, UPS",Hydroxymethylbilane synthase,609806,"Porphyria, acute intermittent, nonerythroid variant",176000,AD,-,HMBS
"DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13",Dolichyl-phosphate N-acetylglucosamine phosphotransferase,191350,"Congenital disorder of glycosylation, type Ij",608093,AR,-,DPAGT1
"DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13",Dolichyl-phosphate N-acetylglucosamine phosphotransferase,191350,"Myasthenic syndrome, congenital, 13, with tubular aggregates",614750,AR,-,DPAGT1
"CBL, CBL2, NSLL",Cas-Br-M ecotropic retroviral transforming sequence (Oncogene CBL2),165360,?Juvenile myelomonocytic leukemia,607785,"AD,SMu",mutation identified in 1 JMML family,CBL
"CBL, CBL2, NSLL",Cas-Br-M ecotropic retroviral transforming sequence (Oncogene CBL2),165360,Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia,613563,AD,-,CBL
"C1QTNF5, CTRP5, LORD",C1q- and tumor necrosis factor-related protein 5,608752,"Retinal degeneration, late-onset, autosomal dominant",605670,AD,-,C1QTNF5
"MFRP, MCOP5, NNO2",Membrane-type frizzled-related protein,606227,"Microphthalmia, isolated 5",611040,AR,-,MFRP
"MFRP, MCOP5, NNO2",Membrane-type frizzled-related protein,606227,Nanophthalmos 2,609549,-,-,MFRP
"NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1",Nectin 1,600644,Cleft lip/palate-ectodermal dysplasia syndrome,225060,AR,-,NECTIN1
"NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1",Nectin 1,600644,Orofacial cleft 7,225060,AR,-,NECTIN1
"TECTA, DFNA8, DFNA12, DFNB21","Tectorin, alpha",602574,"Deafness, autosomal dominant 8/12",601543,AD,-,TECTA
"TECTA, DFNA8, DFNA12, DFNB21","Tectorin, alpha",602574,"Deafness, autosomal recessive 21",603629,AR,-,TECTA
"SC5DL, ERG3",Sterol C5-desaturase-like,602286,Lathosterolosis,607330,AR,-,SC5DL
"CLMP, ASAM, ACAM, CSBS",Coxsackievirus- and adenovirus receptor-like membrane protein,611693,Congenital short bowel syndrome,615237,AR,-,CLMP
"SCN3B, SCNB3, BRGDA7, ATFB16","Sodium channel, voltage-gated, type III, beta subunit",608214,"Atrial fibrillation, familial, 16",613120,AD,-,SCN3B
"SCN3B, SCNB3, BRGDA7, ATFB16","Sodium channel, voltage-gated, type III, beta subunit",608214,Brugada syndrome 7,613120,AD,-,SCN3B
"SIAE, AIS6",Sialic acid acetylesterase,610079,"{Autoimmune disease, susceptibility to, 6}",613551,-,-,SIAE
"ROBO3, RBIG1, RIG1, HGPPS1","Roundabout, Drosophila, homolog of, 3",608630,"Gaze palsy, familial horizontal, with progressive scoliosis, 1",607313,AR,-,ROBO3
"HEPACAM, MLC2A, MLC2B",Hepatocyte cell adhesion molecule,611642,Megalencephalic leukoencephalopathy with subcortical cysts 2A,613925,AR,-,HEPACAM
"HEPACAM, MLC2A, MLC2B",Hepatocyte cell adhesion molecule,611642,"Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation",613926,AD,-,HEPACAM
"STT3A, ITM1, TMC","STT3A, subunit of the oligosaccharyltransferase complex (catalytic)",601134,"?Congenital disorder of glycosylation, type Iw",615596,AR,mutation identified in 1 family,STT3A
"HYLS1, FLJ32915",HYLS1 gene,610693,Hydrolethalus syndrome,236680,AR,-,HYLS1
"PUS3, MRT55",Pseudouridylate synthase 3,616283,"?Mental retardation, autosomal recessive 55",617051,AR,mutation identified in 1 MRT55 family,PUS3
"CDON, CDO, HPE11",Cell adhesion molecule-related/downregulated by oncogenes,608707,Holoprosencephaly 11,614226,"AD,IC",-,CDON
FOXRED1,FAD-dependent oxidoreductase domain-containing protein 1,613622,Leigh syndrome due to mitochondrial complex I deficiency,256000,"Mi,AR",-,FOXRED1
FOXRED1,FAD-dependent oxidoreductase domain-containing protein 1,613622,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",-,FOXRED1
"TIRAP, BACTS1",TIR domain-containing adaptor protein,606252,"{Bacteremia, protection against}",614382,-,-,TIRAP
"TIRAP, BACTS1",TIR domain-containing adaptor protein,606252,"{Malaria, protection against}",611162,-,-,TIRAP
"TIRAP, BACTS1",TIR domain-containing adaptor protein,606252,"{Pneumococcal disease, invasive, protection against}",610799,-,-,TIRAP
"TIRAP, BACTS1",TIR domain-containing adaptor protein,606252,"{Tuberculosis, protection against}",607948,-,-,TIRAP
"DCPS, HINT5, DCS1, ARS","Decapping enzyme, scavenger",610534,Al-Raqad syndrome,616459,AR,-,DCPS
"KIRREL3, NEPH2, KIAA1867, KIRRE, MRD4",Kin of IRRE-like 3,607761,"Mental retardation, autosomal dominant 4",612581,-,-,KIRREL3
"FLI1, BDPLT21",Friend leukemia virus integration 1,193067,"Bleeding disorder, platelet-type, 21",617443,"AD,AR",fused with EWS in Ewing sarcoma,FLI1
"KCNJ1, ROMK1","Potassium inwardly-rectifying channel, subfamily J, member 1",600359,"Bartter syndrome, type 2",241200,AR,-,KCNJ1
"KCNJ5, GIRK4, KATP1, LQT13","Potassium inwardly-rectifying channel, subfamily J, member 5",600734,"Hyperaldosteronism, familial, type III",613677,AD,-,KCNJ5
"KCNJ5, GIRK4, KATP1, LQT13","Potassium inwardly-rectifying channel, subfamily J, member 5",600734,Long QT syndrome 13,613485,AD,-,KCNJ5
"ST14, MTSP1, ARCI11",Suppression of tumorigenicity 14,606797,"Ichthyosis, congenital, autosomal recessive 11",602400,AR,-,ST14
"HJCD, HCLAP",Histiocytosis with joint contractures and sensorineural deafness,602782,Histiocytosis-lymphadenopathy plus syndrome,602782,AR,-,HJCD
OPCML,Opioid-binding protein/cell adhesion molecule-like,600632,"{Ovarian cancer, somatic}",167000,-,-,OPCML
JAM3,Junctional adhesion molecule 3,606871,"Hemorrhagic destruction of the brain, subependymal calcification, and cataracts",613730,AR,-,JAM3
ACAD8,"Acyl-CoA dehydrogenase family, member 8",604773,Isobutyryl-CoA dehydrogenase deficiency,611283,-,-,ACAD8
EDS8,"Ehlers-Danlos syndrome, type VIII",130080,"Ehlers-Danlos syndrome, type VIII",130080,AD,prob. genetic heterogeneity,EDS8
PKS,Pallister-Killian syndrome,601803,Pallister-Killian syndrome,601803,SMo,-,PKS
"WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2",WNK lysine deficient protein kinase 1,605232,"Neuropathy, hereditary sensory and autonomic, type II",201300,AR,-,WNK1
"WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2",WNK lysine deficient protein kinase 1,605232,"Pseudohypoaldosteronism, type IIC",614492,AD,-,WNK1
"CACNA2D4, RCD4","Calcium channel, voltage-dependent, alpha-2/delta subunit 4",608171,Retinal cone dystrophy 4,610478,AR,-,CACNA2D4
"CACNA1C, CACNL1A1, CCHL1A1, TS","Calcium channel, voltage-dependent, L type, alpha 1C subunit",114205,Brugada syndrome 3,611875,-,-,CACNA1C
"CACNA1C, CACNL1A1, CCHL1A1, TS","Calcium channel, voltage-dependent, L type, alpha 1C subunit",114205,Timothy syndrome,601005,AD,-,CACNA1C
"CCND2, MPPH3",Cyclin D2,123833,Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3,615938,AD,-,CCND2
"FGF23, ADHR, HPDR2, PHPTC",Fibroblast growth factor 23,605380,"Hypophosphatemic rickets, autosomal dominant",193100,AD,-,FGF23
"FGF23, ADHR, HPDR2, PHPTC",Fibroblast growth factor 23,605380,"Osteomalacia, tumor-induced",-,-,-,FGF23
"FGF23, ADHR, HPDR2, PHPTC",Fibroblast growth factor 23,605380,"Tumoral calcinosis, hyperphosphatemic, familial",211900,AR,-,FGF23
NDUFA9,"NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 9",603834,Leigh syndrome due to mitochondrial complex I deficiency,256000,"Mi,AR",-,NDUFA9
"KCNA1, AEMK, EA1","Potassium voltage-gated channel, shaker-related subfamily, member 1",176260,Episodic ataxia/myokymia syndrome,160120,AD,close to VWF,KCNA1
"KCNA5, ATFB7","Potassium voltage-gated channel, shaker-related subfamily, member 5",176267,"Atrial fibrillation, familial, 7",612240,AD,-,KCNA5
"VWF, F8VWF",Coagulation factor VIII VWF (von Willebrand factor),613160,"von Willebrand disease, type 1",193400,AD,pseudogene on chr. 22,VWF
"VWF, F8VWF",Coagulation factor VIII VWF (von Willebrand factor),613160,"von Willebrand disease, types 2A, 2B, 2M, and 2N",613554,"AD,AR",-,VWF
"VWF, F8VWF",Coagulation factor VIII VWF (von Willebrand factor),613160,"von Willibrand disease, type 3",277480,AR,-,VWF
"TNFRSF1A, TNFR1, TNFAR, FPF, MS5","Tumor necrosis factor receptor superfamily, member 1A",191190,"Periodic fever, familial",142680,AD,-,TNFRSF1A
"TNFRSF1A, TNFR1, TNFAR, FPF, MS5","Tumor necrosis factor receptor superfamily, member 1A",191190,"{Multiple sclerosis, susceptibility to, 5}",614810,-,-,TNFRSF1A
"SCNN1A, BESC2","Sodium channel, nonvoltage-gated 1, alpha",600228,Bronchiectasis with or without elevated sweat chloride 2,613021,AD,-,SCNN1A
"SCNN1A, BESC2","Sodium channel, nonvoltage-gated 1, alpha",600228,"Pseudohypoaldosteronism, type I",264350,AR,-,SCNN1A
"CD27, TNFRSF7, S152. LPFS2",CD27 antigen,186711,Lymphoproliferative syndrome 2,615122,AR,-,CD27
"VAMP1, SYB1, SPAX1",Vesicle-associated membrane protein-1 (synaptobrevin-1),185880,"Spastic ataxia 1, autosomal dominant",108600,AD,-,VAMP1
"CHD4, SIHIWES",Chromodomain helicase DNA-binding protein-4,603277,Sifrim-Hitz-Weiss syndrome,617159,AD,-,CHD4
CD4,CD4 antigen (p55),186940,OKT4 epitope deficiency,613949,-,CD = \'cluster of differentiation\' = nomenclature of leukocyte differentiation antigens,CD4
"GNB3, CSNB1H","Guanine nucleotide-binding protein, beta polypeptide-3",139130,"Night blindness, congenital stationary, type 1H",617024,AR,-,GNB3
"GNB3, CSNB1H","Guanine nucleotide-binding protein, beta polypeptide-3",139130,"{Hypertension, essential, susceptibility to}",145500,Mu,-,GNB3
"TPI1, TPID",Triosephosphate isomerase-1,190450,Hemolytic anemia due to triosephosphate isomerase deficiency,615512,AR,-,TPI1
"ATN1, DRPLA, HRS, NOD",Atrophin 1,607462,Dentatorubro-pallidoluysian atrophy,125370,AD,-,ATN1
"C12orf57, C10, TEMTYS",Chromosome 12 open reading frame 57,615140,Temtamy syndrome,218340,AR,-,C12orf57
"EMG1, NEP1, C2F, BWCNS","Essential for mitotic growth 1, S. cerevisiae, homolog of",611531,Bowen-Conradi syndrome,211180,AR,-,EMG1
"C1S, EDSPD2","Complement component-1, s subcomponent",120580,C1s deficiency,613783,-,-,C1S
"C1S, EDSPD2","Complement component-1, s subcomponent",120580,"Ehlers-Danlos syndrome, periodontal type, 2",617174,AD,-,C1S
"C1R, EDSPD1","Complement component-1, r subcomponent",613785,"Ehlers-Danlos syndrome, periodontal type, 1",130080,AD,-,C1R
"PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5",Peroxisome biogenesis factor 5,600414,Peroxisome biogenesis disorder 2A (Zellweger),214110,AR,-,PEX5
"PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5",Peroxisome biogenesis factor 5,600414,Peroxisome biogenesis disorder 2B,202370,AR,-,PEX5
"PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5",Peroxisome biogenesis factor 5,600414,"Rhizomelic chondrodysplasia punctata, type 5",616716,AR,-,PEX5
"GDF3, KFS3, MCOPCB6, MCOP7",Growth differentiation factor 3,606522,"Klippel-Feil syndrome 3, autosomal dominant",613702,-,-,GDF3
"GDF3, KFS3, MCOPCB6, MCOP7",Growth differentiation factor 3,606522,Microphthalmia with coloboma 6,613703,AD,-,GDF3
"GDF3, KFS3, MCOPCB6, MCOP7",Growth differentiation factor 3,606522,"Microphthalmia, isolated 7",613704,AD,-,GDF3
"NECAP1, EIEE21",NECAP endocytosis-associated protein 1,611623,"?Epileptic encephalopathy, early infantile, 21",615833,AR,mutation identified in 1 EIEE21 family,NECAP1
"AICDA, AID, HIGM2",Activation-induced cytidine deaminase,605257,"Immunodeficiency with hyper-IgM, type 2",605258,AR,-,AICDA
"MFAP5, MAGP2, AAT9",Microfibril-associated protein 5,601103,"Aortic aneurysm, familial thoracic 9",616166,AD,-,MFAP5
"PHC1, EDR1, HPH1, RAE28, MCPH11",Polyhomeotic-like 1,602978,"?Microcephaly 11, primary, autosomal recessive",615414,AR,mutations identified in 1 family,PHC1
"A2M , A2MD",Alpha-2-macroglobulin,103950,Alpha-2-macroglobulin deficiency,614036,AD,cluster of genes,A2M 
"A2M , A2MD",Alpha-2-macroglobulin,103950,"{Alzheimer disease, susceptibility to}",104300,AD,-,A2M 
"CLEC7A, CLECSF12, DECTIN1, CANDF4","C-type lectin domain family 7, member A",606264,"Candidiasis, familial, 4, autosomal recessive",613108,AR,in natural killer gene complex,CLEC7A
"CLEC7A, CLECSF12, DECTIN1, CANDF4","C-type lectin domain family 7, member A",606264,"{Aspergillosis, susceptibility to}",614079,-,-,CLEC7A
"OLR1, LOX1","Low density lipoprotein, oxidized, receptor 1",602601,"{Myocardial infarction, susceptibility to}",608446,-,-,OLR1
"ETV6, TEL, THC5",ETS variant gene-6 (TEL oncogene),600618,"Leukemia, acute myeloid, somatic",601626,-,fused to PDGFRB or AML1 in leukemia,ETV6
"ETV6, TEL, THC5",ETS variant gene-6 (TEL oncogene),600618,Thrombocytopenia 5,616216,AD,-,ETV6
"LRP6, ADCAD2, STHAG7",Low density lipoprotein receptor-related protein 6,603507,"Tooth agenesis, selective, 7",616724,AD,-,LRP6
"LRP6, ADCAD2, STHAG7",Low density lipoprotein receptor-related protein 6,603507,"{Coronary artery disease, autosomal dominant, 2}",610947,AD,-,LRP6
"CDKN1B, KIP1, CDKN4, MEN4","Cyclin-dependent kinase inhibitor 1B (p27, Kip1)",600778,"Multiple endocrine neoplasia, type IV",610755,AD,-,CDKN1B
"GRIN2B, NMDAR2B, MRD6, EIEE27","Glutamate receptor, ionotropic, N-methyl D-aspartate 2B",138252,"Epileptic encephalopathy, early infantile, 27",616139,AD,-,GRIN2B
"GRIN2B, NMDAR2B, MRD6, EIEE27","Glutamate receptor, ionotropic, N-methyl D-aspartate 2B",138252,"Mental retardation, autosomal dominant 6",613970,AD,-,GRIN2B
"GUCY2C, GUC2C, DIAR6, MECIL",Guanylate cyclase 2C (heat stable enterotoxin receptor),601330,Diarrhea 6,614616,AD,-,GUCY2C
"GUCY2C, GUC2C, DIAR6, MECIL",Guanylate cyclase 2C (heat stable enterotoxin receptor),601330,Meconium ileus,614665,AR,-,GUCY2C
"ART4, DO, DOK1",ADP-ribosyltransferase-4 (Dombrock blood group),110600,"[Blood group, Dombrock]",616060,-,-,ART4
MGP,Matrix Gla protein,154870,Keutel syndrome,245150,AR,-,MGP
"PDE6H, RCD3, ACHM6","Phosphodiesterase 6H, cGMP-specific, cone, gamma",601190,Achromatopsia 6,610024,"AD,AR",-,PDE6H
"PDE6H, RCD3, ACHM6","Phosphodiesterase 6H, cGMP-specific, cone, gamma",601190,Retinal cone dystrophy 3,610024,"AD,AR",-,PDE6H
"PTPRO, GLEPP1, NPHS6","Protein tyrosine phosphatase, receptor type, O",600579,"Nephrotic syndrome, type 6",614196,AR,-,PTPRO
"EPS8, DFNB102",Epidermal growth factor receptor pathway substrate-8,600206,"?Deafness, autosomal recessive 102",615974,AR,mutation identified in 1 DFNB102 family,EPS8
"PLCZ1, SPGF17","Phospholipase C, zeta-1",608075,?Spermatogenic failure 17,617214,AR,mutation identified in 1 SPGF17 family,PLCZ1
HYT4,"Hypertension, essential, susceptibility to, 4",608742,"{Hypertension, essential, susceptibility to, 4}",145500,Mu,-,HYT4
"PDE3A, HTNB","Phosphodiesterase 3A, cGMP-inhibited",123805,Hypertension and brachydactyly syndrome,112410,AD,-,PDE3A
"SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR","Solute carrier organic anion transporter family, member 1B3",605495,"Hyperbilirubinemia, Rotor type, digenic",237450,DR,HBLRR digenic with SLCO1B1,SLCO1B3
"SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR","Solute carrier organic anion transporter family, member 1B1",604843,"Hyperbilirubinemia, Rotor type, digenic",237450,DR,HBLRR digenic with SLCO1B3,SLCO1B1
"PYROXD1, MFM8",Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1,617220,"Myopathy, myofibrillar, 8",617258,AR,-,PYROXD1
GYS2,"Glycogen synthase-2, liver",138571,"Glycogen storage disease 0, liver",240600,AR,-,GYS2
"LDHB, LDHBD",Lactate dehydrogenase B,150100,[Lactate dehydrogenase-B deficiency],614128,-,-,LDHB
"ABCC9, SUR2, CMD1O, ATFB12, CANTU","ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2)",601439,"Atrial fibrillation, familial, 12",614050,AD,-,ABCC9
"ABCC9, SUR2, CMD1O, ATFB12, CANTU","ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2)",601439,"Cardiomyopathy, dilated, 1O",608569,-,-,ABCC9
"ABCC9, SUR2, CMD1O, ATFB12, CANTU","ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2)",601439,Hypertrichotic osteochondrodysplasia,239850,AD,-,ABCC9
"SOX5, LAMSHF",SRY-box 5,604975,Lamb-Shaffer syndrome,616803,AD,some LAMSHF patients have 12p12 deletions,SOX5
"KRAS, KRAS2, RASK2, NS, CFC2, RALD",Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog,190070,"Arteriovenous malformation of the brain, somatic",108010,-,pseudogene KRAS1P on 6p12-p11,KRAS
"KRAS, KRAS2, RASK2, NS, CFC2, RALD",Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog,190070,"Bladder cancer, somatic",109800,-,-,KRAS
"KRAS, KRAS2, RASK2, NS, CFC2, RALD",Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog,190070,"Breast cancer, somatic",114480,-,-,KRAS
"KRAS, KRAS2, RASK2, NS, CFC2, RALD",Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog,190070,Cardiofaciocutaneous syndrome 2,615278,-,-,KRAS
"KRAS, KRAS2, RASK2, NS, CFC2, RALD",Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog,190070,"Gastric cancer, somatic",137215,-,-,KRAS
"KRAS, KRAS2, RASK2, NS, CFC2, RALD",Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog,190070,"Leukemia, acute myeloid",601626,AD,-,KRAS
"KRAS, KRAS2, RASK2, NS, CFC2, RALD",Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog,190070,"Lung cancer, somatic",211980,-,-,KRAS
"KRAS, KRAS2, RASK2, NS, CFC2, RALD",Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog,190070,Noonan syndrome 3,609942,AD,-,KRAS
"KRAS, KRAS2, RASK2, NS, CFC2, RALD",Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog,190070,"Pancreatic carcinoma, somatic",260350,-,-,KRAS
"KRAS, KRAS2, RASK2, NS, CFC2, RALD",Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog,190070,RAS-associated autoimmune leukoproliferative disorder,614470,AD,-,KRAS
"KRAS, KRAS2, RASK2, NS, CFC2, RALD",Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog,190070,"Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic",163200,-,-,KRAS
"BHLHE41, BHLHB3, DEC2, SHARP1","Basic helix-loop-helix domain-containing protein, member E41",606200,[Short sleeper],612975,AD,-,BHLHE41
"ITPR2, ANHD","Inositol 1,4,5-triphosphate receptor, type 2",600144,"?Anhidrosis, isolated, with normal sweat glands",106190,AR,mutation has been identified in 1 ANHD family,ITPR2
"PTHLH, BDE2",Parathyroid hormone-like hormone,168470,"Brachydactyly, type E2",613382,AD,-,PTHLH
"PTHLH, BDE2",Parathyroid hormone-like hormone,168470,Humoral hypercalcemia of malignancy,-,-,-,PTHLH
"DDX11, CHLR1, KRG2",DEAD/H box-11 (CHL1-related helicase gene-1),601150,Warsaw breakage syndrome,613398,AR,-,DDX11
"FGD4, FRABIN, CMT4H","FYVE, RhoGEF, and PH domain-containing protein 4",611104,"Charcot-Marie-Tooth disease, type 4H",609311,AR,-,FGD4
"DNM1L, DRP1, DVLP, DYMPLE, EMPF1, OPA5",Dynamin 1-like,603850,"Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1",614388,"AD,AR",-,DNM1L
"DNM1L, DRP1, DVLP, DYMPLE, EMPF1, OPA5",Dynamin 1-like,603850,Optic atrophy 5,610708,AD,-,DNM1L
"YARS2, TYRRS, MLASA2",Tyrosyl-tRNA synthetase 2,610957,"Myopathy, lactic acidosis, and sideroblastic anemia 2",613561,AR,-,YARS2
"PKP2, ARVD9",Plakophilin-2,602861,Arrhythmogenic right ventricular dysplasia 9,609040,AD,pseudogene on 12p13,PKP2
"ALG10, KCR1","Alg10, S. cerevisiae, homolog of",603313,"{Long QT syndrome, acquired, reduced susceptibility to}",613688,AD,-,ALG10
"KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B",Kinesin family member 21A,608283,"Fibrosis of extraocular muscles, congenital, 1",135700,AD,-,KIF21A
"KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B",Kinesin family member 21A,608283,"Fibrosis of extraocular muscles, congenital, 3B",135700,AD,-,KIF21A
"LRRK2, PARK8",Leucine-rich repeat kinase 2 (dardarin),609007,{Parkinson disease 8},607060,AD,-,LRRK2
"CNTN1, MYPCN",Contactin 1,600016,"?Myopathy, congenital, Compton-North",612540,AR,mutation identified in 1 MYPCN family,CNTN1
"PRICKLE1, RILP, EPM1B",Prickle-like 1,608500,"Epilepsy, progressive myoclonic 1B",612437,AR,-,PRICKLE1
"IRAK4, REN64, IPD1",Interleukin 1 receptor-associated kinase 4,606883,"Invasive pneumococcal disease, recurrent isolated, 1",610799,-,-,IRAK4
"IRAK4, REN64, IPD1",Interleukin 1 receptor-associated kinase 4,606883,IRAK4 deficiency,607676,-,-,IRAK4
"ANO6, TMEM16F, SCTS, BDPLT7",Anoctamin 6,608663,Scott syndrome,262890,AR,-,ANO6
"ARID2, BAF200, KIAA1557, CSS6",AT-rich interaction domain-containing protein 2,609539,Coffin-Siris syndrome 6,617808,AD,-,ARID2
VDR,"Vitamin D (1,25-dihydroxyvitamin D3) receptor",601769,"?Osteoporosis, involutional",166710,AD,-,VDR
VDR,"Vitamin D (1,25-dihydroxyvitamin D3) receptor",601769,"Rickets, vitamin D-resistant, type IIA",277440,AR,-,VDR
COL2A1,"Collagen II, alpha-1 polypeptide",120140,"Achondrogenesis, type II or hypochondrogenesis",200610,AD,-,COL2A1
COL2A1,"Collagen II, alpha-1 polypeptide",120140,Avascular necrosis of the femoral head,608805,AD,-,COL2A1
COL2A1,"Collagen II, alpha-1 polypeptide",120140,Czech dysplasia,609162,AD,-,COL2A1
COL2A1,"Collagen II, alpha-1 polypeptide",120140,"Epiphyseal dysplasia, multiple, with myopia and deafness",132450,AD,-,COL2A1
COL2A1,"Collagen II, alpha-1 polypeptide",120140,Kniest dysplasia,156550,AD,-,COL2A1
COL2A1,"Collagen II, alpha-1 polypeptide",120140,Legg-Calve-Perthes disease,150600,AD,-,COL2A1
COL2A1,"Collagen II, alpha-1 polypeptide",120140,Osteoarthritis with mild chondrodysplasia,604864,AD,-,COL2A1
COL2A1,"Collagen II, alpha-1 polypeptide",120140,"Platyspondylic skeletal dysplasia, Torrance type",151210,AD,-,COL2A1
COL2A1,"Collagen II, alpha-1 polypeptide",120140,SED congenita,183900,AD,-,COL2A1
COL2A1,"Collagen II, alpha-1 polypeptide",120140,SMED Strudwick type,184250,AD,-,COL2A1
COL2A1,"Collagen II, alpha-1 polypeptide",120140,"Spondyloepiphyseal dysplasia, Stanescu type",616583,AD,-,COL2A1
COL2A1,"Collagen II, alpha-1 polypeptide",120140,Spondyloperipheral dysplasia,271700,AD,-,COL2A1
COL2A1,"Collagen II, alpha-1 polypeptide",120140,"Stickler sydrome, type I, nonsyndromic ocular",609508,AD,-,COL2A1
COL2A1,"Collagen II, alpha-1 polypeptide",120140,"Stickler syndrome, type I",108300,AD,-,COL2A1
COL2A1,"Collagen II, alpha-1 polypeptide",120140,Vitreoretinopathy with phalangeal epiphyseal dysplasia,-,-,-,COL2A1
"PFKM, GSD7","Phosphofructokinase, muscle type",610681,Glycogen storage disease VII,232800,AR,incorrectly assigned to chr.1,PFKM
"ADCY6, LCCS8",Adenylate cyclase-6,600294,?Lethal congenital contracture syndrome 8,616287,AR,mutation identified in 1 LCCS8 family,ADCY6
"CCDC65, CILD27",Coiled-coil domain-containing protein 65,611088,"Ciliary dyskinesia, primary, 27",615504,AR,-,CCDC65
"WNT10B, SHFM6, STHAG8","Wingless-type MMTV integration site family, member 10B",601906,Split-hand/foot malformation 6,225300,AR,-,WNT10B
"WNT10B, SHFM6, STHAG8","Wingless-type MMTV integration site family, member 10B",601906,"Tooth agenesis, selective, 8",617073,AD,-,WNT10B
"WNT1, INT1, OI15, BMND16","Wingless-type MMTV integration site family, member 1 (oncogene INT1)",164820,"Osteogenesis imperfecta, type XV",615220,AR,-,WNT1
"WNT1, INT1, OI15, BMND16","Wingless-type MMTV integration site family, member 1 (oncogene INT1)",164820,"{Osteoporosis, early-onset, susceptibility to, autosomal dominant}",615221,-,-,WNT1
"KMT2D, MLL2, ALR, KABUK1",Lysine (K)-specific methyltransferase 2D,602113,Kabuki syndrome 1,147920,AD,-,KMT2D
"DHH, SRXY7, GDXYM",Desert hedgehog,605423,"46XY partial gonadal dysgenesis, with minifascicular neuropathy",607080,-,-,DHH
"DHH, SRXY7, GDXYM",Desert hedgehog,605423,46XY sex reversal 7,233420,AR,-,DHH
"TUBA1A, TUBA3, LIS3","Tubulin, alpha-1A",602529,Lissencephaly 3,611603,AD,-,TUBA1A
PRPH,Peripherin,170710,"{Amyotrophic lateral sclerosis, susceptibility to}",105400,"AD,AR",-,PRPH
AQP2,Aquaporin-2 (collecting duct),107777,"Diabetes insipidus, nephrogenic",125800,"AD,AR",-,AQP2
"AQP5, PPKB",Aquaporin-5,600442,"Palmoplantar keratoderma, Bothnian type",600231,AD,-,AQP5
"GPD1, HTGTI","Glycerol-3-phosphate dehydrogenase, soluble",138420,"Hypertriglyceridemia, transient infantile",614480,AR,-,GPD1
"COX14, C12orf62",Cytochrome c oxidase assembly protein COX14,614478,?Mitochondrial complex IV deficiency,220110,"Mi,AR",mutation identified in 1 Cox4 deficient family,COX14
"DIP2B, KIAA1463","Disco-interacting protein 2, Drosophila, homolog of, B",611379,"Mental retardation, FRA12A type",136630,AD,-,DIP2B
"SLC11A2, NRAMP2, DCT1, DMT1, AHMIO1",Solute carrier family 11 (proton-coupled divalent metal ion transporter) member 2,600523,"Anemia, hypochromic microcytic, with iron overload 1",206100,AR,-,SLC11A2
"SCN8A, CIAT, EIEE13, BFIS5","Sodium channel, voltage gated, type VIII, alpha polypeptide",600702,?Cognitive impairment with or without cerebellar ataxia,614306,AD,mutation identified in 1 CIAT family,SCN8A
"SCN8A, CIAT, EIEE13, BFIS5","Sodium channel, voltage gated, type VIII, alpha polypeptide",600702,"Epileptic encephalopathy, early infantile, 13",614558,AD,-,SCN8A
"SCN8A, CIAT, EIEE13, BFIS5","Sodium channel, voltage gated, type VIII, alpha polypeptide",600702,"Seizures, benign familial infantile, 5",617080,AD,-,SCN8A
"ACVRL1, ACVRLK1, ALK1, HHT2","Activin A receptor, type II-like kinase 1",601284,"Telangiectasia, hereditary hemorrhagic, type 2",600376,AD,-,ACVRL1
"KRT86, KRTHB6, HB6",Keratin 86,601928,Monilethrix,158000,AD,-,KRT86
"KRT81, KRTHB1, HB1",Keratin 81,602153,Monilethrix,158000,AD,-,KRT81
"KRT83, KRTHB3, HB3, MNLIX, EKVP5",Keratin 83,602765,Erythrokeratodermia variabilis et progressiva 5,617756,AR,-,KRT83
"KRT83, KRTHB3, HB3, MNLIX, EKVP5",Keratin 83,602765,Monilethrix,158000,AD,-,KRT83
"KRT85, KRTHB5, HB5, ECTD4",Keratin 85,602767,"Ectodermal dysplasia 4, hair/nail type",602032,AR,-,KRT85
"KRT75, K6HF, PFB",Keratin 75,609025,"{Pseudofolliculitis barbae, susceptibility to}",612318,-,-,KRT75
"KRT6B, PC4",Keratin 6B,148042,Pachyonychia congenita 4,615728,-,-,KRT6B
"KRT6C, PPKNEFD",Keratin 6C,612315,"Palmoplantar keratoderma, nonepidermolytic, focal or diffuse",615735,AD,-,KRT6C
"KRT6A, PC3",Keratin 6A,148041,Pachyonychia congenita 3,615726,-,-,KRT6A
"KRT5, DDD1",Keratin 5,148040,Dowling-Degos disease 1,179850,AD,-,KRT5
"KRT5, DDD1",Keratin 5,148040,"Epidermolysis bullosa simplex, Dowling-Meara type",131760,AD,-,KRT5
"KRT5, DDD1",Keratin 5,148040,"Epidermolysis bullosa simplex, Koebner type",131900,AD,-,KRT5
"KRT5, DDD1",Keratin 5,148040,"Epidermolysis bullosa simplex, recessive 1",601001,AR,-,KRT5
"KRT5, DDD1",Keratin 5,148040,"Epidermolysis bullosa simplex, Weber-Cockayne type",131800,AD,-,KRT5
"KRT5, DDD1",Keratin 5,148040,Epidermolysis bullosa simplex-MCR,609352,-,-,KRT5
"KRT5, DDD1",Keratin 5,148040,Epidermolysis bullosa simplex-MP,131960,AD,-,KRT5
"KRT71, K6IRS1, KRT6IRS1, HYPT13",Keratin 71,608245,?Hypotrichosis 13,615896,AD,mutation identified in 1 HYPT13 family,KRT71
"KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH",Keratin 74,608248,"?Ectodermal dysplasia 7, hair/nail type",614929,AR,mutation identified in 1 HYPT3 family and ECTD7 family,KRT74
"KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH",Keratin 74,608248,?Hypotrichosis 3,613981,AD,-,KRT74
"KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH",Keratin 74,608248,"Woolly hair, autosomal dominant",194300,AD,-,KRT74
"KRT2, KRT2A, KRT2E",Keratin 2,600194,Ichthyosis bullosa of Siemens,146800,AD,-,KRT2
"KRT1, EPPK, NEPPK, EHK",Keratin 1,139350,Epidermolytic hyperkeratosis,113800,"AD,AR",close to Hox-3 in mouse; class II keratin,KRT1
"KRT1, EPPK, NEPPK, EHK",Keratin 1,139350,"Ichthyosis histrix, Curth-Macklin type",146590,AD,-,KRT1
"KRT1, EPPK, NEPPK, EHK",Keratin 1,139350,"Ichthyosis, cyclic, with epidermolytic hyperkeratosis",607602,AD,-,KRT1
"KRT1, EPPK, NEPPK, EHK",Keratin 1,139350,Keratosis palmoplantaris striata III,607654,-,-,KRT1
"KRT1, EPPK, NEPPK, EHK",Keratin 1,139350,"Palmoplantar keratoderma, epidermolytic",144200,AD,-,KRT1
"KRT1, EPPK, NEPPK, EHK",Keratin 1,139350,"Palmoplantar keratoderma, nonepidermolytic",600962,AD,-,KRT1
KRT3,Keratin 3,148043,Meesmann corneal dystrophy,122100,AD,-,KRT3
"KRT4, CYK4, WSN1",Keratin 4,123940,White sponge nevus 1,193900,AD,class II keratin,KRT4
KRT8,Keratin 8,148060,"Cirrhosis, cryptogenic",215600,AR,-,KRT8
KRT8,Keratin 8,148060,"{Cirrhosis, noncryptogenic, susceptibility to}",215600,AR,-,KRT8
KRT18,Keratin 18,148070,"Cirrhosis, cryptogenic",215600,AR,"contiguous to KRT8, type II heteromer partner",KRT18
KRT18,Keratin 18,148070,"{Cirrhosis, noncryptogenic, susceptibility to}",215600,AR,-,KRT18
"AAAS, AAA",Aladin,605378,Achalasia-addisonianism-alacrimia syndrome,231550,AR,-,AAAS
"SP7, OSX, OI12",Transcription factor Sp7,606633,"?Osteogenesis imperfecta, type XII",613849,AR,mutation identified in 1 OI12 patient,SP7
"AMHR2, AMHR","Anti-Mullerian hormone receptor, type II",600956,"Persistent Mullerian duct syndrome, type II",261550,AR,-,AMHR2
"HOXC13, HOX3G, ECTD9",Homeo box-C13,142976,"Ectodermal dysplasia 9, hair/nail type",614931,AR,fused with NUP98 in AML,HOXC13
"HNRNPA1, IBMPFD3, ALS20",Heterogeneous nuclear ribonucleoprotein A1,164017,?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3,615424,AD,mutation identified in 1 family with IBMPFD3,HNRNPA1
"HNRNPA1, IBMPFD3, ALS20",Heterogeneous nuclear ribonucleoprotein A1,164017,Amyotrophic lateral sclerosis 20,615426,AD,-,HNRNPA1
ITGA7,"Integrin, alpha-7",600536,"Muscular dystrophy, congenital, due to ITGA7 deficiency",613204,AR,-,ITGA7
RDH5,Retinol dehydrogenase-5,601617,Fundus albipunctatus,136880,"AD,AR",-,RDH5
"MMP19, MMP18, CODA",Matrix metalloproteinase-19,601807,Cavitary optic disc anomalies,611543,AD,triplication in upstream regulatory region,MMP19
SUOX,Sulfite oxidase,606887,Sulfite oxidase deficiency,272300,AR,-,SUOX
"RPS26, DBA10",Ribosomal protein S26,603701,Diamond-Blackfan anemia 10,613309,AD,-,RPS26
"ERBB3, LCCS2",Transformation gene ERBB-3,190151,Lethal congenital contractural syndrome 2,607598,AR,-,ERBB3
"SLC39A5, MYP24","Solute carrier family 39 (zinc transporter), member 5",608730,"Myopia 24, autosomal dominant",615946,AD,-,SLC39A5
"STAT2, IMD44",Signal transducer and activator of transcription 2,600556,Immunodeficiency 44,616636,AR,-,STAT2
"MIP, AQP0, CTRCT15",Major intrinsic protein of lens fiber,154050,"Cataract 15, multiple types",615274,AD,slightly distal to AQP2,MIP
"SDR9C7, SDRO, ARCI13",Short chain dehydrogenase/reductase family 9C member 7,609769,"Ichthyosis, congenital, autosomal recessive 13",617574,AR,-,SDR9C7
"TAC3, NKNB, HH10","Tachykinin 3 (neuromedin K, neurokinin B)",162330,Hypogonadotropic hypogonadism 10 with or without anosmia,614839,AR,-,TAC3
"LRP1, A2MR, KPA",Low density lipoprotein-related protein-1 (alpha-2-macroglobulin receptor),107770,?Keratosis pilaris atrophicans,604093,AR,mutation identified in 1 KPA family,LRP1
"STAC3, NAM",SH3 and cystein-rich domains 3,615521,Native American myopathy,255995,AR,-,STAC3
"MARS, MTRNS, METRS, ILLD, CMT2U",Methioninyl-tRNA synthetase,156560,"Charcot-Marie-Tooth disease, axonal, type 2U",616280,AD,-,MARS
"MARS, MTRNS, METRS, ILLD, CMT2U",Methioninyl-tRNA synthetase,156560,Interstitial lung and liver disease,615486,AR,-,MARS
"DDIT3, GADD153, CHOP10",DNA-damage-inducible transcript-3,126337,Myxoid liposarcoma,613488,-,fused with FUS in myxoid liposarcoma,DDIT3
"KIF5A, NKHC, SPG10, NEIMY",Kinesin family member 5A,602821,"Myoclonus, intractable, neonatal",617235,AD,-,KIF5A
"KIF5A, NKHC, SPG10, NEIMY",Kinesin family member 5A,602821,"Spastic paraplegia 10, autosomal dominant",604187,AD,-,KIF5A
"B4GALNT1, GALGT, GALNACT, SPG26","Beta-1,4-N-acetylgalactosaminyltransferase 1",601873,"Spastic paraplegia 26, autosomal recessive",609195,AR,-,B4GALNT1
GLC1P,"Glaucoma 1, open angle, P",177700,"Glaucoma 1, open angle, P",177700,AD,caused by 300kb duplication,GLC1P
"CDK4, CMM3",Cyclin-dependent kinase 4,123829,"{Melanoma, cutaneous malignant, 3}",609048,AD,-,CDK4
"CYP27B1, VDD1, PDDR","Cytochrome P450, subfamily XXVIIB, polypeptide 1",609506,"Vitamin D-dependent rickets, type I",264700,AR,-,CYP27B1
"TSFM, COXPD3","Ts translation elongation factor, mitochondrial",604723,Combined oxidative phosphorylation deficiency 3,610505,AR,-,TSFM
"DPY19L2, SPGF9",DPY19-like 2,613893,Spermatogenic failure 9,613958,AR,pseudogene on 7p14.3,DPY19L2
"RXYLT1, TMEM5, MDDGA10",Ribitol xylosyltransferase 1,605862,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10",615041,AR,-,RXYLT1
"SRGAP1, KIAA1304, NMTC2","Slit-robo GTPase-activating protein, rho, 1",606523,"{Thyroid cancer, nonmedullary, 2}",188470,AD,-,SRGAP1
"TBK1, NAK, FTDALS4, IIAE8",TANK-binding kinase 1,604834,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,616439,AD,-,TBK1
"TBK1, NAK, FTDALS4, IIAE8",TANK-binding kinase 1,604834,"{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}",617900,AD,-,TBK1
"GNS, G6S",N-acetylglucosamine-6-sulfatase,607664,Mucopolysaccharidosis type IIID,252940,AR,-,GNS
"LEMD3, MAN1",LEM domain-containing 3,607844,Buschke-Ollendorff syndrome,166700,AD,-,LEMD3
"LEMD3, MAN1",LEM domain-containing 3,607844,Osteopoikilosis with or without melorheostosis,166700,AD,-,LEMD3
"MSRB3, DFNB74",Methionine sulfoxide reductase B3,613719,"Deafness, autosomal recessive 74",613718,AR,-,MSRB3
"HMGA2, HMGIC, BABL",High-mobility group AT-hook 2,600698,"Leiomyoma, uterine, somatic",150699,-,"fusion partners with RAD51B, ALDH2, COX6C, HEI10 in uterine leiomyomas",HMGA2
"IRAK3, IRAKM, ASRT5",Interleukin 1 receptor-associated kinase 3,604459,{Asthma susceptibility 5},611064,-,-,IRAK3
"GRIP1, FRASRS3",Glutamate receptor-interacting protein 1,604597,Fraser syndrome 3,617667,AR,-,GRIP1
"IFNG, IFG, IFI","Interferon, gamma",147570,"{AIDS, rapid progression to}",609423,-,"3 introns; none in IFF, IFL",IFNG
"IFNG, IFG, IFI","Interferon, gamma",147570,{Aplastic anemia},609135,-,-,IFNG
"IFNG, IFG, IFI","Interferon, gamma",147570,"{Hepatitis C virus, response to therapy of}",609532,-,-,IFNG
"IFNG, IFG, IFI","Interferon, gamma",147570,"{TSC2 angiomyolipomas, renal, modifier of}",613254,AD,-,IFNG
"IFNG, IFG, IFI","Interferon, gamma",147570,"{Tuberculosis, protection against}",607948,-,-,IFNG
"NUP107, NUP84, NPHS11","Nucleoporin, 107kD",607617,"Nephrotic syndrome, type 11",616730,AR,-,NUP107
"MDM2, ACTFS","Mouse double minute 2, homolog of (p53-binding protein)",164785,"{Accelerated tumor formation, susceptibility to}",614401,-,-,MDM2
LYZ,Lysozyme,153450,"Amyloidosis, renal",105200,AD,-,LYZ
"TPH2, NTPH, ADHD7",Tryptophan hydroxylase 2,607478,"{Attention deficit-hyperactivity disorder, susceptibility to, 7}",613003,-,-,TPH2
"TPH2, NTPH, ADHD7",Tryptophan hydroxylase 2,607478,"{Unipolar depression, susceptibility to}",608516,-,-,TPH2
"BBS10, C12orf58, FLJ23560",BBS10 gene,610148,Bardet-Biedl syndrome 10,615987,AR,-,BBS10
"OTOGL, C12orf64, DFNB84B",Otogelin-like protein,614925,"Deafness, autosomal recessive 84B",614944,AR,-,OTOGL
"PTPRQ, PTPGMC1, DFNB84A, DFNA73","Protein-tyrosine phosphatase, receptor-type, Q",603317,"Deafness, autosomal dominant 73",617663,AD,mutation identified in 1 DFNA73 family,PTPRQ
"PTPRQ, PTPGMC1, DFNB84A, DFNA73","Protein-tyrosine phosphatase, receptor-type, Q",603317,"Deafness, autosomal recessive 84A",613391,AR,-,PTPRQ
"MYF6, CNM3",Myogenic factor-6,159991,Centronuclear myopathy 3,614408,AD,"6.5kb upstream from MYF5; both prob. 12q15, by H",MYF6
"ALX1, CART1, FND3",Aristaless-like homeobox 1 (cartilage homeoprotein 1),601527,?Frontonasal dysplasia 3,613456,-,mutation identified in 1 FND3 patient,ALX1
"CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14","Centrosomal protein, 290kD",610142,?Bardet-Biedl syndrome 14,615991,AR,mutation identified in 1 BBS14 family,CEP290
"CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14","Centrosomal protein, 290kD",610142,Joubert syndrome 5,610188,AR,-,CEP290
"CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14","Centrosomal protein, 290kD",610142,Leber congenital amaurosis 10,611755,-,-,CEP290
"CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14","Centrosomal protein, 290kD",610142,Meckel syndrome 4,611134,AR,-,CEP290
"CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14","Centrosomal protein, 290kD",610142,Senior-Loken syndrome 6,610189,AR,-,CEP290
"TMTC3, SMILE, LIS8",Transmembrane and tetratricopeptide repeat domains-containing protein 3,617218,Lissencephaly 8,617255,AR,-,TMTC3
"KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69","KIT ligand (mast cell growth factor; steel, mouse, homolog of)",184745,"Deafness, autosomal dominant 69, unilateral or asymmetric",616697,AD,associated with dbSNP rs12821256,KITLG
"KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69","KIT ligand (mast cell growth factor; steel, mouse, homolog of)",184745,Hyperpigmentation with or without hypopigmentation,145250,AD,-,KITLG
"KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69","KIT ligand (mast cell growth factor; steel, mouse, homolog of)",184745,"[Skin/hair/eye pigmentation 7, blond/brown hair]",611664,-,-,KITLG
PACD,"Corneal dystrophy, posterior amorphous",612868,"Corneal dystrophy, posterior amorphous",612868,AD,contiguous gene deletion syndrome,PACD
"DUSP6, MKP3, PYST1, HH19",Dual-specificity phosphatase-6,602748,Hypogonadotropic hypogonadism 19 with or without anosmia,615269,AD,-,DUSP6
"POC1B, PIX1, CORD20","POC1 centriolar protein, Chlamydomonas, homolog of, B",614784,Cone-rod dystrophy 20,615973,AR,-,POC1B
"KERA, CNA2",Keratocan,603288,"Cornea plana 2, autosomal recessive",217300,AR,-,KERA
"DCN, CSCD",Decorin,125255,"Corneal dystrophy, congenital stromal",610048,AD,conflicting assignments to 12q23 and 12q13.2,DCN
MDD1,Major depressive disorder,608520,Major depressive disorder 1,608516,-,max lod with D12S1706,MDD1
"CRADD, RAIDD, MRT34",Caspase and RIP adaptor with death domain,603454,"Mental retardation, autosomal recessive 34, with variant lissencephaly",614499,AR,-,CRADD
"CEP83, CCDC41, NPHP18","Centrosomal protein, 83kD",615847,Nephronophthisis 18,615862,AR,-,CEP83
NDUFA12,"NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 12",614530,Leigh syndrome due to mitochondrial complex 1 deficiency,256000,"Mi,AR",-,NDUFA12
"HAL, HSTD",Histidine ammonia-lyase (histidase),609457,[Histidinemia],235800,"AD,AR",-,HAL
"SLC25A3, PHC","Solute carrier family 25 (mitochondrial carrier), member 3",600370,Mitochondrial phosphate carrier deficiency,610773,-,-,SLC25A3
"SLC17A8, VGLUT3, DFNA25","Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 (vesicular glutamate transporter 3)",607557,"Deafness, autosomal dominant 25",605583,AD,-,SLC17A8
"NR1H4, FXR, RIP14, PFIC5",Nuclear receptor subfamily 1 group H member 4,603826,"Cholestasis, progressive familial intrahepatic, 5",617049,AR,-,NR1H4
"MYBPC1, LCCS4","Myosin-binding protein C, slow type",160794,"Arthrogryposis, distal, type 1B",614335,AD,-,MYBPC1
"MYBPC1, LCCS4","Myosin-binding protein C, slow type",160794,Lethal congenital contracture syndrome 4,614915,AR,-,MYBPC1
"SYCP3, SCP3, COR1, SPGF4, RPRGL4",Synaptonemal complex protein 3,604759,"Pregnancy loss, recurrent, 4",270960,AD,-,SYCP3
"SYCP3, SCP3, COR1, SPGF4, RPRGL4",Synaptonemal complex protein 3,604759,Spermatogenic failure 4,270960,AD,-,SYCP3
"GNPTAB, GNPTA","N-acetylglucosamine-1-phosphate transferase, alpha/beta subunits",607840,Mucolipidosis II alpha/beta,252500,AR,conflicting assignment to 4q,GNPTAB
"GNPTAB, GNPTA","N-acetylglucosamine-1-phosphate transferase, alpha/beta subunits",607840,Mucolipidosis III alpha/beta,252600,AR,-,GNPTAB
IGF1,"Insulin-like growth factor-1, or somatomedin C",147440,Growth retardation with deafness and mental retardation due to IGF1 deficiency,608747,AR,-,IGF1
"PAH, PKU1",Phenylalanine hydroxylase,612349,Phenylketonuria,261600,AR,close to IGF1,PAH
"PAH, PKU1",Phenylalanine hydroxylase,612349,"[Hyperphenylalaninemia, non-PKU mild]",261600,AR,-,PAH
"ASCL1, ASH1","Achaete-scute complex, Drosophila, homolog-like 1",100790,"Central hypoventilation syndrome, congenital",209880,AD,distal to PAH and proximal to TRA1,ASCL1
"ASCL1, ASH1","Achaete-scute complex, Drosophila, homolog-like 1",100790,Haddad syndrome,209880,AD,-,ASCL1
"WASHC4, KIAA1033, SWIP, MRT43","WASH complex, subunit 4",615748,"?Mental retardation, autosomal recessive 43",615817,AR,mutation identified in 1 MRT43 family,WASHC4
"POLR3B, RPC2, C128, HLD8","Polymerase III, RNA, subunit B",614366,"Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism",614381,AR,-,POLR3B
"CRY1, PHLL1, DSPD",Cryptochrome 1 (photolyase-like),601933,"{Delayed sleep phase disorder, susceptibility to}",614163,AD,-,CRY1
"ISCU, HML","Iron-sulfur cluster scaffold, E. coli, homolog of",611911,"Myopathy with lactic acidosis, hereditary",255125,AR,-,ISCU
"DAO, DAMOX",D-amino-acid oxidase,124050,{Schizophrenia},181500,AD,tightly linked to SCA2,DAO
"UNG, DGU, HIGM5",Uracil-DNA glycosylase,191525,"Immunodeficiency with hyper IgM, type 5",608106,AR,-,UNG
"UBE3B, BPIDS, KOS",Ubiquitin-protein ligase E3B,608047,Kaufman oculocerebrofacial syndrome,244450,AR,-,UBE3B
MMAB,MMAB gene,607568,"Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type",251110,AR,-,MMAB
"MVK, MVLK, POROK3",Mevalonate kinase,251170,Hyper-IgD syndrome,260920,AR,-,MVK
"MVK, MVLK, POROK3",Mevalonate kinase,251170,Mevalonic aciduria,610377,AR,-,MVK
"MVK, MVLK, POROK3",Mevalonate kinase,251170,"Porokeratosis 3, multiple types",175900,AD,-,MVK
"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3","Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)",605427,"?Avascular necrosis of femoral head, primary, 2",617383,AD,mutation identified in 1 ANFH2 family,TRPV4
"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3","Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)",605427,Brachyolmia type 3,113500,AD,-,TRPV4
"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3","Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)",605427,"Digital arthropathy-brachydactyly, familial",606835,AD,-,TRPV4
"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3","Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)",605427,"Hereditary motor and sensory neuropathy, type IIc",606071,AD,-,TRPV4
"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3","Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)",605427,Metatropic dysplasia,156530,AD,-,TRPV4
"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3","Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)",605427,Parastremmatic dwarfism,168400,AD,-,TRPV4
"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3","Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)",605427,Scapuloperoneal spinal muscular atrophy,181405,AD,-,TRPV4
"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3","Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)",605427,"SED, Maroteaux type",184095,AD,-,TRPV4
"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3","Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)",605427,"Spinal muscular atrophy, distal, congenital nonprogressive",600175,AD,-,TRPV4
"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3","Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)",605427,"Spondylometaphyseal dysplasia, Kozlowski type",184252,AD,-,TRPV4
"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3","Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)",605427,[Sodium serum level QTL 1],613508,-,-,TRPV4
"IFT81, DV1, CDV1R, SRTD19","Intraflagellar transport 81, Chlamydomonas, homolog of",605489,Short-rib thoracic dysplasia 19 with or without polydactyly 19,617895,AR,-,IFT81
"ATP2A2, ATP2B, DAR","ATPase, Ca++ transporting, slow-twitch, cardiac muscle-2",108740,Acrokeratosis verruciformis,101900,AD,-,ATP2A2
"ATP2A2, ATP2B, DAR","ATPase, Ca++ transporting, slow-twitch, cardiac muscle-2",108740,Darier disease,124200,AD,-,ATP2A2
"TECT1, JBTS13","Tectonic family, member 1",609863,Joubert syndrome 13,614173,AR,-,TECT1
"MYL2, CMH10","Myosin, light polypeptide-2, regulatory, cardiac, slow",160781,"Cardiomyopathy, hypertrophic, 10",608758,AD,-,MYL2
"SH2B3, LNK",SH2B adaptor protein 3,605093,"Erythrocytosis, somatic",133100,-,-,SH2B3
"SH2B3, LNK",SH2B adaptor protein 3,605093,"Myelofibrosis, somatic",254450,-,-,SH2B3
"SH2B3, LNK",SH2B adaptor protein 3,605093,"Thrombocythemia, somatic",187950,-,-,SH2B3
"ATXN2, ATX2, SCA2, ASL13",Ataxin-2,601517,Spinocerebellar ataxia 2,183090,AD,-,ATXN2
"ATXN2, ATX2, SCA2, ASL13",Ataxin-2,601517,"{Amyotrophic lateral sclerosis, susceptibility to, 13}",183090,AD,-,ATXN2
"ATXN2, ATX2, SCA2, ASL13",Ataxin-2,601517,"{Parkinson disease, late-onset, susceptibility to}",168600,"IC,Mu",-,ATXN2
ALDH2,"Aldehyde dehydrogenase 2 family, mitochondrial",100650,"Alcohol sensitivity, acute",610251,AD,-,ALDH2
ALDH2,"Aldehyde dehydrogenase 2 family, mitochondrial",100650,"{Esophageal cancer, alcohol-related, susceptibility to}",-,-,-,ALDH2
ALDH2,"Aldehyde dehydrogenase 2 family, mitochondrial",100650,"{Hangover, susceptibility to}",610251,AD,-,ALDH2
ALDH2,"Aldehyde dehydrogenase 2 family, mitochondrial",100650,"{Sublingual nitroglycerin, susceptibility to poor response to}",-,-,-,ALDH2
"PTPN11, PTP2C, SHP2, NS1, JMML, METCDS","Protein tyrosine phosphatase, nonreceptor-type, 11",176876,LEOPARD syndrome 1,151100,AD,-,PTPN11
"PTPN11, PTP2C, SHP2, NS1, JMML, METCDS","Protein tyrosine phosphatase, nonreceptor-type, 11",176876,"Leukemia, juvenile myelomonocytic, somatic",607785,-,-,PTPN11
"PTPN11, PTP2C, SHP2, NS1, JMML, METCDS","Protein tyrosine phosphatase, nonreceptor-type, 11",176876,Metachondromatosis,156250,AD,-,PTPN11
"PTPN11, PTP2C, SHP2, NS1, JMML, METCDS","Protein tyrosine phosphatase, nonreceptor-type, 11",176876,Noonan syndrome 1,163950,AD,-,PTPN11
TBX5,T-box 5,601620,Holt-Oram syndrome,142900,AD,-,TBX5
TBX3,T-box 3,601621,Ulnar-mammary syndrome,181450,AD,-,TBX3
"MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD",Mediator complex subunit 13-like,608771,Mental retardation and distinctive facial features with or without cardiac defects,616789,AD,-,MED13L
"MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD",Mediator complex subunit 13-like,608771,"Transposition of the great arteries, dextro-looped 1",608808,AD,-,MED13L
"HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A",Heat-shock 22-kD protein 8,608014,"Charcot-Marie-Tooth disease, axonal, type 2L",608673,AD,-,HSPB8
"HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A",Heat-shock 22-kD protein 8,608014,"Neuropathy, distal hereditary motor, type IIA",158590,AD,-,HSPB8
"CIT, STK21, CRIK, MCPH17",Citron rho-interacting serine/threonine kinase,605629,"Microcephaly 17, primary, autosomal recessive",617090,AR,-,CIT
"COX6A1, CMTRID","Cytochrome c oxidase, subunit VIa, polypeptide-1",602072,"Charcot-Marie-Tooth disease, recessive intermediate D",616039,AR,pseudogenes on chr.7 and chr.6,COX6A1
"ACADS, SCAD","Acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain",606885,"Acyl-CoA dehydrogenase, short-chain, deficiency of",201470,AR,-,ACADS
"HNF1A, TCF1, MODY3, IDDM20",HNF1 homeobox B,142410,"Diabetes mellitus, insulin-dependent, 20",612520,-,-,HNF1A
"HNF1A, TCF1, MODY3, IDDM20",HNF1 homeobox B,142410,"Hepatic adenoma, somatic",142330,-,-,HNF1A
"HNF1A, TCF1, MODY3, IDDM20",HNF1 homeobox B,142410,"MODY, type III",600496,AD,-,HNF1A
"HNF1A, TCF1, MODY3, IDDM20",HNF1 homeobox B,142410,Renal cell carcinoma,144700,-,-,HNF1A
"HNF1A, TCF1, MODY3, IDDM20",HNF1 homeobox B,142410,"{Diabetes mellitus, insulin-dependent}",222100,AR,-,HNF1A
"HNF1A, TCF1, MODY3, IDDM20",HNF1 homeobox B,142410,"{Diabetes mellitus, noninsulin-dependent, 2}",125853,AD,-,HNF1A
"ORAI1, TMEM142A, CRACM1, IMD9, TAM2",ORAI calcium release-activated calcium modulator 1,610277,Immunodeficiency 9,612782,AR,-,ORAI1
"ORAI1, TMEM142A, CRACM1, IMD9, TAM2",ORAI calcium release-activated calcium modulator 1,610277,"Myopathy, tubular aggregate, 2",615883,AD,-,ORAI1
HPD,4-hydroxyphenylpyruvate dioxygenase,609695,Hawkinsinuria,140350,AD,-,HPD
HPD,4-hydroxyphenylpyruvate dioxygenase,609695,"Tyrosinemia, type III",276710,AR,-,HPD
"SMAC, DIABLO, DFNA64",Second mitochondria-derived activator of caspase,605219,"Deafness, autosomal dominant 64",614152,AD,-,SMAC
"VPS33A, MPSPS","Vacuolar protein sorting 33, yeast, homolog of, A",610034,Mucopolysaccharidosis-plus syndrome,617303,AR,-,VPS33A
"C12orf65, COXPD7, SPG55",Chromosome 12 open reading frame 65,613541,Combined oxidative phosphorylation deficiency 7,613559,AR,-,C12orf65
"C12orf65, COXPD7, SPG55",Chromosome 12 open reading frame 65,613541,"Spastic paraplegia 55, autosomal recessive",615035,AR,-,C12orf65
"EIF2B1, EIF2BA","Eukaryotic translation initiation factor 2B, subunit 1",606686,Leukoencephalopathy with vanishing white matter,603896,AR,-,EIF2B1
"TCTN2, TECT2, MKS8, JBTS24","Tectonic family, member 2",613846,?Meckel syndrome 8,613885,AR,mutation identified in 1 MKS8 family,TCTN2
"TCTN2, TECT2, MKS8, JBTS24","Tectonic family, member 2",613846,Joubert syndrome 24,616654,AR,-,TCTN2
"ATP6V0A2, WSS, ARCL2A","ATPase, H+ transporting, lysosomal, V0 subunit A2",611716,"Cutis laxa, autosomal recessive, type IIA",219200,AR,-,ATP6V0A2
"ATP6V0A2, WSS, ARCL2A","ATPase, H+ transporting, lysosomal, V0 subunit A2",611716,Wrinkly skin syndrome,278250,AR,-,ATP6V0A2
"SCARB1, CD36L1, CLA1, HDLQTL6","Scavenger receptor class B, member 1 (CD36 antigen-like 1)",601040,[High density lipoprotein cholesterol level QTL6],610762,-,-,SCARB1
"PUS1, MLASA1",Pseudourine synthase 1,608109,"Myopathy, lactic acidosis, and sideroblastic anemia 1",600462,AR,-,PUS1
"P2RX2, P2X2, DFNA41","Purinergic receptor P2X, ligand-gated ion channel, 2",600844,"Deafness, autosomal dominant 41",608224,AD,-,P2RX2
"POLE1, CRCS12, FILS","Polymerase (DNA directed), epsilon-1",174762,FILS syndrome,615139,AR,-,POLE1
"POLE1, CRCS12, FILS","Polymerase (DNA directed), epsilon-1",174762,"{Colorectal cancer, susceptibility to, 12}",615083,AD,-,POLE1
"ANKLE2, LEM4, KIAA0692, MCPH16",Ankyrin repeat- and LEM domain-containing protein 2,616062,"?Microcephaly 16, primary, autosomal recessive",616681,AR,mutation identified in 1 MCPH16 family,ANKLE2
"GJA3, CX46, CZP3, CAE3, CTRCT14","Gap junction protein, alpha-3, 46kD (connexin 46)",121015,"Cataract 14, multiple types",601885,AD,-,GJA3
"GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID","Gap junction protein, beta-2, 26kD (connexin 26)",121011,Bart-Pumphrey syndrome,149200,AD,-,GJB2
"GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID","Gap junction protein, beta-2, 26kD (connexin 26)",121011,"Deafness, autosomal dominant 3A",601544,AD,-,GJB2
"GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID","Gap junction protein, beta-2, 26kD (connexin 26)",121011,"Deafness, autosomal recessive 1A",220290,"DD,AR",-,GJB2
"GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID","Gap junction protein, beta-2, 26kD (connexin 26)",121011,Hystrix-like ichthyosis with deafness,602540,AD,-,GJB2
"GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID","Gap junction protein, beta-2, 26kD (connexin 26)",121011,Keratitis-ichthyosis-deafness syndrome,148210,AD,-,GJB2
"GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID","Gap junction protein, beta-2, 26kD (connexin 26)",121011,"Keratoderma, palmoplantar, with deafness",148350,AD,-,GJB2
"GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID","Gap junction protein, beta-2, 26kD (connexin 26)",121011,Vohwinkel syndrome,124500,AD,-,GJB2
"GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2","Gap junction protein, beta-6 (connexin-30)",604418,"Deafness, autosomal dominant 3B",612643,AD,-,GJB6
"GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2","Gap junction protein, beta-6 (connexin-30)",604418,"Deafness, autosomal recessive 1B",612645,AR,-,GJB6
"GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2","Gap junction protein, beta-6 (connexin-30)",604418,"Deafness, digenic GJB2/GJB6",220290,"DD,AR",-,GJB6
"GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2","Gap junction protein, beta-6 (connexin-30)",604418,"Ectodermal dysplasia 2, Clouston type",129500,AD,-,GJB6
"FGF9, SYNS3",Fibroblast growth factor-9 (glia-activating factor),600921,Multiple synostoses syndrome 3,612961,AD,-,FGF9
"SGCG, LGMD2C, DMDA1, SCG3","Sarcoglycan, gamma (35kD dystrophin-associated glycoprotein)",608896,"Muscular dystrophy, limb-girdle, type 2C",253700,AR,-,SGCG
"SACS, ARSACS",Sacsin,604490,"Spastic ataxia, Charlevoix-Saguenay type",270550,AR,-,SACS
"MIPEP, COXPD31",Mitochondrial intermediate peptidase,602241,Combined oxidative phosphorylation deficiency 31,617228,AR,-,MIPEP
"CENPJ, CPAP, MCPH6, SCKL4",Centromeric protein J,609279,?Seckel syndrome 4,613676,AR,mutation identified in 1 SCKL4 family,CENPJ
"CENPJ, CPAP, MCPH6, SCKL4",Centromeric protein J,609279,"Microcephaly 6, primary, autosomal recessive",608393,AR,-,CENPJ
"ATP8A2, ATPIB, CAMRQ4","ATPase, class I, type 8A, member 2",605870,"?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4",615268,AR,-,ATP8A2
RNF6,RING finger protein-6,604242,"Esophageal carcinoma, somatic",133239,-,-,RNF6
"RPL21, HYPT12",Ribosomal protein L21,603636,Hypotrichosis 12,615885,AD,-,RPL21
"POLR1D, RPA16, RPAC2, TCS2","Polymerase I, RNA, subunit D",613715,Treacher Collins syndrome 2,613717,"AD,AR",-,POLR1D
"PDX1, IPF1, MODY4, PAGEN1",Pancreas/duodenum homeobox protein 1,600733,"MODY, type IV",606392,-,-,PDX1
"PDX1, IPF1, MODY4, PAGEN1",Pancreas/duodenum homeobox protein 1,600733,Pancreatic agenesis 1,260370,AR,-,PDX1
"PDX1, IPF1, MODY4, PAGEN1",Pancreas/duodenum homeobox protein 1,600733,"{Diabetes mellitus, type II, susceptibility to}",125853,AD,-,PDX1
FLT3,fms-related tyrosine kinase-3,136351,"Leukemia, acute lymphoblastic, somatic",613065,-,-,FLT3
FLT3,fms-related tyrosine kinase-3,136351,"Leukemia, acute myeloid, reduced survival in, somatic",601626,-,-,FLT3
FLT3,fms-related tyrosine kinase-3,136351,"Leukemia, acute myeloid, somatic",601626,-,-,FLT3
"POMP, UMP1",Proteasome maturation protein,613386,Keratosis linearis with ichthyosis congenita and sclerosing keratoderma,601952,AR,-,POMP
"ALOX5AP, FLAP",Arachidonate 5-lipoxygenase-activating protein,603700,"{Stroke, susceptibility to}",601367,Mu,-,ALOX5AP
"B3GLCT, B3GALTL, B3GTL",Beta 3-glucosyltransferase,610308,Peters-plus syndrome,261540,AR,-,B3GLCT
"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",BRCA2 gene,600185,"Fanconi anemia, complementation group D1",605724,AR,-,BRCA2
"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",BRCA2 gene,600185,Wilms tumor,194070,"AD,SMu",-,BRCA2
"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",BRCA2 gene,600185,"{Breast cancer, male, susceptibility to}",114480,AD,-,BRCA2
"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",BRCA2 gene,600185,"{Breast-ovarian cancer, familial, 2}",612555,AD,-,BRCA2
"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",BRCA2 gene,600185,{Glioblastoma 3},613029,AR,-,BRCA2
"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",BRCA2 gene,600185,{Medulloblastoma},155255,"AD,AR",-,BRCA2
"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",BRCA2 gene,600185,{Pancreatic cancer 2},613347,-,-,BRCA2
"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",BRCA2 gene,600185,{Prostate cancer},176807,AD,-,BRCA2
"KL, KLOTHO",Klotho,604824,"Tumoral calcinosis, hyperphosphatemic",211900,AR,-,KL
"KL, KLOTHO",Klotho,604824,"{Coronary artery disease, susceptibility to}",-,-,-,KL
SPG20,Spartin,607111,Troyer syndrome,275900,AR,-,SPG20
RFXAP,Regulatory factor X-associated protein,601861,"Bare lymphocyte syndrome, type II, complementation group D",209920,AR,-,RFXAP
"MADH9, SMAD9, MADH6, PPH2","Mothers against decapentaplegic, Drosophila, homolog of, 9",603295,"Pulmonary hypertension, primary, 2",615342,AD,-,MADH9
"EXOSC8, OIP2, RRP43, PCH1C",Exosome component 8,606019,"Pontocerebellar hypoplasia, type 1C",616081,AR,-,EXOSC8
"UFM1, HLD14",Ubiquitin-fold modifier 1,610553,"Leukodystrophy, hypomyelinating, 14",617899,AR,-,UFM1
"FREM2, FRASRS2",FRAS1-related extracellular matrix protein 2,608945,Fraser syndrome 2,617666,AR,-,FREM2
"DEL13q14, C13DELq14",Chromosome 13q14 deletion syndrome,613884,Chromosome 13q14 deletion syndrome,613884,"AD,IC",-,DEL13q14
"COG6, COD2, KIAA1134, CDG2L, SHNS",Component of oligomeric golgi complex 6,606977,"Congenital disorder of glycosylation, type IIl",614576,AR,-,COG6
"COG6, COD2, KIAA1134, CDG2L, SHNS",Component of oligomeric golgi complex 6,606977,Shaheen syndrome,615328,AR,-,COG6
"FOXO1A, FKHR",Forkhead box O1A (forkhead in rhabdomyosarcoma),136533,"Rhabdomyosarcoma, alveolar",268220,AR,chimeric with PAX3 in t(2;13); fuses with PAX3,FOXO1A
"SLC25A15, ORNT1, HHH","Solute carrier family 25 (mitochondrial carrier), member 15 (ornithine transporter 1)",603861,Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome,238970,AR,with deficiency of factors VII and X in 3 unrelated cases,SLC25A15
"TNFSF11, OPGL, TRANCE, OPTB2","Tumor necrosis factor ligand superfamily, member 11 (osteoprotegerin ligand)",602642,"Osteopetrosis, autosomal recessive 2",259710,AR,-,TNFSF11
HTR2A,5-hydroxytryptamine (serotonin) receptor-2A,182135,"{Alcohol dependence, susceptibility to}",103780,Mu,-,HTR2A
HTR2A,5-hydroxytryptamine (serotonin) receptor-2A,182135,"{Anorexia nervosa, susceptibility to}",606788,-,-,HTR2A
HTR2A,5-hydroxytryptamine (serotonin) receptor-2A,182135,"{Major depressive disorder, response to citalopram therapy in}",608516,-,-,HTR2A
HTR2A,5-hydroxytryptamine (serotonin) receptor-2A,182135,"{Obsessive-compulsive disorder, susceptibility to}",164230,AD,-,HTR2A
HTR2A,5-hydroxytryptamine (serotonin) receptor-2A,182135,"{Schizophrenia, susceptibility to}",181500,AD,-,HTR2A
HTR2A,5-hydroxytryptamine (serotonin) receptor-2A,182135,"{Seasonal affective disorder, susceptibility to}",608516,-,-,HTR2A
"SUCLA2, MTDPS5","Succinate-CoA ligase, ADP-forming, beta subunit",603921,Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria),612073,AR,-,SUCLA2
"NUDT15, MTH2, NUDT15D",Nucleoside diphosphate-linked moiety X motif 15,615792,"{Thiopurines, poor metabolism of, 2}",616903,AD,-,NUDT15
"ITM2B, BRI, ABRI, FBD, RDGCA",Integral membrane protein 2B (BRI gene),603904,?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities,616079,AD,mutation identified in 1 RDGCA family,ITM2B
"ITM2B, BRI, ABRI, FBD, RDGCA",Integral membrane protein 2B (BRI gene),603904,"Dementia, familial British",176500,AD,-,ITM2B
"ITM2B, BRI, ABRI, FBD, RDGCA",Integral membrane protein 2B (BRI gene),603904,"Dementia, familial Danish",117300,AD,-,ITM2B
RB1,Retinoblastoma-1,614041,"Bladder cancer, somatic",109800,-,-,RB1
RB1,Retinoblastoma-1,614041,"Osteosarcoma, somatic",259500,-,-,RB1
RB1,Retinoblastoma-1,614041,Retinoblastoma,180200,"AD,SMu",-,RB1
RB1,Retinoblastoma-1,614041,"Retinoblastoma, trilateral",180200,"AD,SMu",-,RB1
RB1,Retinoblastoma-1,614041,"Small cell cancer of the lung, somatic",182280,-,-,RB1
"LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8",Lysophosphatidic acid receptor 6,609239,Hypotrichosis 8,278150,AR,in intron 17 of RB gene,LPAR6
"LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8",Lysophosphatidic acid receptor 6,609239,"Woolly hair, autosomal recessive 1, with or without hypotrichosis",278150,AR,-,LPAR6
"RCBTB1, CLLD7, GLP, RDEOA",RCC1 domain- and BTB domain-containing protein 1,607867,Retinal dystrophy with or without extraocular anomalies,617175,AR,-,RCBTB1
"RNASEH2B, DLEU8, FLJ11712, AGS2","Ribonuclease H2, subunit B",610326,Aicardi-Goutieres syndrome 2,610181,AR,-,RNASEH2B
"ATP7B, WND","ATPase, Cu++ transporting, beta polypeptide",606882,Wilson disease,277900,AR,-,ATP7B
"ALG11, KIAA1266, CDG1P","Alg11, S. cerevisiae, homolog of",613666,"Congenital disorder of glycosylation, type Ip",613661,AR,-,ALG11
ATXN8,Ataxin 8,613289,Spinocerebellar ataxia 8,608768,AD,CAG repeat results in polyglutamine expansion protein,ATXN8
"DIAPH3, DIA2, DRF3, AUNA1, NSDAN","Diaphanous, Drosophila, homolog of, 3",614567,"Auditory neuropathy, autosomal dominant, 1",609129,AD,-,DIAPH3
"ATXN8OS, SCA8, KLHL1AS",Ataxin 8 opposite strand,603680,Spinocerebellar ataxia 8,608768,AD,due to CTG repeat in untranslated DNA,ATXN8OS
"PIBF1, JBTS33",Progesterone-induced blocking factor 1,607532,Joubert syndrome 33,617767,AR,-,PIBF1
"TBC1D4, AS160, KIAA0603, NIDDM5","TPC1 domain family, member 4",612465,"{Diabetes mellitus, noninsulin-dependent, 5}",616087,-,-,TBC1D4
CLN5,CLN5 gene,608102,"Ceroid lipofuscinosis, neuronal, 5",256731,AR,-,CLN5
"EDNRB, HSCR2, ABCDS, WS4A",Endothelin receptor type B,131244,ABCD syndrome,600501,AR,?piebald lethal in mouse,EDNRB
"EDNRB, HSCR2, ABCDS, WS4A",Endothelin receptor type B,131244,"Waardenburg syndrome, type 4A",277580,"AD,AR",-,EDNRB
"EDNRB, HSCR2, ABCDS, WS4A",Endothelin receptor type B,131244,"{Hirschsprung disease, susceptibility to, 2}",600155,AD,-,EDNRB
"SPRY2, IGAN3","Sprouty, Drosophila, homolog of, 2",602466,"{?IgA nephropathy, susceptibility to, 3}",616818,AD,mutation identified in 1 IGAN3 family,SPRY2
"SLITRK1, KIAA1910, TTM","SLIT- and NTRK-like family, member 1",609678,?Trichotillomania,613229,"AD,Mu",mutation identified in 1 TTM patient,SLITRK1
"SLITRK1, KIAA1910, TTM","SLIT- and NTRK-like family, member 1",609678,Tourette syndrome,137580,AD,-,SLITRK1
"SLITRK6, DFNMYP","SLIT- and NTRK-like family, member 6",609681,Deafness and myopia,221200,AR,-,SLITRK6
"MIR17HG, MIRH1, MIHG1, MIRHG1, C13orf25, FGLDS2",Micro RNA 17 host gene,609415,Feingold syndrome 2,614326,AD,-,MIR17HG
"GPC6, OMIMD1",Glypican 6,604404,Omodysplasia 1,258315,AR,-,GPC6
"MCOR, C13DELq32, DEL13q32","Microcoria, congenital (chromosome 13q32 deletion syndrome)",156600,"Microcoria, congenital",156600,AD,35-80kb deletion encompassing TGDS and GPR180,MCOR
SCZD7,"Schizophrenia susceptibility locus, chromosome 13q-related",603176,{Schizophrenia},181500,AD,-,SCZD7
"TGDS, SDR2E1, CATMANS","TDP-glucose 4,6-dehydratase",616146,Catel-Manzke syndrome,616145,AR,-,TGDS
"CLDN10, OSPL, CPETRL3, HELIX",Claudin 10,617579,HELIX syndrome,617671,AR,-,CLDN10
"DNAJC3, PRKRI, P58, ACPHD","DnaJ, E. coli, homolog of, subfamily C, member 3 (protein kinase inhibitor p58)",601184,"?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus",616192,AR,mutation identified in 1 ACPHD family,DNAJC3
"ZIC2, HPE5","ZIC family, member 2",603073,Holoprosencephaly 5,609637,AD,-,ZIC2
PCCA,"Propionyl Coenzyme A carboxylase, alpha polypeptide",232000,Propionicacidemia,606054,AR,-,PCCA
"NALCN, IHPRF1, CLIFAHDD","Sodium leak channel, nonselective",611549,"Congenital contractures of the limbs and face, hypotonia, and developmental delay",616266,AD,-,NALCN
"NALCN, IHPRF1, CLIFAHDD","Sodium leak channel, nonselective",611549,"Hypotonia, infantile, with psychomotor retardation and characteristic facies 1",615419,AR,-,NALCN
"FGF14, FHF4, SCA27",Fibroblast growth factor-14,601515,Spinocerebellar ataxia 27,609307,AD,-,FGF14
"ERCC5, XPG, COFS3","Excision-repair, complementing defective, in Chinese hamster, number 5",133530,Cerebrooculofacioskeletal syndrome 3,616570,AR,-,ERCC5
"ERCC5, XPG, COFS3","Excision-repair, complementing defective, in Chinese hamster, number 5",133530,"Xeroderma pigmentosum, group G",278780,AR,-,ERCC5
"ERCC5, XPG, COFS3","Excision-repair, complementing defective, in Chinese hamster, number 5",133530,"Xeroderma pigmentosum, group G/Cockayne syndrome",278780,AR,-,ERCC5
"SLC10A2, NTCP2, PBAM","Solute carrier family 10 (sodium/bile acid cotransporter family), member 2",601295,"Bile acid malabsorption, primary",613291,AR,-,SLC10A2
"DAOA, G72",D-amino acid oxidase activator,607408,{Schizophrenia},181500,AD,-,DAOA
"LIG4, LIG4S","Ligase IV, DNA, ATP-dependent",601837,LIG4 syndrome,606593,AR,-,LIG4
"LIG4, LIG4S","Ligase IV, DNA, ATP-dependent",601837,"{Multiple myeloma, resistance to}",254500,SMu,-,LIG4
IRS2,Insulin receptor substrate 2,600797,"{Diabetes mellitus, noninsulin-dependent}",125853,AD,-,IRS2
"COL4A1, POREN1, HANAC, ICH, BSVD, RATOR","Collagen IV, alpha-1 polypeptide",120130,"?Retinal arteries, tortuosity of",180000,AD,mutation identified in 1 RATOR family,COL4A1
"COL4A1, POREN1, HANAC, ICH, BSVD, RATOR","Collagen IV, alpha-1 polypeptide",120130,"Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps",611773,AD,-,COL4A1
"COL4A1, POREN1, HANAC, ICH, BSVD, RATOR","Collagen IV, alpha-1 polypeptide",120130,Brain small vessel disease with or without ocular anomalies,607595,AD,-,COL4A1
"COL4A1, POREN1, HANAC, ICH, BSVD, RATOR","Collagen IV, alpha-1 polypeptide",120130,Porencephaly 1,175780,AD,-,COL4A1
"COL4A1, POREN1, HANAC, ICH, BSVD, RATOR","Collagen IV, alpha-1 polypeptide",120130,Schizencephaly,269160,-,-,COL4A1
"COL4A1, POREN1, HANAC, ICH, BSVD, RATOR","Collagen IV, alpha-1 polypeptide",120130,"{Hemorrhage, intracerebral, susceptibility to}",614519,-,-,COL4A1
"COL4A2, POREN2, ICH","Collagen IV, alpha-2 polypeptide",120090,Porencephaly 2,614483,AD,-,COL4A2
"COL4A2, POREN2, ICH","Collagen IV, alpha-2 polypeptide",120090,"{Hemorrhage, intracerebral, susceptibility to}",614519,-,-,COL4A2
"CARS2, COXPD27",Cysteinyl-tRNA synthetase 2,612800,Combined oxidative phosphorylation deficiency 27,616672,AR,-,CARS2
ING1,Inhibitor of growth 1,601566,"Squamous cell carcinoma, head and neck, somatic",275355,-,-,ING1
F7,Coagulation factor VII,613878,Factor VII deficiency,227500,AR,-,F7
F7,Coagulation factor VII,613878,"{Myocardial infarction, decreased susceptibility to}",608446,-,-,F7
F10,Coagulation factor X,613872,Factor X deficiency,227600,AR,-,F10
"PROZ, PZ",Protein Z,176895,[Protein Z deficiency],614024,-,-,PROZ
"GRK1, RHOK, RK",G protein-dependent receptor kinase 1 (rhodopsin kinase),180381,Oguchi disease-2,613411,-,-,GRK1
"CHAMP1, ZNF828, C13orf8, KIAA1802, MRD40",Chromosome alignment-maintaining phosphoprotein 1,616327,"Mental retardation, autosomal dominant 40",616579,AD,-,CHAMP1
"DEL14q11q22, C14DELq11q22",Chromosome 14q11-q22 deletion syndrome,613457,Chromosome 14q11-q22 deletion syndrome,613457,IC,contiguous gene syndrome,DEL14q11q22
"OSGEP, FLJ20411, GAMOS3",O-sialoglycoprotein endopeptidase,610107,Galloway-Mowat syndrome 3,617729,AR,-,OSGEP
"PNP, NP",Purine nucleoside phosphorylase,164050,Immunodeficiency due to purine nucleoside phosphorylase deficiency,613179,AR,centromeric to TCRA,PNP
"ANG, RNASE5, ALS9",Angiogenin,105850,Amyotrophic lateral sclerosis 9,611895,-,proximal to TCRA/TCRD,ANG
"RPGRIP1, LCA6, CORD13",Retinitis pigmentosa GTPase regulator-interacting protein,605446,Cone-rod dystrophy 13,608194,-,-,RPGRIP1
"RPGRIP1, LCA6, CORD13",Retinitis pigmentosa GTPase regulator-interacting protein,605446,Leber congenital amaurosis 6,613826,-,-,RPGRIP1
"CHD8, DUPLIN, KIAA1564, AUTS18",Chromodomain helicase DNA-binding protein 8,610528,"{Autism, susceptibility to, 18}",615032,AD,-,CHD8
"SALL2, HSAL2, COLB",Sal-like 2,602219,"?Coloboma, ocular, autosomal recessive",216820,AR,mutation identified in 1 COLB family,SALL2
"TRAC, TRCA, TRA, IMD7",T-cell receptor alpha,186880,"Immunodeficiency 7, TCR-alpha/beta deficient",615387,AR,cen--V-C--ter,TRAC
"SLC7A7, LPI","Solute carrier family 7 (cationic amino acid transporter, y+ system), member 7",603593,Lysinuric protein intolerance,222700,AR,-,SLC7A7
"MMP14, WNCHRS",Matrix metalloproteinase 14 (membrane-inserted),600754,?Winchester syndrome,277950,-,mutation identified in 1 family,MMP14
"CEBPE, CRP1","CCAAT/enhancer-binding protein (C/EBP), epsilon",600749,Specific granule deficiency,245480,AR,-,CEBPE
"PABPN1, PABP2, PAB2","Poly(A)-binding protein, nuclear 1",602279,Oculopharyngeal muscular dystrophy,164300,AD,-,PABPN1
"MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3","Myosin, heavy polypeptide-6, cardiac muscle, alpha",160710,Atrial septal defect 3,614089,-,-,MYH6
"MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3","Myosin, heavy polypeptide-6, cardiac muscle, alpha",160710,"Cardiomyopathy, dilated, 1EE",613252,-,-,MYH6
"MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3","Myosin, heavy polypeptide-6, cardiac muscle, alpha",160710,"Cardiomyopathy, hypertrophic, 14",613251,AD,-,MYH6
"MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3","Myosin, heavy polypeptide-6, cardiac muscle, alpha",160710,{Sick sinus syndrome 3},614090,-,-,MYH6
"MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD","Myosin, heavy polypeptide-7, cardiac muscle, beta",160760,"Cardiomyopathy, dilated, 1S",613426,AD,5'-B-4.5kb-A-3',MYH7
"MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD","Myosin, heavy polypeptide-7, cardiac muscle, beta",160760,"Cardiomyopathy, hypertrophic, 1",192600,AD,-,MYH7
"MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD","Myosin, heavy polypeptide-7, cardiac muscle, beta",160760,Laing distal myopathy,160500,AD,-,MYH7
"MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD","Myosin, heavy polypeptide-7, cardiac muscle, beta",160760,Left ventricular noncompaction 5,613426,AD,-,MYH7
"MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD","Myosin, heavy polypeptide-7, cardiac muscle, beta",160760,"Myopathy, myosin storage, autosomal dominant",608358,AD,-,MYH7
"MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD","Myosin, heavy polypeptide-7, cardiac muscle, beta",160760,"Myopathy, myosin storage, autosomal recessive",255160,AR,-,MYH7
"MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD","Myosin, heavy polypeptide-7, cardiac muscle, beta",160760,"Scapuloperoneal syndrome, myopathic type",181430,AD,-,MYH7
"ZFHX2, ZFH5, ZNF409, KIAA1056, KIAA1762, MARSIS",Zinc finger homeobox 2,617828,?Marsili syndrome,147430,AD,mutation identified in 1 MARSIS family,ZFHX2
"NRL, D14S46E, RP27",Neural retina leucine zipper,162080,"Retinal degeneration, autosomal recessive, clumped pigment type",-,-,-,NRL
"NRL, D14S46E, RP27",Neural retina leucine zipper,162080,Retinitis pigmentosa 27,613750,AD,-,NRL
"TINF2, TIN2, DKCA3",TRF1-interacting nuclear factor 2,604319,"Dyskeratosis congenita, autosomal dominant 3",613990,AD,-,TINF2
"TINF2, TIN2, DKCA3",TRF1-interacting nuclear factor 2,604319,Revesz syndrome,268130,AD,-,TINF2
"TGM1, ICR2, ARCI1","Transglutaminase-1 (K polypeptide epidermal type I, protein-glutamine gamma-glutamyltransferase)",190195,"Ichthyosis, congenital, autosomal recessive 1",242300,AR,-,TGM1
"FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1",Forkhead box G1B,164874,"Rett syndrome, congenital variant",613454,AD,-,FOXG1
"PRKD1, PRKCM, PKD, CHDED",Protein kinase D1,605435,Congenital heart defects and ectodermal dysplasia,617364,AD,-,PRKD1
"COCH, DFNA9",Cochlin,603196,"Deafness, autosomal dominant 9",601369,AD,-,COCH
"AP4S1, CPSQ6, SPG52","Adaptor-related protein complex 4, sigma-1 subunit",607243,"Spastic paraplegia 52, autosomal recessive",614067,AR,-,AP4S1
"NUBPL, IND1",Nucleotide-binding protein-like protein,613621,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",-,NUBPL
"CFL2, NEM7","Cofilin 2, muscle",601443,"Nemaline myopathy 7, autosomal recessive",610687,AR,-,CFL2
"PSMA6, PROS27, P27K","Proteasome subunit, alpha-type, 6",602855,"{Myocardial infarction, susceptibility to}",608446,-,-,PSMA6
"NFKBIA, IKBA","Nuclear factor of kappa light chain gene enhancer in B-cells inhibitor, alpha",164008,"Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency",612132,AD,-,NFKBIA
"NKX2-1, TITF1, NKX2A, TTF1, NMTC1",NK2 homeobox 1,600635,"Chorea, hereditary benign",118700,AD,-,NKX2-1
"NKX2-1, TITF1, NKX2A, TTF1, NMTC1",NK2 homeobox 1,600635,"Choreoathetosis, hypothyroidism, and neonatal respiratory distress",610978,AD,-,NKX2-1
"NKX2-1, TITF1, NKX2A, TTF1, NMTC1",NK2 homeobox 1,600635,"{Thyroid cancer, nonmedullary, 1}",188550,AD,-,NKX2-1
"PAX9, STHAG3",Paired box gene 9,167416,"Tooth agenesis, selective, 3",604625,AD,-,PAX9
"SEC23A, CLSD","Sec23, S. cerevisiae, homolog of, A",610511,Craniolenticulosutural dysplasia,607812,AR,-,SEC23A
"TRAPPC6B, TPC6, NEDMEBA","Trafficking protein particle complex, subunit 6B",610397,"Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy",617862,-,-,TRAPPC6B
"RPS29, DBA13",Ribosomal protein S29,603633,Diamond-Blackfan anemia 13,615909,AD,-,RPS29
"MGAT2, CDGS2, CDG2A","Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyl- transferase",602616,"Congenital disorder of glycosylation, type IIa",212066,AR,-,MGAT2
"KTU, C14orf104, CILD10","Kintoun, Medaka, homolog of",612517,"Ciliary dyskinesia, primary, 10",612518,-,-,KTU
"SOS2, NS9","Son of sevenless, Drosophila, homolog of, 2",601247,Noonan syndrome 9,616559,AD,-,SOS2
"L2HGDH, C14orf160, L2HGA",L-2-hydroxyglutarate dehydrogenase,609584,L-2-hydroxyglutaric aciduria,236792,AR,-,L2HGDH
"FRIASS, DEL14q22, C14DELq22",Frias syndrome,609640,Frias syndrome,609640,AD,deletion spans 4.1 Mb on 14q22.1-q22.3,FRIASS
"ATL1, SPG3A, HSN1D",Atlastin GTPase 1,606439,"Neuropathy, hereditary sensory, type ID",613708,AD,-,ATL1
"ATL1, SPG3A, HSN1D",Atlastin GTPase 1,606439,"Spastic paraplegia 3A, autosomal dominant",182600,AD,-,ATL1
"NIN, KIAA1565, SCKL7",Ninein,608684,?Seckel syndrome 7,614851,AR,mutation identified in 1 SCKL7 family,NIN
PYGL,"Phosphorylase, glycogen, liver",613741,Glycogen storage disease VI,232700,AR,-,PYGL
"PTGDR, AS1, ASRT1",Prostaglandin D2 receptor,604687,"{Asthma, susceptibility to, 1}",607277,-,-,PTGDR
PTGER2,"Prostaglandin E receptor 2, EP2 subtype, 53kD",176804,"{Asthma, aspirin-induced, susceptibility to}",208550,AR,-,PTGER2
"DDHD1, PAPLA1, KIAA1705, SPG28",DDHD domain-containing protein 1,614603,"Spastic paraplegia 28, autosomal recessive",609340,AR,-,DDHD1
"BMP4, BMP2B1, BMP2B, MCOPS6, OFC11",Bone morphogenetic protein-4,112262,"Microphthalmia, syndromic 6",607932,AD,-,BMP4
"BMP4, BMP2B1, BMP2B, MCOPS6, OFC11",Bone morphogenetic protein-4,112262,Orofacial cleft 11,600625,-,-,BMP4
"GCH1, DYT5, HPABH4B",GTP cyclohydrolase 1,600225,"Dystonia, DOPA-responsive, with or without hyperphenylalaninemia",128230,"AD,AR",-,GCH1
"GCH1, DYT5, HPABH4B",GTP cyclohydrolase 1,600225,"Hyperphenylalaninemia, BH4-deficient, B",233910,AR,-,GCH1
"TMEM260, C14orf101, SHDRA",Transmembrane protein 260,617449,Structural heart defects and renal anomalies syndrome,617478,AR,-,TMEM260
"OTX2, MCOPS5, CPHD6","Orthodenticle, Drosophila, homolog of, 2",600037,"Microphthalmia, syndromic 5",610125,AD,-,OTX2
"OTX2, MCOPS5, CPHD6","Orthodenticle, Drosophila, homolog of, 2",600037,"Pituitary hormone deficiency, combined, 6",613986,AD,-,OTX2
"OTX2, MCOPS5, CPHD6","Orthodenticle, Drosophila, homolog of, 2",600037,"Retinal dystrophy, early-onset, with or without pituitary dysfunction",610125,AD,-,OTX2
"KIAA0586, TALPID3, JBTS23, SRTD14",KIAA0586 gene,610178,Joubert syndrome 23,616490,AR,-,KIAA0586
"KIAA0586, TALPID3, JBTS23, SRTD14",KIAA0586 gene,610178,Short-rib thoracic dysplasia 14 with polydactyly,616546,AR,-,KIAA0586
"DACT1, DPR1, DAPPER1, FRODO, TBS2","Dapper, antagonist of beta-catenin, 1",607861,?Townes-Brocks syndrome 2,617466,AD,mutation identified in 1 TBS2 family,DACT1
"SIX6, ODRMD","Sine oculis homeo box, Drosophila, homolog of, 6",606326,Optic disc anomalies with retinal and/or macular dystrophy,212550,AR,-,SIX6
"SIX1, BOS3, DFNA23","Sine oculis homeo box, Drosophila, homolog of, 1",601205,Branchiootic syndrome 3,608389,AD,-,SIX1
"SIX1, BOS3, DFNA23","Sine oculis homeo box, Drosophila, homolog of, 1",601205,"Deafness, autosomal dominant 23",605192,AD,-,SIX1
"TRMT5, TRM5, KIAA1393, COXPD26","tRNA methyltransferase 5, S. cerevisiae, homolog of",611023,Combined oxidative phosphorylation deficiency 26,616539,AR,-,TRMT5
"PRKCH, PKCL, PRKCL","Protein kinase C, eta",605437,"{Cerebral infarction, susceptibility to}",601367,Mu,-,PRKCH
"SYNE2, NUANCE, KIAA1011, EDMD5",Spectrin repeat-containing nuclear envelope protein 2 (nesprin 2),608442,"Emery-Dreifuss muscular dystrophy 5, autosomal dominant",612999,AD,-,SYNE2
"MTHFD1, MTHFC, CIMAH",Methylenetetrahydrofolate dehydrogenase 1,172460,Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia,617780,AR,trifunctional protein,MTHFD1
"MTHFD1, MTHFC, CIMAH",Methylenetetrahydrofolate dehydrogenase 1,172460,"{Neural tube defects, folate-sensitive, susceptibility to}",601634,AR,-,MTHFD1
"SPTB, SPH2, EL3, HS2","Spectrin, beta, erythrocytic",182870,"Anemia, neonatal hemolytic, fatal and near-fatal",-,-,-,SPTB
"SPTB, SPH2, EL3, HS2","Spectrin, beta, erythrocytic",182870,Elliptocytosis-3,-,-,-,SPTB
"SPTB, SPH2, EL3, HS2","Spectrin, beta, erythrocytic",182870,"Spherocytosis, type 2",616649,AD,-,SPTB
MAX,MAX protein,154950,"{Pheochromocytoma, susceptibility to}",171300,AD,interacts with MYC,MAX
"GPHN, GPH, KIAA1385, GEPH, MOCODC",Gephyrin,603930,Molybdenum cofactor deficiency C,615501,AR,-,GPHN
"RDH11, PSDR1, RALR1, RDJCSS",Retinol dehydrogenase 11,607849,"?Retinal dystrophy, juvenile cataracts, and short stature syndrome",616108,AR,mutation identified in 1 RDJCSS family,RDH11
"RDH12, LCA13",Retinol dehydrogenase 12,608830,Leber congenital amaurosis 13,612712,AR,near RDH11,RDH12
"ZFYVE26, KIAA0321, SPG15",Zinc finger FYVE domain-containing protein 26,612012,"Spastic paraplegia 15, autosomal recessive",270700,AR,-,ZFYVE26
"ACTN1, BDPLT15","Actinin, alpha-1",102575,"Bleeding disorder, platelet-type, 15",615193,AD,-,ACTN1
"SMOC1, OAS",SPARC-related modular calcium-binding 1,608488,Microphthalmia with limb anomalies,206920,AR,-,SMOC1
"PSEN1, AD3, ACNINV3",Presenilin 1,104311,"?Acne inversa, familial, 3",613737,AD,mutation identified in 1 ACNINV3 family,PSEN1
"PSEN1, AD3, ACNINV3",Presenilin 1,104311,"Alzheimer disease, type 3",607822,AD,-,PSEN1
"PSEN1, AD3, ACNINV3",Presenilin 1,104311,"Alzheimer disease, type 3, with spastic paraparesis and apraxia",607822,AD,-,PSEN1
"PSEN1, AD3, ACNINV3",Presenilin 1,104311,"Alzheimer disease, type 3, with spastic paraparesis and unusual plaques",607822,AD,-,PSEN1
"PSEN1, AD3, ACNINV3",Presenilin 1,104311,"Cardiomyopathy, dilated, 1U",613694,AD,-,PSEN1
"PSEN1, AD3, ACNINV3",Presenilin 1,104311,"Dementia, frontotemporal",600274,AD,-,PSEN1
"PSEN1, AD3, ACNINV3",Presenilin 1,104311,Pick disease,172700,"AD,IC",-,PSEN1
"DNAL1, C14orf168, CILD16","Dynein, axonemal, light chain 1",610062,"Ciliary dyskinesia, primary, 16",614017,AR,-,DNAL1
"COQ6, CGI10, COQ10D6","Coq6, S. cerevisiae, homolog of",614647,"Coenzyme Q10 deficiency, primary, 6",614650,AR,-,COQ6
"ALDH6A1, MMSDH","Aldehyde dehydrogenase 6 family, member A1 (methylmalonate semialdehyde dehydrogenase)",603178,Methylmalonate semialdehyde dehydrogenase deficiency,614105,AR,-,ALDH6A1
"CHX10, HOX10, MCOP2, MCOPCB3",C. elegans ceh-10 homeo domain-containing homolog,142993,Microphthalmia with coloboma 3,610092,-,-,CHX10
"CHX10, HOX10, MCOP2, MCOPCB3",C. elegans ceh-10 homeo domain-containing homolog,142993,"Microphthalmia, isolated 2",610093,-,-,CHX10
"ABCD4, PXMP1L, P79R, PMP69, MAHCJ","ATP-binding cassette, subfamily D, member 4 (peroxisomal membrane protein 1-like)",603214,"Methylmalonic aciduria and homocystinuria, cblJ type",614857,AR,-,ABCD4
"NPC2, HE1",Epididymal secretory protein HE1,601015,"Niemann-pick disease, type C2",607625,AR,-,NPC2
"ISCA2, MMDS4","Iron-sulfur cluster assembly 2, S. cerevisiae, homolog of",615317,Multiple mitochondrial dysfunctions syndrome 4,616370,AR,-,ISCA2
"LTBP2, LTBP3, GLC3D, MSPKA, WMS3",Latent transforming growth factor beta binding protein-2,602091,"?Weill-Marchesani syndrome 3, recessive",614819,AR,mutation identified in 1 WMS3 family,LTBP2
"LTBP2, LTBP3, GLC3D, MSPKA, WMS3",Latent transforming growth factor beta binding protein-2,602091,"Glaucoma 3, primary congenital, D",613086,-,-,LTBP2
"LTBP2, LTBP3, GLC3D, MSPKA, WMS3",Latent transforming growth factor beta binding protein-2,602091,"Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma",251750,AR,-,LTBP2
EIF2B2,"Eukaryotic translation initiation factor 2B, subunit 2",606454,Leukoencephalopathy with vanishing white matter,603896,AR,-,EIF2B2
EIF2B2,"Eukaryotic translation initiation factor 2B, subunit 2",606454,Ovarioleukodystrophy,603896,AR,-,EIF2B2
"MLH3, HNPCC7",Mismatch repair gene MLH3,604395,"Colorectal cancer, hereditary nonpolyposis, type 7",614385,-,-,MLH3
"MLH3, HNPCC7",Mismatch repair gene MLH3,604395,"Colorectal cancer, somatic",114500,-,-,MLH3
"MLH3, HNPCC7",Mismatch repair gene MLH3,604395,"{Endometrial cancer, susceptibility to}",608089,-,-,MLH3
"NEK9, NERCC1, LCCS10, APUG, NC",Never in mitosis gene A-related kinase 9,609798,"?Arthrogryposis, Perthes disease, and upward gaze palsy",614262,AR,mutation identified in 1 APUG family,NEK9
"NEK9, NERCC1, LCCS10, APUG, NC",Never in mitosis gene A-related kinase 9,609798,Lethal congenital contracture syndrome 10,617022,AR,-,NEK9
"NEK9, NERCC1, LCCS10, APUG, NC",Never in mitosis gene A-related kinase 9,609798,"Nevus comedonicus, somatic",617025,-,-,NEK9
"FLVCR2, C14orf58, CCT, PVHH, EPV",Feline leukemia virus subgroup C receptor 2,610865,Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome,225790,AR,-,FLVCR2
"TTLL5, STAMP, KIAA0998, CORD19","Tubulin tyrosine ligase-like family, member 5",612268,Cone-rod dystrophy 19,615860,AR,-,TTLL5
"TGFB3, ARVD1, RNHF, LDS5","Transforming growth factor, beta-3",190230,Arrhythmogenic right ventricular dysplasia 1,107970,AD,-,TGFB3
"TGFB3, ARVD1, RNHF, LDS5","Transforming growth factor, beta-3",190230,Loeys-Dietz syndrome 5,615582,AD,-,TGFB3
"IFT43, C14orf179, CED3, SRTD18, RP81","Intraflagellar transport 43, Chlamydomonas, homolog of",614068,?Cranioectodermal dysplasia 3,614099,AR,mutation identified in 1 CED3 family and 1 RP81 family,IFT43
"IFT43, C14orf179, CED3, SRTD18, RP81","Intraflagellar transport 43, Chlamydomonas, homolog of",614068,?Retinitis pigmentosa 81,617871,AR,-,IFT43
"IFT43, C14orf179, CED3, SRTD18, RP81","Intraflagellar transport 43, Chlamydomonas, homolog of",614068,Short-rib thoracic dysplasia 18 with polydactyly,617866,AR,-,IFT43
"ESRRB, ESRL2, DFNB35",Estrogen-related receptor beta,602167,"Deafness, autosomal recessive 35",608565,AR,-,ESRRB
"POMT2, MDDGA2, MDDGB2, MDDGC2",Putative protein O-mannosyltransferase 2,607439,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2",613150,AR,-,POMT2
"POMT2, MDDGA2, MDDGB2, MDDGC2",Putative protein O-mannosyltransferase 2,607439,"Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2",613156,AR,-,POMT2
"POMT2, MDDGA2, MDDGB2, MDDGC2",Putative protein O-mannosyltransferase 2,607439,"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2",613158,AR,-,POMT2
"GSTZ1, MAAI, MAAID","Glutathione S-transferase, zeta-1 (maleylacetoacetate isomerase)",603758,[Maleylacetoacetate isomerase deficiency],617596,AR,-,GSTZ1
"VIPAS39, VIPAR, SPE39, C14orf133","VPS33B-interacting protein, apical-basolateral polarity regulator, spe-39 homolog",613401,"Arthrogryposis, renal dysfunction, and cholestasis 2",613404,AR,-,VIPAS39
"SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C","Serine palmitoyltransferase, long-chain base subunit 2",605713,"Neuropathy, hereditary sensory and autonomic, type IC",613640,AD,-,SPTLC2
"TSHR, CHNG1",Thyroid-stimulating hormone receptor,603372,"Hyperthyroidism, familial gestational",603373,-,-,TSHR
"TSHR, CHNG1",Thyroid-stimulating hormone receptor,603372,"Hyperthyroidism, nonautoimmune",609152,"AD,IC",-,TSHR
"TSHR, CHNG1",Thyroid-stimulating hormone receptor,603372,"Hypothyroidism, congenital, nongoitrous, 1",275200,AR,-,TSHR
"TSHR, CHNG1",Thyroid-stimulating hormone receptor,603372,"Thyroid adenoma, hyperfunctioning, somatic",-,-,-,TSHR
"TSHR, CHNG1",Thyroid-stimulating hormone receptor,603372,Thyroid carcinoma with thyrotoxicosis,-,-,-,TSHR
GALC,Galactosylceramidase,606890,Krabbe disease,245200,AR,-,GALC
"SPATA7, HSD3, LCA3",Spermatogenesis-associated protein 7,609868,Leber congenital amaurosis 3,604232,-,-,SPATA7
"SPATA7, HSD3, LCA3",Spermatogenesis-associated protein 7,609868,"Retinitis pigmentosa, juvenile, autosomal recessive",604232,-,-,SPATA7
"ZC3H14, SUT2, MRT56",Zinc finger CCCH domain-containing protein 14,613279,"Mental retardation, autosomal recessive 56",617125,AR,-,ZC3H14
"TTC8, BBS8, RP51",Tetratricopeptide repeat domain 8,608132,?Retinitis pigmentosa 51,613464,AR,mutation identified in 1 RP51 family,TTC8
"TTC8, BBS8, RP51",Tetratricopeptide repeat domain 8,608132,Bardet-Biedl syndrome 8,615985,AR,-,TTC8
"DUP14q32, C14DUPq32","Chromosome 14q32 duplication syndrome, 700kB",616604,"{Myeloproliferative neoplasms, familial, susceptibility to}",616604,AD,heterozygous germline duplication of 700kb,DUP14q32
KAOGS,Kagami-Ogata syndrome,608149,Kagami-Ogata syndrome,608149,IC,uniparental isodisomy of imprinted region of chromosome 14,KAOGS
TEMPS,Temple syndrome (maternal uniparental disomy chromosome 14),616222,Temple syndrome,616222,IC,-,TEMPS
TDP1,Tyrosyl-DNA phosphodiesterase 1,607198,"Spinocerebellar ataxia, autosomal recessive with axonal neuropathy",607250,-,-,TDP1
"CALM1, PHKD, CPVT4, LQT14","Calmodulin-1 (phosphorylase kinase, delta)",114180,Long QT syndrome 14,616247,AD,-,CALM1
"CALM1, PHKD, CPVT4, LQT14","Calmodulin-1 (phosphorylase kinase, delta)",114180,"Ventricular tachycardia, catecholaminergic polymorphic, 4",614916,AD,-,CALM1
"GPR68, OGR1, AI2A6",G protein-coupled receptor 68,601404,"Amelogenesis imperfecta, hypomaturation type, IIA6",617217,AR,-,GPR68
"CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40",Coiled-coil domain-containing protein 88C,611204,?Spinocerebellar ataxia 40,616053,AD,mutation identified in 1 SCA40 family,CCDC88C
"CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40",Coiled-coil domain-containing protein 88C,611204,"Hydrocephalus, nonsyndromic, autosomal recessive",236600,AR,-,CCDC88C
"FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD",Fibulin 5,604580,"Cutis laxa, autosomal dominant 2",614434,-,-,FBLN5
"FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD",Fibulin 5,604580,"Cutis laxa, autosomal recessive, type IA",219100,AR,-,FBLN5
"FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD",Fibulin 5,604580,"Macular degeneration, age-related, 3",608895,AD,-,FBLN5
"FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD",Fibulin 5,604580,"Neuropathy, hereditary, with or without age-related macular degeneration",608895,AD,-,FBLN5
"TRIP11, TRIP230, CEV14, ACG1A",Thyroid hormone receptor interactor 11,604505,"Achondrogenesis, type IA",200600,AR,-,TRIP11
"ATXN3, MJD, SCA3",Ataxin-3 (josephin),607047,Machado-Joseph disease,109150,AD,-,ATXN3
"SLC24A4, NCKX4, SHEP6, AI2A5","Solute carrier family 24 (sodium/potassium/calcium exchanger), member 4",609840,"Amelogenesis imperfecta, type IIA5",615887,AR,-,SLC24A4
"SLC24A4, NCKX4, SHEP6, AI2A5","Solute carrier family 24 (sodium/potassium/calcium exchanger), member 4",609840,"[Skin/hair/eye pigmentation 6, blond/brown hair]",210750,AR,-,SLC24A4
"SLC24A4, NCKX4, SHEP6, AI2A5","Solute carrier family 24 (sodium/potassium/calcium exchanger), member 4",609840,"[Skin/hair/eye pigmentation 6, blue/green eyes]",210750,AR,-,SLC24A4
"CBG, SERPINA6",Corticosteroid-binding globulin,122500,Corticosteroid-binding globulin deficiency,611489,"AD,AR",-,CBG
"SERPINA1, PI, AAT","Alpha-1-antitrypsin (serpin peptidase inhibitor, clade A, member 1)",107400,Emphysema due to AAT deficiency,613490,AR,-,SERPINA1
"SERPINA1, PI, AAT","Alpha-1-antitrypsin (serpin peptidase inhibitor, clade A, member 1)",107400,"Emphysema-cirrhosis, due to AAT deficiency",613490,AR,-,SERPINA1
"SERPINA1, PI, AAT","Alpha-1-antitrypsin (serpin peptidase inhibitor, clade A, member 1)",107400,Hemorrhagic diathesis due to antithrombin Pittsburgh,613490,AR,-,SERPINA1
"SERPINA1, PI, AAT","Alpha-1-antitrypsin (serpin peptidase inhibitor, clade A, member 1)",107400,"{Pulmonary disease, chronic obstructive, susceptibility to}",606963,-,-,SERPINA1
"GSC, SAMS",Goosecoid,138890,"Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities",602471,AR,-,GSC
"DICER1, HERNA, KIAA0928, MNG1, RMSE2","Dicer, Drosophila, homolog of, 1",606241,"Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors",138800,AD,-,DICER1
"DICER1, HERNA, KIAA0928, MNG1, RMSE2","Dicer, Drosophila, homolog of, 1",606241,Pleuropulmonary blastoma,601200,AD,-,DICER1
"DICER1, HERNA, KIAA0928, MNG1, RMSE2","Dicer, Drosophila, homolog of, 1",606241,"Rhabdomyosarcoma, embryonal, 2",180295,-,-,DICER1
"GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC",Glutaredoxin 5,609588,"Anemia, sideroblastic, 3, pyridoxine-refractory",616860,AR,-,GLRX5
"GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC",Glutaredoxin 5,609588,"Spasticity, childhood-onset, with hyperglycinemia",616859,AR,-,GLRX5
"VRK1, PCH1A",Vaccinia-related kinase-1,602168,Pontocerebellar hypoplasia type 1A,607596,AR,-,VRK1
"BCL11B, CTIP2, IMD49",C-cell CLL/lymphoma 11B,606558,?Immunodeficiency 49,617237,AD,mutation identified in 1 IMD49 patient,BCL11B
"EML1, EMAPL, EMAP, BH",Echinoderm microtubule associated protein like 1,602033,Band heterotopia,600348,AR,-,EML1
"YY1, GADEVS",YY1 transcription factor,600013,Gabriele-de Vries syndrome,617557,AD,-,YY1
"WARS, HMN9",Tryptophanyl-tRNA synthetase,191050,"Neuronopathy, distal hereditary motor, type IX",617721,-,-,WARS
"DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1","Dynein, cytoplasmic-1, heavy chain-1",600112,"Charcot-Marie-Tooth disease, axonal, type 20",614228,AD,-,DYNC1H1
"DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1","Dynein, cytoplasmic-1, heavy chain-1",600112,"Mental retardation, autosomal dominant 13",614563,AD,-,DYNC1H1
"DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1","Dynein, cytoplasmic-1, heavy chain-1",600112,"Spinal muscular atrophy, lower extremity-predominant 1, AD",158600,AD,-,DYNC1H1
"TECPR2, KIAA0329, SPG49",Tectonin beta-propeller repeat-containing protein 2,615000,"Spastic paraplegia 49, autosomal recessive",615031,AR,-,TECPR2
"TRAF3, CD40BP, LAP1, CAP1, CRAF1, IIAE5",TNF receptor-associated factor 3,601896,"{?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}",614849,-,mutation identified in 1 IIAE5 patient,TRAF3
AMN,"Amnionless, mouse, homolog of",605799,"Megaloblastic anemia-1, Norwegian type",261100,AR,-,AMN
"APOPT1, APOP","Apoptogenic protein 1, mitochondrial",616003,Mitochondrial complex IV deficiency,220110,"Mi,AR",-,APOPT1
"XRCC3, CMM6","X-ray-repair, complementing defective, repair in Chinese hamster cells-3",600675,"{Breast cancer, susceptibility to}",114480,AD,-,XRCC3
"XRCC3, CMM6","X-ray-repair, complementing defective, repair in Chinese hamster cells-3",600675,"{Melanoma, cutaneous malignant, 6}",613972,-,-,XRCC3
"INF2, FSGS5, C14orf173, CMTDIE",Inverted formin 2,610982,"Charcot-Marie-Tooth disease, dominant intermediate E",614455,AD,-,INF2
"INF2, FSGS5, C14orf173, CMTDIE",Inverted formin 2,610982,"Glomerulosclerosis, focal segmental, 5",613237,-,-,INF2
"ADSL1, MPD5",Adenylosuccinate synthase-like 1,612498,"Myopathy, distal, 5",617030,AR,-,ADSL1
"AKT1, CWS6",Murine thymoma viral (v-akt) oncogene homolog-1,164730,"Breast cancer, somatic",114480,-,proximal to IGH,AKT1
"AKT1, CWS6",Murine thymoma viral (v-akt) oncogene homolog-1,164730,"Colorectal cancer, somatic",114500,-,-,AKT1
"AKT1, CWS6",Murine thymoma viral (v-akt) oncogene homolog-1,164730,Cowden syndrome 6,615109,-,-,AKT1
"AKT1, CWS6",Murine thymoma viral (v-akt) oncogene homolog-1,164730,"Ovarian cancer, somatic",167000,-,-,AKT1
"AKT1, CWS6",Murine thymoma viral (v-akt) oncogene homolog-1,164730,"Proteus syndrome, somatic",176920,-,-,AKT1
"AKT1, CWS6",Murine thymoma viral (v-akt) oncogene homolog-1,164730,"{Schizophrenia, susceptibility to}",181500,AD,-,AKT1
"ZBTB42, ZNF925, LCCS6",Zinc finger- and BTB domain-containing protein 42,613915,?Lethal congenital contracture syndrome 6,616248,AR,mutation identified in 1 LCCS6 family,ZBTB42
"BRF1, TAF3C, GTF3B, TF3B90, CFDS","BRF1, S. cerevisiae, homolog of (TATA box-binding protein-associated factor 3C)",604902,Cerebellofaciodental syndrome,616202,AR,-,BRF1
"IGHM, MU, AGM1",Constant region of heavy chain of IgM,147020,Agammaglobulinemia 1,601495,AR,-,IGHM
RC14S,Ring chromosome 14 syndrome,616606,Ring chromosome 14 syndrome,616606,IC,-,RC14S
AUTS4,"Autism, susceptibility to, 4",608636,{Autism susceptibility 4},608636,AD,-,AUTS4
HYT2,"Hypertension, essential, susceptibility to, 2",604329,"{Hypertension, essential, susceptibility to, 2}",145500,Mu,-,HYT2
"DEL15q11.2, C15DELq11.2",Chromosome 15q11.2 deletion syndrome,615656,Chromosome 15q11.2 deletion syndrome,615656,AD,deleted region spans 300-500kb between BP1 and BP2,DEL15q11.2
"NIPA1, SPG6",Nonimprinted gene in Prader-Willi syndrome/Angelman syndrome chromosome region 1,608145,"Spastic paraplegia 6, autosomal dominant",600363,AD,-,NIPA1
"MKRN3, ZFP127, ZNF127, CPPB2",Makorin 3,603856,"Precocious puberty, central, 2",615346,AD,expressed only from paternal allele,MKRN3
"MAGEL2, NDNL1, SHFYNG",MAGE-like 2,605283,Schaaf-Yang syndrome,615547,AD,-,MAGEL2
NDN,Necdin,602117,Prader-Willi syndrome,176270,IC,-,NDN
SNRPN,Small nuclear ribonucleoprotein polypeptide N,182279,Prader-Willi syndrome,176270,IC,-,SNRPN
"UBE3A, ANCR",Ubiquitin protein ligase E3A,601623,Angelman syndrome,105830,IC,same location as PWS,UBE3A
"GABRB3, ECA5, EIEE43","Gamma-aminobutyric acid (GABA) A receptor, beta-3",137192,"Epileptic encephalopathy, early infantile, 43",617113,AD,-,GABRB3
"GABRB3, ECA5, EIEE43","Gamma-aminobutyric acid (GABA) A receptor, beta-3",137192,"{Epilepsy, childhood absence, susceptibility to, 5}",612269,-,-,GABRB3
"OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1","Pink-eye dilution, murine, homolog of (oculocutaneous albinism II)",611409,"Albinism, brown oculocutaneous",203200,AR,?hypopigmentation in PWS and AS,OCA2
"OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1","Pink-eye dilution, murine, homolog of (oculocutaneous albinism II)",611409,"Albinism, oculocutaneous, type II",203200,AR,-,OCA2
"OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1","Pink-eye dilution, murine, homolog of (oculocutaneous albinism II)",611409,"[Skin/hair/eye pigmentation 1, blond/brown hair]",227220,AR,-,OCA2
"OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1","Pink-eye dilution, murine, homolog of (oculocutaneous albinism II)",611409,"[Skin/hair/eye pigmentation 1, blue/nonblue eyes]",227220,AR,-,OCA2
"HERC2, SHEP1, MRT38",HECT domain and RCC1-like domain 2,605837,"Mental retardation, autosomal recessive 38",615516,AR,mutations in intron 4,HERC2
"HERC2, SHEP1, MRT38",HECT domain and RCC1-like domain 2,605837,"[Skin/hair/eye pigmentation 1, blond/brown hair]",227220,AR,-,HERC2
"HERC2, SHEP1, MRT38",HECT domain and RCC1-like domain 2,605837,"[Skin/hair/eye pigmentation 1, blue/nonblue eyes]",227220,AR,-,HERC2
"NSMCE3, NDNL2, MAGEG1, LICS","NSE3 homolog, SMC5-SMC6 complex component",608243,"Lung disease, immunodeficiency, and chromosome breakage syndrome",617241,AR,-,NSMCE3
"DEL15q13.3, MICRODEL15q13.3",Chromosome 15q13.3 microdeletion syndrome,612001,Chromosome 15q13.3 microdeletion syndrome,612001,-,-,DEL15q13.3
"FAN1, MTMR15, KIAA1018, KMIN",FANCD2/FANCI-associated nuclease 1,613534,"Interstitial nephritis, karyomegalic",614817,AR,-,FAN1
"TRPM1, MLSN1, CSNB1C","Transient receptor potential cation channel, subfamily M, member 1 (melastatin)",603576,"Night blindness, congenital stationary (complete), 1C, autosomal recessive",613216,-,-,TRPM1
"DEL15q14, C15DELq14",Chromosome 15q14 deletion syndrome,616898,Chromosome 15q14 deletion syndrome,616898,AD,-,DEL15q14
"SLC12A6, KCC3A, KCC3B, KCC3, ACCPN","Solute carrier family 12 (potassium/chloride transporters), member 6",604878,Agenesis of the corpus callosum with peripheral neuropathy,218000,AR,-,SLC12A6
"NOLA3, NOP10, DKCB1","Nucleolar protein family A, member 3",606471,"Dyskeratosis congenita, autosomal recessive 1",224230,AR,-,NOLA3
"ACTC1, CMD1R, CMH11, ASD5, LVNC4","Actin, alpha, cardiac muscle",102540,Atrial septal defect 5,612794,AD,-,ACTC1
"ACTC1, CMD1R, CMH11, ASD5, LVNC4","Actin, alpha, cardiac muscle",102540,"Cardiomyopathy, dilated, 1R",613424,AD,-,ACTC1
"ACTC1, CMD1R, CMH11, ASD5, LVNC4","Actin, alpha, cardiac muscle",102540,"Cardiomyopathy, hypertrophic, 11",612098,AD,-,ACTC1
"ACTC1, CMD1R, CMH11, ASD5, LVNC4","Actin, alpha, cardiac muscle",102540,Left ventricular noncompaction 4,613424,AD,-,ACTC1
C15orf41,Chromosome 15 open reading fram 41,615626,"Dyserythropoietic anemia, congenital, type Ib",615631,AR,-,C15orf41
"MEIS2, MRG1, CPCMR","Meis1, mouse, homolog of, 2",601740,"Cleft palate, cardiac defects, and mental retardation",600987,AD,-,MEIS2
"SPRED1, NFLS",Sprouty-related EVH1 domain-containing protein 1,609291,Legius syndrome,611431,AD,-,SPRED1
"EIF2AK4, GCN2, KIAA1338, PVOD2",Eukaryotic translation initiation factor 2-alpha kinase 4,609280,Pulmonary venoocclusive disease 2,234810,AR,-,EIF2AK4
"BUB1B, BUBR1, MVA1","Budding uninhibited by benzimidazoles 1, S. cerevisiae, homolog of, beta",602860,"Colorectal cancer, somatic",114500,-,-,BUB1B
"BUB1B, BUBR1, MVA1","Budding uninhibited by benzimidazoles 1, S. cerevisiae, homolog of, beta",602860,Mosaic variegated aneuploidy syndrome 1,257300,AR,-,BUB1B
"BUB1B, BUBR1, MVA1","Budding uninhibited by benzimidazoles 1, S. cerevisiae, homolog of, beta",602860,[Premature chromatid separation trait],176430,AD,-,BUB1B
IVD,Isovaleryl Coenzyme A dehydrogenase,607036,Isovaleric acidemia,243500,AR,-,IVD
"CHST14, D4ST1, ATCS, EDSMC1",Carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14,608429,"Ehlers-Danlos syndrome, musculocontractural type 1",601776,AR,-,CHST14
"KNL1, CASC5, AF15Q14, KIAA1570, D40, MCPH4",Kinetochore scaffold 1,609173,"Microcephaly 4, primary, autosomal recessive",604321,AR,-,KNL1
"RAD51A, RECA, MRMV2, FANCR","RAD51, S. cerevisiae, homolog of, A (E. coli RecA homolog)",179617,"?Fanconi anemia, complementation group R",617244,AD,mutation identified in 1 FANCR patient,RAD51A
"RAD51A, RECA, MRMV2, FANCR","RAD51, S. cerevisiae, homolog of, A (E. coli RecA homolog)",179617,Mirror movements 2,614508,AD,-,RAD51A
"RAD51A, RECA, MRMV2, FANCR","RAD51, S. cerevisiae, homolog of, A (E. coli RecA homolog)",179617,"{Breast cancer, susceptibility to}",114480,AD,-,RAD51A
"DLL4, AOS6",Delta-like 4,605185,Adams-Oliver syndrome 6,616589,AD,-,DLL4
"NDUFAF1, CIA30, CGI65","NADH-ubiquinone oxidoreductase 1 alpha subcomplex, assembly factor 1",606934,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",-,NDUFAF1
"MAPKBP1, JNKBP1, NPHP20",Mitogen-activated protein kinase-binding protein 1,616786,Nephronophthisis 20,617271,AR,-,MAPKBP1
"CAPN3, CANP3","Calpain, large polypeptide L3",114240,"Muscular dystrophy, limb-girdle, type 2A",253600,AR,-,CAPN3
"CDAN1, CDA1, CDAN1A",Codanin 1,607465,"Dyserythropoietic anemia, congenital, type Ia",224120,AR,-,CDAN1
"TTBK2, SCA11",Tau tubulin kinase 2,611695,Spinocerebellar ataxia 11,604432,AD,-,TTBK2
"UBR1, JBS",Ubiquitin-protein ligase E3-alpha,605981,Johanson-Blizzard syndrome,243800,AR,-,UBR1
"EPB42, SPH5",Erythrocyte surface protein band 4.2,177070,"Spherocytosis, type 5",612690,-,-,EPB42
"TGM5, TGX, PSS2",Transglutaminase 5,603805,Peeling skin syndrome 2,609796,AR,-,TGM5
"DEL15q15.3, C15DELq15.3",Chromosome 15q15.3 deletion syndrome,611102,Deafness and male infertility,611102,AR,-,DEL15q15.3
"HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq","Polyposis syndrome, mixed, hereditary 1",601228,"Polyposis syndrome, mixed hereditary 1",601228,AD,duplication of 40kb of 15q resulting in overexpression of GREM1,HMPS1
"HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq","Polyposis syndrome, mixed, hereditary 1",601228,"{Colorectal cancer, susceptibility to, 4}",601228,AD,-,HMPS1
"TUBGCP4, GCP4, MCCRP3",Tubulin-gamma complex-associated protein 4,609610,"Microcephaly and chorioretinopathy, autosomal recessive, 3",616335,AR,-,TUBGCP4
"STRC, DFNB16",Stereocilin,606440,"Deafness, autosomal recessive 16",603720,AR,-,STRC
"SPG11, KIAA1840, FLJ21439, ALS5, CMT2X",Spastascin,610844,"Amyotrophic lateral sclerosis 5, juvenile",602099,AR,-,SPG11
"SPG11, KIAA1840, FLJ21439, ALS5, CMT2X",Spastascin,610844,"Charcot-Marie-Tooth disease, axonal, type 2X",616668,AR,-,SPG11
"SPG11, KIAA1840, FLJ21439, ALS5, CMT2X",Spastascin,610844,"Spastic paraplegia 11, autosomal recessive",604360,AR,-,SPG11
"PATL2, PAT1A, OOMD4","Protein associated with topoisomerase II, S. Cerevisiae, homolog of",614661,Oocyte maturation defect 4,617743,AR,-,PATL2
"B2M, IMD43",Beta-2-microglobulin,109700,"?Amyloidosis, familial visceral",105200,AD,mutation identified in 1 FVA family,B2M
"B2M, IMD43",Beta-2-microglobulin,109700,Immunodeficiency 43,241600,AR,-,B2M
"DUOX2, THOX2, TDH6",Dual oxidase 2 (thyroid oxidase 2),606759,Thyroid dyshormonogenesis 6,607200,AR,-,DUOX2
"DUOXA2, TDH5",Dual oxidase maturation factor 2,612772,Thyroid dyshormonogenesis 5,274900,AR,head-to-head with DUOX2,DUOXA2
"GATM, AGAT, CCDS3",L-arginine:glycine amidinotransferase,602360,Cerebral creatine deficiency syndrome 3,612718,AR,-,GATM
"BLOC1S6, BLOS6, PLDN, PA, HPS9","Biogenesis of lysosome-related organelles complex 1, subunit 6",604310,?Hermansky-pudlak syndrome 9,614171,AR,mutation identified in 1 HPS9 patient,BLOC1S6
"SLC24A5, NCKX5, SHEP4, OCA6","Solute carrier family 24 (sodium/potassium/calcium exchanger), member 5",609802,"Albinism, oculocutaneous, type VI",113750,AR,-,SLC24A5
"SLC24A5, NCKX5, SHEP4, OCA6","Solute carrier family 24 (sodium/potassium/calcium exchanger), member 5",609802,"[Skin/hair/eye pigmentation 4, fair/dark skin]",113750,AR,-,SLC24A5
"SLC12A1, NKCC2","Solute carrier family 12 (sodium/potassium/chloride transporters), member 1",600839,"Bartter syndrome, type 1",601678,AR,-,SLC12A1
"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",Fibrillin-1,134797,Acromicric dysplasia,102370,AD,-,FBN1
"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",Fibrillin-1,134797,"Ectopia lentis, familial",129600,AD,-,FBN1
"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",Fibrillin-1,134797,Geleophysic dysplasia 2,614185,AD,-,FBN1
"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",Fibrillin-1,134797,Marfan lipodystrophy syndrome,616914,AD,-,FBN1
"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",Fibrillin-1,134797,Marfan syndrome,154700,AD,-,FBN1
"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",Fibrillin-1,134797,MASS syndrome,604308,-,-,FBN1
"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",Fibrillin-1,134797,Stiff skin syndrome,184900,AD,-,FBN1
"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",Fibrillin-1,134797,"Weill-Marchesani syndrome 2, dominant",608328,AD,-,FBN1
"CEP152, KIAA0912, MCPH9, SCKL5","Centrosomal protein, 152kD",613529,"Microcephaly 9, primary, autosomal recessive",614852,AR,-,CEP152
"CEP152, KIAA0912, MCPH9, SCKL5","Centrosomal protein, 152kD",613529,Seckel syndrome 5,613823,AR,-,CEP152
HDC,Histidine decarboxylase,142704,"{Gilles de la Tourette syndrome, susceptibility to}",137580,AD,-,HDC
"USP8, HUMORF8, PITA4",Ubiquitin-specific protease 8,603158,"Pituitary adenoma 4, ACTH-secreting, somatic",219090,-,-,USP8
"TRPM7, LTRPC7, CHAK, ALSPDC","Transient receptor potential cation channel, subfamily M, member 7",605692,"{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}",105500,AD,-,TRPM7
"AP4E1, SPG51, CPSQ4, STUT1","Adaptor-related protein complex 4, epsilon-1 subunit",607244,"Spastic paraplegia 51, autosomal recessive",613744,AR,-,AP4E1
"AP4E1, SPG51, CPSQ4, STUT1","Adaptor-related protein complex 4, epsilon-1 subunit",607244,"Stuttering, familial persistent, 1",184450,AD,-,AP4E1
"CYP19A1, CYP19, ARO","Cytochrome P450, family 19, subfamily A, polypeptide 1 (aromatization of androgens)",107910,Aromatase deficiency,613546,-,close to CYP11 in mouse,CYP19A1
"CYP19A1, CYP19, ARO","Cytochrome P450, family 19, subfamily A, polypeptide 1 (aromatization of androgens)",107910,Aromatase excess syndrome,139300,AD,-,CYP19A1
"GLDN, CRGL2, LCCS11",Gliomedin,608603,Lethal congenital contracture syndrome 11,617194,AR,-,GLDN
"DMXL2, RC3, KIAA0856, PEPNS, DFNA71",DMX-like 2,612186,"?Deafness, autosomal dominant 71",617605,AD,mutation identified in 1 PEPNS family and 1 DFNA71 family,DMXL2
"DMXL2, RC3, KIAA0856, PEPNS, DFNA71",DMX-like 2,612186,?Polyendocrine-polyneuropathy syndrome,616113,AR,-,DMXL2
"GNB5, GB5, IDDCA, LADCI","Guanine nucleotide-binding protein, beta-5",604447,Intellectual developmental disorder with cardiac arrhythmia,617173,AR,-,GNB5
"GNB5, GB5, IDDCA, LADCI","Guanine nucleotide-binding protein, beta-5",604447,Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia,617182,AR,-,GNB5
"MYO5A, MYH12, GS1",Myosin Va,160777,"Griscelli syndrome, type 1",214450,AR,-,MYO5A
"WDR72, AI2A3",WD repeat-containing protein 72,613214,"Amelogenesis imperfecta, type IIA3",613211,AR,-,WDR72
"RAB27A, RAM, GS2",Ras-associated protein RAB27A,603868,"Griscelli syndrome, type 2",607624,AR,-,RAB27A
"DNAAF4, DYX1C1, DYXC1, DYX1, CILD25","Dynein, axonemal, assembly factor 4",608706,"Ciliary dyskinesia, primary, 25",615482,AR,not confirmed by some studies,DNAAF4
"DNAAF4, DYX1C1, DYXC1, DYX1, CILD25","Dynein, axonemal, assembly factor 4",608706,"{Dyslexia, susceptibility to, 1}",127700,AD,-,DNAAF4
"TCF12, HTF4, CRS3","Transcription factor-12 (HTF4, helix-loop-helix transcription factors-4)",600480,Craniosynostosis 3,615314,AD,-,TCF12
"LIPC, HL, LIPH, HDLCQ12","Lipase C, hepatic",151670,Hepatic lipase deficiency,614025,AR,-,LIPC
"LIPC, HL, LIPH, HDLCQ12","Lipase C, hepatic",151670,[High density lipoprotein cholesterol level QTL 12],612797,-,-,LIPC
"LIPC, HL, LIPH, HDLCQ12","Lipase C, hepatic",151670,"{Diabetes mellitus, noninsulin-dependent}",125853,AD,-,LIPC
"ADAM10, MADM, RAK, AD18",A disintegrin and metalloprotease domain 10,602192,Reticulate acropigmentation of Kitamura,615537,AD,-,ADAM10
"ADAM10, MADM, RAK, AD18",A disintegrin and metalloprotease domain 10,602192,"{Alzheimer disease 18, susceptibility to}",615590,-,-,ADAM10
"MYO1E, MYO1C, FSGS6",Myosin IE,601479,"Glomerulosclerosis, focal segmental, 6",614131,AR,-,MYO1E
"VPS13C, KIAA1421, PARK23","Vacuolar protein sorting 13, yeast, homolog of, C",608879,"Parkinson disease 23, autosomal recessive, early onset",616840,AR,-,VPS13C
"TPM1, CMH3, CMD1Y , LVNC9","Tropomyosin 1, alpha",191010,"Cardiomyopathy, dilated, 1Y",611878,AD,-,TPM1
"TPM1, CMH3, CMD1Y , LVNC9","Tropomyosin 1, alpha",191010,"Cardiomyopathy, hypertrophic, 3",115196,AD,-,TPM1
"TPM1, CMH3, CMD1Y , LVNC9","Tropomyosin 1, alpha",191010,Left ventricular noncompaction 9,611878,AD,-,TPM1
CA12,Carbonic anhydrase XII,603263,"Hyperchlorhidrosis, isolated",143860,AR,-,CA12
"HERC1, MDFPMR",HECT domain and RCC1-like domain 1,605109,"Macrocephaly, dysmorphic facies, and psychomotor retardation",617011,AR,-,HERC1
"PPIB, CYPB, OI9",Peptidyl-prolyl isomerase B,123841,"Osteogenesis imperfecta, type IX",259440,AR,-,PPIB
"TRIP4, ASC1, SMABF1, MDCDC",Thyroid hormone receptor interactor 4,604501,"?Muscular dystrophy, congenital, Davignon-Chauveau type",617066,AR,mutation identified in 1 MDCDC family,TRIP4
"TRIP4, ASC1, SMABF1, MDCDC",Thyroid hormone receptor interactor 4,604501,Spinal muscular atrophy with congenital bone fractures 1,616866,AR,-,TRIP4
"ACP33, MAST, SPG21","Acidic cluster protein, 33kD, (maspardin)",608181,Mast syndrome,248900,AR,-,ACP33
"MTFMT, COXPD15",Mitochondrial methionyl-tRNA formyltransferase,611766,Combined oxidative phosphorylation deficiency 15,614947,AR,-,MTFMT
"KBTBD13, NEM6",Kelch repeat and BTB/POZ domains-containing protein 13,613727,"Nemaline myopathy 6, autosomal dominant",609273,AD,-,KBTBD13
CILP,Cartilage intermediate layer protein,603489,"{Lumbar disc disease, susceptibility to}",603932,-,-,CILP
"SLC24A1, NCKX1, CSNB1D","Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1",603617,"Night blindness, congenital stationary (complete), 1D, autosomal recessive",613830,AR,-,SLC24A1
"MAP2K1, PRKMK1, MKK1, MEK1, CFC3",Mitogen-activated protein kinase kinase 1,176872,Cardiofaciocutaneous syndrome 3,615279,-,pseudogene on 8p21,MAP2K1
"SMAD6, MADH6, AOVD2","Mothers against decapentaplegic, Drosophila, homolog of, 6",602931,Aortic valve disease 2,614823,AD,-,SMAD6
"SMAD6, MADH6, AOVD2","Mothers against decapentaplegic, Drosophila, homolog of, 6",602931,"{Craniosynostosis 7, susceptibility to}",617439,AD,-,SMAD6
"SMAD3, MADH3, LDS3","Mothers against decapentaplegic, Drosophila, homolog of, 3",603109,Loeys-Dietz syndrome 3,613795,AD,-,SMAD3
"AAGAB, p34, PPKP1A, PPKP1, KPPP1",Alpha- and gamma-adaptin-binding protein,614888,"Keratoderma, palmoplantar, punctate type IA",148600,AD,-,AAGAB
"CLN6, CLN4A",CLN6 gene,606725,"Ceroid lipofuscinosis, neuronal, 6",601780,AR,-,CLN6
"CLN6, CLN4A",CLN6 gene,606725,"Ceroid lipofuscinosis, neuronal, Kufs type, adult onset",204300,AR,-,CLN6
"NR2E3, PNR, ESCS, RP37","Nuclear receptor subfamily 2, group E, member 3",604485,Enhanced S-cone syndrome,268100,AR,near BBS4,NR2E3
"NR2E3, PNR, ESCS, RP37","Nuclear receptor subfamily 2, group E, member 3",604485,Retinitis pigmentosa 37,611131,"AD,AR",-,NR2E3
"HEXA, TSD","Hexosaminidase A, alpha polypeptide",606869,"GM2-gangliosidosis, several forms",272800,AR,on 15q+ in APL,HEXA
"HEXA, TSD","Hexosaminidase A, alpha polypeptide",606869,Tay-Sachs disease,272800,AR,-,HEXA
"HEXA, TSD","Hexosaminidase A, alpha polypeptide",606869,[Hex A pseudodeficiency],272800,AR,-,HEXA
BBS4,BBS4 gene,600374,Bardet-Biedl syndrome 4,615982,AR,-,BBS4
"HCN4, SSS2",Hyperpolarization-activated cyclic nucleotide-gated potassium channel 4,605206,Brugada syndrome 8,613123,-,-,HCN4
"HCN4, SSS2",Hyperpolarization-activated cyclic nucleotide-gated potassium channel 4,605206,Sick sinus syndrome 2,163800,AD,-,HCN4
"LOXL1, LOXL",Lysyl oxidase-like 1,153456,"{Exfoliation syndrome, susceptibility to}",177650,AD,-,LOXL1
"STRA6, MCOPS9, MCOPCB8","Stimulated by retinoic acid 6, mouse, homolog of",610745,"Microphthalmia, isolated, with coloboma 8",601186,AR,-,STRA6
"STRA6, MCOPS9, MCOPCB8","Stimulated by retinoic acid 6, mouse, homolog of",610745,"Microphthalmia, syndromic 9",601186,AR,-,STRA6
"CYP11A1, P450SCC","Cytochrome P450, subfamily XIA, polypeptide 1 (cholesterol side chain cleavage enzyme)",118485,"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete",613743,-,-,CYP11A1
"SEMA7A, SEMAL, SEMAK1, CDW108, JMH",Semaphorin 7A,607961,"[Blood group, John-Milton-Hagen system]",614745,-,-,SEMA7A
"EDC3, YJDC, MRT50","Enhancer of mRNA decapping 3, S. cerevisiae, homolog of",609842,"?Mental retardation, autosomal recessive 50",616460,AR,mutation identified in 1 MRT50 family,EDC3
"MPI, PMI1, CDG1B",Mannosephosphate isomerase (phosphomannose isomerase 1),154550,"Congenital disorder of glycosylation, type Ib",602579,AR,-,MPI
"SIN3A, WITKOS","Sin3, yeast, homolog of, A",607776,Witteveen-Kolk syndrome,613406,AD,-,SIN3A
"ETFA, GA2, MADD","Electron transfer flavoprotein, alpha polypeptide",608053,Glutaric acidemia IIA,231680,AR,-,ETFA
"PSTPIP1, PSTPIP, CD2BP1, PAPAS",Proline-serine-threonine phosphatase-interacting protein 1,606347,"Pyogenic sterile arthritis, pyoderma gangrenosum, and acne",604416,AD,-,PSTPIP1
"DEL15q25, C15DELq25",Chromosome 15q25 deletion syndrome,614294,Chromosome 15q25 deletion syndrome,614294,AD,"chr15:82,889,423-83,552,890, NCBI36",DEL15q25
"CIB2, KIP2",Calcium- and integrin-binding protein 2,605564,"Deafness, autosomal recessive 48",609439,AR,-,CIB2
"CIB2, KIP2",Calcium- and integrin-binding protein 2,605564,"Usher syndrome, type IJ",614869,AR,-,CIB2
"CHRNA5, LNCR2","Cholinergic receptor, neuronal nicotinic, alpha polypeptide-5",118505,{Lung cancer susceptibility 2},612052,-,-,CHRNA5
"CHRNA5, LNCR2","Cholinergic receptor, neuronal nicotinic, alpha polypeptide-5",118505,"{Nicotine dependence, susceptibility to}",612052,-,-,CHRNA5
"CHRNA3, LNCR2, PAOD2","Cholinergic receptor, neuronal nicotinic, alpha polypeptide-3",118503,{Lung cancer susceptibility 2},612052,-,-,CHRNA3
"MIR184, MIRN184, KTCNCT, EDICT",Micro RNA 184,613146,EDICT syndrome,614303,AD,-,MIR184
FAH,Fumarylacetoacetase,613871,"Tyrosinemia, type I",276700,AR,-,FAH
"ARNT2, WEDAS",Aryl hydrocarbon receptor nuclear translocator 2,606036,?Webb-Dattani syndrome,615926,AR,mutation identified in 1 WEDAS family,ARNT2
"RPS17, RPS17L1, RPS17L2, DBA4",Ribosomal protein S17,180472,Diamond-Blackfan anemia 4,612527,AD,previously on chr.11; pseudogenes on 5q33-qter and 17q,RPS17
"AP3B2, NAPTB, EIEE48","Adaptor-related protein complex 3, beta 2 subunit",602166,"Epileptic encephalopathy, early infantile, 48",617276,AR,-,AP3B2
"HOMER2, HOMER2B, HOMER2A, DFNA68","Homer, homolog 2 (Drosophila)",604799,"?Deafness, autosomal dominant 68",616707,AD,mutation identified in 1 DFNA68 family,HOMER2
"WDR73, HSPC264, GAMOS1",WD repeat-containing protein 73,616144,Galloway-Mowat syndrome 1,251300,AR,-,WDR73
MDD2,Major depressive disorder 2,608691,Major depressive disorder 2,608516,-,-,MDD2
"AGBL1, CCP4, FECD8",ATP/GTP-binding protein-like 1,615496,"Corneal dystrophy, Fuchs endothelial, 8",615523,AD,-,AGBL1
"DEL15q26qter, C15DELq26qter",Chromosome 15q26-qter deletion syndrome,612626,Chromosome 15q26-qter deletion syndrome,612626,IC,contiguous gene deletion syndrome,DEL15q26qter
LVSKS,Levy-Shanske syndrome (tetrasomy 15q26),614846,Levy-Shanske syndrome,614846,-,-,LVSKS
"ACAN, AGC1, CSPG1, MSK16, SEDK, SSOAOD","Aggrecan (chondroitin sulfate proteoglycan-1, large aggregating proteoglycan, antigen identifies by monoclonal antibody A0122)",155760,"?Spondyloepimetaphyseal dysplasia, aggrecan type",612813,AR,mutation identified in 1 SEDK family and 1 SEMDAG family,ACAN
"ACAN, AGC1, CSPG1, MSK16, SEDK, SSOAOD","Aggrecan (chondroitin sulfate proteoglycan-1, large aggregating proteoglycan, antigen identifies by monoclonal antibody A0122)",155760,"?Spondyloepiphyseal dysplasia, Kimberley type",608361,AD,-,ACAN
"ACAN, AGC1, CSPG1, MSK16, SEDK, SSOAOD","Aggrecan (chondroitin sulfate proteoglycan-1, large aggregating proteoglycan, antigen identifies by monoclonal antibody A0122)",155760,"Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans",165800,AD,-,ACAN
RLBP1,"Retinaldehyde-binding protein-1, cellular",180090,Bothnia retinal dystrophy,607475,AR,-,RLBP1
RLBP1,"Retinaldehyde-binding protein-1, cellular",180090,Fundus albipunctatus,136880,"AD,AR",-,RLBP1
RLBP1,"Retinaldehyde-binding protein-1, cellular",180090,Newfoundland rod-cone dystrophy,607476,-,-,RLBP1
RLBP1,"Retinaldehyde-binding protein-1, cellular",180090,Retinitis punctata albescens,136880,"AD,AR",-,RLBP1
"FANCI, KIAA1794",FANCI gene,611360,"Fanconi anemia, complementation group I",609053,AR,-,FANCI
"POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS","Polymerase (DNA directed), gamma",174763,Mitochondrial DNA depletion syndrome 4A (Alpers type),203700,AR,PEO also digenic with C10orf2,POLG
"POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS","Polymerase (DNA directed), gamma",174763,Mitochondrial DNA depletion syndrome 4B (MNGIE type),613662,AR,-,POLG
"POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS","Polymerase (DNA directed), gamma",174763,Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE),607459,AR,-,POLG
"POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS","Polymerase (DNA directed), gamma",174763,"Progressive external ophthalmoplegia, autosomal dominant 1",157640,AD,-,POLG
"POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS","Polymerase (DNA directed), gamma",174763,"Progressive external ophthalmoplegia, autosomal recessive 1",258450,AR,-,POLG
"KIF7, HLS2, ACLS, JBTS12, AGBK",Kinesin family member 7,611254,?Al-Gazali-Bakalinova syndrome,607131,AR,mutation identified in 1 HLS2 family and 1 AGBK family,KIF7
"KIF7, HLS2, ACLS, JBTS12, AGBK",Kinesin family member 7,611254,?Hydrolethalus syndrome 2,614120,AR,-,KIF7
"KIF7, HLS2, ACLS, JBTS12, AGBK",Kinesin family member 7,611254,Acrocallosal syndrome,200990,AR,-,KIF7
"KIF7, HLS2, ACLS, JBTS12, AGBK",Kinesin family member 7,611254,Joubert syndrome 12,200990,AR,-,KIF7
"PLIN1, PLIN, FPLD4",Perilipin 1,170290,"Lipodystrophy, familial partial, type 4",613877,AD,-,PLIN1
"MESP2, SCDO2",Mesoderm posterior bHLH transcription factor 2,605195,"Spondylocostal dysostosis 2, autosomal recessive",608681,-,-,MESP2
"IDH2, IDPM, D2HGA2","Isocitrate dehydrogenase, mitochondrial",147650,D-2-hydroxyglutaric aciduria 2,613657,-,-,IDH2
"RECQL3, RECQ2, BLM, BS","DNA helicase, RecQ-like 3",604610,Bloom syndrome,210900,AR,-,RECQL3
VPS33B,"Vacuolar protein sorting 33, yeast, homolog of, B",608552,"Arthrogryposis, renal dysfunction, and cholestasis 1",208085,AR,-,VPS33B
"CHD2, EEOC",Chromodomain helicase DNA binding protein-2,602119,"Epileptic encephalopathy, childhood-onset",615369,AD,-,CHD2
"NR2F2, TFCOUP2, ARP1, CHTD4","Nuclear receptor subfamily 2, group F, member 2 (transcription factor COUP 2)",107773,"Congenital heart defects, multiple types, 4",615779,AD,-,NR2F2
IGF1R,Insulin-like growth factor-1 receptor,147370,"Insulin-like growth factor I, resistance to",270450,"AD,AR",-,IGF1R
"MEF2A, ADCAD1","MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A)",600660,"{Coronary artery disease, autosomal dominant, 1}",608320,AD,-,MEF2A
"ADAMTS17, WMS4","A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 17",607511,"Weill-Marchesani 4 syndrome, recessive",613195,AR,-,ADAMTS17
"CERS3, LASS3, ARCI9",Ceramide synthase 3,615276,"Ichthyosis, congenital, autosomal recessive 9",615023,AR,-,CERS3
"LINS1, WINS1, FLJ10583, MRT27","Lines, Drosophila, homolog of, 1",610350,"Mental retardation, autosomal recessive 27",614340,AR,-,LINS1
"ALDH1A3, ALDH6, MCOP8","Aldehyde dehydrogenase 1 family, member A3",600463,"Microphthalmia, isolated 8",615113,AR,-,ALDH1A3
"CHSY1, KIAA0990, TPBS",Carbohydrate synthase 1,608183,Temtamy preaxial brachydactyly syndrome,605282,AR,-,CHSY1
ADHD1,"Attention deficit-hyperactivity disorder, susceptibility to, 1",608903,{Attention deficit-hyperactivity disorder},143465,AD,max lod at D16S3114,ADHD1
"DEL16p13.3, RSTSS",Chromosome 16p13.3 deletion syndrome (Rubinstein-Taybi deletion syndrome),610543,Chromosome 16p13.3 deletion syndrome,610543,-,contiguous gene deletion syndrome,DEL16p13.3
"DUP16p13.3, C16DUPq13.3",Chromosome 16p13.3 duplication syndrome,613458,Chromosome 16p13.3 duplication syndrome,613458,"AD,IC",contiguous gene duplication syndrome,DUP16p13.3
"HBHR, ATR1","Alpha-thalassemia/mental retardation syndrome, type 1",141750,"Alpha-thalassemia/mental retardation syndrome, type 1",141750,AD,contiguous gene syndrome involving deletion of HBA1 and HBA2,HBHR
PKDTS,"Polycystic kidney disease, infantile severe, with tuberous sclerosis",600273,"Polycystic kidney disease, infantile severe, with tuberous sclerosis",600273,AD,contiguous gene syndrome caused by deletion of TSC2 and PKD1,PKDTS
"NPRL3, CGTHBA, FFEVF3",Nitrogen permease regulator-like 3,600928,"Epilepsy, familial focal, with variable foci 3",617118,AD,-,NPRL3
"HBA2, HBH",Hemoglobin alpha-2,141850,Erythrocytosis,-,-,-,HBA2
"HBA2, HBH",Hemoglobin alpha-2,141850,Heinz body anemia,140700,AD,-,HBA2
"HBA2, HBH",Hemoglobin alpha-2,141850,"Hemoglobin H disease, nondeletional",613978,-,-,HBA2
"HBA2, HBH",Hemoglobin alpha-2,141850,Hypochromic microcytic anemia,-,-,-,HBA2
"HBA2, HBH",Hemoglobin alpha-2,141850,"Thalassemia, alpha-",604131,-,-,HBA2
"HBA1, HBH",Hemoglobin alpha-1,141800,"Erythremias, alpha-",-,-,"1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3'",HBA1
"HBA1, HBH",Hemoglobin alpha-1,141800,"Heinz body anemias, alpha-",140700,AD,-,HBA1
"HBA1, HBH",Hemoglobin alpha-1,141800,"Hemoglobin H disease, nondeletional",613978,-,-,HBA1
"HBA1, HBH",Hemoglobin alpha-1,141800,"Methemoglobinemias, alpha-",-,-,-,HBA1
"HBA1, HBH",Hemoglobin alpha-1,141800,"Thalassemias, alpha-",604131,-,-,HBA1
"AXIN1, AXIN",Axis inhibitor 1,603816,?Caudal duplication anomaly,607864,-,hypermethylation of AXIN1 promoter seen in 1 CDUP patient,AXIN1
"AXIN1, AXIN",Axis inhibitor 1,603816,"Hepatocellular carcinoma, somatic",114550,-,-,AXIN1
"STUB1, CHIP, SCAR16",STIP1 homologous and U box-containing protein 1,607207,"Spinocerebellar ataxia, autosomal recessive 16",615768,AR,-,STUB1
"CCDC78, C16orf25, CNM4",Coiled-coil domain-containing protein 78,614666,?Centronuclear myopathy 4,614807,AD,mutation identified in 1 CNM4 family,CCDC78
"LMF1, TMEM112",Lipase maturation factor 1,611761,"Lipase deficiency, combined",246650,AR,-,LMF1
"CACNA1H, EIG6, ECA6, HALD4","Calcium channel, voltage-dependent, T type, alpha-1H subunit",607904,"Hyperaldosteronism, familial, type IV",617027,AD,-,CACNA1H
"CACNA1H, EIG6, ECA6, HALD4","Calcium channel, voltage-dependent, T type, alpha-1H subunit",607904,"{Epilepsy, childhood absence, susceptibility to, 6}",611942,-,-,CACNA1H
"CACNA1H, EIG6, ECA6, HALD4","Calcium channel, voltage-dependent, T type, alpha-1H subunit",607904,"{Epilepsy, idiopathic generalized, susceptibility to, 6}",611942,-,-,CACNA1H
GNPTAG,"N-acetylglucosamine-1-phosphotransferase, gamma subunit",607838,Mucolipidosis III gamma,252605,AR,-,GNPTAG
"CLCN7, CLC7, OPTA2, OPTB4",Chloride channel-7,602727,"Osteopetrosis, autosomal dominant 2",166600,AD,-,CLCN7
"CLCN7, CLC7, OPTA2, OPTB4",Chloride channel-7,602727,"Osteopetrosis, autosomal recessive 4",611490,-,-,CLCN7
"TELO2, TEL2, CLK2, KIAA0683, HCLK2, YHFS","Telomere maintenance 2, S. cerevisiae, homolog of",611140,You-Hoover-Fong syndrome,616954,AR,-,TELO2
"IFT140, KIAA0590, SRTD9, MZSDS, RP80","Intraflagellar transport 140, Chlamydomonas, homolog of",614620,Retinitis pigmentosa 80,617781,AR,-,IFT140
"IFT140, KIAA0590, SRTD9, MZSDS, RP80","Intraflagellar transport 140, Chlamydomonas, homolog of",614620,Short-rib thoracic dysplasia 9 with or without polydactyly,266920,AR,-,IFT140
"MRPS34, MRPS12, COXPD32",Mitochondrial ribosomal protein S34,611994,Combined oxidative phosphorylation deficiency 32,617664,AR,-,MRPS34
"IGFALS, ALS, ACLSD","Insulin-like growth factor-binding protein, acid-labile subunit",601489,"Acid-labile subunit, deficiency of",615961,-,-,IGFALS
"MEIOB, SPGF22",Meiosis-specific protein with OB domains,617670,?Spermatogenic failure 22,617706,AR,mutation identified in one SPGF22 family,MEIOB
"GFER, ERV1, ALR","Growth factor, erv1, S. cerevisiae, homolog of (augmenter of liver regeneration)",600924,"Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay",613076,-,-,GFER
"NTHL1, OCTS3, FAP3","Endonuclease III, E. coli, homolog of",602656,Familial adenomatous polyposis 3,616415,AR,-,NTHL1
"TSC2, LAM",Tuberin (tuberous sclerosis 2 gene),191092,"?Focal cortical dysplasia, type II, somatic",607341,-,somatic mutation identified in 1 FCORD2 patient,TSC2
"TSC2, LAM",Tuberin (tuberous sclerosis 2 gene),191092,"Lymphangioleiomyomatosis, somatic",606690,-,-,TSC2
"TSC2, LAM",Tuberin (tuberous sclerosis 2 gene),191092,Tuberous sclerosis-2,613254,AD,-,TSC2
PKD1,Polycystin-1,601313,Polycystic kidney disease 1,173900,AD,-,PKD1
"ABCA3, ABC3, SMDP3",ATP-binding cassette-3,601615,"Surfactant metabolism dysfunction, pulmonary, 3",610921,AR,-,ABCA3
"TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65","TBC1 domain family, member 24",613577,"Deafness , autosomal recessive 86",614617,AR,-,TBC1D24
"TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65","TBC1 domain family, member 24",613577,"Deafness, autosomal dominant 65",616044,AD,-,TBC1D24
"TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65","TBC1 domain family, member 24",613577,DOORS syndrome,220500,AR,-,TBC1D24
"TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65","TBC1 domain family, member 24",613577,"Epileptic encephalopathy, early infantile, 16",615338,AR,-,TBC1D24
"TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65","TBC1 domain family, member 24",613577,"Myoclonic epilepsy, infantile, familial",605021,AR,-,TBC1D24
"THOC6, FSAP35, BBIS",THO complex subunit 6,615403,Beaulieu-Boycott-Innes syndrome,613680,AR,-,THOC6
"MEFV, MEF, FMF",Pyrin (marenostrin),608107,"Familial Mediterranean fever, AD",134610,AD,between D16S80 and D16S283,MEFV
"MEFV, MEF, FMF",Pyrin (marenostrin),608107,"Familial Mediterranean fever, AR",249100,AR,-,MEFV
"SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP","Slx4, S. cerevisiae, homolog of",613278,"Fanconi anemia, complementation group P",613951,AR,-,SLX4
"DNASE1, DNL1",Deoxyribonuclease I,125505,"{Systemic lupus erythematosus, susceptibility to}",152700,AD,-,DNASE1
"CREBBP, CBP, RSTS1",CREB binding protein,600140,Rubinstein-Taybi syndrome 1,180849,AD,fusion partner with MORF in AML; fusion partner with MLL in therapy-related acute leukemia; fusion partner with MOZ in AML,CREBBP
"GLIS2, NPHP7",GLIS family zinc finger protein 2,608539,Nephronophthisis 7,611498,-,-,GLIS2
"PAM16, MAGMAS, SMDMDM","Presequence translocase-associated motor 16, S. cerevisiae, homolog of",614336,"Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type",613320,AR,-,PAM16
"SEPT12, SPGF10",Septin 12,611562,Spermatogenic failure 10,614822,AD,-,SEPT12
"ROGDI, KTZS","Rogdi, Drosophila, homolog of",614574,Kohlschutter-Tonz syndrome,226750,AR,-,ROGDI
"ALG1, HMAT1, HMT1, CDG1K","Alg1, yeast, homolog of (beta-1,4 mannosyltransferase)",605907,"Congenital disorder of glycosylation, type Ik",608540,AR,-,ALG1
"DEL16p13.2, C16DELp13.2",Chromosome 16p13.2 deletion syndrome,616863,Chromosome 16p13.2 deletion syndrome,616863,AD,-,DEL16p13.2
"ABAT, GABAT",4-aminobutyrate aminotransferase,137150,GABA-transaminase deficiency,613163,AR,-,ABAT
"PMM2, CDG1A",Phosphomannomutase 2,601785,"Congenital disorder of glycosylation, type Ia",212065,AR,-,PMM2
"GRIN2A, NMDAR2A, FESD, LKS","Glutamate receptor, ionotropic, N-methyl D-aspartate 2A",138253,"Epilepsy, focal, with speech disorder and with or without mental retardation",245570,AD,-,GRIN2A
"EMP2, NPHS10",Epithelial membrane protein 2,602334,"Nephrotic syndrome, type 10",615861,AR,-,EMP2
"CIITA, MHC2TA, C2TA",Class II major histocompatibility complex transactivator,600005,"Bare lymphocyte syndrome, type II, complementation group A",209920,AR,-,CIITA
"CIITA, MHC2TA, C2TA",Class II major histocompatibility complex transactivator,600005,"{Rheumatoid arthritis, susceptibility to}",180300,-,-,CIITA
"LITAF, CMT1C",LPS-induced TNFA factor,603795,"Charcot-Marie-Tooth disease, type 1C",601098,AD,-,LITAF
"ERCC4, XPF, FANCQ, XFEPS","Excision-repair, complementing defective, in Chinese hamster, number 4",133520,?XFE progeroid syndrome,610965,-,mutation identified in 1 XFEPS patient,ERCC4
"ERCC4, XPF, FANCQ, XFEPS","Excision-repair, complementing defective, in Chinese hamster, number 4",133520,"Fanconi anemia, complementation group Q",615272,AR,-,ERCC4
"ERCC4, XPF, FANCQ, XFEPS","Excision-repair, complementing defective, in Chinese hamster, number 4",133520,"Xeroderma pigmentosum, group F",278760,AR,-,ERCC4
"ERCC4, XPF, FANCQ, XFEPS","Excision-repair, complementing defective, in Chinese hamster, number 4",133520,"Xeroderma pigmentosum, type F/Cockayne syndrome",278760,AR,-,ERCC4
"PARN, DAN, DKCB6, PFBMFT4",Polyadenylate-specific ribonuclease,604212,"Dyskeratosis congenita, autosomal recessive 6",616353,AR,-,PARN
"PARN, DAN, DKCB6, PFBMFT4",Polyadenylate-specific ribonuclease,604212,"Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4",616371,AD,-,PARN
"NDE1, NUDE, LIS4, MHAC",nudE neurodevelopment protein 1,609449,?Microhydranencephaly,605013,AR,mutation identified in 1 MHAC family,NDE1
"NDE1, NUDE, LIS4, MHAC",nudE neurodevelopment protein 1,609449,Lissencephaly 4 (with microcephaly),614019,AR,-,NDE1
"MYH11, AAT4, FAA4","Myosin, heavy polypeptide-11, smooth muscle",160745,"Aortic aneurysm, familial thoracic 4",132900,AD,fused with CBFB by inversion in acute myelomonocytic leukemia,MYH11
"ABCC6, ARA, ABC34, MLP1, PXE, GACI2","ATP-binding cassette, subfamily C, member 6",603234,"Arterial calcification, generalized, of infancy, 2",614473,AR,-,ABCC6
"ABCC6, ARA, ABC34, MLP1, PXE, GACI2","ATP-binding cassette, subfamily C, member 6",603234,Pseudoxanthoma elasticum,264800,AR,-,ABCC6
"ABCC6, ARA, ABC34, MLP1, PXE, GACI2","ATP-binding cassette, subfamily C, member 6",603234,"Pseudoxanthoma elasticum, forme fruste",177850,AD,-,ABCC6
"DEL16p12.1, C16DELp12.1","Chromosome 16p12.1 deletion syndrome, 520kb",136570,"Chromosome 16p12.1 deletion syndrome, 520kb",136570,-,between 21.85-22.37 Mb,DEL16p12.1
"XYLT1, XT1, DBQD2",Xylosyltransferase 1,608124,Desbuquois dysplasia 2,615777,AR,-,XYLT1
"XYLT1, XT1, DBQD2",Xylosyltransferase 1,608124,"{Pseudoxanthoma elasticum, modifier of severity of}",264800,AR,-,XYLT1
"ARL6IP1, KIAA0069, SPG61",ADP-ribosylation factor-like 6 interacting protein 1,607669,"?Spastic paraplegia 61, autosomal recessive",615685,AR,mutation identified in 1 family,ARL6IP1
"COQ7, CLK1, COQ10D8","COQ7, S. cerevisiae, homolog of",601683,"?Coenzyme Q10 deficiency, primary, 8",616733,AR,mutation identified in 1 COQ10D8 patient,COQ7
"UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2","Uromodulin (uromucoid, Tamm-Horsfall glycoprotein)",191845,Glomerulocystic kidney disease with hyperuricemia and isosthenuria,609886,-,-,UMOD
"UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2","Uromodulin (uromucoid, Tamm-Horsfall glycoprotein)",191845,"Hyperuricemic nephropathy, familial juvenile 1",162000,AD,-,UMOD
"UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2","Uromodulin (uromucoid, Tamm-Horsfall glycoprotein)",191845,Medullary cystic kidney disease 2,603860,-,-,UMOD
"DEL16p12.1p11.2, C16DELp12.1p11.2",Chromosome 16p12.2-p11.2 deletion syndrome,613604,Chromosome 16p12.2-p11.2 deletion syndrome,613604,IC,17.1-8.7 Mb contiguous gene deletion syndrome,DEL16p12.1p11.2
"CRYM, DFNA40","Crystallin, mu",123740,"Deafness, autosomal dominant 40",616357,AD,-,CRYM
"OTOA, DFNB22",Otoancorin,607038,"Deafness, autosomal recessive 22",607039,AR,-,OTOA
"UQCRC2, MC3DN5",Ubiquinol-cytochrome c reductase core protein II,191329,"Mitochondrial complex III deficiency, nuclear type 5",615160,AR,-,UQCRC2
"SCNN1G, PHA1, BESC3","Sodium channel, nonvoltage-gated 1, gamma",600761,Bronchiectasis with or without elevated sweat chloride 3,613071,AD,same 400kb fragment as SCNN1B,SCNN1G
"SCNN1G, PHA1, BESC3","Sodium channel, nonvoltage-gated 1, gamma",600761,Liddle syndrome,177200,AD,-,SCNN1G
"SCNN1G, PHA1, BESC3","Sodium channel, nonvoltage-gated 1, gamma",600761,"Pseudohypoaldosteronism, type I",264350,AR,-,SCNN1G
"SCNN1B, BESC1","Sodium channel, nonvoltage-gated 1, beta",600760,Bronchiectasis with or without elevated sweat chloride 1,211400,AD,-,SCNN1B
"SCNN1B, BESC1","Sodium channel, nonvoltage-gated 1, beta",600760,Liddle syndrome,177200,AD,-,SCNN1B
"SCNN1B, BESC1","Sodium channel, nonvoltage-gated 1, beta",600760,"Pseudohypoaldosteronism, type I",264350,AR,-,SCNN1B
"COG7, CDG2E",Component of oligomeric golgi complex 7,606978,"Congenital disorder of glycosylation, type IIe",608779,-,-,COG7
"EARS2, KIAA1970, COXPD12",Glutamyl-tRNA synthetase 2,612799,Combined oxidative phosphorylation deficiency 12,614924,AR,-,EARS2
"PALB2, FANCN, PNCA3",Partner and localizer of BRCA2,610355,"Fanconi anemia, complementation group N",610832,-,-,PALB2
"PALB2, FANCN, PNCA3",Partner and localizer of BRCA2,610355,"{Breast cancer, susceptibility to}",114480,AD,-,PALB2
"PALB2, FANCN, PNCA3",Partner and localizer of BRCA2,610355,"{Pancreatic cancer, susceptibility to, 3}",613348,-,-,PALB2
"IL4R, IL4RA",Interleukin-4 receptor,147781,"{AIDS, slow progression to}",609423,-,-,IL4R
"IL4R, IL4RA",Interleukin-4 receptor,147781,"{Atopy, susceptibility to}",147050,AD,-,IL4R
"IL21R, IMD56",Interleukin 21 receptor,605383,Immunodeficiency 56,615207,AR,fusion partner with BCL6,IL21R
"IL21R, IMD56",Interleukin 21 receptor,605383,"[IgE, elevated level of]",147050,AD,-,IL21R
"KATNIP, KIAA0556",Katanin-interacting protein,616650,Joubert syndrome 26,616784,AR,-,KATNIP
"CLN3, BTS",Battenin,607042,"Ceroid lipofuscinosis, neuronal, 3",204200,AR,-,CLN3
"BMIQ16, DEL16p.11.2, C16DELp11.2","Chromosome 16p11.2 deletion syndrome, 220kb",613444,"Chromosome 16p11.2 deletion syndrome, 220kb",613444,-,-,BMIQ16
"BMIQ16, DEL16p.11.2, C16DELp11.2","Chromosome 16p11.2 deletion syndrome, 220kb",613444,[Body mass index QTL16],613444,-,-,BMIQ16
"DEL16p11.2, C16DELp11.2, AUTS14A","Chromosome 16p11.2 deletion syndrome, 593kb",611913,"Chromosome 16p11.2 deletion syndrome, 593kb",611913,-,-,DEL16p11.2
"DEL16p11.2, C16DELp11.2, AUTS14A","Chromosome 16p11.2 deletion syndrome, 593kb",611913,{Autism susceptibility 14A},611913,-,-,DEL16p11.2
"DUP16p11.2, C16DUPp11.2, AUTS14B",Chromosome 16p11.2 duplication syndrome,614671,Chromosome 16p11.2 duplication syndrome,614671,-,-,DUP16p11.2
"DUP16p11.2, C16DUPp11.2, AUTS14B",Chromosome 16p11.2 duplication syndrome,614671,"{Autism, susceptibility to, 14B}",614671,-,-,DUP16p11.2
INV16p11,Chromosome 16p11 inversion (0.45Mb),615835,-,-,-,-,INV16p11
"TUFM, EFTU, COXPD4","Tu translation elongation factor, mitochondrial",602389,Combined oxidative phosphorylation deficiency 4,610678,AR,pseudogene on chr.17,TUFM
"ATP2A1, SERCA1","ATPase, Ca++ transporting, fast-twitch, 1",108730,Brody myopathy,601003,AR,-,ATP2A1
"CD19, CVID3",CD19 antigen,107265,"Immunodeficiency, common variable, 3",613493,AR,-,CD19
"LAT, IMD52",Linker for activation of T cells,602354,Immunodeficiency 52,617514,AR,-,LAT
"KIF22, KNSL4, KID, OBP, SEMDJL2",Kinesin family member 22,603213,"Spondyloepimetaphyseal dysplasia with joint laxity, type 2",603546,AD,-,KIF22
"PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA",Proline-rich transmembrane protein 2,614386,"Convulsions, familial infantile, with paroxysmal choreoathetosis",602066,AD,-,PRRT2
"PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA",Proline-rich transmembrane protein 2,614386,Episodic kinesigenic dyskinesia 1,128200,AD,-,PRRT2
"PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA",Proline-rich transmembrane protein 2,614386,"Seizures, benign familial infantile, 2",605751,AD,-,PRRT2
"ALDOA, GSD12","Aldolase A, fructose-bisphosphatase",103850,Glycogen storage disease XII,611881,AR,pseudogenes on 3 and 10,ALDOA
"TBX6, SCDO5",T-box 6,602427,Spondylocostal dysostosis 5,122600,"AD,AR",-,TBX6
"CORO1A, TACO, CLIPINA, IMD8",Coronin 1A,605000,Immunodeficiency 8,615401,AR,-,CORO1A
"SRCAP, SWR1, KIAA0309, FLHS",SNF2-related CBP activator protein,611421,Floating-Harbor syndrome,136140,AD,-,SRCAP
"PHKG2, GSD9C","Phosphorylase kinase, gamma 2 (testis/liver)",172471,Cirrhosis due to liver phosphorylase kinase deficiency,-,-,-,PHKG2
"PHKG2, GSD9C","Phosphorylase kinase, gamma 2 (testis/liver)",172471,Glycogen storage disease IXc,613027,AR,-,PHKG2
"HSD3B7, CBAS1",3-beta-hydroxy-delta-5-C27-steroid oxidoreductase,607764,"Bile acid synthesis defect, congenital, 1",607765,AR,-,HSD3B7
"STX1B, GEFSP9",Syntaxin 1B,601485,"Generalized epilepsy with febrile seizures plus, type 9",616172,AD,-,STX1B
"VKORC1, VKOR, VKCFD2, FLJ00289","Vitamin K epoxide reductase complex, subunit 1",608547,"Vitamin K-dependent clotting factors, combined deficiency of, 2",607473,-,-,VKORC1
"VKORC1, VKOR, VKCFD2, FLJ00289","Vitamin K epoxide reductase complex, subunit 1",608547,Warfarin resistance,122700,AD,-,VKORC1
"BCKDK, BDK, BCKDKD",Branched-chain alpha-keto acid dehydrogenase kinase,614901,Branched-chain ketoacid dehydrogenase kinase deficiency,614923,-,-,BCKDK
"FUS, TLS, ALS6, ETM4","Fusion, derived from 12-16 translocation, malignant liposarcoma",137070,"Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia",608030,-,"fused with DDIT3 in myxoid liposarcoma, with ERG in leukemia, and ATF1 in angiomatoid fibrous histiocytoma",FUS
"FUS, TLS, ALS6, ETM4","Fusion, derived from 12-16 translocation, malignant liposarcoma",137070,"Essential tremor, hereditary, 4",614782,AD,-,FUS
"ARMC5, AIMAH2",Armadillo repeat-containing protein 5,615549,ACTH-independent macronodular adrenal hyperplasia 2,615954,"AD,SMu",-,ARMC5
"SLC5A2, SGLT2","Solute carrier family 5 (sodium/glucose cotransporter), member 2",182381,Renal glucosuria,233100,"AD,AR",-,SLC5A2
"VPS35, MEM3, PARK17","Vacuolar protein sorting 35, yeast, homolog of",601501,{Parkinson disease 17},614203,AD,-,VPS35
"ORC6, ORC6L","Origin recognition complex, subunit 6, S. cerevisiae, homolog of",607213,Meier-Gorlin syndrome 3,613803,AR,-,ORC6
"GPT2, ALT2, MRT49",Glutamate pyruvate transaminase 2,138210,"Mental retardation, autosomal recessive 49",616281,AR,-,GPT2
PHKB,"Phosphorylase kinase, beta polypeptide",172490,"Phosphorylase kinase deficiency of liver and muscle, autosomal recessive",261750,AR,-,PHKB
"ABCC11, MRP8, EWWD, WW","ATP-binding cassette, subfamily C, member 11",607040,"[Axillary odor, variation in]",117800,AD,-,ABCC11
"ABCC11, MRP8, EWWD, WW","ATP-binding cassette, subfamily C, member 11",607040,"[Colostrum secretion, variation in]",117800,AD,-,ABCC11
"ABCC11, MRP8, EWWD, WW","ATP-binding cassette, subfamily C, member 11",607040,"[Earwax, wet/dry]",117800,AD,-,ABCC11
"ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19",Zinc finger protein 423,604557,Joubert syndrome 19,614844,"AD,AR",-,ZNF423
"ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19",Zinc finger protein 423,604557,Nephronophthisis 14,614844,"AD,AR",-,ZNF423
"NOD2, CARD15, IBD1, CD, YAOS, BLAUS",Nucleotide-binding oligomerization domain protein 2,605956,Blau syndrome,186580,AD,-,NOD2
"NOD2, CARD15, IBD1, CD, YAOS, BLAUS",Nucleotide-binding oligomerization domain protein 2,605956,"{Inflammatory bowel disease 1, Crohn disease}",266600,Mu,-,NOD2
"NOD2, CARD15, IBD1, CD, YAOS, BLAUS",Nucleotide-binding oligomerization domain protein 2,605956,"{Psoriatic arthritis, susceptibility to}",607507,-,-,NOD2
"NOD2, CARD15, IBD1, CD, YAOS, BLAUS",Nucleotide-binding oligomerization domain protein 2,605956,{Yao syndrome},617321,Mu,-,NOD2
"CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS",CYLD gene,605018,Brooke-Spiegler syndrome,605041,AD,behaves as tumor suppressor,CYLD
"CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS",CYLD gene,605018,"Cylindromatosis, familial",132700,AD,-,CYLD
"CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS",CYLD gene,605018,"Trichoepithelioma, multiple familial, 1",601606,AD,-,CYLD
"SALL1, HSAL1, TBS",Sal-like 1,602218,Townes-Brocks branchiootorenal-like syndrome,107480,AD,-,SALL1
"SALL1, HSAL1, TBS",Sal-like 1,602218,Townes-Brocks syndrome 1,107480,AD,-,SALL1
"RPGRIP1L, KIAA1005, JBTS7, MKS5",RPGRIP1-like,610937,COACH syndrome,216360,AR,-,RPGRIP1L
"RPGRIP1L, KIAA1005, JBTS7, MKS5",RPGRIP1-like,610937,Joubert syndrome 7,611560,AR,-,RPGRIP1L
"RPGRIP1L, KIAA1005, JBTS7, MKS5",RPGRIP1-like,610937,Meckel syndrome 5,611561,AR,-,RPGRIP1L
"FTO, GDFD, BMIQ14",Fat mass- and obesity-associated gene,610966,"Growth retardation, developmental delay, facial dysmorphism",612938,AR,-,FTO
"FTO, GDFD, BMIQ14",Fat mass- and obesity-associated gene,610966,"{Obesity, susceptibility to, BMIQ14}",612460,AR,-,FTO
"IRX5, HMMS",Iroquois homeo box protein 5,606195,Hamamy syndrome,611174,AR,-,IRX5
"MMP2, CLG4A, MONA","Matrix metalloproteinase 2 (gelatinase A, 72kD type IV collagenase)",120360,"Multicentric osteolysis, nodulosis, and arthropathy",259600,AR,"near MT1,2",MMP2
"SLC6A2, NAT1, NET1","Solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, cocaine- and antidepressant-sensitive",163970,Orthostatic intolerance,604715,-,-,SLC6A2
"GNAO1, EIEE17, NEDIM","Guanine nucleotide-binding protein (G protein), alpha-activating activity",139311,"Epileptic encephalopathy, early infantile, 17",615473,AD,close to MT1 in mouse,GNAO1
"GNAO1, EIEE17, NEDIM","Guanine nucleotide-binding protein (G protein), alpha-activating activity",139311,Neurodevelopmental disorder with involuntary movements,617493,AD,-,GNAO1
"BBS2, RP74",Bardet-Biedl syndrome 2,606151,Bardet-Biedl syndrome 2,615981,AR,-,BBS2
"BBS2, RP74",Bardet-Biedl syndrome 2,606151,Retinitis pigmentosa 74,616562,AR,-,BBS2
"NUP93, NIC96, KIAA0095, NPHS12","Nucleoporin, 93kD",614351,"Nephrotic syndrome, type 12",616892,AR,-,NUP93
"SLC12A3, NCCT, TSC","Solute carrier family 12 (sodium/potassium/chloride transporters), member 3",600968,Gitelman syndrome,263800,AR,-,SLC12A3
"CETP, HDLCQ10","Cholesteryl ester transfer protein, plasma",118470,Hyperalphalipoproteinemia,143470,AD,-,CETP
"CETP, HDLCQ10","Cholesteryl ester transfer protein, plasma",118470,[High density lipoprotein cholesterol level QTL 10],143470,AD,-,CETP
"RSPRY1, KIAA1972, SEMDFA",RING finger- and SPRY domain-containing protein 11,616585,"Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type",616723,AR,-,RSPRY1
"ARL2BP, BART",ADP ribosylation factor-like 2-binding protein,615407,Retinitis pigmentosa with or without situs inversus,615434,AR,-,ARL2BP
"COQ9, C16orf49, COQ10D5","Coq9, S. cerevisiae, homolog of",612837,"Coenzyme Q10 deficiency, primary, 5",614654,AR,-,COQ9
"ADGRG1, GPR56, TM7XN1, BFPP, BPPR",Adhesion G protein-coupled receptor G1,604110,"Polymicrogyria, bilateral frontoparietal",606854,AR,-,ADGRG1
"ADGRG1, GPR56, TM7XN1, BFPP, BPPR",Adhesion G protein-coupled receptor G1,604110,"Polymicrogyria, bilateral perisylvian",615752,-,-,ADGRG1
"KATNB1, LIS6","Katanin, p80 subunit, B1",602703,"Lissencephaly 6, with microcephaly",616212,AR,-,KATNB1
"CNGB1, CNCG3L, CNCG2, RP45","Cyclic nucleotide gated channel, beta 1",600724,Retinitis pigmentosa 45,613767,AR,-,CNGB1
"USB1, C16orf57, PN",U6 small nuclear RNA biogenesis phosphodiesterase 1,613276,Poikiloderma with neutropenia,604173,AR,-,USB1
"BEAN, SCA31","Brain-expressed, associated with NEDD4",612051,Spinocerebellar ataxia 31,117210,AD,-,BEAN
"TK2, MTDPS2, PEOB3","Thymidine kinase, mitochondrial",188250,"?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3",617069,AR,mutation identified in 1 PEOB3 family,TK2
"TK2, MTDPS2, PEOB3","Thymidine kinase, mitochondrial",188250,Mitochondrial DNA depletion syndrome 2 (myopathic type),609560,AR,-,TK2
"C16DELq22, DEL16q22",Chromosome 16q22 deletion syndrome,614541,Chromosome 16q22 deletion syndrome,614541,IC,-,C16DELq22
"CBFB, PEBP2B","Core-binding factor, beta subunit",121360,"Myeloid leukemia, acute, M4/M4Eo subtype, somatic",601626,-,inv(16)(p13;q22); fuses to MYH11,CBFB
"HSF4, CTM, CTRCT5",Heat-shock transcription factor 4,602438,"Cataract 5, multiple types",116800,AD,-,HSF4
"NOL3, NOP, MYC, ARC, FCM",Nucleolar protein 3,605235,"Myoclonus, familial cortical",614937,AD,-,NOL3
"HSD11B2, HSD11K, AME",Hydroxysteroid (11-beta) dehydrogenase 2,614232,Apparent mineralocorticoid excess,218030,AR,-,HSD11B2
"AGRP, ART, AGRT","Agouti-related transcript, mouse, homolog of",602311,"{Leanness, inherited}",-,-,-,AGRP
"AGRP, ART, AGRT","Agouti-related transcript, mouse, homolog of",602311,"{Obesity, late-onset}",601665,"AD,Mu,AR",-,AGRP
"CTCF, MRD21",CCCTC-binding factor,604167,"Mental retardation, autosomal dominant 21",615502,AD,-,CTCF
"ACD, PTOP, PIP1, TINT1","Acd, mouse, homolog of",609377,"?Dyskeratosis congenita, autosomal dominant 6",616553,"AD,AR",mutation has been identified in 1 DKCA7 and 1 DKCB7 family,ACD
"ACD, PTOP, PIP1, TINT1","Acd, mouse, homolog of",609377,"?Dyskeratosis congenita, autosomal recessive 7",616553,"AD,AR",-,ACD
LCAT,Lecithin-cholesterol acyltransferase,606967,Fish-eye disease,136120,AR,very close to HP,LCAT
LCAT,Lecithin-cholesterol acyltransferase,606967,Norum disease,245900,AR,-,LCAT
"PRMT7, KIAA1933, SBIDDS",Protein arginine N-methyltransferase 7,610087,"Short stature, brachydactyly, intellectual developmental disability, and seizures",617157,AR,-,PRMT7
"CDH3, CDHP, PCAD, HJMD",Cadherin-3 (P-cadherin),114021,"Ectodermal dysplasia, ectrodactyly, and macular dystrophy",225280,AR,in mouse tightly linked to ECAD,CDH3
"CDH3, CDHP, PCAD, HJMD",Cadherin-3 (P-cadherin),114021,"Hypotrichosis, congenital, with juvenile macular dystrophy",601553,AR,-,CDH3
"CDH1, UVO, LCAM, ECAD, BCDS1",Cadherin-1 (E-cadherin; uvomorulin),192090,Blepharocheilodontic syndrome 1,119580,AD,near LCAT,CDH1
"CDH1, UVO, LCAM, ECAD, BCDS1",Cadherin-1 (E-cadherin; uvomorulin),192090,"Endometrial carcinoma, somatic",608089,-,-,CDH1
"CDH1, UVO, LCAM, ECAD, BCDS1",Cadherin-1 (E-cadherin; uvomorulin),192090,"Gastric cancer, familial diffuse, with or without cleft lip and/or palate",137215,AD,-,CDH1
"CDH1, UVO, LCAM, ECAD, BCDS1",Cadherin-1 (E-cadherin; uvomorulin),192090,"Ovarian carcinoma, somatic",167000,-,-,CDH1
"CDH1, UVO, LCAM, ECAD, BCDS1",Cadherin-1 (E-cadherin; uvomorulin),192090,"{Breast cancer, lobular}",114480,AD,-,CDH1
"CDH1, UVO, LCAM, ECAD, BCDS1",Cadherin-1 (E-cadherin; uvomorulin),192090,"{Prostate cancer, susceptibility to}",176807,AD,-,CDH1
"COG8, DOR1, CDG2H",Component of oligomeric golgi complex 8,606979,"Congenital disorder of glycosylation, type IIh",611182,-,-,COG8
"AARS, CMT2N, EIEE29",Alanyl-tRNA synthetase,601065,"Charcot-Marie-Tooth disease, axonal, type 2N",613287,AD,-,AARS
"AARS, CMT2N, EIEE29",Alanyl-tRNA synthetase,601065,"Epileptic encephalopathy, early infantile, 29",616339,AR,-,AARS
"COG4, COD1, CDG2J",Component of oligomeric golgi complex 4,606976,"Congenital disorder of glycosylation, type IIj",613489,AR,-,COG4
"VAC14, TAX1BP2, TRX, SNDC","Vac14, S. cerevisiae, homolog of",604632,"Striatonigral degeneration, childhood-onset",617054,AR,-,VAC14
"HYDIN, HYDIN1, CILD5","Hydin, mouse, homolog of",610812,"Ciliary dyskinesia, primary, 5",608647,AR,duplicated copy on 1q21.1,HYDIN
TAT,"Tyrosine aminotransferase, soluble",613018,"Tyrosinemia, type II",276600,AR,-,TAT
"DHODH, URA1, POADS",Dihydroorotate dehydrogenase,126064,Miller syndrome,263750,AR,-,DHODH
HP,Haptoglobin,140100,[Anhaptoglobinemia],614081,-,just distal to fra16q22.1,HP
HP,Haptoglobin,140100,[Hypohaptoglobinemia],614081,-,-,HP
"ZFHX3, ATBF1",Zinc finger homeobox 3,104155,"{Prostate cancer, susceptibility to, somatic}",176807,-,-,ZFHX3
"RFWD3, FANCW",RING finger and WD repeat domains-containing protein 3,614151,"?Fanconi anemia, complementation group W",617784,AR,mutation identified in 1 FANCW patient,RFWD3
"FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35",Fatty acid 2-hydroxylase,611026,"Spastic paraplegia 35, autosomal recessive",612319,AR,-,FA2H
"CHST6, MCDC1","Carbohydrate sulfotransferase-6 (GlcNAc-6-sulfotransferase, corneal)",605294,Macular corneal dystrophy,217800,AR,-,CHST6
"TMEM231, JBTS20, MKS11",Transmembrane protein 231,614949,Joubert syndrome 20,614970,AR,-,TMEM231
"TMEM231, JBTS20, MKS11",Transmembrane protein 231,614949,Meckel syndrome 11,615397,AR,-,TMEM231
"KARS, CMTRIB, DFNB89",Lysyl-tRNA synthetase,601421,"?Charcot-Marie-Tooth disease, recessive intermediate, B",613641,AR,mutation identified in 1 CMTRIB patient,KARS
"KARS, CMTRIB, DFNB89",Lysyl-tRNA synthetase,601421,"Deafness, autosomal recessive 89",613916,AR,-,KARS
"ADAMTS18, MMCAT","A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 18",607512,"Microcornea, myopic chorioretinal atrophy, and telecanthus",615458,AR,-,ADAMTS18
"WWOX, FOR, SCAR12, EIEE28",WW domain-containing oxidoreductase,605131,"Epileptic encephalopathy, early infantile, 28",616211,AR,-,WWOX
"WWOX, FOR, SCAR12, EIEE28",WW domain-containing oxidoreductase,605131,"Esophageal squamous cell carcinoma, somatic",133239,-,-,WWOX
"WWOX, FOR, SCAR12, EIEE28",WW domain-containing oxidoreductase,605131,"Spinocerebellar ataxia, autosomal recessive 12",614322,AR,-,WWOX
"MAF, CCA4, CTRCT21, AYGRP",v-Maf avian musculoaponeurotic fibrosarcoma oncogene homolog,177075,Ayme-Gripp syndrome,601088,AD,-,MAF
"MAF, CCA4, CTRCT21, AYGRP",v-Maf avian musculoaponeurotic fibrosarcoma oncogene homolog,177075,"Cataract 21, multiple types",610202,AD,-,MAF
"GCSH, NKH",Glycine cleavage system H protein,238330,Glycine encephalopathy,605899,AR,-,GCSH
"BCO1, BCMO1, BCDO",Beta-carotene oxygenase 1,605748,"?Hypercarotenemia and vitamin A deficiency, autosomal dominant",115300,AD,mutation identified in 1 HCVAD patient,BCO1
"GAN, GAN1",Gigaxonin,605379,Giant axonal neuropathy-1,256850,AR,-,GAN
"PLCG2, FCAS3, APLAID","Phospholipase C, gamma 2",600220,"Autoinflammation, antibody deficiency, and immune dysregulation syndrome",614878,AD,-,PLCG2
"PLCG2, FCAS3, APLAID","Phospholipase C, gamma 2",600220,Familial cold autoinflammatory syndrome 3,614468,AD,-,PLCG2
"MLYCD, MCD",Malonyl-CoA decarboxylase,606761,Malonyl-CoA decarboxylase deficiency,248360,AR,-,MLYCD
"SLC38A8, FVH2","Solute carrier family 38 (amino acid transporter), member 8",615585,"Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis",609218,AR,-,SLC38A8
"DNAAF1, LRRC50, ODA7, CILD13","Dynein, axonemal, assembly factor 1",613190,"Ciliary dyskinesia, primary, 13",613193,AR,-,DNAAF1
"IRF8, ICSBP1, IMD32A, IMD32B",Interferon regulatory factor 8,601565,"Immunodeficiency 32A, mycobacteriosis, autosomal dominant",614893,AD,-,IRF8
"IRF8, ICSBP1, IMD32A, IMD32B",Interferon regulatory factor 8,601565,"Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive",614894,AR,-,IRF8
"FOXF1, FKHL5, ACDMPV",Forkhead box F1,601089,Alveolar capillary dysplasia with misalignment of pulmonary veins,265380,AD,-,FOXF1
"FOXC2, FKHL14, MFH1",Forkhead box C2,602402,Lymphedema-distichiasis syndrome,153400,AD,-,FOXC2
"FOXC2, FKHL14, MFH1",Forkhead box C2,602402,Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus,153400,AD,-,FOXC2
"FBXO31, FBX31, FBXO14, FBX14, MRT45",F-box only protein 31,609102,"?Mental retardation, autosomal recessive 45",615979,AR,mutation identified in 1 MRT45 family,FBXO31
"JPH3, JP3, HDL2",Junctophilin 3,605268,?Huntington disease-like 2,606438,AD,mutation identified in 1 HDL2 family,JPH3
"CA5A, CA5AD",Carbonic anhydrase VA (mitochondrial),114761,Hyperammonemia due to carbonic anhydrase VA deficiency,615751,AR,pseudogene on 16p,CA5A
"ZNF469, KIAA1858, BCS1",Zinc finger protein 469,612078,Brittle cornea syndrome 1,229200,AR,-,ZNF469
CYBA,"Cytochrome b-245, alpha polypeptide",608508,"Chronic granulomatous disease, autosomal, due to deficiency of CYBA",233690,AR,-,CYBA
"MVD, MPD, POROK7",Mevalonate pyrophosphate decarboxylase,603236,"Porokeratosis 7, multiple types",614714,AD,-,MVD
"PIEZO1, FAM38A, MIB, DHS, LMPH3",PIEZO1 ion channel,611184,Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema,194380,AD,-,PIEZO1
"PIEZO1, FAM38A, MIB, DHS, LMPH3",PIEZO1 ion channel,611184,"Lymphedema, hereditary, III",616843,AR,-,PIEZO1
CDT1,Chromatin licensing and DNA replication factor 1,605525,Meier-Gorlin syndrome 4,613804,AR,-,CDT1
"APRT, APRTD",Adenine phosphoribosyltransferase,102600,Adenine phosphoribosyltransferase deficiency,614723,AR,"telomeric to GALNS, transcribed in same cen-tel direction",APRT
"GALNS, MPS4A",Galactosamine (N-acetyl)-6-sulfate sulfatase,612222,Mucopolysaccharidosis IVA,253000,AR,centromeric to APRT,GALNS
ACSF3,Acyl-CoA synthetase family member 3,614245,Combined malonic and methylmalonic aciduria,614265,-,-,ACSF3
"CDH15, CDH14, CDH3, MRD3","Cadherin-15, M-cadherin (myotubule)",114019,"Mental retardation, autosomal dominant 3",612580,-,tightly linked to Aprt in mouse,CDH15
"ANKRD11, ANCO1, KBGS",Ankyrin repeat domain-containing protein 11,611192,KBG syndrome,148050,AD,-,ANKRD11
"PGN, SPG7, CMAR, CAR",Paraplegin,602783,"Spastic paraplegia 7, autosomal recessive",607259,"AD,AR",-,PGN
"CHMP1A, PCOLN3, PRSM1, PCH8","CHMP family, member 1A",164010,"Pontocerebellar hypoplasia, type 8",614961,AR,-,CHMP1A
"CDK10, PISSLRE, ALSAS",Cyclin-dependent kinase 10,603464,Al Kaissi syndrome,617694,AR,-,CDK10
"FANCA, FACA, FA1, FA, FAA","Fanconi anemia, complementation group A",607139,"Fanconi anemia, complementation group A",227650,AR,linkage heterogeneity,FANCA
"MC1R, SHEP2, CMM5",Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor),155555,"[Analgesia from kappa-opioid receptor agonist, female-specific]",613098,-,-,MC1R
"MC1R, SHEP2, CMM5",Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor),155555,"[Skin/hair/eye pigmentation 2, blond hair/fair skin]",266300,AR,-,MC1R
"MC1R, SHEP2, CMM5",Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor),155555,"[Skin/hair/eye pigmentation 2, red hair/fair skin]",266300,AR,-,MC1R
"MC1R, SHEP2, CMM5",Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor),155555,"{Albinism, oculocutaneous, type II, modifier of}",203200,AR,-,MC1R
"MC1R, SHEP2, CMM5",Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor),155555,"{Melanoma, cutaneous malignant, 5}",613099,-,-,MC1R
"MC1R, SHEP2, CMM5",Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor),155555,{UV-induced skin damage},266300,AR,-,MC1R
"TUBB3, TUBB4, CFEOM3A, CDCBM1","Tubulin, beta-3",602661,"Cortical dysplasia, complex, with other brain malformations 1",614039,AD,-,TUBB3
"TUBB3, TUBB4, CFEOM3A, CDCBM1","Tubulin, beta-3",602661,"Fibrosis of extraocular muscles, congenital, 3A",600638,AD,-,TUBB3
"GAS8, GAS11, CILD33",Growth arrest-specific 8,605178,"Ciliary dyskinesia, primary, 33",616726,AR,-,GAS8
CACD1,"Choroidal dystrophy, central areolar 1",215500,"Choroidal dystrophy, central areolar 1",215500,AR,-,CACD1
"DUP17p13.3, C17DUPp13.3",Chromosome 17p13.3 duplication syndrome,613215,Chromosome 17p13.3 duplication syndrome,613215,-,includes LIS1 and/or YWHAE,DUP17p13.3
"MDLS, MDS, MDCR, DEL17p13.3, C17DELp13.3",Miller-Dieker lissencephaly syndrome (chromosome 17p13.3 deletion syndrome),247200,Miller-Dieker lissencephaly syndrome,247200,AD,-,MDLS
"SHFLD3, DUP17p13.3, C17DUPp13.3",Split-hand/foot malformation with long bone deficiency 3,612576,Split-hand/foot malformation with long bone deficiency 3,612576,AD,max lod at or near D17S1533; contiguous gene duplication syndrome,SHFLD3
"VPS53, HCCS1, PCH2E","Vacuolar protein sorting 53, S. cerevisiae, homolog of",615850,"Pontocerebellar hypoplasia, type 2E",615851,AR,-,VPS53
"GEMIN4, NEDMCR","Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities",606969,"Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities",617913,-,-,GEMIN4
"BHLHA9, BHLHF42, MSSD, CCSPD","Basic helix-loop-helix family, member A9",615416,"?Camptosynpolydactyly, complex",607539,AR,mutation identified in 1 CCSPD family,BHLHA9
"BHLHA9, BHLHF42, MSSD, CCSPD","Basic helix-loop-helix family, member A9",615416,"Syndactyly, mesoaxial synostotic, with phalangeal reduction",609432,AR,-,BHLHA9
"INPP5K, SKIP, MDCCAID",Inositol polyphosphate-5-phosphatase K,607875,"Muscular dystrophy, congenital, with cataracts and intellectual disability",617404,AR,-,INPP5K
"PRPF8, PRPC8, RP13","Precursor mRNA-processing factor 8, S. cerevisiae, homolog of",607300,Retinitis pigmentosa 13,600059,AD,-,PRPF8
"WDR81, CAMRQ2",WD repeat-containing protein 81,614218,"Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2",610185,AR,-,WDR81
"PLI, SERPINF2",Alpha-2-plasmin inhibitor,613168,Alpha-2-plasmin inhibitor deficiency,262850,AR,-,PLI
"SERPINF1, PEDF, OI6","Serpin peptidase inhibitor, clade F, member 1",172860,"Osteogenesis imperfecta, type VI",613982,-,same region as RP13,SERPINF1
"DPH1, DPH2L1, OVCA1, DEDSSH","DPH1, S. cerevisiae, homolog of (ovarian cancer gene 1)",603527,"Developmental delay with short stature, dysmorphic features, and sparse hair",616901,AR,-,DPH1
"PAFAH1B1, LIS1","Platelet-activating factor acetylhydrolase, isoform 1B, alpha subunit",601545,Lissencephaly 1,607432,IC,-,PAFAH1B1
"PAFAH1B1, LIS1","Platelet-activating factor acetylhydrolase, isoform 1B, alpha subunit",601545,Subcortical laminar heterotopia,607432,IC,-,PAFAH1B1
ASPA,Aspartoacylase (aminoacylase-2),608034,Canavan disease,271900,AR,-,ASPA
"TRPV3, OLMS, FNEPPK2","Transient receptor potential cation channel, subfamily V, member 3",607066,"?Palmoplantar keratoderma, nonepidermolytic, focal 2",616400,AD,mutation identified in 1 FNEPPK2 family,TRPV3
"TRPV3, OLMS, FNEPPK2","Transient receptor potential cation channel, subfamily V, member 3",607066,Olmsted syndrome,614594,AD,-,TRPV3
"SHPK, CARKL",Sedoheptulokinase,605060,[Sedoheptulokinase deficiency],617213,AR,-,SHPK
CTNS,Cystinosin,606272,"Cystinosis, atypical nephropathic",219800,AR,?3 allelic forms,CTNS
CTNS,Cystinosin,606272,"Cystinosis, late-onset juvenile or adolescent nephropathic",219900,AR,-,CTNS
CTNS,Cystinosin,606272,"Cystinosis, nephropathic",219800,AR,-,CTNS
CTNS,Cystinosin,606272,"Cystinosis, ocular nonnephropathic",219750,AR,-,CTNS
"ZMYND15, SPGF14",Zinc finger MYND-containing protein 15,614312,?Spermatogenic failure 14,615842,AR,mutation identified in 1 SPGF14 family,ZMYND15
"CHRNE, SCCMS, CMS4A, CMS4B, CMS4C","Cholinergic receptor, nicotinic, epsilon polypeptide",100725,"Myasthenic syndrome, congenital, 4A, slow-channel",605809,"AD,AR",-,CHRNE
"CHRNE, SCCMS, CMS4A, CMS4B, CMS4C","Cholinergic receptor, nicotinic, epsilon polypeptide",100725,"Myasthenic syndrome, congenital, 4B, fast-channel",616324,AR,-,CHRNE
"CHRNE, SCCMS, CMS4A, CMS4B, CMS4C","Cholinergic receptor, nicotinic, epsilon polypeptide",100725,"Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency",608931,AR,-,CHRNE
"GP1BA, BSS, BDPLT1, VWDP, BDPLT3","Glycoprotein Ib, platelet, alpha polypeptide",606672,"Bernard-Soulier syndrome, type A1 (recessive)",231200,AR,-,GP1BA
"GP1BA, BSS, BDPLT1, VWDP, BDPLT3","Glycoprotein Ib, platelet, alpha polypeptide",606672,"Bernard-Soulier syndrome, type A2 (dominant)",153670,AD,-,GP1BA
"GP1BA, BSS, BDPLT1, VWDP, BDPLT3","Glycoprotein Ib, platelet, alpha polypeptide",606672,"von Willebrand disease, platelet-type",177820,AD,-,GP1BA
"GP1BA, BSS, BDPLT1, VWDP, BDPLT3","Glycoprotein Ib, platelet, alpha polypeptide",606672,"{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}",258660,AR,-,GP1BA
"PFN1, ALS18",Profilin-1,176610,Amyotrophic lateral sclerosis 18,614808,-,-,PFN1
"ENO3, GSD13","Enolase-3, beta, muscle",131370,?Glycogen storage disease XIII,612932,AR,mutation identified in 1 GSD13 patient,ENO3
"KIF1C, LTXS1, KIAA0706, SPAX2",Kinesin family member 1C,603060,"Spastic ataxia 2, autosomal recessive",611302,AR,-,KIF1C
"SLC52A1, GPR172B, GPCR42, PAR2, FLJ10060, RBFVD","Solute carrier family 52, riboflavin transporter, member 1",607883,Riboflavin deficiency,615026,AD,-,SLC52A1
"C1QBP, HABP1, COXPD33",Complement component C1q binding protein (hyaluronic acid-binding protein 1),601269,Combined oxidative phosphorylation deficiency 33,617713,AR,-,C1QBP
"NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, MSPC, AIADK","NLR family, pyrin domain containing 1",606636,Autoinflammation with arthritis and dyskeratosis,617388,"AD,AR",-,NLRP1
"NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, MSPC, AIADK","NLR family, pyrin domain containing 1",606636,"Palmoplantar carcinoma, multiple self-healing",615225,AD,-,NLRP1
"NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, MSPC, AIADK","NLR family, pyrin domain containing 1",606636,{Vitiligo-associated multiple autoimmune disease susceptibility 1},606579,-,-,NLRP1
"AIPL1, LCA4",Arylhydrocarbon-interacting receptor protein-like 1,604392,Cone-rod dystrophy,604393,AR,LCA1 due to GUCY2D mutation also on 17p13.1,AIPL1
"AIPL1, LCA4",Arylhydrocarbon-interacting receptor protein-like 1,604392,Leber congenital amaurosis 4,604393,AR,-,AIPL1
"AIPL1, LCA4",Arylhydrocarbon-interacting receptor protein-like 1,604392,"Retinitis pigmentosa, juvenile",604393,AR,-,AIPL1
"PITPNM3, NIR1, CORD5","Phosphatidylinositol transfer protein, membrane-associated, 3",608921,Cone-rod dystrophy 5,600977,AD,-,PITPNM3
"DEL17p13.1, C17DELp13.1",Chromosome 17p13.1 deletion syndrome,613776,Chromosome 17p13.1 deletion syndrome,613776,AD,contiguous gene deletion syndrome,DEL17p13.1
"KIAA0753, OFIP, OFD15",KIAA0753 gene,617112,?Orofaciodigital syndrome XV,617127,AR,mutation identified in 1 OFD15 patient,KIAA0753
"SLC13A5, NACT, EIEE25","Solute carrier family 13 (sodium-dependent citrate transporter), member 5",608305,"Epileptic encephalopathy, early infantile, 25",615905,AR,-,SLC13A5
"ACADVL, VLCAD","Acyl-Coenzyme A dehydrogenase, very long chain",609575,VLCAD deficiency,201475,AR,-,ACADVL
"CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C","Cholinergic receptor, nicotinic, beta polypeptide-1, muscle",100710,"?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency",616314,AR,mutation identified in 1 CMS2C family,CHRNB1
"CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C","Cholinergic receptor, nicotinic, beta polypeptide-1, muscle",100710,"Myasthenic syndrome, congenital, 2A, slow-channel",616313,AD,-,CHRNB1
"MPDU1, SL15, CDGIF",Mannose-P-dolichol utilization defect 1,604041,"Congenital disorder of glycosylation, type If",609180,AR,-,MPDU1
"TP53, P53, LFS1 , BCC7",Tumor protein p53,191170,Adrenal cortical carcinoma,202300,AR,-,TP53
"TP53, P53, LFS1 , BCC7",Tumor protein p53,191170,Breast cancer,114480,AD,-,TP53
"TP53, P53, LFS1 , BCC7",Tumor protein p53,191170,Choroid plexus papilloma,260500,AD,-,TP53
"TP53, P53, LFS1 , BCC7",Tumor protein p53,191170,Colorectal cancer,114500,AD,-,TP53
"TP53, P53, LFS1 , BCC7",Tumor protein p53,191170,Hepatocellular carcinoma,114550,SMu,-,TP53
"TP53, P53, LFS1 , BCC7",Tumor protein p53,191170,Li-Fraumeni syndrome,151623,AD,-,TP53
"TP53, P53, LFS1 , BCC7",Tumor protein p53,191170,Nasopharyngeal carcinoma,607107,-,-,TP53
"TP53, P53, LFS1 , BCC7",Tumor protein p53,191170,Osteosarcoma,259500,AR,-,TP53
"TP53, P53, LFS1 , BCC7",Tumor protein p53,191170,Pancreatic cancer,260350,"AD,Mu,SMu",-,TP53
"TP53, P53, LFS1 , BCC7",Tumor protein p53,191170,{Basal cell carcinoma 7},614740,-,-,TP53
"TP53, P53, LFS1 , BCC7",Tumor protein p53,191170,{Glioma susceptibility 1},137800,"AD,SMu",-,TP53
"WRAP53, TCAB1, WDR79, DKCB3",WD repeat-containing protein antisense to TP53,612661,"Dyskeratosis congenita, autosomal recessive 3",613988,AR,-,WRAP53
"GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1","Guanylate cyclase 2D, membrane, retina-specific",600179,?Central areolar choroidal dystrophy 1,215500,AR,mutation identified in 1 CACD1 family,GUCY2D
"GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1","Guanylate cyclase 2D, membrane, retina-specific",600179,Cone-rod dystrophy 6,601777,AD,-,GUCY2D
"GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1","Guanylate cyclase 2D, membrane, retina-specific",600179,Leber congenital amaurosis 1,204000,AR,-,GUCY2D
"ALOX12B, ARCI2","Archidonate 12-lipoxygenase, R type",603741,"Ichthyosis, congenital, autosomal recessive 2",242100,AR,-,ALOX12B
"ALOXE3, ARCI3",Arachidonate lipoxygenase 3,607206,"Ichthyosis, congenital, autosomal recessive 3",606545,AR,-,ALOXE3
"HES7, SCDO4","Hairy/enhancer of split, Drosophila, homolog of, 7",608059,"Spondylocostal dysostosis 4, autosomal recessive",613686,AR,-,HES7
"TMEM107, MKS13, JBTS29",Transmembrane protein 107,616183,?Joubert syndrome 29,617562,AR,mutation identified in 1 JBTS29,TMEM107
"TMEM107, MKS13, JBTS29",Transmembrane protein 107,616183,Meckel syndrome 13,617562,AR,-,TMEM107
"TMEM107, MKS13, JBTS29",Transmembrane protein 107,616183,Orofaciodigital syndrome XVI,617563,AR,-,TMEM107
"SNORD118, LCC","Small nucleolar RNA, C/D box, 118",616663,"Leukoencephalopathy, brain calcifications, and cysts",614561,AR,-,SNORD118
"CTC1, CRMCC, C17orf68, AAF132",Conserved telomere maintenance component 1,613129,Cerebroretinal microangiopathy with calcifications and cysts,612199,AR,-,CTC1
"RPL26, DBA11",Ribosomal protein L26,603704,?Diamond-Blackfan anemia 11,614900,AD,mutation identified in 1 family,RPL26
"PIK3R5, p101","Phosphatidylinositol 3-kinase, regulatory subunit 5",611317,Ataxia-oculomotor apraxia 3,615217,AR,-,PIK3R5
"MYH8, DA7","Myosin, heavy polypeptide-8, skeletal muscle, perinatal",160741,Carney complex variant,608837,-,-,MYH8
"MYH8, DA7","Myosin, heavy polypeptide-8, skeletal muscle, perinatal",160741,Trismus-pseudocamptodactyly syndrome,158300,AD,-,MYH8
"MYH2, MYPOP","Myosin, heavy polypeptide-2, skeletal muscle, adult",160740,Proximal myopathy and ophthalmoplegia,605637,"AD,AR",-,MYH2
"MYH3, DA2A, DA2B, DA8","Myosin, heavy polypeptide-3, skeletal muscle, embryonic",160720,"Arthrogryposis, distal, type 2A",193700,AD,-,MYH3
"MYH3, DA2A, DA2B, DA8","Myosin, heavy polypeptide-3, skeletal muscle, embryonic",160720,"Arthrogryposis, distal, type 2B",601680,AD,-,MYH3
"MYH3, DA2A, DA2B, DA8","Myosin, heavy polypeptide-3, skeletal muscle, embryonic",160720,"Arthrogryposis, distal, type 8",178110,AD,-,MYH3
"SCO1, SCOD1",SCO1 cytochrome c oxidase assembly protein,603644,Mitochondrial complex IV deficiency,220110,"Mi,AR",-,SCO1
YUHAL,Yuan-Harel-Lupski syndrome,616652,Yuan-Harel-Lupski syndrome,616652,AD,contiguous gene duplication syndrome,YUHAL
"ELAC2, HPC2, COXPD17","elaC, E. coli, homolog 2",605367,Combined oxidative phosphorylation deficiency 17,615440,AR,at ~365cR,ELAC2
"ELAC2, HPC2, COXPD17","elaC, E. coli, homolog 2",605367,"{Prostate cancer, hereditary, 2, susceptibility to}",614731,-,-,ELAC2
COX10,"Cytochrome c oxidase, subunit X",602125,Leigh syndrome due to mitochondrial COX4 deficiency,256000,"Mi,AR",-,COX10
COX10,"Cytochrome c oxidase, subunit X",602125,Mitochondrial complex IV deficiency,220110,"Mi,AR",-,COX10
"PMP22, CMT1A, CMT1E, DSS, CIDP",Peripheral myelin protein-22,601097,"?Neuropathy, inflammatory demyelinating",139393,?AD,mutation identified in 1 CIDP family,PMP22
"PMP22, CMT1A, CMT1E, DSS, CIDP",Peripheral myelin protein-22,601097,"Charcot-Marie-Tooth disease, type 1A",118220,AD,-,PMP22
"PMP22, CMT1A, CMT1E, DSS, CIDP",Peripheral myelin protein-22,601097,"Charcot-Marie-Tooth disease, type 1E",118300,AD,-,PMP22
"PMP22, CMT1A, CMT1E, DSS, CIDP",Peripheral myelin protein-22,601097,Dejerine-Sottas disease,145900,"AD,AR",-,PMP22
"PMP22, CMT1A, CMT1E, DSS, CIDP",Peripheral myelin protein-22,601097,"Neuropathy, recurrent, with pressure palsies",162500,AD,-,PMP22
"PMP22, CMT1A, CMT1E, DSS, CIDP",Peripheral myelin protein-22,601097,Roussy-Levy syndrome,180800,AD,-,PMP22
"TTC19, MC3DN2",Tetratricopeptide repeat domain 19,613814,"Mitochondrial complex III deficiency, nuclear type 2",615157,AR,-,TTC19
ADHD2,"Attention deficit-hyperactivity disorder, susceptibility to, 2",608904,{Attention deficit-hyperactivity disorder},143465,AD,-,ADHD2
PTLS,Potocki-Lupski syndrome,610883,Potocki-Lupski syndrome,610883,IC,contiguous gene syndrome,PTLS
"PIGL, CHIME","Phosphatidylinositol glycan, class L",605947,CHIME syndrome,280000,AR,-,PIGL
"TNFRSF13B, TACI, CVID2","Tumor necrosis factor receptor superfamily, member 13B",604907,"Immunodeficiency, common variable, 2",240500,"AD,AR",-,TNFRSF13B
"TNFRSF13B, TACI, CVID2","Tumor necrosis factor receptor superfamily, member 13B",604907,Immunoglobulin A deficiency 2,609529,-,-,TNFRSF13B
"FLCN, BHD",Folliculin,607273,Birt-Hogg-Dube syndrome,135150,AD,-,FLCN
"FLCN, BHD",Folliculin,607273,"Colorectal cancer, somatic",114500,-,-,FLCN
"FLCN, BHD",Folliculin,607273,"Pneumothorax, primary spontaneous",173600,AD,-,FLCN
"FLCN, BHD",Folliculin,607273,"Renal carcinoma, chromophobe, somatic",144700,-,-,FLCN
"RAI1, SMCR, SMS",Retinoic acid-induced gene 1,607642,Smith-Magenis syndrome,182290,"AD,IC",-,RAI1
"ATPAF2, ATP12, MC5DN1","ATP synthase, mitochondrial F1 complex, assembly factor 2",608918,"?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1",604273,AR,mutation identified in 1 MC5DN1 patient,ATPAF2
"MYO15A, DFNB3",Myosin XVA,602666,"Deafness, autosomal recessive 3",600316,AR,-,MYO15A
"B9D1, MKSR1, MKS9, JBTS27",B9 domain-containing protein 1,614144,?Meckel syndrome 9,614209,AR,mutation identified in 1 MKS9 patient,B9D1
"B9D1, MKSR1, MKS9, JBTS27",B9 domain-containing protein 1,614144,Joubert syndrome 27,617120,AR,-,B9D1
"ALDH3A2, ALDH10, SLS, FALDH","Aldehyde dehydrogenase 3 family, member A2 (fatty aldehyde dehydrogenase)",609523,Sjogren-Larsson syndrome,270200,AR,-,ALDH3A2
AKAP10,A-kinase anchor protein 10,604694,"{Cardiac conduction defect, susceptibility to}",115080,AD,-,AKAP10
"KCNJ18, KIR2.6, TTPP2","Potassium channel, inwardly rectifying, subfamily J, member 18",613236,"{Thyrotoxic periodic paralysis, susceptibility to, 2}",613239,IC,-,KCNJ18
HYT1,"Hypertension, essential, susceptibility to, 1",603918,"{Hypertension, essential, susceptibility to, 1}",145500,Mu,~18cM distal to ACE,HYT1
"CCL3L1, SCYA3L1, LD78","Chemokine, C-C motif, ligand 3-like 1",601395,"{HIV/AIDS, susceptibility to}",609423,-,varies in copy number 1-10,CCL3L1
"DEL17q11.2, C17DELq11.2","Chromosome 17q11.2 deletion syndrome, 1.4Mb (NF1 microdeletion syndrome)",613675,"Chromosome 17q11.2 deletion syndrome, 1.4Mb",613675,AD,-,DEL17q11.2
"NOS2A, NOS2","Nitric oxide synthase 2A, inducible, hepatocytes",163730,"{Hypertension, susceptibility to}",145500,Mu,?cluster of 3 NOS2 genes,NOS2A
"NOS2A, NOS2","Nitric oxide synthase 2A, inducible, hepatocytes",163730,"{Malaria, resistance to}",611162,-,-,NOS2A
"TMEM199, VMA12, VPH2, C17orf32, CDG2P",Transmembrane protein 199,616815,"Congenital disorder of glycosylation, type IIp",616829,AR,-,TMEM199
"SLC46A1, HCP1, PCFT","Solute carrier family 46 (folate transporter), member 1",611672,"Folate malabsorption, hereditary",229050,AR,-,SLC46A1
"FOXN1, WHN",Forkhead box N1 (winged helix nude),600838,"T-cell immunodeficiency, congenital alopecia, and nail dystrophy",601705,AR,-,FOXN1
"UNC119, HRG4, IMD13","Unc119, C. elegans, homolog of (human retinal gene 4)",604011,?Cone-rod dystrophy,-,-,mutation identified in 1 IMD13 family and CORD family,UNC119
"UNC119, HRG4, IMD13","Unc119, C. elegans, homolog of (human retinal gene 4)",604011,?Immunodeficiency 13,615518,AD,-,UNC119
"NEK8, JCK, NPHP9, RHPD2",Never in mitosis gene A-related kinase 8,609799,?Nephronophthisis 9,613824,-,mutations identified in 1 family with NPHP9,NEK8
"NEK8, JCK, NPHP9, RHPD2",Never in mitosis gene A-related kinase 8,609799,Renal-hepatic-pancreatic dysplasia 2,615415,AR,-,NEK8
"ERAL1, ERAL1A, ERAL1B, PRLTS6",ERA G-protein-like 1,607435,Perrault syndrome 6,617565,AR,-,ERAL1
"CRYBA1, CRYB1, CTRCT10","Crystallin, beta A1",123610,"Cataract 10, multiple types",600881,AD,centromeric to NF1,CRYBA1
"SLC6A4, HTT, OCD1","Solute carrier family 6 (neurotransmitter transporter, serotonin), member 4",182138,{Anxiety-related personality traits},607834,-,-,SLC6A4
"SLC6A4, HTT, OCD1","Solute carrier family 6 (neurotransmitter transporter, serotonin), member 4",182138,{Obsessive-compulsive disorder},164230,AD,-,SLC6A4
"RNF135, MMFD",Ring finger protein 135,611358,"Macrocephaly, macrosomia, facial dysmorphism syndrome",614192,-,-,RNF135
"NF1, VRNF, WSS, NFNS","Neurofibromin (neurofibromatosis, type I)",613113,"Leukemia, juvenile myelomonocytic",607785,"AD,SMu",-,NF1
"NF1, VRNF, WSS, NFNS","Neurofibromin (neurofibromatosis, type I)",613113,"Neurofibromatosis, familial spinal",162210,AD,-,NF1
"NF1, VRNF, WSS, NFNS","Neurofibromin (neurofibromatosis, type I)",613113,"Neurofibromatosis, type 1",162200,AD,-,NF1
"NF1, VRNF, WSS, NFNS","Neurofibromin (neurofibromatosis, type I)",613113,Neurofibromatosis-Noonan syndrome,601321,AD,-,NF1
"NF1, VRNF, WSS, NFNS","Neurofibromin (neurofibromatosis, type I)",613113,Watson syndrome,193520,AD,-,NF1
"TMEM98, NNO4",Transmembrane protein 98,615949,Nanophthalmos 4,615972,AD,-,TMEM98
"DEL17q12, C17DELq12",Chromosome 17q12 deletion syndrome,614527,Chromosome 17q12 deletion syndrome,614527,AD,-,DEL17q12
"DUP17q12, C17DUPq12",Chromosome 17q12 duplication syndrome,614526,Chromosome 17q12 duplication syndrome,614526,AD,-,DUP17q12
"CCL2, SCYA2, MCP1, MCAF","Small inducible cytokine A2 (monocyte chemotactic protein, homologous to mouse Sig-je)",158105,"{Coronary artery disease, modifier of}",-,-,-,CCL2
"CCL2, SCYA2, MCP1, MCAF","Small inducible cytokine A2 (monocyte chemotactic protein, homologous to mouse Sig-je)",158105,"{HIV-1, resistance to}",609423,-,-,CCL2
"CCL2, SCYA2, MCP1, MCAF","Small inducible cytokine A2 (monocyte chemotactic protein, homologous to mouse Sig-je)",158105,"{Mycobacterium tuberculosis, susceptibility to}",607948,-,-,CCL2
"CCL2, SCYA2, MCP1, MCAF","Small inducible cytokine A2 (monocyte chemotactic protein, homologous to mouse Sig-je)",158105,"{Spina bifida, susceptibility to}",182940,AD,-,CCL2
"CCL11, SCYA11","Chemokine, C-C motif, ligand 11",601156,"{Asthma, susceptibility to}",600807,AD,-,CCL11
"CCL11, SCYA11","Chemokine, C-C motif, ligand 11",601156,"{HIV1, resistance to}",609423,-,-,CCL11
"RAD51D, RAD51L3, BROVCA4","RAD51, S. cerevisiae, homolog of, D",602954,"{Breast-ovarian cancer, familial, susceptibility to, 4}",614291,-,-,RAD51D
"UNC45B, SMUNC45, CTRCT43","UNC45, C. elegans, homolog of, B",611220,?Cataract 43,616279,AD,mutation identified in 1 CTRCT43 family,UNC45B
"SLFN14, BDPLT20","Schlafen family, member 14",614958,"Bleeding disorder, platelet-type, 20",616913,AD,-,SLFN14
"PEX12, PBD3A",Peroxisome biogenesis factor 12,601758,Peroxisome biogenesis disorder 3A (Zellweger),614859,AR,-,PEX12
"PEX12, PBD3A",Peroxisome biogenesis factor 12,601758,Peroxisome biogenesis disorder 3B,266510,AR,-,PEX12
"TAF15, TAF2N, RBP56","TAF15 RNA polymerase II, TATA box-binding protein-associated factor, 68kD",601574,"Chondrosarcoma, extraskeletal myxoid",612237,-,fusion gene with CSMF,TAF15
"CCL3, SCYA3, MIP1A","Chemokine, C-C motif, ligand 3",182283,"{HIV infection, resistance to}",609423,-,"in 47kb, CCL18-CCL3-CCL4",CCL3
"ZNHIT3, TRIP3, PEHO",Zinc finger HIT domain-containing protein 3,604500,PEHO syndrome,260565,AR,-,ZNHIT3
"PIGW, HPMRS5","Phosphatidylinositol glycan, class W",610275,Glycosylphosphatidylinositol biosynthesis defect 11,616025,AR,-,PIGW
"HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11",HNF1 homeobox B (transcription factor 2),189907,"Diabetes mellitus, noninsulin-dependent",125853,AD,-,HNF1B
"HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11",HNF1 homeobox B (transcription factor 2),189907,Renal cysts and diabetes syndrome,137920,AD,-,HNF1B
"HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11",HNF1 homeobox B (transcription factor 2),189907,{Renal cell carcinoma},144700,-,-,HNF1B
"GPR179, GPR158L, GPR158L1, CSNB1E",G protein-coupled receptor 179,614515,"Night blindness, congenital stationary (complete), 1E, autosomal recessive",614565,AR,-,GPR179
"TCAP, LGMD2G, CMH25",Telethonin,604488,"Cardiomyopathy, hypertrophic, 25",607487,AD,-,TCAP
"TCAP, LGMD2G, CMH25",Telethonin,604488,"Muscular dystrophy, limb-girdle, type 2G",601954,AR,-,TCAP
"PGAP3, PERLD1, CAB2, MGC9753, HPMRS4",Post-GPI attachment to proteins 3,611801,Hyperphosphatasia with mental retardation syndrome 4,615716,AR,-,PGAP3
"ERBB2, NGL, NEU, HER2",Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog),164870,"Adenocarcinoma of lung, somatic",211980,-,-,ERBB2
"ERBB2, NGL, NEU, HER2",Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog),164870,"Gastric cancer, somatic",613659,-,-,ERBB2
"ERBB2, NGL, NEU, HER2",Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog),164870,"Glioblastoma, somatic",137800,-,-,ERBB2
"ERBB2, NGL, NEU, HER2",Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog),164870,"Ovarian cancer, somatic",-,-,-,ERBB2
"THRA, ERBA1, THRA1, CHNG6","Thyroid hormone receptor, alpha (oncogene ERBA1)",190120,"Hypothyroidism, congenital, nongoitrous, 6",614450,AD,-,THRA
"CDC6, CDC18L, MGORS5","Cell division cycle 6, S. cerevisiae, homolog of",602627,?Meier-Gorlin syndrome 5,613805,AR,mutation identified in 1 MGORS5 patient,CDC6
RARA,"Retinoic acid receptor, alpha polypeptide",180240,"Leukemia, acute promyelocytic",612376,-,fused with MYL in APL,RARA
"SMARCE1, BAF57, CSS5","SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily E, member 1",603111,Coffin-Siris syndrome 5,616938,AD,-,SMARCE1
"SMARCE1, BAF57, CSS5","SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily E, member 1",603111,"{Meningioma, familial, susceptibility to}",607174,AD,-,SMARCE1
"KRT25, K25, KRT24IRS1, ARWH3","Keratin 25, type I",616646,"Woolly hair, autosomal recessive 3",616760,AR,-,KRT25
"KRT10, EHK, BCIE, BIE",Keratin 10,148080,Epidermolytic hyperkeratosis,113800,"AD,AR",in cluster of class I keratins,KRT10
"KRT10, EHK, BCIE, BIE",Keratin 10,148080,Ichthyosis with confetti,609165,AD,-,KRT10
"KRT10, EHK, BCIE, BIE",Keratin 10,148080,"Ichthyosis, cyclic, with epidermolytic hyperkeratosis",607602,AD,-,KRT10
KRT12,Keratin 12,601687,Meesmann corneal dystrophy,122100,AD,-,KRT12
"KRT13, WSN2",Keratin 13,148065,White sponge nevus 2,615785,AD,"in same PFGE fragment as KRT10, KRT15",KRT13
"KRT9, EPPK",Keratin 9,607606,"Palmoplantar keratoderma, epidermolytic",144200,AD,-,KRT9
KRT14,Keratin 14,148066,Dermatopathia pigmentosa reticularis,125595,AD,-,KRT14
KRT14,Keratin 14,148066,"Epidermolysis bullosa simplex, Dowling-Meara type",131760,AD,-,KRT14
KRT14,Keratin 14,148066,"Epidermolysis bullosa simplex, Koebner type",131900,AD,-,KRT14
KRT14,Keratin 14,148066,"Epidermolysis bullosa simplex, recessive 1",601001,AR,-,KRT14
KRT14,Keratin 14,148066,"Epidermolysis bullosa simplex, Weber-Cockayne type",131800,AD,-,KRT14
KRT14,Keratin 14,148066,Naegeli-Franceschetti-Jadassohn syndrome,161000,AD,-,KRT14
"KRT16, FNEPPK, PC1",Keratin 16,148067,Pachyonychia congenita 1,167200,AD,probably 17q21-q22,KRT16
"KRT16, FNEPPK, PC1",Keratin 16,148067,"Palmoplantar keratoderma, nonepidermolytic, focal",613000,AD,-,KRT16
"KRT17, PC2, PCHC1",Keratin 17,148069,Pachyonychia congenita 2,167210,AD,~5' to KRT16; probably 17q21-q22,KRT17
"KRT17, PC2, PCHC1",Keratin 17,148069,Steatocystoma multiplex,184500,AD,-,KRT17
"JUP, DP3, PDGB, ARVD12",Junction plakoglobin,173325,Arrhythmogenic right ventricular dysplasia 12,611528,AD,incorrectly mapped to 7; close to BRCA1,JUP
"JUP, DP3, PDGB, ARVD12",Junction plakoglobin,173325,Naxos disease,601214,AR,-,JUP
"FKBP10, FKBP65, OI11, BRKS1",FK506-binding protein 10,607063,Bruck syndrome 1,259450,AR,-,FKBP10
"FKBP10, FKBP65, OI11, BRKS1",FK506-binding protein 10,607063,"Osteogenesis imperfecta, type XI",610968,AR,-,FKBP10
"KLHL10, SPGF11",Kelch-like 10,608778,Spermatogenic failure 11,615081,AD,-,KLHL10
"TTC25, CILD35",Tetratricopeptide repeat domain-containing protein 25,617095,"Ciliary dyskinesia, primary, 35",617092,AR,-,TTC25
"HCRT, OX, NRCLP1",Hypocretin,602358,?Narcolepsy 1,161400,AD,mutation identified in 1 NRCLP1 patient,HCRT
STAT5B,Signal transducer and activator of transcription 5B,604260,Growth hormone insensitivity with immunodeficiency,245590,-,fused with RARA in PML,STAT5B
STAT5B,Signal transducer and activator of transcription 5B,604260,"Leukemia, acute promyelocytic, somatic",102578,-,-,STAT5B
"STAT3, APRF, HIES, ADMIO1",Signal transducer and activator of transcription-3 (acute-phase response factor),102582,"Autoimmune disease, multisystem, infantile-onset, 1",615952,AD,-,STAT3
"STAT3, APRF, HIES, ADMIO1",Signal transducer and activator of transcription-3 (acute-phase response factor),102582,Hyper-IgE recurrent infection syndrome,147060,AD,-,STAT3
"CAVIN1, PTRF",Caveolae-associated protein 1,603198,"Lipodystrophy, congenital generalized, type 4",613327,AR,-,CAVIN1
"NAGLU, MPS3B, CMT2V","N-acetylglucosaminidase, alpha-",609701,"?Charcot-Marie-Tooth disease, axonal, type 2V",616491,AD,mutation identified in 1 CMT2V family,NAGLU
"NAGLU, MPS3B, CMT2V","N-acetylglucosaminidase, alpha-",609701,Mucopolysaccharidosis type IIIB (Sanfilippo B),252920,AR,-,NAGLU
"COASY, NBIA6",Coenzyme A synthase,609855,Neurodegeneration with brain iron accumulation 6,615643,AR,-,COASY
"PSMC3IP, TBPIP, GT198, HOP2, ODG3",PSMC3-interacting protein,608665,Ovarian dysgenesis 3,614324,AR,-,PSMC3IP
"TUBG1, CDCBM4","Tubulin, gamma 1",191135,"Cortical dysplasia, complex, with other brain malformations 4",615412,AD,-,TUBG1
"CNTNAP1, CASPR, P190",Contactin-associated protein 1,602346,Lethal congenital contracture syndrome 7,616286,AR,-,CNTNAP1
"WNK4, PRKWNK4, PHA2B",WNK lysine deficient protein kinase 4,601844,"Pseudohypoaldosteronism, type IIB",614491,AD,-,WNK4
"DUP17q21.31, C17DUPq21.31",Chromosome 17q21.31 duplication syndrome,613533,Chromosome 17q21.31 duplication syndrome,613533,-,contiguous gene duplication syndrome,DUP17q21.31
"G6PC, G6PT","Glucose-6-phosphatase, catalytic",613742,Glycogen storage disease Ia,232200,AR,-,G6PC
"RPL27, DBA16",Ribosomal protein L27,607526,?Diamond-Blackfan anemia 16,617408,AD,mutation identified in 1 DBA16 patient,RPL27
"BRCA1, PSCP, BROVCA1, PNCA4, FANCS",Breast cancer-1 gene,113705,"Fanconi anemia, complementation group S",617883,AR,-,BRCA1
"BRCA1, PSCP, BROVCA1, PNCA4, FANCS",Breast cancer-1 gene,113705,"{Breast-ovarian cancer, familial, 1}",604370,"AD,Mu",-,BRCA1
"BRCA1, PSCP, BROVCA1, PNCA4, FANCS",Breast cancer-1 gene,113705,"{Pancreatic cancer, susceptibility to, 4}",614320,-,-,BRCA1
"MEOX1, MOX1, KFS2","Mesenchyme homeo box 1 (Mox1, mouse, homolog of)",600147,Klippel-Feil syndrome 2,214300,AR,-,MEOX1
"SOST, VBCH, CDD, SOST1",Sclerostin,605740,"Craniodiaphyseal dysplasia, autosomal dominant",122860,AD,-,SOST
"SOST, VBCH, CDD, SOST1",Sclerostin,605740,Sclerosteosis 1,269500,AR,-,SOST
"SOST, VBCH, CDD, SOST1",Sclerostin,605740,Van Buchem disease,239100,AR,-,SOST
NAGS,N-acetylglutamate synthase,608300,N-acetylglutamate synthase deficiency,237310,AR,-,NAGS
"G6PC3, UGRP, SCN4","Glucose-6-phosphatase, catalytic, 3",611045,Dursun syndrome,612541,AR,-,G6PC3
"G6PC3, UGRP, SCN4","Glucose-6-phosphatase, catalytic, 3",611045,"Neutropenia, severe congenital 4, autosomal recessive",612541,AR,-,G6PC3
"UBTF, UBF, CONDBA","Upstream binding transcription factor, RNA polymerase I",600673,"Neurodegeneration, childhood-onset, with brain atrophy",617672,AD,-,UBTF
"SLC4A1, AE1, EPB3, SPH4, SAO, CHC","Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)",109270,Cryohydrocytosis,185020,AD,-,SLC4A1
"SLC4A1, AE1, EPB3, SPH4, SAO, CHC","Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)",109270,"Ovalocytosis, SA type",166900,AD,-,SLC4A1
"SLC4A1, AE1, EPB3, SPH4, SAO, CHC","Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)",109270,"Renal tubular acidosis, distal, AD",179800,AD,-,SLC4A1
"SLC4A1, AE1, EPB3, SPH4, SAO, CHC","Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)",109270,"Renal tubular acidosis, distal, AR",611590,AR,-,SLC4A1
"SLC4A1, AE1, EPB3, SPH4, SAO, CHC","Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)",109270,"Spherocytosis, type 4",612653,AD,-,SLC4A1
"SLC4A1, AE1, EPB3, SPH4, SAO, CHC","Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)",109270,"[Blood group, Diego]",110500,-,-,SLC4A1
"SLC4A1, AE1, EPB3, SPH4, SAO, CHC","Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)",109270,"[Blood group, Froese]",601551,-,-,SLC4A1
"SLC4A1, AE1, EPB3, SPH4, SAO, CHC","Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)",109270,"[Blood group, Swann]",601550,-,-,SLC4A1
"SLC4A1, AE1, EPB3, SPH4, SAO, CHC","Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)",109270,"[Blood group, Waldner]",112010,-,-,SLC4A1
"SLC4A1, AE1, EPB3, SPH4, SAO, CHC","Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)",109270,"[Blood group, Wright]",112050,-,-,SLC4A1
"SLC4A1, AE1, EPB3, SPH4, SAO, CHC","Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)",109270,"[Malaria, resistance to]",611162,-,-,SLC4A1
"GRN, CLN11",Granulin,138945,"Aphasia, primary progressive",607485,AD,-,GRN
"GRN, CLN11",Granulin,138945,"Ceroid lipofuscinosis, neuronal, 11",614706,AR,-,GRN
"GRN, CLN11",Granulin,138945,Frontotemporal lobar degeneration with ubiquitin-positive inclusions,607485,AD,-,GRN
"ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16","Integrin, alpha-2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B)",607759,"Bleeding disorder, platelet-type, 16, autosomal dominant",187800,AD,3' to GP3A; BAK platelet antigen,ITGA2B
"ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16","Integrin, alpha-2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B)",607759,Glanzmann thrombasthenia,273800,AR,-,ITGA2B
"ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16","Integrin, alpha-2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B)",607759,"Thrombocytopenia, neonatal alloimmune, BAK antigen related",-,-,-,ITGA2B
"EFTUD2, KIAA0031, MFDGA",Elongation factor Tu GTP-binding domain-containing 2,603892,"Mandibulofacial dysostosis, Guion-Almeida type",610536,AD,-,EFTUD2
"CCDC103, SMH, PR46B, CILD17",Coiled-coil domain-containing protein 103,614677,"Ciliary dyskinesia, primary, 17",614679,AR,-,CCDC103
"GFAP, ALXDRD",Glial fibrillary acidic protein,137780,Alexander disease,203450,AD,-,GFAP
"PLEKHM1, AP162, KIAA0356, OPTB6","Pleckstrin homology domain-containing protein, family M, member 1",611466,"Osteopetrosis, autosomal recessive 6",611497,-,-,PLEKHM1
"MAPT, MTBT1, DDPAC, MSTD",Microtubule-associated protein tau,157140,"Dementia, frontotemporal, with or without parkinsonism",600274,AD,see 6p21,MAPT
"MAPT, MTBT1, DDPAC, MSTD",Microtubule-associated protein tau,157140,Pick disease,172700,"AD,IC",-,MAPT
"MAPT, MTBT1, DDPAC, MSTD",Microtubule-associated protein tau,157140,"Supranuclear palsy, progressive",601104,AD,-,MAPT
"MAPT, MTBT1, DDPAC, MSTD",Microtubule-associated protein tau,157140,"Supranuclear palsy, progressive atypical",260540,AR,-,MAPT
"MAPT, MTBT1, DDPAC, MSTD",Microtubule-associated protein tau,157140,"{Parkinson disease, susceptibility to}",168600,"IC,Mu",-,MAPT
"KANSL1, KIAA1267, MSL1V1, KDVS",KAT8 regulatory NSL complex subunit 1,612452,Koolen-De Vries syndrome,610443,AD,-,KANSL1
"WNT3, INT4, TETAMS","Wingless-type MMTV integration site family, member 3",165330,?Tetra-amelia syndrome,273395,AR,mutation identified in 1 TETAMS family,WNT3
"GOSR2, GS27, EPM6",Golgi snap receptor complex member 2,604027,"Epilepsy, progressive myoclonic 6",614018,AR,-,GOSR2
MYL4,"Myosin, light polypeptide-4, alkali, atrial, embryonic",160770,"?Atrial fibrillation, familial, 18",617280,AD,mutation identified in 1 ATFB18 family,MYL4
"ITGB3, GP3A, GT, BDPLT2, BDPLT16","Integrin, beta-3 (platelet glycoprotein IIIa; antigen CD61)",173470,"Bleeding disorder, platelet-type, 16, autosomal dominant",187800,AD,in same 260kb fragment as GP2B; PL(A) platelet antigen,ITGB3
"ITGB3, GP3A, GT, BDPLT2, BDPLT16","Integrin, beta-3 (platelet glycoprotein IIIa; antigen CD61)",173470,Glanzmann thrombasthenia,273800,AR,-,ITGB3
"ITGB3, GP3A, GT, BDPLT2, BDPLT16","Integrin, beta-3 (platelet glycoprotein IIIa; antigen CD61)",173470,"Purpura, posttransfusion",-,-,-,ITGB3
"ITGB3, GP3A, GT, BDPLT2, BDPLT16","Integrin, beta-3 (platelet glycoprotein IIIa; antigen CD61)",173470,"Thrombocytopenia, neonatal alloimmune",-,-,-,ITGB3
"ITGB3, GP3A, GT, BDPLT2, BDPLT16","Integrin, beta-3 (platelet glycoprotein IIIa; antigen CD61)",173470,"{Myocardial infarction, susceptibility to}",608446,-,-,ITGB3
"TBX21, TBET",T-box 21,604895,Asthma and nasal polyps,208550,AR,-,TBX21
"TBX21, TBET",T-box 21,604895,"{Asthma, aspirin-induced, susceptibility to}",208550,AR,-,TBX21
PNPO,Pyridoxamine 5'-phosphate oxidase,603287,Pyridoxamine 5'-phosphate oxidase deficiency,610090,AR,-,PNPO
"HOXB1, HOX2I, HCFP3",Homeo box-B1,142968,"Facial paresis, hereditary congenital, 3",614744,AR,-,HOXB1
PHB,Prohibitin,176705,"{Breast cancer, susceptibility to}",114480,AD,-,PHB
"DLX4, DLX7, DLX8, OFC15",Distal-less homeo box-4,601911,?Orofacial cleft 15,616788,AD,mutation identified in 1 OFC15 family,DLX4
"DLX3, TDO, AI4",Distal-less homeo box-3,600525,"Amelogenesis imperfecta, type IV",104510,AD,-,DLX3
"DLX3, TDO, AI4",Distal-less homeo box-3,600525,Trichodontoosseous syndrome,190320,AD,-,DLX3
"ITGA3, CD49C, GAPB3, ILNEB","Integrin, alpha-3",605025,"Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital",614748,AR,-,ITGA3
"SGCA, ADL, DAG2, LGMD2D, DMDA2","Sarcoglycan, alpha (50kD dystrophin-associated glycoprotein; adhalin)",600119,"Muscular dystrophy, limb-girdle, type 2D",608099,AR,-,SGCA
"COL1A1, OI1, OI2, OI3, OI4, EDSARTH1","Collagen I, alpha-1 polypeptide",120150,Caffey disease,114000,AD,fused with PDGFB in DFPB,COL1A1
"COL1A1, OI1, OI2, OI3, OI4, EDSARTH1","Collagen I, alpha-1 polypeptide",120150,"Ehlers-Danlos syndrome, arthrochalasia type, 1",130060,AD,-,COL1A1
"COL1A1, OI1, OI2, OI3, OI4, EDSARTH1","Collagen I, alpha-1 polypeptide",120150,"Osteogenesis imperfecta, type I",166200,AD,-,COL1A1
"COL1A1, OI1, OI2, OI3, OI4, EDSARTH1","Collagen I, alpha-1 polypeptide",120150,"Osteogenesis imperfecta, type II",166210,AD,-,COL1A1
"COL1A1, OI1, OI2, OI3, OI4, EDSARTH1","Collagen I, alpha-1 polypeptide",120150,"Osteogenesis imperfecta, type III",259420,AD,-,COL1A1
"COL1A1, OI1, OI2, OI3, OI4, EDSARTH1","Collagen I, alpha-1 polypeptide",120150,"Osteogenesis imperfecta, type IV",166220,AD,-,COL1A1
"COL1A1, OI1, OI2, OI3, OI4, EDSARTH1","Collagen I, alpha-1 polypeptide",120150,"{Bone mineral density variation QTL, osteoporosis}",166710,AD,-,COL1A1
"XYLT2, XT2, SOS",Xylosyltransferase 2,608125,Spondyloocular syndrome,605822,AR,-,XYLT2
"XYLT2, XT2, SOS",Xylosyltransferase 2,608125,"{Pseudoxanthoma elasticum, modifier of severity of}",264800,AR,-,XYLT2
"CACNA1G, SCA42","Calcium channel, voltage-dependent, T type, alpha-1G subunit",604065,Spinocerebellar ataxia 42,616795,AD,-,CACNA1G
"NME1, NM23","Non-metastatic cells 1, protein (NM23A) expressed in",156490,Neuroblastoma,256700,"AD,IC",-,NME1
"NOG, SYM1, SYNS1A","Noggin, mouse, homolog of",602991,"Brachydactyly, type B2",611377,AD,-,NOG
"NOG, SYM1, SYNS1A","Noggin, mouse, homolog of",602991,Multiple synostoses syndrome 1,186500,AD,-,NOG
"NOG, SYM1, SYNS1A","Noggin, mouse, homolog of",602991,Stapes ankylosis with broad thumbs and toes,184460,AD,-,NOG
"NOG, SYM1, SYNS1A","Noggin, mouse, homolog of",602991,"Symphalangism, proximal, 1A",185800,AD,-,NOG
"NOG, SYM1, SYNS1A","Noggin, mouse, homolog of",602991,Tarsal-carpal coalition syndrome,186570,AD,-,NOG
"DGKE, NPHS7, AHUS7","Diacylglycerol kinase, epsilon, 64-kD",601440,"Nephrotic syndrome, type 7",615008,AR,-,DGKE
"DGKE, NPHS7, AHUS7","Diacylglycerol kinase, epsilon, 64-kD",601440,"{Hemolytic uremic syndrome, atypical, susceptibility to, 7}",615008,AR,-,DGKE
"EPX, EPXD",Eosinophil peroxidase,131399,[Eosinophil peroxidase deficiency],261500,AR,-,EPX
"MKS1, MKS, BBS13, JBTS28",MKS1 gene,609883,Bardet-Biedl syndrome 13,615990,AR,frequent in Finland,MKS1
"MKS1, MKS, BBS13, JBTS28",MKS1 gene,609883,Joubert syndrome 28,617121,AR,-,MKS1
"MKS1, MKS, BBS13, JBTS28",MKS1 gene,609883,Meckel syndrome 1,249000,AR,-,MKS1
MPO,Myeloperoxidase,606989,Myeloperoxidase deficiency,254600,AR,translocated in t(15;17)(q22;q11.2),MPO
MPO,Myeloperoxidase,606989,"{Alzheimer disease, susceptibility to}",104300,AD,-,MPO
MPO,Myeloperoxidase,606989,"{Lung cancer, protection against, in smokers}",-,-,-,MPO
"RNF43, RNF124, SSPCS",Ring finger protein 43,612482,Sessile serrated polyposis cancer syndrome,617108,AD,-,RNF43
"TEX14, SPGF23",Testis-expressed gene 14,605792,?Spermatogenic failure 23,617707,AR,mutation identified in 1 SPGF23 family,TEX14
"RAD51C, FANCO, BROVCA3","RAD51, S. cerevisiae, homolog of, C",602774,"Fanconi anemia, complementation group O",613390,AR,-,RAD51C
"RAD51C, FANCO, BROVCA3","RAD51, S. cerevisiae, homolog of, C",602774,"{Breast-ovarian cancer, familial, susceptibility to, 3}",613399,-,-,RAD51C
"TRIM37, MUL, KIAA0898",Tripartite motif-containing 37,605073,Mulibrey nanism,253250,AR,-,TRIM37
"DEL17q23.1q23.2, C17DELq23.1q23.2",Chromosome 17q23.1-q23.2 deletion syndrome,613355,Chromosome 17q23.1-q23.2 deletion syndrome,613355,IC,-,DEL17q23.1q23.2
"DUP17q23.1q23.2, C17DUPq23.1q23.2",Chromosome 17q23.1-q23.2 duplication syndrome,613618,Chromosome 17q23.1-q23.2 duplication syndrome,613618,AD,2.2 Mb contiguous gene duplication syndrome,DUP17q23.1q23.2
"CLTC, MRD56","Clathrin, heavy polypeptide (Hc)",118955,"Mental retardation, autosomal dominant 56",617854,-,fusion gene with TFE3 in renal adenocarcinoma,CLTC
"PTRH2, BIT1, IMNEPD",Peptidyl-tRNA hydrolase 2,608625,"Infantile-onset multisystem neurologic, endocrine, and pancreatic disease",616263,AR,-,PTRH2
"CA4, RP17",Carbonic anhydrase IV,114760,Retinitis pigmentosa 17,600852,AD,-,CA4
"PPM1D, WIP1, IDDGIP","Protein phosphatase, magnesium-dependent, 1, delta isoform",605100,"Breast cancer, somatic",114480,-,amplified in breast cancer,PPM1D
"PPM1D, WIP1, IDDGIP","Protein phosphatase, magnesium-dependent, 1, delta isoform",605100,Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold,617450,AD,-,PPM1D
"TBX4, ICPPS",T-box 4,601719,Ischiocoxopodopatellar syndrome,147891,AD,-,TBX4
"BRIP1, BACH1, FANCJ",BRCA1-associated C-terminal helicase 1,605882,"Breast cancer, early-onset",114480,AD,?or 17q23,BRIP1
"BRIP1, BACH1, FANCJ",BRCA1-associated C-terminal helicase 1,605882,"Fanconi anemia, complementation group J",609054,-,-,BRIP1
"ACE, DCP1, ACE1, MVCD3, ICH",Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1),106180,Renal tubular dysgenesis,267430,AR,-,ACE
"ACE, DCP1, ACE1, MVCD3, ICH",Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1),106180,"[Angiotensin I-converting enzyme, benign serum increase]",-,-,-,ACE
"ACE, DCP1, ACE1, MVCD3, ICH",Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1),106180,{Microvascular complications of diabetes 3},612624,-,-,ACE
"ACE, DCP1, ACE1, MVCD3, ICH",Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1),106180,"{Myocardial infarction, susceptibility to}",-,-,-,ACE
"ACE, DCP1, ACE1, MVCD3, ICH",Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1),106180,"{SARS, progression of}",-,-,-,ACE
"ACE, DCP1, ACE1, MVCD3, ICH",Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1),106180,"{Stroke, hemorrhagic}",614519,-,-,ACE
"TACO1, CCDC44",Translational activator of mitochondrially encoded cytochrome c oxidase subunit I,612958,Mitochondrial complex IV deficiency,220110,"Mi,AR",-,TACO1
"STRADA, STRAD, LYK5",STE20-related kinase adaptor alpha,608626,"Polyhydramnios, megalencephaly, and symptomatic epilepsy",611087,AR,-,STRADA
"SMARCD2, BAF60B, SGD2","SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily d, member 2",601736,Specific granule deficiency 2,617475,AR,-,SMARCD2
"GH1, GHN, IGHD1B",Growth hormone-1,139250,"Growth hormone deficiency, isolated, type IA",262400,AR,5'-GH1-CSHP1-CSH1-GH2-CSH2-3',GH1
"GH1, GHN, IGHD1B",Growth hormone-1,139250,"Growth hormone deficiency, isolated, type IB",612781,-,-,GH1
"GH1, GHN, IGHD1B",Growth hormone-1,139250,"Growth hormone deficiency, isolated, type II",173100,AD,-,GH1
"GH1, GHN, IGHD1B",Growth hormone-1,139250,Kowarski syndrome,262650,AR,-,GH1
"CD79B, IGB, B29, AGM6",CD79B antigen,147245,Agammaglobulinemia 6,612692,AR,-,CD79B
"SCN4A, HYPP, NAC1A, HOKPP2, CMS16","Sodium channel, voltage-gated, type IV, alpha polypeptide",603967,"Hyperkalemic periodic paralysis, type 2",170500,AD,21.5kb from GH1,SCN4A
"SCN4A, HYPP, NAC1A, HOKPP2, CMS16","Sodium channel, voltage-gated, type IV, alpha polypeptide",603967,"Hypokalemic periodic paralysis, type 2",613345,AD,-,SCN4A
"SCN4A, HYPP, NAC1A, HOKPP2, CMS16","Sodium channel, voltage-gated, type IV, alpha polypeptide",603967,"Myasthenic syndrome, congenital, 16",614198,AR,-,SCN4A
"SCN4A, HYPP, NAC1A, HOKPP2, CMS16","Sodium channel, voltage-gated, type IV, alpha polypeptide",603967,"Myotonia congenita, atypical, acetazolamide-responsive",608390,AD,-,SCN4A
"SCN4A, HYPP, NAC1A, HOKPP2, CMS16","Sodium channel, voltage-gated, type IV, alpha polypeptide",603967,Paramyotonia congenita,168300,AD,-,SCN4A
"POLG2, POLGB, PEOA4","Polymerase, DNA, gamma-2",604983,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4",610131,AD,-,POLG2
SRXY10,"46,XY sex reversal 10",616425,46XY sex reversal 10,616425,AD,deletion of 32.5kb XYSR regulatory region upstream of SOX9,SRXY10
"RGS9, PERRS",Regulator of G protein signaling 9,604067,Bradyopsia,608415,-,-,RGS9
"AXIN2, ODCRCS","Axis inhibitor 2 (conductin, mouse, homolog of)",604025,"Colorectal cancer, somatic",114500,-,-,AXIN2
"AXIN2, ODCRCS","Axis inhibitor 2 (conductin, mouse, homolog of)",604025,Oligodontia-colorectal cancer syndrome,608615,AD,-,AXIN2
"HTGH, DEL17q24","Hypertrichosis terminalis, generalized, with or without gingival hyperplasia (chromosome 17q24 microdeletion syndrome)",135400,"Hypertrichosis terminalis, generalized, with or without gingival hyperplasia",135400,AR,-,HTGH
"PSMD12, P55, STISS","Proteasome 26S subunit, non-ATPase, 12",604450,Stankiewicz-Isidor syndrome,617516,AD,-,PSMD12
"BPTF, FALZ, FAC1, NURF301, NEDDFL",Bromodomain PHD finger transcription factor,601819,Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies,617755,AD,-,BPTF
"PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1","Protein kinase, cAMP-dependent, regulatory, type I, alpha",188830,"Acrodysostosis 1, with or without hormone resistance",101800,AD,fused with RET to form PTC2,PRKAR1A
"PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1","Protein kinase, cAMP-dependent, regulatory, type I, alpha",188830,"Adrenocortical tumor, somatic",-,-,-,PRKAR1A
"PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1","Protein kinase, cAMP-dependent, regulatory, type I, alpha",188830,"Carney complex, type 1",160980,AD,-,PRKAR1A
"PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1","Protein kinase, cAMP-dependent, regulatory, type I, alpha",188830,"Myxoma, intracardiac",255960,AD,-,PRKAR1A
"PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1","Protein kinase, cAMP-dependent, regulatory, type I, alpha",188830,"Pigmented nodular adrenocortical disease, primary, 1",610489,AD,-,PRKAR1A
"FAM20A, AIGFS, AI1G","Family with sequence similarity 20, member A",611062,"Amelogenesis imperfecta, type IG (enamel-renal syndrome)",204690,AR,-,FAM20A
"SRXX2, DUP17q24.3",46XX sex reversal 2,278850,46XX sex reversal 2,278850,AD,duplication or triplication of 68kb XXSR regulatory region upstream of SOX9,SRXX2
"KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9","Potassium channel, inwardly rectifying, subfamily J, member 2",600681,Andersen syndrome,170390,AD,-,KCNJ2
"KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9","Potassium channel, inwardly rectifying, subfamily J, member 2",600681,"Atrial fibrillation, familial, 9",613980,AD,-,KCNJ2
"KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9","Potassium channel, inwardly rectifying, subfamily J, member 2",600681,Short QT syndrome 3,609622,-,-,KCNJ2
"SOX9, CMD1, SRA1",SRY (sex-determining region Y)-box 9,608160,Acampomelic campomelic dysplasia,114290,AD,-,SOX9
"SOX9, CMD1, SRA1",SRY (sex-determining region Y)-box 9,608160,Campomelic dysplasia,114290,AD,-,SOX9
"SOX9, CMD1, SRA1",SRY (sex-determining region Y)-box 9,608160,Campomelic dysplasia with autosomal sex reversal,114290,AD,-,SOX9
DSPS,"Delayed sleep phase syndrome, susceptibility to",614163,"{Delayed sleep phase syndrome, susceptibility to}",614163,AD,associated with rs28936679 in AANAT,DSPS
"COG1, LDLB, KIAA1381, CDG2G",Component of oligomeric golgi complex 1,606973,"Congenital disorder of glycosylation, type IIg",611209,-,-,COG1
"DNAI2, CILD9","Dynein, axonemal, intermediate chain 2",605483,"Ciliary dyskinesia, primary, 9, with or without situs inversus",612444,-,-,DNAI2
"SLC9A3R1, EBP50, NHERF1, NPHLOP2","Solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulatory factor 1",604990,"Nephrolithiasis/osteoporosis, hypophosphatemic, 2",612287,AD,-,SLC9A3R1
"FDXR, ADXR, ANOA",Ferredoxin reductase (adrenodoxin reductase),103270,Auditory neuropathy and optic atrophy,617717,AR,-,FDXR
"SANS, USH1G",Scaffold protein containing ankyrin repeats and SAM domain,607696,"Usher syndrome, type 1G",606943,AR,?allelic to DFNA20,SANS
"MRPS7, COXPD34",Mitochondrial ribosomal protein S7,611974,?Combined oxidative phosphorylation deficiency 34,617872,AR,mutation identified in 1 COXPD34 family,MRPS7
"SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4","Solute carrier family 25 (mitochondrial deoxynucleotide carrier), member 19",606521,"Microcephaly, Amish type",607196,AR,-,SLC25A19
"SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4","Solute carrier family 25 (mitochondrial deoxynucleotide carrier), member 19",606521,Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type),613710,AR,-,SLC25A19
"TSEN54, SEN54, PCH2A, PCH4, PCH5","tRNA splicing endonuclease 54, S. cerevisiae, homolog of",608755,?Pontocerebellar hypoplasia type 5,610204,AR,mutation identified in 1 PCH5 patient,TSEN54
"TSEN54, SEN54, PCH2A, PCH4, PCH5","tRNA splicing endonuclease 54, S. cerevisiae, homolog of",608755,Pontocerebellar hypoplasia type 2A,277470,AR,-,TSEN54
"TSEN54, SEN54, PCH2A, PCH4, PCH5","tRNA splicing endonuclease 54, S. cerevisiae, homolog of",608755,Pontocerebellar hypoplasia type 4,225753,AR,-,TSEN54
ITGB4,"Integrin, beta-4",147557,Epidermolysis bullosa of hands and feet,131800,AD,-,ITGB4
ITGB4,"Integrin, beta-4",147557,"Epidermolysis bullosa, junctional, non-Herlitz type",226650,AR,-,ITGB4
ITGB4,"Integrin, beta-4",147557,"Epidermolysis bullosa, junctional, with pyloric atresia",226730,AR,-,ITGB4
GALK1,Galactokinase-1,604313,Galactokinase deficiency with cataracts,230200,AR,-,GALK1
"UNC13D, MUNC13-4, HPLH3, HLH3, FHL3","UNC13, C. elegans, homolog of, D",608897,"Hemophagocytic lymphohistiocytosis, familial, 3",608898,-,-,UNC13D
"WBP2, DFNB107",WW domain-binding protein 2,606962,"Deafness, autosomal recessive 107",617639,AR,-,WBP2
"ACOX1, ACOX, SCOX","Acyl-Coenzyme A oxidase 1, palmitoyl",609751,Peroxisomal acyl-CoA oxidase deficiency,264470,AR,-,ACOX1
"RHBDF2, IRHOM2, TOC","Rhomboid 5, Drosophila, homolog of, 2",614404,Tylosis with esophageal cancer,148500,AD,-,RHBDF2
"PRCD, RP36","PRCD, Dog, homolog of",610598,Retinitis pigmentosa 36,610599,-,-,PRCD
"METTL23, C17orf95, MRT44",Methyltransferase-like 23,615262,"Mental retardation, autosomal recessive 44",615942,AR,-,METTL23
"SEPT9, MSF, MSF1, NAPB",Septin 9,604061,"Amyotrophy, hereditary neuralgic",162100,AD,-,SEPT9
"SEPT9, MSF, MSF1, NAPB",Septin 9,604061,"Leukemia, acute myeloid, therapy-related",-,-,-,SEPT9
"SEPT9, MSF, MSF1, NAPB",Septin 9,604061,Ovarian carcinoma,-,-,-,SEPT9
"TMC6, EVER1, EV1",Transmembrane channel-like 6,605828,Epidermodysplasia verruciformis,226400,AR,-,TMC6
"TMC8, EVER2, EV2",Transmembrane channel-like 8,605829,Epidermodysplasia verruciformis,226400,AR,previously mapped to 2p24-p21,TMC8
"CANT1, SCAN1, DBQD1, EDM7",Calcium-activated nucleotidase 1,613165,Desbuquois dysplasia 1,251450,AR,-,CANT1
"CANT1, SCAN1, DBQD1, EDM7",Calcium-activated nucleotidase 1,613165,"Epiphyseal dysplasia, multiple, 7",617719,AR,-,CANT1
"CBX2, M33, SRXY5","Chromobox homolog 2, Drosophila polycomb class",602770,?46XY sex reversal 5,613080,AR,mutation identified in 1 SRXY5 patient,CBX2
"CCDC40, KIAA1640",Coiled-coil domain-containing protein 40,613799,"Ciliary dyskinesia, primary, 15",613808,-,-,CCDC40
GAA,"Glucosidase, acid alpha-",606800,Glycogen storage disease II,232300,AR,distal to TK1,GAA
"DDX48, EIF4A3, MUK34, NMP265, KIAA0111, RCPS",DEAD/H Box 48,608546,Robin sequence with cleft mandible and limb anomalies,268305,AR,-,DDX48
"CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP",Caspase recruitment domain-containing protein 14,607211,Pityriasis rubra pilaris,173200,AD,-,CARD14
"CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP",Caspase recruitment domain-containing protein 14,607211,Psoriasis 2,602723,AD,-,CARD14
"SGSH, MPS3A, SFMD",N-sulfoglucosamine sulfohydrolase (sulfamidase),605270,Mucopolysaccharidosis type IIIA (Sanfilippo A),252900,AR,-,SGSH
"RNF213, ALO17, KIAA1618, MYMY2",Ring finger protein 213,613768,"{Moyamoya disease 2, susceptibility to}",607151,-,-,RNF213
"ACTG1, DFNA20, DFNA26, BRWS2","Actin, gamma-1",102560,Baraitser-Winter syndrome 2,614583,AD,-,ACTG1
"ACTG1, DFNA20, DFNA26, BRWS2","Actin, gamma-1",102560,"Deafness, autosomal dominant 20/26",604717,AD,-,ACTG1
"FSCN2, RFSN, RP30","Fascin, sea urchin, homolog of, 2",607643,Retinitis pigmentosa 30,607921,-,within 200kb of ACTG1,FSCN2
"PDE6G, PDEG, RP57","Phosphodiesterase-6G, cGMP-specific, rod, gamma",180073,Retinitis pigmentosa 57,613582,AR,-,PDE6G
GCGR,Glucagon receptor,138033,"{Diabetes mellitus, noninsulin-dependent}",125853,AD,-,GCGR
"P4HB, PROHB, CLCRP1","Procollagen-proline, 2-oxoglutarate-4-dioxygenase, beta polypeptide",176790,Cole-Carpenter syndrome 1,112240,AD,-,P4HB
"ARHGDIA, GDIA1, NPHS8",Rho GDP dissociation inhibitor (GDI) alpha,601925,"Nephrotic syndrome, type 8",615244,AR,-,ARHGDIA
"PYCR1, PRO3, ARCL2B, ARCL3B",Pyrroline-5-carboxylate reductase-1,179035,"Cutis laxa, autosomal recessive, type IIB",612940,AR,-,PYCR1
"PYCR1, PRO3, ARCL2B, ARCL3B",Pyrroline-5-carboxylate reductase-1,179035,"Cutis laxa, autosomal recessive, type IIIB",614438,-,-,PYCR1
"ASPSCR1, RCC17, ASPL, ASPS","Alveolar soft-part sarcoma chromosome region, candidate 1",606236,Alveolar soft-part sarcoma,606243,-,t(X;17)(p11.2;q25),ASPSCR1
"DCXR, P34H, PNTSU",Dicarbonyl/L-xylulose reductase,608347,[Pentosuria],260800,AR,-,DCXR
"CSNK1D, ASPS, FASPS2","Casein kinase-1, delta",600864,"Advanced sleep-phase syndrome, familial, 2",615224,AD,-,CSNK1D
"TBCD, PEBAT",Tubulin-specific chaperone D,604649,"Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum",617193,AR,-,TBCD
"ZNF750, FLJ13841",Zinc finger protein 750,610226,Seborrhea-like dermatitis with psoriasiform elements,610227,-,-,ZNF750
"DEL18p, C18DELp",Chromosome 18p deletion syndrome,146390,Chromosome 18p deletion syndrome,146390,AD,-,DEL18p
SCZD8,"Schizophrenia susceptibility locus, chromosome 18-related",603206,{Schizophrenia},181500,AD,-,SCZD8
TET18P,Tetrasomy 18p,614290,Tetrasomy 18p,614290,-,-,TET18P
"SMCHD1, KIAA0650, BAMS",Structural maintenance of chromosomes flexible hinge domain-containing protein 1,614982,Bosma arhinia microphthalmia syndrome,603457,AD,-,SMCHD1
"SMCHD1, KIAA0650, BAMS",Structural maintenance of chromosomes flexible hinge domain-containing protein 1,614982,"Fascioscapulohumeral muscular dystrophy 2, digenic",158901,-,-,SMCHD1
LPIN2,Lipin 2,605519,Majeed syndrome,609628,-,-,LPIN2
"TGIF1, HPE4",TG-interacting factor 1,602630,Holoprosencephaly 4,142946,AD,-,TGIF1
"LAMA1, PTBHS","Laminin, alpha-1",150320,Poretti-Boltshauser syndrome,615960,AR,-,LAMA1
NDUFV2,"NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kD",600532,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",pseudogene on 19q13.3-qter,NDUFV2
"APCDD1, HHS, HYPT1, HTS",Adenomatosis polyposis coli down-regulated 1,607479,Hypotrichosis 1,605389,AD,-,APCDD1
"PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT",PIEZO-type mechanosensitive ion channel component 2,613629,?Marden-Walker syndrome,248700,AD,mutation identified in 1 MWKS patient,PIEZO2
"PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT",PIEZO-type mechanosensitive ion channel component 2,613629,"Arthrogryposis, distal, type 3",114300,AD,-,PIEZO2
"PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT",PIEZO-type mechanosensitive ion channel component 2,613629,"Arthrogryposis, distal, type 5",108145,AD,-,PIEZO2
"PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT",PIEZO-type mechanosensitive ion channel component 2,613629,"Arthrogryposis, distal, with impaired proprioception and touch",617146,AR,-,PIEZO2
"GNAL, DYT25","Guanine nucleotide-binding protein, alpha-subunit, olfactory type",139312,Dystonia 25,615073,AD,-,GNAL
"TUBB6, FPVEPD","Tubulin, beta-6",615103,"?Facial palsy, congenitla, with ptosis and velopharyngeal dysfunction",617732,AD,mutation identified in 1 FPVEPD family,TUBB6
"AFG3L2, SCA28, SPAX5",ATPase family gene 3-like 2,604581,"Spastic ataxia 5, autosomal recessive",614487,AR,-,AFG3L2
"AFG3L2, SCA28, SPAX5",ATPase family gene 3-like 2,604581,Spinocerebellar ataxia 28,610246,AD,-,AFG3L2
MC2R,Melanocortin-2 receptor (ACTH receptor),607397,"Glucocorticoid deficiency, due to ACTH unresponsiveness",202200,AR,-,MC2R
DEL18q,Chromosome 18q deletion syndrome,601808,Chromosome 18q deletion syndrome,601808,AD,-,DEL18q
"GREB1L, C18orf6, KIAA1772, RHDA3",GREB1-like protein,617782,Renal hypodysplasia/aplasia 3,617805,-,-,GREB1L
"MIB1, MIB, DIP1, KIAA1323, LVNC7","Mindbomb, Drosophila, homolog of, 1",608677,Left ventricular noncompaction 7,615092,AD,-,MIB1
"GATA6, AVSD5, ASD9, PACHD",GATA-binding protein-6,601656,Atrial septal defect 9,614475,AD,-,GATA6
"GATA6, AVSD5, ASD9, PACHD",GATA-binding protein-6,601656,Atrioventricular septal defect 5,614474,AD,-,GATA6
"GATA6, AVSD5, ASD9, PACHD",GATA-binding protein-6,601656,Pancreatic agenesis and congenital heart defects,600001,AD,-,GATA6
"GATA6, AVSD5, ASD9, PACHD",GATA-binding protein-6,601656,Persistent truncus arteriosus,217095,-,-,GATA6
"GATA6, AVSD5, ASD9, PACHD",GATA-binding protein-6,601656,Tetralogy of Fallot,187500,AD,-,GATA6
"RBBP8, RIM, SCKL2, JWDS",Retinoblastoma-binding protein 8,604124,Jawad syndrome,251255,AR,-,RBBP8
"RBBP8, RIM, SCKL2, JWDS",Retinoblastoma-binding protein 8,604124,"Pancreatic carcinoma, somatic",-,-,-,RBBP8
"RBBP8, RIM, SCKL2, JWDS",Retinoblastoma-binding protein 8,604124,Seckel syndrome 2,606744,AR,-,RBBP8
"NPC1, NPC",NPC1 gene,607623,"Niemann-Pick disease, type C1",257220,AR,some families not linked to 18; type D prob. allelic,NPC1
"NPC1, NPC",NPC1 gene,607623,"Niemann-Pick disease, type D",257220,AR,-,NPC1
"LAMA3, LOCS","Laminin, alpha-3 (nicein, 150kD; kalinin, 165kD; BM600, 150kD; epiligrin)",600805,"Epidermolysis bullosa, generalized atrophic benign",226650,AR,-,LAMA3
"LAMA3, LOCS","Laminin, alpha-3 (nicein, 150kD; kalinin, 165kD; BM600, 150kD; epiligrin)",600805,"Epidermolysis bullosa, junctional, Herlitz type",226700,AR,-,LAMA3
"LAMA3, LOCS","Laminin, alpha-3 (nicein, 150kD; kalinin, 165kD; BM600, 150kD; epiligrin)",600805,Laryngoonychocutaneous syndrome,245660,AR,-,LAMA3
"TAF4B, TAF2C2, TAFII105, SPGF13","TAF4b RNA polymerase II, TATA box-binding protein-associated factor, 105kD",601689,?Spermatogenic failure 13,615841,AR,mutation identified in 1 SPGF13 family,TAF4B
"KCTD1, SENS",Potassium channel tetramerization domain-containing 1,613420,Scalp-ear-nipple syndrome,181270,AD,-,KCTD1
"DSC3, DSC4",Desmocollin-3,600271,?Hypotrichosis and recurrent skin vesicles,613102,AR,mutation identified in 1 HYPTSV family,DSC3
"DSC2, DSC3, ARVD11",Desmocollin-2,125645,Arrhythmogenic right ventricular dysplasia 11,610476,"AD,AR",-,DSC2
"DSC2, DSC3, ARVD11",Desmocollin-2,125645,Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair,610476,"AD,AR",-,DSC2
"DSG1, PPKS1, SPPK1, EPKHE",Desmoglein-1,125670,"Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE",615508,AR,pemphigus foliaceous antigen,DSG1
"DSG1, PPKS1, SPPK1, EPKHE",Desmoglein-1,125670,"Keratosis palmoplantaris striata I, AD",148700,AD,-,DSG1
"DSG4, LAH, HYPT6",Desmoglein 4,607892,Hypotrichosis 6,607903,AR,-,DSG4
"DSG2, ARVD10, ARVC10, CMD1BB",Desmoglein-2,125671,Arrhythmogenic right ventricular dysplasia 10,610193,AD,-,DSG2
"DSG2, ARVD10, ARVC10, CMD1BB",Desmoglein-2,125671,"Cardiomyopathy, dilated, 1BB",612877,-,-,DSG2
"TTR, PALB",Transthyretin (prealbumin),176300,"Amyloidosis, hereditary, transthyretin-related",105210,AD,-,TTR
"TTR, PALB",Transthyretin (prealbumin),176300,"Carpal tunnel syndrome, familial",115430,AD,-,TTR
"TTR, PALB",Transthyretin (prealbumin),176300,[Dystransthyretinemic hyperthyroxinemia],145680,AD,-,TTR
"RNF125, TRAC1, TNORS",RING finger protein 125,610432,Tenorio syndrome,616260,AD,-,RNF125
"ASXL3, KIAA1713, BRPS",Additional sex combs-like 3,615115,Bainbridge-Ropers syndrome,615485,-,-,ASXL3
"DTNA, D18S892E, DRP3, LVNC1","Dystobrevin, alpha (dystrophin-related protein 3)",601239,"Left ventricular noncompaction 1, with or without congenital heart defects",604169,AD,-,DTNA
"MAPRE2, EB2, RP1, CSCSC2","Microtubule-associated protein, RP/EB family, member 2",605789,"Symmetric circumferential skin creases, congenital, 2",616734,AD,-,MAPRE2
"ELP2, STATIP1, MRT58","Elongator acetyltransferase complex, subunit 2",616054,"Mental retardation, autosomal recessive 58",617270,AR,-,ELP2
"MOCOS, MCS, XAN2",Molybdenum cofactor sulfurase,613274,"Xanthinuria, type II",603592,AR,-,MOCOS
"SETBP1, KIAA0437, SEB, MRD29",SET-binding protein 1,611060,"Mental retardation, autosomal dominant 29",616078,AD,fused with NUP98 in ALL,SETBP1
"SETBP1, KIAA0437, SEB, MRD29",SET-binding protein 1,611060,Schinzel-Giedion midface retraction syndrome,269150,AD,-,SETBP1
"SLC14A1, JK, UTE, UT1","Solute carrier family 14 (urea transporter), member 1 (Kidd blood group)",613868,"[Blood group, Kidd]",111000,-,previous suggestion of chr.7 or chr.2,SLC14A1
"EPG5, KIAA1632, HEEW1, VICIS","Ectopic P-granules autophagy protein 5, C. elegans, homolog of",615068,Vici syndrome,242840,AR,-,EPG5
"ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22","ATP synthase, H+ transporting (ATPase, mitochondrial)",164360,?Combined oxidative phosphorylation deficiency 22,616045,AR,"pseudogenes on chr. 2, chr. 9, and chr.16; mutation identified in 1 MC5DN4 family and 1 COXPD22 family",ATP5A1
"ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22","ATP synthase, H+ transporting (ATPase, mitochondrial)",164360,"?Mitochondrial complex (ATP synthase) deficiency, nuclear type 4",615228,AR,-,ATP5A1
"LOXHD1, DFNB77",Lipoxygenase homology domains-containing 1,613072,"Deafness, autosomal recessive 77",613079,AR,-,LOXHD1
"IER3IP1, MEDS",Immediate-early response 3-interacting protein 1,609382,"Microcephaly, epilepsy, and diabetes syndrome",614231,AR,-,IER3IP1
"SMAD7, MADH7, CRCS3","Mothers against decapentaplegic, Drosophila, homolog of, 7",602932,"{Colorectal cancer, susceptibility to, 3}",612229,-,-,SMAD7
"DYM, FLJ90130, DMC, SMC",Dymeclin,607461,Dyggve-Melchior-Clausen disease,223800,AR,-,DYM
"DYM, FLJ90130, DMC, SMC",Dymeclin,607461,Smith-McCort dysplasia,607326,AR,-,DYM
"MYO5B, KIAA1119",Myosin VB,606540,Microvillus inclusion disease,251850,AR,-,MYO5B
"CCDC11, HTX6",Coiled-coil domain-containing protein 11,614759,"Heterotaxy, visceral, 6, autosomal recessive",614779,AR,-,CCDC11
"SMAD4, MADH4, DPC4, JIP, MYHRS","Mothers against decapentaplegic, Drosophila, homolog of, 4",600993,Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,175050,AD,-,SMAD4
"SMAD4, MADH4, DPC4, JIP, MYHRS","Mothers against decapentaplegic, Drosophila, homolog of, 4",600993,Myhre syndrome,139210,AD,-,SMAD4
"SMAD4, MADH4, DPC4, JIP, MYHRS","Mothers against decapentaplegic, Drosophila, homolog of, 4",600993,"Pancreatic cancer, somatic",260350,-,-,SMAD4
"SMAD4, MADH4, DPC4, JIP, MYHRS","Mothers against decapentaplegic, Drosophila, homolog of, 4",600993,"Polyposis, juvenile intestinal",174900,AD,-,SMAD4
"DCC, MRMV1, HGPPS2",Deleted in colorectal carcinoma,120470,"Colorectal cancer, somatic",114500,-,-,DCC
"DCC, MRMV1, HGPPS2",Deleted in colorectal carcinoma,120470,"Esophageal carcinoma, somatic",133239,-,-,DCC
"DCC, MRMV1, HGPPS2",Deleted in colorectal carcinoma,120470,"Gaze palsy, familial horizontal, with progressive scoliosis, 2",617542,AR,-,DCC
"DCC, MRMV1, HGPPS2",Deleted in colorectal carcinoma,120470,Mirror movements 1 and/or agenesis of the corpus callosum,157600,AD,-,DCC
"TCF4, SEF2, ITF2, PTHS, FECD3",Transcription factor-4 (immunoglobulin transcription factor-2),602272,"Corneal dystrophy, Fuchs endothelial, 3",613267,AD,-,TCF4
"TCF4, SEF2, ITF2, PTHS, FECD3",Transcription factor-4 (immunoglobulin transcription factor-2),602272,Pitt-Hopkins syndrome,610954,AD,-,TCF4
"FECH, FCE",Ferrochelatase,612386,"Protoporphyria, erythropoietic, autosomal recessive",177000,AR,-,FECH
"ATP8B1, FIC1, BRIC, PFIC1, ICP1","ATPase, class I, type 8B, member 1",602397,"Cholestasis, benign recurrent intrahepatic",243300,AR,-,ATP8B1
"ATP8B1, FIC1, BRIC, PFIC1, ICP1","ATPase, class I, type 8B, member 1",602397,"Cholestasis, intrahepatic, of pregnancy, 1",147480,AD,-,ATP8B1
"ATP8B1, FIC1, BRIC, PFIC1, ICP1","ATPase, class I, type 8B, member 1",602397,"Cholestasis, progressive familial intrahepatic 1",211600,AR,-,ATP8B1
"NEDD4L, KIAA0439, RSP5, PVNH7",Ubiquitin protein ligase NEDD4-like,606384,Periventricular nodular heterotopia 7,617201,AD,-,NEDD4L
"MALT1, MLT, IMD12",Mucosa-associated lymphoid tissue lymphoma translocation gene 1,604860,Immunodeficiency 12,615468,AR,fused with API2 in MALT lymphoma,MALT1
"RAX, RX, MCOP3",Retina and anterior neural fold homeobox gene,601881,"Microphthalmia, isolated 3",611038,AR,-,RAX
"LMAN1, ERGIC53, F5F8D, MCFD1","Lectin, mannose-binding, 1",601567,Combined factor V and VIII deficiency,227300,AR,-,LMAN1
"CCBE1, KIAA1983, HKLLS1",Collagen and calcium-binding EGF domain-containing protein 1,612753,Hennekam lymphangiectasia-lymphedema syndrome 1,235510,AR,-,CCBE1
MC4R,Melanocortin-4 receptor,155541,"Obesity, autosomal dominant",601665,"AD,Mu,AR",-,MC4R
"PIGN, MCAHS1","Phosphatidylinositol glycan, class N",606097,Multiple congenital anomalies-hypotonia-seizures syndrome 1,614080,AR,-,PIGN
"TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2","Tumor necrosis factor receptor superfamily, member 11A",603499,"Osteolysis, familial expansile",174810,AD,-,TNFRSF11A
"TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2","Tumor necrosis factor receptor superfamily, member 11A",603499,"Osteopetrosis, autosomal recessive 7",612301,-,-,TNFRSF11A
"TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2","Tumor necrosis factor receptor superfamily, member 11A",603499,"{Paget disease of bone 2, early-onset}",602080,AD,-,TNFRSF11A
"KDSR, FVT1, EKVP4",3-ketodihydrosphingosine reductase,136440,Erythrokeratodermia variabilis et progressiva 4,617526,AR,~10kb 5' to BCL2,KDSR
"SERPINB7, MEGSIN, PPKN","Serpin peptidase inhibitor, clade B (ovalbumin), member 7",603357,"Palmoplantar keratoderma, Nagashima type",615598,AR,-,SERPINB7
"DUP18pDEL18q, DUP18qDEL18p",Chromosome 18 pericentric inversion,609334,Chromosome 18 pericentric inversion,609334,-,-,DUP18pDEL18q
"SERPINB8, PI8, CAP2, PSS5","Serpin family B, member 8",601697,Peeling skin syndrome 5,617115,AR,-,SERPINB8
"RTTN, MSSP",Rotatin,610436,"Microcephaly, short stature, and polymicrogyria with seizures",614833,AR,-,RTTN
"CYB5A, MCB5",Cytochrome b5,613218,"?Methemoglobinemia, type IV",250790,AR,"pseudogenes on X, 14q, 20p; mutation identified in 1 MET5 patient",CYB5A
"TSHZ1, TSH1, CAA",Teashirt zinc finger homeobox 1,614427,"Aural atresia, congenital",607842,AD,-,TSHZ1
"CTDP1, FCP1, CCFDN","C-terminal domain of RNA polymerase II subunit A, phosphatase of, subunit 1",604927,"Congenital cataracts, facial dysmorphism, and neuropathy",604168,AR,-,CTDP1
"TXNL4A, DIM1, BMKS",Thioredoxin-like 4A,611595,Burn-McKeown syndrome,608572,AR,-,TXNL4A
PPNAD4,"Pigmented nodular adrenocortical disease, primary, 4",615830,"Pigmented nodular adrenocortical disease, primary, 4",615830,AD,duplication of 294kb to 2.7Mb on 19p13,PPNAD4
BSG,Basigin (blood group OK),109480,"[Blood group, OK]",111380,-,-,BSG
"ELANE, ELA2, SCN1","Elastase, neutrophil-expressed",130130,"Neutropenia, cyclic",162800,AD,-,ELANE
"ELANE, ELA2, SCN1","Elastase, neutrophil-expressed",130130,"Neutropenia, severe congenital 1, autosomal dominant",202700,AD,-,ELANE
"CFD, ADN",Complement factor D,134350,Complement factor D deficiency,613912,AR,-,CFD
"KISS1R, GPR54, HH8, CPPB1",KISS1 receptor,604161,"?Precocious puberty, central, 1",176400,AD,mutation identified in 1 CPPB1 patient,KISS1R
"KISS1R, GPR54, HH8, CPPB1",KISS1 receptor,604161,Hypogonadotropic hypogonadism 8 with or without anosmia,614837,AR,-,KISS1R
"ABCA7, ABCX, AD9","ATP-binding cassette, subfamily A, member 7",605414,"{Alzheimer disease 9, susceptibility to}",608907,AD,-,ABCA7
"GPX4, SMDS",Glutathione peroxidase-4 (phospholipid hydroperoxidase),138322,"Spondylometaphyseal dysplasia, Sedaghatian type",250220,AR,-,GPX4
"STK11, PJS, LKB1",Serine/threonine protein kinase-11,602216,"Melanoma, malignant, somatic",-,-,-,STK11
"STK11, PJS, LKB1",Serine/threonine protein kinase-11,602216,Pancreatic cancer,260350,"AD,Mu,SMu",-,STK11
"STK11, PJS, LKB1",Serine/threonine protein kinase-11,602216,Peutz-Jeghers syndrome,175200,AD,-,STK11
"STK11, PJS, LKB1",Serine/threonine protein kinase-11,602216,"Testicular tumor, somatic",273300,-,-,STK11
"NDUFS7, PSST","NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kD (NADH-coenzyme Q reductase)",601825,Leigh syndrome,256000,"Mi,AR",-,NDUFS7
"GAMT, CCDS2",Guanidinoacetate methyltransferase,601240,Cerebral creatine deficiency syndrome 2,612736,AR,-,GAMT
"APC2, APCL, SOTOS3",APC2 gene,612034,?Sotos syndrome 3,617169,AR,mutation identified in 1 SOTOS3 family,APC2
"REEP6, DP1L1, TB2L1, C19orf32, RP77",Receptor expression-enhancing protein 6,609346,Retinitis pigmentosa 77,617304,AR,-,REEP6
"TCF3, E2A, AGM8",Transcription factor-3 (E2A immunoglobulin enhancer-binding factors E12/E47),147141,"Agammaglobulinemia 8, autosomal dominant",616941,AD,-,TCF3
"ADAT3, TAD3, MRT36","Adenosine deaminase, tRNA-specific, 3",615302,"Mental retardation, autosomal recessive 36",615286,AR,-,ADAT3
"AP3D1, HPS10","Adaptor-related protein complex 3, delta-1 subunit",607246,?Hermansky-Pudlak syndrome 10,617050,AR,mutation identified in 1 HPS10 patient,AP3D1
"AMH, MIF",Anti-Mullerian hormone,600957,"Persistent Mullerian duct syndrome, type I",261550,AR,-,AMH
"LMNB2, LMN2, EPM9",Lamin B2,150341,"?Epilepsy, progressive myoclonic, 9",616540,AR,mutation identified in 1 EPM9 family,LMNB2
"LMNB2, LMN2, EPM9",Lamin B2,150341,"{Lipodystrophy, partial, acquired, susceptibility to}",608709,AD,-,LMNB2
"TLE6, GRG6, PREMBL",Transducin-like enhancer of split 6,612399,Preimplantation embryonic lethality,616814,AR,-,TLE6
"GNA11, HHC2, HYPOC2","Guanine nucleotide-binding protein, Gq class, GNA11",139313,"Hypocalcemia, autosomal dominant 2",615361,AD,-,GNA11
"GNA11, HHC2, HYPOC2","Guanine nucleotide-binding protein, Gq class, GNA11",139313,"Hypocalciuric hypercalcemia, type II",145981,AD,-,GNA11
"GIPC3, DFNB15, DFNB72, DFNB95",GAIP C-terminus-interacting protein 3,608792,"Deafness, autosomal recessive 15",601869,AR,-,GIPC3
"TBXA2R, BDPLT13",Thromboxane A2 receptor,188070,"{Bleeding disorder, platelet-type, 13, susceptibility to}",614009,AD,-,TBXA2R
"PIP5K1C, LCCS3","Phosphatidylinositol-4-phosphate 5-kinase, type I, gamma",606102,Lethal congenital contractural syndrome 3,611369,AR,-,PIP5K1C
"RAX2, RAXL1, QRX, CORD11, ARMD6",Retina and anterior neural fold homeobox 2,610362,"?Macular degeneration, age-related, 6",613757,-,mutation identified in 1 ARMD6 patient,RAX2
"RAX2, RAXL1, QRX, CORD11, ARMD6",Retina and anterior neural fold homeobox 2,610362,Cone-rod dystrophy 11,610381,AD,-,RAX2
"ATCAY, CLAC, KIAA1872",Caytaxin,608179,"Ataxia, cerebellar, Cayman type",601238,AR,-,ATCAY
"EEF2, EF2, SCA26",Eukaryotic translation elongation factor-2,130610,?Spinocerebellar ataxia 26,609306,AD,mutation identified in 1 family,EEF2
"MAP2K2, PRKMK2, MEK2, MKK2, CFC4",Mitogen-activated protein kinase kinase 2,601263,Cardiofaciocutaneous syndrome 4,615280,-,previously assigned to 7q32,MAP2K2
"SH3GL1, EEN",SH3 domain GRB2-like 1 (Extra 11-19 leukemia fusion gene),601768,"Leukemia, acute myeloid",601626,AD,-,SH3GL1
"TICAM1, TRIF, IIAE6",TIR domain-containing adaptor molecule 1,607601,"{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}",614850,-,-,TICAM1
"LONP1, PRSS15, LON, CODASS","lon peptidase 1, mitochondrial",605490,CODAS syndrome,600373,AR,-,LONP1
FUT6,"Fucosyltransferase 6 (alpha (1,3) fucosyltransferase)",136836,Fucosyltransferase 6 deficiency,613852,-,"in cluster with FUT3, FUT5",FUT6
NDUFA11,"NADH-dehydrogenase 1 alpha subcomplex, 11",612638,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",-,NDUFA11
"CLPP, PRLTS3, DFNB81","ATP-dependent protease ClpAP, E. coli, proteolytic subunit, homolog of",601119,Perrault syndrome 3,614129,AR,-,CLPP
"TUBB4A, DYT4, HLD6","Tubulin, beta-4A",602662,"Dystonia 4, torsion, autosomal dominant",128101,AD,-,TUBB4A
"TUBB4A, DYT4, HLD6","Tubulin, beta-4A",602662,"Leukodystrophy, hypomyelinating, 6",612438,AD,-,TUBB4A
"C3, ARMD9, AHUS5",Complement component-3,120700,C3 deficiency,613779,AR,LE ~7cM in males vs. C3 RFLP,C3
"C3, ARMD9, AHUS5",Complement component-3,120700,"{Hemolytic uremic syndrome, atypical, susceptibility to, 5}",612925,AD,-,C3
"C3, ARMD9, AHUS5",Complement component-3,120700,"{Macular degeneration, age-related, 9}",611378,-,-,C3
"INSR, HHF5",Insulin receptor,147670,"Diabetes mellitus, insulin-resistant, with acanthosis nigricans",610549,-,1 gene for alpha and beta subunits,INSR
"INSR, HHF5",Insulin receptor,147670,"Hyperinsulinemic hypoglycemia, familial, 5",609968,AD,-,INSR
"INSR, HHF5",Insulin receptor,147670,Leprechaunism,246200,AR,-,INSR
"INSR, HHF5",Insulin receptor,147670,Rabson-Mendenhall syndrome,262190,AR,-,INSR
"ARHGEF18, KIAA0521, RP78",Rho guanine nucleotide exchange factor 18,616432,Retinitis pigmentosa 78,617433,AR,-,ARHGEF18
"MCOLN1, ML4",Mucolipin 1,605248,Mucolipidosis IV,252650,AR,-,MCOLN1
"PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS",Patatin-like phospholipase domain-containing protein 6,603197,?Laurence-Moon syndrome,245800,AR,mutation identified in 1 LMNS family,PNPLA6
"PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS",Patatin-like phospholipase domain-containing protein 6,603197,Boucher-Neuhauser syndrome,215470,AR,-,PNPLA6
"PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS",Patatin-like phospholipase domain-containing protein 6,603197,Oliver-McFarlane syndrome,275400,AR,-,PNPLA6
"PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS",Patatin-like phospholipase domain-containing protein 6,603197,"Spastic paraplegia 39, autosomal recessive",612020,AR,-,PNPLA6
"PET100, C19orf79","PET100, S. cerevisiae, homolog of",614770,Mitochondrial complex IV deficiency,220110,"Mi,AR",-,PET100
"STXBP2, UNC18B, FHL5",Syntaxin binding protein 2,601717,"Hemophagocytic lymphohistiocytosis, familial, 5",613101,-,-,STXBP2
"RETN, RSTN, FIZZ3",Resistin,605565,"{Diabetes mellitus, noninsulin-dependent, susceptibility to}",125853,AD,-,RETN
"RETN, RSTN, FIZZ3",Resistin,605565,"{Hypertension, insulin resistance-related, susceptibility to}",125853,AD,-,RETN
"CD209, CDSIGN",CD209 antigen,604672,"{Dengue fever, protection against}",614371,-,-,CD209
"CD209, CDSIGN",CD209 antigen,604672,"{HIV type 1, susceptibility to}",609423,-,-,CD209
"CD209, CDSIGN",CD209 antigen,604672,"{Mycobacterium tuberculosis, susceptibility to}",607948,-,-,CD209
"CD320, 8D6, 8D6A, TCBLR",CD320 molecule,606475,"Methylmalonic aciduria, transient, due to transcobalamin receptor defect",613646,-,-,CD320
"RPS28, DBA15",Ribosomal protein S28,603685,Diamond Blackfan anemia 15 with mandibulofacial dysostosis,606164,AD,-,RPS28
"ANGPTL4, PGAR, HFARP, FIAF, TGQTL",Angiopoietin-like 4,605910,"Plasma triglyceride level QTL, low",615881,AD,-,ANGPTL4
"RAB11B, NDAGSCW",Ras-associated protein RAB11B,604198,"Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter",617807,-,-,RAB11B
"ADAMTS10, WMS1","A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 10",608990,"Weill-Marchesani syndrome 1, recessive",277600,AR,-,ADAMTS10
"DNMT1, MCMT, HSN1E, ADCADN",DNA methyltransferase 1,126375,"Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant",604121,AD,-,DNMT1
"DNMT1, MCMT, HSN1E, ADCADN",DNA methyltransferase 1,126375,"Neuropathy, hereditary sensory, type IE",614116,AD,-,DNMT1
"S1PR2, EDG5, DFNB68",Sphingosine-1-phosphate receptor 2,605111,"Deafness, autosomal recessive 68",610419,AR,-,S1PR2
ICAM1,Intercellular adhesion molecule-1,147840,"{Malaria, cerebral, susceptibility to}",611162,-,close to Ldlr in mouse,ICAM1
"ICAM4, CD242, LW",Intracellular adhesion molecule 4,614088,"[Blood group, Landsteiner-Wiener]",111250,-,"close to C3, LU",ICAM4
"TYK2, IMD35",Tyrosine kinase 2,176941,Immunodeficiency 35,611521,AR,-,TYK2
"DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5",Dynamin-2,602378,Centronuclear myopathy 1,160150,AD,1 LCCS5 family identified with mutation,DNM2
"DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5",Dynamin-2,602378,"Charcot-Marie-Tooth disease, axonal type 2M",606482,AD,-,DNM2
"DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5",Dynamin-2,602378,"Charcot-Marie-Tooth disease, dominant intermediate B",606482,AD,-,DNM2
"DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5",Dynamin-2,602378,Lethal congenital contracture syndrome 5,615368,AR,-,DNM2
"SMARCA4, BRG1, RTPS2, MRD16, CSS4","SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4",603254,Coffin-Siris syndrome 4,614609,AD,-,SMARCA4
"SMARCA4, BRG1, RTPS2, MRD16, CSS4","SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4",603254,{Rhabdoid tumor predisposition syndrome 2},613325,AD,-,SMARCA4
"LDLR, FHC, FH, LDLCQ2",Low density lipoprotein receptor,606945,"Hypercholesterolemia, familial",143890,AD,~20cM distal to C3,LDLR
"LDLR, FHC, FH, LDLCQ2",Low density lipoprotein receptor,606945,LDL cholesterol level QTL2,143890,AD,-,LDLR
"KANK2, ANKRD25, KIAA1518, PPKWH, NPHS16",KN motif- and ankyrin repeat domain-containing protein 2,614610,Nephrotic syndrome 16,617783,AR,-,KANK2
"KANK2, ANKRD25, KIAA1518, PPKWH, NPHS16",KN motif- and ankyrin repeat domain-containing protein 2,614610,Palmoplantar keratoderma and woolly hair,616099,AR,-,KANK2
"DOCK6, KIAA1395, AOS2",Dedicator of cytokinesis 6,614194,Adams-Oliver syndrome 2,614219,AR,-,DOCK6
EPOR,Erythropoietin receptor,133171,"[Erythrocytosis, familial, 1]",133100,AD,-,EPOR
"CCDC151, CILD30",Coiled-coil domain-containing protein 151,615956,"Ciliary dyskinesia, primary, 30",616037,AR,-,CCDC151
"PRKCSH, G19P1, PCLD1",Protein kinase C substrate 80K-H,177060,Polycystic liver disease 1,174050,AD,-,PRKCSH
"ACP5, SPENCDI","Acid phosphatase 5, tartrate resistant",171640,Spondyloenchondrodysplasia with immune dysregulation,607944,AR,incorrectly assigned to 15 by A,ACP5
"DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13",Chromosome 19p13.13 deletion syndrome (Chromosome 19p13.13 duplication syndrome),613638,Chromosome 19p13.13 deletion syndrome,613638,-,contiguous gene syndrome,DEL19p13.13
"DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13",Chromosome 19p13.13 deletion syndrome (Chromosome 19p13.13 duplication syndrome),613638,Chromosome 19p13.13 duplication syndrome,613638,-,-,DEL19p13.13
"MAN2B1, MANB","Mannosidase, alpha, class 2B, member 1",609458,"Mannosidosis, alpha-, types I and II",248500,AR,-,MAN2B1
"RNASEH2A, RNHIA, AGS4","Ribonuclease H2, large subunit",606034,Aicardi-Goutieres syndrome 4,610333,AR,-,RNASEH2A
"KLF1, EKLF, INLU, HBFQTL6, CDAN4","Kruppel-like factor 1, erythroid",600599,Blood group--Lutheran inhibitor,111150,-,-,KLF1
"KLF1, EKLF, INLU, HBFQTL6, CDAN4","Kruppel-like factor 1, erythroid",600599,"Dyserythropoietic anemia, congenital, type IV",613673,AD,-,KLF1
"KLF1, EKLF, INLU, HBFQTL6, CDAN4","Kruppel-like factor 1, erythroid",600599,[Hereditary persistence of fetal hemoglobin],613566,-,-,KLF1
GCDH,Glutaryl-Coenzyme A dehydrogenase,608801,"Glutaricaciduria, type I",231670,AR,-,GCDH
"CALR, SSA",Sicca syndrome antigen A (autoantigen Ro; calreticulin),109091,"Myelofibrosis, somatic",254450,-,"distal to C3, near LDLR",CALR
"CALR, SSA",Sicca syndrome antigen A (autoantigen Ro; calreticulin),109091,"Thrombocythemia, somatic",187950,-,-,CALR
"NFIX, NF1A, SOTOS2, MRSHSS",Nuclear factor I/X (CCAAT-binding transcription factor),164005,Marshall-Smith syndrome,602535,AD,-,NFIX
"NFIX, NF1A, SOTOS2, MRSHSS",Nuclear factor I/X (CCAAT-binding transcription factor),164005,Sotos syndrome 2,614753,AD,-,NFIX
"NACC1, BTBD14B, NECFM","Nucleus accumbens-associated protein 1, BEN and BTB/POZ domains-containing",610672,"Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination",617393,AD,-,NACC1
"CACNA1A, CACNL1A4, SCA6, EIEE42","Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit",601011,"Epileptic encephalopathy, early infantile, 42",617106,AD,-,CACNA1A
"CACNA1A, CACNL1A4, SCA6, EIEE42","Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit",601011,"Episodic ataxia, type 2",108500,AD,-,CACNA1A
"CACNA1A, CACNL1A4, SCA6, EIEE42","Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit",601011,"Migraine, familial hemiplegic, 1",141500,AD,-,CACNA1A
"CACNA1A, CACNL1A4, SCA6, EIEE42","Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit",601011,"Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia",141500,AD,-,CACNA1A
"CACNA1A, CACNL1A4, SCA6, EIEE42","Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit",601011,Spinocerebellar ataxia 6,183086,AD,-,CACNA1A
"CC2D1A, MRT3",Coiled-coil and C2 domain-containing 1A,610055,"Mental retardation, autosomal recessive 3",608443,AR,-,CC2D1A
PRKACA,"Protein kinase, cAMP-dependent, catalytic, alpha",601639,"Cushing syndrome, ACTH-independent adrenal, somatic",615830,-,-,PRKACA
"TECR, GPSN2, TER, SC2, MRT14","Trans-2,3-enoyl-CoA reductase",610057,"Mental retardation, autosomal recessive 14",614020,AR,-,TECR
"ADGRE2, EMR2, VBU",Adhesion G protein-coupled receptor E2,606100,Vibratory urticaria,125630,AD,-,ADGRE2
"CASP14, ARCI12","Caspase 14, apoptosis-related cysteine protease",605848,"Ichthyosis, congenital, autosomal recessive 12",617320,AR,-,CASP14
"NOTCH3, CADASIL1, CASIL, IMF2, LMNS","Notch, Drosophila, homolog of, 3",600276,"?Myofibromatosis, infantile 2",615293,AD,mutation identified in 1 IMF2 family,NOTCH3
"NOTCH3, CADASIL1, CASIL, IMF2, LMNS","Notch, Drosophila, homolog of, 3",600276,Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1,125310,AD,-,NOTCH3
"NOTCH3, CADASIL1, CASIL, IMF2, LMNS","Notch, Drosophila, homolog of, 3",600276,Lateral meningocele syndrome,130720,AD,-,NOTCH3
"CYP4F22, ARCI5, LI3","Cytochrome P450, family 4, subfamily F, polypeptide 22",611495,"Ichthyosis, congenital, autosomal recessive 5",604777,AR,-,CYP4F22
"CALR3, CRT2, CMH19",Calreticulin 3,611414,"?Cardiomyopathy, hypertrophic, 19",613875,AD,mutation identified in 1 CMH19 patient,CALR3
"CPAMD8, KIAA1283, ASGD8",Complement component 3- and pregnancy zone protein-like alpha-2-macroglobin domain-containing protein 8,608841,Anterior segment dysgenesis 8,617319,AR,-,CPAMD8
"MYO9B, MYR5, CELIAC4",Myosin IXB,602129,"{Celiac disease, susceptibility to, 4}",609753,-,-,MYO9B
"GTPBP3, MSS1, COXPD23",GTP-binding protein 3,608536,Combined oxidative phosphorylation deficiency 23,616198,AR,-,GTPBP3
INSL3,"Insulin-like 3, Leydig cell",146738,Cryptorchidism,219050,AD,-,INSL3
"JAK3, JAKL","Janus kinase 3 (Janus kinase, leukocyte)",600173,"SCID, autosomal recessive, T-negative/B-positive type",600802,AR,-,JAK3
"SLC5A5, NIS, TDH1","Solute carrier family 5 (sodium iodide symporter), member-5",601843,Thyroid dyshormonogenesis 1,274400,AR,-,SLC5A5
"IL12RB1, IMD30","Interleukin-12 receptor, beta-1",601604,Immunodeficiency 30,614891,AR,-,IL12RB1
"PIK3R2, MPPH1","Phosphatidylinositol 3-kinase, regulatory subunit 2",603157,Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1,603387,AD,-,PIK3R2
"CRLF1, CISS1",Cytokine-like factor 1,604237,Cold-induced sweating syndrome 1,272430,AR,-,CRLF1
"COMP, EDM1, MED, PSACH",Cartilage oligomeric matrix protein,600310,"Epiphyseal dysplasia, multiple, 1",132400,AD,-,COMP
"COMP, EDM1, MED, PSACH",Cartilage oligomeric matrix protein,600310,Pseudoachondroplasia,177170,AD,-,COMP
"CERS1, LASS1, UOG1, EPM8",Ceramide synthase 1,606919,"?Epilepsy, progressive myoclonic, 8",616230,AR,mutation identified in 1 EPM8 family,CERS1
"GDF1, DTGA3, DORV, RAI",Growth/differentiation factor 1,602880,Double-outlet right ventricle,217095,-,-,GDF1
"GDF1, DTGA3, DORV, RAI",Growth/differentiation factor 1,602880,Right atrial isomerism,208530,AR,-,GDF1
"GDF1, DTGA3, DORV, RAI",Growth/differentiation factor 1,602880,Tetralogy of Fallot,187500,AD,-,GDF1
"GDF1, DTGA3, DORV, RAI",Growth/differentiation factor 1,602880,"Transposition of great arteries, dextro-looped 3",613854,AD,-,GDF1
RFXANK,"Regulatory factor X, ankyrin repeat-containing",603200,"MHC class II deficiency, complementation group B",209920,AR,-,RFXANK
"NDUFA13, GRIM19","NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 13",609435,"{Thyroid carcinoma, Hurthle cell}",607464,-,-,NDUFA13
HPCQTL19,Prostate cancer aggressiveness quantitative trait locus on chromosome 19,607592,{Prostate cancer aggressiveness QTL},176807,AD,D19S902,HPCQTL19
"C19orf12, NBIA4, SPG43",Chromosome 19 open reading frame 12,614297,"?Spastic paraplegia 43, autosomal recessive",615043,AR,mutation identified in 1 SPG43 family,C19orf12
"C19orf12, NBIA4, SPG43",Chromosome 19 open reading frame 12,614297,Neurodegeneration with brain iron accumulation 4,614298,AR,-,C19orf12
"DEL19q13.11d, C19DELq13.11d","Chromosome 19q13.11 deletion syndrome, distal",613026,"Chromosome 19q13.11 deletion syndrome, distal",613026,AD,contiguous gene syndrome,DEL19q13.11d
"DEL19q13.11p, C19DELq13.11p","Chromosome 19q13.11 deletion syndrome, proximal",617219,"Chromosome 19q13.11 deletion syndrome, proximal",617219,AD,-,DEL19q13.11p
"RGS9BP, R9AP, RGS9, PERRS",Regulator of G protein signaling 9-binding protein,607814,Bradyopsia,608415,-,-,RGS9BP
"SLC7A9, CSNU3","Solute carrier family 7 (cationic amino acid transporter, y+ system), member 9",604144,Cystinuria,220100,"AD,AR",-,SLC7A9
"CEBPA, CEBP","CCAAT/enhancer-binding protein (C/EBP), alpha",116897,"?Leukemia, acute myeloid",601626,AD,germline mutation identified in 1 AML family,CEBPA
"CEBPA, CEBP","CCAAT/enhancer-binding protein (C/EBP), alpha",116897,"Leukemia, acute myeloid, somatic",601626,-,-,CEBPA
PEPD,Peptidase D (prolidase),613230,Prolidase deficiency,170100,AR,closely linked to APOC2,PEPD
"CHST8, GALNAC4ST1, PSS3",Carbohydrate sulfotransferase 8,610190,?Peeling skin syndrome 3,616265,AR,mutation has been identified in 1 PSS3 family,CHST8
GPI,Glucose phosphate isomerase; neuroleukin,172400,"Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency",613470,AR,-,GPI
"SCN1B, GEFSP1, BRGDA5, ATFB13, EIEE52","Sodium channel, voltage-gated, type I, beta polypeptide",600235,"Atrial fibrillation, familial, 13",615377,AD,-,SCN1B
"SCN1B, GEFSP1, BRGDA5, ATFB13, EIEE52","Sodium channel, voltage-gated, type I, beta polypeptide",600235,Brugada syndrome 5,612838,-,-,SCN1B
"SCN1B, GEFSP1, BRGDA5, ATFB13, EIEE52","Sodium channel, voltage-gated, type I, beta polypeptide",600235,"Cardiac conduction defect, nonspecific",612838,-,-,SCN1B
"SCN1B, GEFSP1, BRGDA5, ATFB13, EIEE52","Sodium channel, voltage-gated, type I, beta polypeptide",600235,"Epilepsy, generalized, with febrile seizures plus, type 1",604233,AD,-,SCN1B
"SCN1B, GEFSP1, BRGDA5, ATFB13, EIEE52","Sodium channel, voltage-gated, type I, beta polypeptide",600235,"Epileptic encephalopathy, early infantile, 52",617350,AR,-,SCN1B
"LGI4, AMCNMY","Leucine-rich gene, glioma-inactivated, 4",608303,"Arthrogryposis multiplex congenita, neurogenic, with myelin defect",617468,AR,-,LGI4
"HAMP, LEAP1, HEPC, HFE2B",Hepcidin antimicrobial peptide,606464,"Hemochromatosis, type 2B",613313,AR,digenic form with HAMP and HFE mutations,HAMP
"MAG, GMA, SPG75",Myelin-associated glycoprotein,159460,"Spastic paraplegia 75, autosomal recessive",616680,AR,-,MAG
COX6B1,"Cytochrome c oxidase, subunit VIb polypeptide 1 (ubiquitous)",124089,Mitochondrial complex IV deficiency,220110,"Mi,AR",-,COX6B1
"KMT2B, MLL4, KIAA0304, DYT28",Lysine (K)-specific methyltransferase 2B,606834,"Dystonia 28, childhood-onset",617284,AD,-,KMT2B
"PSENEN, PEN2, ACNINV2","Presenilin enhancer 2, C. elegans, homolog of",607632,"Acne inversa, familial, 2, with or without Dowling-Degos disease",613736,AD,-,PSENEN
"NPHS1, NPHN",Nephrin,602716,"Nephrotic syndrome, type 1",256300,AR,-,NPHS1
"TYROBP, PLOSL, DAP12",TYRO protein tyrosine kinase-binding protein,604142,Nasu-Hakola disease,221770,AR,-,TYROBP
SDHAF1,Succinate dehydrogenase complex assembly factor 1,612848,Mitochondrial complex II deficiency,252011,AR,-,SDHAF1
"SYNE4, NESP4, C19orf46, DFNB76",Spectrin repeat-containing nuclear envelope protein 4,615535,"Deafness, autosomal recessive 76",615540,AR,-,SYNE4
"WDR62, C19orf14, MCPH2",WD repeat-containing protein 62,613583,"Microcephaly 2, primary, autosomal recessive, with or without cortical malformations",604317,AR,-,WDR62
"SIPA1L3, SPAL3, SPAR3, KIAA0545, CTRCT45",SIPA1-like protein 3,616655,?Cataract 45,616851,AR,mutation identified in 1 CTRCT45 family,SIPA1L3
"SPINT2, HAI2, DIAR3","Serine protease inhibitor, Kunitz-type, 2 (hepatocyte growth factor activator inhibitor 2; bikunin, placental)",605124,"Diarrhea 3, secretory sodium, congenital, syndromic",270420,AR,-,SPINT2
"RYR1, MHS, CCO","Ryanodine receptor-1, skeletal",180901,Central core disease,117000,"AD,AR",-,RYR1
"RYR1, MHS, CCO","Ryanodine receptor-1, skeletal",180901,King-Denborough syndrome,145600,AD,-,RYR1
"RYR1, MHS, CCO","Ryanodine receptor-1, skeletal",180901,Minicore myopathy with external ophthalmoplegia,255320,AR,-,RYR1
"RYR1, MHS, CCO","Ryanodine receptor-1, skeletal",180901,"Neuromuscular disease, congenital, with uniform type 1 fiber",117000,"AD,AR",-,RYR1
"RYR1, MHS, CCO","Ryanodine receptor-1, skeletal",180901,{Malignant hyperthermia susceptibility 1},145600,AD,-,RYR1
"ACTN4, FSGS1, FSGS","Actinin, alpha-4",604638,"Glomerulosclerosis, focal segmental, 1",603278,AD,-,ACTN4
SARS2,Seryl-tRNA synthetase 2,612804,"Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis",613845,AR,-,SARS2
"IFNL3, IL28B","Interferon, lambda 3",607402,"{Hepatitis C virus infection, response to therapy of}",609532,-,-,IFNL3
"PLEKHG2, CLG, LDAMD","Pleckstrin homology domain-containing protein, family G, member 2",611893,Leukodystrophy and acquired microcephaly with or without dystonia,616763,AR,-,PLEKHG2
"TIMM50, TIM50, MGCA9","Translocase of inner mitochondrial membrane 50, yeast, homolog of",607381,"3-methylglutaconic aciduria, type IX",617698,AR,-,TIMM50
"DLL3, SCDO1","Delta, Drosophila, homolog of",602768,"Spondylocostal dysostosis 1, autosomal recessive",277300,AR,-,DLL3
"DYRK1B, MIRK, AOMS3",Dual-specificity tyrosine phosphorylation-regulated kinase 1B,604556,Abdominal obesity-metabolic syndrome 3,615812,AD,-,DYRK1B
"AKT2, HIHGHH",Murine thymoma viral (v-akt) homolog-2,164731,"Diabetes mellitus, type II",125853,AD,-,AKT2
"AKT2, HIHGHH",Murine thymoma viral (v-akt) homolog-2,164731,Hypoinsulinemic hypoglycemia with hemihypertrophy,240900,AD,-,AKT2
"PLD3, HUK4, SCA46","Phospholipase D family, member 3",615698,?Spinocerebellar ataxia 46,617770,AD,mutation identified in 1 SCA46 family,PLD3
"PRX, CMT4F",Periaxin,605725,"Charcot-Marie-Tooth disease, type 4F",614895,AR,-,PRX
"PRX, CMT4F",Periaxin,605725,Dejerine-Sottas disease,145900,"AD,AR",-,PRX
"SPTBN4, QV, CMND","Spectrin, beta, nonerythrocytic, 4 (quivering, mouse, homolog of)",606214,"?Myopathy, congenital, with neuropathy and deafness",617519,AR,mutation identified in 1 CMND patient,SPTBN4
"LTBP4, LTBP4S, LTBP4L, ARCL1C",Latent transforming growth factor-beta-binding protein 4,604710,"Cutis laxa, autosomal recessive, type IC",613177,AR,-,LTBP4
"COQ8B, ADCK4, NPHS9",Coenzyme Q8B,615567,"Nephrotic syndrome, type 9",615573,AR,-,COQ8B
ITPKC,"Inositol 1,4,5-trisphosphate 3-kinase C",606476,"{Kawasaki disease, susceptibility to}",611775,-,-,ITPKC
"CYP2A6, CYP2A3, CYP2A, P450C2A","Cytochrome P450, subfamily IIA, phenobarbital-inducible, polypeptide 6",122720,Coumarin resistance,122700,AD,-,CYP2A6
"CYP2A6, CYP2A3, CYP2A, P450C2A","Cytochrome P450, subfamily IIA, phenobarbital-inducible, polypeptide 6",122720,"{Lung cancer, resistance to}",211980,AR,-,CYP2A6
"CYP2A6, CYP2A3, CYP2A, P450C2A","Cytochrome P450, subfamily IIA, phenobarbital-inducible, polypeptide 6",122720,"{Nicotine addiction, protection from}",188890,-,-,CYP2A6
"CYP2B6, CYP2B, EFVM","Cytochrome P450, family 2, subfamily B, polypeptide 6",123930,"Efavirenz, poor metabolism of",614546,-,same NotI fragment as CYP2A,CYP2B6
"CYP2B6, CYP2B, EFVM","Cytochrome P450, family 2, subfamily B, polypeptide 6",123930,"{Efavirenz central nervous system toxicity, susceptibility to}",614546,-,-,CYP2B6
"TGFB1, DPD1, CED","Transforming growth factor, beta-1",190180,Camurati-Engelmann disease,131300,AD,-,TGFB1
"TGFB1, DPD1, CED","Transforming growth factor, beta-1",190180,"{Cystic fibrosis lung disease, modifier of}",219700,AR,-,TGFB1
"B9D2, MKS10, JBTS34",B9 domain-containing protein 2,611951,?Meckel syndrome 10,614175,AR,mutation identified in 1 MKS10 family,B9D2
"B9D2, MKS10, JBTS34",B9 domain-containing protein 2,611951,Joubert syndrome 34,614175,AR,-,B9D2
"BCKDHA, MSUD1","Branched chain keto acid dehydrogenase E1, alpha polypeptide",608348,"Maple syrup urine disease, type Ia",248600,AR,-,BCKDHA
"RPS19, DBA, DBA1",Ribosomal protein S19,603474,Diamond-Blackfan anemia 1,105650,AD,-,RPS19
"CD79A, IGA",CD79A antigen (immunoglobulin-associated alpha),112205,Agammaglobulinemia 3,613501,AR,-,CD79A
"ATP1A3, DYT12, RDP, AHC2, CAPOS","ATPase, Na+K+ transporting, alpha-3 polypeptide",182350,Alternating hemiplegia of childhood 2,614820,AD,-,ATP1A3
"ATP1A3, DYT12, RDP, AHC2, CAPOS","ATPase, Na+K+ transporting, alpha-3 polypeptide",182350,CAPOS syndrome,601338,AD,-,ATP1A3
"ATP1A3, DYT12, RDP, AHC2, CAPOS","ATPase, Na+K+ transporting, alpha-3 polypeptide",182350,Dystonia-12,128235,AD,-,ATP1A3
"ERF, PE2, CRS4, CHYTS",ETS2 repressor factor,611888,Chitayat syndrome,617180,AD,-,ERF
"ERF, PE2, CRS4, CHYTS",ETS2 repressor factor,611888,Craniosynostosis 4,600775,AD,-,ERF
"CIC, KIAA0306, MRD45","Capicua, Drosophila, homolog of",612082,"Mental retardation, autosomal dominant 45",617600,AD,-,CIC
"MEGF8, EGFL4, CRPT2",Multiple epidermal growth factor-like domains 8,604267,Carpenter syndrome 2,614976,AR,-,MEGF8
"LIPE, LHS, FPLD6","Lipase E, hormone-sensitive",151750,"Lipodystrophy, familial partial, type 6",615980,AR,-,LIPE
"ETHE1, HSCO, D83198",ETHE1 gene,608451,Ethylmalonic encephalopathy,602473,AR,-,ETHE1
"XRCC1, SCAR26","X-ray-repair, complementing defective, repair in Chinese hamster cells-1",194360,"?Spinocerebellar ataxia, autosomal recessive 26",617633,AR,mutation identified in 1 SCAR26 patient,XRCC1
"C19orf61, SMG9, HBMS",Chromosome 19 open reading frame 61,613176,Heart and brain malformation syndrome,616920,AR,-,C19orf61
"KCNN4, KCA4, SK4, DHS2","Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4",602754,Dehydrated hereditary stomatocytosis 2,616689,AD,-,KCNN4
"CEACAM16, CEAL2, DFNA4B",Carcinoembryonic antigen-related cell adhesion molecule 16,614591,"Deafness, autosomal dominant 4B",614614,AD,-,CEACAM16
"LU, AU, BCAM",B-cell adhesion molecule,612773,"[Blood group, Auberger system]",111200,-,linked to SE,LU
"LU, AU, BCAM",B-cell adhesion molecule,612773,"[Blood group, Lutheran null]",247420,AR,-,LU
"LU, AU, BCAM",B-cell adhesion molecule,612773,"[Blood group, Lutheran system]",111200,-,-,LU
"APOE, AD2, LPG, LDLCQ5",Apolipoprotein E,107741,Alzheimer disease-2,104310,AD,possible 2nd locus for AD2 on chr.19,APOE
"APOE, AD2, LPG, LDLCQ5",Apolipoprotein E,107741,"Hyperlipoproteinemia, type III",617347,-,-,APOE
"APOE, AD2, LPG, LDLCQ5",Apolipoprotein E,107741,Lipoprotein glomerulopathy,611771,-,-,APOE
"APOE, AD2, LPG, LDLCQ5",Apolipoprotein E,107741,Sea-blue histiocyte disease,269600,AR,-,APOE
"APOE, AD2, LPG, LDLCQ5",Apolipoprotein E,107741,"{?Macular degeneration, age-related}",603075,AD,-,APOE
"APOE, AD2, LPG, LDLCQ5",Apolipoprotein E,107741,"{Coronary artery disease, severe, susceptibility to}",617347,-,-,APOE
APOC2,Apolipoprotein C-II,608083,"Hyperlipoproteinemia, type Ib",207750,AR,-,APOC2
"RELB, IREL, IMD53",v-rel avian reticuloendotheliosis viral oncogene homolog B,604758,?Immunodeficiency 53,617585,AR,mutation identified in 1 IMD53 family,RELB
"BLOC1S3, BLOS3, HPS8","Biogenesis of lysosome-related organelles complex 1, subunit 3",609762,Hermansky-Pudlak syndrome 8,614077,AR,-,BLOC1S3
"ERCC2, EM9, XPD, COFS2, TTD1","Excision repair cross complementing rodent repair deficiency, complementation group-2",126340,?Cerebrooculofacioskeletal syndrome 2,610756,AR,< 250kb from ERCC1; mutation identified in 1 COFS2 patient,ERCC2
"ERCC2, EM9, XPD, COFS2, TTD1","Excision repair cross complementing rodent repair deficiency, complementation group-2",126340,"Trichothiodystrophy 1, photosensitive",601675,AR,-,ERCC2
"ERCC2, EM9, XPD, COFS2, TTD1","Excision repair cross complementing rodent repair deficiency, complementation group-2",126340,"Xeroderma pigmentosum, group D",278730,AR,-,ERCC2
"ERCC1, UV20, COFS4","Excision repair cross complementing rodent repair deficiency, complementation group-1",126380,Cerebrooculofacioskeletal syndrome 4,610758,AR,distal to CKM,ERCC1
"RTN2, NSPL1, SPG12",Reticulon-2,603183,"Spastic paraplegia 12, autosomal dominant",604805,AD,-,RTN2
"OPA3, MGA3",OPA3 gene,606580,"3-methylglutaconic aciduria, type III",258501,AR,-,OPA3
"OPA3, MGA3",OPA3 gene,606580,Optic atrophy 3 with cataract,165300,AD,-,OPA3
"SIX5, DMAHP, BOR2","Sine oculis homeo box, Drosophila, homolog of, 5",600963,Branchiootorenal syndrome 2,610896,-,-,SIX5
"DMPK, DM, DMK",Dystrophia myotonica-protein kinase,605377,Myotonic dystrophy 1,160900,AD,distal to APOLP2; distal to CKM,DMPK
"CCDC8, 3M3",Coiled-coil domain-containing protein 8,614145,3-M syndrome 3,614205,AR,-,CCDC8
"FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5",Fukutin-related protein,606596,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5",613153,AR,-,FKRP
"FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5",Fukutin-related protein,606596,"Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5",606612,AR,-,FKRP
"FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5",Fukutin-related protein,606596,"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5",607155,AR,-,FKRP
"AP2S1, CLAPS2, AP17, HHC3","Adaptor-related protein complex 2, sigma 1 subunit",602242,"Hypocalciuric hypercalcemia, type III",600740,AD,-,AP2S1
"KPTN, 2E4, MRT41",Kaptin,615620,"Mental retardation, autosomal recessive 41",615637,AR,-,KPTN
"CRX, CORD2, CRD, LCA7",Cone-rod homeo box-containing gene,602225,Cone-rod retinal dystrophy-2,120970,AD,-,CRX
"CRX, CORD2, CRD, LCA7",Cone-rod homeo box-containing gene,602225,Leber congenital amaurosis 7,613829,-,-,CRX
"CCDC114, CILD20",Coiled-coil domain-containing protein 114,615038,"Ciliary dyskinesia, primary, 20",615067,AR,-,CCDC114
"GRIN2D, NMDAR2D, EIEE46","Glutamate receptor, ionotropic, N-methyl-D-aspartate 2D",602717,"Epileptic encephalopathy, early infantile, 46",617162,AD,-,GRIN2D
"SULT2B1, ARCI14","Sulfotransferase family 2B, member 1",604125,"Ichthyosis, congenital, autosomal recessive 14",617571,AR,-,SULT2B1
"FUT2, SE, B12QTL1",Fucosyltransferase-2 (secretor),182100,[Bombay phenotype],-,-,"H, SE = alpha-L-fucosyltransferases; from common ancestral genes; tightly linked to FUT1",FUT2
"FUT2, SE, B12QTL1",Fucosyltransferase-2 (secretor),182100,"{Norwalk virus infection, resistance to}",-,-,-,FUT2
"FUT2, SE, B12QTL1",Fucosyltransferase-2 (secretor),182100,{Vitamin B12 plasma level QTL1},612542,-,-,FUT2
"FUT1, H, HH",Fucosyltransferase-1 (Bombay phenotype),211100,[Bombay phenotype],616754,AR,SE tightly linked,FUT1
BAX,BCL2-associated X protein,600040,"Colorectal cancer, somatic",114500,-,-,BAX
BAX,BCL2-associated X protein,600040,"T-cell acute lymphoblastic leukemia, somatic",613065,-,-,BAX
"FTL, NBIA3, LFTD","Ferritin, light chain",134790,Hyperferritinemia-cataract syndrome,600886,AD,-,FTL
"FTL, NBIA3, LFTD","Ferritin, light chain",134790,"L-ferritin deficiency, dominant and recessive",615604,"AD,AR",-,FTL
"FTL, NBIA3, LFTD","Ferritin, light chain",134790,Neurodegeneration with brain iron accumulation 3,606159,AD,-,FTL
"GYS1, GYS",Glycogen synthase,138570,"Glycogen storage disease 0, muscle",611556,AR,-,GYS1
"LHB, HH23","Luteinizing hormone, beta polypeptide",152780,Hypogonadotropic hypogonadism 23 with or without anosmia,228300,AR,"beta chains of FSH, TSH on 11p, 1p, respectively",LHB
"NTF4 , NTF5, NT5, NT4, GLC1O",Neurotrophin-4 (neurotrophin-4/5),162662,"Glaucoma 1, open angle, 1O",613100,-,"3 genes, ? functional, also on 19",NTF4 
"TRPM4, PFHB1B","Transient receptor potential cation channel, subfamily M, member 4",606936,"Progressive familial heart block, type IB",604559,AD,-,TRPM4
"IRF3, IIAE7",Interferon regulatory factor 3,603734,"{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}",616532,AD,-,IRF3
"CPT1C, SPG73",Carnitine palmitoyltransferase IC,608846,"?Spastic paraplegia 73, autosomal dominant",616282,AD,mutation identified in 1 SPG73 family,CPT1C
"FUZ, NTD","Fuzzy, Drosophila, homolog of",610622,Neural tube defects,182940,AD,-,FUZ
"MED25, PTOV2, ARC92, CMT2B2, BVSYS","Mediator of RNA polymerase II transcription, subunit 25, S. cerevisiae, homolog of",610197,"?Charcot-Marie-Tooth disease, type 2B2",605589,AR,mutation identified in 1 CMT2B2 family,MED25
"MED25, PTOV2, ARC92, CMT2B2, BVSYS","Mediator of RNA polymerase II transcription, subunit 25, S. cerevisiae, homolog of",610197,Basel-Vanagait-Smirin-Yosef syndrome,616449,AR,-,MED25
"PNKP, PNK, MCSZ, EIEE10, AOA4",Polynucleotide kinase 3' phosphatase,605610,Ataxia-oculomotor apraxia 4,616267,AR,-,PNKP
"PNKP, PNK, MCSZ, EIEE10, AOA4",Polynucleotide kinase 3' phosphatase,605610,"Microcephaly, seizures, and developmental delay",613402,AR,-,PNKP
"NUP62, SNDI, IBSN","Nucleoporin, 62-kD",605815,"Striatonigral degeneration, infantile",271930,AR,-,NUP62
"MYH14, KIAA2034, DFNA4A, PNMHH","Myosin, heavy chain 14, nonmuscle",608568,"?Peripheral neuropathy, myopathy, hoarseness, and hearing loss",614369,AD,mutation identified in 1 PNMHH family,MYH14
"MYH14, KIAA2034, DFNA4A, PNMHH","Myosin, heavy chain 14, nonmuscle",608568,"Deafness, autosomal dominant 4A",600652,AD,-,MYH14
"KCNC3, SCA13","Potassium voltage-gated channel, Shaw-related subfamily, member 3",176264,Spinocerebellar ataxia 13,605259,AD,-,KCNC3
"POLD1, CRCS10, MDPL","Polymerase (DNA directed), delta 1, catalytic subunit",174761,"Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome",615381,AD,-,POLD1
"POLD1, CRCS10, MDPL","Polymerase (DNA directed), delta 1, catalytic subunit",174761,"{Colorectal cancer, susceptibility to, 10}",612591,AD,-,POLD1
"ACPT, AI1J","Acid phosphatase, testicular",606362,"Amelogenesis imperfecta, type IJ",617297,AR,-,ACPT
"KLK1, KLKR",Kallikrein 1,147910,"[Kallikrein, decreased urinary activity of]",615953,-,~10cM distal to APOC2,KLK1
"KLK4, EMSP1, PRSS17, AI2A1",Kallikrein-related peptidase 4,603767,"Amelogenesis imperfecta, type IIA1",204700,AR,-,KLK4
"ETFB, MADD","Electron transfer flavoprotein, beta polypeptide",130410,Glutaric acidemia IIB,231680,AR,-,ETFB
"LIM2, MP19, CTRCT19","Lens intrinsic protein 2, 19kD",154045,"Cataract 19, multiple types",615277,AR,same cosmid as ETFB,LIM2
"PPP2R1A, MRD36","Protein phosphatase 2, structural/regulatory subunit A, alpha",605983,"Mental retardation, autosomal dominant 36",616362,AD,-,PPP2R1A
"NLRP12, NALP12, PYPAF7, RNO, FCAS2","NLR family, pyrin domain containing 12",609648,Familial cold autoinflammatory syndrome 2,611762,AD,-,NLRP12
"PRKCG, PKCC, PKCG, SCA14","Protein kinase C, gamma polypeptide",176980,Spinocerebellar ataxia 14,605361,AD,-,PRKCG
"PRPF31, PRP31, RP11","Precursor RNA-processing factor 31, S. cerevisiae, homolog of",606419,Retinitis pigmentosa 11,600138,AD,-,PRPF31
"MBOAT7, BB1, LENG4, MRT57",Membrane bound O-acyltransferase domain containing 7,606048,"Mental retardation, autosomal recessive 57",617188,AR,-,MBOAT7
"TSEN34, PCH2C, LENG5, SEN34","tRNA splicing endonuclease 34, S. cerevisiae, homolog of",608754,?Pontocerebellar hypoplasia type 2C,612390,-,mutation identified in 1 PCH2C patient,TSEN34
"KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1","Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1",604946,"{AIDS, delayed/rapid progression to}",609423,-,-,KIR3DL1
"NALP7, NOD12, PYPAF3, HYDM","NACHT domain-, leucine-rich repeat-, and PYD-containing protein 7",609661,"Hydatidiform mole, recurrent, 1",231090,AR,-,NALP7
"GP6, GPIV, BDPLT11","Glycoprotein VI, platelet",605546,"Bleeding disorder, platelet-type, 11",614201,AR,-,GP6
"TNNT1, ANM, NEM5","Troponin-T1, skeletal, slow",191041,"Nemaline myopathy 5, Amish type",605355,AR,-,TNNT1
"TNNI3, CMH7, CMD2A, RCM1, CMD1FF","Troponin-I, cardiac",191044,"?Cardiomyopathy, dilated, 2A",611880,AR,mutation identified in 1 CMD2A family,TNNI3
"TNNI3, CMH7, CMD2A, RCM1, CMD1FF","Troponin-I, cardiac",191044,"Cardiomyopathy, dilated, 1FF",613286,-,-,TNNI3
"TNNI3, CMH7, CMD2A, RCM1, CMD1FF","Troponin-I, cardiac",191044,"Cardiomyopathy, familial restrictive, 1",115210,AD,-,TNNI3
"TNNI3, CMH7, CMD2A, RCM1, CMD1FF","Troponin-I, cardiac",191044,"Cardiomyopathy, hypertrophic, 7",613690,AD,-,TNNI3
"DNAAF3, PF22, DAB1, CILD2","Dynein, axonemal, assembly factor 3",614566,"Ciliary dyskinesia, primary, 2",606763,AR,-,DNAAF3
"AURKC, STK13, AIE2, SPGF5",Aurora kinase C,603495,Spermatogenic failure 5,243060,AR,-,AURKC
"RBCK1, HOIL1, PGBM1, PBMEI",RANBP-type and C3HC4-type zinc finger-containing 1,610924,Polyglucosan body myopathy 1 with or without immunodeficiency,615895,AR,-,RBCK1
"TBC1D20, C20orf140, WARBM4","TBC1 domain family, member 20",611663,Warburg micro syndrome 4,615663,AR,-,TBC1D20
"CSNK2A1, CK2A1, OCNDS","Casein kinase-2, alpha-1 polypeptide",115440,Okur-Chung neurodevelopmental syndrome,617062,AD,pseudogene on 11p15,CSNK2A1
"SLC52A3, C20orf54, RFT2, BVVLS1","Solute carrier family 52, riboflavin transporter, member 3",613350,?Fazio-Londe disease,211500,AR,mutation identified in 1 FZLD family,SLC52A3
"SLC52A3, C20orf54, RFT2, BVVLS1","Solute carrier family 52, riboflavin transporter, member 3",613350,Brown-Vialetto-Van Laere syndrome 1,211530,AR,-,SLC52A3
"RSPO4, CRISTIN4","R-spondin family, member 4",610573,Anonychia congenita,206800,AR,-,RSPO4
"PDYN, SCA23",Prodynorphin,131340,Spinocerebellar ataxia 23,610245,AD,-,PDYN
"TGM3, UHS2","Transglutaminase-3 (E polypeptide, protein-glutamine-gamma-glutamyl transferase)",600238,?Uncombable hair syndrome 2,617251,AR,mutation identified in 1 UHS2 patient,TGM3
"TGM6, TG6, TGY, SCA35",Transglutaminase 6,613900,Spinocerebellar ataxia 35,613908,AD,-,TGM6
"SNRPB, CCMS",Small nuclear ribonucleoprotein polypeptides B and B1,182282,Cerebrocostomandibular syndrome,117650,AD,-,SNRPB
"NOP56, SCA36","Nop56, S. cerevisiae, homolog of",614154,Spinocerebellar ataxia 36,614153,AD,-,NOP56
"IDH3B, RP46","Isocitrate dehydrogenase 3, beta subunit",604526,Retinitis pigmentosa 46,612572,-,-,IDH3B
"AVP, AVRP, VP","Arginine vasopressin (neurophysin II, antidiuretic hormone)",192340,"Diabetes insipidus, neurohypophyseal",125700,AD,distal 20p,AVP
"DDRGK1, UFBP1, C20orf116, SEMDSH",DDRGK domain-containing protein 1,616177,"Spondyloepimetaphyseal dysplasia, Shohat type",602557,AR,-,DDRGK1
"ITPA, EIEE35",Inosine triphosphatase-A,147520,"Epileptic encephalopathy, early infantile, 35",616647,AR,-,ITPA
"ITPA, EIEE35",Inosine triphosphatase-A,147520,[Inosine triphosphatase deficiency],613850,-,-,ITPA
"SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4","Solute carrier family 4 (sodium borate cotransporter), member 11",610206,"Corneal dystrophy, Fuchs endothelial, 4",613268,-,-,SLC4A11
"SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4","Solute carrier family 4 (sodium borate cotransporter), member 11",610206,Corneal endothelial dystrophy and perceptive deafness,217400,AR,-,SLC4A11
"SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4","Solute carrier family 4 (sodium borate cotransporter), member 11",610206,"Corneal endothelial dystrophy, autosomal recessive",217700,AR,-,SLC4A11
"PANK2, NBIA1, PKAN, HARP",Pantothenate kinase 2,606157,HARP syndrome,607236,AR,-,PANK2
"PANK2, NBIA1, PKAN, HARP",Pantothenate kinase 2,606157,Neurodegeneration with brain iron accumulation 1,234200,AR,-,PANK2
"PRNP, PRIP, KURU, CJD",Prion protein (p27-30),176640,"Cerebral amyloid angiopathy, PRNP-related",137440,AD,pter-PRNP-SCG1-BMP2A-PAX1-cen,PRNP
"PRNP, PRIP, KURU, CJD",Prion protein (p27-30),176640,Creutzfeldt-Jakob disease,123400,AD,-,PRNP
"PRNP, PRIP, KURU, CJD",Prion protein (p27-30),176640,Gerstmann-Straussler disease,137440,AD,-,PRNP
"PRNP, PRIP, KURU, CJD",Prion protein (p27-30),176640,Huntington disease-like 1,603218,AD,-,PRNP
"PRNP, PRIP, KURU, CJD",Prion protein (p27-30),176640,"Insomnia, fatal familial",600072,AD,-,PRNP
"PRNP, PRIP, KURU, CJD",Prion protein (p27-30),176640,Prion disease with protracted course,606688,AD,-,PRNP
"PRNP, PRIP, KURU, CJD",Prion protein (p27-30),176640,"{Kuru, susceptibility to}",245300,-,-,PRNP
BMND7,Bone mineral density QTL 7,611738,{Osteoporosis},166710,AD,most significant association with haplotype C,BMND7
"PCNA, ATLD2",Proliferating cell nuclear antigen,176740,?Ataxia-telangiectasia-like disorder 2,615919,AR,pseudogenes on X and 6; mutation identified in one ATLD2 family,PCNA
"PROKR2, PKR2, GPR73L1, HH3",Prokineticin receptor 2,607123,Hypogonadotropic hypogonadism 3 with or without anosmia,244200,AD,-,PROKR2
"MCM8, POF10",Minichromosome maintenance complement component 8,608187,?Premature ovarian failure 10,612885,AR,mutation identified in 1 POF10 family,MCM8
"KIND1, URP1, C20orf42",Kindlin 1,607900,Kindler syndrome,173650,AR,-,KIND1
"BMP2, BMP2A, BDA2, SSFSC",Bone morphogenetic protein-2,112261,"Brachydactyly, type A2",112600,AD,-,BMP2
"BMP2, BMP2A, BDA2, SSFSC",Bone morphogenetic protein-2,112261,"Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies",617877,AD,-,BMP2
"BMP2, BMP2A, BDA2, SSFSC",Bone morphogenetic protein-2,112261,"{HFE hemochromatosis, modifier of}",235200,AR,-,BMP2
"PLCB1, KIAA0581, PLCB1A, PLCB1B, EIEE12","Phospholipase C, beta-1",607120,"Epileptic encephalopathy, early infantile, 12",613722,AR,-,PLCB1
"PLCB4, ARCND2","Phospholipase C, beta 4",600810,Auriculocondylar syndrome 2,614669,"AD,AR",-,PLCB4
"SNAP25, CMS18","Synaptosomal-associated protein, 25kD",600322,"?Myasthenic syndrome, congenital, 18",616330,AD,mutation identified in 1 CMS18 patient,SNAP25
"MKKS, HMCS, KMS, MKS, BBS6",McKusick-Kaufman syndrome gene,604896,Bardet-Biedl syndrome 6,605231,AR,-,MKKS
"MKKS, HMCS, KMS, MKS, BBS6",McKusick-Kaufman syndrome gene,604896,McKusick-Kaufman syndrome,236700,AR,-,MKKS
"JAG1, AGS1, AHD",Jagged 1,601920,"?Deafness, congenital heart defects, and posterior embryotoxon",-,-,mutation identified in 1 DFNCDPE family,JAG1
"JAG1, AGS1, AHD",Jagged 1,601920,Alagille syndrome 1,118450,AD,-,JAG1
"JAG1, AGS1, AHD",Jagged 1,601920,Tetralogy of Fallot,187500,AD,-,JAG1
"NDUFAF5, C20orf7","NADH dehydrogenase (ubiquinone) complex I, assembly factor T",612360,Mitochondrial complex 1 deficiency,252010,"XLD,Mi,AR",-,NDUFAF5
"FLRT3, HH21",Fibronectin-like domain-containing leucine-rich transmembrane protein-3,604808,Hypogonadotropic hypogonadism 21 with anosmia,615271,AD,-,FLRT3
"BFSP1, CP115, CTRCT33",Beaded filament structural protein-1 (filensin),603307,"Cataract 33, multiple types",611391,"AD,AR",-,BFSP1
"MGME1, C20orf72, MTDPS11",Mitochondrial genome maintenance exonuclease 1,615076,Mitochondrial DNA depletion syndrome 11,615084,AR,-,MGME1
"OVOL2, ZNF339, PPCD1",ovo-like 2,616441,"Corneal dystrophy, posterior polymorphous, 1",122000,AD,-,OVOL2
"SEC23B, CDAN2, HEMPAS, CWS7","Sec23, S. cerevisiae, homolog of, B",610512,Cowden syndrome 7,616858,AD,-,SEC23B
"SEC23B, CDAN2, HEMPAS, CWS7","Sec23, S. cerevisiae, homolog of, B",610512,"Dyserythropoietic anemia, congenital, type II",224100,AR,-,SEC23B
"RIN2, MACS",RAS and RAB interactor 2,610222,"Macrocephaly, alopecia, cutis laxa, and scoliosis",613075,AR,-,RIN2
"KIZ, KIZUNA, C20orf19, RP69",Kizuna centrosomal protein,615757,Retinitis pigmentosa 69,615780,AR,-,KIZ
"PAX1, OFC2",Paired box homeotic gene-1,167411,?Otofaciocervical syndrome 2,615560,AR,mutation identified in 1 family,PAX1
"THBD, THRM, AHUS6, THPH12",Thrombomodulin,188040,Thrombophilia due to thrombomodulin defect,614486,-,-,THBD
"THBD, THRM, AHUS6, THPH12",Thrombomodulin,188040,"{Hemolytic uremic syndrome, atypical, susceptibility to, 6}",612926,AD,-,THBD
"GZF1, ZNF336, JLSM",GDNF-inducible zinc finger protein 1,613842,"Joint laxity, short stature, and myopia",617662,AR,-,GZF1
"CST3, ARMD11",Cystatin C,604312,Cerebral amyloid angiopathy,105150,AD,proximal to 20p11.2,CST3
"CST3, ARMD11",Cystatin C,604312,"{Macular degeneration, age-related, 11}",611953,-,-,CST3
"VSX1, RINX, KTCN1, CAASDS","Visual system homeo box gene 1, zebrafish, homolog of",605020,?Craniofacial anomalies and anterior segment dysgenesis syndrome,614195,-,mutation identified in 1 CAASDS family,VSX1
"VSX1, RINX, KTCN1, CAASDS","Visual system homeo box gene 1, zebrafish, homolog of",605020,Keratoconus 1,148300,AD,-,VSX1
"ABHD12, PHARC",Abhydrolase domain-containing protein 12,613599,"Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract",612674,AR,-,ABHD12
"GINS1, PSF1, KIAA0186, IMD55",GINS complex subunit 1,610608,Immunodeficiency 55,617827,AR,-,GINS1
HYT5,"Hypertension, essential, susceptibility to, 5",610261,"{Hypertension, essential, susceptibility to, 5}",145500,Mu,-,HYT5
MBCS,Mulchandani-Bhoj-Conlin syndrome,617352,Mulchandani-Bhoj-Conlin syndrome,617352,-,maternal uniparental disomy of imprinted region,MBCS
COX4I2,"Cytochrome c oxidase, subunit IV, isoform 2",607976,"Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis",612714,AR,-,COX4I2
"MYLK2, MLCK",Myosin light chain kinase 2,606566,"Cardiomyopathy, hypertrophic, 1, digenic",192600,AD,-,MYLK2
"POFUT1, OFUCT1, KIAA0180, DDD2",Protein O-fucosyltransferase 1,607491,Dowling-Degos disease 2,615327,AD,-,POFUT1
"ASXL1, KIAA0978, BOPS, MDS",Additional sex combs-like 1,612990,Bohring-Opitz syndrome,605039,AD,-,ASXL1
"ASXL1, KIAA0978, BOPS, MDS",Additional sex combs-like 1,612990,"Myelodysplastic syndrome, somatic",614286,-,-,ASXL1
"DNMT3B, ICF1",DNA methyltransferase 3B,602900,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,242860,AR,-,DNMT3B
"SUN5, TSARG4, SPAG4L, SPGF16",Sad1 and Unc84 domain-containing protein 5,613942,Spermatogenic failure 16,617187,AR,-,SUN5
"SNTA1, SNT1, TACIP1, LQT12","Syntrophin, alpha-1",601017,Long QT syndrome 12,612955,AD,-,SNTA1
"CHMP4B, SNF7, CTPP3, CTRCT31","CHMP family, member 4B",610897,"Cataract 31, multiple types",605387,AD,-,CHMP4B
"ASIP, AGTIL, SHEP9","Agouti, mouse, signaling protein",600201,"[Skin/hair/eye pigmentation 9, brown/nonbrown eyes]",611742,-,-,ASIP
"ASIP, AGTIL, SHEP9","Agouti, mouse, signaling protein",600201,"[Skin/hair/eye pigmentation 9, dark/light hair]",611742,-,-,ASIP
"AHCY, SAHH",S-adenosylhomocysteine hydrolase,180960,Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase,613752,AR,~13cM from ADA,AHCY
"ITCH, AIP4, NAPP1, ADMFD","Itchy, mouse, homolog of",606409,"Autoimmune disease, multisystem, with facial dysmorphism",613385,AR,-,ITCH
"GSS, GSHS",Glutathione synthetase,601002,Glutathione synthetase deficiency,266130,AR,-,GSS
"GSS, GSHS",Glutathione synthetase,601002,Hemolytic anemia due to glutathione synthetase deficiency,231900,AR,-,GSS
"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1),601146,"?Acromesomelic dysplasia, Hunter-Thompson type",201250,AR,mutation identified in 1 AMDHT family,GDF5
"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1),601146,"Brachydactyly, type A1, C",615072,"AD,AR",-,GDF5
"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1),601146,"Brachydactyly, type A2",112600,AD,-,GDF5
"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1),601146,"Brachydactyly, type C",113100,AD,-,GDF5
"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1),601146,"Chondrodysplasia, Grebe type",200700,AR,-,GDF5
"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1),601146,Du Pan syndrome,228900,AR,-,GDF5
"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1),601146,Multiple synostoses syndrome 2,610017,AD,-,GDF5
"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1),601146,"Symphalangism, proximal, 1B",615298,-,-,GDF5
"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1),601146,{Osteoarthritis-5},612400,-,-,GDF5
"RBM12, KIAA0765, SCZD19",RNA-binding motif protein 12,607179,"{Schizophrenia 19, susceptibility to}",617629,AD,-,RBM12
"EPB41L1, MRD11",Erythrocyte membrane protein band 4.1-like 1,602879,"?Mental retardation, autosomal dominant 11",614257,-,mutation identified in 1 patient,EPB41L1
"SAMHD1, AGS5, DCIP, CHBL2",SAM domain- and HD domain-containing protein 1,606754,?Chilblain lupus 2,614415,AD,mutation identified in 1 CHBL2 family,SAMHD1
"SAMHD1, AGS5, DCIP, CHBL2",SAM domain- and HD domain-containing protein 1,606754,Aicardi-Goutieres syndrome 5,612952,AR,-,SAMHD1
"SRC, ASV, SRC1, THC6","Protooncogene SRC, Rous sarcoma",190090,?Thrombocytopenia 6,616937,AD,mutation identified in 1 THC6 family,SRC
"SRC, ASV, SRC1, THC6","Protooncogene SRC, Rous sarcoma",190090,"Colon cancer, advanced, somatic",114500,-,-,SRC
NIDDM3,Noninsulin-dependent diabetes mellitus 3,603694,"{Diabetes mellitus, noninsulin-dependent}",125853,AD,-,NIDDM3
"MAFB, KRML, MCTO, DURS3","v-MAF musculoaponeurotic fibrosarcoma oncogene family, protein B",608968,Duane retraction syndrome 3,617041,AD,-,MAFB
"MAFB, KRML, MCTO, DURS3","v-MAF musculoaponeurotic fibrosarcoma oncogene family, protein B",608968,Multicentric carpotarsal osteolysis syndrome,166300,AD,-,MAFB
HPC3,"Prostate cancer, hereditary, 3",608656,"{Prostate cancer, susceptibility to, 3}",176807,AD,-,HPC3
IFT52,"Intraflagellar transport 52, Chlamydomonas, homolog of",617094,Short-rib thoracic dysplasia 16 with or without polydactyly,617102,AR,-,IFT52
"JPH2, JP2, CMH17",Junctophilin 2,605267,"Cardiomyopathy, hypertrophic, 17",613873,AD,-,JPH2
"HNF4A, TCF14, MODY1, FRTS4","Hepatocyte nuclear factor 4, alpha (transcription factor-14)",600281,"Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young",616026,AD,-,HNF4A
"HNF4A, TCF14, MODY1, FRTS4","Hepatocyte nuclear factor 4, alpha (transcription factor-14)",600281,"MODY, type I",125850,AD,-,HNF4A
"HNF4A, TCF14, MODY1, FRTS4","Hepatocyte nuclear factor 4, alpha (transcription factor-14)",600281,"{Diabetes mellitus, noninsulin-dependent}",125853,AD,-,HNF4A
ADA,Adenosine deaminase,608958,"Adenosine deaminase deficiency, partial",102700,"AR,SMo",-,ADA
ADA,Adenosine deaminase,608958,Severe combined immunodeficiency due to ADA deficiency,102700,"AR,SMo",-,ADA
"STK4, MST1, KRS2, TIIAC",Serine/threonine protein kinase 4,604965,"T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations",614868,-,-,STK4
"PIGT, NDAP, PNH2, MCAHS3","Phosphatidylinositol glycan, class T",610272,?Paroxysmal nocturnal hemoglobinuria 2,615399,"AD,SMu",mutation identified in 1 PNH2 family,PIGT
"PIGT, NDAP, PNH2, MCAHS3","Phosphatidylinositol glycan, class T",610272,Multiple congenital anomalies-hypotonia-seizures syndrome 3,615398,AR,-,PIGT
"CTSA, PPGB, GSL, NGBE, GLB2",Cathepsin A (protective protein for beta-galactosidase),613111,Galactosialidosis,256540,AR,-,CTSA
"ZNF335, NIF1, NIF2, MCPH10",Zinc finger protein 335,610827,"?Microcephaly 10, primary, autosomal recessive",615095,AR,mutation identified in 1 MCPH10 family,ZNF335
"MMP9, CLG4B, MANDP2","Matrix metalloproteinase 9 (gelatinase B, 92kD type IV collagenase)",120361,Metaphyseal anadysplasia 2,613073,-,-,MMP9
"SLC12A5, KCC2, KIAA1176, EIEE34, EIG14","Solute carrier family 12, (potassium-chloride transporter) member 5",606726,"Epileptic encephalopathy, early infantile, 34",616645,AR,-,SLC12A5
"SLC12A5, KCC2, KIAA1176, EIEE34, EIG14","Solute carrier family 12, (potassium-chloride transporter) member 5",606726,"{Epilepsy, idiopathic generalized, susceptibility to, 14}",616685,AD,-,SLC12A5
"CD40, TNFRSF5",CD40 antigen,109535,"Immunodeficiency with hyper-IgM, type 3",606843,AR,-,CD40
"ELMO2, CED12, VMPI",Engulfment and cell motility gene 2,606421,"Vascular malformation, primary intraosseous",606893,AR,-,ELMO2
"TP53RK, PRPK, GAMOS4",TP53-regulating kinase,608679,Galloway-Mowat syndrome 4,617730,AR,-,TP53RK
"SLC2A10, GLUT10, ATS","Solute carrier family 2 (facilitated glucose transporter), member 10",606145,Arterial tortuosity syndrome,208050,AR,-,SLC2A10
"ARFGEF2, BIG2, PVNH2","ADP-ribosylation factor guanine nucleotide-exchange factor 2, brefeldin A-inhibited",605371,Periventricular heterotopia with microcephaly,608097,AR,-,ARFGEF2
"KCNB1, EIEE26","Potassium voltage-gated channel, Shab-related subfamily, member 1",600397,"Epileptic encephalopathy, early infantile, 26",616056,AD,-,KCNB1
"PTGIS, CYP8A1, PGIS, CYP8",Prostaglandin I2 synthase,601699,"Hypertension, essential",145500,Mu,-,PTGIS
"PTPN1, PTP1B","Protein tyrosine phosphatase, nonreceptor-type, 1",176885,"{Insulin resistance, susceptibility to}",125853,AD,20pter-q12 by REa,PTPN1
"ADNP, ADNP1, KIAA0784, HVDAS, MRD28",Activity-dependent neuroprotector homeobox,611386,Helsmoortel-van der Aa syndrome,615873,AD,-,ADNP
"DPM1, MPDS, CDGIE","Dolichyl-phosphate mannosyltransferase 1, catalytic subunit",603503,"Congenital disorder of glycosylation, type Ie",608799,AR,-,DPM1
"SALL4, HSAL4",sal-like 4,607343,Duane-radial ray syndrome,607323,AD,-,SALL4
"SALL4, HSAL4",sal-like 4,607343,IVIC syndrome,147750,AD,-,SALL4
"CYP24A1, CYP24, HCINF1","Cytochrome P450, family 24, subfamily A, polypeptide 1 (vitamin D 24-hydroxylase)",126065,"Hypercalcemia, infantile, 1",143880,AR,-,CYP24A1
"MC3R, BMIQ9",Melanocortin-3 receptor,155540,"{Mycobacterium tuberculosis, protection against}",607948,-,-,MC3R
"MC3R, BMIQ9",Melanocortin-3 receptor,155540,"{Obesity, severe, susceptibility to, BMIQ9}",602025,-,-,MC3R
"AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK",Aurora kinase A,603072,"{Colon cancer, susceptibility to}",114500,AD,-,AURKA
"PCK1, PCKDC",Phosphoenolpyruvate carboxykinase-1 (soluble),614168,"?Phosphoenolpyruvate carboxykinase deficiency, cytosolic",261680,AR,mutation identified in 1 PCKDC family,PCK1
"VAPB, VAPC, ALS8",Vesicle-associated membrane protein-associated protein B,605704,Amyotrophic lateral sclerosis 8,608627,AD,-,VAPB
"VAPB, VAPC, ALS8",Vesicle-associated membrane protein-associated protein B,605704,"Spinal muscular atrophy, late-onset, Finkel type",182980,AD,-,VAPB
"STX16, SYN16",Syntaxin 16,603666,"Pseudohypoparathyroidism, type IB",603233,AD,-,STX16
"GNASAS1, GNASAS, SANG, NESPAS",GNAS antisense RNA 1,610540,"Pseudohypoparathyroidism, type IB",603233,AD,-,GNASAS1
"GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3","GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)",139320,ACTH-independent macronodular adrenal hyperplasia,219080,IC,-,GNAS
"GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3","GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)",139320,"McCune-Albright syndrome, somatic, mosaic",174800,-,-,GNAS
"GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3","GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)",139320,"Osseous heteroplasia, progressive",166350,AD,-,GNAS
"GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3","GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)",139320,"Pituitary adenoma 3, multiple types, somatic",617686,-,-,GNAS
"GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3","GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)",139320,Pseudohypoparathyroidism Ia,103580,AD,-,GNAS
"GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3","GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)",139320,Pseudohypoparathyroidism Ib,603233,AD,-,GNAS
"GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3","GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)",139320,Pseudohypoparathyroidism Ic,612462,AD,-,GNAS
"GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3","GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)",139320,Pseudopseudohypoparathyroidism,612463,AD,-,GNAS
TUBB1,"Tubulin, beta-1",612901,"Macrothrombocytopenia, autosomal dominant, TUBB1-related",613112,AD,-,TUBB1
"ATP5E, MC5DN3","ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit",606153,"?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3",614053,-,pseudogene on 4q25; mutation identified in 1 MC5DN3 patient,ATP5E
"EDN3, WS4B, HSCR4",Endothelin-3,131242,"Central hypoventilation syndrome, congenital",209880,AD,-,EDN3
"EDN3, WS4B, HSCR4",Endothelin-3,131242,"Waardenburg syndrome, type 4B",613265,"AD,AR",-,EDN3
"EDN3, WS4B, HSCR4",Endothelin-3,131242,"{Hirschsprung disease, susceptibility to, 4}",613712,AD,-,EDN3
"OSBPL2, ORP2, KIAA0772, DNFA67",Oxysterol-binding protein-like protein 2,606731,"Deafness, autosomal dominant 67",616340,AD,-,OSBPL2
"COL9A3, EDM3, IDD","Collagen IX, alpha-3 polypeptide",120270,"Epiphyseal dysplasia, multiple, 3, with or without myopathy",600969,AD,-,COL9A3
"COL9A3, EDM3, IDD","Collagen IX, alpha-3 polypeptide",120270,"{Intervertebral disc disease, susceptibility to}",603932,-,-,COL9A3
"SLC17A9, C20orf59, POROK8","Solute carrier family 17, member 9",612107,"Porokeratosis 8, disseminated superficial actinic type",616063,AD,-,SLC17A9
"CHRNA4, ENFL1","Cholinergic receptor, nicotinic, alpha polypeptide-4",118504,"Epilepsy, nocturnal frontal lobe, 1",600513,AD,-,CHRNA4
"CHRNA4, ENFL1","Cholinergic receptor, nicotinic, alpha polypeptide-4",118504,"{Nicotine addiction, susceptibility to}",188890,-,-,CHRNA4
"KCNQ2, EBN1, EIEE7, BFNS1","Potassium voltage-gated channel, KQT-like subfamily, member 2",602235,"Epileptic encephalopathy, early infantile, 7",613720,AD,-,KCNQ2
"KCNQ2, EBN1, EIEE7, BFNS1","Potassium voltage-gated channel, KQT-like subfamily, member 2",602235,Myokymia,121200,AD,-,KCNQ2
"KCNQ2, EBN1, EIEE7, BFNS1","Potassium voltage-gated channel, KQT-like subfamily, member 2",602235,"Seizures, benign neonatal, 1",121200,AD,-,KCNQ2
"EEF1A2, EIEE33, MRD38","Eukaryotic translation elongation factor-1, alpha-2",602959,"Epileptic encephalopathy, early infantile, 33",616409,AD,-,EEF1A2
"EEF1A2, EIEE33, MRD38","Eukaryotic translation elongation factor-1, alpha-2",602959,"Mental retardation, autosomal dominant 38",616393,AD,-,EEF1A2
"RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3",Regulator of telomere elongation helicase 1,608833,"Dyskeratosis congenita, autosomal dominant 4",615190,"AD,AR",-,RTEL1
"RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3",Regulator of telomere elongation helicase 1,608833,"Dyskeratosis congenita, autosomal recessive 5",615190,"AD,AR",-,RTEL1
"RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3",Regulator of telomere elongation helicase 1,608833,"Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3",616373,AD,-,RTEL1
"DNAJC5, DNAJC5A, CSP, CLN4B","DNAJ/HSP40 homolog, subfamily C, member 5",611203,"Ceroid lipofuscinosis, neuronal, 4, Parry type",162350,AD,-,DNAJC5
"PRPF6, PRP6, ANT1, TOM, C20orf14","Precursor mRNA-processing factor 6, S. cerevisiae, homolog of",613979,Retinitis pigmentosa 60,613983,AD,-,PRPF6
"SOX18, HLTS, HLTRS","SOX18, mouse, homolog of",601618,Hypotrichosis-lymphedema-telangiectasia syndrome,607823,AR,-,SOX18
"SOX18, HLTS, HLTRS","SOX18, mouse, homolog of",601618,Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome,137940,AD,-,SOX18
"LIPI, LPDL, PRED5",Lipase I,609252,"{Hypertriglyceridemia, susceptibility to}",145750,AD,-,LIPI
"PRSS7, ENTK","Protease, serine, 7 (enterokinase)",606635,Enterokinase deficiency,226200,AR,-,PRSS7
"APP, AAA, CVAP, AD1",Amyloid beta (A4) precursor protein,104760,"Alzheimer disease 1, familial",104300,AD,proximal to SOD; very distal q21 or boundary with q22,APP
"APP, AAA, CVAP, AD1",Amyloid beta (A4) precursor protein,104760,"Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants",605714,AD,-,APP
"SOD1, ALS1","Superoxide dismutase-1, soluble",147450,Amyotrophic lateral sclerosis 1,105400,"AD,AR",mid q22.1,SOD1
"MRAP, FALP, C21orf61, GCCD2, FGD2",Melanocortin 2 receptor accessory protein,609196,Glucocorticoid deficiency 2,607398,AR,-,MRAP
"C21orf59, CILD26",Chromosome 21 open reading frame 59,615494,"Ciliary dyskinesia, primary, 26",615500,AR,-,C21orf59
"SYNJ1, PARK20, EIEE53",Synaptojanin 1,604297,"Epileptic encephalopathy, early infantile, 53",617389,AR,-,SYNJ1
"SYNJ1, PARK20, EIEE53",Synaptojanin 1,604297,"Parkinson disease 20, early-onset",615530,AR,-,SYNJ1
"IFNAR2, IMD45","Interferon, alpha, beta, and omega, receptor 2",602376,?Immunodeficiency 45,616669,AR,mutation identified in 1 IMD45 family,IFNAR2
"IFNAR2, IMD45","Interferon, alpha, beta, and omega, receptor 2",602376,"{Hepatitis B virus, susceptibility to}",610424,-,-,IFNAR2
"CRFB4, IBD25","Cytokine receptor, family II, member 4",123889,"Inflammatory bowel disease 25, early onset, autosomal recessive",612567,AR,35kb distal to IFNAR; D21S58,CRFB4
"CRFB4, IBD25","Cytokine receptor, family II, member 4",123889,"{Hepatitis B virus, susceptibility to}",610424,-,-,CRFB4
"IFNGR2, IFNGT1, IFGR2, IMD28",Interferon gamma receptor-2 (interferon gamma transducer 1),147569,"Immunodeficiency 28, mycobacteriosis",614889,AR,-,IFNGR2
"SON, TOKIMS",SON DNA-binding protein,182465,ZTTK syndrome,617140,AD,-,SON
"DONSON, C21orf60, MISSLA, MIMIS",Downstream neighbor of SON,611428,"Microcephaly, short stature, and limb abnormalities",617604,AR,-,DONSON
"DONSON, C21orf60, MISSLA, MIMIS",Downstream neighbor of SON,611428,Microcephaly-micromelia syndrome,251230,AR,-,DONSON
"KCNE2, MIRP1, LQT6, ATFB4","Potassium voltage-gated channel, Isk-related family, member 2",603796,"Atrial fibrillation, familial, 4",611493,-,-,KCNE2
"KCNE2, MIRP1, LQT6, ATFB4","Potassium voltage-gated channel, Isk-related family, member 2",603796,Long QT syndrome 6,613693,AD,-,KCNE2
"KCNE1, JLNS, LQT5, JLNS2","Potassium voltage-gated channel, Isk-related subfamily, member 1",176261,Jervell and Lange-Nielsen syndrome 2,612347,AR,-,KCNE1
"KCNE1, JLNS, LQT5, JLNS2","Potassium voltage-gated channel, Isk-related subfamily, member 1",176261,Long QT syndrome 5,613695,AD,-,KCNE1
"RUNX1, CBFA2, AML1",Runt-related transcription factor 1 (aml1 oncogene),151385,"Leukemia, acute myeloid",601626,AD,-,RUNX1
"RUNX1, CBFA2, AML1",Runt-related transcription factor 1 (aml1 oncogene),151385,"Platelet disorder, familial, with associated myeloid malignancy",601399,AD,-,RUNX1
"CLDN14, DFNB29",Claudin 14,605608,"Deafness, autosomal recessive 29",614035,AR,-,CLDN14
"HLCS, HCS",Holocarboxylase synthetase,609018,Holocarboxylase synthetase deficiency,253270,AR,-,HLCS
"PIGP, DSCR5, EIEE55","Phosphatidylinositol glycan, class P",605938,"?Epileptic encephalopathy, early infantile, 55",617599,AR,mutation identified one EIEE55 family,PIGP
"DYRK1A, MNBH, MNB, MRD7","Dual specificity tyrosine-(Y)-phosphorylation regulated kinase-1A (\'minibrain\', Drosophila, homolog of)",600855,"Mental retardation, autosomal dominant 7",614104,AD,?triplicate state responsible for mental defect in Down syndrome,DYRK1A
"KCNJ6, GIRK2, KCNJ7, KPLBS","Potassium inwardly-rectifying channel, subfamily J, member 6",600877,Keppen-Lubinsky syndrome,614098,AD,-,KCNJ6
"DCR, DSCR",Down syndrome chromosome region,190685,Down syndrome,190685,IC,many genes are involved in this phenotype,DCR
"RIPK4, NKRD3, DIK, PPS2",Receptor-interacting serine-threonine kinase 4,605706,"Popliteal pterygium syndrome, Bartsocas-Papas type",263650,AR,-,RIPK4
"TMPRSS3, ECHOS1, DFNB8, DFNB10","Transmembrane protease, serine 3",605511,"Deafness, autosomal recessive 8/10",601072,AR,-,TMPRSS3
"RSPH1, TSGA2, TSA2, CILD24","Radial spoke head 1, Chlamydomonas, homolog of",609314,"Ciliary dyskinesia, primary, 24",615481,AR,-,RSPH1
CBS,Cystathionine beta-synthase,613381,"Homocystinuria, B6-responsive and nonresponsive types",236200,AR,subtelomeric,CBS
CBS,Cystathionine beta-synthase,613381,"Thrombosis, hyperhomocysteinemic",236200,AR,-,CBS
"CRYAA, CRYA1, CTRCT9","Crystallin, alpha A",123580,"Cataract 9, multiple types",604219,"AD,AR",-,CRYAA
"SIK1, SNF1LK, MSK, EIEE30",Salt-inducible kinase 1,605705,"Epileptic encephalopathy, early infantile, 30",616341,AD,-,SIK1
"CSTB, STFB, EPM1, PME, EPM1A, ULD",Cystatin B (stefin B),601145,"Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)",254800,AR,-,CSTB
"AIRE, APECED, APS1",Autoimmune regulator,607358,"Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia",240300,"AD,AR",-,AIRE
"C21orf2, SMDAX, RDMS",Chromosome 21 open reading frame 2,603191,Retinal dystrophy with macular staphyloma,617547,AR,-,C21orf2
"C21orf2, SMDAX, RDMS",Chromosome 21 open reading frame 2,603191,"Spondylometaphyseal dysplasia, axial",602271,AR,-,C21orf2
"TSPEAR, C21orf29, DFNB98",Thrombospondin-type laminin G domain and EAR repeats,612920,"?Deafness, autosomal recessive 98",614861,AR,mutation identified in 1 DFNB98 family,TSPEAR
"ITGB2, CD18, LCAMB, LAD","Integrin, beta-2 (antigen CD18 (p95), lymphocyte function-associated antigen-1; macrophage antigen, beta polypeptide)",600065,Leukocyte adhesion deficiency,116920,AR,"common subunit for CR3, LFA1, and P150,95",ITGB2
"COL18A1, KNO1","Collagen XVIII, alpha-1 polypeptide",120328,"Knobloch syndrome, type 1",267750,AR,-,COL18A1
"COL6A1, BTHLM1, UCHMD1","Collagen VI, alpha-1 polypeptide",120220,Bethlem myopathy 1,158810,"AD,AR",-,COL6A1
"COL6A1, BTHLM1, UCHMD1","Collagen VI, alpha-1 polypeptide",120220,Ullrich congenital muscular dystrophy 1,254090,"AD,AR",-,COL6A1
"COL6A2, BTHLM1, UCMD1","Collagen VI, alpha-2 polypeptide",120240,"?Myosclerosis, congenital",255600,AR,mutation identified in 1 MYSCL family,COL6A2
"COL6A2, BTHLM1, UCMD1","Collagen VI, alpha-2 polypeptide",120240,Bethlem myopathy 1,158810,"AD,AR",-,COL6A2
"COL6A2, BTHLM1, UCMD1","Collagen VI, alpha-2 polypeptide",120240,Ullrich congenital muscular dystrophy 1,254090,"AD,AR",-,COL6A2
FTCD,Formiminotransferase cyclodeminase,606806,Glutamate formiminotransferase deficiency,229100,AR,-,FTCD
"LSS, OSC, CTRCT44",Lanosterol synthase,600909,Cataract 44,616509,AR,-,LSS
"PCNT, PCNT2, KEN, SCKL4, MOPD2",Pericentrin,605925,"Microcephalic osteodysplastic primordial dwarfism, type II",210720,AR,-,PCNT
"CECR, CES",Cat eye syndrome,115470,Cat eye syndrome,115470,AD,partial tetrasomy of 22q11,CECR
"IL17RA, IL17R, IMD51",Interleukin 17 receptor A,605461,Immunodeficiency 51,613953,AR,-,IL17RA
"CECR1, PAN, SNEDS","Cat eye syndrome chromosome region, candidate 1",607575,?Sneddon syndrome,182410,AR,mutation identified in 1 SNEDS family,CECR1
"CECR1, PAN, SNEDS","Cat eye syndrome chromosome region, candidate 1",607575,"Polyarteritis nodosa, childhood-onset",615688,AR,-,CECR1
"DEL22q11.2, C22DELq11.2","Chromosome 22q11.2 deletion syndrome, distal",611867,"Chromosome 22q11.2 deletion syndrome, distal",611867,-,-,DEL22q11.2
DER22t11-22,Emanuel syndrome (supernumerary der(22)t(11;22) syndrome),609029,Emanuel syndrome,609029,ICB,-,DER22t11-22
DER22t8-22,Supernumerary der(22)t(8;22) syndrome,613700,Supernumerary der(22)t(8-22) syndrome,613700,-,-,DER22t8-22
DUP22q11.2,Chromosome 22q11.2 microduplication syndrome,608363,Chromosome 22q11.2 microduplication syndrome,608363,"AD,IC",contiguous gene microduplication syndrome,DUP22q11.2
"ATP6V1E1, ATP6E, ARCL2C","ATPase, H+ transporting, lysosomal, 31kD, V1 subunit E isoform 1",108746,"Cutis laxa, autosomal recessive, type IIC",617402,AR,-,ATP6V1E1
"PEX26, PBD7A, PBD7B",Peroxisome biogenesis factor 26,608666,Peroxisome biogenesis disorder 7A (Zellweger),614872,AR,-,PEX26
"PEX26, PBD7A, PBD7B",Peroxisome biogenesis factor 26,608666,Peroxisome biogenesis disorder 7B,614873,AR,-,PEX26
"TUBA8, TUBAL2, CDCBM8","Tubulin, alpha 8",605742,"Cortical dysplasia, complex, with other brain malformations 8",613180,AR,-,TUBA8
"USP18, UBP43, ISG43, PTORCH2",Ubiquitin-specific protease 18,607057,Pseudo-TORCH syndrome 2,617397,AR,-,USP18
"PRODH, PRODH2, SCZD4",Proline dehydrogenase (proline oxidase),606810,"Hyperprolinemia, type I",239500,AR,-,PRODH
"PRODH, PRODH2, SCZD4",Proline dehydrogenase (proline oxidase),606810,"{Schizophrenia, susceptibility to, 4}",600850,AD,-,PRODH
"SLC25A1, SLC20A3, CTP, D2L2AD","Solute carrier family 25 (mitochondrial citrate transporter), member 1",190315,Combined D-2- and L-2-hydroxyglutaric aciduria,615182,AR,-,SLC25A1
"CDC45L, CDC45L2, MGORS7","Cell division cycle 45, S. Cerevisiae, homolog-like",603465,Meier-Gorlin syndrome 7,617063,AR,-,CDC45L
"GP1BB, BS, BDPLT1","Glycoprotein Ib, platelet, beta polypeptide",138720,"Bernard-Soulier syndrome, type B",231200,AR,-,GP1BB
"GP1BB, BS, BDPLT1","Glycoprotein Ib, platelet, beta polypeptide",138720,"Giant platelet disorder, isolated",231200,AR,-,GP1BB
"TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR",T-box 1,602054,Conotruncal anomaly face syndrome,217095,-,-,TBX1
"TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR",T-box 1,602054,DiGeorge syndrome,188400,AD,-,TBX1
"TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR",T-box 1,602054,Tetralogy of Fallot,187500,AD,-,TBX1
"TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR",T-box 1,602054,Velocardiofacial syndrome,192430,AD,-,TBX1
"TXNRD2, TRXR2, SELZ, GCCD5",Thioredoxin reductase 2,606448,?Glucocorticoid deficiency 5,617825,AR,mutation identified in 1 GCCD5 family,TXNRD2
COMT,Catechol-O-methyltransferase,116790,"{Panic disorder, susceptibility to}",167870,?AD,-,COMT
COMT,Catechol-O-methyltransferase,116790,"{Schizophrenia, susceptibility to}",181500,AD,-,COMT
"TANGO2, C22orf25, MECRCN","Transport and golgi organization 2, Drosophila, homolog of",616830,"Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration",616878,AR,-,TANGO2
"RTN4R, NOGOR",NOGO receptor (reticulon 4 receptor),605566,"{Schizophrenia, susceptibility to}",181500,AD,-,RTN4R
"SCARF2, SREC2, VDEGS","Scavenger receptor class F, member 2",613619,Van den Ende-Gupta syndrome,600920,AR,-,SCARF2
"PI4KA, PIK4CA, PMGYCHA","Phosphatidylinositol 4-kinase, catalytic, alpha",600286,"Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis",616531,AR,-,PI4KA
"HCF2, HC2, SERPIND1, THPH10",Heparin cofactor II,142360,Thrombophilia due to heparin cofactor II deficiency,612356,AD,proximal to BCR,HCF2
"SNAP29, CEDNIK","Synaptosomal-associated protein, 29kD",604202,"Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome",609528,AR,-,SNAP29
"LZTR1, SWNTS2, NS10",Leucine-zipper-like regulator-1,600574,Noonan syndrome 10,616564,AD,-,LZTR1
"LZTR1, SWNTS2, NS10",Leucine-zipper-like regulator-1,600574,"{Schwannomatosis-2, susceptibility to}",615670,AD,-,LZTR1
"BCR, CML, PHL, ALL",Breakpoint cluster region,151410,"Leukemia, acute lymphocytic, somatic",613065,-,Ph1=t(9;22) (q34.1;q11.21); fused with ABL in CML,BCR
"BCR, CML, PHL, ALL",Breakpoint cluster region,151410,"Leukemia, chronic myeloid, somatic",608232,-,-,BCR
"IGLL1, IGO, IGL5, VPREB2, AGM2",Immunoglobulin lambda-like polypeptide 1 (immunoglobulin omega peptide),146770,Agammaglobulinemia 2,613500,AR,between BCR2 and BCR4; distal to IGLC,IGLL1
"CHCHD10, FTDALS2, SMAJ, IMMD",Coiled-coil-helix-coiled-coil-helix domain-containing protein 10,615903,"?Myopathy, isolated mitochondrial, autosomal dominant",616209,AD,mutation identified in 1 IMMD family,CHCHD10
"CHCHD10, FTDALS2, SMAJ, IMMD",Coiled-coil-helix-coiled-coil-helix domain-containing protein 10,615903,Frontotemporal dementia and/or amyotrophic lateral sclerosis 2,615911,AD,-,CHCHD10
"CHCHD10, FTDALS2, SMAJ, IMMD",Coiled-coil-helix-coiled-coil-helix domain-containing protein 10,615903,"Spinal muscular atrophy, Jokela type",615048,AD,-,CHCHD10
"SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",601607,Coffin-Siris syndrome 3,614608,AD,-,SMARCB1
"SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",601607,"Rhabdoid tumors, somatic",609322,-,-,SMARCB1
"SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",601607,{Rhabdoid tumor predisposition syndrome 1},609322,AD,-,SMARCB1
"SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",601607,"{Schwannomatosis-1, susceptibility to}",162091,AD,-,SMARCB1
MIF,Macrophage migration inhibitory factor,153620,"{Rheumatoid arthritis, systemic juvenile, susceptibility to}",604302,-,previously assigned to chr.19,MIF
"SPECC1L, KIAA0376, OBLFC1, GBBB2",Sperm antigen with calponin homology and coiled-coil domains 1-like,614140,"?Facial clefting, oblique, 1",600251,AD,mutation identified in 1 OBLFC1 patient,SPECC1L
"SPECC1L, KIAA0376, OBLFC1, GBBB2",Sperm antigen with calponin homology and coiled-coil domains 1-like,614140,"Opitz GBBB syndrome, type II",145410,AD,-,SPECC1L
"UPB1, BUP1",Beta-ureidopropionase,606673,Beta-ureidopropionase deficiency,613161,AR,-,UPB1
"CRYBB3, CRYB3, CATCN2, CTRCT22","Crystallin, beta-B3",123630,Cataract 22,609741,"AD,AR",-,CRYBB3
"CRYBB2, CRYB2, CTRCT3, CCA2","Crystallin, beta-B2",123620,"Cataract 3, multiple types",601547,AD,2nd CRYB2 gene in same region,CRYBB2
"MYO18B, KFS4",Myosin XVIIIB,607295,"Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism",616549,AR,-,MYO18B
HPS4,HPS gene 4,606682,Hermansky-Pudlak syndrome 4,614073,AR,-,HPS4
"CRYBB1, CATCN3, CTRCT17","Crystallin, beta B1",600929,"Cataract 17, multiple types",611544,"AD,AR",-,CRYBB1
"CRYBA4, CTRCT23","Crystallin, beta polypeptide A4",123631,Cataract 23,610425,-,-,CRYBA4
"MIAT, C22orf35",MIAT gene,611082,"{Myocardial infarction, susceptibility to}",608446,-,-,MIAT
"MN1, MGCR",Meningioma chromosome region,156100,Meningioma,607174,AD,fused with TEL in AML,MN1
"CHEK2, RAD53, CHK2, CDS1, LFS2","Checkpoint kinase 2, S. pombe, homolog of (RAD53, S. cerevisiae, homolog of)",604373,Li-Fraumeni syndrome,609265,-,-,CHEK2
"CHEK2, RAD53, CHK2, CDS1, LFS2","Checkpoint kinase 2, S. pombe, homolog of (RAD53, S. cerevisiae, homolog of)",604373,"Osteosarcoma, somatic",259500,-,-,CHEK2
"CHEK2, RAD53, CHK2, CDS1, LFS2","Checkpoint kinase 2, S. pombe, homolog of (RAD53, S. cerevisiae, homolog of)",604373,"{Breast and colorectal cancer, susceptibility to}",-,-,-,CHEK2
"CHEK2, RAD53, CHK2, CDS1, LFS2","Checkpoint kinase 2, S. pombe, homolog of (RAD53, S. cerevisiae, homolog of)",604373,"{Breast cancer, susceptibility to}",114480,AD,-,CHEK2
"CHEK2, RAD53, CHK2, CDS1, LFS2","Checkpoint kinase 2, S. pombe, homolog of (RAD53, S. cerevisiae, homolog of)",604373,"{Prostate cancer, familial, susceptibility to}",176807,AD,-,CHEK2
"XBP1, XBP2",X-box-binding protein-1,194355,"{Major affective disorder-7, susceptibility to}",612371,-,pseudogene on chr.5,XBP1
"KREMEN1, KRM1, ECTD13",Kringle domain-containing transmembrane protein 1,609898,"Ectodermal dysplasia 13, hair/tooth type",617392,AR,-,KREMEN1
"EWSR1, EWS",Ewing sarcoma breakpoint region-1,133450,Ewing sarcoma,612219,-,t(11;22)(q24;q12); t(21;22)(q22;q12),EWSR1
"EWSR1, EWS",Ewing sarcoma breakpoint region-1,133450,Neuroepithelioma,612219,-,-,EWSR1
"NEFH, CMT2CC","Neurofilament, heavy polypeptide",162230,"?{Amyotrophic lateral sclerosis, susceptibility to}",105400,"AD,AR",mutation identified in 1 family with ALS susceptibility,NEFH
"NEFH, CMT2CC","Neurofilament, heavy polypeptide",162230,"Charcot-Marie-Tooth disease, axonal, type 2CC",616924,AD,-,NEFH
NF2,Merlin,607379,"Meningioma, NF2-related, somatic",607174,-,loss of heterozygosity,NF2
NF2,Merlin,607379,"Neurofibromatosis, type 2",101000,AD,-,NF2
NF2,Merlin,607379,"Schwannomatosis, somatic",162091,-,-,NF2
"TCN2, TC2",Transcobalamin II,613441,Transcobalamin II deficiency,275350,AR,linked to P1,TCN2
"MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z",MORC family CW-type zinc finger protein 2,616661,"Charcot-Marie-Tooth disease, axonal, type 2Z",616688,AD,-,MORC2
"DEPDC5, KIAA0645, FFEVF1",DEP domain-containing protein 5,614191,"Epilepsy, familial focal, with variable foci 1",604364,AD,-,DEPDC5
HPC6,"Prostate cancer, hereditary, 6",609558,"{Prostate cancer, susceptibility to}",176807,AD,between D22S1265 and D22S277,HPC6
"SLC5A1, SGLT1","Solute carrier family 5 (sodium/glucose transporter), member 1",182380,Glucose/galactose malabsorption,606824,AR,-,SLC5A1
"FBXO7, FBX7, FBX, PKPS, PARK15",F-box only protein 7,605648,"Parkinson disease 15, autosomal recessive",260300,AR,-,FBXO7
"TIMP3, SFD",Tissue inhibitor of metalloproteinase-3,188826,Sorsby fundus dystrophy,136900,AD,-,TIMP3
"LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6",Acetylglucosaminyltransferase-like protein,603590,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6",613154,AR,-,LARGE
"LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6",Acetylglucosaminyltransferase-like protein,603590,"Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6",608840,AR,-,LARGE
"HMOX1, HMOX1D",Heme oxygenase 1,141250,Heme oxygenase-1 deficiency,614034,-,-,HMOX1
"HMOX1, HMOX1D",Heme oxygenase 1,141250,"{Pulmonary disease, chronic obstructive, susceptibility to}",606963,-,-,HMOX1
"MCM5, CDC46, MGORS8","Minichromosome maintenance, S. cerevisiae, homolog of, 5",602696,?Meier-Gorlin syndrome 8,617564,AR,mutation identified in 1 MGORS8 patient,MCM5
APOL4,Apolipoprotein L4,607254,{Schizophrenia},181500,AD,-,APOL4
APOL2,Apolipoprotein L2,607252,{Schizophrenia},181500,AD,-,APOL2
"APOL1, FSGS4",Apolipoprotein L1,603743,"{End-stage renal disease, nondiabetic, susceptibility to}",612551,-,-,APOL1
"APOL1, FSGS4",Apolipoprotein L1,603743,"{Glomerulosclerosis, focal segmental, 4, susceptibility to}",612551,-,-,APOL1
"MYH9, MHA, FTNS, DFNA17, BDPLT6","Myosin, heavy polypeptide-9, nonmuscle",160775,"Deafness, autosomal dominant 17",603622,AD,-,MYH9
"MYH9, MHA, FTNS, DFNA17, BDPLT6","Myosin, heavy polypeptide-9, nonmuscle",160775,Epstein syndrome,153650,AD,-,MYH9
"MYH9, MHA, FTNS, DFNA17, BDPLT6","Myosin, heavy polypeptide-9, nonmuscle",160775,Fechtner syndrome,153640,AD,-,MYH9
"MYH9, MHA, FTNS, DFNA17, BDPLT6","Myosin, heavy polypeptide-9, nonmuscle",160775,Macrothrombocytopenia and progressive sensorineural deafness,600208,AD,-,MYH9
"MYH9, MHA, FTNS, DFNA17, BDPLT6","Myosin, heavy polypeptide-9, nonmuscle",160775,May-Hegglin anomaly,155100,AD,-,MYH9
"MYH9, MHA, FTNS, DFNA17, BDPLT6","Myosin, heavy polypeptide-9, nonmuscle",160775,Sebastian syndrome,605249,AD,-,MYH9
"TXN2, TRX2, MTRX, COXPD29",Thioredoxin 2,609063,?Combined oxidative phosphorylation deficiency 29,616811,AR,mutation identified in 1 COXPD29 patient,TXN2
"CACNG2, MRD10","Calcium channel, voltage-dependent, gamma-2 subunit (stargazin)",602911,"?Mental retardation, autosomal dominant 10",614256,-,mutation identified one MRD10 patient,CACNG2
"IFT27, RABL4, BBS19","Intraflagellar transport 27, Chlamydomonas, homolog of",615870,?Bardet-Biedl syndrome 19,615996,AR,mutation identified in 1 BBS19 family,IFT27
"NCF4, P40PHOX, CGD3",Neutrophil cytosolic factor-4,601488,"?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III",613960,AR,mutation identified in 1 CGD3 patient,NCF4
"CSF2RB, SMDP5","Colony-stimulating factor-2 receptor, beta, low-affinity",138981,"Surfactant metabolism dysfunction, pulmonary, 5",614370,AR,-,CSF2RB
KCTD17,Potassium channel tetramerization domain-containing protein 17,616386,"Dystonia 26, myoclonic",616398,AD,-,KCTD17
"TMPRSS6, IRIDA","Transmembrane protease, serine 6 (matriptase 2)",609862,Iron-refractory iron deficiency anemia,206200,AR,-,TMPRSS6
"DUP22q13, C22DUPq13",Chromosome 22q13 duplication syndrome,615538,Chromosome 22q13 duplication syndrome,615538,IC,-,DUP22q13
RAC2,"Ras-related C3 botulinum toxin substrate 3 (rho family, small GTP-binding protein Rac2)",602049,Neutrophil immunodeficiency syndrome,608203,-,-,RAC2
LGALS2,"Lectin, galactoside-binding, soluble, 2",150571,"{Myocardial infarction, susceptibility to}",608446,-,-,LGALS2
"TRIOBP, KIAA1662",Trio- and F-actin-binding protein,609761,"Deafness, autosomal recessive 28",609823,AR,-,TRIOBP
"SOX10, WS4, WS4C, PCWH",SRY (sex-determining region Y)-box-10,602229,PCWH syndrome,609136,AD,megacolon and spotting in mice,SOX10
"SOX10, WS4, WS4C, PCWH",SRY (sex-determining region Y)-box-10,602229,"Waardenburg syndrome, type 2E, with or without neurologic involvement",611584,AD,-,SOX10
"SOX10, WS4, WS4C, PCWH",SRY (sex-determining region Y)-box-10,602229,"Waardenburg syndrome, type 4C",613266,AD,-,SOX10
"PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14","Phospholipase A2, group VI",603604,Infantile neuroaxonal dystrophy 1,256600,AR,-,PLA2G6
"PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14","Phospholipase A2, group VI",603604,Neurodegeneration with brain iron accumulation 2B,610217,AR,-,PLA2G6
"PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14","Phospholipase A2, group VI",603604,"Parkinson disease 14, autosomal recessive",612953,AR,-,PLA2G6
"DNAL4, MRMV3","Dynein, axonemal, light chain 4",610565,?Mirror movements 3,616059,AR,mutation identified in 1 MRMV3 family,DNAL4
"PDGFB, SIS, IBGC5","Platelet-derived growth factor, beta polypeptide (oncogene SIS)",190040,"Basal ganglia calcification, idiopathic, 5",615483,AD,fused with COL1A1 in DFSP,PDGFB
"PDGFB, SIS, IBGC5","Platelet-derived growth factor, beta polypeptide (oncogene SIS)",190040,Dermatofibrosarcoma protuberans,607907,-,-,PDGFB
"PDGFB, SIS, IBGC5","Platelet-derived growth factor, beta polypeptide (oncogene SIS)",190040,"Meningioma, SIS-related",607174,AD,-,PDGFB
ADSL,Adenylosuccinate lyase,608222,Adenylosuccinase deficiency,103050,AR,ade(-)I; bifunctional,ADSL
"XPNPEP3, APP3, NPHPL1",X-prolyl aminopeptidase 3,613553,Nephronophthisis-like nephropathy 1,613159,AR,-,XPNPEP3
"EP300, RSTS2","E1A-binding protein, 300kD",602700,"Colorectal cancer, somatic",114500,-,-,EP300
"EP300, RSTS2","E1A-binding protein, 300kD",602700,Rubinstein-Taybi syndrome 2,613684,AD,-,EP300
"ACO2, ICRD, OPA9","Aconitase, mitochondrial",100850,?Optic atrophy 9,616289,AR,distal to Ph1 break; mutation identified in 1 OPA9 family,ACO2
"ACO2, ICRD, OPA9","Aconitase, mitochondrial",100850,Infantile cerebellar-retinal degeneration,614559,AR,-,ACO2
"TNFRSF13C, BAFFR, CVID4","Tumor necrosis factor receptor superfamily, member 13C",606269,"Immunodeficiency, common variable, 4",613494,AR,-,TNFRSF13C
NAGA,"Acetylgalactosaminidase, alpha-N- (alpha-galactosidase B)",104170,Kanzaki disease,609242,AR,proximal to Ph1 break,NAGA
NAGA,"Acetylgalactosaminidase, alpha-N- (alpha-galactosidase B)",104170,"Schindler disease, type I",609241,AR,-,NAGA
NAGA,"Acetylgalactosaminidase, alpha-N- (alpha-galactosidase B)",104170,"Schindler disease, type III",609241,AR,-,NAGA
"CYP2D6, CPD6, P450DB1","Cytochrome P450, subfamily IID, polypeptide 6",124030,{Codeine sensitivity},608902,AR,-,CYP2D6
"CYP2D6, CPD6, P450DB1","Cytochrome P450, subfamily IID, polypeptide 6",124030,{Debrisoquine sensitivity},608902,AR,-,CYP2D6
"CYB5R3, DIA1, B5R",Cytochrome b5 reductase 3,613213,"Methemoglobinemia, type I",250800,AR,-,CYB5R3
"CYB5R3, DIA1, B5R",Cytochrome b5 reductase 3,613213,"Methemoglobinemia, type II",250800,AR,-,CYB5R3
"A4GALT, P1PK","Alpha 1,4-galactosyltransferase",607922,NOR polyagglutination syndrome,111400,-,-,A4GALT
"A4GALT, P1PK","Alpha 1,4-galactosyltransferase",607922,"[Blood group, P1Pk system, p phenotype]",111400,-,-,A4GALT
"A4GALT, P1PK","Alpha 1,4-galactosyltransferase",607922,"[Blood group, P1Pk system, P(2) phenotype]",111400,-,-,A4GALT
FBLN1,Fibulin 1,135820,"Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses",608180,AD,-,FBLN1
"ATXN10, SCA10",Ataxin 10,611150,Spinocerebellar ataxia 10,603516,AD,ATTCTn repeat in intron 9,ATXN10
"TRMU, MTO2",tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase,610230,"Liver failure, transient infantile",613070,AR,-,TRMU
"TRMU, MTO2",tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase,610230,"{Deafness, mitochondrial, modifier of}",580000,Mi,-,TRMU
"ALG12, CDG1G",Dolichyl-P-mannose:Man-7-GlcNAc-2-PP-dolichyl-alpha-6- mannosyltransferase,607144,"Congenital disorder of glycosylation, type Ig",607143,-,-,ALG12
"MLC1, LVM, VL",MLC1 gene,605908,Megalencephalic leukoencephalopathy with subcortical cysts,604004,AR,-,MLC1
"TUBGCP6, GCP6, KIAA1669, MCCRP1",Tubulin-gamma complex-associated protein 6,610053,"Microcephaly and chorioretinopathy, autosomal recessive, 1",251270,AR,-,TUBGCP6
"SBF1, MTMR5, CMT4B3",SET-binding factor 1 (myotubularin-related protein 5),603560,"Charcot-Marie-Tooth disease, type 4B3",615284,AR,-,SBF1
"SCO2, CEMCOX1, MYP6",SCO2 cytochrome c oxidase assembly protein,604272,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1",604377,AR,-,SCO2
"SCO2, CEMCOX1, MYP6",SCO2 cytochrome c oxidase assembly protein,604272,Myopia 6,608908,AD,-,SCO2
"TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1",Thymidine phosphorylase,131222,Mitochondrial DNA depletion syndrome 1 (MNGIE type),603041,AR,-,TYMP
"CHKB, CHKL, CKEKB, EKB, MDCMC","Choline kinase, beta",612395,"Muscular dystrophy, congenital, megaconial type",602541,AR,-,CHKB
ARSA,Arylsulfatase A,607574,Metachromatic leukodystrophy,250100,AR,-,ARSA
"SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15",SH3 and multiple ankyrin repeat domains 3,606230,Phelan-McDermid syndrome,606232,AD,-,SHANK3
"SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15",SH3 and multiple ankyrin repeat domains 3,606230,{Schizophrenia 15},613950,-,-,SHANK3
"SHOX, GCFX, SS, PHOG",Short stature homeo box,312865,Langer mesomelic dysplasia,249700,AR,pseudoautosomal; ?gene causing short stature in Turner syndrome,SHOX
"SHOX, GCFX, SS, PHOG",Short stature homeo box,312865,Leri-Weill dyschondrosteosis,127300,AD,-,SHOX
"SHOX, GCFX, SS, PHOG",Short stature homeo box,312865,"Short stature, idiopathic familial",300582,-,-,SHOX
"CSF2RA, SMDP4","Colony-stimulating factor-2 receptor, alpha, low-affinity, granulocyte-macrophage",306250,"Surfactant metabolism dysfunction, pulmonary, 4",300770,-,order in PAR: pter-CSF2RA-IL3RA-ANT3-ASMT-MIC2-cen,CSF2RA
"ARSE, CDPX1, CDPXR",Arylsulfatase E,300180,"Chondrodysplasia punctata, X-linked recessive",302950,XLR,CDPX1 in contiguous gene syndrome with STS,ARSE
"NLGN4, KIAA1260, AUTSX2, ASPGX2",Neuroligin 4,300427,"Mental retardation, X-linked",300495,"XL,IC,Mu",-,NLGN4
"NLGN4, KIAA1260, AUTSX2, ASPGX2",Neuroligin 4,300427,"{Asperger syndrome susceptibility, X-linked 2}",300497,"XL,IC,Mu",-,NLGN4
"NLGN4, KIAA1260, AUTSX2, ASPGX2",Neuroligin 4,300427,"{Autism susceptibility, X-linked 2}",300495,"XL,IC,Mu",-,NLGN4
"STS, ARSC1, ARSC, SSDD, XLI","Steroid sulfatase, microsomal (arylsulfatase C, isozyme S)",300747,"Ichthyosis, X-linked",308100,XLR,nonlyonizing,STS
"KAL1, KMS, ADMLX, HH1",Kallmann syndrome-1 sequence (anosmin-1),300836,Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1),308700,XLR,with ichthyosis in probable microdeletion syndrome,KAL1
"GPR143, OA1, NYS6",G protein-coupled receptor 143,300808,"Nystagmus 6, congenital, X-linked",300814,-,linked to XG,GPR143
"GPR143, OA1, NYS6",G protein-coupled receptor 143,300808,"Ocular albinism, type I, Nettleship-Falls type",300500,XL,-,GPR143
"CLCN4, MRX49, MRX15",Chloride channel-4,302910,"Mental retardation, X-linked 49/15",300114,XLR,-,CLCN4
"MID1, OGS1, BBBG1, FXY, OSX",Midline-1,300552,"Opitz GBBB syndrome, type I",300000,XLR,type II defect on chr.22,MID1
"HCCS, MCOPS7, LSDMCA1",Holocytochrome c synthase (cytochrome c heme-lyase),300056,Linear skin defects with multiple congenital anomalies 1,309801,XLD,-,HCCS
"AMELX, AMG, AIH1, AMGX, AI1E",Amelogenin,300391,"Amelogenesis imperfecta, type 1E",301200,XLD,also Y,AMELX
"FRMPD4, PRESO, KIAA0316, MRX104",FERM and PDZ domains-containing protein 4,300838,"Mental retardation, X-linked 104",300983,XLR,-,FRMPD4
"TRAPPC2, SEDL, SEDT",Trafficking protein particle complex 2 (sedlin),300202,Spondyloepiphyseal dysplasia tarda,313400,XLR,-,TRAPPC2
"OFD1, CXorf5, SGBS2, JBTS10, RP23",OFD1 protein,300170,?Retinitis pigmentosa 23,300424,XLR,mutation identified in 1 RP23 family,OFD1
"OFD1, CXorf5, SGBS2, JBTS10, RP23",OFD1 protein,300170,Joubert syndrome 10,300804,XLR,-,OFD1
"OFD1, CXorf5, SGBS2, JBTS10, RP23",OFD1 protein,300170,Orofaciodigital syndrome I,311200,XLD,-,OFD1
"OFD1, CXorf5, SGBS2, JBTS10, RP23",OFD1 protein,300170,"Simpson-Golabi-Behmel syndrome, type 2",300209,XLR,-,OFD1
"FAAP95, FAAP90, FLJ34064, FANCB","Fanconi anemia-associated polypeptide, 95kD",300515,"Fanconi anemia, complementation group B",300514,-,-,FAAP95
"PIGA, PNH1, MCAHS2","Phosphatidylinositol glycan, class A",311770,Multiple congenital anomalies-hypotonia-seizures syndrome 2,300868,XLR,pseudogene on chr.12,PIGA
"PIGA, PNH1, MCAHS2","Phosphatidylinositol glycan, class A",311770,"Paroxysmal nocturnal hemoglobinuria, somatic",300818,-,-,PIGA
"AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS","Adaptor-related protein complex 1, sigma-2 subunit",300629,"Mental retardation, X-linked syndromic 5",304340,XLR,-,AP1S2
"NHS, CXN, CTRCT40",NHS gene,300457,"Cataract 40, X-linked",302200,XL,-,NHS
"NHS, CXN, CTRCT40",NHS gene,300457,Nance-Horan syndrome,302350,XLD,-,NHS
MEHMO,"MEHMO syndrome (Mental retardation, epileptic seizures, hypogonadism and hypogenitalism, microcephaly, and obesity)",300148,MEHMO syndrome,300148,-,-,MEHMO
"CDKL5, STK9, ISSX, EIEE2",Cyclin-dependent kinase-like 5 (serine/threonine protein kinase 9),300203,"Epileptic encephalopathy, early infantile, 2",300672,XLD,-,CDKL5
"RS1, XLRS1",Retinoschisin,300839,Retinoschisis,312700,XLR,25cM from XG,RS1
"PHKA2, PHK, XLG, PYKL, GSD9A","Phosphorylase kinase, liver, alpha-2 subunit",300798,"Glycogen storage disease, type IXa1",306000,XLR,-,PHKA2
"PHKA2, PHK, XLG, PYKL, GSD9A","Phosphorylase kinase, liver, alpha-2 subunit",300798,"Glycogen storage disease, type IXa2",306000,XLR,-,PHKA2
"ADGRG2, GPR64, HE6, CBAVDX",Adhesion G protein-coupled receptor G2,300572,"Vas deferens, congenital bilateral aplasia of, X-linked",300985,XL,-,ADGRG2
"PDHA1, PHE1A, PDHAD","Pyruvate dehydrogenase, E1-alpha polypeptide-1",300502,Pyruvate dehydrogenase E1-alpha deficiency,312170,XLD,-,PDHA1
"RPS6KA3, RSK2, MRX19","Ribosomal protein S6 kinase, 90kD, polypeptide 3",300075,Coffin-Lowry syndrome,303600,"XLD,IC",-,RPS6KA3
"RPS6KA3, RSK2, MRX19","Ribosomal protein S6 kinase, 90kD, polypeptide 3",300075,"Mental retardation, X-linked 19",300844,XLD,-,RPS6KA3
"CNKSR2, CNK2, KIAA0902, MRXSHG",connector enhancer of KSR 2,300724,"Mental retardation, X-linked, syndromic, Houge type",301008,XL,conflicting assignment to chr.1,CNKSR2
"SMPX, DFNX4","Small muscle protein, X-linked",300226,"Deafness, X-linked 4",300066,XLD,-,SMPX
"MBTPS2, S2P, IFAP, KFSDX, OLMSX","Membrane-bound transcription factor protease, site 2",300294,"?Olmsted syndrome, X-linked",300918,XLR,mutation identified in 1 OLMSX family,MBTPS2
"MBTPS2, S2P, IFAP, KFSDX, OLMSX","Membrane-bound transcription factor protease, site 2",300294,IFAP syndrome with or without BRESHECK syndrome,308205,XLR,-,MBTPS2
"MBTPS2, S2P, IFAP, KFSDX, OLMSX","Membrane-bound transcription factor protease, site 2",300294,"Keratosis follicularis spinulosa decalvans, X-linked",308800,XLR,-,MBTPS2
"SMS, SRS, MRSR",Spermine synthase,300105,"Mental retardation, X-linked, Snyder-Robinson type",309583,XLR,-,SMS
"PHEX, HYP, HPDR1, LXHR","Phosphate regulating endopeptidase homolog, X-linked",300550,"Hypophosphatemic rickets, X-linked dominant",307800,XLD,-,PHEX
"PTCHD1, AUTSX4",Patched domain-containing protein 1,300828,"{Autism, susceptibility to, X-linked 4}",300830,XLR,-,PTCHD1
"KLHL15, KIAA1677",Kelch-like 15,300980,"Mental retardation, X-linked 103",300982,XLR,-,KLHL15
"EIF2S3, EIF2G, MEHMO, MRXSBRK","Eukaryotic translation initiation factor 2, subunit 3",300161,MEHMO syndrome,300148,-,-,EIF2S3
"PDK3, CMTX6","Pyruvate dehydrogenase kinase, isoenzyme 3",300906,"?Charcot-Marie-Tooth disease, X-linked dominant, 6",300905,XLD,1 family identified with mutation,PDK3
POLA1,"Polymerase, DNA, alpha-1",312040,"Pigmentary disorder, reticulate, with systemic manifestations, X-linked",301220,XLR,-,POLA1
"DELXp21, CXDELp21",Chromosome Xp21 deletion syndrome,300679,Chromosome Xp21 deletion syndrome,300679,-,contiguous gene deletion syndrome,DELXp21
"ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32","Aristaless-related homeobox, X-linked",300382,"Epileptic encephalopathy, early infantile, 1",308350,XLR,-,ARX
"ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32","Aristaless-related homeobox, X-linked",300382,Hydranencephaly with abnormal genitalia,300215,XL,-,ARX
"ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32","Aristaless-related homeobox, X-linked",300382,"Lissencephaly, X-linked 2",300215,XL,-,ARX
"ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32","Aristaless-related homeobox, X-linked",300382,"Mental retardation, X-linked 29 and others",300419,XLR,-,ARX
"ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32","Aristaless-related homeobox, X-linked",300382,Partington syndrome,309510,XLR,-,ARX
"ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32","Aristaless-related homeobox, X-linked",300382,Proud syndrome,300004,XL,-,ARX
"IL1RAPL1, IL1R8, MRX21, MRX34",Il-1 receptor accessory protein-like 1,300206,"Mental retardation, X-linked 21/34",300143,XLR,-,IL1RAPL1
"NR0B1, DAX1, AHC, AHX, SRXY2","Nuclear receptor subfamily 0, group B, member 1",300473,"46XY sex reversal 2, dosage-sensitive",300018,XL,distal to GK,NR0B1
"NR0B1, DAX1, AHC, AHX, SRXY2","Nuclear receptor subfamily 0, group B, member 1",300473,"Adrenal hypoplasia, congenital",300200,XLR,-,NR0B1
GK,Glycerol kinase,300474,Glycerol kinase deficiency,307030,XLR,2Mb distal to DMD; pseudogene on 4q32,GK
"DMD, BMD, CMD3B",Dystrophin,300377,Becker muscular dystrophy,300376,XLR,dystrophin gene; cen-5'-3'-pter; 2Mb; ?Xp21.13,DMD
"DMD, BMD, CMD3B",Dystrophin,300377,"Cardiomyopathy, dilated, 3B",302045,XL,-,DMD
"DMD, BMD, CMD3B",Dystrophin,300377,Duchenne muscular dystrophy,310200,XLR,-,DMD
"XK, MCLDS",Kell blood group precursor,314850,McLeod syndrome with or without chronic granulomatous disease,300842,XL,~500kb distal to CGD,XK
"CYBB, CGD, AMCBX2, IMD34","Cytochrome b-245, beta polypeptide",300481,"Chronic granulomatous disease, X-linked",306400,XLR,proximal to DMD,CYBB
"CYBB, CGD, AMCBX2, IMD34","Cytochrome b-245, beta polypeptide",300481,"Immunodeficiency 34, mycobacteriosis, X-linked",300645,XLR,-,CYBB
"RPGR, RP3, CRD, RP15, COD1, CORDX1",Retinitis pigmentosa GTPase regulator,312610,"Cone-rod dystrophy, X-linked, 1",304020,XL,-,RPGR
"RPGR, RP3, CRD, RP15, COD1, CORDX1",Retinitis pigmentosa GTPase regulator,312610,"Macular degeneration, X-linked atrophic",300834,XLR,-,RPGR
"RPGR, RP3, CRD, RP15, COD1, CORDX1",Retinitis pigmentosa GTPase regulator,312610,Retinitis pigmentosa 3,300029,-,-,RPGR
"RPGR, RP3, CRD, RP15, COD1, CORDX1",Retinitis pigmentosa GTPase regulator,312610,"Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness",300455,-,-,RPGR
OTC,Ornithine transcarbamylase,300461,Ornithine transcarbamylase deficiency,311250,XLR,"proximal to DMD, CGD",OTC
"TSPAN7, TM4SF2, MXS1, A15, MRX58",Tetraspanin 7,300096,"Mental retardation, X-linked 58",300210,XLR,-,TSPAN7
"BCOR, KIAA1575, MCOPS2, MAA2, ANOP2",BCL6 corepressor,300485,"Microphthalmia, syndromic 2",300166,XLD,-,BCOR
"ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS","ATPase, H+ transporting, lysosomal, accessory protein 2",300556,"?Parkinsonism with spasticity, X-linked",300911,XLR,mutation identified in 1 XPDS family,ATP6AP2
"ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS","ATPase, H+ transporting, lysosomal, accessory protein 2",300556,"Mental retardation, X-linked, syndromic, Hedera type",300423,XLR,-,ATP6AP2
"USP9X, DFFRX, MRX99, MRXS99F","Ubiquitin-specific protease-9, X chromosome (Drosophila fat facets related, X-linked)",300072,"Mental retardation, X-linked 99",300919,XLR,-,USP9X
"USP9X, DFFRX, MRX99, MRXS99F","Ubiquitin-specific protease-9, X chromosome (Drosophila fat facets related, X-linked)",300072,"Mental retardation, X-linked 99, syndromic, female-restricted",300968,XLD,-,USP9X
"DDX3X, DDX3, DBX, MRX102","DEAD/H box-3, X-linked",300160,"Mental retardation, X-linked 102",300958,"XLD,XLR",-,DDX3X
"NYX, CSNB1A, NBM1",Nyctalopin,300278,"Night blindness, congenital stationary (complete), 1A, X-linked",310500,XLR,-,NYX
"CASK, MICPCH, FGS4, CMG, MRXSNA",Calcium/calmodulin-dependent serine protein kinase,300172,FG syndrome 4,300422,-,-,CASK
"CASK, MICPCH, FGS4, CMG, MRXSNA",Calcium/calmodulin-dependent serine protein kinase,300172,Mental retardation and microcephaly with pontine and cerebellar hypoplasia,300749,XLD,-,CASK
"CASK, MICPCH, FGS4, CMG, MRXSNA",Calcium/calmodulin-dependent serine protein kinase,300172,"Mental retardation, with or without nystagmus",300422,-,-,CASK
"DELXp11.3, CXDELp11.3",Chromosome Xp11.3 deletion syndrome (X-linked mental retardation with retinitis pigmentosa),300578,Chromosome Xp11.3 deletion syndrome,300578,XLR,-,DELXp11.3
"MAOA, BRNRS",Monoamine oxidase A,309850,Brunner syndrome,300615,XLR,"NDP, MAOA, MAOB closely linked",MAOA
"MAOA, BRNRS",Monoamine oxidase A,309850,{Antisocial behavior},300615,XLR,-,MAOA
"NDP, ND, EVR2",Norrin,300658,"Exudative vitreoretinopathy 2, X-linked",305390,-,-,NDP
"NDP, ND, EVR2",Norrin,300658,Norrie disease,310600,XLR,-,NDP
"KDM6A, UTX, KABUK2",Lysine (K)-specific demethylase 6A,300128,Kabuki syndrome 2,300867,XLD,UTY also in mouse and man; escapes inactivation,KDM6A
RP2,"Retinitis pigmentosa-2, X-linked recessive",300757,Retinitis pigmentosa 2,312600,XL,-,RP2
"NDUFB11, LSDMCA3","NADH-dehydrogenase 1 beta subcomplex, 11",300403,?Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",mutation identified in 1 COX I deficient patient,NDUFB11
"NDUFB11, LSDMCA3","NADH-dehydrogenase 1 beta subcomplex, 11",300403,Linear skin defects with multiple congenital anomalies 3,300952,XLD,-,NDUFB11
"RBM10, DXS8237E, KIAA0122, TARPS",RNA-binding motif protein 10,300080,TARP syndrome,311900,XLR,-,RBM10
"UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1",Ubiquitin-like modifier-activating enzyme 1,314370,"Spinal muscular atrophy, X-linked 2, infantile",301830,XLR,escapes inactivation,UBA1
SYN1,Synapsin I,313440,"Epilepsy, X-linked, with variable learning disabilities and behavior disorders",300491,"XLD,XLR",5kb from PFC,SYN1
"DUPXp11.23p11.22, CXDUPp11.23p11.22",Chromosome Xp11.23-p11.22 duplication syndrome,300801,Chromosome Xp11.23-p11.22 duplication syndrome,300801,XLD,-,DUPXp11.23p11.22
"PFC, PFD","Properdin P factor, complement",300383,"Properdin deficiency, X-linked",312060,XLR,-,PFC
"FTSJ1, JM23, SPB1, MRX44, MRX9",FTSJ homolog 1,300499,"Mental retardation, X-linked 9/44",309549,XLR,-,FTSJ1
"PORCN, PORC, DHOF, FODH","Porcupine, Drosophila, homolog of",300651,Focal dermal hypoplasia,305600,XLD,-,PORCN
"EBP, CDPX2, CPXD, CPX, MEND",Emopamil-binding protein,300205,"Chondrodysplasia punctata, X-linked dominant",302960,XLD,-,EBP
"EBP, CDPX2, CPXD, CPX, MEND",Emopamil-binding protein,300205,MEND syndrome,300960,XLR,-,EBP
"WAS, IMD2, THC1, SCNX",Wiskott-Aldrich syndrome gene,300392,"Neutropenia, severe congenital, X-linked",300299,XLR,t(18;X)(q11.2;p11.2); distal to TIMP,WAS
"WAS, IMD2, THC1, SCNX",Wiskott-Aldrich syndrome gene,300392,"Thrombocytopenia, X-linked",313900,XLR,-,WAS
"WAS, IMD2, THC1, SCNX",Wiskott-Aldrich syndrome gene,300392,"Thrombocytopenia, X-linked, intermittent",313900,XLR,-,WAS
"WAS, IMD2, THC1, SCNX",Wiskott-Aldrich syndrome gene,300392,Wiskott-Aldrich syndrome,301000,XLR,-,WAS
"GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP",GATA-binding protein-1 (globin transcription factor-1),305371,"Anemia, X-linked, with/without neutropenia and/or platelet abnormalities",300835,XLR,-,GATA1
"GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP",GATA-binding protein-1 (globin transcription factor-1),305371,"Leukemia, megakaryoblastic, with or without Down syndrome, somatic",190685,-,-,GATA1
"GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP",GATA-binding protein-1 (globin transcription factor-1),305371,"Thrombocytopenia with beta-thalassemia, X-linked",314050,XLR,-,GATA1
"GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP",GATA-binding protein-1 (globin transcription factor-1),305371,"Thrombocytopenia, X-linked, with or without dyserythropoietic anemia",300367,XLR,-,GATA1
"HDAC6, CPBHM",Histone deacetylase 6,300272,"?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia",300863,XLD,mutation identified in 1 CPBHM family,HDAC6
"PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8",Polyglutamine-binding protein 1,300463,Renpenning syndrome,309500,XLR,-,PQBP1
"SLC35A2, UGALT, UGTL, UGT2, CDGX, CDG2M","Solute carrier family 35 (UDP-galactose transporter), member 2",314375,"Congenital disorder of glycosylation, type IIm",300896,"XLD,SMo",-,SLC35A2
"TFE3, RCCX1",Transcription factor for IgH enhancer,314310,"Renal cell carcinoma, papillary, 1",300854,-,fuses with PRCC in RCCP,TFE3
"WDR45, WIPI4, NBIA5",WD repeat-containing protein 45,300526,Neurodegeneration with brain iron accumulation 5,300894,XLD,?pseudogene on 4q31.3,WDR45
"SYP, MRXSYP",Synaptophysin,313475,"Mental retardation, X-linked 96",300802,XLD,-,SYP
"CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2","Calcium channel, voltage-dependent, alpha-1F subunit",300110,Aland Island eye disease,300600,XL,-,CACNA1F
"CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2","Calcium channel, voltage-dependent, alpha-1F subunit",300110,"Cone-rod dystrophy, X-linked, 3",300476,XLR,-,CACNA1F
"CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2","Calcium channel, voltage-dependent, alpha-1F subunit",300110,"Night blindness, congenital stationary (incomplete), 2A, X-linked",300071,XL,-,CACNA1F
"CCDC22, RTSC2",Coiled-coil domain-containing protein 22,300859,Ritscher-Schinzel syndrome 2,300963,XLR,-,CCDC22
"FOXP3, IPEX, AIID, XPID, PIDX",Forkhead box P3 (scurfin),300292,"Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked",304790,XLR,-,FOXP3
"FOXP3, IPEX, AIID, XPID, PIDX",Forkhead box P3 (scurfin),300292,"{Diabetes mellitus, type I, susceptibility to}",222100,AR,-,FOXP3
"USP27X, USP22L, MRX105","Ubiquitin-specific protease 27, X-linked",300975,Mental retardation 105,300984,XLR,-,USP27X
"CLCN5, CLCK2, NPHL2, DENTS, NPHL1",Chloride channel-5,300008,Dent disease,300009,XLR,-,CLCN5
"CLCN5, CLCK2, NPHL2, DENTS, NPHL1",Chloride channel-5,300008,Hypophosphatemic rickets,300554,XLR,-,CLCN5
"CLCN5, CLCK2, NPHL2, DENTS, NPHL1",Chloride channel-5,300008,"Nephrolithiasis, type I",310468,XLR,-,CLCN5
"CLCN5, CLCK2, NPHL2, DENTS, NPHL1",Chloride channel-5,300008,"Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis",308990,XLR,-,CLCN5
"DUPXp11.22, MRX17, MRX31",Xp11.22 microduplication syndrome,300705,Xp11.22 microduplication syndrome,300705,-,minimal duplicated region 228 kb overlapping HUWE1 and HSD17B10,DUPXp11.22
"SHROOM4, KIAA1202, SDSX",Shroom family member 4,300579,Stocco dos Santos X-linked mental retardation syndrome,300434,XL,-,SHROOM4
"BMP15, GDF9B, ODG2, POF4",Bone morphogenetic protein 15,300247,Ovarian dysgenesis 2,300510,XL,-,BMP15
"BMP15, GDF9B, ODG2, POF4",Bone morphogenetic protein 15,300247,Premature ovarian failure 4,300510,XL,-,BMP15
"KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ","Lysine-specific demethylase 5C (Jumonji, AT-rich interactive domain 1C)",314690,"Mental retardation, X-linked, syndromic, Claes-Jensen type",300534,XLR,escapes inactivation,KDM5C
"IQSEC2, KIAA0522, MRX1, MRX78",IQ motif- and Sec7 domain-containing protein 2,300522,"Mental retardation, X-linked 1/78",309530,XLD,-,IQSEC2
"SMC1A, SMC1L1, SMC1, DXS423E, KIAA0178, CDLS2","Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of; DXS423E; SB1.8)",300040,Cornelia de Lange syndrome 2,300590,XLD,escapes lyonization,SMC1A
"HSD17B10, HADH2, ERAB, MRXS10, HSD10MD",17-beta-hydroxysteroid dehydrogenase X,300256,HSD10 mitochondrial disease,300438,XLD,-,HSD17B10
"HUWE1, UREB1, KIAA0312, LASU1","HECT, UBA, and WWE domains-containing protein 1",300697,"Mental retardation, X-linked syndromic, Turner type",300706,-,-,HUWE1
"PHF8, ZNF422, KIAA1111, MRXSSD",PHD finger protein 8,300560,"Mental retardation syndrome, X-linked, Siderius type",300263,XLR,-,PHF8
"TSR2, WGG1, DBA14","TSR2, 20S rRNA accumulation, S. cerevisiae, homolog of",300945,?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis,300946,XLR,mutation identified in 1 DBA14 family,TSR2
"FGD1, FGDY, AAS, MRXS16","FYVE, RhoGEF, and PH domain-containing protein 1",300546,Aarskog-Scott syndrome,305400,XLR,-,FGD1
"FGD1, FGDY, AAS, MRXS16","FYVE, RhoGEF, and PH domain-containing protein 1",300546,"Mental retardation, X-linked syndromic 16",305400,XLR,-,FGD1
"MAGED2, MAGED, BARTS5","Melanoma antigen, family D, 2",300470,"Bartter syndrome, type 5, antenatal, transient",300971,XLR,-,MAGED2
"ALAS2, ANH1, ASB, XLEPP, XLSA, SIDBA1","Aminolevulinate, delta-, synthase-2",301300,"Anemia, sideroblastic, 1",300751,XLR,-,ALAS2
"ALAS2, ANH1, ASB, XLEPP, XLSA, SIDBA1","Aminolevulinate, delta-, synthase-2",301300,"Protoporphyria, erythropoietic, X-linked",300752,XLD,-,ALAS2
"UBQLN2, PLIC2, CHAP1, ALS15",Ubiquilin 2,300264,"Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia",300857,XLD,-,UBQLN2
"ARHGEF9, PEM2, KIAA0424, EIEE8",Rho guanine nucleotide exchange factor 9,300429,"Epileptic encephalopathy, early infantile, 8",300607,XLR,-,ARHGEF9
"AMER1, FAM123B, WTX, OSCS",APC membrane recruitment protein 1,300647,Osteopathia striata with cranial sclerosis,300373,XLD,-,AMER1
"ZC4H2, KIAA1166, WRWF",Zinc finger C4H2 domain-containing protein,300897,Wieacker-Wolff syndrome,314580,XLR,-,ZC4H2
"LAS1L, WTS",Las1-like ribosome biogenesis factor,300964,Wilson-Turner syndrome,309585,XLR,-,LAS1L
"MSN, IMD50",Moesin,309845,Immunodeficiency 50,300988,XLR,-,MSN
"AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1",Androgen receptor (dihydrotestosterone receptor),313700,Androgen insensitivity,300068,XLR,-,AR
"AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1",Androgen receptor (dihydrotestosterone receptor),313700,"Androgen insensitivity, partial, with or without breast cancer",312300,XLR,-,AR
"AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1",Androgen receptor (dihydrotestosterone receptor),313700,"Hypospadias 1, X-linked",300633,XLR,-,AR
"AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1",Androgen receptor (dihydrotestosterone receptor),313700,Spinal and bulbar muscular atrophy of Kennedy,313200,XLR,-,AR
"AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1",Androgen receptor (dihydrotestosterone receptor),313700,"{Prostate cancer, susceptibility to}",176807,AD,-,AR
"OPHN1, MRX60",Oligophrenin-1,300127,"Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance",300486,XLR,-,OPHN1
"EFNB1, EPLG2, CFNS, CFND",eph-related receptor tyrosine kinase ligand 2 (ephrin B1),300035,Craniofrontonasal dysplasia,304110,XLD,?CFNS also on Xp22,EFNB1
"EDA, ED1, ECTD1, HED1, STHAGX1",Ectodysplasin A,300451,"Ectodermal dysplasia 1, hypohidrotic, X-linked",305100,XLR,-,EDA
"EDA, ED1, ECTD1, HED1, STHAGX1",Ectodysplasin A,300451,"Tooth agenesis, selective, X-linked 1",313500,XLD,-,EDA
IGBP1,Immunoglobulin-binding protein 1,300139,"Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia",300472,XLR,-,IGBP1
"ARR3, MYP26","Arrestin 3, retinal",301770,"Myopia 26, X-linked, female-limited",301010,XL,-,ARR3
"KIF4A, KIF4, MRX100",Kinesin family member 4A,300521,"?Mental retardation, X-linked 100",300923,XLR,mutation identified in 1 MRX100 family,KIF4A
"DLG3, NEDLG, SAP102, MRX90","Discs large, Drosophila, homolog of, 3",300189,"Mental retardation, X-linked 90",300850,XLR,-,DLG3
"TEX11, SPGFX2",Testis-expressed gene 11,300311,"Spermatogenic failure, X-linked, 2",309120,XLR,-,TEX11
"IL2RG, SCIDX1, SCIDX, IMD4","Interleukin-2 receptor, gamma",308380,"Combined immunodeficiency, X-linked, moderate",312863,XLR,linked to DXS159,IL2RG
"IL2RG, SCIDX1, SCIDX, IMD4","Interleukin-2 receptor, gamma",308380,"Severe combined immunodeficiency, X-linked",300400,XLR,-,IL2RG
"MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX","Mediator of RNA polymerase II transcription, subunit 12, S. cerevisiae, homolog of",300188,Lujan-Fryns syndrome,309520,XLR,-,MED12
"MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX","Mediator of RNA polymerase II transcription, subunit 12, S. cerevisiae, homolog of",300188,"Ohdo syndrome, X-linked",300895,XLR,-,MED12
"MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX","Mediator of RNA polymerase II transcription, subunit 12, S. cerevisiae, homolog of",300188,Opitz-Kaveggia syndrome,305450,XLR,-,MED12
"NLGN3, ASPGX1, AUTSX1",Neuroligin 3,300336,"{Asperger syndrome susceptibility, X-linked 1}",300494,"XL,IC,Mu",-,NLGN3
"NLGN3, ASPGX1, AUTSX1",Neuroligin 3,300336,"{Autism susceptibility, X-linked 1}",300425,"XL,IC,Mu",-,NLGN3
"GJB1, CX32, CMTX1","Gap junction protein, beta-1, 32kD (connexin 32)",304040,"Charcot-Marie-Tooth neuropathy, X-linked dominant, 1",302800,XLD,-,GJB1
"NONO, NRB54, MRXS34","Non-Pou domain-containing octamer (ATGCAAAT) binding protein (nuclear RNA-binding protein, 54-kD)",300084,"Mental retardation, X-linked, syndromic 34",300967,XL,2Mb proximal to PHKA1,NONO
"TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33","TAF1 RNA polymerase II, TATA box-binding protein-associated factor, 250kD",313650,"Dystonia-Parkinsonism, X-linked",314250,XLR,SVA retrotransposon insertion,TAF1
"TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33","TAF1 RNA polymerase II, TATA box-binding protein-associated factor, 250kD",313650,"Mental retardation, X-linked, syndromic 33",300966,XLR,-,TAF1
"OGT, MRX106",O-linked N-acetylglucosamine transferase,300255,"Mental retardation, X-linked 106",300997,XLR,-,OGT
"HDAC8, MRXS6, CDLS5",Histone deacetylase 8,300269,Cornelia de Lange syndrome 5,300882,XLD,-,HDAC8
PHKA1,"Phosphorylase kinase, muscle, alpha polypeptide",311870,Muscle glycogenosis,300559,XLR,?proximal and close to PGKA;,PHKA1
"XIC, XCE, XIST, SXI1",X chromosome controlling element (X-inactivation center),314670,"X-inactivation, familial skewed",300087,-,"q13-q21; metaphase bend, or fold, at q13.3-q21.1",XIC
"SLC16A2, DXS128, XPCT","Solute carrier family 16 (monocarboxylic acid transporters), member 2",300095,Allan-Herndon-Dudley syndrome,300523,XL,-,SLC16A2
"RNF12, RLIM, MRX61",Putative RING zinc finger protein NY-REN-43 antigen,300379,"Mental retardation, X-linked 61",300978,XLR,-,RNF12
"NEXMIF, KIAA2022, MRX98",Neurite extension and migration factor,300524,"Mental retardation, X-linked 98",300912,XLD,inv(X)(q13;p22),NEXMIF
"ABCB7, ABC7, ASAT",ATP-binding cassette-7,300135,"Anemia, sideroblastic, with ataxia",301310,XLR,-,ABCB7
"ZDHHC15, MRX91",Zinc finger DHHC domain-containing protein 15,300576,"?Mental retardation, X-linked 91",300577,XLD,disruption of ZDHHC15 identified in 1 patient,ZDHHC15
"DELXq21, CXDELq21",Chromosome Xq21 deletion syndrome,303110,"Choroideremia, deafness, and mental retardation",303110,XLR,at least CHM and POU3F4 deleted,DELXq21
"FGF16, MF4",Fibroblast growth factor 16,300827,Metacarpal 4-5 fusion,309630,XLR,previously mapped to 8q21.3,FGF16
"ATRX, XH2, XNP, SHS, SFM1, MRXHF1",ATR-X gene (helicase 2; X-linked nuclear protein),300032,"Alpha-thalassemia myelodysplasia syndrome, somatic",300448,-,-,ATRX
"ATRX, XH2, XNP, SHS, SFM1, MRXHF1",ATR-X gene (helicase 2; X-linked nuclear protein),300032,Alpha-thalassemia/mental retardation syndrome,301040,XLD,-,ATRX
"ATRX, XH2, XNP, SHS, SFM1, MRXHF1",ATR-X gene (helicase 2; X-linked nuclear protein),300032,"Mental retardation-hypotonic facies syndrome, X-linked",309580,XLR,-,ATRX
"MAGT1, IAP, XMEN",Magnesium transporter 1,300715,"Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia",300853,-,-,MAGT1
"COX7B, LSDMCA2","Cytochrome c oxidase, subunit VIIb",300885,Linear skin defects with multiple congenital anomalies 2,300887,XLD,-,COX7B
"ATP7A, MNK, MK, OHS, SMAX3","ATPase, Cu++ transporting, alpha polypeptide",300011,Menkes disease,309400,XLR,"probably Xq13.2-q13.3, ~150kb prox. to PGK1",ATP7A
"ATP7A, MNK, MK, OHS, SMAX3","ATPase, Cu++ transporting, alpha polypeptide",300011,Occipital horn syndrome,304150,XLR,-,ATP7A
"ATP7A, MNK, MK, OHS, SMAX3","ATPase, Cu++ transporting, alpha polypeptide",300011,"Spinal muscular atrophy, distal, X-linked 3",300489,XLR,-,ATP7A
"PGK1, PGKA",Phosphoglycerate kinase-1,311800,Phosphoglycerate kinase 1 deficiency,300653,XLR,"?Xq13.3; pseudogenes PGK1P1 on Xq, PGK1P2 on chr. 6",PGK1
"TBX22, CPX, ABERS",T-box 22,300307,?Abruzzo-Erickson syndrome,302905,XL,1 ABERS family identified with mutation,TBX22
"TBX22, CPX, ABERS",T-box 22,300307,Cleft palate with ankyloglossia,303400,XL,-,TBX22
"BRWD3, MRX93",Bromodomain-and WD repeat-containing protein 3,300553,"Mental retardation, X-linked 93",300659,XLR,-,BRWD3
"POU3F4, DFN3, DFNX2","POU domain, class 3, transcription factor 4",300039,"Deafness, X-linked 2",304400,XLR,-,POU3F4
"ZNF711, ZNF6, CMPX1, MRX97",Zinc finger protein-711,314990,"Mental retardation, X-linked 97",300803,XL,-,ZNF711
"FLJ22792, POF1B, POF2B",FLJ22792 gene,300603,?Premature ovarian failure 2B,300604,XLR,mutation identified in 1 POF2B family,FLJ22792
"CHM, TCD",Rab escort protein 1,300390,Choroideremia,303100,XLD,-,CHM
"DIAPH2, DIA, POF2A","Diaphanous, Drosophila, homolog of, 2",300108,?Premature ovarian failure 2A,300511,XLD,mutation identified in 1 POF2A family,DIAPH2
"PCDH19, KIAA1313, EFMR, EIEE9",Protocadherin 19,300460,"Epileptic encephalopathy, early infantile, 9",300088,XL,-,PCDH19
"SRPX2, SRPUL, RESDX","SUSHI repeat-containing protein, X-linked, 2",300642,"?Rolandic epilepsy, mental retardation, and speech dyspraxia",300643,-,mutation identified in 1 RESDX family,SRPX2
"TIMM8A, DFN1, DDP, MTS, DDP1","Translocase of inner mitochondrial membrane 8, yeast, homolog of, A",300356,Mohr-Tranebjaerg syndrome,304700,XLR,-,TIMM8A
"BTK, AGMX1, IMD1, XLA, AT",Bruton agammaglobulinemia tyrosine kinase,300300,Agammaglobulinemia and isolated hormone deficiency,307200,XLR,-,BTK
"BTK, AGMX1, IMD1, XLA, AT",Bruton agammaglobulinemia tyrosine kinase,300300,"Agammaglobulinemia, X-linked 1",300755,XLR,-,BTK
GLA,"Galactosidase, alpha",300644,Fabry disease,301500,XL,-,GLA
GLA,"Galactosidase, alpha",300644,"Fabry disease, cardiac variant",301500,XL,-,GLA
"HNRNPH2, NRPH2, MRXSB",Heterogeneous nuclear ribonucleoprotein H2,300610,"Mental retardation, X-linked, syndromic, Bain type",300986,XLD,"second signal at 6q25.3-q26, pseudogene?",HNRNPH2
"PLP1, PMD, HLD1, SPG2",Proteolipid protein 1,300401,Pelizaeus-Merzbacher disease,312080,XLR,-,PLP1
"PLP1, PMD, HLD1, SPG2",Proteolipid protein 1,300401,"Spastic paraplegia 2, X-linked",312920,XLR,-,PLP1
"AMMEC, DELXq22.3, CXDELq22.3","Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis (AMME complex)",300194,"Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis",300194,-,contiguous gene deletion syndrome,AMMEC
"TBG, TBGQTL",Thyroxine-binding globulin,314200,[Thyroxine-binding globulin QTL],300932,-,-,TBG
"PIH1D3, CILD36",PIH1 domain-containing protein 3,300933,"Ciliary dyskinesia, primary, 36, X-linked",300991,XLR,-,PIH1D3
"PRPS1, CMTX5, DFNX1, DFN2",Phosphoribosyl pyrophosphate synthetase-1,311850,Arts syndrome,301835,XLR,-,PRPS1
"PRPS1, CMTX5, DFNX1, DFN2",Phosphoribosyl pyrophosphate synthetase-1,311850,"Charcot-Marie-Tooth disease, X-linked recessive, 5",311070,XLR,-,PRPS1
"PRPS1, CMTX5, DFNX1, DFN2",Phosphoribosyl pyrophosphate synthetase-1,311850,"Deafness, X-linked 1",304500,XL,-,PRPS1
"PRPS1, CMTX5, DFNX1, DFN2",Phosphoribosyl pyrophosphate synthetase-1,311850,"Gout, PRPS-related",300661,XLR,-,PRPS1
"PRPS1, CMTX5, DFNX1, DFN2",Phosphoribosyl pyrophosphate synthetase-1,311850,Phosphoribosylpyrophosphate synthetase superactivity,300661,XLR,-,PRPS1
"MID2, MRX101",Midline 2,300204,"?Mental retardation, X-linked 101",300928,XLR,mutation identified in 1 MRX101 family,MID2
"COL4A6, DELXq22.3, CXDELq22.3, DFNX6","Collagen IV, alpha-6 polypeptide",303631,"?Deafness, X-linked 6",300914,XLR,mutation identified in 1 DFNX6 family,COL4A6
"COL4A5, ATS, ASLN","Collagen IV, alpha-5 polypeptide",303630,Alport syndrome,301050,XLD,diffuse leiomyomatosis with Alport syndrome = contiguous gene syndrome with COL4A6,COL4A5
"ACSL4, FACL4, ACS4, MRX63",Acyl-CoA synthetase long-chain family member 4,300157,"Mental retardation, X-linked 63",300387,XLD,-,ACSL4
"AMMECR1, MFHIEN","Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis chromosomal region gene 1",300195,"Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis",300990,XLR,-,AMMECR1
"CHRDL1, VOPT, MGC1",Chordin-like 1,300350,"Megalocornea 1, X-linked",309300,XLR,-,CHRDL1
"PAK3, MRX30, MRX47",p21-activated kinase-3,300142,"Mental retardation, X-linked 30/47",300558,XLR,-,PAK3
"DCX, DBCN, LISX",Doublecortin,300121,"Lissencephaly, X-linked",300067,XL,-,DCX
"DCX, DBCN, LISX",Doublecortin,300121,"Subcortical laminal heterotopia, X-linked",300067,XL,-,DCX
"ALG13, GLT28D1, CDG1S, EIEE36","Alg13, S. cerevisiae, homolog of",300776,"?Congenital disorder of glycosylation, type Is",300884,XLD,mutation identified in 1 CDG1S male patient,ALG13
"ALG13, GLT28D1, CDG1S, EIEE36","Alg13, S. cerevisiae, homolog of",300776,"Epileptic encephalopathy, early infantile, 36",300884,XLD,-,ALG13
"PLS3, BMND18",Plastin 3,300131,"Bone mineral density QTL18, osteoporosis",300910,XLD,-,PLS3
"UBE2A, RAD6A, MRXSN, MRXS30",Ubiquitin-conjugating enzyme E2A (RAD6 homolog),312180,"Mental retardation, X-linked syndromic, Nascimento-type",300860,XLR,-,UBE2A
"UPF3B, RENT3B, MRXS14","UPF3 regulator of nonsense transcripts, yeast, homolog of, B",300298,"Mental retardation, X-linked, syndromic 14",300676,XLR,-,UPF3B
"RNF113A, ZNF183, TTD5",RING finger protein 113A,300951,"?Trichothiodystrophy 5, nonphotosensitive",300953,XLD,mutation identified in 1 TTD5 family,RNF113A
"NDUFA1, MWFE","NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kD",300078,Mitochondrial complex I deficiency,252010,"XLD,Mi,AR",-,NDUFA1
"LAMP2, LAMPB, LGP110",Lysosome-associated membrane protein-2,309060,Danon disease,300257,XLD,-,LAMP2
"CUL4B, MRXSC, MRXHF2, SFM2, MRXS15",Cullin-4B,300304,"Mental retardation, X-linked, syndromic 15 (Cabezas type)",300354,XLR,-,CUL4B
"C1GALT1C1, COSMC, C1GALT2, TNPS",C1GALT1-specific chaperone 1,300611,"Tn polyagglutination syndrome, somatic",300622,-,-,C1GALT1C1
GLUD2,Glutamate dehydrogenase-2,300144,"{Parkinson disease, age of onset, modifier}",168600,"IC,Mu",-,GLUD2
DUPXq25,Xq25 duplication syndrome,300979,Xq25 duplication syndrome,300979,XL,-,DUPXq25
"GRIA3, GLUR3, MRX94","Glutamate receptor, ionotropic, AMPA 3",305915,"Mental retardation, X-linked 94",300699,XLR,-,GRIA3
"THOC2, THO2, MRX12, MRX35","THO complex 2 (Tho2, yeast, homolog of)",300395,"Mental retardation, X-linked 12/35",300957,XLR,-,THOC2
"XIAP, BIRC4, API3, XLP2","Inhibitor of apoptosis, X-linked",300079,"Lymphoproliferative syndrome, X-linked, 2",300635,XLR,-,XIAP
"SH2D1A, LYP, IMD5, XLP, XLPD1",SH2 domain protein 1A,300490,"Lymphoproliferative syndrome, X-linked, 1",308240,XLR,1cM from DXS42; no recombination with DXS37,SH2D1A
"OCRL, LOCR, OCRL1, NPHL2",Phosphatidylinositol polyphosphate 5-phosphatase (OCRL gene),300535,Dent disease 2,300555,XLR,-,OCRL
"OCRL, LOCR, OCRL1, NPHL2",Phosphatidylinositol polyphosphate 5-phosphatase (OCRL gene),300535,Lowe syndrome,309000,XLR,-,OCRL
"XPNPEP2, AEACEI",X-prolyl aminopeptidase 2 (aminopeptidase P),300145,"{Angioedema induced by ACE inhibitors, susceptibility to}",300909,-,-,XPNPEP2
"ZDHHC9, DHHC9, MRXSZ",Zinc finger DHHC domain-containing protein 9,300646,"Mental retardation, X-linked syndromic, Raymond type",300799,-,-,ZDHHC9
"AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5","Apoptosis-inducing factor, mitochondrion-associated, 1",300169,Combined oxidative phosphorylation deficiency 6,300816,XLR,-,AIFM1
"AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5","Apoptosis-inducing factor, mitochondrion-associated, 1",300169,Cowchock syndrome,310490,XLR,-,AIFM1
"AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5","Apoptosis-inducing factor, mitochondrion-associated, 1",300169,"Deafness, X-linked 5",300614,XLR,-,AIFM1
"IGSF1, IGDC1, CHTE","Immunoglobulin superfamily, member 1",300137,"Hypothyroidism, central, and testicular enlargement",300888,XLR,-,IGSF1
"FRMD7, NYS1, XIPAN",FERM domain-containing 7,300628,"Nystagmus 1, congenital, X-linked",310700,XL,-,FRMD7
"FRMD7, NYS1, XIPAN",FERM domain-containing 7,300628,"Nystagmus, infantile periodic alternating, X-linked",310700,XL,-,FRMD7
"GPC3, SDYS, SGBS1",Glypican 3,300037,"Simpson-Golabi-Behmel syndrome, type 1",312870,XLR,-,GPC3
"GPC3, SDYS, SGBS1",Glypican 3,300037,"Wilms tumor, somatic",194070,-,-,GPC3
"PHF6, BFLS",PHD finger protein 6,300414,Borjeson-Forssman-Lehmann syndrome,301900,XLR,-,PHF6
"HPRT1, HPRT",Hypoxanthine phosphoribosyltransferase 1,308000,HPRT-related gout,300323,XLR,-,HPRT1
"HPRT1, HPRT",Hypoxanthine phosphoribosyltransferase 1,308000,Lesch-Nyhan syndrome,300322,XLR,-,HPRT1
"CXDUPq26.3, DUPXq26.3, XLAG",Chromosome Xq26.3 duplication syndrome,300942,Chromosome Xq26.3 duplication syndrome,300942,XLD,-,CXDUPq26.3
SRXX3,46XX sex reversal 3,300833,46XX sex reversal 3,300833,XLD,due to deletion/duplication/rearrangement upstream of SOX3,SRXX3
"SLC9A6, NHE6","Solute carrier family 9 (sodium/hydrogen exchanger), member 6",300231,"Mental retardation, X-linked syndromic, Christianson type",300243,XLD,-,SLC9A6
"FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU",Four-and-a-half LIM domains 1,300163,?Uruguay faciocardiomusculoskeletal syndrome,300280,XLR,mutation identified in 1 FCMSU family,FHL1
"FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU",Four-and-a-half LIM domains 1,300163,"Emery-Dreifuss muscular dystrophy 6, X-linked",300696,XLR,-,FHL1
"FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU",Four-and-a-half LIM domains 1,300163,"Myopathy, X-linked, with postural muscle atrophy",300696,XLR,-,FHL1
"FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU",Four-and-a-half LIM domains 1,300163,"Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset",300717,XLD,-,FHL1
"FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU",Four-and-a-half LIM domains 1,300163,"Reducing body myopathy, X-linked 1b, with late childhood or adult onset",300718,XL,-,FHL1
"FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU",Four-and-a-half LIM domains 1,300163,"Scapuloperoneal myopathy, X-linked dominant",300695,XLD,-,FHL1
"TNFSF5, CD40LG, HIGM1, IGM","Tumor necrosis factor ligand superfamily, member 5",300386,"Immunodeficiency, X-linked, with hyper-IgM",308230,XLR,Between DSX144E and DSX300,TNFSF5
"ARHGEF6, MRX46, COOL2",Rho guanine nucleotide exchange factor-6,300267,"Mental retardation, X-linked 46",300436,XLR,-,ARHGEF6
"RBMX, MRXS11","RNA-binding motif protein, X chromosome",300199,"?Mental retardation, X-linked, syndromic 11, Shashi type",300238,XLR,mutation identified in 1 MRXS11 family,RBMX
"GPR101, PAGH2, PITA2",G protein-coupled receptor 101,300393,"Pituitary adenoma 2, GH-secreting",300943,-,-,GPR101
"ZIC3, HTX1, HTX, VACTERLX","Zic family, member 3",300265,"Congenital heart defects, nonsyndromic, 1, X-linked",306955,XLR,-,ZIC3
"ZIC3, HTX1, HTX, VACTERLX","Zic family, member 3",300265,"Heterotaxy, visceral, 1, X-linked",306955,XLR,-,ZIC3
"ZIC3, HTX1, HTX, VACTERLX","Zic family, member 3",300265,"VACTERL association, X-linked",314390,XLR,-,ZIC3
"HTC2, HCG, CGH, CXINSq27.1","Hypertrichosis, congenital generalized",307150,"Hypertrichosis, congenital generalized",307150,XLD,palindrome-mediated interchromosomal insertion at Xq27.1,HTC2
"F9, HEMB, THPH8",Coagulation factor IX (plasma thromboplastic component),300746,Hemophilia B,306900,XLR,distal to HPRT; proximal part of Xq27,F9
"F9, HEMB, THPH8",Coagulation factor IX (plasma thromboplastic component),300746,"Thrombophilia, X-linked, due to factor IX defect",300807,-,-,F9
"F9, HEMB, THPH8",Coagulation factor IX (plasma thromboplastic component),300746,"{Deep venous thrombosis, protection against}",300807,-,-,F9
"F9, HEMB, THPH8",Coagulation factor IX (plasma thromboplastic component),300746,{Warfarin sensitivity},122700,AD,-,F9
"SOX3, MRGH",SRY (sex determining region Y)-box 3,313430,"Mental retardation, X-linked, with isolated growth hormone deficiency",300123,-,P mutant in BFLS,SOX3
"SOX3, MRGH",SRY (sex determining region Y)-box 3,313430,"Panhypopituitarism, X-linked",312000,XL,-,SOX3
"DUPXq27.3q28, CXDUPq27.3q28",Chromosome Xq27.3-q28 duplication syndrome,300869,Chromosome Xq27.3-q28 duplication syndrome,300869,XLR,-,DUPXq27.3q28
"FMR1, FRAXA, POF1",FMR1 gene,309550,Fragile X syndrome,300624,XLD,8-8.7Mb from telomere,FMR1
"FMR1, FRAXA, POF1",FMR1 gene,309550,Fragile X tremor/ataxia syndrome,300623,XLD,-,FMR1
"FMR1, FRAXA, POF1",FMR1 gene,309550,Premature ovarian failure 1,311360,XL,-,FMR1
"DUPXq28, CXq28",Chromosome Xq28 duplication syndrome,300815,Chromosome Xq28 duplication syndrome,300815,-,-,DUPXq28
"MYMY4, CXDELq38","Moyamoya disease 4 with short stature, hypergonadotropic hypogonadism and facial dysmorphism",300845,Moyamoya disease 4,300845,XLR,contiguous gene deletion syndrome (3.4kb),MYMY4
"AFF2, FMR2, FRAXE, MRX2","AF4/FMR2 family, member 2 (fragile site, X-linked, E)",300806,"Mental retardation, X-linked, FRAXE type",309548,XLR,-,AFF2
"IDS, MPS2, SIDS",Iduronate 2-sulfatase (Hunter syndrome),300823,Mucopolysaccharidosis II,309900,XLR,telomeric IDS2 source of inversion in IDS,IDS
"MAMLD1, CXorf6, F18, HYSP2",Mastermind-like domain containing 1,300120,"Hypospadias 2, X-linked",300758,XLR,near MTM1 in microdeletion,MAMLD1
"MTM1, MTMX",Myotubularin,300415,"Myotubular myopathy, X-linked",310400,XLR,close to F8,MTM1
"HMGB3, HMG4, HMG2A, MCOPS13",High-mobility group box 3 (high mobility group protein 4),300193,"?Microphthalmia, syndromic 13",300915,XL,mutation identified in 1 MCOPS13 family,HMGB3
"VMA21, XMEA","Vma21, S. cerevisiae, homolog of",300913,"Myopathy, X-linked, with excessive autophagy",310440,XLR,-,VMA21
NSDHL,NAD(P)H steroid dehydrogenase-like protein,300275,CHILD syndrome,308050,XLD,-,NSDHL
NSDHL,NAD(P)H steroid dehydrogenase-like protein,300275,CK syndrome,300831,XLR,-,NSDHL
"BGN, SEMDX, MRLS",Biglycan,301870,Meester-Loeys syndrome,300989,XL,proximal Xq28,BGN
"BGN, SEMDX, MRLS",Biglycan,301870,"Spondyloepimetaphyseal dysplasia, X-linked",300106,XLR,-,BGN
"ATP2B3, PMCA3, SCAX1","ATPase, Ca++ transporting, plasma membrane, 3",300014,"?Spinocerebellar ataxia, X-linked 1",302500,XLR,mutation identified in 1 family,ATP2B3
"FAM58A, STAR","Family with sequence similarity 58, member A",300708,STAR syndrome,300707,XLD,-,FAM58A
"SLC6A8, CRTR, CCDS1","Solute carrier family 6 (neurotransmitter transporter, creatine), member 8",300036,Cerebral creatine deficiency syndrome 1,300352,XLR,distal to G6PD,SLC6A8
"BCAP31, BAP31, DXS1357E, DDCH",B-cell receptor-associated protein 31,300398,"Deafness, dystonia, and cerebral hypomyelination",300475,XLR,-,BCAP31
"ABCD1, ALD, AMN","ATP-binding cassette, subfamily D, member 1",300371,Adrenoleukodystrophy,300100,XLR,about 650kb from GCP/RCP,ABCD1
"ABCD1, ALD, AMN","ATP-binding cassette, subfamily D, member 1",300371,"Adrenomyeloneuropathy, adult",300100,XLR,-,ABCD1
"SSR4, TRAPD, CDG1Y","Signal sequence receptor, delta",300090,"Congenital disorder of glycosylation, type Iy",300934,XLR,-,SSR4
"L1CAM, CAML1, HSAS1, MASA, SPG1",L1 cell adhesion molecule,308840,"Corpus callosum, partial agenesis of",304100,XLR,between RCP/GCP cluster and G6PD,L1CAM
"L1CAM, CAML1, HSAS1, MASA, SPG1",L1 cell adhesion molecule,308840,CRASH syndrome,303350,XLR,-,L1CAM
"L1CAM, CAML1, HSAS1, MASA, SPG1",L1 cell adhesion molecule,308840,Hydrocephalus due to aqueductal stenosis,307000,XLR,-,L1CAM
"L1CAM, CAML1, HSAS1, MASA, SPG1",L1 cell adhesion molecule,308840,Hydrocephalus with congenital idiopathic intestinal pseudoobstruction,307000,XLR,-,L1CAM
"L1CAM, CAML1, HSAS1, MASA, SPG1",L1 cell adhesion molecule,308840,Hydrocephalus with Hirschsprung disease,307000,XLR,-,L1CAM
"L1CAM, CAML1, HSAS1, MASA, SPG1",L1 cell adhesion molecule,308840,MASA syndrome,303350,XLR,-,L1CAM
"AVPR2, DIR, DI1, ADHR",Arginine vasopressin receptor-2,300538,"Diabetes insipidus, nephrogenic",304800,XLR,-,AVPR2
"AVPR2, DIR, DI1, ADHR",Arginine vasopressin receptor-2,300538,Nephrogenic syndrome of inappropriate antidiuresis,300539,XLR,-,AVPR2
"NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1","N-alpha-acetyltransferase 10, NatA catalytic subunit",300013,"?Microphthalmia, syndromic 1",309800,XL,mutation identified in 1 MCOPS1 family,NAA10
"NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1","N-alpha-acetyltransferase 10, NatA catalytic subunit",300013,Ogden syndrome,300855,"XLD,XLR",-,NAA10
"HCFC1, HCF1, MRX3",Host cell factor C1 (VP16-accessory protein),300019,"Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type )",309541,XLR,50kb distal to V2R,HCFC1
"MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13",Methyl-CpG-binding protein-2,300005,"Encephalopathy, neonatal severe",300673,XLR,70kb centromeric of RCP/GCP,MECP2
"MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13",Methyl-CpG-binding protein-2,300005,"Mental retardation, X-linked syndromic, Lubs type",300260,XLR,-,MECP2
"MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13",Methyl-CpG-binding protein-2,300005,"Mental retardation, X-linked, syndromic 13",300055,XLR,-,MECP2
"MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13",Methyl-CpG-binding protein-2,300005,Rett syndrome,312750,XLD,-,MECP2
"MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13",Methyl-CpG-binding protein-2,300005,"Rett syndrome, atypical",312750,XLD,-,MECP2
"MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13",Methyl-CpG-binding protein-2,300005,"Rett syndrome, preserved speech variant",312750,XLD,-,MECP2
"MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13",Methyl-CpG-binding protein-2,300005,"{Autism susceptibility, X-linked 3}",300496,"XL,IC,Mu",-,MECP2
"OPN1LW, RCP, CBP, CBBM","Red cone pigment (opsin 1, long-wave-sensitive)",300822,Blue cone monochromacy,303700,XLR,5' to CBD,OPN1LW
"OPN1LW, RCP, CBP, CBBM","Red cone pigment (opsin 1, long-wave-sensitive)",300822,"Colorblindness, protan",303900,XL,-,OPN1LW
"OPN1MW, GCP, CBD, CBBM","Green cone pigment (opsin 1, medium-wave-sensitive)",300821,Blue cone monochromacy,303700,XLR,linked to G6PD; multiple genes,OPN1MW
"OPN1MW, GCP, CBD, CBBM","Green cone pigment (opsin 1, medium-wave-sensitive)",300821,"Colorblindness, deutan",303800,XL,-,OPN1MW
"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS","Filamin A, alpha (actin-binding protein-280)",300017,"Cardiac valvular dysplasia, X-linked",314400,XLR,-,FLNA
"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS","Filamin A, alpha (actin-binding protein-280)",300017,Congenital short bowel syndrome,300048,XLR,-,FLNA
"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS","Filamin A, alpha (actin-binding protein-280)",300017,FG syndrome 2,300321,-,-,FLNA
"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS","Filamin A, alpha (actin-binding protein-280)",300017,Frontometaphyseal dysplasia 1,305620,XLR,-,FLNA
"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS","Filamin A, alpha (actin-binding protein-280)",300017,"Heterotopia, periventricular",300049,XLD,-,FLNA
"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS","Filamin A, alpha (actin-binding protein-280)",300017,"Intestinal pseudoobstruction, neuronal",300048,XLR,-,FLNA
"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS","Filamin A, alpha (actin-binding protein-280)",300017,Melnick-Needles syndrome,309350,XLD,-,FLNA
"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS","Filamin A, alpha (actin-binding protein-280)",300017,"Otopalatodigital syndrome, type I",311300,XLD,-,FLNA
"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS","Filamin A, alpha (actin-binding protein-280)",300017,"Otopalatodigital syndrome, type II",304120,XLD,-,FLNA
"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS","Filamin A, alpha (actin-binding protein-280)",300017,Terminal osseous dysplasia,300244,XLD,-,FLNA
"EMD, EDMD, STA",Emerin,300384,"Emery-Dreifuss muscular dystrophy 1, X-linked",310300,XLR,in distal Xq28,EMD
"RPL10, DXS648, QM, AUTSX5, MRXS35",Ribosomal protein L10,312173,"Mental retardation, X-linked, syndromic, 35",300998,XLR,-,RPL10
"RPL10, DXS648, QM, AUTSX5, MRXS35",Ribosomal protein L10,312173,"{Autism, susceptibility to, X-linked 5}",300847,-,-,RPL10
"TAZ, EFE2, BTHS, CMD3A, LVNCX",Tafazzin,300394,Barth syndrome,302060,XLR,-,TAZ
"ATP6AP1, ATP6IP1, ATP6S1, VATPS1","ATPase, H+ transporting, lysosomal, accessory protein 1",300197,Immunodeficiency 47,300972,XLR,-,ATP6AP1
"GDI1, RABGD1A, MRX41, MRX48",GDP dissociation inhibitor 1,300104,"Mental retardation, X-linked 41",300849,XLD,-,GDI1
"LAGE3, ITBA2, GAMOS2",L antigen family member 3,300060,"Galloway-Mowat syndrome 2, X-linked",301006,XLR,-,LAGE3
"G6PD, G6PD1",Glucose-6-phosphate dehydrogenase,305900,"Hemolytic anemia, G6PD deficient (favism)",300908,XLD,-,G6PD
"G6PD, G6PD1",Glucose-6-phosphate dehydrogenase,305900,{Resistance to malaria due to G6PD deficiency},611162,-,-,G6PD
"IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33","Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase of, gamma (NF-kappa-B essential modulator)",300248,"Ectodermal dysplasia, hypohidrotic, with immune deficiency",300291,-,-,IKBKG
"IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33","Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase of, gamma (NF-kappa-B essential modulator)",300248,"Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency",300301,-,-,IKBKG
"IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33","Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase of, gamma (NF-kappa-B essential modulator)",300248,Immunodeficiency 33,300636,XLR,-,IKBKG
"IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33","Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase of, gamma (NF-kappa-B essential modulator)",300248,"Immunodeficiency, isolated",300584,-,-,IKBKG
"IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33","Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase of, gamma (NF-kappa-B essential modulator)",300248,Incontinentia pigmenti,308300,XLD,-,IKBKG
"IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33","Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase of, gamma (NF-kappa-B essential modulator)",300248,"Invasive pneumococcal disease, recurrent isolated, 2",300640,-,-,IKBKG
"DKC1, DKCX",Dyskerin,300126,"Dyskeratosis congenita, X-linked",305000,XLR,-,DKC1
"F8, F8C, HEMA","Coagulation factor VIII, procoagulant component",300841,Hemophilia A,306700,XLR,cen-G6PD-3' end of F8C-5'-ter; 1.1Mb from telomere,F8
"RAB39B, MRX72, WSMN",Ras-associated protein RAB39B,300774,?Waisman syndrome,311510,XLR,mutation identified in 1 WSMN family,RAB39B
"RAB39B, MRX72, WSMN",Ras-associated protein RAB39B,300774,"Mental retardation, X-linked 72",300271,XLR,-,RAB39B
"CLIC2, XAP121, MRXS32",Chloride intracellular channel 2,300138,"?Mental retardation, X-linked, syndromic 32",300886,XLR,mutation identified in 1 MRXS32 family,CLIC2
"TMLHE, BBOX2, TMLH, TMLHED, AUTSX6",Epsilon-trimethyllysine hydroxylase,300777,"{Autism, susceptibility to, X-linked 6}",300872,XLR,-,TMLHE
SHOXY,"Short stature homeo box, Y-linked",400020,Langer mesomelic dysplasia,249700,AR,pseudoautosomal,SHOXY
SHOXY,"Short stature homeo box, Y-linked",400020,Leri-Weill dyschondrosteosis,127300,AD,-,SHOXY
SHOXY,"Short stature homeo box, Y-linked",400020,"Short stature, idiopathic familial",300582,-,-,SHOXY
"SRY, TDF, TDY, SRXX1, SRXY1",Sex-determining region Y (testis determining factor),480000,46XX sex reversal 1,400045,-,-,SRY
"SRY, TDF, TDY, SRXX1, SRXY1",Sex-determining region Y (testis determining factor),480000,46XY sex reversal 1,400044,-,-,SRY
"DELYq11, CYDELq11, SPGFY1",Chromosome Yq11 interstitial deletion syndrome,400042,"Spermatogenic failure, Y-linked, 1",400042,-,contiguous gene deletion syndrome,DELYq11
"USP9Y, DFFRY, SPGFY2","Ubiquitin-specific protease-9, Y chromosome (Drosophila fat facets related, Y-linked)",400005,"Spermatogenic failure, Y-linked, 2",415000,YL,-,USP9Y
